$MOL
4-Methoxybenzoic acid
C8H8O3
100-09-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 O 6.6687 4.6201 0.0 0
M  V30 5 C 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Methoxyphenyl)-1-pyrrolidinylmethanone
C12H15NO2
69838-98-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 O 9.1059 4.6201 0.0 0
M  V30 4 C 10.4396 3.8501 0.0 0
M  V30 5 C 5.1048 2.3101 0.0 0
M  V30 6 C 6.4384 1.5400 0.0 0
M  V30 7 C 5.1048 3.8501 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 6.4384 4.6201 0.0 0
M  V30 10 C 7.7722 3.8501 0.0 0
M  V30 11 N 2.4374 2.3101 0.0 0
M  V30 12 C 2.2763 3.8416 0.0 0
M  V30 13 C 1.0304 1.6837 0.0 0
M  V30 14 C 0.7700 4.1618 0.0 0
M  V30 15 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 4
M  V30 5 1 3 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-09-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 69838-98-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42449684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective C-N Bond Cleavage in Unstrained Pyrrolidines Enabled by Lewis
Acid and Photoredox Catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aida, Kazuhiro; Hirao, Marina; Saitoh, Tsuyoshi; Yamamoto, Takashi;
Einaga, Yasuaki; Ota, Eisuke; Yamaguchi, Junichiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2024), 146(44), 30698-30707

$RFMT $RIREG SCHEME2 STEP1
$RXN



  3  1
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Vinylpyridine
C7H7N
100-43-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Pyridinyl)ethyl 1-pyrrolidinecarbodithioate
C12H16N2S2
1939164-98-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 2.3101 0.0 0
M  V30 2 S 6.6685 3.0801 0.0 0
M  V30 3 S 8.0022 0.7700 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 6 N 9.3360 3.0801 0.0 0
M  V30 7 C 9.4969 4.6116 0.0 0
M  V30 8 C 10.7428 2.4536 0.0 0
M  V30 9 C 11.0032 4.9318 0.0 0
M  V30 10 C 11.7732 3.5981 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 N 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-43-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1939164-98-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26071668
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, green chemistry, regioselective, no solvent (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A one-pot three-component synthesis of dithiocarbamates starting from
vinyl pyridines and vinyl pyrazine under solvent- and catalyst-free
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Halimehjani, Azim Ziyaei; Martens, Jurgen; Schluter, Torben
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2016), 72(27-28), 3958-3965

$RFMT $RIREG SCHEME3 STEP1
$RXN



  3  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxycoumarin
C9H6O3
1076-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 O 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-3-(phenyl-1-pyrrolidinylmethyl)-2H-1-benzopyran-2-one
C20H19NO3
1330776-87-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0
M  V30 2 O 6.6685 2.3698 0.0 0
M  V30 3 O 4.0012 6.9899 0.0 0
M  V30 4 C 5.3348 4.6799 0.0 0
M  V30 5 C 6.6685 3.9098 0.0 0
M  V30 6 C 5.3348 6.2199 0.0 0
M  V30 7 C 8.0023 4.6799 0.0 0
M  V30 8 O 6.6685 6.9899 0.0 0
M  V30 9 C 8.0023 6.2199 0.0 0
M  V30 10 C 9.3360 3.9098 0.0 0
M  V30 11 C 9.3360 6.9899 0.0 0
M  V30 12 C 10.6697 4.6799 0.0 0
M  V30 13 C 10.6697 6.2199 0.0 0
M  V30 14 N 4.0012 2.3698 0.0 0
M  V30 15 C 5.2470 1.4646 0.0 0
M  V30 16 C 2.7553 1.4646 0.0 0
M  V30 17 C 4.7712 0.0000 0.0 0
M  V30 18 C 3.2311 0.0000 0.0 0
M  V30 19 C 2.6673 4.6799 0.0 0
M  V30 20 C 2.6673 6.2199 0.0 0
M  V30 21 C 1.3337 3.9098 0.0 0
M  V30 22 C 1.3337 6.9899 0.0 0
M  V30 23 C 0.0000 4.6799 0.0 0
M  V30 24 C 0.0000 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 14
M  V30 3 1 1 19
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 2 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 9
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1076-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1330776-87-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-15721899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Methylene-2,4-chromandione in situ trapping: introducing molecular
diversity on 4-hydroxycoumarin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Montagut-Romans, Adrien; Boulven, Manon; Lemaire, Marc; Popowycz,
Florence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(6), 4540-4544

$RFMT $RIREG SCHEME4 STEP1
$RXN



  3  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Naphthol
C10H8O
135-19-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 C 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 3.0801 4.0010 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Phenyl-1-pyrrolidinylmethyl)-2-naphthalenol
C21H21NO
374690-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 3.7710 0.0 0
M  V30 2 O 6.9301 6.4385 0.0 0
M  V30 3 C 4.6201 5.1047 0.0 0
M  V30 4 C 3.0800 5.1047 0.0 0
M  V30 5 C 5.3901 6.4385 0.0 0
M  V30 6 C 2.3100 6.4385 0.0 0
M  V30 7 C 2.3100 3.7710 0.0 0
M  V30 8 C 4.6201 7.7722 0.0 0
M  V30 9 C 3.0800 7.7722 0.0 0
M  V30 10 C 0.7700 6.4385 0.0 0
M  V30 11 C 0.7700 3.7710 0.0 0
M  V30 12 C 0.0000 5.1047 0.0 0
M  V30 13 C 6.9301 3.7710 0.0 0
M  V30 14 C 7.7001 5.1047 0.0 0
M  V30 15 C 7.7001 2.4374 0.0 0
M  V30 16 C 9.2401 5.1047 0.0 0
M  V30 17 C 9.2401 2.4374 0.0 0
M  V30 18 C 10.0101 3.7710 0.0 0
M  V30 19 N 4.6201 2.4374 0.0 0
M  V30 20 C 3.0885 2.2765 0.0 0
M  V30 21 C 5.2464 1.0304 0.0 0
M  V30 22 C 2.7683 0.7700 0.0 0
M  V30 23 C 4.1020 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 13
M  V30 3 1 1 19
M  V30 4 1 2 5
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 2 4 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 2 7 11
M  V30 13 2 8 9
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 135-19-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 374690-61-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36274582
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7705-08-0
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, Betti reaction, no solvent, optimization study,
optimized on solvent, optimized on temperature, optimized on catalyst,
optimized on stoichiometry of catalyst, optimized on time
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Revisiting the Synthesis of Betti Bases: Facile, One-pot, and Efficient
Synthesis of Betti Bases Promoted by FeCl3·6H2O
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Haq, Atta ul; Naheed, Shazia; Iftikhar, Ramsha; Zahoor, Ameer Fawad;
Ahmad, Sajjad
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Current Organic Synthesis (2022), 19(5), 569-577

$RFMT $RIREG SCHEME5 STEP1
$RXN



  3  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,3-Diphenyl-2-propyn-1-yl)pyrrolidine
C19H19N
615253-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 3.7710 0.0 0
M  V30 2 C 4.6201 3.7710 0.0 0
M  V30 3 C 6.1601 3.7710 0.0 0
M  V30 4 N 2.3100 2.4374 0.0 0
M  V30 5 C 0.7785 2.2765 0.0 0
M  V30 6 C 2.9364 1.0304 0.0 0
M  V30 7 C 0.4583 0.7700 0.0 0
M  V30 8 C 1.7920 0.0000 0.0 0
M  V30 9 C 2.3100 5.1047 0.0 0
M  V30 10 C 0.7700 5.1047 0.0 0
M  V30 11 C 3.0800 6.4385 0.0 0
M  V30 12 C 0.0000 6.4385 0.0 0
M  V30 13 C 2.3100 7.7722 0.0 0
M  V30 14 C 0.7700 7.7722 0.0 0
M  V30 15 C 7.7001 3.7710 0.0 0
M  V30 16 C 8.4701 5.1047 0.0 0
M  V30 17 C 8.4701 2.4374 0.0 0
M  V30 18 C 10.0101 5.1047 0.0 0
M  V30 19 C 10.0101 2.4374 0.0 0
M  V30 20 C 10.7801 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 9
M  V30 4 3 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 615253-71-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-2569360
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-57-5
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM supported catalyst
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, nanocrystalline CeO2 used as support, reaction
is not sensitive to air
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Supported gold(III) catalysts for highly efficient three-component
coupling reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xin; Corma, Avelino
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2008), 47(23), 4358-4361

$RFMT $RIREG SCHEME5 STEP1
$RXN



  3  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,3-Diphenyl-2-propyn-1-yl)pyrrolidine
C19H19N
615253-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 3.7710 0.0 0
M  V30 2 C 4.6201 3.7710 0.0 0
M  V30 3 C 6.1601 3.7710 0.0 0
M  V30 4 N 2.3100 2.4374 0.0 0
M  V30 5 C 0.7785 2.2765 0.0 0
M  V30 6 C 2.9364 1.0304 0.0 0
M  V30 7 C 0.4583 0.7700 0.0 0
M  V30 8 C 1.7920 0.0000 0.0 0
M  V30 9 C 2.3100 5.1047 0.0 0
M  V30 10 C 0.7700 5.1047 0.0 0
M  V30 11 C 3.0800 6.4385 0.0 0
M  V30 12 C 0.0000 6.4385 0.0 0
M  V30 13 C 2.3100 7.7722 0.0 0
M  V30 14 C 0.7700 7.7722 0.0 0
M  V30 15 C 7.7001 3.7710 0.0 0
M  V30 16 C 8.4701 5.1047 0.0 0
M  V30 17 C 8.4701 2.4374 0.0 0
M  V30 18 C 10.0101 5.1047 0.0 0
M  V30 19 C 10.0101 2.4374 0.0 0
M  V30 20 C 10.7801 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 9
M  V30 4 3 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 615253-71-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35770648
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-57-5
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM supported on ordered mesoporous carbon
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, no solvent, catalyst prepared
and used, N-doped ordered mesoporous carbon support used, catalyst can be
recycled and reused
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Gold nanoparticles immobilized on N-doped ordered mesoporous carbon: An
efficient catalyst for A3 and KA2 coupling reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Latifi Rad, Sheida; Eftekhari-Sis, Bagher; Vahdati-Khajeh, Saleh; Zirak,
Maryam; Safin, Damir A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Applied Organometallic Chemistry (2023), 37(4), e7059

$RFMT $RIREG SCHEME5 STEP1
$RXN



  3  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,3-Diphenyl-2-propyn-1-yl)pyrrolidine
C19H19N
615253-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 3.7710 0.0 0
M  V30 2 C 4.6201 3.7710 0.0 0
M  V30 3 C 6.1601 3.7710 0.0 0
M  V30 4 N 2.3100 2.4374 0.0 0
M  V30 5 C 0.7785 2.2765 0.0 0
M  V30 6 C 2.9364 1.0304 0.0 0
M  V30 7 C 0.4583 0.7700 0.0 0
M  V30 8 C 1.7920 0.0000 0.0 0
M  V30 9 C 2.3100 5.1047 0.0 0
M  V30 10 C 0.7700 5.1047 0.0 0
M  V30 11 C 3.0800 6.4385 0.0 0
M  V30 12 C 0.0000 6.4385 0.0 0
M  V30 13 C 2.3100 7.7722 0.0 0
M  V30 14 C 0.7700 7.7722 0.0 0
M  V30 15 C 7.7001 3.7710 0.0 0
M  V30 16 C 8.4701 5.1047 0.0 0
M  V30 17 C 8.4701 2.4374 0.0 0
M  V30 18 C 10.0101 5.1047 0.0 0
M  V30 19 C 10.0101 2.4374 0.0 0
M  V30 20 C 10.7801 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 9
M  V30 4 3 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 615253-71-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-23531241
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-50-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, copper supported on polymer beads decorated
with dendritic system catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Polymer Beads Decorated with Dendritic Systems as Supports for A3
Coupling Catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bukowska, Agnieszka; Bester, Karol; Pytel, Maciej; Bukowski, Wiktor
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Catalysis Letters (2021), 151(2), 422-434

$RFMT $RIREG SCHEME5 STEP1
$RXN



  3  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,3-Diphenyl-2-propyn-1-yl)pyrrolidine
C19H19N
615253-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 3.7710 0.0 0
M  V30 2 C 4.6201 3.7710 0.0 0
M  V30 3 C 6.1601 3.7710 0.0 0
M  V30 4 N 2.3100 2.4374 0.0 0
M  V30 5 C 0.7785 2.2765 0.0 0
M  V30 6 C 2.9364 1.0304 0.0 0
M  V30 7 C 0.4583 0.7700 0.0 0
M  V30 8 C 1.7920 0.0000 0.0 0
M  V30 9 C 2.3100 5.1047 0.0 0
M  V30 10 C 0.7700 5.1047 0.0 0
M  V30 11 C 3.0800 6.4385 0.0 0
M  V30 12 C 0.0000 6.4385 0.0 0
M  V30 13 C 2.3100 7.7722 0.0 0
M  V30 14 C 0.7700 7.7722 0.0 0
M  V30 15 C 7.7001 3.7710 0.0 0
M  V30 16 C 8.4701 5.1047 0.0 0
M  V30 17 C 8.4701 2.4374 0.0 0
M  V30 18 C 10.0101 5.1047 0.0 0
M  V30 19 C 10.0101 2.4374 0.0 0
M  V30 20 C 10.7801 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 9
M  V30 4 3 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 615253-71-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-19791170
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 189114-61-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2240142-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Gold(I) Acyclic Diaminocarbenes for the Synthesis of
Propargylamines and Indolizines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aliaga-Lavrijsen, Melanie; Herrera, Raquel P.; Villacampa, M. Dolores;
Gimeno, M. Concepcion
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2018), 3(8), 9805-9813

$RFMT $RIREG SCHEME5 STEP1
$RXN



  3  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,3-Diphenyl-2-propyn-1-yl)pyrrolidine
C19H19N
615253-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 3.7710 0.0 0
M  V30 2 C 4.6201 3.7710 0.0 0
M  V30 3 C 6.1601 3.7710 0.0 0
M  V30 4 N 2.3100 2.4374 0.0 0
M  V30 5 C 0.7785 2.2765 0.0 0
M  V30 6 C 2.9364 1.0304 0.0 0
M  V30 7 C 0.4583 0.7700 0.0 0
M  V30 8 C 1.7920 0.0000 0.0 0
M  V30 9 C 2.3100 5.1047 0.0 0
M  V30 10 C 0.7700 5.1047 0.0 0
M  V30 11 C 3.0800 6.4385 0.0 0
M  V30 12 C 0.0000 6.4385 0.0 0
M  V30 13 C 2.3100 7.7722 0.0 0
M  V30 14 C 0.7700 7.7722 0.0 0
M  V30 15 C 7.7001 3.7710 0.0 0
M  V30 16 C 8.4701 5.1047 0.0 0
M  V30 17 C 8.4701 2.4374 0.0 0
M  V30 18 C 10.0101 5.1047 0.0 0
M  V30 19 C 10.0101 2.4374 0.0 0
M  V30 20 C 10.7801 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 9
M  V30 4 3 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 615253-71-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-11074018
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1313-99-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed Teflon-coated screw cap vial used, catalyst
prepared and used, recyclable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM NiO nanoparticles catalyzed three component coupling reaction of
aldehyde, amine and terminal alkynes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gajengi, Aravind L.; Sasaki, Takehiko; Bhanage, Bhalchandra M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Catalysis Communications (2015), 72174-179

$RFMT $RIREG SCHEME6 STEP1
$RXN



  3  1
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Vinylpyridine
C7H7N
100-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Pyridinyl)ethyl 1-pyrrolidinecarbodithioate
C12H16N2S2
1939164-84-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 2.3101 0.0 0
M  V30 2 S 6.6685 3.0801 0.0 0
M  V30 3 S 8.0022 0.7700 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 6 N 9.3360 3.0801 0.0 0
M  V30 7 C 9.4969 4.6116 0.0 0
M  V30 8 C 10.7428 2.4536 0.0 0
M  V30 9 C 11.0032 4.9318 0.0 0
M  V30 10 C 11.7732 3.5981 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 N 2.6673 0.7700 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-69-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1939164-84-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25065695
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, green chemistry, regioselective, no solvent (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A one-pot three-component synthesis of dithiocarbamates starting from
vinyl pyridines and vinyl pyrazine under solvent- and catalyst-free
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Halimehjani, Azim Ziyaei; Martens, Jurgen; Schluter, Torben
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2016), 72(27-28), 3958-3965

$RFMT $RIREG SCHEME7 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Stereoisomer of [(1,2,3-η)-(2E)-2-buten-1-yl]nitrosyl[(1,2,3,4,5-η)-1,2,3,4,5...
C18H33NOSiW
1013662-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5611 2.4800 0.0 0 CHG=-1 VAL=4
M  V30 2 Si 5.8139 1.7590 0.0 0
M  V30 3 C 6.6857 2.2601 0.0 0
M  V30 4 C 5.8139 0.3861 0.0 0
M  V30 5 C 6.6857 1.2553 0.0 0
M  V30 6 N 1.3499 2.4800 0.0 0 VAL=4
M  V30 7 O 0.5471 2.9427 0.0 0 CHG=1 VAL=3
M  V30 8 C 3.0092 6.8033 0.0 0
M  V30 9 C 3.5461 4.7759 0.0 0
M  V30 10 C 2.4749 4.7759 0.0 0
M  V30 11 C 0.0000 4.8654 0.0 0
M  V30 12 C 6.0236 4.8500 0.0 0
M  V30 13 C 5.2105 0.7772 0.0 0
M  V30 14 W 2.9555 1.5519 0.0 0 CHG=2 VAL=10
M  V30 15 C 3.0092 5.8753 0.0 0 CHG=-1 VAL=4
M  V30 16 C 3.7865 3.8785 0.0 0 VAL=5
M  V30 17 C 2.2345 3.8785 0.0 0 VAL=5
M  V30 18 C 0.9051 4.6557 0.0 0 VAL=5
M  V30 19 C 5.1159 4.6557 0.0 0 VAL=5
M  V30 20 C 2.9555 0.0000 0.0 0 VAL=5
M  V30 21 C 4.2850 0.7772 0.0 0 VAL=5
M  V30 22 C 1.6235 0.7772 0.0 0 CHG=-1 VAL=4
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 3 6 7
M  V30 7 1 6 14
M  V30 8 1 8 15
M  V30 9 1 9 16
M  V30 10 1 10 17
M  V30 11 1 11 18
M  V30 12 1 12 19
M  V30 13 1 13 21
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 14 20
M  V30 20 1 14 21
M  V30 21 1 14 22
M  V30 22 1 15 18
M  V30 23 1 15 19
M  V30 24 1 16 17
M  V30 25 2 16 19
M  V30 26 2 17 18
M  V30 27 2 20 21
M  V30 28 1 20 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2-(1-Methyl-2-propen-1-yl)-1-pyrrolidinyl]nitrosyl[(1,2,3,4,5-η)-1,2,3,4,5-p...
C22H40N2OSiW
1018686-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8617 2.0860 0.0 0 CHG=-1 VAL=4
M  V30 2 Si 10.8557 3.2364 0.0 0
M  V30 3 C 12.1595 2.4810 0.0 0
M  V30 4 C 10.8557 4.6284 0.0 0
M  V30 5 C 12.8037 4.3638 0.0 0
M  V30 6 N 6.4536 0.6979 0.0 0 VAL=4
M  V30 7 O 5.2496 0.0000 0.0 0 CHG=1 VAL=3
M  V30 8 C 6.4536 10.1425 0.0 0
M  V30 9 C 5.7902 7.4583 0.0 0
M  V30 10 C 7.1170 7.4583 0.0 0
M  V30 11 C 10.6027 7.4046 0.0 0
M  V30 12 C 2.3008 7.4046 0.0 0
M  V30 13 C 2.4196 5.7941 0.0 0
M  V30 14 C 1.2156 6.4881 0.0 0
M  V30 15 C 3.6275 6.4881 0.0 0
M  V30 16 C 0.0000 5.8132 0.0 0
M  V30 17 W 6.4536 3.4780 0.0 0 CHG=2 VAL=8
M  V30 18 C 6.4536 8.7505 0.0 0 CHG=-1 VAL=4
M  V30 19 C 5.4298 6.1162 0.0 0 VAL=5
M  V30 20 C 7.4775 6.1162 0.0 0 VAL=5
M  V30 21 C 9.2337 7.1400 0.0 0 VAL=5
M  V30 22 C 3.6697 7.1400 0.0 0 VAL=5
M  V30 23 N 3.6735 3.4780 0.0 0 CHG=-1 VAL=3
M  V30 24 C 2.4196 4.4021 0.0 0
M  V30 25 C 3.2364 2.0668 0.0 0
M  V30 26 C 1.2271 3.4780 0.0 0
M  V30 27 C 1.7141 2.0668 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 3 6 7
M  V30 7 1 6 17
M  V30 8 1 8 18
M  V30 9 1 9 19
M  V30 10 1 10 20
M  V30 11 1 11 21
M  V30 12 1 12 22
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 24
M  V30 16 2 14 16
M  V30 17 1 17 18
M  V30 18 1 17 19
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 1 17 22
M  V30 22 1 17 23
M  V30 23 1 18 21
M  V30 24 1 18 22
M  V30 25 1 19 20
M  V30 26 2 19 22
M  V30 27 2 20 21
M  V30 28 1 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1013662-81-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018686-83-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-562-CAS-1635371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Complex 12 was synthesized by dissolving 5 (30 mg, 0.56 mmol) in
pyrrolidine (2 mL) for 4 d. The 1H NMR spectrum of the crude product in
C6D6 revealed the quantitative conversion of 5 into 12. Unfortunately,
multiple attempts to obtain 12 as a tractable solid were unsuccessful. IR
(cm-1) 1561 (s, νNO). 1H NMR (400 MHz, C6D6) δ -0.50 (overlapping d, 2H,
CH2SiMe3), 0.38 (s, 9H, CMe3), 1.67 (s, 15H, C5Me5), 2.90-3.08 (m, 3H,
MeCH and pyrrolidine NCH2), 4.97-5.03 (m, 2H, pyrrolidine NCH and
H2C=CH), 5.17 (d,3JHH = 17.2, 1H, H2C=CH), 5.98 (ddd, 3JHH = 7.2, 3JHH =
10.4, 3JHH =17.2, 1H, H2C=CH). Other pyrrolidine CH2 signals are
obscured. 13C{1H} NMR (100 MHz, C6D6) δ -7.0 (CH2SiMe3), 3.3 (CH2SiMe3),
9.9 (C5Me5), 14.5 (H2C=CH-CHMe), 25.8 (pyrrolidine CH2), 27.5
(pyrrolidine CH2), 45.3 (H2C=CH-CHMe), 58.6 (pyrrolidine NCH2), 80.9
(pyrrolidine NCH), 109.0 (C5Me5), 114.1 (H2C=CH), 142.8 (H2C=CH). MS
(LREI, m/z, probe temperature 120 °C) 560 [M+].
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Different Modes of Reactivity of Cp*W(NO)(alkyl)(η3-allyl) Complexes with
Cyclic Amines: The Influence of the Allyl Ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tsang, Jenkins Y. K.; Buschhaus, Miriam S. A.; Fujita-Takayama, Chikako;
Patrick, Brian O.; Legzdins, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organometallics (2008), 27(7), 1634-1644

$RFMT $RIREG SCHEME8 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[(4-fluorophenyl)methyl]-5,6,8,9-tetrahydro-4-[[(trifluor...
C21H23F4N3O5S
1023954-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.5378 3.6437 0.0 0
M  V30 2 S 7.3078 2.3101 0.0 0 VAL=6
M  V30 3 C 5.9741 1.5400 0.0 0
M  V30 4 O 8.0778 0.9764 0.0 0
M  V30 5 O 8.6414 3.0801 0.0 0
M  V30 6 F 4.6404 2.3101 0.0 0
M  V30 7 F 4.6404 0.7700 0.0 0
M  V30 8 F 5.9741 0.0000 0.0 0
M  V30 9 C 11.1579 6.3112 0.0 0
M  V30 10 C 2.6673 9.4349 0.0 0
M  V30 11 O 2.6673 10.9749 0.0 0
M  V30 12 O 1.3337 8.6648 0.0 0
M  V30 13 C 1.3337 11.7449 0.0 0
M  V30 14 C 2.1037 13.0786 0.0 0
M  V30 15 C 0.0000 12.5149 0.0 0
M  V30 16 C 0.5637 10.4112 0.0 0
M  V30 17 F 14.2379 11.6460 0.0 0
M  V30 18 C 7.3078 4.9774 0.0 0
M  V30 19 C 6.5378 6.3112 0.0 0
M  V30 20 N 8.8478 4.9774 0.0 0
M  V30 21 C 7.3078 7.6449 0.0 0
M  V30 22 C 5.0150 6.0816 0.0 0
M  V30 23 C 9.6178 6.3112 0.0 0
M  V30 24 N 8.8478 7.6449 0.0 0
M  V30 25 C 6.7452 9.0785 0.0 0
M  V30 26 C 3.8860 7.1291 0.0 0
M  V30 27 C 5.2735 9.5323 0.0 0
M  V30 28 N 4.0012 8.6648 0.0 0
M  V30 29 C 11.9279 7.6449 0.0 0
M  V30 30 C 11.1579 8.9786 0.0 0
M  V30 31 C 13.4679 7.6449 0.0 0
M  V30 32 C 11.9279 10.3122 0.0 0
M  V30 33 C 14.2379 8.9786 0.0 0
M  V30 34 C 13.4679 10.3122 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 23
M  V30 10 1 9 29
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 28
M  V30 14 1 11 13
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 17 34
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 2 20 23
M  V30 24 2 21 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 24
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 2-[(4-fluorophenyl)methyl]-5,6,8,9-tetrahydro-4-(1-pyrrolid...
C24H31FN4O2
1065112-91-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.1579 5.1047 0.0 0
M  V30 2 C 2.6673 8.2284 0.0 0
M  V30 3 O 2.6673 9.7684 0.0 0
M  V30 4 O 1.3337 7.4584 0.0 0
M  V30 5 C 1.3337 10.5385 0.0 0
M  V30 6 C 0.5637 9.2048 0.0 0
M  V30 7 C 0.0000 11.3085 0.0 0
M  V30 8 C 2.1037 11.8721 0.0 0
M  V30 9 F 14.2379 10.4396 0.0 0
M  V30 10 C 6.5378 5.1047 0.0 0
M  V30 11 C 7.3078 3.7711 0.0 0
M  V30 12 C 7.3078 6.4384 0.0 0
M  V30 13 C 5.0150 4.8751 0.0 0
M  V30 14 N 8.8478 3.7711 0.0 0
M  V30 15 N 8.8478 6.4384 0.0 0
M  V30 16 C 6.7452 7.8720 0.0 0
M  V30 17 C 3.8860 5.9227 0.0 0
M  V30 18 C 9.6178 5.1047 0.0 0
M  V30 19 C 5.2735 8.3259 0.0 0
M  V30 20 N 4.0012 7.4584 0.0 0
M  V30 21 N 6.5378 2.4373 0.0 0
M  V30 22 C 5.0062 2.2763 0.0 0
M  V30 23 C 7.1642 1.0304 0.0 0
M  V30 24 C 4.6860 0.7700 0.0 0
M  V30 25 C 6.0197 0.0000 0.0 0
M  V30 26 C 11.9279 6.4384 0.0 0
M  V30 27 C 13.4679 6.4384 0.0 0
M  V30 28 C 11.1579 7.7721 0.0 0
M  V30 29 C 14.2379 7.7721 0.0 0
M  V30 30 C 11.9279 9.1059 0.0 0
M  V30 31 C 13.4679 9.1059 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 20
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 9 31
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 21
M  V30 16 2 12 15
M  V30 17 1 12 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 18
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 29 2 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 30
M  V30 33 2 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1023954-05-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1065112-91-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9259778
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 127-19-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Tert-butyl
2-(4-fluorobenzyl)-4-pyrrolidin-1-yl-5,6,8,9-tetrahydro-7H-pyrimido[4,5,d]azepine-7-carboxylate
To a solution of the product of Preparation 5, Step C (90.0mg, 0.18mmol)
in DMA (2mL) was added pyrrolidine (0.074mL, 0.89mmol) and the reaction
was stirred for 48h. The reaction mixture was concentrated in vacuo and
the material was used without further purification. Assume 100% yield.
LRMS ES+ and AP+ m/z 427 [MH]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimido[4,5-d]azepine derivatives as 5-HT2C agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Andrews, Mark David; Blagg, Julian; Brennan, Paul Edward; Fish, Paul
Vincent; Roberts, Lee Richard; Storer, Robert Ian; Whitlock, Gavin
Alistair
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008117169 A1 2008-10-02

$RFMT $RIREG SCHEME9 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Butanaminium, N,N,N-tributyl-, (T-4)-trifluoro(5-formyl-2-furanyl)borate(1-...
C16H36N.C5H3BF3O2
1025113-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 2.8236 13.7497 0.0 0 CHG=3 VAL=4
M  V30 2 F 1.2836 13.7497 0.0 0 CHG=-1 VAL=1
M  V30 3 F 2.8236 12.2097 0.0 0 CHG=-1 VAL=1
M  V30 4 F 2.8236 15.2897 0.0 0 CHG=-1 VAL=1
M  V30 5 C 7.9793 15.4249 0.0 0
M  V30 6 O 9.3861 14.7986 0.0 0
M  V30 7 C 4.3636 13.7497 0.0 0 CHG=-1 VAL=4
M  V30 8 O 5.2688 14.9955 0.0 0
M  V30 9 C 5.2688 12.5038 0.0 0
M  V30 10 C 6.7333 14.5197 0.0 0
M  V30 11 C 6.7333 12.9797 0.0 0
M  V30 12 N 5.3348 5.3348 0.0 0 CHG=1 VAL=4
M  V30 13 C 4.0012 4.5648 0.0 0
M  V30 14 C 6.6685 6.1048 0.0 0
M  V30 15 C 4.5648 6.6685 0.0 0
M  V30 16 C 6.1048 4.0012 0.0 0
M  V30 17 C 2.6673 5.3348 0.0 0
M  V30 18 C 8.0023 5.3348 0.0 0
M  V30 19 C 5.3348 8.0023 0.0 0
M  V30 20 C 5.3348 2.6673 0.0 0
M  V30 21 C 1.3337 4.5648 0.0 0
M  V30 22 C 9.3360 6.1048 0.0 0
M  V30 23 C 4.5648 9.3360 0.0 0
M  V30 24 C 6.1048 1.3337 0.0 0
M  V30 25 C 0.0000 5.3348 0.0 0
M  V30 26 C 10.6697 5.3348 0.0 0
M  V30 27 C 5.3348 10.6697 0.0 0
M  V30 28 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 1 21 25
M  V30 25 1 22 26
M  V30 26 1 23 27
M  V30 27 1 24 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Butanaminium, N,N,N-tributyl-, (T-4)-trifluoro[5-(1-pyrrolidinylmethyl)-2-f...
C16H36N.C9H12BF3NO
1025113-66-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 9.0852 13.7497 0.0 0 CHG=3 VAL=4
M  V30 2 F 10.6252 13.7497 0.0 0 CHG=-1 VAL=1
M  V30 3 F 9.0852 12.2097 0.0 0 CHG=-1 VAL=1
M  V30 4 F 9.0852 15.2897 0.0 0 CHG=-1 VAL=1
M  V30 5 C 3.9294 15.4249 0.0 0
M  V30 6 C 7.5452 13.7497 0.0 0 CHG=-1 VAL=4
M  V30 7 O 6.6400 14.9955 0.0 0
M  V30 8 C 6.6400 12.5038 0.0 0
M  V30 9 C 5.1753 14.5197 0.0 0
M  V30 10 C 5.1753 12.9797 0.0 0
M  V30 11 N 2.5226 14.7984 0.0 0
M  V30 12 C 1.1890 15.5684 0.0 0
M  V30 13 C 2.2025 13.2921 0.0 0
M  V30 14 C 0.0445 14.5380 0.0 0
M  V30 15 C 0.6708 13.1310 0.0 0
M  V30 16 N 5.3348 5.3348 0.0 0 CHG=1 VAL=4
M  V30 17 C 4.0012 4.5648 0.0 0
M  V30 18 C 6.6685 6.1048 0.0 0
M  V30 19 C 4.5648 6.6685 0.0 0
M  V30 20 C 6.1048 4.0012 0.0 0
M  V30 21 C 2.6673 5.3348 0.0 0
M  V30 22 C 8.0023 5.3348 0.0 0
M  V30 23 C 5.3348 8.0023 0.0 0
M  V30 24 C 5.3348 2.6673 0.0 0
M  V30 25 C 1.3337 4.5648 0.0 0
M  V30 26 C 9.3360 6.1048 0.0 0
M  V30 27 C 4.5648 9.3360 0.0 0
M  V30 28 C 6.1048 1.3337 0.0 0
M  V30 29 C 0.0000 5.3348 0.0 0
M  V30 30 C 10.6697 5.3348 0.0 0
M  V30 31 C 5.3348 10.6697 0.0 0
M  V30 32 C 5.3348 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 1 22 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 1 25 29
M  V30 30 1 26 30
M  V30 31 1 27 31
M  V30 32 1 28 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1025113-55-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1025113-66-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-12654461
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-18-6
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 590-29-4
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7789-29-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure A for the Reductive
Amination of Tetrabutylammonium(Formylaryl)trifluoroborates using
Palladium-Catalyzed Formate. Tetrabutylammonium
(4-((Piperidin-1-yl)methyl)furan-2-yl)trifluoroborate. A test tube
containing activated 4 Å molecular sieves and tetrabutylammonium
(4-formylfuran-2-yl)trifluoroborate was evacuated under vacuum (0.01
Torr) for 15 min. DMF (1 mL), piperidine (60 mg, 0.71mmol), and formic
acid (28 mg, 0.61 mmol) were then added with stirring. The solution was
heated under nitrogen for 5 h at 70 °C, after which potassium formate
(100 mg, 1.19 mmol) and palladiumacetate (5 mg, 0.02 mmol, 6 mol %) were
added, and stirring was continued for an additional 4 h. Heat was
removed, and the reaction mixture was cooled to room temperature. Aqueous
KHF2 (1 mL,4.5 M) was then added, and the solution was stirred for 20
min. The mixture was filtered, and the white solid was rinsed with CH2Cl2
(2 x 5 mL). The filtrate was washed with H2O, 3 M NaOH, and brine, and
dried (MgSO4), and the solvent was removed to give the product.
Tetrabutylammonium 5-((Pyrrolidin-1-yl)methyl)furan-2-yltrifluoroborate
as a deep yellow oil, yield 153 mg, 100%. IR = 2961 cm-1; 1H NMR (500
MHz, CDCl3): δ 0.90 (t, J = 8 Hz, 12H), 1.26 - 1.34 (m, 8H), 1.43 - 1.51
(m, 8H), 1.65 (s, 4H), 2.48 (s, 4H), 3.07 (t, J = 9 Hz, 8H), 3.56 (s,
2H), 5.96 (d, J = 3 Hz, 1H), 6.16 (d, J = 3 Hz, 1H); 13C NMR (125.8 MHz,
CDCl3): δ 13.6, 19.5, 23.5, 23.7, 52.4, 53.7, 58.3, 106.9, 111.7, 151.9;
19F NMR (471 MHz, CDCl3): δ -141.2; 11B NMR (128 MHz, CDCl3): δ 0.86;
HRMS (ESI): calcd for C9H12BF3NO [M-C16H36N]- 218.0964, found 218.0951.
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Functionalization of Organotrifluoroborates: Reductive Amination
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Molander, Gary A.; Cooper, David J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(10), 3885-3891

$RFMT $RIREG SCHEME10 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-Methyl-2-[2-(2-pyridinyl)ethynyl]-1H-indol-3-yl]ethanone
C18H14N2O
1029882-78-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6078 1.1444 0.0 0
M  V30 2 C 3.5773 0.0000 0.0 0
M  V30 3 O 6.1141 0.8242 0.0 0
M  V30 4 C 6.5770 3.8549 0.0 0
M  V30 5 C 8.1170 3.8549 0.0 0
M  V30 6 C 4.6078 6.5653 0.0 0
M  V30 7 C 2.6673 3.0849 0.0 0
M  V30 8 C 4.1320 2.6091 0.0 0
M  V30 9 C 2.6673 4.6249 0.0 0
M  V30 10 C 1.3336 2.3149 0.0 0
M  V30 11 C 5.0370 3.8549 0.0 0
M  V30 12 N 4.1320 5.1008 0.0 0
M  V30 13 C 1.3336 5.3949 0.0 0
M  V30 14 C 0.0000 3.0849 0.0 0
M  V30 15 C 0.0000 4.6249 0.0 0
M  V30 16 C 9.6570 3.8549 0.0 0
M  V30 17 C 10.4270 5.1886 0.0 0
M  V30 18 N 10.4270 2.5211 0.0 0
M  V30 19 C 11.9670 5.1886 0.0 0
M  V30 20 C 11.9670 2.5211 0.0 0
M  V30 21 C 12.7370 3.8549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 1 5 16
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 1 13 15
M  V30 17 2 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-Methyl-2-[(1E)-2-(2-pyridinyl)-2-(1-pyrrolidinyl)ethenyl]-1H-indol-3-yl]...
C22H23N3O
1029883-08-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6799 3.8549 0.0 0
M  V30 2 C 3.9099 5.1886 0.0 0
M  V30 3 C 6.6491 1.1444 0.0 0
M  V30 4 C 7.6797 0.0000 0.0 0
M  V30 5 O 5.1428 0.8242 0.0 0
M  V30 6 C 6.6491 6.5655 0.0 0
M  V30 7 C 6.2199 3.8549 0.0 0
M  V30 8 C 7.1251 2.6091 0.0 0
M  V30 9 N 7.1251 5.1008 0.0 0
M  V30 10 C 8.5897 3.0849 0.0 0
M  V30 11 C 8.5897 4.6249 0.0 0
M  V30 12 C 9.9233 2.3149 0.0 0
M  V30 13 C 9.9233 5.3949 0.0 0
M  V30 14 C 11.2571 3.0849 0.0 0
M  V30 15 C 11.2571 4.6249 0.0 0
M  V30 16 N 2.3699 5.1886 0.0 0
M  V30 17 C 1.4647 6.4344 0.0 0
M  V30 18 C 1.4647 3.9427 0.0 0
M  V30 19 C 0.0000 5.9586 0.0 0
M  V30 20 C 0.0000 4.4186 0.0 0
M  V30 21 C 4.0440 6.7227 0.0 0
M  V30 22 C 2.7826 7.6061 0.0 0
M  V30 23 N 5.4397 7.3735 0.0 0
M  V30 24 C 2.9168 9.1402 0.0 0
M  V30 25 C 5.5740 8.9077 0.0 0
M  V30 26 C 4.3125 9.7910 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 2 16
M  V30 4 1 2 21
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 3 8
M  V30 8 1 6 9
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1029882-78-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1029883-08-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-2245150
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedures for aminobenzannulation
reaction: Method A: To a solution of starting material (1 mmol) in dry
dichloromethane (5 mL) under argon was added successively activated
molecular sieves (4 Å, pulver < 5μ, 6 weight equiv.) and amine (3
equiv.). The mixture was stirred overnight at room temperature.
Filtration through celite, evaporation of solvent and purification by
flash chromatography on silica gel (using cyclohexane/EtOAc mixtures)
afforded the desired products.
1-[1-Methyl-2-(2-pyridin-2-yl-2-pyrrolidin-1-ylvinyl)-1Hindol-
3-yl]ethanone (44): Yellow solid, Method A: quant. mp 200 °C; IR (neat)
3048, 2966, 2873, 1623, 1584, 1563; 1H NMR (300 MHz, CDCl3, δ) 8.61 (d, J
= 4.3 Hz, 1H), 8.19 (d, J = 7.9 Hz, 1H), 7.35-7.32 (m, 1H), 7.18 (dd, J =
7.4, 7.4 Hz, 1H), 7.14-7.08 (m, 2H), 7.01 (d, J = 8.0 Hz, 1H), 6.88 (d, J
= 7.9 Hz, 1H), 5.59 (s, 1H), 3.33-3.30 (m, 4H), 3.18 (s, 3H), 2.70 (s,
3H), 2.01-1.99 (m, 4H); 13C NMR (75 MHz, CDCl3, δ) 194.1, 155.6, 151.5,
149.5, 146.7, 137.0, 136.6, 127.3, 125.1, 123.2, 122.1, 122.0, 121.5,
114.8, 109.3, 89.0, 49.3 (2C), 31.2, 31.0, 25.4 (2C); HRMS-CI (m/z) for
[C22H23N3O + H]+ calcd 346.1919, found 346.1917.
$DTYPE RXN:VAR(1):NOTES
$DATUM 4A mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rapid Access to Amino-Substituted Quinoline, (Di)Benzofuran, and
Carbazole Heterocycles through an Aminobenzannulation Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tiano, Martin; Belmont, Philippe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(11), 4101-4109

$RFMT $RIREG SCHEME11 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-[2-(2-Pyridinyl)ethynyl]-3-benzofuranyl]ethanone
C17H11NO2
1029882-92-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6079 1.1444 0.0 0
M  V30 2 C 3.5773 0.0000 0.0 0
M  V30 3 O 6.1142 0.8242 0.0 0
M  V30 4 C 6.5771 3.8550 0.0 0
M  V30 5 C 8.1171 3.8550 0.0 0
M  V30 6 C 2.6673 3.0850 0.0 0
M  V30 7 C 4.1320 2.6091 0.0 0
M  V30 8 C 2.6673 4.6250 0.0 0
M  V30 9 C 1.3337 2.3150 0.0 0
M  V30 10 C 5.0371 3.8550 0.0 0
M  V30 11 O 4.1320 5.1008 0.0 0
M  V30 12 C 1.3337 5.3950 0.0 0
M  V30 13 C 0.0000 3.0850 0.0 0
M  V30 14 C 0.0000 4.6250 0.0 0
M  V30 15 C 9.6571 3.8550 0.0 0
M  V30 16 C 10.4271 5.1886 0.0 0
M  V30 17 N 10.4271 2.5213 0.0 0
M  V30 18 C 11.9672 5.1886 0.0 0
M  V30 19 C 11.9672 2.5213 0.0 0
M  V30 20 C 12.7372 3.8550 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 3 4 5
M  V30 5 1 4 10
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-[(1E)-2-(2-Pyridinyl)-2-(1-pyrrolidinyl)ethenyl]-3-benzofuranyl]ethanone
C21H20N2O2
1029883-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6080 1.1445 0.0 0
M  V30 2 C 6.1143 0.8244 0.0 0
M  V30 3 O 3.5774 0.0000 0.0 0
M  V30 4 C 6.5772 3.8551 0.0 0
M  V30 5 C 7.3472 5.1887 0.0 0
M  V30 6 C 4.1320 2.6091 0.0 0
M  V30 7 C 5.0372 3.8551 0.0 0
M  V30 8 C 2.6674 3.0851 0.0 0
M  V30 9 O 4.1320 5.1009 0.0 0
M  V30 10 C 2.6674 4.6251 0.0 0
M  V30 11 C 1.3338 2.3151 0.0 0
M  V30 12 C 1.3338 5.3951 0.0 0
M  V30 13 C 0.0000 3.0851 0.0 0
M  V30 14 C 0.0000 4.6251 0.0 0
M  V30 15 N 8.8872 5.1887 0.0 0
M  V30 16 C 9.7924 3.9429 0.0 0
M  V30 17 C 9.7924 6.4346 0.0 0
M  V30 18 C 11.2571 4.4187 0.0 0
M  V30 19 C 11.2571 5.9587 0.0 0
M  V30 20 C 6.5772 6.5224 0.0 0
M  V30 21 C 7.3472 7.8560 0.0 0
M  V30 22 N 5.0372 6.5224 0.0 0
M  V30 23 C 6.5772 9.1898 0.0 0
M  V30 24 C 4.2672 7.8560 0.0 0
M  V30 25 C 5.0372 9.1898 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 7
M  V30 6 1 5 15
M  V30 7 1 5 20
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 10
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1029882-92-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1029883-05-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-13513080
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedures for aminobenzannulation
reaction: Method B: To a solution of starting material (1 mmol) in dry
dichloroethane (5 mL) under argon was added successively activated
molecular sieves (4 Å, pulver < 5μ, 6 weight equiv.) and amine (3-6
equiv.). The mixture was stirred at reflux until completion (3 hours-2
days). Filtration through celite, evaporation of solvent and purification
by flash chromatography on silica gel (using cyclohexane/EtOAc mixtures)
afforded the desired products. 1-(3-Phenyldibenzofuran-1-yl)pyrrolidine
(39): Brown oil, Method B: 55%.
1-[2-(2-Pyridin-2-yl-2-pyrrolidin-1-ylvinyl)benzofuran-3-yl]- ethanone
(41): Yellow/brown solid, Method B: quant. mp 145-148 °C; IR (neat) 3052,
2976, 2871, 1640; 1H NMR (300 MHz, CDCl3, δ) 8.71 (s, 1H), 7.75-7.70 (m,
1H), 7.59 (d, J = 8.0 Hz, 1H), 7.37-7.33 (m, 2H), 7.08 (dd, J = 7.7, 7.7
Hz, 1H), 6.93 (dd, J = 7.7, 7.7 Hz, 1H), 6.58 (d, J = 8.3 Hz, 1H), 6.45
(s, 1H), 3.35 (br s, 4H), 2.58 (s, 3H), 1.94 (br s, 4H); 13C NMR (75 MHz,
CDCl3, δ) 193.1, 163.7, 156.6, 154.4, 152.3, 149.4, 136.4, 127.1, 124.1,
123.1 (2C), 122.2, 119.7, 110.0, 109.7, 87.6, 49.1 (2C), 31.5, 25.3 (2C);
HRMS-EI (m/z) for [C21H20N2O2]+• calcd 332.1525, found 332.1525.
$DTYPE RXN:VAR(1):NOTES
$DATUM 4A mol. sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rapid Access to Amino-Substituted Quinoline, (Di)Benzofuran, and
Carbazole Heterocycles through an Aminobenzannulation Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tiano, Martin; Belmont, Philippe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(11), 4101-4109

$RFMT $RIREG SCHEME12 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phosphorus(1+), [2′-deoxy-3′,5′-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-2-(h...
C35H63N7O5PSi2.F6P
1032327-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  57 59 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 15.2854 14.4128 0.0 0
M  V30 2 C 16.0554 13.0791 0.0 0
M  V30 3 O 10.6653 17.0802 0.0 0
M  V30 4 P 11.4353 18.4139 0.0 0 CHG=1 VAL=4
M  V30 5 N 12.2053 19.7476 0.0 0
M  V30 6 N 10.1016 19.1839 0.0 0
M  V30 7 N 12.9230 18.0154 0.0 0
M  V30 8 C 11.4353 21.0814 0.0 0
M  V30 9 C 13.7453 19.7476 0.0 0
M  V30 10 C 8.7680 18.4139 0.0 0
M  V30 11 C 10.1016 20.7239 0.0 0
M  V30 12 C 14.0119 19.1043 0.0 0
M  V30 13 C 13.3215 16.5278 0.0 0
M  V30 14 C 5.5384 11.6145 0.0 0
M  V30 15 O 4.3938 10.5840 0.0 0
M  V30 16 Si 2.9293 11.0598 0.0 0
M  V30 17 C 1.4646 11.5359 0.0 0
M  V30 18 C 2.4534 9.5953 0.0 0
M  V30 19 C 3.4051 12.5245 0.0 0
M  V30 20 C 0.9887 10.0711 0.0 0
M  V30 21 C 0.0000 12.0117 0.0 0
M  V30 22 C 1.9404 13.0004 0.0 0
M  V30 23 O 6.5737 8.4281 0.0 0
M  V30 24 Si 7.2001 7.0211 0.0 0
M  V30 25 C 7.8264 5.6143 0.0 0
M  V30 26 C 5.7933 6.3948 0.0 0
M  V30 27 C 8.6069 7.6476 0.0 0
M  V30 28 C 9.2334 6.2406 0.0 0
M  V30 29 C 8.4529 4.2073 0.0 0
M  V30 30 C 6.4196 4.9878 0.0 0
M  V30 31 C 11.4353 13.0791 0.0 0
M  V30 32 N 10.9594 11.6145 0.0 0
M  V30 33 C 12.9753 13.0791 0.0 0
M  V30 34 N 10.6653 14.4128 0.0 0
M  V30 35 C 12.2053 10.7093 0.0 0
M  V30 36 C 13.7453 14.4128 0.0 0
M  V30 37 N 13.4513 11.6145 0.0 0
M  V30 38 C 11.4353 15.7466 0.0 0
M  V30 39 N 12.9753 15.7466 0.0 0
M  V30 40 C 9.4949 11.1385 0.0 0
M  V30 41 O 8.2488 12.0438 0.0 0
M  V30 42 C 9.0188 9.6740 0.0 0
M  V30 43 C 7.0030 11.1385 0.0 0
M  V30 44 C 7.4788 9.6740 0.0 0
M  V30 45 C 17.5954 13.0791 0.0 0
M  V30 46 C 18.3654 14.4128 0.0 0
M  V30 47 C 18.3654 11.7454 0.0 0
M  V30 48 C 19.9054 14.4128 0.0 0
M  V30 49 C 19.9054 11.7454 0.0 0
M  V30 50 C 20.6754 13.0791 0.0 0
M  V30 51 P 10.3377 1.3337 0.0 0 CHG=5 VAL=6
M  V30 52 F 8.7977 1.3337 0.0 0 CHG=-1 VAL=1
M  V30 53 F 11.8778 1.3337 0.0 0 CHG=-1 VAL=1
M  V30 54 F 9.5677 2.6673 0.0 0 CHG=-1 VAL=1
M  V30 55 F 11.1077 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 56 F 11.1077 2.6673 0.0 0 CHG=-1 VAL=1
M  V30 57 F 9.5677 0.0000 0.0 0 CHG=-1 VAL=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 36
M  V30 3 1 2 45
M  V30 4 1 3 4
M  V30 5 1 3 38
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 7 12
M  V30 14 1 7 13
M  V30 15 1 14 15
M  V30 16 1 14 43
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 17 20
M  V30 22 1 17 21
M  V30 23 1 17 22
M  V30 24 1 23 24
M  V30 25 1 23 44
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 24 27
M  V30 29 1 25 28
M  V30 30 1 25 29
M  V30 31 1 25 30
M  V30 32 1 31 32
M  V30 33 1 31 33
M  V30 34 2 31 34
M  V30 35 1 32 35
M  V30 36 1 32 40
M  V30 37 2 33 36
M  V30 38 1 33 37
M  V30 39 1 34 38
M  V30 40 2 35 37
M  V30 41 1 36 39
M  V30 42 2 38 39
M  V30 43 1 40 41
M  V30 44 1 40 42
M  V30 45 1 41 43
M  V30 46 1 42 44
M  V30 47 1 43 44
M  V30 48 2 45 46
M  V30 49 1 45 47
M  V30 50 1 46 48
M  V30 51 2 47 49
M  V30 52 2 48 50
M  V30 53 1 49 50
M  V30 54 1 51 52
M  V30 55 1 51 53
M  V30 56 1 51 54
M  V30 57 1 51 55
M  V30 58 1 51 56
M  V30 59 1 51 57
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2′-Deoxy-3′,5′-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-6-O-(phenylmethyl)-2-...
C33H53N5O4Si2
1032327-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 48 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 14.4610 10.2053 0.0 0
M  V30 2 C 15.2310 11.5391 0.0 0
M  V30 3 C 4.7141 7.4071 0.0 0
M  V30 4 O 4.3938 8.9134 0.0 0
M  V30 5 Si 2.9292 9.3893 0.0 0
M  V30 6 C 1.4645 9.8651 0.0 0
M  V30 7 C 2.4534 7.9247 0.0 0
M  V30 8 C 3.4051 10.8540 0.0 0
M  V30 9 C 1.9406 11.3298 0.0 0
M  V30 10 C 0.0000 10.3412 0.0 0
M  V30 11 C 0.9887 8.4006 0.0 0
M  V30 12 O 5.7493 4.2207 0.0 0
M  V30 13 Si 6.3758 2.8137 0.0 0
M  V30 14 C 7.0021 1.4070 0.0 0
M  V30 15 C 7.7826 3.4402 0.0 0
M  V30 16 C 4.9688 2.1874 0.0 0
M  V30 17 C 8.4091 2.0333 0.0 0
M  V30 18 C 7.6286 0.0000 0.0 0
M  V30 19 C 5.5953 0.7805 0.0 0
M  V30 20 C 10.6110 8.8717 0.0 0
M  V30 21 N 10.1351 7.4071 0.0 0
M  V30 22 C 12.1510 8.8717 0.0 0
M  V30 23 N 9.8410 10.2053 0.0 0
M  V30 24 C 11.3810 6.5019 0.0 0
M  V30 25 C 12.9210 10.2053 0.0 0
M  V30 26 N 12.6268 7.4071 0.0 0
M  V30 27 C 10.6110 11.5391 0.0 0
M  V30 28 N 12.1510 11.5391 0.0 0
M  V30 29 C 8.6704 6.9311 0.0 0 CFG=1
M  V30 30 O 7.4245 7.8363 0.0 0
M  V30 31 C 8.1945 5.4666 0.0 0
M  V30 32 C 6.1787 6.9311 0.0 0 CFG=2
M  V30 33 C 6.6545 5.4666 0.0 0 CFG=2
M  V30 34 N 9.8410 12.8728 0.0 0
M  V30 35 C 8.3094 13.0337 0.0 0
M  V30 36 C 10.4674 14.2796 0.0 0
M  V30 37 C 7.9893 14.5401 0.0 0
M  V30 38 C 9.3229 15.3101 0.0 0
M  V30 39 C 16.7710 11.5391 0.0 0
M  V30 40 C 17.5410 10.2053 0.0 0
M  V30 41 C 17.5410 12.8728 0.0 0
M  V30 42 C 19.0810 10.2053 0.0 0
M  V30 43 C 19.0810 12.8728 0.0 0
M  V30 44 C 19.8510 11.5391 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 39
M  V30 4 1 3 4
M  V30 5 1 32 3 CFG=1
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 5 8
M  V30 10 1 6 9
M  V30 11 1 6 10
M  V30 12 1 6 11
M  V30 13 1 12 13
M  V30 14 1 33 12 CFG=3
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 1 14 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 2 20 23
M  V30 24 1 21 24
M  V30 25 1 29 21 CFG=1
M  V30 26 2 22 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 2 24 26
M  V30 30 1 25 28
M  V30 31 2 27 28
M  V30 32 1 27 34
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 1 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 2 39 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 2 41 43
M  V30 47 2 42 44
M  V30 48 1 43 44
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 29 32 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1032327-78-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1032327-83-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13246529
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM O6-Benzyl-3’,5’-bis-O-(tert-butyldimethylsilyl)-2-(pyrrolidin-1-
yl)-2’-deoxyinosine (4c). As described for the synthesis of 4a,
pyrrolidinyl derivative 4c was prepared by a reaction between nucleoside
phosphonium salt 3 (69.7 mg, 0.078 mmol) and pyrrolidine (26.0 μL, 0.312
mmol) in dry DME (0.8 mL) at room temperature over 23 h. The reaction
mixture was directly loaded onto a bed of SiO2 and the product was eluted
using EtOAc to give 50.0 mg (quantitative yield) of compound 4c as a
clear gum.
O6-Benzyl-3’,5’-bis-O-(tert-butyldimethylsilyl)-2-(pyrrolidin-1-
yl)-2’-deoxyinosine (4c)., 50.0 mg (quantitative yield) Rf (20% EtOAc in
hexanes) = 0.24. 1H NMR (500 MHz, CDCl3): δ 7.74 (s, 1H, H-8), 7.51 (d,
1H, Ar-H, J = 7.3), 7.33 (t, 2H, Ar-H, J = 7.5), 7.28-7.26 (m, 1H, Ar-H),
6.28 (t, 1H, H-1’, J = 6.7), 5.58 (ABquart, 2H, CH2), J = 12.4), 4.59
(quint, 1H, H-3’, J = 2.9), 3.96 (m, 1H, H-4’), 3.83 (dd, 1H, H-5’, J =
11.0, 5.9), 3.76 (dd, 1H, H-5’, J = 11.0, 3.8), 3.58 (br t, 4H,
pyrrolidinyl NCH2, J ~ 6.4), 2.79 (app quint, 1H, H-2’, J ~ 6.6), 2.27
(ddd, 1H, H-2’, J = 13.1, 6.1, 3.4), 1.98-1.95 (m, 4H, pyrrolidinyl CH2),
0.92, 0.90 (2s, 18H, t- Bu), 0.10, 0.07, 0.06 (3s, 12H, SiCH3). 13C NMR
(125 MHz, CDCl3): δ 160.1, 157.2, 153.9, 137.3, 137.2, 128.2, 128.19,
127.7, 114.6, 87.6, 84.2, 72.4, 67.4, 63.2, 47.0, 25.9, 25.7, 25.5, 18.4,
18.0, -4.7, -4.8, -5.4, -5.45.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic Utility of an Isolable Nucleoside Phosphonium Salt
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bae, Suyeal; Lakshman, Mahesh K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2008), 10(11), 2203-2206

$RFMT $RIREG SCHEME13 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-3,6-dichloropyridazine
C4HBrCl2N2
10344-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.5400 0.0000 0.0 0
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 N 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Dichloro-4-(1-pyrrolidinyl)pyridazine
C8H9Cl2N3
21415-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.4374 4.9318 0.0 0
M  V30 2 Cl 7.7722 1.8517 0.0 0
M  V30 3 C 3.7710 2.6217 0.0 0
M  V30 4 C 3.7710 4.1617 0.0 0
M  V30 5 C 5.1047 1.8517 0.0 0
M  V30 6 N 5.1047 4.9318 0.0 0
M  V30 7 C 6.4385 2.6217 0.0 0
M  V30 8 N 6.4385 4.1617 0.0 0
M  V30 9 N 2.4374 1.8517 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 2.2765 0.3202 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 7
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10344-42-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21415-33-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2574986
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM c) 3,6-Dichloro-4-(pyrrolidin-1-yl) pyridazine. To a slurry of
4-bromo-3,6-dichloropyridazine (115 g, 0.51 mol) and potassium carbonate
(209 g, 1.5 mol) in DMF (11) was added pyrrolidine (46 ml, 0.56 mol) at
0°C with stirring. The mixture was allowed to warm to room temperature
and then stirred under nitrogen overnight. Water (1.5 l) was added and
the resultant slurry was filtered. The residue was washed thoroughly with
water and diethyl ether, yielding the title compound. c) Yield: (110 g,
100%), fine white powder. 1H NMR (250 MHz, CDCl3) δ 2.03 (4H, m), 3.64
(4H, m), 6.46 (1H, s); MS (ES+) m/e 218/220 [MH]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazolylmethoxytriazolopyridazines as GABAA receptor
ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carling, William Robert; Mitchinson, Andrew; Russell, Michael Geoffrey
Neil; Street, Leslie Joseph
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000047582 A1 2000-08-17

$RFMT $RIREG SCHEME14 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-N4-(4-chlorophenyl)-4,5-pyrimidinediamine
C10H8Cl2N4
103505-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 N 1.5400 4.0011 0.0 0
M  V30 3 Cl 0.0000 1.3338 0.0 0
M  V30 4 Cl 10.7800 4.0011 0.0 0
M  V30 5 C 3.8500 2.6674 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 N 4.6200 1.3338 0.0 0
M  V30 8 C 1.5400 1.3338 0.0 0
M  V30 9 C 3.8500 0.0000 0.0 0
M  V30 10 N 2.3100 0.0000 0.0 0
M  V30 11 C 6.1600 4.0011 0.0 0
M  V30 12 C 6.9300 5.3349 0.0 0
M  V30 13 C 6.9300 2.6674 0.0 0
M  V30 14 C 8.4700 5.3349 0.0 0
M  V30 15 C 8.4700 2.6674 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 6
M  V30 4 1 3 8
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N4-(4-Chlorophenyl)-6-(1-pyrrolidinyl)-4,5-pyrimidinediamine
C14H16ClN5
686344-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.9098 1.3338 0.0 0
M  V30 2 N 6.9898 1.3338 0.0 0
M  V30 3 Cl 13.1498 1.3338 0.0 0
M  V30 4 C 3.9098 4.0011 0.0 0
M  V30 5 C 4.6798 2.6674 0.0 0
M  V30 6 N 4.6798 5.3349 0.0 0
M  V30 7 C 6.2198 2.6674 0.0 0
M  V30 8 C 6.2198 5.3349 0.0 0
M  V30 9 N 6.9898 4.0011 0.0 0
M  V30 10 N 2.3698 4.0011 0.0 0
M  V30 11 C 1.4645 5.2469 0.0 0
M  V30 12 C 1.4645 2.7552 0.0 0
M  V30 13 C 0.0000 4.7711 0.0 0
M  V30 14 C 0.0000 3.2311 0.0 0
M  V30 15 C 8.5298 1.3338 0.0 0
M  V30 16 C 9.2998 2.6674 0.0 0
M  V30 17 C 9.2998 0.0000 0.0 0
M  V30 18 C 10.8398 2.6674 0.0 0
M  V30 19 C 10.8398 0.0000 0.0 0
M  V30 20 C 11.6098 1.3338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 7
M  V30 3 1 2 15
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 10
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 103505-49-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 686344-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9500015
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of purines as cannabinoid receptor ligands (CB-1 receptor
antagonists).
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Griffith, David Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004037823 A1 2004-05-06

$RFMT $RIREG SCHEME15 STEP1
$RXN



  3  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimethylsilyl cyanide
C4H9NSi
7677-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(4-Chlorophenyl)-1-pyrrolidineacetonitrile
C12H13ClN2
64661-37-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.0801 0.0 0
M  V30 2 C 3.7711 1.5400 0.0 0
M  V30 3 N 3.7711 0.0000 0.0 0
M  V30 4 Cl 9.1059 6.1601 0.0 0
M  V30 5 C 5.1047 3.8501 0.0 0
M  V30 6 C 5.1047 5.3901 0.0 0
M  V30 7 C 6.4385 3.0801 0.0 0
M  V30 8 C 6.4385 6.1601 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 C 7.7722 5.3901 0.0 0
M  V30 11 N 2.4374 3.8501 0.0 0
M  V30 12 C 1.0304 3.2237 0.0 0
M  V30 13 C 2.2763 5.3816 0.0 0
M  V30 14 C 0.0000 4.3681 0.0 0
M  V30 15 C 0.7700 5.7018 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 3 2 3
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 7677-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 64661-37-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-346-CAS-12468001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 144026-79-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM polymer-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, flow system, Strecker reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of the heterogeneously catalyzed Strecker reaction conducted
under continuous flow
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wiles, Charlotte; Watts, Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2008), (33), 5597-5613

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Chlorophenyl)-1-pyrrolidinylmethanone
C11H12ClNO
19202-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 Cl 9.1059 4.6201 0.0 0
M  V30 4 C 5.1048 2.3101 0.0 0
M  V30 5 C 5.1048 3.8501 0.0 0
M  V30 6 C 6.4386 1.5400 0.0 0
M  V30 7 C 6.4386 4.6201 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 N 2.4374 2.3101 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19202-05-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41356624
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1313-99-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7440-02-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 112-40-3
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, catalyst prepared and used, reusable catalyst, 88% isolated
yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A cooperative nanoscale ZnO-NiO-Ni heterojunction for sustainable
catalytic amidation of aldehydes with secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shelte, Amishwar Raysing; Patil, Rahul Daga; Pratihar, Sanjay
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Sustainability (2024), 2(9), 2615-2625

$RFMT $RIREG SCHEME16 STEP1
$RXN



  2  1
$MOL
4-Chlorobenzaldehyde
C7H5ClO
104-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Chlorophenyl)-1-pyrrolidinylmethanone
C11H12ClNO
19202-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 Cl 9.1059 4.6201 0.0 0
M  V30 4 C 5.1048 2.3101 0.0 0
M  V30 5 C 5.1048 3.8501 0.0 0
M  V30 6 C 6.4386 1.5400 0.0 0
M  V30 7 C 6.4386 4.6201 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 N 2.4374 2.3101 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-88-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19202-05-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23961001
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, photochemical, blue LED used (460 nm), catalyst prepared
and used, sealed reactor used, optimization study, optimized on catalyst
and solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photocatalytic aldehydes/alcohols/toluenes oxidative amidation over
bifunctional Pd/MOFs: Effect of Fe-O clusters and Lewis acid sites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Heyan; Cheng, Hongmei; Zang, Cuicui; Tan, Jiangwei; Sun, Bin;
Bian, Fengxia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2021), 401279-287

$RFMT $RIREG SCHEME17 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzyl alcohol
C8H10O2
105-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Methoxyphenyl)methyl]pyrrolidine
C12H17NO
122439-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 0.0000 0.0 0
M  V30 2 O 9.1059 3.0801 0.0 0
M  V30 3 C 10.4396 2.3101 0.0 0
M  V30 4 C 5.1048 0.7700 0.0 0
M  V30 5 C 6.4384 0.0000 0.0 0
M  V30 6 C 5.1048 2.3101 0.0 0
M  V30 7 C 7.7722 0.7700 0.0 0
M  V30 8 C 6.4384 3.0801 0.0 0
M  V30 9 C 7.7722 2.3101 0.0 0
M  V30 10 N 2.4374 0.7700 0.0 0
M  V30 11 C 1.0304 0.1437 0.0 0
M  V30 12 C 2.2763 2.3016 0.0 0
M  V30 13 C 0.0000 1.2881 0.0 0
M  V30 14 C 0.7700 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105-13-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 122439-15-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-18533460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3144-16-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2171540-25-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM conversion 77%, catalyst prepared and used (stage 2)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Alkylation of cyclic amines with alcohols catalyzed by Ru(II) complexes
bearing N-Heterocyclic carbenes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ulu, Oznur Dogan; Gurbuz, Nevin; Ozdemir, Ismail
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2018), 74(6), 645-651

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluorobenzonitrile
C7H3BrFN
105942-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 7.7001 2.6673 0.0 0
M  V30 3 F 4.6201 0.0000 0.0 0
M  V30 4 Br 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8500 1.3337 0.0 0
M  V30 7 C 3.8500 4.0010 0.0 0
M  V30 8 C 2.3100 1.3337 0.0 0
M  V30 9 C 2.3100 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-(1-pyrrolidinyl)benzonitrile
C11H11BrN2
1359821-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4374 0.7700 0.0 0
M  V30 2 N 1.1037 0.0000 0.0 0
M  V30 3 Br 7.7722 3.8501 0.0 0
M  V30 4 C 3.7711 3.0801 0.0 0
M  V30 5 C 3.7711 1.5400 0.0 0
M  V30 6 C 5.1048 3.8501 0.0 0
M  V30 7 C 5.1048 0.7700 0.0 0
M  V30 8 C 6.4386 3.0801 0.0 0
M  V30 9 C 6.4386 1.5400 0.0 0
M  V30 10 N 2.4374 3.8501 0.0 0
M  V30 11 C 2.2765 5.3816 0.0 0
M  V30 12 C 1.0304 3.2236 0.0 0
M  V30 13 C 0.7700 5.7018 0.0 0
M  V30 14 C 0.0000 4.3682 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105942-08-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1359821-89-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20786404
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds and uses thereof in treatment
and prophylaxis of hepatitis B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019100735 A1 2019-05-31

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluorobenzonitrile
C7H3BrFN
105942-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 7.7001 2.6673 0.0 0
M  V30 3 F 4.6201 0.0000 0.0 0
M  V30 4 Br 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8500 1.3337 0.0 0
M  V30 7 C 3.8500 4.0010 0.0 0
M  V30 8 C 2.3100 1.3337 0.0 0
M  V30 9 C 2.3100 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-(1-pyrrolidinyl)benzonitrile
C11H11BrN2
1359821-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4374 0.7700 0.0 0
M  V30 2 N 1.1037 0.0000 0.0 0
M  V30 3 Br 7.7722 3.8501 0.0 0
M  V30 4 C 3.7711 3.0801 0.0 0
M  V30 5 C 3.7711 1.5400 0.0 0
M  V30 6 C 5.1048 3.8501 0.0 0
M  V30 7 C 5.1048 0.7700 0.0 0
M  V30 8 C 6.4386 3.0801 0.0 0
M  V30 9 C 6.4386 1.5400 0.0 0
M  V30 10 N 2.4374 3.8501 0.0 0
M  V30 11 C 2.2765 5.3816 0.0 0
M  V30 12 C 1.0304 3.2236 0.0 0
M  V30 13 C 0.7700 5.7018 0.0 0
M  V30 14 C 0.0000 4.3682 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105942-08-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1359821-89-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-19625467
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused tricyclic compounds as anti-hepatitis B virus agents
and uses thereof in medicine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Xinchang; Ren, Qingyun; Huang, Jianzhou; Xiong, Zhimin; Xiong,
Jinfeng; Li, You; Liu, Yang; Zou, Zhifu; Yan, Guanghua; Goldmann,
Siegfried; Zhang, Yingjun
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018219356 A1 2018-12-06

$RFMT $RIREG SCHEME18 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluorobenzonitrile
C7H3BrFN
105942-08-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 N 7.7001 2.6673 0.0 0
M  V30 3 F 4.6201 0.0000 0.0 0
M  V30 4 Br 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8500 1.3337 0.0 0
M  V30 7 C 3.8500 4.0010 0.0 0
M  V30 8 C 2.3100 1.3337 0.0 0
M  V30 9 C 2.3100 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-(1-pyrrolidinyl)benzonitrile
C11H11BrN2
1359821-89-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4374 0.7700 0.0 0
M  V30 2 N 1.1037 0.0000 0.0 0
M  V30 3 Br 7.7722 3.8501 0.0 0
M  V30 4 C 3.7711 3.0801 0.0 0
M  V30 5 C 3.7711 1.5400 0.0 0
M  V30 6 C 5.1048 3.8501 0.0 0
M  V30 7 C 5.1048 0.7700 0.0 0
M  V30 8 C 6.4386 3.0801 0.0 0
M  V30 9 C 6.4386 1.5400 0.0 0
M  V30 10 N 2.4374 3.8501 0.0 0
M  V30 11 C 2.2765 5.3816 0.0 0
M  V30 12 C 1.0304 3.2236 0.0 0
M  V30 13 C 0.7700 5.7018 0.0 0
M  V30 14 C 0.0000 4.3682 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 105942-08-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1359821-89-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9590233
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 19 Synthesis of TRY 1167 [00143] TRY 1167
4-(4-benzoylpiperazin-1-yl)-2-(pyrrolidin-1-yl)benzonitrile [00144]
4-bromo-2-fluorobenzonitrile (5.00 g, 25 mmol), pyrrolidine (2.5 mL, 30
mmol), DIPEA (6.5 mL, 37.5 mmol) and NMP (20 mL) were added to a tube.
The tube was sealed and stirred at room temperature overnight. The
reaction mixture was diluted with water and EtOAc. The aqueous layer was
back-extracted with EtOAc (3x). The combined organic layers were then
washed with H2O, 1N HCl (2x), saturated NaHCO3, H2O and brine before
drying with Na2SO4. The material was filtered and concentrated under
reduced pressure to give a solid. 6.2 g, crude yellow solid.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino substituted biaryl compounds as anti-amyloid agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reed, Mark A.; Yadav, Arun; Banfield, Scott C.; Barden, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012119035 A1 2012-09-07

$RFMT $RIREG SCHEME19 STEP1
$RXN



  2  1
$MOL
Quinone
C6H4O2
106-51-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Pyrrolidinyl)-2,5-cyclohexadiene-1,4-dione
C10H11NO2
197805-39-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.4374 4.9318 0.0 0
M  V30 2 O 7.7722 1.8517 0.0 0
M  V30 3 C 3.7710 2.6217 0.0 0
M  V30 4 C 3.7710 4.1617 0.0 0
M  V30 5 C 5.1047 1.8517 0.0 0
M  V30 6 C 5.1047 4.9318 0.0 0
M  V30 7 C 6.4385 2.6217 0.0 0
M  V30 8 C 6.4385 4.1617 0.0 0
M  V30 9 N 2.4374 1.8517 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 2.2765 0.3202 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 106-51-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 197805-39-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8369642
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM "On water": unprecedented nucleophilic substitution and addition
reactions with 1,4-quinones in aqueous suspension
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tandon, Vishnu K.; Maurya, Hardesh K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2009), 50(43), 5896-5902

$RFMT $RIREG SCHEME20 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3,3-difluoro-4,4-dihydroxy-1-piperidinecarboxylate
C10H17F2NO4
1067914-83-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7996 2.8502 0.0 0
M  V30 2 O 6.5696 4.1839 0.0 0
M  V30 3 O 6.5696 1.5166 0.0 0
M  V30 4 C 8.1096 4.1839 0.0 0
M  V30 5 C 8.1096 5.7239 0.0 0
M  V30 6 C 9.6496 4.1839 0.0 0
M  V30 7 C 8.1096 2.6439 0.0 0
M  V30 8 F 0.5025 0.9899 0.0 0
M  V30 9 F 2.2171 0.0000 0.0 0
M  V30 10 O 0.0000 3.8401 0.0 0
M  V30 11 O 0.0000 1.8603 0.0 0
M  V30 12 N 4.2596 2.8502 0.0 0
M  V30 13 C 3.4896 1.5166 0.0 0
M  V30 14 C 3.4896 4.1839 0.0 0
M  V30 15 C 1.9496 1.5166 0.0 0
M  V30 16 C 1.9496 4.1839 0.0 0
M  V30 17 C 1.1796 2.8502 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 15
M  V30 9 1 9 15
M  V30 10 1 10 17
M  V30 11 1 11 17
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1(2H)-Pyridinecarboxylic acid, 3,3-difluoro-3,6-dihydro-4-(1-pyrrolidinyl)-, ...
C14H22F2N2O2
2957830-11-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 3.2326 0.9899 0.0 0
M  V30 2 F 4.9473 0.0000 0.0 0
M  V30 3 C 8.5298 2.8502 0.0 0
M  V30 4 O 9.2998 4.1839 0.0 0
M  V30 5 O 9.2998 1.5166 0.0 0
M  V30 6 C 10.8398 4.1839 0.0 0
M  V30 7 C 10.8398 2.6439 0.0 0
M  V30 8 C 12.3798 4.1839 0.0 0
M  V30 9 C 10.8398 5.7239 0.0 0
M  V30 10 C 3.9098 2.8502 0.0 0
M  V30 11 C 4.6798 1.5166 0.0 0
M  V30 12 C 4.6798 4.1839 0.0 0
M  V30 13 C 6.2198 1.5166 0.0 0
M  V30 14 C 6.2198 4.1839 0.0 0
M  V30 15 N 6.9898 2.8502 0.0 0
M  V30 16 N 2.3698 2.8502 0.0 0
M  V30 17 C 1.4645 1.6044 0.0 0
M  V30 18 C 1.4645 4.0961 0.0 0
M  V30 19 C 0.0000 2.0802 0.0 0
M  V30 20 C 0.0000 3.6202 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 15
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 16
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1067914-83-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2957830-11-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37545745
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark trap used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of new benzimidazole pyridine derivatives for modulating SIK
activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Awale, Mahendra; Berchtold, Stefan; Charpentier, Julie; Colombano,
Heloise; Decoret, Guillaume; Groebke Zbinden, Katrin; Grossmann, Nicole;
Haap, Wolfgang; Harris, Philip Anthony; Hert, Jerome; Kallenbach, Jonah
Milton; Kramer, Christian; Kreis, Lukas; Krumm, Danny; Lucas Cabre,
Xavier; Manevski, Nenad; Pflieger, Philippe; Pourmousa Abkenar, Amir
Mohsen; Rauber, Etienne; Tan, Dazhi; Wach, Jean-Yves; Wermuth, Roger
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023139085 A1 2023-07-27

$RFMT $RIREG SCHEME21 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Acetyl-5-(4-fluorophenyl)-1,3-cyclohexanedione
C14H13FO3
1083067-13-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 0.0000 0.0 0
M  V30 2 O 2.3101 5.3350 0.0 0
M  V30 3 C 0.7700 2.6675 0.0 0
M  V30 4 C 0.0000 4.0012 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 F 11.5503 2.6675 0.0 0
M  V30 7 C 5.3901 2.6675 0.0 0
M  V30 8 C 4.6201 1.3338 0.0 0
M  V30 9 C 4.6201 4.0012 0.0 0
M  V30 10 C 3.0801 1.3338 0.0 0
M  V30 11 C 3.0801 4.0012 0.0 0
M  V30 12 C 2.3101 2.6675 0.0 0
M  V30 13 C 6.9302 2.6675 0.0 0
M  V30 14 C 7.7002 4.0012 0.0 0
M  V30 15 C 7.7002 1.3338 0.0 0
M  V30 16 C 9.2402 4.0012 0.0 0
M  V30 17 C 9.2402 1.3338 0.0 0
M  V30 18 C 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 6 18
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(4-Fluorophenyl)-2-[1-(1-pyrrolidinyl)ethylidene]-1,3-cyclohexanedione
C18H20FNO2
1083067-14-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6217 3.7710 0.0 0
M  V30 2 C 1.8517 5.1048 0.0 0
M  V30 3 O 4.1617 1.1037 0.0 0
M  V30 4 O 4.1617 6.4384 0.0 0
M  V30 5 F 13.4017 3.7710 0.0 0
M  V30 6 C 4.1617 3.7710 0.0 0
M  V30 7 C 4.9317 2.4374 0.0 0
M  V30 8 C 4.9317 5.1048 0.0 0
M  V30 9 C 6.4717 2.4374 0.0 0
M  V30 10 C 6.4717 5.1048 0.0 0
M  V30 11 C 7.2417 3.7710 0.0 0
M  V30 12 N 1.8517 2.4374 0.0 0
M  V30 13 C 0.3202 2.2764 0.0 0
M  V30 14 C 2.4782 1.0306 0.0 0
M  V30 15 C 0.0000 0.7700 0.0 0
M  V30 16 C 1.3336 0.0000 0.0 0
M  V30 17 C 8.7817 3.7710 0.0 0
M  V30 18 C 9.5517 5.1048 0.0 0
M  V30 19 C 9.5517 2.4374 0.0 0
M  V30 20 C 11.0917 5.1048 0.0 0
M  V30 21 C 11.0917 2.4374 0.0 0
M  V30 22 C 11.8617 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 6
M  V30 3 1 1 12
M  V30 4 2 3 7
M  V30 5 2 4 8
M  V30 6 1 5 22
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 11 17
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1083067-13-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1083067-14-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5986529
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-based Identification of Hsp90 Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barker, John J.; Barker, Oliver; Boggio, Roberto; Chauhan, Viddhata;
Cheng, Robert K. Y.; Corden, Vincent; Courtney, Stephen M.; Edwards,
Neil; Falque, Virginie M.; Fusar, Fulvia; Gardiner, Mihaly; Hamelin,
Estelle M. N.; Hesterkamp, Thomas; Ichihara, Osamu; Jones, Richard S.;
Mather, Owen; Mercurio, Ciro; Minucci, Saverio; Montalbetti, Christian A.
G. N.; Muller, Annett; Patel, Deepti; Phillips, Banu G.; Varasi, Mario;
Whittaker, Mark; Winkler, Dirk; Yarnold, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2009), 4(6), 963-966

$RFMT $RIREG SCHEME22 STEP1
$RXN



  2  1
$MOL
2-Bromopyridine
C5H4BrN
109-04-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Pyrrolidinyl)pyridine
C9H12N2
54660-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3698 1.3337 0.0 0
M  V30 2 C 1.4646 0.0878 0.0 0
M  V30 3 C 1.4646 2.5795 0.0 0
M  V30 4 C 0.0000 0.5636 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 3.9098 1.3337 0.0 0
M  V30 7 C 4.6798 0.0000 0.0 0
M  V30 8 N 4.6798 2.6673 0.0 0
M  V30 9 C 6.2198 0.0000 0.0 0
M  V30 10 C 6.2198 2.6673 0.0 0
M  V30 11 C 6.9898 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-04-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54660-06-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1153851
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7778-53-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2903-48-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for N-arylation: An
oven-dried Schlenk tube was charged with CuI (19 mg, 0.1 mmol), DMPAO (38
mg, 0.2 mmol), aryl halide (1 mmol), K3PO4 (2 mmol). The tube was
evacuated and backfilled with argon, and then amine (1.5 mmol) and DMSO
(1 mL) was added. The reaction mixture was stirred at 90 oC for 48 h.
After aryl halide was consumed, water was added and the mixture was
extracted with ethyl acetate. The organic layer was dried over Na2SO4 and
evaporated. The residue was purified by chromatography to give the
desired product. 2-Pyrrolidinopyridine (3au)25. Yield 100%. 1H NMR (300
MHz, CDCl3) δ 8.15 (d, J = 3.0 Hz, 1H), 7.39 (td, J = 1.5, 6.0 Hz, 1H),
6.48 (dd, J = 4.8, 4.2 Hz, 1H), 6.31 (d, J = 6.0 Hz, 1H), 3.46-3.38 (m,
4H), 2.01-1.93 (m, 4H); 13C NMR (100 MHz, CDCl3) δ 157.2, 148.0, 136.7,
110.9, 106.4, 46.5, 25.4; ESI-MS m/z 149 (M + H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM Ullmann-type conditions, catalyst ligand prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM CuI/DMPAO-Catalyzed N-Arylation of Acyclic Secondary Amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yu; Yang, Xinye; Yao, Qizheng; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(12), 3056-3059

$RFMT $RIREG SCHEME23 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-3-methyl-1-[[(methylsulfonyl)oxy]methyl]butyl]carba...
C12H25NO5S
109687-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0 CFG=1
M  V30 2 N 5.3900 5.3347 0.0 0
M  V30 3 C 7.7000 4.0011 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 C 3.8500 5.3347 0.0 0
M  V30 6 O 8.4700 5.3347 0.0 0
M  V30 7 C 6.1600 1.3338 0.0 0
M  V30 8 O 3.0800 6.6685 0.0 0
M  V30 9 O 3.0800 4.0011 0.0 0
M  V30 10 S 10.0100 5.3347 0.0 0 VAL=6
M  V30 11 C 7.7000 1.3338 0.0 0
M  V30 12 C 5.3900 0.0000 0.0 0
M  V30 13 C 1.5400 6.6685 0.0 0
M  V30 14 C 10.0100 6.8747 0.0 0
M  V30 15 O 11.5500 5.3347 0.0 0
M  V30 16 O 10.0100 3.7947 0.0 0
M  V30 17 C 1.5400 8.2085 0.0 0
M  V30 18 C 0.0000 6.6685 0.0 0
M  V30 19 C 1.5400 5.1285 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 10 14
M  V30 14 2 10 15
M  V30 15 2 10 16
M  V30 16 1 13 17
M  V30 17 1 13 18
M  V30 18 1 13 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-3-methyl-1-(1-pyrrolidinylmethyl)butyl]carbamate
C15H30N2O2
1379661-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.1617 4.0011 0.0 0 CFG=2
M  V30 2 C 2.6217 4.0011 0.0 0
M  V30 3 N 4.9317 5.3347 0.0 0
M  V30 4 C 4.9317 2.6674 0.0 0
M  V30 5 C 6.4717 5.3347 0.0 0
M  V30 6 C 4.1617 1.3338 0.0 0
M  V30 7 O 7.2417 6.6685 0.0 0
M  V30 8 O 7.2417 4.0011 0.0 0
M  V30 9 C 4.9317 0.0000 0.0 0
M  V30 10 C 2.6217 1.3338 0.0 0
M  V30 11 C 8.7817 6.6685 0.0 0
M  V30 12 C 8.7817 5.1285 0.0 0
M  V30 13 C 10.3217 6.6685 0.0 0
M  V30 14 C 8.7817 8.2085 0.0 0
M  V30 15 N 1.8517 5.3347 0.0 0
M  V30 16 C 2.4782 6.7417 0.0 0
M  V30 17 C 0.3202 5.4958 0.0 0
M  V30 18 C 1.3336 7.7721 0.0 0
M  V30 19 C 0.0000 7.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 15
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109687-65-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1379661-36-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21897574
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antimalarial activity of new 4-aminoquinolines active
against drug resistant strains
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kondaparla, Srinivasarao; Soni, Awakash; Manhas, Ashan; Srivastava,
Kumkum; Puri, Sunil K.; Katti, S. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(107), 105676-105689

$RFMT $RIREG SCHEME24 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-[[(methylsulfonyl)oxy]methyl]-2-phenylethyl]carba...
C15H23NO5S
109687-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0 CFG=1
M  V30 2 C 6.1600 4.0011 0.0 0
M  V30 3 N 6.1600 6.6685 0.0 0
M  V30 4 C 3.8500 5.3347 0.0 0
M  V30 5 C 7.7000 6.6685 0.0 0
M  V30 6 O 3.0800 6.6685 0.0 0
M  V30 7 O 8.4700 8.0021 0.0 0
M  V30 8 O 8.4700 5.3347 0.0 0
M  V30 9 S 1.5400 6.6685 0.0 0 VAL=6
M  V30 10 C 10.0100 8.0021 0.0 0
M  V30 11 C 1.5400 5.1285 0.0 0
M  V30 12 O 0.0000 6.6685 0.0 0
M  V30 13 O 1.5400 8.2085 0.0 0
M  V30 14 C 10.0100 6.4621 0.0 0
M  V30 15 C 11.5500 8.0021 0.0 0
M  V30 16 C 10.0100 9.5421 0.0 0
M  V30 17 C 5.3900 2.6674 0.0 0
M  V30 18 C 3.8500 2.6674 0.0 0
M  V30 19 C 6.1600 1.3336 0.0 0
M  V30 20 C 3.0800 1.3338 0.0 0
M  V30 21 C 5.3900 0.0000 0.0 0
M  V30 22 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 17
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 10 15
M  V30 16 1 10 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 2 19 21
M  V30 21 2 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-1-(phenylmethyl)-2-(1-pyrrolidinyl)ethyl]-, 1,1-dimethyl...
C18H28N2O2
869377-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9538 5.1047 0.0 0 CFG=1
M  V30 2 C 6.7238 3.7711 0.0 0
M  V30 3 C 6.7238 6.4386 0.0 0
M  V30 4 N 4.4137 5.1047 0.0 0
M  V30 5 C 3.6437 6.4386 0.0 0
M  V30 6 O 2.1037 6.4386 0.0 0
M  V30 7 O 4.4137 7.7722 0.0 0
M  V30 8 C 1.3337 7.7722 0.0 0
M  V30 9 C 2.6673 8.5423 0.0 0
M  V30 10 C 0.5637 9.1059 0.0 0
M  V30 11 C 0.0000 7.0022 0.0 0
M  V30 12 N 5.9538 2.4374 0.0 0
M  V30 13 C 6.5801 1.0304 0.0 0
M  V30 14 C 4.4222 2.2763 0.0 0
M  V30 15 C 5.4357 0.0000 0.0 0
M  V30 16 C 4.1020 0.7700 0.0 0
M  V30 17 C 8.2638 6.4386 0.0 0
M  V30 18 C 9.0338 5.1047 0.0 0
M  V30 19 C 9.0338 7.7722 0.0 0
M  V30 20 C 10.5739 5.1047 0.0 0
M  V30 21 C 10.5739 7.7722 0.0 0
M  V30 22 C 11.3439 6.4386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 12
M  V30 5 1 3 17
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 109687-66-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 869377-95-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21897583
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antimalarial activity of new 4-aminoquinolines active
against drug resistant strains
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kondaparla, Srinivasarao; Soni, Awakash; Manhas, Ashan; Srivastava,
Kumkum; Puri, Sunil K.; Katti, S. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(107), 105676-105689

$RFMT $RIREG SCHEME25 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-tricyclo[3.3.1.13,7]dec-1-ylcarbamodithioate
C13H21NS2
1107665-46-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5263 3.0148 0.0 0
M  V30 2 C 6.8612 2.2441 0.0 0
M  V30 3 S 8.1962 3.0148 0.0 0
M  V30 4 S 6.8612 0.7026 0.0 0
M  V30 5 C 9.5311 2.2441 0.0 0
M  V30 6 C 10.8661 3.0148 0.0 0
M  V30 7 C 4.1914 2.2441 0.0 0
M  V30 8 C 2.9021 3.0835 0.0 0
M  V30 9 C 4.2737 0.7078 0.0 0
M  V30 10 C 2.4961 2.2333 0.0 0
M  V30 11 C 1.6951 2.3866 0.0 0
M  V30 12 C 3.0667 0.0111 0.0 0
M  V30 13 C 1.2891 1.5364 0.0 0
M  V30 14 C 0.0000 2.3755 0.0 0
M  V30 15 C 1.7776 0.8504 0.0 0
M  V30 16 C 1.3714 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 11 14
M  V30 14 1 11 15
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 13 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Tricyclo[3.3.1.13,7]dec-1-yl-1-pyrrolidinecarbothioamide
C15H24N2S
29456-86-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.5214 1.8518 0.0 0
M  V30 2 C 6.8551 2.6218 0.0 0
M  V30 3 S 6.8551 4.1619 0.0 0
M  V30 4 C 4.1876 2.6218 0.0 0
M  V30 5 C 2.8995 1.7833 0.0 0
M  V30 6 C 4.2699 4.1567 0.0 0
M  V30 7 C 2.4939 2.6328 0.0 0
M  V30 8 C 1.6936 2.4794 0.0 0
M  V30 9 C 3.0640 4.8530 0.0 0
M  V30 10 C 1.2880 3.3289 0.0 0
M  V30 11 C 0.0000 2.4905 0.0 0
M  V30 12 C 1.7759 4.0142 0.0 0
M  V30 13 C 1.3702 4.8639 0.0 0
M  V30 14 N 8.1889 1.8518 0.0 0
M  V30 15 C 9.5958 2.4781 0.0 0
M  V30 16 C 8.3499 0.3202 0.0 0
M  V30 17 C 10.6263 1.3337 0.0 0
M  V30 18 C 9.8562 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 1 2 14
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 10 11
M  V30 16 1 10 13
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1107665-46-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 29456-86-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-15538132
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly efficient and catalyst-free synthesis of unsymmetrical thioureas
under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Halimehjani, Azim Ziyaei; Pourshojaei, Yaghoub; Saidi, Mohammad R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2009), 50(1), 32-34

$RFMT $RIREG SCHEME26 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1-(3-chloropropyl)-1H-indazole
C10H10BrClN2
1108184-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2708 3.1884 0.0 0
M  V30 2 C 8.7355 2.7126 0.0 0
M  V30 3 C 9.8799 3.7430 0.0 0
M  V30 4 Cl 11.3446 3.2671 0.0 0
M  V30 5 Br 0.0000 2.4782 0.0 0
M  V30 6 C 4.6200 2.4782 0.0 0
M  V30 7 C 3.8500 1.1444 0.0 0
M  V30 8 N 6.1264 2.1580 0.0 0
M  V30 9 C 3.8500 3.8118 0.0 0
M  V30 10 C 2.3100 1.1444 0.0 0
M  V30 11 C 4.8806 0.0000 0.0 0
M  V30 12 N 6.2874 0.6263 0.0 0
M  V30 13 C 2.3100 3.8118 0.0 0
M  V30 14 C 1.5400 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 14
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 2 7 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 12
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1-[3-(1-pyrrolidinyl)propyl]-1H-indazole
C14H18BrN3
1108184-27-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5654 3.1884 0.0 0
M  V30 2 C 5.1008 2.7124 0.0 0
M  V30 3 C 3.9564 3.7429 0.0 0
M  V30 4 Br 13.8362 2.4780 0.0 0
M  V30 5 C 9.2162 2.4780 0.0 0
M  V30 6 C 9.9862 1.1444 0.0 0
M  V30 7 N 7.7098 2.1578 0.0 0
M  V30 8 C 9.9862 3.8118 0.0 0
M  V30 9 C 8.9558 0.0000 0.0 0
M  V30 10 C 11.5262 1.1444 0.0 0
M  V30 11 N 7.5489 0.6263 0.0 0
M  V30 12 C 11.5262 3.8118 0.0 0
M  V30 13 C 12.2962 2.4780 0.0 0
M  V30 14 N 2.4917 3.2671 0.0 0
M  V30 15 C 1.2459 4.1721 0.0 0
M  V30 16 C 2.0158 1.8024 0.0 0
M  V30 17 C 0.0000 3.2671 0.0 0
M  V30 18 C 0.4759 1.8024 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 14
M  V30 5 1 4 13
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 9 11
M  V30 14 1 10 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1108184-26-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1108184-27-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12395025
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM d) 5-Bromo-1-(3-(pyrrolidin-1-yl)propyl)-1H-indazole [00167] To a
solution of 5-bromo-1-(3-chloropropyl)-1H-indazole (2.14 g, 7.84 mmol) in
DMF (40 mL) was added potassium iodide (1.3 mg, 7.8 mmol) and K2CO3(5.40
g, 39.2 mmol) under N2(g). Then pyrrolidine (17.2 ml, 26.6 mmol) was
added. The reaction was heated to 50&#x00B0;C for 20 h. The reaction was
diluted with EtOAc (100 mL) and washed with a 5% LiCl solution (4×). The
organics were dried (Na2SO4), filtered, and concentrated to give the
title compound (2.48 g, quant.) as a brown oil:. 1H NMR (300 MHz, CDCl3)
&#x03B4; 7.93 (s, 1H), 7.85 (d, J=1.2 Hz, 1H), 7.45-7.41 (dd, J=8.9, 1.7
Hz, 1H), 7.36 (d, J=8.9 Hz, 1H), 4.45 (t, J=6.7 Hz, 1H), 2.44-2.36 (m,
6H), 2.15-2.07 (m, 2H), 1.78-1.74 (m, 4H); ESI MS m/z 308 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-pyridinone substituted indazoles as
melanin-concentrating hormone (MCH1) receptor selective antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guzzo, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009015037 A2 2009-01-29

$RFMT $RIREG SCHEME27 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tris(pentafluorophenyl)borane
C18BF15
1109-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 6.6684 7.7000 0.0 0
M  V30 2 F 10.6694 6.9300 0.0 0
M  V30 3 F 8.0020 11.5500 0.0 0
M  V30 4 F 5.3347 11.5500 0.0 0
M  V30 5 F 2.6673 6.9300 0.0 0
M  V30 6 F 9.3358 4.6200 0.0 0
M  V30 7 F 4.0009 4.6200 0.0 0
M  V30 8 F 13.3367 8.4700 0.0 0
M  V30 9 F 10.6694 13.0900 0.0 0
M  V30 10 F 2.6673 13.0900 0.0 0
M  V30 11 F 0.0000 8.4700 0.0 0
M  V30 12 F 9.3358 1.5400 0.0 0
M  V30 13 F 4.0009 1.5400 0.0 0
M  V30 14 F 13.3367 11.5500 0.0 0
M  V30 15 F 0.0000 11.5500 0.0 0
M  V30 16 F 6.6684 0.0000 0.0 0
M  V30 17 C 9.3358 9.2400 0.0 0
M  V30 18 C 10.6694 8.4700 0.0 0
M  V30 19 C 9.3356 10.7800 0.0 0
M  V30 20 C 12.0031 9.2400 0.0 0
M  V30 21 C 10.6694 11.5500 0.0 0
M  V30 22 C 12.0031 10.7800 0.0 0
M  V30 23 C 4.0009 9.2400 0.0 0
M  V30 24 C 4.0009 10.7800 0.0 0
M  V30 25 C 2.6673 8.4700 0.0 0
M  V30 26 C 2.6673 11.5500 0.0 0
M  V30 27 C 1.3336 9.2400 0.0 0
M  V30 28 C 1.3336 10.7800 0.0 0
M  V30 29 C 6.6684 4.6200 0.0 0
M  V30 30 C 8.0020 3.8500 0.0 0
M  V30 31 C 5.3347 3.8500 0.0 0
M  V30 32 C 8.0020 2.3100 0.0 0
M  V30 33 C 5.3347 2.3100 0.0 0
M  V30 34 C 6.6684 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 2 18
M  V30 5 1 3 19
M  V30 6 1 4 24
M  V30 7 1 5 25
M  V30 8 1 6 30
M  V30 9 1 7 31
M  V30 10 1 8 20
M  V30 11 1 9 21
M  V30 12 1 10 26
M  V30 13 1 11 27
M  V30 14 1 12 32
M  V30 15 1 13 33
M  V30 16 1 14 22
M  V30 17 1 15 28
M  V30 18 1 16 34
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Boron, tris(pentafluorophenyl)(pyrrolidine)-, (T-4)-
C22H9BF15N
357213-85-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 7.7000 8.4700 0.0 0 CHG=3 VAL=4
M  V30 2 F 4.6200 5.8026 0.0 0
M  V30 3 F 4.6200 11.1373 0.0 0
M  V30 4 F 10.7800 11.1373 0.0 0
M  V30 5 F 10.7800 5.8026 0.0 0
M  V30 6 F 5.0326 4.6200 0.0 0
M  V30 7 F 10.3674 4.6200 0.0 0
M  V30 8 F 1.5400 5.8026 0.0 0
M  V30 9 F 1.5400 11.1373 0.0 0
M  V30 10 F 13.8600 11.1373 0.0 0
M  V30 11 F 13.8600 5.8026 0.0 0
M  V30 12 F 5.0326 1.5400 0.0 0
M  V30 13 F 10.3674 1.5400 0.0 0
M  V30 14 F 0.0000 8.4700 0.0 0
M  V30 15 F 15.4000 8.4700 0.0 0
M  V30 16 F 7.7000 0.0000 0.0 0
M  V30 17 C 4.6200 8.4700 0.0 0 CHG=-1 VAL=4
M  V30 18 C 3.8500 7.1364 0.0 0
M  V30 19 C 3.8500 9.8036 0.0 0
M  V30 20 C 2.3100 7.1364 0.0 0
M  V30 21 C 2.3100 9.8036 0.0 0
M  V30 22 C 1.5400 8.4700 0.0 0
M  V30 23 C 10.7800 8.4700 0.0 0 CHG=-1 VAL=4
M  V30 24 C 11.5500 9.8036 0.0 0
M  V30 25 C 11.5500 7.1364 0.0 0
M  V30 26 C 13.0900 9.8036 0.0 0
M  V30 27 C 13.0900 7.1364 0.0 0
M  V30 28 C 13.8600 8.4700 0.0 0
M  V30 29 C 7.7000 4.6200 0.0 0 CHG=-1 VAL=4
M  V30 30 C 6.3664 3.8500 0.0 0
M  V30 31 C 9.0336 3.8500 0.0 0
M  V30 32 C 6.3664 2.3100 0.0 0
M  V30 33 C 9.0336 2.3100 0.0 0
M  V30 34 C 7.7000 1.5400 0.0 0
M  V30 35 N 7.7000 11.5500 0.0 0 VAL=4
M  V30 36 C 8.9459 12.4552 0.0 0
M  V30 37 C 6.4541 12.4552 0.0 0
M  V30 38 C 8.4700 13.9198 0.0 0
M  V30 39 C 6.9300 13.9198 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 1 23
M  V30 3 1 1 29
M  V30 4 1 1 35
M  V30 5 1 2 18
M  V30 6 1 3 19
M  V30 7 1 4 24
M  V30 8 1 5 25
M  V30 9 1 6 30
M  V30 10 1 7 31
M  V30 11 1 8 20
M  V30 12 1 9 21
M  V30 13 1 10 26
M  V30 14 1 11 27
M  V30 15 1 12 32
M  V30 16 1 13 33
M  V30 17 1 14 22
M  V30 18 1 15 28
M  V30 19 1 16 34
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 22
M  V30 26 1 23 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 1 29 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 34
M  V30 38 1 35 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1109-15-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 357213-85-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28170559
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-[Tris(pentafluorophenyl)borane]pyrrolidine (19). A solution of
pyrrolidine (0.34 g, 4.78 mmol) in 3 mL of dichloromethane was added at
room temperature under nitrogen atmosphere to a solution of
tris(pentafluorophenyl)borane (2.44 g, 4.77 mmol) in 15 mL of
dichloromethane in a 25 mL Schlenk flask. A light exothermicity was
observed. The reaction mixture was stirred for 30 min at room
temperature, and then the solvent was evaporated in vacuo to give a white
powder as product (yield = 100%):
N-[Tris(pentafluorophenyl)borane]pyrrolidine (19), yield 100%. mp
205.0-206.9 °C; 1H NMR (CD2Cl2) δ 1.84-2.09 (m, 4H, H3, H3', H4, H4'),
2.68-2.86 (m, 2H, H2 and H5), 3.44-3.54 (m, 2H, H2' and H5'), 6.30 (bs,
1H, NH); 13C NMR (CD2Cl2) δ 23.86 (C3 and C4), 50.37 (C2 and C5).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Reactivity of (C6F5)3B-N-Heterocycle Complexes. 1.
Generation of Highly Acidic sp3 Carbons in Pyrroles and Indoles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guidotti, Simona; Camurati, Isabella; Focante, Francesca; Angellini,
Luca; Moscardi, Gilberto; Resconi, Luigi; Leardini, Rino; Nanni, Daniele;
Mercandelli, Pierluigi; Sironi, Angelo; Beringhelli, Tiziana; Maggioni,
Daniela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2003), 68(14), 5445-5465

$RFMT $RIREG SCHEME28 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Heptenoic acid
C7H12O2
1119-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 9 C 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Pyrrolidinyl)-6-hepten-1-one
C11H19NO
95018-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4384 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4396 2.3101 0.0 0
M  V30 8 C 11.7733 1.5400 0.0 0
M  V30 9 N 2.4373 2.3101 0.0 0
M  V30 10 C 1.0304 1.6836 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 0.0000 2.8281 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1119-60-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95018-93-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17876120
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective Intermolecular Cross-Enolate-Type Coupling of Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaiser, Daniel; Teskey, Christopher J.; Adler, Pauline; Maulide, Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(45), 16040-16043

$RFMT $RIREG SCHEME29 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexyl isothiocyanate
C7H11NS
1122-82-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Cyclohexyl-1-pyrrolidinecarbothioamide
C11H20N2S
15260-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0
M  V30 2 N 4.6201 1.3337 0.0 0
M  V30 3 S 4.6201 4.0010 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 7.8354 1.4215 0.0 0
M  V30 6 C 7.8354 3.9132 0.0 0
M  V30 7 C 9.3000 1.8973 0.0 0
M  V30 8 C 9.3000 3.4374 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 9
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-82-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15260-45-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-18878337
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thiourea-Group IV transition metal catalysts and polymerization systems
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krasovskiy, Arkady L.; Szuromi, Endre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018063799 A1 2018-04-05

$RFMT $RIREG SCHEME30 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimethylsilyl cyanide
C4H9NSi
7677-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(4-Bromophenyl)-1-pyrrolidineacetonitrile
C12H13BrN2
701053-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.0801 0.0 0
M  V30 2 C 3.7711 1.5400 0.0 0
M  V30 3 N 3.7711 0.0000 0.0 0
M  V30 4 Br 9.1059 6.1601 0.0 0
M  V30 5 C 5.1047 3.8501 0.0 0
M  V30 6 C 5.1047 5.3901 0.0 0
M  V30 7 C 6.4385 3.0801 0.0 0
M  V30 8 C 6.4385 6.1601 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 C 7.7722 5.3901 0.0 0
M  V30 11 N 2.4374 3.8501 0.0 0
M  V30 12 C 1.0304 3.2237 0.0 0
M  V30 13 C 2.2763 5.3816 0.0 0
M  V30 14 C 0.0000 4.3681 0.0 0
M  V30 15 C 0.7700 5.7018 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 3 2 3
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 7677-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701053-88-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-346-CAS-11006699
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10049-08-8
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM complexes with EDTA; polymer-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(4-Bromophenyl)-2-(pyrrolidin-2-yl)acetonitrile (Entry 5).9 Employing
4-bromobenzaldehyde and pyrrolidine as precursors, the micro reaction was
conducted at a total flow rate of 20 μL min-1, affording the title
compound as a pale yellow oil (0.040 g, 99.9%). δ H (400 MHz, CDCl3/TMS)
1.82 (4H, m, 2 × CH2), 2.57-2.67 (4H, m, 2 × CH2), 5.00 (1H, s, CH), 7.38
(2H, d, J 10.9, 2 × ArH) and 7.48 (2H, d, J 10.9, 2 × ArH), NH not
observed; δ C (100 MHz, CDCl3/TMS) 23.1 (2 × CH2), 49.8 (2 × CH2), 58.3
(CH), 115.3 (CN), 122.4 (C0Br), 128.9 (2 × CH), 131.9 (2 × CH) and 133.1
(C0).
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, Strecker reaction, flow system used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An Integrated Microreactor for the Multicomponent Synthesis of
α-Aminonitriles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wiles, Charlotte; Watts, Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2008), 12(5), 1001-1006

$RFMT $RIREG SCHEME31 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Bromophenyl)methyl]pyrrolidine
C11H14BrN
4897-55-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.0801 0.0 0
M  V30 2 Br 9.1059 0.0000 0.0 0
M  V30 3 C 5.1048 2.3101 0.0 0
M  V30 4 C 6.4386 3.0801 0.0 0
M  V30 5 C 5.1048 0.7700 0.0 0
M  V30 6 C 7.7722 2.3101 0.0 0
M  V30 7 C 6.4386 0.0000 0.0 0
M  V30 8 C 7.7722 0.7700 0.0 0
M  V30 9 N 2.4374 2.3101 0.0 0
M  V30 10 C 1.0304 2.9364 0.0 0
M  V30 11 C 2.2763 0.7785 0.0 0
M  V30 12 C 0.0000 1.7920 0.0 0
M  V30 13 C 0.7700 0.4583 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 8
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4897-55-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35865138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrazine-2-carboxamides as HPK1 inhibitors for
the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nilsson Lill, Sten; Giblin, Kathryn; Kettle, Jason Grant; Goldberg,
Frederick Woolf; Grimster, Neil Patrick; Morrill, Lucas; Escobar,
Randolph; Metrano, Anthony; Song, Kun; Sheppeck, James; Ziegler, Robert
Evans; Wu, Ye; Sha, Li; Wu, Dedong; Grebe, Tyler; Mfuh, Adelphe; Balazs,
Amber; Shields, Jason
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023001794 A1 2023-01-26

$RFMT $RIREG SCHEME32 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromobenzaldehyde
C7H5BrO
1122-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Bromophenyl)-1-pyrrolidinylmethanone
C11H12BrNO
5543-27-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 Br 9.1059 4.6201 0.0 0
M  V30 4 C 5.1048 2.3101 0.0 0
M  V30 5 C 5.1048 3.8501 0.0 0
M  V30 6 C 6.4386 1.5400 0.0 0
M  V30 7 C 6.4386 4.6201 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 N 2.4374 2.3101 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1122-91-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 5543-27-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41356622
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1313-99-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7440-02-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 112-40-3
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, catalyst prepared and used, reusable catalyst, 91% isolated
yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A cooperative nanoscale ZnO-NiO-Ni heterojunction for sustainable
catalytic amidation of aldehydes with secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shelte, Amishwar Raysing; Patil, Rahul Daga; Pratihar, Sanjay
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Sustainability (2024), 2(9), 2615-2625

$RFMT $RIREG SCHEME33 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzyloxycarbonylglycine
C10H11NO4
1138-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 N 8.0022 2.3101 0.0 0
M  V30 5 O 6.6685 0.0000 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 C 10.6697 2.3101 0.0 0
M  V30 8 O 12.0033 1.5400 0.0 0
M  V30 9 O 10.6697 3.8501 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 C 2.6673 3.8501 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl N-[2-oxo-2-(1-pyrrolidinyl)ethyl]carbamate
C14H18N2O3
56414-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 2.3100 0.0 0
M  V30 2 C 9.3359 3.0800 0.0 0
M  V30 3 O 10.6697 0.7700 0.0 0
M  V30 4 N 8.0022 2.3100 0.0 0
M  V30 5 C 6.6686 3.0800 0.0 0
M  V30 6 O 5.3348 2.3100 0.0 0
M  V30 7 O 6.6686 4.6200 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 N 12.0033 3.0800 0.0 0
M  V30 10 C 12.1642 4.6116 0.0 0
M  V30 11 C 13.4101 2.4535 0.0 0
M  V30 12 C 13.6707 4.9317 0.0 0
M  V30 13 C 14.4407 3.5981 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 15 C 1.3338 3.0800 0.0 0
M  V30 16 C 2.6675 0.7700 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 18 C 1.3338 0.0000 0.0 0
M  V30 19 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 14
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1138-80-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56414-65-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11613899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 39968-33-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Part A: Phenylmethyl [2-oxo-2-(1-pyrrolidinyl)ethyl]carbamate.
Pyrrolidine (248 μL, 3 mmol), N-CBZ-glycine (628 mg, 3 mmol), and HOAt
(408 mg, 3 mmol) were dissolved in 10 mL of dichloromethane. NMM (0.66
mL, 6 mmol) was added, followed by EDC (575 mg, 3 mmol). After stirring
overnight at room temperature, the reaction mixture was diluted with
dichloromethane, washed with water, saturated aqueous NaHCO3 solution,
and saturated aqueous NH4Cl solution, then dried (Na2SO4) and evaporated
to yield phenylmethyl [2-oxo-2-(1-pyrrolidinyl)ethyl]carbamate as a beige
solid (782 mg, 100%). LCMS:(M+H)+: 263.1.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [(Pyrimidinylhydrazino)-3-oxopropyl]hydroxyformamide derivatives as
bacterial peptide deformylase inhibitors and preparation, pharmaceutical
compositions and use in the treatment of bacterial infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qin, Donghui; Norton, Beth; Liao, Xiangmin; Knox, Andrew Nicholson; Fang,
Yuhong; Lee, Jinhwa; Dreabit, Jason Christopher; Christensen, Siegfried
Benjamin, IV; Benowitz, Andrew B.; Aubart, Kelly M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009061879 A1 2009-05-14

$RFMT $RIREG SCHEME34 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-3-pyridinecarboxaldehyde
C6H4ClNO
114077-82-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 Cl 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 N 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyridine, 4-chloro-3-(1-pyrrolidinylmethyl)-
C10H13ClN2
2243023-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 Cl 1.3337 0.0000 0.0 0
M  V30 3 C 2.6675 2.3100 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 2.6675 3.8500 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 N 1.3337 4.6201 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 N 5.3348 2.3100 0.0 0
M  V30 10 C 6.7417 1.6837 0.0 0
M  V30 11 C 5.4957 3.8416 0.0 0
M  V30 12 C 7.7722 2.8281 0.0 0
M  V30 13 C 7.0021 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 4
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 114077-82-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2243023-20-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-19368724
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product further converted to oxalic acid salt with 97% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroaromatic electrophiles for reactivating or realkylating aged
acetylcholinesterase inhibited by or conjugated to organophosphorus
compounds and methods of using thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hadad, Christopher; Callam, Christopher; Beck, Jeremy; Zhuang, Qinggeng;
Franjesevic, Andrew; Corrigan, Thomas; McElroy, Craig
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018152329 A1 2018-08-23

$RFMT $RIREG SCHEME35 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 6-Oxa-3-azabicyclo[3.1.0]hexane-3-carboxylate
C9H15NO3
114214-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8737 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 C 7.7598 2.1037 0.0 0
M  V30 9 C 7.7598 3.6437 0.0 0
M  V30 10 O 9.0934 2.8737 0.0 0
M  V30 11 C 6.2952 1.6278 0.0 0
M  V30 12 C 6.2952 4.1195 0.0 0
M  V30 13 N 5.3900 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 10
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (3′R,4′R)-4′-hydroxy[1,3′-bipyrrolidine]-1′-carboxylate
C13H24N2O3
960289-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.1127 0.0000 0.0 0
M  V30 2 C 7.7401 4.0287 0.0 0
M  V30 3 O 9.0737 3.2587 0.0 0
M  V30 4 O 7.7401 5.5688 0.0 0
M  V30 5 C 10.4075 4.0287 0.0 0
M  V30 6 C 9.6375 5.3624 0.0 0
M  V30 7 C 11.7412 4.7987 0.0 0
M  V30 8 C 11.1776 2.6951 0.0 0
M  V30 9 C 3.9690 2.7406 0.0 0 CFG=1
M  V30 10 C 4.9994 3.8850 0.0 0
M  V30 11 C 4.7390 1.4070 0.0 0 CFG=2
M  V30 12 N 6.4064 3.2587 0.0 0
M  V30 13 C 6.2455 1.7271 0.0 0
M  V30 14 N 2.4374 2.9016 0.0 0
M  V30 15 C 1.6674 4.2352 0.0 0
M  V30 16 C 1.4070 1.7572 0.0 0
M  V30 17 C 0.1609 3.9151 0.0 0
M  V30 18 C 0.0000 2.3835 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14 CFG=3
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 114214-49-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 960289-55-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-7452657
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (±)-trans-4'-Hydroxy-[1,3']bipyrrolidinyl-1'-carboxylic acid tert-butyl
ester. Dissolve 6-oxa-3-aza-bicyclo [3.1.0]hexane-3-carboxylic acid
tert-butylester (prepare according to Syn. Comm. V26 (8) p 1499, 1996)
(1.25 g, 6.75 mmol) in pyrrolidine (8 mL) and water (12 mL). Warm to 50°C
and stir in a sealed vessel for 3 days. Dilute the mixture with saturated
sodium bicarbonate and extract three times with dichloromethane. Dry the
organics over sodium sulfate, filter, and evaporate. Purify by silica gel
chromatography, eluting with 0-15% methanol (2N NH3)/CH2Cl2 to give 1.73
g (100%) of the title compound as a yellow oil. 1H NMR(CDCl3) δ 1.43 (s,
9H), 1.77 (m,4H), 2.08 (bs,1H), 2.60 (m, 4H), 2.72 (bs, 1H), 3.27 (m,1H),
3.65 (m,1H), 4.29 (m,1H)
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thieno[2,3-c]pyridine derivatives as MCH receptor
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amegadzie, Albert Kudzovi; Dao, Yen; Gardinier, Kevin Matthew; Garmene,
David Joseph; Green, Steven James; Hembre, Erik James; Lu, Jianliang;
Spinazze, Patrick Gianpietro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007146759 A2 2007-12-21

$RFMT $RIREG SCHEME36 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[5-Bromo-6-oxo-4-[[(1R,2R,3R,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]ami...
C21H24BrN3O3
1149587-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 6.3143 0.0 0
M  V30 2 C 1.1967 4.1660 0.0 0
M  V30 3 C 4.3782 3.4893 0.0 0
M  V30 4 N 6.4086 6.9300 0.0 0
M  V30 5 Br 9.0760 8.4700 0.0 0
M  V30 6 O 11.7433 6.9300 0.0 0
M  V30 7 C 15.7444 1.5400 0.0 0
M  V30 8 O 15.7444 0.0000 0.0 0
M  V30 9 O 17.0780 2.3100 0.0 0
M  V30 10 C 2.6824 5.8717 0.0 0 CFG=1
M  V30 11 C 1.4085 5.6914 0.0 0
M  V30 12 C 2.8669 7.9992 0.0 0
M  V30 13 C 4.1197 5.0076 0.0 0 CFG=1
M  V30 14 C 2.3621 6.8356 0.0 0 CFG=2
M  V30 15 C 5.0749 6.1600 0.0 0 CFG=2
M  V30 16 C 3.8805 5.9569 0.0 0
M  V30 17 C 7.7422 6.1600 0.0 0
M  V30 18 C 9.0760 6.9300 0.0 0
M  V30 19 C 7.7422 4.6200 0.0 0
M  V30 20 C 10.4096 6.1600 0.0 0
M  V30 21 N 9.0760 3.8500 0.0 0
M  V30 22 N 10.4096 4.6200 0.0 0
M  V30 23 C 11.7433 3.8500 0.0 0
M  V30 24 C 13.0769 4.6200 0.0 0
M  V30 25 C 11.7433 2.3100 0.0 0
M  V30 26 C 14.4107 3.8500 0.0 0
M  V30 27 C 13.0769 1.5400 0.0 0
M  V30 28 C 14.4107 2.3100 0.0 0
M  V30 29 H 2.3758 4.3625 0.0 0
M  V30 30 H 1.0509 7.6432 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 11
M  V30 3 1 13 3 CFG=3
M  V30 4 1 15 4 CFG=1
M  V30 5 1 4 17
M  V30 6 1 5 18
M  V30 7 2 6 20
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 28
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 29 CFG=1
M  V30 15 1 11 14
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 14 30 CFG=3
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 27 1 22 23
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 10 13 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-[4-(1-pyrrolidinylcarbonyl)phenyl]-5-[[(1R,2R,3R,5S)-2,6,6-trimethy...
C25H31BrN4O2
1149581-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 6.4050 0.0 0
M  V30 2 C 2.1106 7.6669 0.0 0
M  V30 3 C 5.2042 6.6623 0.0 0
M  V30 4 N 5.2423 2.6673 0.0 0
M  V30 5 Br 6.7823 0.0000 0.0 0
M  V30 6 O 9.8624 0.0000 0.0 0
M  V30 7 C 16.0225 2.6673 0.0 0
M  V30 8 O 16.7925 1.3337 0.0 0
M  V30 9 C 2.5443 5.4469 0.0 0 CFG=1
M  V30 10 C 1.5311 6.2401 0.0 0
M  V30 11 C 1.6403 3.5122 0.0 0
M  V30 12 C 4.2212 5.4768 0.0 0 CFG=1
M  V30 13 C 1.7849 4.7724 0.0 0 CFG=2
M  V30 14 C 4.4723 4.0010 0.0 0 CFG=2
M  V30 15 C 3.5393 4.7743 0.0 0
M  V30 16 C 6.7823 2.6673 0.0 0
M  V30 17 C 7.5523 1.3337 0.0 0
M  V30 18 C 7.5523 4.0010 0.0 0
M  V30 19 C 9.0924 1.3337 0.0 0
M  V30 20 N 9.0924 4.0010 0.0 0
M  V30 21 N 9.8624 2.6673 0.0 0
M  V30 22 C 11.4024 2.6673 0.0 0
M  V30 23 C 12.1724 4.0010 0.0 0
M  V30 24 C 12.1724 1.3337 0.0 0
M  V30 25 C 13.7125 4.0010 0.0 0
M  V30 26 C 13.7125 1.3337 0.0 0
M  V30 27 C 14.4825 2.6673 0.0 0
M  V30 28 N 16.7925 4.0010 0.0 0
M  V30 29 C 18.3241 4.1621 0.0 0
M  V30 30 C 16.1660 5.4080 0.0 0
M  V30 31 C 18.6443 5.6684 0.0 0
M  V30 32 C 17.3106 6.4384 0.0 0
M  V30 33 H 3.0334 6.9072 0.0 0
M  V30 34 H 0.2456 4.7285 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 10
M  V30 3 1 12 3 CFG=1
M  V30 4 1 14 4 CFG=3
M  V30 5 1 4 16
M  V30 6 1 5 17
M  V30 7 2 6 19
M  V30 8 2 7 8
M  V30 9 1 7 27
M  V30 10 1 7 28
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 9 33 CFG=3
M  V30 15 1 10 13
M  V30 16 1 11 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 13 34 CFG=1
M  V30 20 1 14 15
M  V30 21 2 16 17
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 2 18 20
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 27 1 21 22
M  V30 28 2 22 23
M  V30 29 1 22 24
M  V30 30 1 23 25
M  V30 31 2 24 26
M  V30 32 2 25 27
M  V30 33 1 26 27
M  V30 34 1 28 29
M  V30 35 1 28 30
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 12 13 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1149587-59-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1149581-83-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9603291
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM SYNTHETIC EXAMPLE 161 4-Bromo-2- [4-(pyrrolidine-1-carbonyl)phenyl]-5-
[(1R,2R,3R,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-3-ylamino]pyridazin-3
(2H) -one 4-{5-Bromo-6-oxo-4-[(1R,2R,3R,5S)-2,6,6- trimethylbicyclo
[3.1.1] hept-3-ylamino] pyridazin-1 (6H) - yl}benzoic acid (30 mg, 0.067
mmol), pyrrolidine (8.3 μL, 0.10 mmol), 1-hydroxybenzotriazole anhydride
(0.9 mg, 0.007 mmol) in dichloromethane (0.6 mL) was stirred with 1-
(3-dimethylaminopropyl) -3- ethylcarbodiimide hydrochloride (16 mg, 0.080
mmol) at room temperature for 22 hours. After completion of the reaction,
the solvent was removed by vacuum distillation, and the resulting residue
was purified by silica gel chromatography (ethyl acetate) to give the
desired product (35 mg, quant.). Morphology: colorless solid LC/MS:
Condition 2, retention time 3.57 min LC/MS(ESI+):499, 501 [M+1]+
LC/MS(ESI-):497, 499 [M-1]- 1H-NMR (CDCl3) δ :1.00 (d, J = 11.0 Hz, 1H),
1.08 (s, 3H), 1.22 (d, J = 7.0 Hz, 3H), 1.29 (s, 3H), 1.75-1.82 (m, 1H),
1.85-2.02 (m, 6H), 2.03-2.09 (m, 1H), 2.45-2.55 (m, 1H), 2.63-2.73 (m,
1H), 3.47 (t, J = 7.0 Hz, 2H), 3.66 (t, J = 7.0 Hz, 2H), 3.87-3.98 (m,
1H), 4.83 (d, J = 8.0 Hz, 1H), 7.57- 7.78 (m, 5H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridazinone derivatives as P2X7 receptor inhibitors and their
preparation, pharmaceutical compositions and use in the treatment of
rheumatoid arthritis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shigeta, Yukihiro; Hirokawa, Yutaka; Nagai, Hiroshi; Nagae, Kei;
Watanabe, Tsuneo; Io, Megumi; Matsuura, Yusuke; Kamon, Junji; Horikawa,
Masato; Takeuchi, Kazuya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009057827 A1 2009-05-07

$RFMT $RIREG SCHEME37 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 7-(bromomethyl)-3,4-dihydro-2(1H)-isoquinolinecarboxylate
C15H20BrNO2
1158756-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0
M  V30 2 O 2.6673 2.3101 0.0 0
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 C 1.3337 3.0801 0.0 0
M  V30 5 C 0.5637 1.7464 0.0 0
M  V30 6 C 0.0000 3.8501 0.0 0
M  V30 7 C 2.1037 4.4137 0.0 0
M  V30 8 C 12.0033 3.0801 0.0 0
M  V30 9 Br 13.3370 2.3101 0.0 0
M  V30 10 C 8.0022 2.3101 0.0 0
M  V30 11 C 8.0022 0.7700 0.0 0
M  V30 12 C 6.6685 3.0801 0.0 0
M  V30 13 C 9.3360 3.0801 0.0 0
M  V30 14 C 6.6685 0.0000 0.0 0
M  V30 15 C 9.3360 0.0000 0.0 0
M  V30 16 N 5.3348 2.3101 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 5.3348 0.7700 0.0 0
M  V30 19 C 10.6697 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 10 13
M  V30 13 1 11 14
M  V30 14 2 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3,4-dihydro-7-(1-pyrrolidinylmethyl)-2(1H)-isoquinolinecarb...
C19H28N2O2
2648500-22-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 O 2.6675 2.3101 0.0 0
M  V30 3 O 4.0012 0.0000 0.0 0
M  V30 4 C 1.3338 1.5400 0.0 0
M  V30 5 C 2.1038 0.2064 0.0 0
M  V30 6 C 0.0000 0.7700 0.0 0
M  V30 7 C 0.5638 2.8737 0.0 0
M  V30 8 C 12.0035 1.5400 0.0 0
M  V30 9 C 8.0023 2.3101 0.0 0
M  V30 10 C 8.0023 3.8501 0.0 0
M  V30 11 C 6.6687 1.5400 0.0 0
M  V30 12 C 9.3360 1.5400 0.0 0
M  V30 13 C 9.3360 4.6201 0.0 0
M  V30 14 C 6.6687 4.6201 0.0 0
M  V30 15 N 5.3348 2.3101 0.0 0
M  V30 16 C 10.6697 2.3101 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 5.3348 3.8501 0.0 0
M  V30 19 N 13.3372 2.3101 0.0 0
M  V30 20 C 14.7440 1.6837 0.0 0
M  V30 21 C 13.4981 3.8416 0.0 0
M  V30 22 C 15.7746 2.8281 0.0 0
M  V30 23 C 15.0045 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 16
M  V30 9 1 8 19
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 2 16 17
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1158756-43-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2648500-22-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-23775808
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Structure-activity relationships of 7-substituted
dimethyltyrosine-tetrahydroisoquinoline opioid peptidomimetics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Montgomery, Deanna; Anand, Jessica P.; Baber, Mason A.; Twarozynski, Jack
J.; Hartman, Joshua G.; Delong, Lennon J.; Traynor, John R.; Mosberg,
Henry I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2019), 24(23), 4302

$RFMT $RIREG SCHEME38 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-(4-formyl-3-pyridinyl)carbamate
C11H14N2O3
116026-95-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.8738 0.0 0
M  V30 2 C 6.1600 2.8738 0.0 0
M  V30 3 O 6.9300 1.5400 0.0 0
M  V30 4 O 6.9300 4.2074 0.0 0
M  V30 5 C 8.4700 1.5400 0.0 0
M  V30 6 C 8.4700 0.0000 0.0 0
M  V30 7 C 10.0100 1.5400 0.0 0
M  V30 8 C 8.4700 3.0800 0.0 0
M  V30 9 C 1.5400 2.8738 0.0 0
M  V30 10 O 0.0000 2.8738 0.0 0
M  V30 11 C 3.8500 4.2074 0.0 0
M  V30 12 C 2.3100 4.2074 0.0 0
M  V30 13 C 4.6200 5.5411 0.0 0
M  V30 14 C 1.5400 5.5411 0.0 0
M  V30 15 N 3.8500 6.8749 0.0 0
M  V30 16 C 2.3100 6.8749 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 1 9 12
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[4-(1-pyrrolidinylmethyl)-3-pyridinyl]carbamate
C15H23N3O2
486422-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 4.0011 0.0 0
M  V30 2 N 6.9898 4.0011 0.0 0
M  V30 3 C 8.5298 4.0011 0.0 0
M  V30 4 O 9.2998 5.3349 0.0 0
M  V30 5 O 9.2998 2.6674 0.0 0
M  V30 6 C 10.8398 5.3349 0.0 0
M  V30 7 C 10.8398 6.8749 0.0 0
M  V30 8 C 12.3798 5.3349 0.0 0
M  V30 9 C 10.8398 3.7949 0.0 0
M  V30 10 C 4.6798 2.6674 0.0 0
M  V30 11 C 6.2198 2.6674 0.0 0
M  V30 12 C 3.9098 1.3338 0.0 0
M  V30 13 C 6.9898 1.3338 0.0 0
M  V30 14 C 4.6798 0.0000 0.0 0
M  V30 15 N 6.2198 0.0000 0.0 0
M  V30 16 N 2.3698 4.0011 0.0 0
M  V30 17 C 1.4645 5.2469 0.0 0
M  V30 18 C 1.4645 2.7552 0.0 0
M  V30 19 C 0.0000 4.7711 0.0 0
M  V30 20 C 0.0000 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 116026-95-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 486422-85-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-20642327
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Investigating Drug-Target Residence Time in Kinases through Enhanced
Sampling Simulations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gobbo, Dorothea; Piretti, Valentina; Di Martino, Rita Maria Concetta;
Tripathi, Shailesh Kumar; Giabbai, Barbara; Storici, Paola; Demitri,
Nicola; Girotto, Stefania; Decherchi, Sergio; Cavalli, Andrea
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Chemical Theory and Computation (2019), 15(8), 4646-4659

$RFMT $RIREG SCHEME39 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6,9-Dihydrobenzo[1,2-b:3,4-b′:5,6-b′′]trifuran-2,5,8(3H)-trione
C12H6O6
1187398-54-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 9.0820 7.8653 0.0 0
M  V30 2 O 0.0000 7.8654 0.0 0
M  V30 3 O 4.5410 0.0000 0.0 0
M  V30 4 C 5.3110 6.5772 0.0 0
M  V30 5 C 3.7710 6.5772 0.0 0
M  V30 6 C 6.0810 5.2436 0.0 0
M  V30 7 C 6.3414 7.7218 0.0 0
M  V30 8 C 3.0010 5.2436 0.0 0
M  V30 9 O 2.7406 7.7218 0.0 0
M  V30 10 C 5.3110 3.9099 0.0 0
M  V30 11 O 7.5873 5.5637 0.0 0
M  V30 12 C 7.7484 7.0953 0.0 0
M  V30 13 C 3.7710 3.9099 0.0 0
M  V30 14 C 1.4947 5.5637 0.0 0
M  V30 15 C 1.3336 7.0954 0.0 0
M  V30 16 C 5.7869 2.4452 0.0 0
M  V30 17 O 3.2952 2.4452 0.0 0
M  V30 18 C 4.5410 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 12
M  V30 2 2 2 15
M  V30 3 2 3 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 2 10 13
M  V30 16 1 10 16
M  V30 17 1 11 12
M  V30 18 1 13 17
M  V30 19 1 14 15
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-5-[2-oxo-2-(1-pyrrolidinyl)ethyl]benzo[1,2-b:3,4-b′]difuran-2,7(3H,...
C16H15NO6
1373485-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.6210 5.2435 0.0 0
M  V30 2 C 8.3910 6.5772 0.0 0
M  V30 3 O 7.6210 7.9110 0.0 0
M  V30 4 O 4.5410 0.0000 0.0 0
M  V30 5 O 6.0810 7.9110 0.0 0
M  V30 6 O 0.0000 7.8652 0.0 0
M  V30 7 C 3.7710 3.9099 0.0 0
M  V30 8 C 5.3110 3.9099 0.0 0
M  V30 9 C 3.0010 5.2435 0.0 0
M  V30 10 C 3.2951 2.4452 0.0 0
M  V30 11 C 6.0810 5.2435 0.0 0
M  V30 12 O 5.7869 2.4452 0.0 0
M  V30 13 C 3.7710 6.5772 0.0 0
M  V30 14 O 1.4947 5.5637 0.0 0
M  V30 15 C 4.5410 1.5400 0.0 0
M  V30 16 C 5.3110 6.5772 0.0 0
M  V30 17 C 2.7406 7.7217 0.0 0
M  V30 18 C 1.3338 7.0952 0.0 0
M  V30 19 N 9.9310 6.5772 0.0 0
M  V30 20 C 10.8362 5.3313 0.0 0
M  V30 21 C 10.8362 7.8232 0.0 0
M  V30 22 C 12.3009 5.8072 0.0 0
M  V30 23 C 12.3009 7.3472 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 1 2 19
M  V30 5 2 4 15
M  V30 6 1 5 16
M  V30 7 2 6 18
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 9 14
M  V30 15 1 10 15
M  V30 16 2 11 16
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 1 13 17
M  V30 20 1 14 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1187398-54-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1373485-10-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11045904
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction complete in 15m, controlled monoaminolysis
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Molecular multifunctionalization via electronically coupled lactones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baker, Matthew B.; Ghiviriga, Ion; Castellano, Ronald K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2012), 3(4), 1095-1099

$RFMT $RIREG SCHEME40 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
D-Glucuronic acid, methyl ester, 2,3,4-tris(2-methylpropanoate)
C19H30O10
1190403-86-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 6.1600 0.0 0 CFG=2
M  V30 2 C 8.0020 5.3900 0.0 0 CFG=2
M  V30 3 C 5.3347 5.3900 0.0 0 CFG=2
M  V30 4 O 6.6684 7.7000 0.0 0
M  V30 5 C 9.3358 6.1600 0.0 0 CFG=2
M  V30 6 O 8.0020 3.8500 0.0 0
M  V30 7 O 4.0009 6.1600 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 5.3347 8.4700 0.0 0
M  V30 10 C 10.6694 5.3900 0.0 0
M  V30 11 O 9.3358 7.7000 0.0 0
M  V30 12 C 8.0020 2.3100 0.0 0
M  V30 13 C 2.6673 5.3900 0.0 0
M  V30 14 O 4.0009 3.0800 0.0 0
M  V30 15 C 5.3347 10.0100 0.0 0
M  V30 16 O 4.0009 7.7000 0.0 0
M  V30 17 O 12.0031 6.1600 0.0 0
M  V30 18 O 10.6694 3.8500 0.0 0
M  V30 19 C 9.3358 1.5400 0.0 0
M  V30 20 O 6.6684 1.5400 0.0 0
M  V30 21 C 1.3336 6.1600 0.0 0
M  V30 22 O 2.6673 3.8500 0.0 0
M  V30 23 C 6.6684 10.7800 0.0 0
M  V30 24 C 4.0009 10.7800 0.0 0
M  V30 25 C 13.3367 5.3900 0.0 0
M  V30 26 C 10.6694 2.3100 0.0 0
M  V30 27 C 9.3358 0.0000 0.0 0
M  V30 28 C 1.3336 7.7000 0.0 0
M  V30 29 C 0.0000 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7 CFG=3
M  V30 7 1 3 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 1 5 11 CFG=3
M  V30 11 1 6 12
M  V30 12 1 7 13
M  V30 13 2 8 14
M  V30 14 1 9 15
M  V30 15 2 9 16
M  V30 16 1 10 17
M  V30 17 2 10 18
M  V30 18 1 12 19
M  V30 19 2 12 20
M  V30 20 1 13 21
M  V30 21 2 13 22
M  V30 22 1 15 23
M  V30 23 1 15 24
M  V30 24 1 17 25
M  V30 25 1 19 26
M  V30 26 1 19 27
M  V30 27 1 21 28
M  V30 28 1 21 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 1 2 3 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
β-D-Glucopyranuronic acid, 1-deoxy-1-(1-pyrrolidinyl)-, methyl ester, 2,3,4-t...
C23H37NO9
1207167-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.4700 8.0020 0.0 0
M  V30 2 C 7.7000 9.3358 0.0 0
M  V30 3 C 8.4700 10.6695 0.0 0
M  V30 4 O 6.1600 9.3358 0.0 0
M  V30 5 C 10.0101 10.6695 0.0 0
M  V30 6 C 7.7000 12.0031 0.0 0
M  V30 7 O 5.3900 8.0020 0.0 0
M  V30 8 C 3.8500 8.0020 0.0 0
M  V30 9 C 3.0800 9.3358 0.0 0
M  V30 10 O 3.0800 6.6684 0.0 0
M  V30 11 C 1.5400 9.3358 0.0 0
M  V30 12 C 3.8500 10.6695 0.0 0
M  V30 13 O 3.8500 5.3347 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 1.5400 4.0011 0.0 0
M  V30 16 O 1.5400 6.6684 0.0 0
M  V30 17 C 2.3100 2.6673 0.0 0
M  V30 18 C 0.0000 4.0011 0.0 0
M  V30 19 C 5.3900 2.6673 0.0 0
M  V30 20 O 6.1600 1.3336 0.0 0
M  V30 21 O 3.8500 2.6673 0.0 0
M  V30 22 C 5.3900 0.0000 0.0 0
M  V30 23 C 7.7000 6.6684 0.0 0 CFG=1
M  V30 24 C 6.1600 6.6684 0.0 0 CFG=1
M  V30 25 C 8.4700 5.3347 0.0 0 CFG=2
M  V30 26 C 5.3900 5.3347 0.0 0 CFG=2
M  V30 27 O 7.7000 4.0011 0.0 0
M  V30 28 C 6.1600 4.0011 0.0 0 CFG=1
M  V30 29 N 10.0101 5.3347 0.0 0
M  V30 30 C 10.9153 4.0889 0.0 0
M  V30 31 C 10.9153 6.5806 0.0 0
M  V30 32 C 12.3798 4.5647 0.0 0
M  V30 33 C 12.3798 6.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 23 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 7 8
M  V30 8 1 24 7 CFG=3
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 26 13 CFG=1
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 15 18
M  V30 19 1 19 20
M  V30 20 2 19 21
M  V30 21 1 28 19 CFG=3
M  V30 22 1 20 22
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 25 29 CFG=3
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 30 1 29 30
M  V30 31 1 29 31
M  V30 32 1 30 32
M  V30 33 1 31 33
M  V30 34 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 23 24 25 26 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1190403-86-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1207167-97-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27347119
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A convenient new synthesis of quaternary ammonium glucuronides of drug
molecules
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iddon, Lisa; Bragg, Ryan A.; Harding, John R.; Stachulski, Andrew V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2010), 66(2), 537-541

$RFMT $RIREG SCHEME41 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chloropropyl)-4-nitrobenzenamine
C9H11ClN2O2
1191091-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6697 3.8501 0.0 0
M  V30 5 Cl 12.0033 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Nitrophenyl)-1-pyrrolidinepropanamine
C13H19N3O2
35386-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 C 10.6698 3.8501 0.0 0
M  V30 5 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 6 O 1.3338 0.0000 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 5.3348 3.8501 0.0 0
M  V30 9 C 4.0012 4.6201 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 2.6675 3.8501 0.0 0
M  V30 12 C 4.0012 1.5400 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 N 12.0035 4.6201 0.0 0
M  V30 15 C 13.4103 3.9936 0.0 0
M  V30 16 C 12.1644 6.1517 0.0 0
M  V30 17 C 14.4409 5.1382 0.0 0
M  V30 18 C 13.6709 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 14
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1191091-29-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35386-02-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13728472
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis and evaluation of 4,5-di-substituted acridone ligands
with high G-quadruplex affinity and selectivity, together with low
toxicity to normal cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cuenca, Francisco; Moore, Michael J. B.; Johnson, Karin; Guyen,
Berangere; De Cian, Anne; Neidle, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(17), 5109-5113

$RFMT $RIREG SCHEME42 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-Chloroacridine
C13H8ClN
1207-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.0011 0.0000 0.0 0
M  V30 2 C 2.6674 3.8500 0.0 0
M  V30 3 C 2.6674 2.3100 0.0 0
M  V30 4 N 4.0011 4.6200 0.0 0
M  V30 5 C 1.3336 4.6200 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 1.3336 1.5400 0.0 0
M  V30 8 C 5.3347 3.8500 0.0 0
M  V30 9 C 0.0000 3.8500 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 6.6685 4.6200 0.0 0
M  V30 13 C 6.6685 1.5400 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 10 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-(1-Pyrrolidinyl)acridine
C17H16N2
1426440-94-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.9098 0.0 0
M  V30 2 C 2.6674 4.6798 0.0 0
M  V30 3 C 5.3347 4.6798 0.0 0
M  V30 4 C 2.6674 6.2198 0.0 0
M  V30 5 C 1.3336 3.9098 0.0 0
M  V30 6 C 5.3347 6.2198 0.0 0
M  V30 7 C 6.6685 3.9098 0.0 0
M  V30 8 N 4.0011 6.9898 0.0 0
M  V30 9 C 1.3336 6.9898 0.0 0
M  V30 10 C 0.0000 4.6798 0.0 0
M  V30 11 C 6.6685 6.9898 0.0 0
M  V30 12 C 8.0022 4.6798 0.0 0
M  V30 13 C 0.0000 6.2198 0.0 0
M  V30 14 C 8.0022 6.2198 0.0 0
M  V30 15 N 4.0011 2.3698 0.0 0
M  V30 16 C 5.2470 1.4645 0.0 0
M  V30 17 C 2.7552 1.4645 0.0 0
M  V30 18 C 4.7711 0.0000 0.0 0
M  V30 19 C 3.2311 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 2 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 2 5 10
M  V30 11 2 6 8
M  V30 12 1 6 11
M  V30 13 2 7 12
M  V30 14 2 9 13
M  V30 15 1 10 13
M  V30 16 2 11 14
M  V30 17 1 12 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1207-69-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1426440-94-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3787210
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM inert
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Unusual reactivities of acridine derivatives in catalytic hydrogenation.
A combined experimental and theoretical study
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mignon, Pierre; Tiano, Martin; Belmont, Philippe; Favre-Reguillon, Alain;
Chermette, Henry; Fache, Fabienne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2013), 37163-69

$RFMT $RIREG SCHEME43 STEP1
$RXN



  3  1
$MOL
Ferrocenecarboxaldehyde
C11H10FeO
12093-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0673 5.0777 0.0 0
M  V30 2 O 3.5322 4.8098 0.0 0
M  V30 3 Fe 1.3042 2.8068 0.0 0 CHG=2 VAL=10
M  V30 4 C 2.6025 4.8098 0.0 0 CHG=-1 VAL=4
M  V30 5 C 1.7868 4.3375 0.0 0 VAL=5
M  V30 6 C 1.3042 5.6373 0.0 0 VAL=5
M  V30 7 C 0.0296 4.8098 0.0 0 VAL=5
M  V30 8 C 0.8438 4.3375 0.0 0 VAL=5
M  V30 9 C 0.0000 0.8290 0.0 0 CHG=-1 VAL=4
M  V30 10 C 2.5744 0.8290 0.0 0 VAL=5
M  V30 11 C 1.7572 1.3013 0.0 0 VAL=5
M  V30 12 C 0.8127 1.3013 0.0 0 VAL=5
M  V30 13 C 1.2761 0.0000 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 3 8
M  V30 8 1 3 9
M  V30 9 1 3 10
M  V30 10 1 3 11
M  V30 11 1 3 12
M  V30 12 1 3 13
M  V30 13 1 4 5
M  V30 14 1 4 6
M  V30 15 2 5 8
M  V30 16 2 6 7
M  V30 17 1 7 8
M  V30 18 1 9 12
M  V30 19 1 9 13
M  V30 20 1 10 11
M  V30 21 2 10 13
M  V30 22 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimethylsilyl cyanide
C4H9NSi
7677-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ferrocene, (cyano-1-pyrrolidinylmethyl)-
C16H18FeN2
843618-94-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0014 8.2793 0.0 0
M  V30 2 C 5.0014 9.1555 0.0 0
M  V30 3 N 5.8776 9.1555 0.0 0
M  V30 4 Fe 2.1266 4.5766 0.0 0 CHG=2 VAL=10
M  V30 5 C 4.2434 7.8424 0.0 0 CHG=-1 VAL=4
M  V30 6 C 2.9134 7.0724 0.0 0 VAL=5
M  V30 7 C 2.1266 9.1917 0.0 0 VAL=5
M  V30 8 C 0.0483 7.8424 0.0 0 VAL=5
M  V30 9 C 1.3759 7.0724 0.0 0 VAL=5
M  V30 10 C 0.0000 1.3517 0.0 0 CHG=-1 VAL=4
M  V30 11 C 4.1976 1.3517 0.0 0 VAL=5
M  V30 12 C 2.8652 2.1217 0.0 0 VAL=5
M  V30 13 C 1.3252 2.1217 0.0 0 VAL=5
M  V30 14 C 2.0807 0.0000 0.0 0 VAL=5
M  V30 15 N 5.7593 7.8424 0.0 0
M  V30 16 C 6.5462 8.4241 0.0 0
M  V30 17 C 6.0345 6.9541 0.0 0
M  V30 18 C 7.2993 7.8424 0.0 0
M  V30 19 C 6.9903 6.9541 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 15
M  V30 4 3 2 3
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 1 4 10
M  V30 11 1 4 11
M  V30 12 1 4 12
M  V30 13 1 4 13
M  V30 14 1 4 14
M  V30 15 1 5 6
M  V30 16 1 5 7
M  V30 17 2 6 9
M  V30 18 2 7 8
M  V30 19 1 8 9
M  V30 20 1 10 13
M  V30 21 1 10 14
M  V30 22 1 11 12
M  V30 23 2 11 14
M  V30 24 2 12 13
M  V30 25 1 15 16
M  V30 26 1 15 17
M  V30 27 1 16 18
M  V30 28 1 17 19
M  V30 29 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 12093-10-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 7677-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 843618-94-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-346-CAS-13935537
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7791-03-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM safety (- drying lithium perchlorate used safety shield)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Lithium perchlorate suspended in methylene chloride, a mild, efficient
and reusable catalyst for the synthesis of ferrocene aminonitrile
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yousefi, Rozbeh; Azizi, Najmedin; Saidi, Mohammad R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2005), 690(1), 76-78

$RFMT $RIREG SCHEME44 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Fluorophenyl)-4-(methylthio)-3-pyridinecarbonitrile
C13H9FN2S
1213704-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 1.5400 0.0 0
M  V30 2 N 5.3347 0.0000 0.0 0
M  V30 3 S 8.0021 3.0800 0.0 0
M  V30 4 C 9.3358 3.8500 0.0 0
M  V30 5 F 1.3336 5.3900 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 5.3347 3.0800 0.0 0
M  V30 8 N 4.0011 5.3900 0.0 0
M  V30 9 C 6.6684 3.8500 0.0 0
M  V30 10 C 5.3347 6.1600 0.0 0
M  V30 11 C 6.6684 5.3900 0.0 0
M  V30 12 C 2.6674 3.0800 0.0 0
M  V30 13 C 1.3336 3.8500 0.0 0
M  V30 14 C 2.6674 1.5400 0.0 0
M  V30 15 C 0.0000 3.0800 0.0 0
M  V30 16 C 1.3336 0.7700 0.0 0
M  V30 17 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 9
M  V30 5 1 5 13
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Fluorophenyl)-4-(1-pyrrolidinyl)-3-pyridinecarbonitrile
C16H14FN3
1213705-05-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.6201 0.0 0
M  V30 2 N 5.3348 6.1601 0.0 0
M  V30 3 F 1.3337 0.7700 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 5.3348 3.0801 0.0 0
M  V30 6 N 4.0012 0.7700 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 5.3348 0.0000 0.0 0
M  V30 9 C 6.6685 0.7700 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 0.0000 3.0801 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 16 N 8.0022 3.0801 0.0 0
M  V30 17 C 8.1633 4.6116 0.0 0
M  V30 18 C 9.4091 2.4537 0.0 0
M  V30 19 C 9.6696 4.9318 0.0 0
M  V30 20 C 10.4396 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 7 16
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1213704-87-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1213705-05-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24936983
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7447-41-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective functionalization of 2-(2'-fluorophenyl)-3-cyanopyridine
and its cyclization to benzo[h]-1,6-naphthyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cailly, Thomas; Begtrup, Mikael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2010), 66(6), 1299-1307

$RFMT $RIREG SCHEME45 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-5-fluorobenzenesulfonyl chloride
C6H3BrClFO2S
1214342-44-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 4.6201 0.0 0 VAL=6
M  V30 2 Cl 0.0000 5.3901 0.0 0
M  V30 3 O 0.5638 3.2864 0.0 0
M  V30 4 O 2.1038 5.9538 0.0 0
M  V30 5 Br 6.6687 4.6201 0.0 0
M  V30 6 F 4.0012 0.0000 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(3-Bromo-5-fluorophenyl)sulfonyl]pyrrolidine
C10H11BrFNO2S
2378496-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 4.6201 0.0 0 VAL=6
M  V30 2 O 4.5411 5.9538 0.0 0
M  V30 3 O 3.0011 3.2864 0.0 0
M  V30 4 Br 9.1059 4.6201 0.0 0
M  V30 5 F 6.4386 0.0000 0.0 0
M  V30 6 C 5.1047 3.8501 0.0 0
M  V30 7 C 6.4386 4.6201 0.0 0
M  V30 8 C 5.1047 2.3101 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 C 6.4386 1.5400 0.0 0
M  V30 11 C 7.7722 2.3101 0.0 0
M  V30 12 N 2.4374 5.3901 0.0 0
M  V30 13 C 1.0304 4.7636 0.0 0
M  V30 14 C 2.2763 6.9217 0.0 0
M  V30 15 C 0.0000 5.9082 0.0 0
M  V30 16 C 0.7700 7.2419 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 1 12
M  V30 5 1 4 9
M  V30 6 1 5 10
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1214342-44-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2378496-23-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-20848402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pladienolide derivatives as spliceosome targeting agents
for treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cook, Andrew; Reynolds, Dominic; Zhong, Cheng; Brawn, Ryan; Ellery,
Shelby; Samarakoon, Thiwanka; Liu, Xiang; Prajapati, Sudeep; Sheehan,
Megan; Lowe, Jason T.; Palacino, James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019200100 A1 2019-10-17

$RFMT $RIREG SCHEME46 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophenyl N-[2-[[4-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]...
C24H23F3N8O5S
1215264-41-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8702 2.6673 0.0 0
M  V30 2 C 7.6403 1.3337 0.0 0
M  V30 3 C 6.8702 0.0000 0.0 0
M  V30 4 O 12.1595 8.7485 0.0 0
M  V30 5 C 13.4932 7.9785 0.0 0
M  V30 6 C 14.8268 8.7485 0.0 0
M  V30 7 N 16.1605 7.9785 0.0 0
M  V30 8 C 17.4943 8.7485 0.0 0
M  V30 9 O 18.8280 7.9785 0.0 0
M  V30 10 O 17.4943 10.2885 0.0 0
M  V30 11 C 1.5063 10.9989 0.0 0
M  V30 12 F 1.1861 12.5052 0.0 0
M  V30 13 F 0.0000 10.6786 0.0 0
M  V30 14 F 1.8265 9.4925 0.0 0
M  V30 15 N 24.1628 11.0585 0.0 0 VAL=5
M  V30 16 O 24.1628 12.5986 0.0 0
M  V30 17 O 25.4965 10.2885 0.0 0
M  V30 18 C 8.1583 6.4384 0.0 0
M  V30 19 C 8.1583 7.9785 0.0 0
M  V30 20 C 9.4920 5.6684 0.0 0
M  V30 21 C 7.0138 5.4080 0.0 0
M  V30 22 N 9.4920 8.7485 0.0 0
M  V30 23 N 10.8257 6.4384 0.0 0
M  V30 24 S 9.1718 4.1621 0.0 0
M  V30 25 C 7.6403 4.0012 0.0 0
M  V30 26 C 10.8257 7.9785 0.0 0
M  V30 27 N 6.8247 8.7485 0.0 0
M  V30 28 C 6.8247 10.2885 0.0 0
M  V30 29 C 5.4908 7.9785 0.0 0
M  V30 30 C 5.4908 11.0585 0.0 0
M  V30 31 C 4.1572 8.7485 0.0 0
M  V30 32 N 4.1572 10.2885 0.0 0
M  V30 33 N 5.1707 12.5650 0.0 0
M  V30 34 C 3.0128 11.3191 0.0 0
M  V30 35 N 3.6391 12.7259 0.0 0
M  V30 36 C 20.1617 8.7485 0.0 0
M  V30 37 C 21.4953 7.9785 0.0 0
M  V30 38 C 20.1617 10.2885 0.0 0
M  V30 39 C 22.8292 8.7485 0.0 0
M  V30 40 C 21.4953 11.0585 0.0 0
M  V30 41 C 22.8292 10.2885 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 26
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 1 9 36
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 34
M  V30 16 2 15 16
M  V30 17 2 15 17
M  V30 18 1 15 41
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 18 21
M  V30 22 1 19 22
M  V30 23 1 19 27
M  V30 24 2 20 23
M  V30 25 1 20 24
M  V30 26 2 21 25
M  V30 27 2 22 26
M  V30 28 1 23 26
M  V30 29 1 24 25
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 2 30 33
M  V30 36 1 31 32
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 2 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 40 41
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-[[4-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-...
C22H27F3N8O2S
1215264-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8702 2.6673 0.0 0
M  V30 2 C 7.6403 1.3337 0.0 0
M  V30 3 C 6.8702 0.0000 0.0 0
M  V30 4 O 12.1595 8.7485 0.0 0
M  V30 5 C 13.4932 7.9785 0.0 0
M  V30 6 C 14.8268 8.7485 0.0 0
M  V30 7 N 16.1607 7.9785 0.0 0
M  V30 8 C 17.4943 8.7485 0.0 0
M  V30 9 O 17.4943 10.2885 0.0 0
M  V30 10 C 1.5065 10.9989 0.0 0
M  V30 11 F 1.8266 9.4925 0.0 0
M  V30 12 F 0.0000 10.6786 0.0 0
M  V30 13 F 1.1861 12.5052 0.0 0
M  V30 14 C 8.1583 6.4384 0.0 0
M  V30 15 C 8.1583 7.9785 0.0 0
M  V30 16 C 9.4920 5.6684 0.0 0
M  V30 17 C 7.0139 5.4080 0.0 0
M  V30 18 N 9.4920 8.7485 0.0 0
M  V30 19 N 10.8258 6.4384 0.0 0
M  V30 20 S 9.1718 4.1621 0.0 0
M  V30 21 C 7.6403 4.0012 0.0 0
M  V30 22 C 10.8258 7.9785 0.0 0
M  V30 23 N 6.8247 8.7485 0.0 0
M  V30 24 C 6.8247 10.2885 0.0 0
M  V30 25 C 5.4910 7.9785 0.0 0
M  V30 26 C 5.4910 11.0585 0.0 0
M  V30 27 C 4.1572 8.7485 0.0 0
M  V30 28 N 4.1572 10.2885 0.0 0
M  V30 29 N 5.1708 12.5650 0.0 0
M  V30 30 C 3.0128 11.3191 0.0 0
M  V30 31 N 3.6391 12.7259 0.0 0
M  V30 32 N 18.8280 7.9785 0.0 0
M  V30 33 C 20.2350 8.6049 0.0 0
M  V30 34 C 18.9891 6.4469 0.0 0
M  V30 35 C 21.2654 7.4604 0.0 0
M  V30 36 C 20.4954 6.1267 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 1 4 5
M  V30 5 1 4 22
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 8 9
M  V30 10 1 8 32
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 30
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 15 23
M  V30 20 2 16 19
M  V30 21 1 16 20
M  V30 22 2 17 21
M  V30 23 2 18 22
M  V30 24 1 19 22
M  V30 25 1 20 21
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 26 29
M  V30 32 1 27 28
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 31
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1215264-41-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1215264-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-11404337
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Pyrrolidine-1-carboxylic acid
{2-[6-propyl-4-(3-trifluoromethyl-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)-thieno[2,3-d]pyrimidin-2-yloxy]-ethyl}-amide
The compound (50 mg, 0.093 mmol) obtained from Preparation Example 9-25-1
was dissolved in dichloromethane 30 mL and cooled to 0°C. Triethylamine
(0.04 mL, 0.279 mmol) and pyrrolidine (0.01 mL, 0.093 mmol) were added
thereto and stirred for 3 hours at room temperature. The reaction
solution was distilled under reduced pressure, diluted with
dichloromethane and washed with water and brine. After the organic layer
was dried with anhydrous magnesium sulfate and distilled under reduced
pressure, the title compound (50 mg, 100.0 %) was obtained by
column-chromatography using 20:1 mixture of dichloromethane and methanol.
Pyrrolidine-1-carboxylic acid
{2-[6-propyl-4-(3-trifluoromethyl-5,6-dihydro-8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl)-thieno[2,3-d]pyrimidin-2-yloxy]-ethyl}-amide,
yield (50 mg, 100.0 %) 1H NMR (400MHz, CDCl3); δ 6.95 (1H, s), 5.30 (2H,
s), 4.95 (1H, br), 4.46 (2H, t), 4.34 (2H, t), 4.32 (2H, t), 3.67 (2H,
q), 3.31 (4H, br), 2.81 (2H, t), 1.87 (4H, br), 1.70 (2H, m), 0.99 (3H,
t)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused heterocycles, especially thienopyrimidines and
thiazolopyrimidines, as platelet aggregation inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Chang Seok; Lee, Tae Hee; Yoon, Sook Kyung; Choi, Jeung Soon; Jang,
Yong Jin; Kim, Sung Wook; Chang, Hye Kyung; Park, Mi Jeong; Kim, Tae Hun;
Ahn, Young Ha; Park, Hee Dong; Park, Hyun Jung; Lim, Dong Chul; Lee, Joo
Youn; Lee, Sung Hack; Park, Wan Su; Oh, Yeong Soo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010027236 A2 2010-03-11

$RFMT $RIREG SCHEME47 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-1a,7b-dihydro-2,2-dimethyl-2H-oxireno[c][1]benzopyran
C11H11BrO2
122262-14-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 1.7145 0.0 0
M  V30 2 C 0.9899 0.0000 0.0 0
M  V30 3 Br 8.1851 3.7570 0.0 0
M  V30 4 C 2.8504 3.7570 0.0 0
M  V30 5 C 1.5166 2.9870 0.0 0
M  V30 6 C 4.1840 2.9870 0.0 0
M  V30 7 O 1.5166 4.5270 0.0 0
M  V30 8 C 1.5166 1.4470 0.0 0
M  V30 9 C 4.1840 1.4470 0.0 0
M  V30 10 C 5.5177 3.7570 0.0 0
M  V30 11 O 2.8504 0.6770 0.0 0
M  V30 12 C 5.5177 0.6770 0.0 0
M  V30 13 C 6.8513 2.9870 0.0 0
M  V30 14 C 6.8513 1.4470 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 8
M  V30 3 1 3 13
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 8 11
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-3,4-dihydro-2,2-dimethyl-4-(1-pyrrolidinyl)-2H-1-benzopyran-3-ol
C15H20BrNO2
309717-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.1830 3.9099 0.0 0
M  V30 2 C 0.9899 7.6670 0.0 0
M  V30 3 C 0.0000 5.9524 0.0 0
M  V30 4 Br 8.1851 3.9099 0.0 0
M  V30 5 C 2.8504 3.9099 0.0 0
M  V30 6 C 4.1840 4.6799 0.0 0
M  V30 7 C 1.5166 4.6799 0.0 0
M  V30 8 C 4.1840 6.2199 0.0 0
M  V30 9 C 5.5177 3.9099 0.0 0
M  V30 10 C 1.5166 6.2199 0.0 0
M  V30 11 O 2.8504 6.9899 0.0 0
M  V30 12 C 5.5177 6.9899 0.0 0
M  V30 13 C 6.8513 4.6799 0.0 0
M  V30 14 C 6.8513 6.2199 0.0 0
M  V30 15 N 2.8504 2.3699 0.0 0
M  V30 16 C 4.0962 1.4647 0.0 0
M  V30 17 C 1.6044 1.4647 0.0 0
M  V30 18 C 3.6204 0.0000 0.0 0
M  V30 19 C 2.0804 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 10
M  V30 3 1 3 10
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 15
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 122262-14-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 309717-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-13759386
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Entry 20: Pyrrolidine (0.074 mL, 0.88 mmol, 3.0 equiv) was added to a
solution of epoxide 22 (75.0 mg, 0.29 mmol, 1.0 equiv) in CH2Cl2 (1.0 mL)
at 25°C. The reaction mixture was stirred at 25 °C for 48 h and then the
solvents were removed under reduced pressure. The crude alcohol was
obtained in 95.0 mg (100% yield) and 1H NMR analysis of the residue
indicated 100% conversion. Table 2, Entry 20, yield 95.0 mg, 100%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Natural Product-like Combinatorial Libraries Based on Privileged
Structures. 3. The "Libraries from Libraries" Principle for Diversity
Enhancement of Benzopyran Libraries
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nicolaou, K. C.; Pfefferkorn, J. A.; Barluenga, S.; Mitchell, H. J.;
Roecker, A. J.; Cao, G.-Q.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2000), 122(41), 9968-9976

$RFMT $RIREG SCHEME48 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-[[1-oxo-3-[4-(trifluoromethyl)phenyl]-2-propen-1-yl][[4-(2-pyridinyl...
C26H21F3N2O3
1227795-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 N 6.9300 5.3347 0.0 0
M  V30 3 C 7.7000 6.6684 0.0 0
M  V30 4 C 7.7000 4.0009 0.0 0
M  V30 5 C 9.2400 6.6684 0.0 0
M  V30 6 O 6.9300 8.0020 0.0 0
M  V30 7 C 6.9300 2.6673 0.0 0
M  V30 8 C 9.2400 4.0009 0.0 0
M  V30 9 C 10.0100 8.0020 0.0 0
M  V30 10 O 7.7000 1.3336 0.0 0
M  V30 11 O 5.3900 2.6673 0.0 0
M  V30 12 C 6.9300 0.0000 0.0 0
M  V30 13 C 16.1700 8.0020 0.0 0
M  V30 14 F 16.1700 6.4620 0.0 0
M  V30 15 F 17.7100 8.0020 0.0 0
M  V30 16 F 16.1700 9.5420 0.0 0
M  V30 17 C 3.0800 9.3358 0.0 0
M  V30 18 C 2.3100 8.0020 0.0 0
M  V30 19 C 4.6200 9.3358 0.0 0
M  V30 20 C 3.0800 6.6684 0.0 0
M  V30 21 C 5.3900 8.0020 0.0 0
M  V30 22 C 4.6200 6.6684 0.0 0
M  V30 23 C 2.3100 10.6694 0.0 0
M  V30 24 C 0.7700 10.6694 0.0 0
M  V30 25 N 3.0800 12.0031 0.0 0
M  V30 26 C 0.0000 12.0031 0.0 0
M  V30 27 C 2.3100 13.3367 0.0 0
M  V30 28 C 0.7700 13.3367 0.0 0
M  V30 29 C 11.5500 8.0020 0.0 0
M  V30 30 C 12.3200 9.3358 0.0 0
M  V30 31 C 12.3200 6.6684 0.0 0
M  V30 32 C 13.8600 9.3358 0.0 0
M  V30 33 C 13.8600 6.6684 0.0 0
M  V30 34 C 14.6300 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 2 5 9 CFG=2
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 9 29
M  V30 13 1 10 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 34
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 23
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl α-[[1-oxo-3-[4-(trifluoromethyl)phenyl]-2-propen-1-yl][[4-(2-pyridinyl...
C30H30F3N3O3
1227795-48-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.2199 9.3360 0.0 0
M  V30 2 C 4.6799 9.3360 0.0 0
M  V30 3 C 6.9899 10.6697 0.0 0
M  V30 4 C 6.9899 8.0022 0.0 0
M  V30 5 C 3.9098 8.0022 0.0 0
M  V30 6 C 3.9098 10.6697 0.0 0
M  V30 7 C 8.5299 8.0022 0.0 0
M  V30 8 O 6.2199 6.6685 0.0 0
M  V30 9 O 4.6799 12.0033 0.0 0
M  V30 10 O 2.3698 10.6697 0.0 0
M  V30 11 C 9.3000 6.6685 0.0 0
M  V30 12 C 3.9098 13.3370 0.0 0
M  V30 13 C 6.2199 1.3337 0.0 0
M  V30 14 F 4.8862 2.1037 0.0 0
M  V30 15 F 5.4499 0.0000 0.0 0
M  V30 16 F 7.5536 0.5637 0.0 0
M  V30 17 C 8.5299 10.6697 0.0 0
M  V30 18 C 9.3000 12.0033 0.0 0
M  V30 19 C 9.3000 9.3360 0.0 0
M  V30 20 C 10.8400 12.0033 0.0 0
M  V30 21 C 10.8400 9.3360 0.0 0
M  V30 22 C 11.6100 10.6697 0.0 0
M  V30 23 N 2.3698 8.0022 0.0 0
M  V30 24 C 1.4646 9.2481 0.0 0
M  V30 25 C 1.4646 6.7563 0.0 0
M  V30 26 C 0.0000 8.7722 0.0 0
M  V30 27 C 0.0000 7.2322 0.0 0
M  V30 28 C 8.5299 5.3348 0.0 0
M  V30 29 C 9.3000 4.0010 0.0 0
M  V30 30 C 6.9899 5.3348 0.0 0
M  V30 31 C 8.5299 2.6673 0.0 0
M  V30 32 C 6.2199 4.0010 0.0 0
M  V30 33 C 6.9899 2.6673 0.0 0
M  V30 34 C 13.1500 10.6697 0.0 0
M  V30 35 C 13.9201 9.3360 0.0 0
M  V30 36 N 13.9201 12.0033 0.0 0
M  V30 37 C 15.4601 9.3360 0.0 0
M  V30 38 C 15.4601 12.0033 0.0 0
M  V30 39 C 16.2301 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 17
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 23
M  V30 10 1 6 9
M  V30 11 2 6 10
M  V30 12 2 7 11 CFG=2
M  V30 13 1 9 12
M  V30 14 1 11 28
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 16
M  V30 18 1 13 33
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 22 34
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 2 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 2 36 38
M  V30 41 2 37 39
M  V30 42 1 38 39
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1227795-46-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1227795-48-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2153798
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure 2 To a stirred solution of the acrylic acid methyl
ester derivative (1 eq) in dry MeCN (10 mL/mmol) was added potassium
carbonate (6 eq) followed by the aromatic amine or carbamate or oxo-amide
NHR13R14 (1.1 eq). The reaction mixture was stirred at rt for 4-15 h or
was refluxed for 20-30 h under nitrogen atmosphere, then filtered and
concentrated in under reduced pressure. FC (n-heptane/EA or DCM/MeOH
system) afforded the pure amino-acid derivative.
rac-2-{(4-Pyridin-2-yl-benzyl)-[3-(4-trifluoromethyl-phenyl)-acryloyl]-amino}-3-pyrrolidin-1-yl-propionic
acid methyl ester Yield: 100% HPLC conditions: Analytic: (B) Agilent 1100
series with DAD, ELSD and MS detection (MS: ESI+/ESI-, AB Sciex
Instruments API 2000 triple quadrupole). Column: Onyx monolithic C18
(100x3 mm). Conditions: eluents: A: MeCN, B: H2O + 0.05% formic acid.
Gradient 10 to 90% A over 4.0 min. Flow rate: 1.8 mL/min. LC-MS: tR =
2.66 min; [M+H]+ = 538.20
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel bis-amides as antimalarial agents and their preparation and use in
the treatment of protozoal infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aissaoui, Hamed; Boss, Christoph; Corminboeuf, Olivier; Frantz,
Marie-Celine; Grisostomi, Corinna
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010058353 A1 2010-05-27

$RFMT $RIREG SCHEME49 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2Z,5α)-2-(Hydroxymethylene)cholestan-3-one
C28H46O2
1233699-25-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6839 4.4757 0.0 0
M  V30 2 C 9.4968 6.9216 0.0 0
M  V30 3 C 1.3338 3.8500 0.0 0
M  V30 4 O 0.0000 3.0800 0.0 0
M  V30 5 C 12.1342 6.6359 0.0 0 CFG=2
M  V30 6 C 12.1342 8.1759 0.0 0
M  V30 7 C 13.4678 5.8659 0.0 0
M  V30 8 C 13.4678 8.9459 0.0 0
M  V30 9 C 13.4678 10.4859 0.0 0
M  V30 10 C 14.8015 11.2559 0.0 0
M  V30 11 C 16.1353 10.4859 0.0 0
M  V30 12 C 14.8015 12.7959 0.0 0
M  V30 13 O 1.3338 0.7700 0.0 0
M  V30 14 C 6.6685 3.8500 0.0 0 CFG=2
M  V30 15 C 8.0022 3.0800 0.0 0 CFG=1
M  V30 16 C 5.3347 3.0800 0.0 0 CFG=2
M  V30 17 C 6.6685 5.3900 0.0 0
M  V30 18 C 9.3358 3.8500 0.0 0 CFG=2
M  V30 19 C 8.0022 1.5400 0.0 0
M  V30 20 C 5.3347 1.5400 0.0 0 CFG=2
M  V30 21 C 4.0011 3.8500 0.0 0
M  V30 22 C 8.0022 6.1600 0.0 0
M  V30 23 C 9.3358 5.3900 0.0 0 CFG=2
M  V30 24 C 10.8005 3.3742 0.0 0
M  V30 25 C 6.6685 0.7700 0.0 0
M  V30 26 C 4.0011 0.7700 0.0 0
M  V30 27 C 2.6674 3.0800 0.0 0
M  V30 28 C 10.8005 5.8659 0.0 0 CFG=1
M  V30 29 C 11.7058 4.6200 0.0 0
M  V30 30 C 2.6674 1.5400 0.0 0
M  V30 31 H 5.7852 5.1114 0.0 0
M  V30 32 H 8.8855 1.8184 0.0 0
M  V30 33 H 10.1289 2.5299 0.0 0
M  V30 34 H 5.3347 0.0000 0.0 0
M  V30 35 H 10.1741 7.2728 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=1
M  V30 2 1 23 2 CFG=1
M  V30 3 1 3 4
M  V30 4 2 3 27
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=1
M  V30 7 1 5 28
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 2 13 30
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 31 CFG=3
M  V30 18 1 15 18
M  V30 19 1 15 19
M  V30 20 1 15 32 CFG=1
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 17 22
M  V30 24 1 18 23
M  V30 25 1 18 24
M  V30 26 1 18 33 CFG=3
M  V30 27 1 19 25
M  V30 28 1 20 25
M  V30 29 1 20 26
M  V30 30 1 20 34 CFG=3
M  V30 31 1 21 27
M  V30 32 1 22 23
M  V30 33 1 23 28
M  V30 34 1 24 29
M  V30 35 1 26 30
M  V30 36 1 27 30
M  V30 37 1 28 29
M  V30 38 1 28 35 CFG=3
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 5 14 15 16 18 20 23 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2Z,5α)-2-(1-Pyrrolidinylmethylene)cholestan-3-one
C32H53NO
2490292-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.1240 2.3791 0.0 0
M  V30 2 C 12.5150 2.6674 0.0 0
M  V30 3 C 3.9098 1.2459 0.0 0
M  V30 4 C 14.6562 4.2335 0.0 0 CFG=2
M  V30 5 C 15.4262 2.8998 0.0 0
M  V30 6 C 15.4262 5.5671 0.0 0
M  V30 7 C 16.9662 2.8998 0.0 0
M  V30 8 C 17.7362 1.5662 0.0 0
M  V30 9 C 19.2762 1.5662 0.0 0
M  V30 10 C 20.0462 2.8998 0.0 0
M  V30 11 C 20.0462 0.2324 0.0 0
M  V30 12 O 2.3698 3.9133 0.0 0
M  V30 13 C 8.5298 3.9133 0.0 0 CFG=2
M  V30 14 C 9.2998 5.2469 0.0 0 CFG=1
M  V30 15 C 6.9898 3.9133 0.0 0 CFG=2
M  V30 16 C 9.2998 2.5797 0.0 0
M  V30 17 C 10.8398 5.2469 0.0 0 CFG=2
M  V30 18 C 8.5298 6.5806 0.0 0
M  V30 19 C 6.2198 5.2469 0.0 0 CFG=2
M  V30 20 C 6.2198 2.5797 0.0 0
M  V30 21 C 10.8398 2.5797 0.0 0
M  V30 22 C 11.6098 3.9133 0.0 0 CFG=2
M  V30 23 C 11.8703 6.3915 0.0 0
M  V30 24 C 6.9898 6.5806 0.0 0
M  V30 25 C 4.6798 5.2469 0.0 0
M  V30 26 C 4.6798 2.5797 0.0 0
M  V30 27 C 13.1162 4.2335 0.0 0 CFG=1
M  V30 28 C 13.2771 5.7650 0.0 0
M  V30 29 C 3.9098 3.9133 0.0 0
M  V30 30 N 2.3698 1.2459 0.0 0
M  V30 31 C 1.4647 0.0000 0.0 0
M  V30 32 C 1.4647 2.4919 0.0 0
M  V30 33 C 0.0000 0.4759 0.0 0
M  V30 34 C 0.0000 2.0159 0.0 0
M  V30 35 H 8.3956 2.3791 0.0 0
M  V30 36 H 9.4340 6.7811 0.0 0
M  V30 37 H 10.8667 6.7868 0.0 0
M  V30 38 H 5.4498 6.5806 0.0 0
M  V30 39 H 13.2771 2.7019 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 15 1 CFG=3
M  V30 2 1 22 2 CFG=3
M  V30 3 2 3 26
M  V30 4 1 3 30
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=3
M  V30 7 1 4 27
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 2 12 29
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 35 CFG=1
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 1 14 36 CFG=3
M  V30 21 1 15 19
M  V30 22 1 15 20
M  V30 23 1 16 21
M  V30 24 1 17 22
M  V30 25 1 17 23
M  V30 26 1 17 37 CFG=1
M  V30 27 1 18 24
M  V30 28 1 19 24
M  V30 29 1 19 25
M  V30 30 1 19 38 CFG=1
M  V30 31 1 20 26
M  V30 32 1 21 22
M  V30 33 1 22 27
M  V30 34 1 23 28
M  V30 35 1 25 29
M  V30 36 1 26 29
M  V30 37 1 27 28
M  V30 38 1 27 39 CFG=1
M  V30 39 1 30 31
M  V30 40 1 30 32
M  V30 41 1 31 33
M  V30 42 1 32 34
M  V30 43 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(8 4 13 14 15 17 19 22 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1233699-25-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2490292-44-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-22635331
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark water separator used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 2',6'-dicyano anilino - steroids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Khaidem, Ibomacha Singh; Khan, Mohd. Ziaur Rahman; Singh, Sagolsem Lokhol
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Journal of Pharmaceutical Research (2020), 9(2), 1065-1070

$RFMT $RIREG SCHEME50 STEP1
$RXN



  2  1
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidinecarbodithioic acid
C5H9NS2
25769-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 S 5.1048 2.3100 0.0 0
M  V30 3 S 3.7710 0.0000 0.0 0
M  V30 4 N 2.4374 2.3100 0.0 0
M  V30 5 C 2.2764 3.8416 0.0 0
M  V30 6 C 1.0306 1.6835 0.0 0
M  V30 7 C 0.7700 4.1617 0.0 0
M  V30 8 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 25769-03-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42238570
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regioselective Markovnikov hydrothiolation of 1-aryl-1,3-butadienes with
dithiocarbamic acid to allyl dithiocarbamates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fernandes, Rodney A.; Moharana, Sanjita; Choudhary, Priyanka; Ranjan,
Ravikant S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2024), 60(86),
12561-12564

$RFMT $RIREG SCHEME51 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
cis-(αS)-α-[[(1,1-Dimethylethoxy)carbonyl]amino]-4-hydroxycyclohexaneacetic acid
C13H23NO5
209796-46-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0792 2.6674 0.0 0 CFG=1
M  V30 2 N 5.8492 4.0011 0.0 0
M  V30 3 C 5.8492 1.3338 0.0 0
M  V30 4 C 7.3892 4.0011 0.0 0
M  V30 5 O 5.0792 0.0000 0.0 0
M  V30 6 O 7.3892 1.3338 0.0 0
M  V30 7 O 8.1592 5.3349 0.0 0
M  V30 8 O 8.1592 2.6674 0.0 0
M  V30 9 C 9.6992 5.3349 0.0 0
M  V30 10 C 9.6992 6.8749 0.0 0
M  V30 11 C 11.2392 5.3349 0.0 0
M  V30 12 C 9.6992 3.7949 0.0 0
M  V30 13 O 0.0000 5.6372 0.0 0
M  V30 14 C 3.5392 2.6674 0.0 0 CFG=1
M  V30 15 C 3.8066 4.1840 0.0 0
M  V30 16 C 2.0921 2.1408 0.0 0
M  V30 17 C 2.6269 5.1739 0.0 0
M  V30 18 C 0.9123 3.1307 0.0 0
M  V30 19 C 1.1798 4.6473 0.0 0 CFG=2
M  V30 20 H 3.8066 1.1508 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 19 13 CFG=1
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 20 CFG=3
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 14 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Methanesulfonyl chloride
CH3ClO2S
124-63-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 C 0.0000 1.5400 0.0 0
M  V30 3 Cl 3.0800 1.5400 0.0 0
M  V30 4 O 1.5400 3.0800 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 1 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbamic acid, [(1S)-1-[cis-4-[(methylsulfonyl)oxy]cyclohexyl]-2-oxo-2-(1-pyr...
C18H32N2O6S
867212-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9537 5.1047 0.0 0 CFG=2
M  V30 2 C 6.7237 3.7710 0.0 0
M  V30 3 N 4.4137 5.1047 0.0 0
M  V30 4 O 8.2638 3.7710 0.0 0
M  V30 5 C 3.6437 6.4384 0.0 0
M  V30 6 O 2.1037 6.4384 0.0 0
M  V30 7 O 4.4137 7.7722 0.0 0
M  V30 8 C 1.3337 7.7722 0.0 0
M  V30 9 C 2.6675 8.5422 0.0 0
M  V30 10 C 0.5636 9.1058 0.0 0
M  V30 11 C 0.0000 7.0022 0.0 0
M  V30 12 O 11.0652 8.0186 0.0 0
M  V30 13 S 11.3327 9.5352 0.0 0 VAL=6
M  V30 14 C 12.8493 9.2678 0.0 0
M  V30 15 O 11.6001 11.0518 0.0 0
M  V30 16 O 9.8161 9.8027 0.0 0
M  V30 17 C 6.7237 6.4384 0.0 0 CFG=2
M  V30 18 C 7.9035 5.4486 0.0 0
M  V30 19 C 6.9912 7.9550 0.0 0
M  V30 20 C 9.3507 5.9753 0.0 0
M  V30 21 C 8.4384 8.4818 0.0 0
M  V30 22 C 9.6180 7.4919 0.0 0 CFG=1
M  V30 23 N 5.9537 2.4374 0.0 0
M  V30 24 C 4.4222 2.2763 0.0 0
M  V30 25 C 6.5802 1.0304 0.0 0
M  V30 26 C 4.1020 0.7700 0.0 0
M  V30 27 C 5.4357 0.0000 0.0 0
M  V30 28 H 5.2767 6.9652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 17
M  V30 4 2 2 4
M  V30 5 1 2 23
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 1 22 12 CFG=3
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 13 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 28 CFG=1
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 17 22)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 209796-46-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 124-63-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 867212-27-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-022-CAS-15411019
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 2:
(S)-[1-(trans-4-Hydroxy-cyclohexyl)-2-oxo-2-pyrrolidin-1-yl-ethyl]-carbamic
acid tert-butyl ester To a solution of
(S)-tert-butoxycarbonylamino-(trans-4-hydroxy-cyclohexyl)-acetic acid (21
g, 77 mmol) in DMF (240 mL) was added pyrrolidine (7.7 mL, 92 mmol),
triethylamine (24 mL, 1691 mmol) and
benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate
(BOP) (38 g, 85 mmol). The mixture was stirred overnight, poured into
water and extracted with dichloromethane (2x). The combined extracts were
washed with 2 N hydrochloric acid, water, saturated sodium bicarbonate
and brine, dried over magnesium sulfate and concentrated to dryness,
leaving a white foam (25 g, 99%). Step 3: (S)-Methanesulfonic acid
cis-4-(1-tert-Butoxycarbonylamino-2-oxo-2-pyrrolidin-1-yl-ethyl)-cyclohexyl
ester To a solution of
(S)-[1-(cis-4-hydroxy-cyclohexyl)-2-oxo-2-pyrrolidin-1-yl-ethyl]-carbamic
acid tert-butyl ester (4.05 g, 12.4 mmol) and diisopropylethylamine (4.3
mL, 25 mmol) in dichloromethane (20 mL) was added drop wise at 0°C.
methanesulfonyl chloride (1.44 mL, 19 mmol). The mixture was stirred at
0°C. for 10 minute then diluted with ethyl acetate, washed with saturated
sodium bicarbonate (2x), water and brine, dried over magnesium sulfate
and concentrated to a solid (5.02 g, 100%). (S)-Methanesulfonic acid
cis-4-(1-tert-Butoxycarbonylamino-2-oxo-2-pyrrolidin-1-yl-ethyl)-cyclohexyl
ester, Yield (5.02 g, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptides as dipeptidyl peptidase-IV inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hulin, Bernard; Parker, Janice C.; Piotrowski, David W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050234065 A1 2005-10-20

$RFMT $RIREG SCHEME52 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(chloromethyl)-4-(2-methyl-1H-indol-3-yl)-4H-1-benzopyran-3-carboxylate
C21H18ClNO3
1257865-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.9208 4.0011 0.0 0
M  V30 2 O 2.1508 2.6673 0.0 0
M  V30 3 O 2.1508 5.3347 0.0 0
M  V30 4 C 0.6108 2.6673 0.0 0
M  V30 5 C 6.5935 8.3955 0.0 0
M  V30 6 C 4.4608 1.3336 0.0 0
M  V30 7 Cl 5.2308 0.0000 0.0 0
M  V30 8 C 5.2308 5.3347 0.0 0
M  V30 9 C 6.7708 5.3347 0.0 0
M  V30 10 C 4.4608 4.0011 0.0 0
M  V30 11 C 7.5408 4.0011 0.0 0
M  V30 12 C 7.5408 6.6684 0.0 0
M  V30 13 C 5.2308 2.6673 0.0 0
M  V30 14 O 6.7708 2.6673 0.0 0
M  V30 15 C 9.0808 4.0011 0.0 0
M  V30 16 C 9.0808 6.6684 0.0 0
M  V30 17 C 9.8508 5.3347 0.0 0
M  V30 18 C 4.4608 6.6684 0.0 0
M  V30 19 C 2.9292 6.8294 0.0 0
M  V30 20 C 5.0872 8.0753 0.0 0
M  V30 21 C 2.6091 8.3357 0.0 0
M  V30 22 C 1.7849 5.7989 0.0 0
M  V30 23 N 3.9427 9.1057 0.0 0
M  V30 24 C 1.1444 8.8116 0.0 0
M  V30 25 C 0.3202 6.2747 0.0 0
M  V30 26 C 0.0000 7.7812 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 20
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 18
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 2 19 22
M  V30 24 1 20 23
M  V30 25 1 21 23
M  V30 26 2 21 24
M  V30 27 1 22 25
M  V30 28 1 24 26
M  V30 29 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(2-methyl-1H-indol-3-yl)-2-(1-pyrrolidinylmethyl)-4H-1-benzopyran-3-...
C25H26N2O3
1257865-30-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0543 6.6684 0.0 0
M  V30 2 O 5.8243 8.0021 0.0 0
M  V30 3 O 3.5143 6.6684 0.0 0
M  V30 4 C 5.0543 9.3358 0.0 0
M  V30 5 C 3.0849 1.2905 0.0 0
M  V30 6 C 8.1343 6.6684 0.0 0
M  V30 7 C 5.0543 4.0011 0.0 0
M  V30 8 C 5.8243 5.3347 0.0 0
M  V30 9 C 5.8243 2.6674 0.0 0
M  V30 10 C 7.3643 5.3347 0.0 0
M  V30 11 C 7.3643 2.6674 0.0 0
M  V30 12 C 5.0543 1.3336 0.0 0
M  V30 13 O 8.1343 4.0011 0.0 0
M  V30 14 C 8.1343 1.3336 0.0 0
M  V30 15 C 5.8243 0.0000 0.0 0
M  V30 16 C 7.3643 0.0000 0.0 0
M  V30 17 C 3.5143 4.0011 0.0 0
M  V30 18 C 2.6091 5.2469 0.0 0
M  V30 19 C 2.6091 2.7552 0.0 0
M  V30 20 C 1.1444 4.7711 0.0 0
M  V30 21 C 2.9292 6.7534 0.0 0
M  V30 22 N 1.1444 3.2311 0.0 0
M  V30 23 C 0.0000 5.8015 0.0 0
M  V30 24 C 1.7849 7.7838 0.0 0
M  V30 25 C 0.3202 7.3079 0.0 0
M  V30 26 N 9.6743 6.6684 0.0 0
M  V30 27 C 10.5795 5.4225 0.0 0
M  V30 28 C 10.5795 7.9144 0.0 0
M  V30 29 C 12.0440 5.8984 0.0 0
M  V30 30 C 12.0440 7.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 5 19
M  V30 6 1 6 10
M  V30 7 1 6 26
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 17
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 13
M  V30 15 1 11 13
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 1 14 16
M  V30 19 2 15 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 2 18 21
M  V30 24 1 19 22
M  V30 25 1 20 22
M  V30 26 2 20 23
M  V30 27 1 21 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1257865-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1257865-30-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1093577
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Streamlined access to functionalized chromenes and quinolines using
domino reactions of salicylic aldehydes and methyl 4-chloro-2-butynoate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bello, Davide; Ruiz-Rodriguez, Javier; Albericio, Fernando; Ramon,
Rosario; Lavilla, Rodolfo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2010), (28), 5373-5379,
S5373/1-S5373/16

$RFMT $RIREG SCHEME53 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Bromomethyl)-6-fluorobenzonitrile
C8H5BrFN
1261686-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 Br 6.6685 3.8500 0.0 0
M  V30 3 C 2.6674 1.5400 0.0 0
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 F 0.0000 3.0800 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 2.6674 3.0800 0.0 0
M  V30 8 C 4.0011 5.3900 0.0 0
M  V30 9 C 1.3338 3.8500 0.0 0
M  V30 10 C 2.6674 6.1600 0.0 0
M  V30 11 C 1.3338 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 3 3 4
M  V30 4 1 3 7
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-6-(1-pyrrolidinylmethyl)benzenemethanamine
C12H17FN2
2342600-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.7700 0.0 0
M  V30 2 N 1.3337 0.0000 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 F 0.0000 2.3101 0.0 0
M  V30 5 C 2.6673 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 1.3337 3.0801 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 2.6673 5.3901 0.0 0
M  V30 11 N 6.6685 3.0801 0.0 0
M  V30 12 C 6.8296 4.6116 0.0 0
M  V30 13 C 8.0755 2.4537 0.0 0
M  V30 14 C 8.3359 4.9318 0.0 0
M  V30 15 C 9.1059 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 3 11
M  V30 5 1 4 7
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1261686-95-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2342600-34-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21907008
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1336-21-6
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-02-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Raney nickel used in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl-substituted sulfonamide compounds and their use
as sodium channel inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Focken, Thilo; Andrez, Jean-Christophe; Burford, Kristen Nicole;
Dehnhardt, Christoph Martin; Grimwood, Michael Edward; Jia, Qi;
Lofstrand, Verner Alexander; Wilson, Michael Scott; Zenova, Alla Yurevna;
Wesolowski, Steven Sigmund; Sun, Shaoyi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020047323 A1 2020-03-05

$RFMT $RIREG SCHEME54 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-methyl-2-[(methylsulfonyl)oxy]ethyl]carbamate
C9H19NO5S
126301-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.1037 0.0 0
M  V30 2 N 5.3348 1.3337 0.0 0
M  V30 3 O 2.6673 1.3337 0.0 0
M  V30 4 O 4.0012 3.6437 0.0 0
M  V30 5 C 6.6685 2.1037 0.0 0 CFG=1
M  V30 6 C 1.3337 2.1037 0.0 0
M  V30 7 C 8.0022 1.3337 0.0 0
M  V30 8 C 6.6685 3.6437 0.0 0
M  V30 9 C 2.1037 3.4374 0.0 0
M  V30 10 C 0.0000 2.8737 0.0 0
M  V30 11 C 0.5637 0.7700 0.0 0
M  V30 12 O 9.3360 2.1037 0.0 0
M  V30 13 S 10.6697 1.3337 0.0 0 VAL=6
M  V30 14 C 11.4397 2.6673 0.0 0
M  V30 15 O 12.0033 0.5637 0.0 0
M  V30 16 O 9.8996 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 5 8 CFG=1
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 12 13
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 2 13 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-1-methyl-2-(1-pyrrolidinyl)ethyl]carbamate
C12H24N2O2
1225209-97-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 0.5637 0.0 0
M  V30 2 C 6.6685 1.3337 0.0 0 CFG=2
M  V30 3 N 5.3348 0.5637 0.0 0
M  V30 4 C 6.6685 2.8737 0.0 0
M  V30 5 C 4.0010 1.3337 0.0 0
M  V30 6 O 2.6673 0.5637 0.0 0
M  V30 7 O 4.0010 2.8737 0.0 0
M  V30 8 C 1.3337 1.3337 0.0 0
M  V30 9 C 2.1037 2.6673 0.0 0
M  V30 10 C 0.0000 2.1037 0.0 0
M  V30 11 C 0.5637 0.0000 0.0 0
M  V30 12 N 9.3360 1.3337 0.0 0
M  V30 13 C 9.4969 2.8652 0.0 0
M  V30 14 C 10.7428 0.7073 0.0 0
M  V30 15 C 11.0032 3.1854 0.0 0
M  V30 16 C 11.7733 1.8517 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 126301-16-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1225209-97-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21897592
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antimalarial activity of new 4-aminoquinolines active
against drug resistant strains
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kondaparla, Srinivasarao; Soni, Awakash; Manhas, Ashan; Srivastava,
Kumkum; Puri, Sunil K.; Katti, S. B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(107), 105676-105689

$RFMT $RIREG SCHEME55 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (1R)-2′-[[(trifluoromethyl)sulfonyl]oxy][1,1′-binaphthalene]-2-carboxy...
C23H15F3O5S
126613-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.0682 2.6268 0.0 0
M  V30 2 O 7.5949 1.1797 0.0 0
M  V30 3 O 8.0580 3.8066 0.0 0
M  V30 4 C 6.6050 0.0000 0.0 0
M  V30 5 O 7.5285 5.4707 0.0 0
M  V30 6 S 8.8622 6.2408 0.0 0 VAL=6
M  V30 7 C 10.4022 3.5735 0.0 0
M  V30 8 O 10.1960 7.0108 0.0 0
M  V30 9 O 8.0922 7.5744 0.0 0
M  V30 10 F 9.6322 2.2396 0.0 0
M  V30 11 F 11.1722 2.2396 0.0 0
M  V30 12 F 11.9422 3.5735 0.0 0
M  V30 13 C 4.4625 3.9832 0.0 0
M  V30 14 C 2.9750 3.5847 0.0 0
M  V30 15 C 5.5514 2.8943 0.0 0
M  V30 16 C 2.5764 2.0970 0.0 0
M  V30 17 C 1.8861 4.6736 0.0 0
M  V30 18 C 5.1529 1.4068 0.0 0
M  V30 19 C 3.6654 1.0081 0.0 0
M  V30 20 C 1.0889 1.6985 0.0 0
M  V30 21 C 0.3986 4.2751 0.0 0
M  V30 22 C 0.0000 2.7874 0.0 0
M  V30 23 C 4.8612 5.4707 0.0 0
M  V30 24 C 3.5274 6.2408 0.0 0
M  V30 25 C 6.1949 6.2408 0.0 0
M  V30 26 C 3.5274 7.7808 0.0 0
M  V30 27 C 2.1938 5.4707 0.0 0
M  V30 28 C 6.1949 7.7808 0.0 0
M  V30 29 C 4.8612 8.5508 0.0 0
M  V30 30 C 2.1938 8.5508 0.0 0
M  V30 31 C 0.8601 6.2408 0.0 0
M  V30 32 C 0.8601 7.7808 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 25
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 7 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 23
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 2 18 19
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 24 27
M  V30 29 1 25 28
M  V30 30 1 26 29
M  V30 31 1 26 30
M  V30 32 2 27 31
M  V30 33 2 28 29
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methanesulfonic acid, trifluoro-, (1R)-2′-(1-pyrrolidinylcarbonyl)[1,1′-binap...
C26H20F3NO4S
476311-85-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4086 5.8204 0.0 0
M  V30 2 S 9.7423 6.5904 0.0 0 VAL=6
M  V30 3 C 11.2823 3.9229 0.0 0
M  V30 4 O 11.0761 7.3604 0.0 0
M  V30 5 O 8.9722 7.9241 0.0 0
M  V30 6 F 10.5123 2.5893 0.0 0
M  V30 7 F 12.0523 2.5893 0.0 0
M  V30 8 F 12.8223 3.9229 0.0 0
M  V30 9 C 2.8732 3.6445 0.0 0
M  V30 10 O 2.2224 5.0402 0.0 0
M  V30 11 C 5.7412 5.8204 0.0 0
M  V30 12 C 4.4074 6.5904 0.0 0
M  V30 13 C 7.0749 6.5904 0.0 0
M  V30 14 C 4.4074 8.1305 0.0 0
M  V30 15 C 3.0738 5.8204 0.0 0
M  V30 16 C 7.0749 8.1305 0.0 0
M  V30 17 C 5.7412 8.9005 0.0 0
M  V30 18 C 3.0738 8.9005 0.0 0
M  V30 19 C 1.7401 6.5904 0.0 0
M  V30 20 C 1.7401 8.1305 0.0 0
M  V30 21 C 5.7412 4.2804 0.0 0
M  V30 22 C 7.0749 3.5104 0.0 0
M  V30 23 C 4.4074 3.5104 0.0 0
M  V30 24 C 7.0749 1.9703 0.0 0
M  V30 25 C 8.4086 4.2804 0.0 0
M  V30 26 C 4.4074 1.9703 0.0 0
M  V30 27 C 5.7412 1.2003 0.0 0
M  V30 28 C 8.4086 1.2003 0.0 0
M  V30 29 C 9.7423 3.5104 0.0 0
M  V30 30 C 9.7423 1.9703 0.0 0
M  V30 31 N 1.9900 2.3830 0.0 0
M  V30 32 C 0.4502 2.3561 0.0 0
M  V30 33 C 2.4913 0.9269 0.0 0
M  V30 34 C 0.0000 0.8834 0.0 0
M  V30 35 C 1.2614 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 2 9 10
M  V30 10 1 9 23
M  V30 11 1 9 31
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 21
M  V30 15 2 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 14 18
M  V30 20 2 15 19
M  V30 21 2 16 17
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 22 25
M  V30 28 1 23 26
M  V30 29 1 24 27
M  V30 30 1 24 28
M  V30 31 2 25 29
M  V30 32 2 26 27
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 126613-07-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 476311-85-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14294212
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-24-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of amides (6a-f); general procedure
To a suspension of amine or dimethylamine hydrochloride (0.66 mmol) in
toluene (2 ml) was added a solution of tRimethylaluminum (2M solution in
toluene, 0.33 ml, 0.66 mmol) at 0°C and the mixture was stirred at room
temperature for 1h. Ester (5)1 (150 mg, 0.33 mmol) was added and the
solution was heated at reflux under argon atmosphere for 3h. The reaction
mixture was cooled to room temperature, quenched with 1N HCl solution (20
ml) and the mixture was extRacted with ethyl acetate (20ml x 2). The
combined organic extRacts were washed with brine (20 ml x 2), dried
(MgSO4), and concentRated in vacuo. The residue was purified by flash
column chromatography on silica gel with ethyl acetate/hexanes (1:2) to
give the pure amide product (quantitative yield) as a white foamy solid.
(R)-2-N,N-Dimethylcarbamoyl-2’-trifluoromathanesulfonyloxy-1,1’-binaphthyl
(6a)
(R)-2-(Pyrrolidine-1-carbonyl)-2’-trifluoromathanesulfonyloxy-1,1’-binaphthyl
(6d) yield 100%. [α]D25 = -56.1 (c = 2.05, CHCl3). IR (KBr) ν 1634
(carbonyl) cm-1. 1H NMR (300 MHz, CDCl3) δ 1.78-1.89 (m, 4H), 3.27-3.50
(4H, m), 7.19 (d, J = 8.4 Hz, 1H), 7.23-7.56 (m, 6H), 7.61 (d, J = 8.4
Hz, 1H), 7.93 (d, J = 7.5 Hz, 1H), 7.96 (d, J = 7.8 Hz, 1H), 8.02 (d, J =
9.0 Hz, 1H), 8.05 (d, J = 8.7 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 24.31,
26.12, 45.48, 48.79, 118.24 (q, JC-F = 318 Hz), 118.78, 123.66, 126.95,
127.11, 127.50, 127.54, 128.10, 128.11, 128.80, 128.90, 129.16, 130.89,
132.08, 132.86, 133.39, 134.33, 136.16, 145.13, 167.90. Anal. Calcd for
C26H20F3NO4S: C, 62.52; H, 4.04; F, 11.41; N, 2.80; O, 12.81; S, 6.42.
Found: C, 62.55; H, 4.07; N, 2.89; S, 6.35.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective additions of diethylzinc and diphenylzinc to aldehydes
using 2-dialkylaminomethyl-2'-hydroxy-1,1'-binaphthyls
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ko, Dong-Hyun; Kim, Kyoung Hoon; Ha, Deok-Chan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2002), 4(21), 3759-3762

$RFMT $RIREG SCHEME56 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-4-oxopyrrolo[1,2-a]quinoxaline-5(4H)-propanoic acid
C14H11FN2O3
1282355-85-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8500 0.0 0
M  V30 2 C 6.6684 4.6201 0.0 0
M  V30 3 C 8.0022 3.8500 0.0 0
M  V30 4 O 9.3359 4.6201 0.0 0
M  V30 5 O 8.0022 2.3100 0.0 0
M  V30 6 O 5.3348 6.9301 0.0 0
M  V30 7 F 1.3337 0.0000 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 N 1.3337 6.1601 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 N 4.0011 4.6201 0.0 0
M  V30 13 C 2.6675 2.3100 0.0 0
M  V30 14 C 2.6675 6.9301 0.0 0
M  V30 15 C 0.1893 7.1905 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 4.0011 6.1601 0.0 0
M  V30 18 C 1.3337 1.5400 0.0 0
M  V30 19 C 2.3473 8.4364 0.0 0
M  V30 20 C 0.8156 8.5973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 17
M  V30 7 1 7 18
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 12 17
M  V30 17 1 13 18
M  V30 18 1 14 17
M  V30 19 2 14 19
M  V30 20 2 15 20
M  V30 21 2 16 18
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Fluoro-5-[3-oxo-3-(1-pyrrolidinyl)propyl]pyrrolo[1,2-a]quinoxalin-4(5H)-one
C18H18FN3O2
2752470-77-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.8501 0.0 0
M  V30 2 C 6.6685 4.6201 0.0 0
M  V30 3 C 8.0022 3.8501 0.0 0
M  V30 4 O 8.0022 2.3101 0.0 0
M  V30 5 O 5.3348 6.9302 0.0 0
M  V30 6 F 1.3337 0.0000 0.0 0
M  V30 7 C 2.6673 3.8501 0.0 0
M  V30 8 C 1.3337 4.6201 0.0 0
M  V30 9 N 4.0010 4.6201 0.0 0
M  V30 10 C 2.6673 2.3101 0.0 0
M  V30 11 N 1.3337 6.1601 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 C 4.0010 6.1601 0.0 0
M  V30 14 C 1.3337 1.5400 0.0 0
M  V30 15 C 2.6673 6.9302 0.0 0
M  V30 16 C 0.1893 7.1906 0.0 0
M  V30 17 C 0.0000 2.3101 0.0 0
M  V30 18 C 2.3472 8.4365 0.0 0
M  V30 19 C 0.8156 8.5974 0.0 0
M  V30 20 N 9.3360 4.6201 0.0 0
M  V30 21 C 9.4969 6.1517 0.0 0
M  V30 22 C 10.7428 3.9936 0.0 0
M  V30 23 C 11.0032 6.4718 0.0 0
M  V30 24 C 11.7733 5.1382 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 20
M  V30 6 2 5 13
M  V30 7 1 6 14
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 12 17
M  V30 18 1 13 15
M  V30 19 2 14 17
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1282355-85-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2752470-77-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30631966
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazoloquinoxalines and related heterocyclic compounds as
imaging agents for imaging of huntingtin protein
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Longbin; Lee, Matthew; Dominguez, Celia; Johnson, Peter David;
Greenaway, Catherine Jane; Khurana, Kanika; Mills, Matthew Robert; Rota,
Filippo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021252775 A1 2021-12-16

$RFMT $RIREG SCHEME57 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Naphthoquinone
C10H6O2
130-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 4.0011 0.0 0
M  V30 2 O 6.1600 4.0011 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.8500 2.6674 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 C 1.5400 1.3338 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 4.6200 1.3338 0.0 0
M  V30 9 C 2.3100 5.3349 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 3.8500 5.3349 0.0 0
M  V30 12 C 3.8500 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Pyrrolidinyl)-1,4-naphthalenedione
C14H13NO2
59641-26-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 C 5.3900 2.6674 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 4.6200 1.3338 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 3.0800 1.3338 0.0 0
M  V30 8 C 2.3100 2.6674 0.0 0
M  V30 9 C 2.3100 5.3349 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 0.7700 5.3349 0.0 0
M  V30 12 C 0.0000 4.0011 0.0 0
M  V30 13 N 6.9300 2.6674 0.0 0
M  V30 14 C 7.8352 3.9133 0.0 0
M  V30 15 C 7.8352 1.4216 0.0 0
M  V30 16 C 9.2998 3.4374 0.0 0
M  V30 17 C 9.2998 1.8974 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 4
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 13
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 8
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 130-15-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59641-26-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-4166412
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM "On water": unprecedented nucleophilic substitution and addition
reactions with 1,4-quinones in aqueous suspension
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tandon, Vishnu K.; Maurya, Hardesh K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2009), 50(43), 5896-5902

$RFMT $RIREG SCHEME58 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-5-fluorobenzotrifluoride
C7H3BrF4
130723-13-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 4.6201 0.0 0
M  V30 2 F 0.5638 3.2864 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 2.1038 5.9538 0.0 0
M  V30 5 Br 6.6687 4.6201 0.0 0
M  V30 6 F 4.0012 0.0000 0.0 0
M  V30 7 C 2.6675 3.8501 0.0 0
M  V30 8 C 4.0012 4.6201 0.0 0
M  V30 9 C 2.6675 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 1 5 10
M  V30 6 1 6 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-Bromo-5-(trifluoromethyl)phenyl]pyrrolidine
C11H11BrF3N
1396780-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 F 2.1037 5.9538 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 0.5637 3.2864 0.0 0
M  V30 5 Br 4.0012 0.0000 0.0 0
M  V30 6 C 5.3348 3.8501 0.0 0
M  V30 7 C 4.0012 4.6201 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 2.6673 3.8501 0.0 0
M  V30 10 C 4.0012 1.5400 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 N 6.6685 4.6201 0.0 0
M  V30 13 C 8.0755 3.9936 0.0 0
M  V30 14 C 6.8296 6.1517 0.0 0
M  V30 15 C 9.1059 5.1382 0.0 0
M  V30 16 C 8.3359 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 130723-13-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1396780-06-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4725577
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 22 Synthesis of TRV 1163 [00155] TRV 1163
phenyl(4-(3-(pyrrolidin-1-yl)-5-(trifluoromethyl)phenyl)piperazin-1-yl)methanone
[00157] 3-bromo-5-fluorobenzotrifluoride (0.7304 g, 3.0 mmol),
pyrrolidine (0.30 mL, 3.6 mmol), DIPEA (0.78 mL, 4.5 mmol) and NMP (4 mL)
were added to a tube. The tube was sealed and heated overnight at 80 °C.
After cooling, the reaction mixture was diluted with water and EtOAc. The
aqueous layer was back-extracted with EtOAc (3x). The combined organic
layers were then washed with H2O, 1N HCl (2x), saturated NaHCO3, H2O and
brine before drying with Na2SO4. The material was filtered and
concentrated under reduced pressure to give an oil. 0.9 g, crude oil.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amino substituted biaryl compounds as anti-amyloid agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reed, Mark A.; Yadav, Arun; Banfield, Scott C.; Barden, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012119035 A1 2012-09-07

$RFMT $RIREG SCHEME59 STEP1
$RXN



  2  1
$MOL
2-Phenyl-6H-[1,2,4]triazino[5,6,1-jk]carbazol-6-one
C19H11N3O
1312543-84-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 5.8783 0.0 0
M  V30 2 C 3.8576 4.6962 0.0 0
M  V30 3 N 4.5325 3.3500 0.0 0
M  V30 4 C 2.3542 4.6075 0.0 0
M  V30 5 C 4.6172 6.0120 0.0 0
M  V30 6 C 3.3677 2.3101 0.0 0
M  V30 7 N 6.0859 3.3055 0.0 0
M  V30 8 C 2.0341 3.0801 0.0 0
M  V30 9 C 1.5391 5.9305 0.0 0
M  V30 10 N 6.1675 5.9578 0.0 0
M  V30 11 C 3.7951 7.3275 0.0 0
M  V30 12 C 3.3677 0.7700 0.0 0
M  V30 13 C 6.9074 4.6073 0.0 0
M  V30 14 C 0.7004 2.3101 0.0 0
M  V30 15 C 2.2558 7.2930 0.0 0
M  V30 16 C 2.0341 0.0000 0.0 0
M  V30 17 C 0.7004 0.7700 0.0 0
M  V30 18 C 8.4468 4.5599 0.0 0
M  V30 19 C 9.2576 5.8692 0.0 0
M  V30 20 C 9.1752 3.2030 0.0 0
M  V30 21 C 10.7969 5.8216 0.0 0
M  V30 22 C 10.7145 3.1555 0.0 0
M  V30 23 C 11.5253 4.4649 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 2 5 10
M  V30 10 1 5 11
M  V30 11 1 6 8
M  V30 12 2 6 12
M  V30 13 2 7 13
M  V30 14 2 8 14
M  V30 15 1 9 15
M  V30 16 1 10 13
M  V30 17 2 11 15
M  V30 18 1 12 16
M  V30 19 1 13 18
M  V30 20 1 14 17
M  V30 21 2 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Phenyl-5-(1-pyrrolidinyl)-6H-[1,2,4]triazino[5,6,1-jk]carbazol-6-one
C23H18N4O
1312543-86-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.5627 4.0736 0.0 0
M  V30 2 C 6.4945 4.9787 0.0 0
M  V30 3 C 5.2370 4.1503 0.0 0
M  V30 4 N 7.7521 4.1503 0.0 0
M  V30 5 C 6.4945 6.4979 0.0 0
M  V30 6 C 5.7235 2.6675 0.0 0
M  V30 7 C 3.8696 4.8885 0.0 0
M  V30 8 C 7.2635 2.6675 0.0 0
M  V30 9 N 9.1196 4.8885 0.0 0
M  V30 10 C 5.1249 7.2262 0.0 0
M  V30 11 N 7.8642 7.2262 0.0 0
M  V30 12 C 4.9534 1.3338 0.0 0
M  V30 13 C 3.8089 6.4268 0.0 0
M  V30 14 C 8.0335 1.3338 0.0 0
M  V30 15 C 9.1802 6.4268 0.0 0
M  V30 16 C 5.7235 0.0000 0.0 0
M  V30 17 C 7.2635 0.0000 0.0 0
M  V30 18 N 2.4522 7.1552 0.0 0
M  V30 19 C 2.2440 8.6810 0.0 0
M  V30 20 C 1.0652 6.4858 0.0 0
M  V30 21 C 0.7284 8.9547 0.0 0
M  V30 22 C 0.0000 7.5978 0.0 0
M  V30 23 C 10.5369 7.1552 0.0 0
M  V30 24 C 11.8462 6.3444 0.0 0
M  V30 25 C 10.5845 8.6944 0.0 0
M  V30 26 C 13.2030 7.0730 0.0 0
M  V30 27 C 11.9412 9.4230 0.0 0
M  V30 28 C 13.2506 8.6122 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 6 8
M  V30 12 2 6 12
M  V30 13 1 7 13
M  V30 14 2 8 14
M  V30 15 2 9 15
M  V30 16 2 10 13
M  V30 17 1 11 15
M  V30 18 1 12 16
M  V30 19 1 13 18
M  V30 20 1 14 17
M  V30 21 1 15 23
M  V30 22 2 16 17
M  V30 23 1 18 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 1 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1312543-84-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1312543-86-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-185-CAS-9343038
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 4.5.2. 2-Phenyl-5-(pyrrolidin-1-yl)-6H-[1,2,4]triazino[5,6,1-jk]carbazol-
6-one (8c). To a stirred solution of
2-phenyl-6H-[1,2,4]triazino-[5,6,1-jk]carbazol-6-one (8a) (30.6 mg; 0.1
mmol) in EtOH (0.5 mL) was added pyrrolidine (0.5 mL, 6 mmol). The
mixture was stirred at ca. 20 °C for 4 h. TLC (t-BuOMe/hexane, 2:1)
showed the absence of the starting material and the presence of a more
polar red compound. The solution was diluted with DCM (15 mL) and washed
with 5% HCl (10 mL) to remove unreacted amine. The organic layer was
separated, dried (Na2SO4), and evaporated in vacuo and the residue
crystallized to afford the title compound 8c. (37.6 mg, 100%) as red
needles. mp 134-137 °C (from DCM/MeOH, 1:2); R f 0.71 (t-BuOMe/hexane,
3:1); (found: C, 75.1; H, 5.1; N, 15.2. C23H18N4O requires C, 75.4; H,
5.0; N, 15.3%); λ max(DCM)/nm 231 (log ε 3.38), 267 inf (3.39), 276
(3.41), 304 (3.30), 371 inf (2.58), 415 inf (3.00) 438 (3.21), 460
(3.06); ν max/cm-1 3049w, 2955w, 2916w, 2870w, 2849w, 1641 m, 1626 m,
1570w, 1510s, 1479w, 1452 m, 1393w, 1368w, 1348w, 1341w, 1321w, 1308w,
1260 m, 1244w, 1229w, 1173w, 1140w, 1105w, 1070w, 1028w, 1007w, 993w,
953w, 937w, 924w, 908w, 858w, 833w, 808w, 785w, 773w; δ H(300 MHz; CDCl3)
8.46-8.43 (2H, m, Ar H), 8.20-8.17 (2H, m, Ar H), 7.55-7.41 (5H, m, Ar
H), 6.17 (1H, s, Ar H), 4.35 (2H, br s, NCH2), 3.52 (2H, br s, NCH2),
2.01 (4H, br s, CH2); δ C(75 MHz; CDCl3) 173.8 (s), 156.8 (s), 155.0 (s),
151.9 (s), 136.5 (s), 135.0 (s), 130.2 (d), 128.5 (d), 127.8 (d), 127.4
(d), 126.3 (s), 125.8 (s), 124.3 (d), 122.1 (d), 112.9 (d), 103.7 (s),
97.9 (d), 52.2 (NCH2), 29.8 (CH2);m/z (EI) 367 (M++1, 30%), 366 (M+,
100), 337 (12), 323 (17), 311 (28), 297 (34), 269 (6), 235 (4), 207 (6),
179 (5), 165 (7), 151 (8), 140 (10), 120 (5), 114 (8), 103 (9), 77 (C6H5
+, 12), 69 (5), 51 (8).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, reaction monitored by TLC
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Triazafluoranthenones via Silver(I)-Mediated Nonoxidative
and Oxidative Intramolecular Palladium-Catalyzed Cyclizations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koutentis, Panayiotis A.; Loizou, Georgia; Lo Re, Daniele
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2011), 76(14), 5793-5802

$RFMT $RIREG SCHEME60 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,7,7-Trimethylbicyclo[2.2.1]heptan-2-one O-(2,4-dinitrophenyl)oxime
C16H19N3O5
13181-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.5028 6.8813 0.0 0
M  V30 2 N 6.3919 5.3347 0.0 0
M  V30 3 O 7.1619 4.0011 0.0 0
M  V30 4 C 2.0052 2.4994 0.0 0
M  V30 5 C 0.0000 4.1605 0.0 0
M  V30 6 N 8.7019 1.3336 0.0 0 VAL=5
M  V30 7 O 9.4719 0.0000 0.0 0
M  V30 8 O 7.1619 1.3336 0.0 0
M  V30 9 N 13.3219 4.0011 0.0 0 VAL=5
M  V30 10 O 14.0919 2.6673 0.0 0
M  V30 11 O 14.0919 5.3347 0.0 0
M  V30 12 C 3.4337 5.7728 0.0 0
M  V30 13 C 4.8519 5.3347 0.0 0
M  V30 14 C 1.5274 3.9635 0.0 0
M  V30 15 C 2.9724 7.0948 0.0 0
M  V30 16 C 3.6190 4.9539 0.0 0
M  V30 17 C 2.2964 5.1578 0.0 0
M  V30 18 C 1.8676 6.6739 0.0 0
M  V30 19 C 8.7019 4.0011 0.0 0
M  V30 20 C 9.4719 2.6673 0.0 0
M  V30 21 C 9.4719 5.3347 0.0 0
M  V30 22 C 11.0119 2.6673 0.0 0
M  V30 23 C 11.0119 5.3347 0.0 0
M  V30 24 C 11.7819 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 2 2 13 CFG=2
M  V30 4 1 3 19
M  V30 5 1 4 14
M  V30 6 1 5 14
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 20
M  V30 10 2 9 10
M  V30 11 2 9 11
M  V30 12 1 9 24
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2,4-Dinitrophenyl)pyrrolidine
C10H11N3O4
14552-00-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.9098 1.3338 0.0 0 VAL=5
M  V30 2 O 4.6798 0.0000 0.0 0
M  V30 3 O 2.3698 1.3338 0.0 0
M  V30 4 N 8.5298 4.0011 0.0 0 VAL=5
M  V30 5 O 9.2998 2.6674 0.0 0
M  V30 6 O 9.2998 5.3349 0.0 0
M  V30 7 C 3.9098 4.0011 0.0 0
M  V30 8 C 4.6798 2.6674 0.0 0
M  V30 9 C 4.6798 5.3349 0.0 0
M  V30 10 C 6.2198 2.6674 0.0 0
M  V30 11 C 6.2198 5.3349 0.0 0
M  V30 12 C 6.9898 4.0011 0.0 0
M  V30 13 N 2.3698 4.0011 0.0 0
M  V30 14 C 1.4645 5.2469 0.0 0
M  V30 15 C 1.4645 2.7552 0.0 0
M  V30 16 C 0.0000 4.7711 0.0 0
M  V30 17 C 0.0000 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13181-22-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14552-00-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4089245
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Kinetic studies on the reactions of O-(2',4'-dinitrophenyl)
1,7,7-trimethylbicyclo[2.2.1]heptan-2-one oxime with nucleophiles in
aprotic solvents - mechanism for the uncatalysed pathway
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhattacharjee, G.; Singh, A. K.; Gupta, Anshu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the Indian Chemical Society (2007), 84(4), 365-369

$RFMT $RIREG SCHEME61 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[2-(tert-Butoxycarbonyl)hydrazinyl]nicotinic acid
C11H15N3O4
133081-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 N 5.3348 3.8501 0.0 0
M  V30 3 C 4.0010 4.6201 0.0 0
M  V30 4 O 2.6673 3.8501 0.0 0
M  V30 5 O 4.0010 6.1601 0.0 0
M  V30 6 C 1.3337 4.6201 0.0 0
M  V30 7 C 0.5637 3.2864 0.0 0
M  V30 8 C 0.0000 5.3901 0.0 0
M  V30 9 C 2.1037 5.9538 0.0 0
M  V30 10 C 12.0033 1.5400 0.0 0
M  V30 11 O 12.0033 0.0000 0.0 0
M  V30 12 O 13.3370 2.3101 0.0 0
M  V30 13 C 8.0022 3.8501 0.0 0
M  V30 14 C 8.0022 2.3101 0.0 0
M  V30 15 N 9.3360 4.6201 0.0 0
M  V30 16 C 9.3360 1.5400 0.0 0
M  V30 17 C 10.6697 3.8501 0.0 0
M  V30 18 C 10.6697 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Hydrazinecarboxylic acid, 2-[5-(1-pyrrolidinylcarbonyl)-2-pyridinyl]-, 1,1-di...
C15H22N4O3
2928631-73-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 9.1059 4.6201 0.0 0
M  V30 4 N 10.4397 3.8501 0.0 0
M  V30 5 C 11.7734 4.6201 0.0 0
M  V30 6 O 13.1071 3.8501 0.0 0
M  V30 7 O 11.7734 6.1601 0.0 0
M  V30 8 C 14.4407 4.6201 0.0 0
M  V30 9 C 13.6707 5.9538 0.0 0
M  V30 10 C 15.7746 5.3901 0.0 0
M  V30 11 C 15.2108 3.2864 0.0 0
M  V30 12 C 5.1049 2.3101 0.0 0
M  V30 13 C 6.4386 1.5400 0.0 0
M  V30 14 C 5.1049 3.8501 0.0 0
M  V30 15 C 7.7722 2.3101 0.0 0
M  V30 16 N 6.4386 4.6201 0.0 0
M  V30 17 C 7.7722 3.8501 0.0 0
M  V30 18 N 2.4374 2.3101 0.0 0
M  V30 19 C 1.0306 1.6837 0.0 0
M  V30 20 C 2.2765 3.8416 0.0 0
M  V30 21 C 0.0000 2.8281 0.0 0
M  V30 22 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 17
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 133081-25-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2928631-73-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37051981
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidinamine derivatives as inhibitors of
cyclin-dependent kinase 12 (CDK12)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Benoit, Guillaume; Carulli, John; Chen, Fei; Chuaqui, Claudio Edmundo;
Ciblat, Stephane; Cooper, Elliot; Dagenais, Robin; Hu, Shanhu; Kabro,
Anzhelika; Laplaca, Derek; Marineau, Jason J.; Moebius, David; Moon,
Diane; Solodinin, Andrei; Whitmore, Kenneth Matthew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023091726 A1 2023-05-25

$RFMT $RIREG SCHEME62 STEP1
$RXN



  2  1
$MOL
7-(2-Pyridinyl)pyrazolo[1,5-a]pyrimidine-3-carboxylic acid
C12H8N4O2
1334490-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3192 3.0202 0.0 0
M  V30 2 O 9.7952 1.5557 0.0 0
M  V30 3 O 10.3497 4.1648 0.0 0
M  V30 4 N 5.3347 3.0800 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 6.6685 2.3100 0.0 0
M  V30 7 N 5.6549 4.5863 0.0 0
M  V30 8 C 4.0011 0.7700 0.0 0
M  V30 9 C 7.8129 3.3404 0.0 0
M  V30 10 N 6.6685 0.7700 0.0 0
M  V30 11 C 7.1866 4.7474 0.0 0
M  V30 12 C 5.3347 0.0000 0.0 0
M  V30 13 C 2.6674 3.0800 0.0 0
M  V30 14 C 1.3336 2.3100 0.0 0
M  V30 15 N 2.6674 4.6200 0.0 0
M  V30 16 C 0.0000 3.0800 0.0 0
M  V30 17 C 1.3336 5.3900 0.0 0
M  V30 18 C 0.0000 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 13
M  V30 9 2 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[7-(2-Pyridinyl)pyrazolo[1,5-a]pyrimidin-3-yl]-1-pyrrolidinylmethanone
C16H15N5O
1469807-67-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.3193 3.0204 0.0 0
M  V30 2 O 9.7952 1.5557 0.0 0
M  V30 3 N 5.3348 3.0800 0.0 0
M  V30 4 C 6.6685 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 5.6550 4.5865 0.0 0
M  V30 7 C 7.8130 3.3406 0.0 0
M  V30 8 N 6.6685 0.7700 0.0 0
M  V30 9 C 4.0011 0.7700 0.0 0
M  V30 10 C 7.1865 4.7474 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 2.6673 3.0800 0.0 0
M  V30 13 C 2.6673 4.6201 0.0 0
M  V30 14 N 1.3337 2.3100 0.0 0
M  V30 15 C 1.3337 5.3901 0.0 0
M  V30 16 C 0.0000 3.0800 0.0 0
M  V30 17 C 0.0000 4.6201 0.0 0
M  V30 18 N 10.3497 4.1648 0.0 0
M  V30 19 C 10.0296 5.6713 0.0 0
M  V30 20 C 11.8814 4.0039 0.0 0
M  V30 21 C 11.3634 6.4413 0.0 0
M  V30 22 C 12.5078 5.4107 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 2 4 7
M  V30 8 1 4 8
M  V30 9 2 5 9
M  V30 10 1 5 12
M  V30 11 2 6 10
M  V30 12 1 7 10
M  V30 13 2 8 11
M  V30 14 1 9 11
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 2 15 17
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1334490-46-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1469807-67-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16633418
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 59483-84-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Parallel synthesis of
7-heteroaryl-pyrazolo[1,5-a]pyrimidine-3-carboxamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ahmetaj, Sizana; Velikanje, Nina; Groselj, Uros; Sterbal, Ines; Prek,
Benjamin; Golobic, Amalija; Kocar, Drago; Dahmann, Georg; Stanovnik,
Branko; Svete, Jurij
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecular Diversity (2013), 17(4), 731-743

$RFMT $RIREG SCHEME63 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Bis[(4-methoxyphenyl)methyl]ethenesulfonamide
C18H21NO4S
133777-96-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 4.0012 0.0 0
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 C 6.9302 5.3348 0.0 0
M  V30 4 S 6.9302 2.6675 0.0 0 VAL=6
M  V30 5 C 7.7002 1.3337 0.0 0
M  V30 6 O 8.2638 3.4375 0.0 0
M  V30 7 O 5.5965 1.8975 0.0 0
M  V30 8 C 6.9302 0.0000 0.0 0
M  V30 9 O 1.5400 9.3360 0.0 0
M  V30 10 C 0.0000 9.3360 0.0 0
M  V30 11 O 13.0903 5.3348 0.0 0
M  V30 12 C 13.8603 6.6685 0.0 0
M  V30 13 C 3.8501 5.3348 0.0 0
M  V30 14 C 2.3101 5.3348 0.0 0
M  V30 15 C 4.6201 6.6685 0.0 0
M  V30 16 C 1.5400 6.6685 0.0 0
M  V30 17 C 3.8501 8.0023 0.0 0
M  V30 18 C 2.3101 8.0023 0.0 0
M  V30 19 C 8.4702 5.3348 0.0 0
M  V30 20 C 9.2402 6.6685 0.0 0
M  V30 21 C 9.2402 4.0012 0.0 0
M  V30 22 C 10.7802 6.6685 0.0 0
M  V30 23 C 10.7802 4.0012 0.0 0
M  V30 24 C 11.5503 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 13
M  V30 5 1 3 19
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 4 7
M  V30 9 2 5 8
M  V30 10 1 9 10
M  V30 11 1 9 18
M  V30 12 1 11 12
M  V30 13 1 11 24
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Bis[(4-methoxyphenyl)methyl]-1-pyrrolidineethanesulfonamide
C22H30N2O4S
2283337-73-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7598 8.0022 0.0 0
M  V30 2 C 8.5298 9.3358 0.0 0
M  V30 3 C 8.5298 6.6684 0.0 0
M  V30 4 S 6.2198 8.0022 0.0 0 VAL=6
M  V30 5 C 4.6798 8.0022 0.0 0
M  V30 6 O 6.2198 9.5422 0.0 0
M  V30 7 O 6.2198 6.4622 0.0 0
M  V30 8 C 3.9098 9.3358 0.0 0
M  V30 9 O 14.6898 9.3358 0.0 0
M  V30 10 C 15.4598 10.6695 0.0 0
M  V30 11 O 5.4498 1.3336 0.0 0
M  V30 12 C 6.2198 0.0000 0.0 0
M  V30 13 C 10.0698 9.3358 0.0 0
M  V30 14 C 10.8398 8.0022 0.0 0
M  V30 15 C 10.8398 10.6695 0.0 0
M  V30 16 C 12.3798 8.0022 0.0 0
M  V30 17 C 12.3798 10.6695 0.0 0
M  V30 18 C 13.1498 9.3358 0.0 0
M  V30 19 C 7.7598 5.3347 0.0 0
M  V30 20 C 6.2198 5.3347 0.0 0
M  V30 21 C 8.5298 4.0011 0.0 0
M  V30 22 C 5.4498 4.0011 0.0 0
M  V30 23 C 7.7598 2.6673 0.0 0
M  V30 24 C 6.2198 2.6673 0.0 0
M  V30 25 N 2.3698 9.3358 0.0 0
M  V30 26 C 1.4645 8.0900 0.0 0
M  V30 27 C 1.4645 10.5817 0.0 0
M  V30 28 C 0.0000 8.5658 0.0 0
M  V30 29 C 0.0000 10.1058 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 13
M  V30 5 1 3 19
M  V30 6 1 4 5
M  V30 7 2 4 6
M  V30 8 2 4 7
M  V30 9 1 5 8
M  V30 10 1 8 25
M  V30 11 1 9 10
M  V30 12 1 9 18
M  V30 13 1 11 12
M  V30 14 1 11 24
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 133777-96-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2283337-73-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-20754827
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel sulfonamide carboxamide compounds as NLRP3
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Miller, David; MacLeod, Angus; Van Wiltenburg, Jimmy; Thom, Stephen;
St-Gallay, Stephen; Shannon, Jonathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019034696 A1 2019-02-21

$RFMT $RIREG SCHEME64 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(2,5-Dichloro-4-pyrimidinyl)methylamino]-5-fluorobenzenesulfonyl chloride
C11H7Cl3FN3O2S
1341200-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6200 0.0 0
M  V30 2 C 4.0011 6.1600 0.0 0
M  V30 3 S 6.6684 6.1600 0.0 0 VAL=6
M  V30 4 Cl 6.6684 7.7000 0.0 0
M  V30 5 O 8.2084 6.1600 0.0 0
M  V30 6 O 5.1284 6.1600 0.0 0
M  V30 7 F 9.3358 1.5400 0.0 0
M  V30 8 Cl 1.3336 6.1600 0.0 0
M  V30 9 Cl 1.3336 0.0000 0.0 0
M  V30 10 C 5.3347 3.8500 0.0 0
M  V30 11 C 6.6684 4.6200 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 8.0021 3.8500 0.0 0
M  V30 14 C 6.6684 1.5400 0.0 0
M  V30 15 C 8.0021 2.3100 0.0 0
M  V30 16 C 2.6674 3.8500 0.0 0
M  V30 17 C 1.3336 4.6200 0.0 0
M  V30 18 N 2.6674 2.3100 0.0 0
M  V30 19 C 0.0000 3.8500 0.0 0
M  V30 20 C 1.3336 1.5400 0.0 0
M  V30 21 N 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 3 6
M  V30 7 1 3 11
M  V30 8 1 7 15
M  V30 9 1 8 17
M  V30 10 1 9 20
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dichloro-N-[4-fluoro-2-(1-pyrrolidinylsulfonyl)phenyl]-N-methyl-4-pyrimid...
C15H15Cl2FN4O2S
1341200-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.0022 4.6201 0.0 0 VAL=6
M  V30 2 O 8.7722 3.2864 0.0 0
M  V30 3 O 7.2322 5.9538 0.0 0
M  V30 4 N 5.3348 6.1601 0.0 0
M  V30 5 C 6.6685 6.9302 0.0 0
M  V30 6 F 5.3348 0.0000 0.0 0
M  V30 7 Cl 5.3348 9.2402 0.0 0
M  V30 8 Cl 0.0000 6.1601 0.0 0
M  V30 9 C 6.6685 3.8501 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 4.0010 3.8501 0.0 0
M  V30 13 C 5.3348 1.5400 0.0 0
M  V30 14 C 4.0010 2.3101 0.0 0
M  V30 15 N 9.3360 5.3901 0.0 0
M  V30 16 C 9.4969 6.9217 0.0 0
M  V30 17 C 10.7428 4.7638 0.0 0
M  V30 18 C 11.0032 7.2419 0.0 0
M  V30 19 C 11.7733 5.9082 0.0 0
M  V30 20 C 4.0010 6.9302 0.0 0
M  V30 21 C 4.0010 8.4702 0.0 0
M  V30 22 N 2.6673 6.1601 0.0 0
M  V30 23 C 2.6673 9.2402 0.0 0
M  V30 24 C 1.3337 6.9302 0.0 0
M  V30 25 N 1.3337 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 15
M  V30 5 1 4 5
M  V30 6 1 4 10
M  V30 7 1 4 20
M  V30 8 1 6 13
M  V30 9 1 7 21
M  V30 10 1 8 24
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1341200-87-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1341200-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-1051543
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General sulfonamide synthesis (procedure E):
The desired sulfonyl chloride (1.00 eq) and DIPEA (2.50 eq) were
dissolved in THF (concentration of limiting reagent 0.05 -0.1 mM). The
desired amine (1.05 eq) was added and the resulting mixture was stirred
at room temperature for 2 h. Following removal of the solvent, the crude
material was purified by flash chromatography.
2-chloro-4-(4-fluoro-2-(pyrrolidin-1-ylsulfonyl)phenyl)-5-methylpyrimidine:
prepared according to procedure E from
2-(2-chloro-5-methylpyrimidin-4-yl)-5-fluorobenzene-1-sulfonyl chloride
and pyrrolidine.
2,5-dichloro-N-(4-fluoro-2-(pyrrolidin-1-ylsulfonyl)phenyl)-N-methylpyrimidin-4-amine:
prepared according to procedure E from
2-((2,5-dichloropyrimidin-4-yl)(methyl)amino)-5-fluorobenzene-1-sulfonyl
chloride and pyrrolidine. 100% yield (pale yellow solid). Flash
chromatography eluent Hex/EtOAc 95/5 gradually increasing to 70/30. 1H
NMR (400 MHz, CDCl3): δ 8.06 (s, 1H), 7.63 (dd, 1H, J = 5.69, 2.9 Hz),
7.31 (m, 1H), 7.21 (t, 1H, J = 9.0 Hz), 3.49 (s, 3H), 3.35 (m, 4H), 1.84
(m, 4H). MS (ESI): m/z 405.0 [M+H]+
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of a Series of Novel AXL
Kinase Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mollard, Alexis; Warner, Steven L.; Call, Lee T.; Wade, Mark L.; Bearss,
Jared J.; Verma, Anupam; Sharma, Sunil; Vankayalapati, Hariprasad;
Bearss, David J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2011), 2(12), 907-912

$RFMT $RIREG SCHEME65 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[7-(2-Fluoro-4-nitrophenoxy)thieno[3,2-b]pyridin-2-yl]-1-methyl-1H-imidazol...
C18H10ClFN4O4S
1342835-55-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9302 4.0012 0.0 0
M  V30 2 F 5.3901 6.6687 0.0 0
M  V30 3 C 14.7383 1.8228 0.0 0
M  V30 4 C 16.9803 4.3127 0.0 0
M  V30 5 Cl 17.8853 5.5586 0.0 0
M  V30 6 O 17.6066 2.9057 0.0 0
M  V30 7 N 0.7700 4.0012 0.0 0 VAL=5
M  V30 8 O 0.0000 2.6675 0.0 0
M  V30 9 O 0.0000 5.3348 0.0 0
M  V30 10 C 9.2402 2.6675 0.0 0
M  V30 11 C 10.0102 1.3338 0.0 0
M  V30 12 C 7.7002 2.6675 0.0 0
M  V30 13 S 10.2706 3.8119 0.0 0
M  V30 14 C 11.5165 1.6540 0.0 0
M  V30 15 N 9.2402 0.0000 0.0 0
M  V30 16 C 6.9302 1.3338 0.0 0
M  V30 17 C 11.6775 3.1856 0.0 0
M  V30 18 C 7.7002 0.0000 0.0 0
M  V30 19 C 5.3901 4.0012 0.0 0
M  V30 20 C 4.6201 5.3348 0.0 0
M  V30 21 C 4.6201 2.6675 0.0 0
M  V30 22 C 3.0801 5.3348 0.0 0
M  V30 23 C 3.0801 2.6675 0.0 0
M  V30 24 C 2.3101 4.0012 0.0 0
M  V30 25 C 13.0113 3.9556 0.0 0
M  V30 26 N 14.4181 3.3292 0.0 0
M  V30 27 N 13.1722 5.4871 0.0 0
M  V30 28 C 15.4485 4.4736 0.0 0
M  V30 29 C 14.6785 5.8073 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 1 19
M  V30 3 1 2 20
M  V30 4 1 3 26
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 28
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 24
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 17
M  V30 19 1 15 18
M  V30 20 2 16 18
M  V30 21 1 17 25
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[2-[7-(2-Fluoro-4-nitrophenoxy)thieno[3,2-b]pyridin-2-yl]-1-methyl-1H-imidazo...
C22H18FN5O4S
1342835-57-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 12.9713 3.9272 0.0 0
M  V30 2 F 14.5113 1.2599 0.0 0
M  V30 3 C 5.1631 6.1056 0.0 0
M  V30 4 C 2.9213 3.6158 0.0 0
M  V30 5 O 2.2948 5.0226 0.0 0
M  V30 6 N 19.1314 3.9272 0.0 0 VAL=5
M  V30 7 O 19.9014 2.5936 0.0 0
M  V30 8 O 19.9014 5.2609 0.0 0
M  V30 9 C 10.6613 5.2609 0.0 0
M  V30 10 C 9.8913 6.5947 0.0 0
M  V30 11 C 12.2013 5.2609 0.0 0
M  V30 12 S 9.6307 4.1165 0.0 0
M  V30 13 C 8.3848 6.2745 0.0 0
M  V30 14 N 10.6613 7.9284 0.0 0
M  V30 15 C 12.9713 6.5947 0.0 0
M  V30 16 C 8.2239 4.7428 0.0 0
M  V30 17 C 12.2013 7.9284 0.0 0
M  V30 18 C 14.5113 3.9272 0.0 0
M  V30 19 C 15.2814 2.5936 0.0 0
M  V30 20 C 15.2814 5.2609 0.0 0
M  V30 21 C 16.8214 2.5936 0.0 0
M  V30 22 C 16.8214 5.2609 0.0 0
M  V30 23 C 17.5914 3.9272 0.0 0
M  V30 24 C 6.8901 3.9728 0.0 0
M  V30 25 N 5.4833 4.5993 0.0 0
M  V30 26 N 6.7291 2.4412 0.0 0
M  V30 27 C 4.4528 3.4547 0.0 0
M  V30 28 C 5.2228 2.1211 0.0 0
M  V30 29 N 2.0160 2.3698 0.0 0
M  V30 30 C 2.4919 0.9052 0.0 0
M  V30 31 C 0.4760 2.3698 0.0 0
M  V30 32 C 1.2460 0.0000 0.0 0
M  V30 33 C 0.0000 0.9052 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 18
M  V30 3 1 2 19
M  V30 4 1 3 25
M  V30 5 2 4 5
M  V30 6 1 4 27
M  V30 7 1 4 29
M  V30 8 2 6 7
M  V30 9 2 6 8
M  V30 10 1 6 23
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 2 13 16
M  V30 19 1 14 17
M  V30 20 2 15 17
M  V30 21 1 16 24
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 2 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1342835-55-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1342835-57-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-1662067
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2:
(2-(7-(2-fluoro-4-nitrophenoxy)thieno[3,2-b]pyridin-2-yl)-1-methyl-1H-imidazol-5-yl)(pyrrolidin-1-yl)methanone
(220) A suspension of the acyl chloride 219 (700 mg, 1.617 mmol) and
pyrrolidine (0.3 mL, 3.63 mmol) in DCM (50 mL) was stirred at room
temperature overnight. The reaction mixture was concentrated. The residue
was triturated with ether to give title compound 220. Beige solid, yield
(756 mg, 1.617 mmol, 100 %). MS: 468.3(MH+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thienopyridinyloxyphenyl ureas as inhibitors of protein
tyrosine kinase activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raeppel, Stephane; Raeppel, Franck; Claridge, Stephen William; Zhan,
Lijie; Gaudette, Frederic; Mannion, Michael; Sato, Norifumi; Yuki, Yohei;
Kishida, Masashi; Vaisburg, Arkadii
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011127567 A1 2011-10-20

$RFMT $RIREG SCHEME66 STEP1
$RXN



  2  1
$MOL
N-(Phenylsulfonyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]p...
C17H13F6NO5S
1348273-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5231 6.9300 0.0 0
M  V30 2 C 1.2616 6.0467 0.0 0
M  V30 3 C 3.2931 8.2636 0.0 0
M  V30 4 O 1.4340 8.0189 0.0 0
M  V30 5 F 0.3782 7.3082 0.0 0
M  V30 6 F 2.1449 4.7851 0.0 0
M  V30 7 F 0.0000 5.1633 0.0 0
M  V30 8 F 4.6268 7.4936 0.0 0
M  V30 9 F 4.0631 9.5973 0.0 0
M  V30 10 F 1.9593 9.0336 0.0 0
M  V30 11 N 7.8579 3.8500 0.0 0
M  V30 12 S 9.1915 4.6200 0.0 0 VAL=6
M  V30 13 C 7.8579 2.3100 0.0 0
M  V30 14 O 8.4215 5.9536 0.0 0
M  V30 15 O 9.9615 3.2862 0.0 0
M  V30 16 C 6.5241 1.5400 0.0 0
M  V30 17 O 6.5241 0.0000 0.0 0
M  V30 18 O 5.1904 2.3100 0.0 0
M  V30 19 C 3.8568 6.1600 0.0 0
M  V30 20 C 5.1904 6.9300 0.0 0
M  V30 21 C 3.8568 4.6200 0.0 0
M  V30 22 C 6.5241 6.1600 0.0 0
M  V30 23 C 5.1904 3.8500 0.0 0
M  V30 24 C 6.5241 4.6200 0.0 0
M  V30 25 C 10.5251 5.3900 0.0 0
M  V30 26 C 10.5251 6.9300 0.0 0
M  V30 27 C 11.8588 4.6200 0.0 0
M  V30 28 C 11.8588 7.7000 0.0 0
M  V30 29 C 13.1926 5.3900 0.0 0
M  V30 30 C 13.1926 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 19
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 3 8
M  V30 9 1 3 9
M  V30 10 1 3 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 24
M  V30 14 2 12 14
M  V30 15 2 12 15
M  V30 16 1 12 25
M  V30 17 1 13 16
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 2 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 2 27 29
M  V30 30 2 28 30
M  V30 31 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-Oxo-2-(1-pyrrolidinyl)ethyl]-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluor...
C21H20F6N2O4S
293754-47-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.5232 9.2999 0.0 0
M  V30 2 C 1.2616 8.4165 0.0 0
M  V30 3 C 3.2932 10.6335 0.0 0
M  V30 4 O 1.4341 10.3888 0.0 0
M  V30 5 F 0.3782 9.6781 0.0 0
M  V30 6 F 0.0000 7.5332 0.0 0
M  V30 7 F 2.1449 7.1551 0.0 0
M  V30 8 F 1.9594 11.4035 0.0 0
M  V30 9 F 4.0630 11.9672 0.0 0
M  V30 10 F 4.6268 9.8635 0.0 0
M  V30 11 N 7.8580 6.2198 0.0 0
M  V30 12 S 9.1916 6.9898 0.0 0 VAL=6
M  V30 13 C 7.8580 4.6798 0.0 0
M  V30 14 O 9.9616 5.6562 0.0 0
M  V30 15 O 8.4216 8.3235 0.0 0
M  V30 16 C 6.5241 3.9098 0.0 0
M  V30 17 O 5.1905 4.6798 0.0 0
M  V30 18 C 3.8568 8.5299 0.0 0
M  V30 19 C 5.1905 9.2999 0.0 0
M  V30 20 C 3.8568 6.9898 0.0 0
M  V30 21 C 6.5241 8.5299 0.0 0
M  V30 22 C 5.1905 6.2198 0.0 0
M  V30 23 C 6.5241 6.9898 0.0 0
M  V30 24 C 10.5253 7.7599 0.0 0
M  V30 25 C 11.8589 6.9898 0.0 0
M  V30 26 C 10.5253 9.2999 0.0 0
M  V30 27 C 13.1927 7.7599 0.0 0
M  V30 28 C 11.8589 10.0699 0.0 0
M  V30 29 C 13.1927 9.2999 0.0 0
M  V30 30 N 6.5241 2.3698 0.0 0
M  V30 31 C 7.7700 1.4646 0.0 0
M  V30 32 C 5.2783 1.4646 0.0 0
M  V30 33 C 7.2942 0.0000 0.0 0
M  V30 34 C 5.7541 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 18
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 2 7
M  V30 8 1 3 8
M  V30 9 1 3 9
M  V30 10 1 3 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 11 23
M  V30 14 2 12 14
M  V30 15 2 12 15
M  V30 16 1 12 24
M  V30 17 1 13 16
M  V30 18 2 16 17
M  V30 19 1 16 30
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 32 1 30 31
M  V30 33 1 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1348273-79-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 293754-47-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7728762
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of compound 10.4. A solution of the
acid (10.2) from above (137 mg, 0.300 mmol) in 4 mL of CH2Cl2 with two
drops of DMF added was treated with a solution of oxalyl chloride (2M in
CH2Cl2, 4 mL) at room temperature for 2 hours. Solvent was evaporated
under reduced pressure to provide an intermediate acyl chloride. To a
solution of acyl chloride in CH2Cl2 was added pyrrolidine (80 (L, 0.958
mmol). After stirring for 30 min, additional CH2Cl2 was added. The
organic layer was washed with 1N HCl (2×) and brine (3×), dried over
MgSO4, and concentrated. The crude product was purified by flushing
chromatography on SiO2 (4:1 hexanes:EtOAc as eluant) to provide 150 mg of
the title compound. Yield: (100%). 1H NMR (CDCl3): δ 7.68 (d, J=8.6 Hz,
2H), 7.60 (d, J=1.6 Hz, 2H), 7.55 (t, J=7.6 Hz, 1H), 7.42 (t, J=7.6 Hz,
2H), 7.35 (t, J=1.6 Hz, 2H), 4.45 (s, 2H), 4.40 (s, 1H), 3.52 (t, J=5.5
Hz, 2H), 3.38 (t, J=5.5 Hz, 2H), 1.95 (m, 2H), 1.82 (m, 2H). MS (ES-):
509 (M-H, 100). Anal. Calcd. for C21H20F6N2O4S: C, 49.41; H, 3.95; N,
5.49; S, 6.28. Found: C, 49.59; H, 4.00; N, 5.42; S, 6.25.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bis(trifluoromethyl)hydroxymethylbenzenesulfonamides,
-ureas, and -carbamates as liver X receptor modulators.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Leping; Medina, Julio C.; Hasegawa, Hirohiko; Cutler, Serena T.; Liu,
Jiwen; Zhu, Liusheng; Shan, Bei; Lustig, Kevin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000054759 A2 2000-09-21

$RFMT $RIREG SCHEME67 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-(2-Chloro-5-formylphenyl)-4-[1-[[2-(trimethylsilyl)ethoxy]methyl]-1H-...
C27H30ClN5O4Si
1357916-76-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 7.8593 2.0507 0.0 0
M  V30 2 C 15.3920 8.0813 0.0 0
M  V30 3 O 16.8567 7.6053 0.0 0
M  V30 4 C 18.0011 8.6359 0.0 0
M  V30 5 C 19.4659 8.1600 0.0 0
M  V30 6 Si 20.6104 9.1905 0.0 0
M  V30 7 C 21.7548 10.2209 0.0 0
M  V30 8 C 19.5798 10.3349 0.0 0
M  V30 9 C 21.6409 8.0459 0.0 0
M  V30 10 C 13.9857 1.4068 0.0 0
M  V30 11 O 14.6120 0.0000 0.0 0
M  V30 12 C 8.0023 9.4744 0.0 0
M  V30 13 N 2.6675 6.3944 0.0 0
M  V30 14 C 1.3337 7.1644 0.0 0
M  V30 15 C 1.3337 8.7044 0.0 0
M  V30 16 O 0.0000 6.3944 0.0 0
M  V30 17 C 10.4396 5.8763 0.0 0
M  V30 18 C 9.6696 4.5426 0.0 0
M  V30 19 C 9.4091 7.0207 0.0 0
M  V30 20 O 8.1633 4.8628 0.0 0
M  V30 21 C 8.0023 6.3944 0.0 0
M  V30 22 C 11.9713 6.0372 0.0 0
M  V30 23 N 12.7413 7.3709 0.0 0
M  V30 24 N 13.0017 4.8928 0.0 0
M  V30 25 N 14.2476 7.0507 0.0 0
M  V30 26 C 14.4086 5.5192 0.0 0
M  V30 27 C 10.2960 3.1357 0.0 0
M  V30 28 C 11.8276 2.9747 0.0 0
M  V30 29 C 9.3908 1.8898 0.0 0
M  V30 30 C 12.4539 1.5678 0.0 0
M  V30 31 C 10.0171 0.4830 0.0 0
M  V30 32 C 11.5487 0.3219 0.0 0
M  V30 33 C 6.6685 7.1644 0.0 0
M  V30 34 C 5.3348 6.3944 0.0 0
M  V30 35 C 6.6685 8.7044 0.0 0
M  V30 36 C 4.0012 7.1644 0.0 0
M  V30 37 C 5.3348 9.4744 0.0 0
M  V30 38 N 4.0012 8.7044 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 29
M  V30 2 1 2 3
M  V30 3 1 2 25
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 2 10 11
M  V30 11 1 10 30
M  V30 12 1 12 35
M  V30 13 1 13 14
M  V30 14 1 13 36
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 17 18
M  V30 18 1 17 19
M  V30 19 1 17 22
M  V30 20 1 18 20
M  V30 21 1 18 27
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 21 33
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 2 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-[5-[2-Chloro-5-(1-pyrrolidinylmethyl)phenyl]-4-[1-[[2-(trimethylsilyl)et...
C31H39ClN6O3Si
1357916-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 13.8955 4.5289 0.0 0
M  V30 2 C 6.3628 10.5594 0.0 0
M  V30 3 O 4.8981 10.0835 0.0 0
M  V30 4 C 3.7537 11.1141 0.0 0
M  V30 5 C 2.2889 10.6381 0.0 0
M  V30 6 Si 1.1444 11.6686 0.0 0
M  V30 7 C 0.0000 12.6991 0.0 0
M  V30 8 C 0.1140 10.5241 0.0 0
M  V30 9 C 2.1750 12.8130 0.0 0
M  V30 10 C 7.7691 3.8850 0.0 0
M  V30 11 C 13.7525 11.9526 0.0 0
M  V30 12 N 19.0873 8.8726 0.0 0
M  V30 13 C 20.4211 9.6426 0.0 0
M  V30 14 C 20.4211 11.1826 0.0 0
M  V30 15 O 21.7548 8.8726 0.0 0
M  V30 16 C 11.3152 8.3545 0.0 0
M  V30 17 C 12.0852 7.0207 0.0 0
M  V30 18 C 12.3456 9.4989 0.0 0
M  V30 19 O 13.5915 7.3410 0.0 0
M  V30 20 C 13.7525 8.8726 0.0 0
M  V30 21 C 9.7835 8.5154 0.0 0
M  V30 22 N 9.0135 9.8491 0.0 0
M  V30 23 N 8.7531 7.3710 0.0 0
M  V30 24 N 7.5072 9.5289 0.0 0
M  V30 25 C 7.3462 7.9974 0.0 0
M  V30 26 C 11.4587 5.6139 0.0 0
M  V30 27 C 9.9272 5.4529 0.0 0
M  V30 28 C 12.3640 4.3680 0.0 0
M  V30 29 C 9.3009 4.0460 0.0 0
M  V30 30 C 11.7376 2.9610 0.0 0
M  V30 31 C 10.2061 2.8001 0.0 0
M  V30 32 C 15.0863 9.6426 0.0 0
M  V30 33 C 16.4199 8.8726 0.0 0
M  V30 34 C 15.0863 11.1826 0.0 0
M  V30 35 C 17.7536 9.6426 0.0 0
M  V30 36 C 16.4199 11.9526 0.0 0
M  V30 37 N 17.7536 11.1826 0.0 0
M  V30 38 N 7.1428 2.4782 0.0 0
M  V30 39 C 5.6365 2.1579 0.0 0
M  V30 40 C 7.9128 1.1444 0.0 0
M  V30 41 C 5.4754 0.6263 0.0 0
M  V30 42 C 6.8824 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 28
M  V30 2 1 2 3
M  V30 3 1 2 24
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 29
M  V30 11 1 10 38
M  V30 12 1 11 34
M  V30 13 1 12 13
M  V30 14 1 12 35
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21
M  V30 20 1 17 19
M  V30 21 1 17 26
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 20 32
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 2 32 34
M  V30 38 2 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 37
M  V30 42 1 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 1 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1357916-76-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1357916-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-671371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 2:
N-(4-{5-[2-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]-4-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-1,2,4-triazol-3-yl)-2-furyl}-5-methylpyridin-2-yl)acetamide.
To a solution of
N-{4-[5-(2-chloro-5-formylphenyl)-4-(1-{[2-(trimethylsilyl)methoxy]methyl}-1H-1,2,4-triazol-3-yl)-2-furyl]-5-methylpyridin-2-yl}acetamide
(0.19 g, 0.34 mmol) in DCM (10 mL) was added pyrrolidine (0.14 mL, 1.68
mmol) and STAB (0.21 g, 1.01 mmol). The mixture was allowed to stir at rt
overnight. The mixture was diluted with water and extracted with DCM. The
organic solutions were combined, dried over MgSO4, filtered and
concentrated. The residue was purified by column chromatography to give
product.
N-(4-{5-[2-chloro-5-(pyrrolidin-1-ylmethyl)phenyl]-4-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-1,2,4-triazol-3-yl)-2-furyl}-5-methylpyridin-2-yl)acetamide,
yield 0.20 g, 100%. LCMS (FA): m/z = 607.7 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxazole and furan derivatives as inhibitors of VPS34
and/or PI3K
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cullis, Courtney A.; Granger, Krista E.; Guo, Jianping; Hirose, Masaaki;
Li, Gang; Mizutani, Miho; Vos, Tricia J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012021615 A1 2012-02-16

$RFMT $RIREG SCHEME68 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4R,5R,6S)-3-(2-Bromophenyl)-4-hydroxy-6-(2-methylpropyl)-1,3-diazabicyclo[3....
C14H17BrN2O2
1360571-33-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.8634 2.7106 0.0 0
M  V30 2 C 10.6334 4.0442 0.0 0
M  V30 3 C 12.1735 4.0442 0.0 0
M  V30 4 C 9.8634 5.3780 0.0 0
M  V30 5 O 5.0492 0.0000 0.0 0
M  V30 6 O 5.0492 5.4211 0.0 0
M  V30 7 Br 3.0800 5.3780 0.0 0
M  V30 8 C 6.9898 1.9406 0.0 0 CFG=1
M  V30 9 N 6.9898 3.4806 0.0 0
M  V30 10 C 8.3234 2.7106 0.0 0 CFG=2
M  V30 11 C 5.5252 1.4647 0.0 0 CFG=1
M  V30 12 C 5.5252 3.9564 0.0 0
M  V30 13 N 4.6200 2.7106 0.0 0
M  V30 14 C 3.0800 2.7106 0.0 0
M  V30 15 C 2.3100 4.0442 0.0 0
M  V30 16 C 2.3100 1.3769 0.0 0
M  V30 17 C 0.7700 4.0442 0.0 0
M  V30 18 C 0.7700 1.3769 0.0 0
M  V30 19 C 0.0000 2.7106 0.0 0
M  V30 20 H 7.6161 0.5338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 11 5 CFG=1
M  V30 6 2 6 12
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 20 CFG=1
M  V30 12 1 9 10
M  V30 13 1 9 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 8 10 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4S,5R,6S)-3-(2-Bromophenyl)-6-(2-methylpropyl)-4-(1-pyrrolidinyl)-1,3-diazab...
C18H24BrN3O
1360571-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.8634 5.2023 0.0 0
M  V30 2 C 10.6334 6.5359 0.0 0
M  V30 3 C 12.1735 6.5359 0.0 0
M  V30 4 C 9.8634 7.8697 0.0 0
M  V30 5 O 5.0492 7.9129 0.0 0
M  V30 6 Br 3.0800 7.8697 0.0 0
M  V30 7 C 6.9898 4.4323 0.0 0 CFG=1
M  V30 8 C 5.5252 3.9564 0.0 0 CFG=1
M  V30 9 N 6.9898 5.9723 0.0 0
M  V30 10 C 8.3234 5.2023 0.0 0 CFG=2
M  V30 11 N 4.6200 5.2023 0.0 0
M  V30 12 C 5.5252 6.4482 0.0 0
M  V30 13 N 5.0492 2.4917 0.0 0
M  V30 14 C 5.9544 1.2459 0.0 0
M  V30 15 C 3.5847 2.0159 0.0 0
M  V30 16 C 5.0492 0.0000 0.0 0
M  V30 17 C 3.5847 0.4759 0.0 0
M  V30 18 C 3.0800 5.2023 0.0 0
M  V30 19 C 2.3100 6.5359 0.0 0
M  V30 20 C 2.3100 3.8687 0.0 0
M  V30 21 C 0.7700 6.5359 0.0 0
M  V30 22 C 0.7700 3.8687 0.0 0
M  V30 23 C 0.0000 5.2023 0.0 0
M  V30 24 H 7.6161 3.0255 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 12
M  V30 6 1 6 19
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 7 24 CFG=1
M  V30 11 1 8 11
M  V30 12 1 8 13 CFG=1
M  V30 13 1 9 10
M  V30 14 1 9 12
M  V30 15 1 11 12
M  V30 16 1 11 18
M  V30 17 1 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 7 8 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1360571-33-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1360571-48-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-3943055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Skeletal Fusion of Small Heterocycles with Amphoteric Molecules
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheung, Lawrence L. W.; He, Zhi; Decker, Shannon M.; Yudin, Andrei K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2011), 50(49), 11798-11802,
S11798/1-S11798/41

$RFMT $RIREG SCHEME69 STEP1
$RXN



  2  1
$MOL
N-[(1,1-Dimethylethoxy)carbonyl]-O-(1,1-dimethylethyl)-L-threonine
C13H25NO5
13734-40-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 18 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0 CFG=1
M  V30 2 C 7.7000 2.6674 0.0 0 CFG=1
M  V30 3 N 5.3900 4.0011 0.0 0
M  V30 4 C 5.3900 1.3338 0.0 0
M  V30 5 O 8.4700 4.0011 0.0 0
M  V30 6 C 8.4700 1.3338 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 O 6.1600 0.0000 0.0 0
M  V30 9 O 3.8500 1.3338 0.0 0
M  V30 10 C 10.0100 4.0011 0.0 0
M  V30 11 O 3.0800 5.3349 0.0 0
M  V30 12 O 3.0800 2.6674 0.0 0
M  V30 13 C 10.0100 2.4611 0.0 0
M  V30 14 C 11.5500 4.0011 0.0 0
M  V30 15 C 10.0100 5.5411 0.0 0
M  V30 16 C 1.5400 5.3349 0.0 0
M  V30 17 C 1.5400 3.7949 0.0 0
M  V30 18 C 0.0000 5.3349 0.0 0
M  V30 19 C 1.5400 6.8749 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=3
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 1 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S,2R)-2-(1,1-dimethylethoxy)-1-(1-pyrrolidinylcarbonyl...
C17H32N2O4
1380104-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 23 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.1046 0.0 0 CFG=2
M  V30 2 C 6.1600 3.7710 0.0 0
M  V30 3 N 6.1600 6.4384 0.0 0
M  V30 4 C 3.8500 5.1046 0.0 0 CFG=1
M  V30 5 O 7.7000 3.7710 0.0 0
M  V30 6 C 7.7000 6.4384 0.0 0
M  V30 7 O 3.0800 6.4384 0.0 0
M  V30 8 C 3.0800 3.7710 0.0 0
M  V30 9 O 8.4700 7.7721 0.0 0
M  V30 10 O 8.4700 5.1046 0.0 0
M  V30 11 C 1.5400 6.4384 0.0 0
M  V30 12 C 10.0100 7.7721 0.0 0
M  V30 13 C 1.5400 4.8984 0.0 0
M  V30 14 C 0.0000 6.4384 0.0 0
M  V30 15 C 1.5400 7.9784 0.0 0
M  V30 16 C 10.0100 9.3121 0.0 0
M  V30 17 C 11.5500 7.7721 0.0 0
M  V30 18 C 10.0100 6.2321 0.0 0
M  V30 19 N 5.3900 2.4374 0.0 0
M  V30 20 C 6.0163 1.0304 0.0 0
M  V30 21 C 3.8585 2.2764 0.0 0
M  V30 22 C 4.8719 0.0000 0.0 0
M  V30 23 C 3.5383 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 19
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8 CFG=1
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 12 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-40-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380104-09-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1721234
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Compound G1: Tert-butyl
(2S,3R)-3-methoxy-1-oxo-1-(pyrrolidin-1-yl)butan-2-ylcarbamate
(2S,3R)-2-(Tert-butoxycarbonylamino)-3-methoxybutanoic acid (643 mg, 2.76
mmol), which is commercially available, and DIPEA (1.440 mL, 8.27mmol)
was mixed in DCM (10 mL). The mixture was cooled to 0 °C. TBTU (974 mg,
3.03 mmol) was added and the mixture stirred at rt for 10 min.
Pyrrolidine (0.274 mL, 3.31 mmol) was added and the resultant mixture was
stirred at rt for 16 h. The mixture was diluted with DCM (10 mL). The
organic phase was washed with NaHCO3 (8% in aq. solution) and brine,
filtered through a phase separator and concentrated under reduced
pressure. The residue was purified via Biotage (gradient; DCM /
iso-propanol, 99:1 to 95:5, KP-SIL 340g column). The solvent was removed
under reduced pressure to give the title compound. Tert-butyl
(2S,3R)-3-tert-butoxy-1-oxo-1-(pyrrolidin-1-yl)butan-2-ylcarbamate, yield
2.60 g, quant. 1H NMR (400 MHz, CDCl3) δ 1.12, 1.19, 1.43, 1.80- 1.98,
3.36- 3.45, 3.48 - 3.61, 3.74, 3.82 - 3.90, 4.39. Total no of protons :
31.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-containing heterocycles as IKACh blockers and their preparation and use
for the treatment of IKACh-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bostroem, Jonas; Granberg, Kenneth; Emtenaes, Hans; Mogemark, Mickael;
Llinas, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012074469 A1 2012-06-07

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Boc-L-valine
C10H19NO4
13734-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0 CFG=2
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 2.6675 3.8501 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 4.0012 4.6201 0.0 0
M  V30 10 O 6.6685 1.5400 0.0 0
M  V30 11 O 5.3348 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.7723 0.9764 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 7.2323 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-2-methyl-1-(1-pyrrolidinylcarbonyl)propyl]carbamate
C14H26N2O3
130013-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.1617 2.6674 0.0 0 CFG=2
M  V30 2 C 2.6217 2.6674 0.0 0
M  V30 3 N 4.9317 4.0011 0.0 0
M  V30 4 C 4.9317 1.3338 0.0 0
M  V30 5 O 1.8517 1.3338 0.0 0
M  V30 6 C 6.4717 4.0011 0.0 0
M  V30 7 C 6.4717 1.3338 0.0 0
M  V30 8 C 4.1617 0.0000 0.0 0
M  V30 9 O 7.2417 5.3349 0.0 0
M  V30 10 O 7.2417 2.6674 0.0 0
M  V30 11 C 8.7817 5.3349 0.0 0
M  V30 12 C 8.7817 3.7949 0.0 0
M  V30 13 C 10.3217 5.3349 0.0 0
M  V30 14 C 8.7817 6.8749 0.0 0
M  V30 15 N 1.8517 4.0011 0.0 0
M  V30 16 C 0.3202 4.1622 0.0 0
M  V30 17 C 2.4782 5.4080 0.0 0
M  V30 18 C 0.0000 5.6684 0.0 0
M  V30 19 C 1.3336 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 2 2 5
M  V30 5 1 2 15
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13734-41-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 130013-62-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-19144988
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor
Antagonists of Lead Compound
(3R)-7-Hydroxy-N-[(1S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
(PDTic)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ondachi, Pauline W.; Kormos, Chad M.; Runyon, Scott P.; Thomas, James B.;
Mascarella, S. Wayne; Decker, Ann M.; Navarro, Hernan A.; Fennell,
Timothy R.; Snyder, Rodney W.; Carroll, F. Ivy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2018), 61(17), 7525-7545

$RFMT $RIREG SCHEME70 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Boc-L-valine
C10H19NO4
13734-41-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0 CFG=2
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 2.6675 3.8501 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 4.0012 4.6201 0.0 0
M  V30 10 O 6.6685 1.5400 0.0 0
M  V30 11 O 5.3348 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.7723 0.9764 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 7.2323 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-2-methyl-1-(1-pyrrolidinylcarbonyl)propyl]carbamate
C14H26N2O3
130013-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.1617 2.6674 0.0 0 CFG=2
M  V30 2 C 2.6217 2.6674 0.0 0
M  V30 3 N 4.9317 4.0011 0.0 0
M  V30 4 C 4.9317 1.3338 0.0 0
M  V30 5 O 1.8517 1.3338 0.0 0
M  V30 6 C 6.4717 4.0011 0.0 0
M  V30 7 C 6.4717 1.3338 0.0 0
M  V30 8 C 4.1617 0.0000 0.0 0
M  V30 9 O 7.2417 5.3349 0.0 0
M  V30 10 O 7.2417 2.6674 0.0 0
M  V30 11 C 8.7817 5.3349 0.0 0
M  V30 12 C 8.7817 3.7949 0.0 0
M  V30 13 C 10.3217 5.3349 0.0 0
M  V30 14 C 8.7817 6.8749 0.0 0
M  V30 15 N 1.8517 4.0011 0.0 0
M  V30 16 C 0.3202 4.1622 0.0 0
M  V30 17 C 2.4782 5.4080 0.0 0
M  V30 18 C 0.0000 5.6684 0.0 0
M  V30 19 C 1.3336 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 2 2 5
M  V30 5 1 2 15
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13734-41-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 130013-62-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-20000226
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tetrahydroisoquinoline derivatives for use as kappa opioid
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carroll, Frank Ivy; Kormos, Chad M.; Ondachi, Pauline W.; Runyon, Scott
P.; Navarro, Hernan A.; Thomas, James B.; Mascarella, S. Wayne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018053222 A1 2018-03-22

$RFMT $RIREG SCHEME71 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methoxy-13-methyl-9H-imidazo[1,5-a][1,2,3]triazolo[1,5-d][1,4]benzodiazepin...
C15H13N5O3
1376936-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7842 4.5435 0.0 0
M  V30 2 O 10.9221 3.0096 0.0 0
M  V30 3 O 12.0434 5.4299 0.0 0
M  V30 4 C 2.7564 1.2092 0.0 0
M  V30 5 O 0.7700 5.2588 0.0 0
M  V30 6 C 0.0000 6.5924 0.0 0
M  V30 7 C 5.3900 5.2588 0.0 0
M  V30 8 N 6.9128 5.4883 0.0 0
M  V30 9 C 4.6200 3.9252 0.0 0
M  V30 10 C 4.6200 6.5924 0.0 0
M  V30 11 C 8.0417 4.4407 0.0 0
M  V30 12 C 7.5602 6.8856 0.0 0
M  V30 13 C 5.1827 2.4916 0.0 0
M  V30 14 C 3.0800 3.9252 0.0 0
M  V30 15 C 3.0800 6.5924 0.0 0
M  V30 16 C 7.9267 2.9051 0.0 0
M  V30 17 C 9.3868 5.1907 0.0 0
M  V30 18 N 9.0892 6.7018 0.0 0
M  V30 19 N 6.6542 2.0376 0.0 0
M  V30 20 C 4.2961 1.2323 0.0 0
M  V30 21 C 2.3100 5.2588 0.0 0
M  V30 22 N 6.6773 0.4977 0.0 0
M  V30 23 N 5.2200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 4 20
M  V30 5 1 5 6
M  V30 6 1 5 21
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 9 14
M  V30 14 1 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 2 12 18
M  V30 18 1 13 19
M  V30 19 2 13 20
M  V30 20 1 14 21
M  V30 21 2 15 21
M  V30 22 1 16 19
M  V30 23 1 17 18
M  V30 24 1 19 22
M  V30 25 1 20 23
M  V30 26 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Methoxy-13-methyl-9H-imidazo[1,5-a][1,2,3]triazolo[1,5-d][1,4]benzodiazepi...
C19H20N6O2
1376936-39-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.7842 4.5435 0.0 0
M  V30 2 O 10.9221 3.0096 0.0 0
M  V30 3 C 2.7564 1.2092 0.0 0
M  V30 4 O 0.7700 5.2588 0.0 0
M  V30 5 C 0.0000 6.5924 0.0 0
M  V30 6 C 5.3900 5.2588 0.0 0
M  V30 7 N 6.9129 5.4883 0.0 0
M  V30 8 C 4.6200 3.9252 0.0 0
M  V30 9 C 4.6200 6.5924 0.0 0
M  V30 10 C 8.0417 4.4409 0.0 0
M  V30 11 C 7.5602 6.8856 0.0 0
M  V30 12 C 5.1827 2.4916 0.0 0
M  V30 13 C 3.0800 3.9252 0.0 0
M  V30 14 C 3.0800 6.5924 0.0 0
M  V30 15 C 9.3868 5.1909 0.0 0
M  V30 16 C 7.9267 2.9052 0.0 0
M  V30 17 N 9.0892 6.7018 0.0 0
M  V30 18 N 6.6543 2.0376 0.0 0
M  V30 19 C 4.2963 1.2323 0.0 0
M  V30 20 C 2.3100 5.2588 0.0 0
M  V30 21 N 6.6773 0.4979 0.0 0
M  V30 22 N 5.2200 0.0000 0.0 0
M  V30 23 N 12.0434 5.4299 0.0 0
M  V30 24 C 13.5007 4.9322 0.0 0
M  V30 25 C 12.0665 6.9697 0.0 0
M  V30 26 C 14.4246 6.1643 0.0 0
M  V30 27 C 13.5380 7.4237 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 15
M  V30 3 1 1 23
M  V30 4 1 3 19
M  V30 5 1 4 5
M  V30 6 1 4 20
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 2 10 15
M  V30 16 1 10 16
M  V30 17 2 11 17
M  V30 18 1 12 18
M  V30 19 2 12 19
M  V30 20 1 13 20
M  V30 21 2 14 20
M  V30 22 1 15 17
M  V30 23 1 16 18
M  V30 24 1 18 21
M  V30 25 1 19 22
M  V30 26 2 21 22
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1376936-49-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1376936-39-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14541591
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 2: Carboxylic acid 38 (91.5 mg, 0.294
mmol) was dissolved in DMF (2 mL). To the solution was added
diisopropylethylamine (0.154 mL, 0.882 mmol), O-(7-azabenzotriazol-1-yl
)-N,N,N',N'-tetramethyluronium hexafluorophosphate (167.6 mg, 0.441
mmol), and diethylamine (91.2 uL, 0.882 mmol) and the mixture was stirred
at RT for 16 h. The mixture was diluted with EtOAc, washed with saturated
NaHCO3 and brine, and dried over MgSO4. Filtration and evaporation of the
filtrate gave crude product which was purified by ISCO (gradient hexanes/
EtOAc). Using a procedure that is substantially similar to the one as
described in Example 2, Step 2, 86.1 mg of compound 38 was converted to
compound 3: 100.7 mg, (100%). (MS:[M+1 = 365]).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzodiazepine derivatives, compositions and methods for treating
cognitive impairment
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lowe, John A., III
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012068149 A1 2012-05-24

$RFMT $RIREG SCHEME72 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-N-[3-(phenylthio)-2-propyn-1-yl]-N-2-propyn-1-ylbenzenesulfonamide
C19H17NO2S2
1380676-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 10.0100 4.0011 0.0 0 VAL=6
M  V30 2 N 8.4700 4.0011 0.0 0
M  V30 3 O 10.0100 5.5411 0.0 0
M  V30 4 O 10.0100 2.4611 0.0 0
M  V30 5 C 7.7000 5.3347 0.0 0
M  V30 6 C 7.7000 2.6674 0.0 0
M  V30 7 C 6.1600 5.3347 0.0 0
M  V30 8 C 8.4700 1.3336 0.0 0
M  V30 9 C 4.6200 5.3347 0.0 0
M  V30 10 C 9.2400 0.0000 0.0 0
M  V30 11 S 3.0800 5.3347 0.0 0
M  V30 12 C 16.1700 4.0011 0.0 0
M  V30 13 C 11.5500 4.0011 0.0 0
M  V30 14 C 12.3200 2.6674 0.0 0
M  V30 15 C 12.3200 5.3347 0.0 0
M  V30 16 C 13.8600 2.6674 0.0 0
M  V30 17 C 13.8600 5.3347 0.0 0
M  V30 18 C 14.6300 4.0011 0.0 0
M  V30 19 C 2.3100 6.6684 0.0 0
M  V30 20 C 0.7700 6.6684 0.0 0
M  V30 21 C 3.0800 8.0021 0.0 0
M  V30 22 C 0.0000 8.0021 0.0 0
M  V30 23 C 2.3100 9.3358 0.0 0
M  V30 24 C 0.7700 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 3 7 9
M  V30 10 3 8 10
M  V30 11 1 9 11
M  V30 12 1 11 19
M  V30 13 1 12 18
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Methylphenyl)sulfonyl]-3-[(phenylthio)methyl]-4-(1-pyrrolidinylmethyl)-...
C23H26N2O2S2
1549712-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3347 7.6443 0.0 0 VAL=6
M  V30 2 O 4.5647 6.3106 0.0 0
M  V30 3 O 6.1047 8.9779 0.0 0
M  V30 4 C 8.9621 3.6156 0.0 0
M  V30 5 C 10.6373 6.5172 0.0 0
M  V30 6 S 11.2636 7.9241 0.0 0
M  V30 7 C 0.0000 10.7243 0.0 0
M  V30 8 N 6.6684 6.8743 0.0 0
M  V30 9 C 6.8293 5.3427 0.0 0
M  V30 10 C 8.0753 7.5008 0.0 0
M  V30 11 C 8.3358 5.0226 0.0 0
M  V30 12 C 9.1058 6.3562 0.0 0
M  V30 13 C 4.0011 8.4143 0.0 0
M  V30 14 C 2.6673 7.6443 0.0 0
M  V30 15 C 4.0011 9.9543 0.0 0
M  V30 16 C 1.3336 8.4143 0.0 0
M  V30 17 C 2.6673 10.7243 0.0 0
M  V30 18 C 1.3336 9.9543 0.0 0
M  V30 19 N 8.0569 2.3698 0.0 0
M  V30 20 C 8.5329 0.9052 0.0 0
M  V30 21 C 6.5169 2.3698 0.0 0
M  V30 22 C 7.2869 0.0000 0.0 0
M  V30 23 C 6.0410 0.9052 0.0 0
M  V30 24 C 12.7953 8.0850 0.0 0
M  V30 25 C 13.7005 6.8392 0.0 0
M  V30 26 C 13.4216 9.4920 0.0 0
M  V30 27 C 15.2321 7.0001 0.0 0
M  V30 28 C 14.9532 9.6529 0.0 0
M  V30 29 C 15.8584 8.4071 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 1 13
M  V30 5 1 4 11
M  V30 6 1 4 19
M  V30 7 1 5 6
M  V30 8 1 5 12
M  V30 9 1 6 24
M  V30 10 1 7 18
M  V30 11 1 8 9
M  V30 12 1 8 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1380676-39-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1549712-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29490741
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13965-03-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 14949-69-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study (based on catalyst, solvent, time and temperature)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel-palladium-catalyzed hydroamination/cyclization of
sulfur-substituted 1,6-diynes with secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nagata, Hayami; Sugimoto, Yuko; Ito, Yukiteru; Tanaka, Miki; Yoshimatsu,
Mitsuhiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(6), 1306-1316

$RFMT $RIREG SCHEME73 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(2E)-4-Bromo-2-buten-1-yl]oxy]-3,6-bis[(1,1-dimethyl-2-propen-1-yl)oxy]-1...
C27H29BrO6
1383484-74-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3111 5.3901 0.0 0
M  V30 2 C 4.9774 4.6201 0.0 0
M  V30 3 C 4.9774 3.0801 0.0 0
M  V30 4 C 3.6437 2.3101 0.0 0
M  V30 5 C 3.6437 0.7700 0.0 0
M  V30 6 Br 2.3101 0.0000 0.0 0
M  V30 7 O 3.6437 6.9302 0.0 0
M  V30 8 C 2.3101 7.7002 0.0 0
M  V30 9 C 1.5400 6.3665 0.0 0
M  V30 10 C 0.9762 8.4702 0.0 0
M  V30 11 C 3.0801 9.0338 0.0 0
M  V30 12 C 0.0000 6.3665 0.0 0
M  V30 13 O 8.9786 11.5503 0.0 0
M  V30 14 O 11.6460 11.5503 0.0 0
M  V30 15 O 14.3134 6.9302 0.0 0
M  V30 16 C 15.6471 7.7002 0.0 0
M  V30 17 C 16.4171 6.3665 0.0 0
M  V30 18 C 16.9809 8.4702 0.0 0
M  V30 19 C 14.8770 9.0338 0.0 0
M  V30 20 C 17.9571 6.3665 0.0 0
M  V30 21 C 7.6449 7.7002 0.0 0
M  V30 22 C 6.3111 6.9302 0.0 0
M  V30 23 C 7.6449 9.2402 0.0 0
M  V30 24 O 8.9786 6.9302 0.0 0
M  V30 25 C 4.9774 7.7002 0.0 0
M  V30 26 C 8.9786 10.0102 0.0 0
M  V30 27 C 6.3111 10.0102 0.0 0
M  V30 28 C 10.3122 7.7002 0.0 0
M  V30 29 C 4.9774 9.2402 0.0 0
M  V30 30 C 10.3122 9.2402 0.0 0
M  V30 31 C 11.6460 6.9302 0.0 0
M  V30 32 C 11.6460 10.0102 0.0 0
M  V30 33 C 12.9797 7.7002 0.0 0
M  V30 34 C 12.9797 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 25
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 2 13 26
M  V30 14 1 14 32
M  V30 15 1 15 16
M  V30 16 1 15 33
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 2 17 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 23 26
M  V30 26 2 23 27
M  V30 27 1 24 28
M  V30 28 2 25 29
M  V30 29 1 26 30
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 28 31
M  V30 33 2 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,6-Bis[(1,1-dimethyl-2-propen-1-yl)oxy]-1-hydroxy-5-[[(2E)-4-(1-pyrrolidinyl...
C31H37NO6
1429302-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.7800 4.9774 0.0 0
M  V30 2 C 12.3200 4.9774 0.0 0
M  V30 3 C 13.0900 3.6438 0.0 0
M  V30 4 C 14.6300 3.6438 0.0 0
M  V30 5 C 15.4000 2.3100 0.0 0
M  V30 6 O 12.3200 7.6447 0.0 0
M  V30 7 C 13.0900 8.9785 0.0 0
M  V30 8 C 14.4236 8.2085 0.0 0
M  V30 9 C 13.8600 10.3121 0.0 0
M  V30 10 C 11.7564 9.7485 0.0 0
M  V30 11 C 15.7573 8.9785 0.0 0
M  V30 12 O 5.3900 8.9785 0.0 0
M  V30 13 O 3.0800 7.6447 0.0 0
M  V30 14 O 3.0800 2.3100 0.0 0
M  V30 15 C 1.5400 2.3100 0.0 0
M  V30 16 C 1.5400 0.7700 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 18 C 1.5400 3.8500 0.0 0
M  V30 19 C 0.2064 0.0000 0.0 0
M  V30 20 C 8.4700 6.3111 0.0 0
M  V30 21 C 10.0100 6.3111 0.0 0
M  V30 22 C 7.7000 7.6447 0.0 0
M  V30 23 O 7.7000 4.9774 0.0 0
M  V30 24 C 10.7800 7.6447 0.0 0
M  V30 25 C 6.1600 7.6447 0.0 0
M  V30 26 C 8.4700 8.9785 0.0 0
M  V30 27 C 6.1600 4.9774 0.0 0
M  V30 28 C 10.0100 8.9785 0.0 0
M  V30 29 C 5.3900 6.3111 0.0 0
M  V30 30 C 5.3900 3.6436 0.0 0
M  V30 31 C 3.8500 6.3111 0.0 0
M  V30 32 C 3.8500 3.6436 0.0 0
M  V30 33 C 3.0800 4.9774 0.0 0
M  V30 34 N 16.9400 2.3100 0.0 0
M  V30 35 C 17.8452 1.0641 0.0 0
M  V30 36 C 17.8452 3.5559 0.0 0
M  V30 37 C 19.3098 1.5400 0.0 0
M  V30 38 C 19.3098 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 4 5
M  V30 6 1 5 34
M  V30 7 1 6 7
M  V30 8 1 6 24
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 8 11
M  V30 13 2 12 25
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 32
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 2 16 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 27 30
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1383484-74-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1429302-07-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15269089
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure for preparation of caged compounds 61-81 and 82-103. To
a stirring solution of compound 37 (0.20 mmol) in DMF (5 mL) was added
potassium carbonate (0.40 mmol) and the corresponding amine or alcohol or
acid (0.30 mmol) and the solution was stirred at 35 °C for 1 h. The
reaction mixture was partitioned between ethyl acetate (15 mL) and water
(20 mL). The water layer was extracted with ethyl acetate (15 mL × 2).
The organic layer was combined, washed with saturated NaCl solution (10
mL × 2), dried over sodium sulfate, fiterted and concentrated to afford
40. Yellow oil, yield 99-100%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Garcinia Xanthones as Orally Active Antitumor Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaojin; Li, Xiang; Sun, Haopeng; Wang, Xiaojian; Zhao, Li; Gao,
Yuan; Liu, Xiaorong; Zhang, Shenglie; Wang, Yanyan; Yang, Yingrui; Zeng,
Su; Guo, Qinglong; You, Qidong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(1), 276-292

$RFMT $RIREG SCHEME74 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(2E)-4-Bromo-2-buten-1-yl]oxy]-6-[(1,1-dimethyl-2-propen-1-yl)oxy]-3-[(1,...
C27H27BrO6
1383484-78-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3111 5.3901 0.0 0
M  V30 2 C 4.9774 4.6201 0.0 0
M  V30 3 C 4.9774 3.0801 0.0 0
M  V30 4 C 3.6437 2.3101 0.0 0
M  V30 5 C 3.6437 0.7700 0.0 0
M  V30 6 Br 2.3101 0.0000 0.0 0
M  V30 7 O 3.6437 6.9302 0.0 0
M  V30 8 C 2.3101 7.7002 0.0 0
M  V30 9 C 1.5400 6.3665 0.0 0
M  V30 10 C 0.9762 8.4702 0.0 0
M  V30 11 C 3.0801 9.0338 0.0 0
M  V30 12 C 0.0000 6.3665 0.0 0
M  V30 13 O 8.9786 11.5503 0.0 0
M  V30 14 O 11.6460 11.5503 0.0 0
M  V30 15 O 14.3134 6.9302 0.0 0
M  V30 16 C 15.6471 7.7002 0.0 0
M  V30 17 C 16.4171 6.3665 0.0 0
M  V30 18 C 16.9809 8.4702 0.0 0
M  V30 19 C 14.8770 9.0338 0.0 0
M  V30 20 C 17.1871 5.0327 0.0 0
M  V30 21 C 7.6449 7.7002 0.0 0
M  V30 22 C 6.3111 6.9302 0.0 0
M  V30 23 C 7.6449 9.2402 0.0 0
M  V30 24 O 8.9786 6.9302 0.0 0
M  V30 25 C 4.9774 7.7002 0.0 0
M  V30 26 C 8.9786 10.0102 0.0 0
M  V30 27 C 6.3111 10.0102 0.0 0
M  V30 28 C 10.3122 7.7002 0.0 0
M  V30 29 C 4.9774 9.2402 0.0 0
M  V30 30 C 10.3122 9.2402 0.0 0
M  V30 31 C 11.6460 6.9302 0.0 0
M  V30 32 C 11.6460 10.0102 0.0 0
M  V30 33 C 12.9797 7.7002 0.0 0
M  V30 34 C 12.9797 9.2402 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 25
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 2 13 26
M  V30 14 1 14 32
M  V30 15 1 15 16
M  V30 16 1 15 33
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 16 19
M  V30 20 3 17 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 23 26
M  V30 26 2 23 27
M  V30 27 1 24 28
M  V30 28 2 25 29
M  V30 29 1 26 30
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 28 31
M  V30 33 2 30 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[(1,1-Dimethyl-2-propen-1-yl)oxy]-3-[(1,1-dimethyl-2-propyn-1-yl)oxy]-1-hyd...
C31H35NO6
1429301-68-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.7800 5.7474 0.0 0
M  V30 2 C 12.3200 5.7474 0.0 0
M  V30 3 C 13.0900 4.4136 0.0 0
M  V30 4 C 14.6300 4.4136 0.0 0
M  V30 5 C 15.4000 3.0800 0.0 0
M  V30 6 O 12.3200 8.4147 0.0 0
M  V30 7 C 13.0900 9.7484 0.0 0
M  V30 8 C 14.4236 8.9784 0.0 0
M  V30 9 C 13.8600 11.0821 0.0 0
M  V30 10 C 11.7564 10.5184 0.0 0
M  V30 11 C 15.7573 9.7484 0.0 0
M  V30 12 O 5.3900 9.7485 0.0 0
M  V30 13 O 3.0800 8.4147 0.0 0
M  V30 14 O 3.0800 3.0800 0.0 0
M  V30 15 C 1.5400 3.0800 0.0 0
M  V30 16 C 1.5400 1.5400 0.0 0
M  V30 17 C 0.0000 3.0800 0.0 0
M  V30 18 C 1.5400 4.6200 0.0 0
M  V30 19 C 1.5400 0.0000 0.0 0
M  V30 20 C 8.4700 7.0811 0.0 0
M  V30 21 C 10.0100 7.0811 0.0 0
M  V30 22 C 7.7000 8.4147 0.0 0
M  V30 23 O 7.7000 5.7474 0.0 0
M  V30 24 C 10.7800 8.4147 0.0 0
M  V30 25 C 6.1600 8.4147 0.0 0
M  V30 26 C 8.4700 9.7485 0.0 0
M  V30 27 C 6.1600 5.7474 0.0 0
M  V30 28 C 10.0100 9.7485 0.0 0
M  V30 29 C 5.3900 7.0811 0.0 0
M  V30 30 C 5.3900 4.4136 0.0 0
M  V30 31 C 3.8500 7.0811 0.0 0
M  V30 32 C 3.8500 4.4136 0.0 0
M  V30 33 C 3.0800 5.7474 0.0 0
M  V30 34 N 16.9400 3.0800 0.0 0
M  V30 35 C 17.8452 1.8341 0.0 0
M  V30 36 C 17.8452 4.3259 0.0 0
M  V30 37 C 19.3098 2.3100 0.0 0
M  V30 38 C 19.3098 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 4 5
M  V30 6 1 5 34
M  V30 7 1 6 7
M  V30 8 1 6 24
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 8 11
M  V30 13 2 12 25
M  V30 14 1 13 31
M  V30 15 1 14 15
M  V30 16 1 14 32
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 3 16 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 22 25
M  V30 26 2 22 26
M  V30 27 1 23 27
M  V30 28 2 24 28
M  V30 29 1 25 29
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 2 27 30
M  V30 33 2 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1383484-78-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1429301-68-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8595881
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure for preparation of caged compounds 46-52 and 53-59. To
a stirring solution of compound 37 (0.20 mmol) in DMF (5 mL) was added
potassium carbonate (0.40 mmol) and the corresponding amine (0.30 mmol)
and the solution was stirred at 35 °C for 1 h. The reaction mixture was
partitioned between ethyl acetate (15 mL) and water (20 mL). The water
layer was extracted with ethyl acetate (15 mL × 2). The organic layer was
combined, washed with saturated NaCl solution (10 mL × 2), dried over
sodium sulfate, fiterted and concentrated to afford 38. Yellow oil, yield
99-100%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Garcinia Xanthones as Orally Active Antitumor Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaojin; Li, Xiang; Sun, Haopeng; Wang, Xiaojian; Zhao, Li; Gao,
Yuan; Liu, Xiaorong; Zhang, Shenglie; Wang, Yanyan; Yang, Yingrui; Zeng,
Su; Guo, Qinglong; You, Qidong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(1), 276-292

$RFMT $RIREG SCHEME75 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[[(2E)-4-Bromo-2-buten-1-yl]oxy]-6-[(1,1-dimethyl-2-propen-1-yl)oxy]-1-hydr...
C22H21BrO5
1383484-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 5.3901 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 C 5.3348 3.0800 0.0 0
M  V30 4 C 4.0011 2.3100 0.0 0
M  V30 5 C 4.0011 0.7700 0.0 0
M  V30 6 Br 2.6673 0.0000 0.0 0
M  V30 7 O 9.3359 6.9301 0.0 0
M  V30 8 C 10.6695 7.7001 0.0 0
M  V30 9 C 11.4396 6.3664 0.0 0
M  V30 10 C 9.8995 9.0337 0.0 0
M  V30 11 C 12.0032 8.4701 0.0 0
M  V30 12 C 12.9796 6.3664 0.0 0
M  V30 13 O 4.0011 11.5501 0.0 0
M  V30 14 O 1.3337 11.5501 0.0 0
M  V30 15 C 5.3348 7.7001 0.0 0
M  V30 16 C 6.6684 6.9301 0.0 0
M  V30 17 C 5.3348 9.2401 0.0 0
M  V30 18 O 4.0011 6.9301 0.0 0
M  V30 19 C 8.0022 7.7001 0.0 0
M  V30 20 C 4.0011 10.0101 0.0 0
M  V30 21 C 6.6684 10.0101 0.0 0
M  V30 22 C 2.6673 7.7001 0.0 0
M  V30 23 C 8.0022 9.2401 0.0 0
M  V30 24 C 2.6673 9.2401 0.0 0
M  V30 25 C 1.3337 6.9301 0.0 0
M  V30 26 C 1.3337 10.0101 0.0 0
M  V30 27 C 0.0000 7.7001 0.0 0
M  V30 28 C 0.0000 9.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 19
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 2 13 20
M  V30 14 1 14 26
M  V30 15 2 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 2 17 21
M  V30 21 1 18 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 22 25
M  V30 27 2 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 2 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[(1,1-Dimethyl-2-propen-1-yl)oxy]-1-hydroxy-5-[[(2E)-4-(1-pyrrolidinyl)-2-b...
C26H29NO5
1429305-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0021 4.6200 0.0 0
M  V30 2 C 9.3358 5.3900 0.0 0
M  V30 3 C 10.6694 4.6200 0.0 0
M  V30 4 C 12.0032 5.3900 0.0 0
M  V30 5 C 13.3369 4.6200 0.0 0
M  V30 6 O 8.0021 7.7000 0.0 0
M  V30 7 C 8.0021 9.2400 0.0 0
M  V30 8 C 9.5421 9.2400 0.0 0
M  V30 9 C 6.4621 9.2400 0.0 0
M  V30 10 C 8.0021 10.7800 0.0 0
M  V30 11 C 10.3121 10.5736 0.0 0
M  V30 12 O 1.3336 5.3900 0.0 0
M  V30 13 O 0.0000 3.0800 0.0 0
M  V30 14 C 5.3347 4.6200 0.0 0
M  V30 15 C 6.6684 5.3900 0.0 0
M  V30 16 C 4.0011 5.3900 0.0 0
M  V30 17 O 5.3347 3.0800 0.0 0
M  V30 18 C 6.6684 6.9300 0.0 0
M  V30 19 C 2.6674 4.6200 0.0 0
M  V30 20 C 4.0011 6.9300 0.0 0
M  V30 21 C 4.0011 2.3100 0.0 0
M  V30 22 C 5.3347 7.7000 0.0 0
M  V30 23 C 2.6674 3.0800 0.0 0
M  V30 24 C 4.0011 0.7700 0.0 0
M  V30 25 C 1.3336 2.3100 0.0 0
M  V30 26 C 2.6674 0.0000 0.0 0
M  V30 27 C 1.3336 0.7700 0.0 0
M  V30 28 N 14.6705 5.3900 0.0 0
M  V30 29 C 14.8314 6.9215 0.0 0
M  V30 30 C 16.0773 4.7637 0.0 0
M  V30 31 C 16.3379 7.2417 0.0 0
M  V30 32 C 17.1079 5.9081 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 4 5
M  V30 6 1 5 28
M  V30 7 1 6 7
M  V30 8 1 6 18
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 2 8 11
M  V30 13 2 12 19
M  V30 14 1 13 25
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 21 24
M  V30 27 2 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1383484-82-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1429305-83-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14598731
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General procedure for preparation of caged compounds 108-129 and 130. To
a stirring solution of compound 42 or 44 (0.20 mmol) in DMF (5 mL) was
added potassium carbonate (0.40 mmol) and the corresponding amine or
alcohol or acid (0.30 mmol) and the solution was stirred at 35°C for 1 h.
The reaction mixture was partitioned between ethyl acetate (15 mL) and
water (20 mL). The water layer was extracted with ethyl acetate (15 mL ×
2). The organic layer was combined, washed with saturated NaCl solution
(10 mL × 2), dried over sodium sulfate, fiterted and concentrated to
afford 43 or 45. Yellow oil, yield 99-100%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Garcinia Xanthones as Orally Active Antitumor Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Xiaojin; Li, Xiang; Sun, Haopeng; Wang, Xiaojian; Zhao, Li; Gao,
Yuan; Liu, Xiaorong; Zhang, Shenglie; Wang, Yanyan; Yang, Yingrui; Zeng,
Su; Guo, Qinglong; You, Qidong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(1), 276-292

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
2,2′,2′′-[[5,11,17,23,29,35-Hexakis(1,1-dimethylethyl)-38,40,42-trimethoxyhep...
C75H96O12
138709-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  87 93 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.0691 11.0120 0.0 0
M  V30 2 C 3.7355 11.7820 0.0 0
M  V30 3 C 3.7355 13.3219 0.0 0
M  V30 4 O 5.0691 14.0918 0.0 0
M  V30 5 O 2.4018 14.0918 0.0 0
M  V30 6 C 6.0600 16.9952 0.0 0
M  V30 7 C 7.5999 16.9952 0.0 0
M  V30 8 C 6.8299 18.3287 0.0 0
M  V30 9 C 4.5201 16.9952 0.0 0
M  V30 10 O 6.2255 10.7045 0.0 0
M  V30 11 C 7.5588 11.4749 0.0 0
M  V30 12 C 1.5399 9.1632 0.0 0
M  V30 13 C 1.5404 7.6233 0.0 0
M  V30 14 C 0.0000 9.1627 0.0 0
M  V30 15 C 1.5394 10.7031 0.0 0
M  V30 16 O 14.7608 11.7844 0.0 0
M  V30 17 C 14.7618 10.2445 0.0 0
M  V30 18 C 15.1003 16.9979 0.0 0
M  V30 19 C 13.5604 16.9970 0.0 0
M  V30 20 C 14.3294 18.3310 0.0 0
M  V30 21 C 16.6402 16.9989 0.0 0
M  V30 22 O 9.5590 7.3949 0.0 0
M  V30 23 C 11.0989 7.3959 0.0 0
M  V30 24 C 11.8681 8.7300 0.0 0
M  V30 25 O 13.4080 8.7310 0.0 0
M  V30 26 O 11.0972 10.0631 0.0 0
M  V30 27 C 6.0648 1.3342 0.0 0
M  V30 28 C 4.7307 2.1032 0.0 0
M  V30 29 C 5.2957 0.0000 0.0 0
M  V30 30 C 7.3989 0.5650 0.0 0
M  V30 31 O 13.4515 9.5654 0.0 0
M  V30 32 C 13.0525 11.0527 0.0 0
M  V30 33 C 11.5650 11.4509 0.0 0
M  V30 34 O 11.1660 12.9381 0.0 0
M  V30 35 O 10.4764 10.3616 0.0 0
M  V30 36 C 19.6252 9.1688 0.0 0
M  V30 37 C 19.6256 7.6288 0.0 0
M  V30 38 C 21.1651 9.1692 0.0 0
M  V30 39 C 19.6247 10.7087 0.0 0
M  V30 40 O 14.7625 6.5500 0.0 0
M  V30 41 C 14.7625 8.0899 0.0 0
M  V30 42 C 15.1051 1.3369 0.0 0
M  V30 43 C 13.5652 1.3369 0.0 0
M  V30 44 C 14.3351 0.0032 0.0 0
M  V30 45 C 16.6450 1.3369 0.0 0
M  V30 46 C 6.8433 12.9371 0.0 0
M  V30 47 C 8.4031 12.9369 0.0 0
M  V30 48 C 5.8316 11.9066 0.0 0
M  V30 49 C 6.0403 14.2973 0.0 0
M  V30 50 C 9.1828 14.2877 0.0 0
M  V30 51 C 5.4456 10.5151 0.0 0
M  V30 52 C 6.8299 15.6615 0.0 0
M  V30 53 C 10.5808 14.6488 0.0 0
M  V30 54 C 8.4062 15.6633 0.0 0
M  V30 55 C 6.2260 9.1646 0.0 0
M  V30 56 C 3.8659 10.5299 0.0 0
M  V30 57 C 11.9792 14.2886 0.0 0
M  V30 58 C 5.4463 7.8138 0.0 0
M  V30 59 C 3.0798 9.1637 0.0 0
M  V30 60 C 12.7597 12.9381 0.0 0
M  V30 61 C 12.7549 15.6645 0.0 0
M  V30 62 C 5.8333 6.4225 0.0 0
M  V30 63 C 3.8669 7.7979 0.0 0
M  V30 64 C 14.3194 12.9394 0.0 0
M  V30 65 C 14.3311 15.6638 0.0 0
M  V30 66 C 6.8457 5.3926 0.0 0
M  V30 67 C 15.3318 11.9095 0.0 0
M  V30 68 C 15.1216 14.3000 0.0 0
M  V30 69 C 8.4053 5.3938 0.0 0
M  V30 70 C 6.0435 4.0319 0.0 0
M  V30 71 C 15.7187 10.5183 0.0 0
M  V30 72 C 9.1858 4.0435 0.0 0
M  V30 73 C 6.8339 2.6682 0.0 0
M  V30 74 C 14.9391 9.1674 0.0 0
M  V30 75 C 17.2982 10.5340 0.0 0
M  V30 76 C 10.5842 3.6833 0.0 0
M  V30 77 C 8.4102 2.6674 0.0 0
M  V30 78 C 15.7197 7.8169 0.0 0
M  V30 79 C 18.0853 9.1683 0.0 0
M  V30 80 C 11.9823 4.0443 0.0 0
M  V30 81 C 15.3335 6.4254 0.0 0
M  V30 82 C 17.2991 7.8021 0.0 0
M  V30 83 C 12.7621 5.3952 0.0 0
M  V30 84 C 12.7589 2.6688 0.0 0
M  V30 85 C 14.3217 5.3949 0.0 0
M  V30 86 C 14.3351 2.6705 0.0 0
M  V30 87 C 15.1248 4.0347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 47
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 52
M  V30 10 1 10 11
M  V30 11 1 10 55
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 59
M  V30 16 1 16 17
M  V30 17 1 16 60
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 65
M  V30 22 1 22 23
M  V30 23 1 22 69
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 2 24 26
M  V30 27 1 27 28
M  V30 28 1 27 29
M  V30 29 1 27 30
M  V30 30 1 27 73
M  V30 31 1 31 32
M  V30 32 1 31 74
M  V30 33 1 32 33
M  V30 34 1 33 34
M  V30 35 2 33 35
M  V30 36 1 36 37
M  V30 37 1 36 38
M  V30 38 1 36 39
M  V30 39 1 36 79
M  V30 40 1 40 41
M  V30 41 1 40 83
M  V30 42 1 42 43
M  V30 43 1 42 44
M  V30 44 1 42 45
M  V30 45 1 42 86
M  V30 46 1 46 47
M  V30 47 1 46 48
M  V30 48 2 46 49
M  V30 49 2 47 50
M  V30 50 1 48 51
M  V30 51 1 49 52
M  V30 52 1 50 53
M  V30 53 1 50 54
M  V30 54 1 51 55
M  V30 55 2 51 56
M  V30 56 2 52 54
M  V30 57 1 53 57
M  V30 58 2 55 58
M  V30 59 1 56 59
M  V30 60 1 57 60
M  V30 61 2 57 61
M  V30 62 1 58 62
M  V30 63 1 58 63
M  V30 64 2 59 63
M  V30 65 2 60 64
M  V30 66 1 61 65
M  V30 67 1 62 66
M  V30 68 1 64 67
M  V30 69 1 64 68
M  V30 70 2 65 68
M  V30 71 1 66 69
M  V30 72 2 66 70
M  V30 73 1 67 71
M  V30 74 2 69 72
M  V30 75 1 70 73
M  V30 76 1 71 74
M  V30 77 2 71 75
M  V30 78 1 72 76
M  V30 79 1 72 77
M  V30 80 2 73 77
M  V30 81 2 74 78
M  V30 82 1 75 79
M  V30 83 1 76 80
M  V30 84 1 78 81
M  V30 85 1 78 82
M  V30 86 2 79 82
M  V30 87 1 80 83
M  V30 88 2 80 84
M  V30 89 1 81 85
M  V30 90 2 83 85
M  V30 91 1 84 86
M  V30 92 1 85 87
M  V30 93 2 86 87
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1,1′,1′′-[[5,11,17,23,29,35-hexakis(1,1-dimethylethyl)-38,40,42-...
C87H117N3O9
608129-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  99 108 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.4243 6.2199 0.0 0
M  V30 2 C 11.4243 4.6799 0.0 0
M  V30 3 C 10.0905 3.9099 0.0 0
M  V30 4 O 8.7568 4.6799 0.0 0
M  V30 5 C 15.1010 2.9314 0.0 0
M  V30 6 C 13.7674 2.1614 0.0 0
M  V30 7 C 15.8710 1.5977 0.0 0
M  V30 8 C 16.4348 3.7014 0.0 0
M  V30 9 O 13.3976 10.7633 0.0 0
M  V30 10 C 12.6267 9.4301 0.0 0
M  V30 11 C 19.6239 10.7594 0.0 0
M  V30 12 C 18.8530 9.4263 0.0 0
M  V30 13 C 20.3930 9.4252 0.0 0
M  V30 14 C 20.3947 12.0926 0.0 0
M  V30 15 O 9.1726 8.3240 0.0 0
M  V30 16 C 8.4031 9.6579 0.0 0
M  V30 17 C 6.0579 2.9329 0.0 0
M  V30 18 C 6.8274 1.5990 0.0 0
M  V30 19 C 5.2874 1.5994 0.0 0
M  V30 20 C 4.5179 2.9334 0.0 0
M  V30 21 O 16.0950 12.6094 0.0 0
M  V30 22 C 17.4290 13.3790 0.0 0
M  V30 23 C 17.4294 14.9190 0.0 0
M  V30 24 O 16.0961 15.6894 0.0 0
M  V30 25 C 15.1059 18.5932 0.0 0
M  V30 26 C 13.5659 18.5937 0.0 0
M  V30 27 C 14.3364 19.9272 0.0 0
M  V30 28 C 16.6459 18.5928 0.0 0
M  V30 29 O 7.8586 9.1292 0.0 0
M  V30 30 C 9.3464 9.5268 0.0 0
M  V30 31 C 10.4347 8.4373 0.0 0
M  V30 32 O 10.0352 6.9500 0.0 0
M  V30 33 C 1.5400 10.7665 0.0 0
M  V30 34 C 1.5389 9.2265 0.0 0
M  V30 35 C 0.0000 10.7676 0.0 0
M  V30 36 C 1.5409 12.3065 0.0 0
M  V30 37 O 9.1759 13.2025 0.0 0
M  V30 38 C 10.7159 13.2025 0.0 0
M  V30 39 C 6.0628 18.5946 0.0 0
M  V30 40 C 5.2928 17.2610 0.0 0
M  V30 41 C 4.5228 18.5948 0.0 0
M  V30 42 C 6.8328 19.9284 0.0 0
M  V30 43 C 14.3177 6.9897 0.0 0
M  V30 44 C 12.7579 6.9899 0.0 0
M  V30 45 C 15.3295 8.0200 0.0 0
M  V30 46 C 15.1207 5.6293 0.0 0
M  V30 47 C 11.9782 5.6388 0.0 0
M  V30 48 C 15.7168 9.4112 0.0 0
M  V30 49 C 14.3310 4.2650 0.0 0
M  V30 50 C 10.5797 5.2780 0.0 0
M  V30 51 C 12.7547 4.2633 0.0 0
M  V30 52 C 14.9376 10.7624 0.0 0
M  V30 53 C 17.2964 9.3949 0.0 0
M  V30 54 C 9.1816 5.6394 0.0 0
M  V30 55 C 15.7185 12.1126 0.0 0
M  V30 56 C 18.0839 10.7604 0.0 0
M  V30 57 C 8.4023 6.9906 0.0 0
M  V30 58 C 8.4046 4.2641 0.0 0
M  V30 59 C 15.3328 13.5043 0.0 0
M  V30 60 C 17.2981 12.1270 0.0 0
M  V30 61 C 6.8425 6.9909 0.0 0
M  V30 62 C 6.8283 4.2662 0.0 0
M  V30 63 C 14.3213 14.5352 0.0 0
M  V30 64 C 5.8310 8.0217 0.0 0
M  V30 65 C 6.0389 5.6308 0.0 0
M  V30 66 C 12.7616 14.5355 0.0 0
M  V30 67 C 15.1249 15.8952 0.0 0
M  V30 68 C 5.4454 9.4133 0.0 0
M  V30 69 C 11.9822 15.8867 0.0 0
M  V30 70 C 14.3356 17.2597 0.0 0
M  V30 71 C 6.2262 10.7636 0.0 0
M  V30 72 C 3.8657 9.3992 0.0 0
M  V30 73 C 10.5840 16.2480 0.0 0
M  V30 74 C 12.7591 17.2621 0.0 0
M  V30 75 C 5.4469 12.1149 0.0 0
M  V30 76 C 3.0800 10.7656 0.0 0
M  V30 77 C 9.1857 15.8871 0.0 0
M  V30 78 C 5.8343 13.5060 0.0 0
M  V30 79 C 3.8675 12.1313 0.0 0
M  V30 80 C 8.4059 14.5361 0.0 0
M  V30 81 C 8.4091 17.2627 0.0 0
M  V30 82 C 6.8460 14.5364 0.0 0
M  V30 83 C 6.8328 17.2610 0.0 0
M  V30 84 C 6.0431 15.8967 0.0 0
M  V30 85 N 10.0905 2.3699 0.0 0
M  V30 86 C 8.8446 1.4647 0.0 0
M  V30 87 C 11.3365 1.4647 0.0 0
M  V30 88 C 9.3205 0.0000 0.0 0
M  V30 89 C 10.8605 0.0000 0.0 0
M  V30 90 N 22.0320 15.3201 0.0 0
M  V30 91 C 23.0419 14.1576 0.0 0
M  V30 92 C 22.8256 16.6399 0.0 0
M  V30 93 C 24.4597 14.7590 0.0 0
M  V30 94 C 24.3260 16.2931 0.0 0
M  V30 95 N 10.0370 9.9251 0.0 0
M  V30 96 C 8.5996 10.4778 0.0 0
M  V30 97 C 11.0069 11.1212 0.0 0
M  V30 98 C 8.6812 12.0156 0.0 0
M  V30 99 C 10.1690 12.4132 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 44
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 85
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 49
M  V30 10 1 9 10
M  V30 11 1 9 52
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 56
M  V30 16 1 15 16
M  V30 17 1 15 57
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 17 62
M  V30 22 1 21 22
M  V30 23 1 21 66
M  V30 24 1 22 23
M  V30 25 2 23 24
M  V30 26 1 23 90
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 1 25 70
M  V30 31 1 29 30
M  V30 32 1 29 71
M  V30 33 1 30 31
M  V30 34 2 31 32
M  V30 35 1 31 95
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 33 36
M  V30 39 1 33 76
M  V30 40 1 37 38
M  V30 41 1 37 80
M  V30 42 1 39 40
M  V30 43 1 39 41
M  V30 44 1 39 42
M  V30 45 1 39 83
M  V30 46 1 43 44
M  V30 47 1 43 45
M  V30 48 2 43 46
M  V30 49 2 44 47
M  V30 50 1 45 48
M  V30 51 1 46 49
M  V30 52 1 47 50
M  V30 53 1 47 51
M  V30 54 1 48 52
M  V30 55 2 48 53
M  V30 56 2 49 51
M  V30 57 1 50 54
M  V30 58 2 52 55
M  V30 59 1 53 56
M  V30 60 1 54 57
M  V30 61 2 54 58
M  V30 62 1 55 59
M  V30 63 1 55 60
M  V30 64 2 56 60
M  V30 65 2 57 61
M  V30 66 1 58 62
M  V30 67 1 59 63
M  V30 68 1 61 64
M  V30 69 1 61 65
M  V30 70 2 62 65
M  V30 71 1 63 66
M  V30 72 2 63 67
M  V30 73 1 64 68
M  V30 74 2 66 69
M  V30 75 1 67 70
M  V30 76 1 68 71
M  V30 77 2 68 72
M  V30 78 1 69 73
M  V30 79 1 69 74
M  V30 80 2 70 74
M  V30 81 2 71 75
M  V30 82 1 72 76
M  V30 83 1 73 77
M  V30 84 1 75 78
M  V30 85 1 75 79
M  V30 86 2 76 79
M  V30 87 1 77 80
M  V30 88 2 77 81
M  V30 89 1 78 82
M  V30 90 2 80 82
M  V30 91 1 81 83
M  V30 92 1 82 84
M  V30 93 2 83 84
M  V30 94 1 85 86
M  V30 95 1 85 87
M  V30 96 1 86 88
M  V30 97 1 87 89
M  V30 98 1 88 89
M  V30 99 1 90 91
M  V30 100 1 90 92
M  V30 101 1 91 93
M  V30 102 1 92 94
M  V30 103 1 93 94
M  V30 104 1 95 96
M  V30 105 1 95 97
M  V30 106 1 96 98
M  V30 107 1 97 99
M  V30 108 1 98 99
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 138709-57-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 608129-78-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-2315882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5,17,29,11,23,35-Hexa-tert-butyl-38,40,42-trimetlioxy-37,39,41-tris[(1-pyrroli-dinecarbonyl)-methoxy]calix[6]arene
(J-4): (COCl)2 (1 mL, 11.45 mmols, 27.2 eq.). was added to a solution of
J-6 (500 mg, 0.42 mmol) in anhydrous CH2Cl2 (40 mL) under argon. After 4
h at reflux, the mixture was evaporated under vacuum to dryness. The
resulting crude product was dissolved in anhydrous benzene (40 mL),
cooled to 0°C and a solution of pyrrolidine (117 μlL, 1.39 mmol, 3.3 eq.)
and Et3N (538 p,L, 3.78 mmols, 9 eq.) in benzene (40 mL) was added
dropwise. After 24 h at room temperature, the organic layer was washed
with water (2 x 50 ML), dried (MgSO4) and evaporated to dryness. The
crude product was purifiedby crystallization (CHCl3/MeOH) to yield J-4.
Colourless solid, yield 567.8 mg, 100%. Mp: 257-259 °C.1H NMR (250 MHz,
CDCl3): δ 7.21 (s, 6H, Ar), 6.61 (s, 6H, Ar), 4.55 (s, 6H, OCH2CO), 4.46
(d, 6H, J= 8.9 Hz, ArCH2Ar), 3.74 (m, 6H, NCH2), 3.68 (m, 6H, NCH2), 3.43
(d, 6H, J = 8.9 Hz, ArCH2Ar), 2.19 (s, 9H, OCH3), 1.91 (m, 6H, CH2), 1.87
(m, 6H, CH2), 1.37 (s, 27H, t-Bu), 0.76 (s, 27H, t-Bu). Anal, calcd for
J-4.2H2O(C87H121N3O11, 1383.90): C 75.45, H 8.81, N 3.03; Found: C 75.54,
H 8.31, N 2.78.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of new capped calixarene compounds, their process of
preparation and their use, particularly as enzymatic mimes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reinaud, Olivia; Jabin, Ivan; Darbost, Ulrich; Yun, Xu-Li; Redon, Sophie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004085441 A1 2004-10-07

$RFMT $RIREG SCHEME76 STEP1
$RXN



  2  1
$MOL
2,2′,2′′-[[5,11,17,23,29,35-Hexakis(1,1-dimethylethyl)-38,40,42-trimethoxyhep...
C75H96O12
138709-57-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  87 93 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.0691 11.0120 0.0 0
M  V30 2 C 3.7355 11.7820 0.0 0
M  V30 3 C 3.7355 13.3219 0.0 0
M  V30 4 O 5.0691 14.0918 0.0 0
M  V30 5 O 2.4018 14.0918 0.0 0
M  V30 6 C 6.0600 16.9952 0.0 0
M  V30 7 C 7.5999 16.9952 0.0 0
M  V30 8 C 6.8299 18.3287 0.0 0
M  V30 9 C 4.5201 16.9952 0.0 0
M  V30 10 O 6.2255 10.7045 0.0 0
M  V30 11 C 7.5588 11.4749 0.0 0
M  V30 12 C 1.5399 9.1632 0.0 0
M  V30 13 C 1.5404 7.6233 0.0 0
M  V30 14 C 0.0000 9.1627 0.0 0
M  V30 15 C 1.5394 10.7031 0.0 0
M  V30 16 O 14.7608 11.7844 0.0 0
M  V30 17 C 14.7618 10.2445 0.0 0
M  V30 18 C 15.1003 16.9979 0.0 0
M  V30 19 C 13.5604 16.9970 0.0 0
M  V30 20 C 14.3294 18.3310 0.0 0
M  V30 21 C 16.6402 16.9989 0.0 0
M  V30 22 O 9.5590 7.3949 0.0 0
M  V30 23 C 11.0989 7.3959 0.0 0
M  V30 24 C 11.8681 8.7300 0.0 0
M  V30 25 O 13.4080 8.7310 0.0 0
M  V30 26 O 11.0972 10.0631 0.0 0
M  V30 27 C 6.0648 1.3342 0.0 0
M  V30 28 C 4.7307 2.1032 0.0 0
M  V30 29 C 5.2957 0.0000 0.0 0
M  V30 30 C 7.3989 0.5650 0.0 0
M  V30 31 O 13.4515 9.5654 0.0 0
M  V30 32 C 13.0525 11.0527 0.0 0
M  V30 33 C 11.5650 11.4509 0.0 0
M  V30 34 O 11.1660 12.9381 0.0 0
M  V30 35 O 10.4764 10.3616 0.0 0
M  V30 36 C 19.6252 9.1688 0.0 0
M  V30 37 C 19.6256 7.6288 0.0 0
M  V30 38 C 21.1651 9.1692 0.0 0
M  V30 39 C 19.6247 10.7087 0.0 0
M  V30 40 O 14.7625 6.5500 0.0 0
M  V30 41 C 14.7625 8.0899 0.0 0
M  V30 42 C 15.1051 1.3369 0.0 0
M  V30 43 C 13.5652 1.3369 0.0 0
M  V30 44 C 14.3351 0.0032 0.0 0
M  V30 45 C 16.6450 1.3369 0.0 0
M  V30 46 C 6.8433 12.9371 0.0 0
M  V30 47 C 8.4031 12.9369 0.0 0
M  V30 48 C 5.8316 11.9066 0.0 0
M  V30 49 C 6.0403 14.2973 0.0 0
M  V30 50 C 9.1828 14.2877 0.0 0
M  V30 51 C 5.4456 10.5151 0.0 0
M  V30 52 C 6.8299 15.6615 0.0 0
M  V30 53 C 10.5808 14.6488 0.0 0
M  V30 54 C 8.4062 15.6633 0.0 0
M  V30 55 C 6.2260 9.1646 0.0 0
M  V30 56 C 3.8659 10.5299 0.0 0
M  V30 57 C 11.9792 14.2886 0.0 0
M  V30 58 C 5.4463 7.8138 0.0 0
M  V30 59 C 3.0798 9.1637 0.0 0
M  V30 60 C 12.7597 12.9381 0.0 0
M  V30 61 C 12.7549 15.6645 0.0 0
M  V30 62 C 5.8333 6.4225 0.0 0
M  V30 63 C 3.8669 7.7979 0.0 0
M  V30 64 C 14.3194 12.9394 0.0 0
M  V30 65 C 14.3311 15.6638 0.0 0
M  V30 66 C 6.8457 5.3926 0.0 0
M  V30 67 C 15.3318 11.9095 0.0 0
M  V30 68 C 15.1216 14.3000 0.0 0
M  V30 69 C 8.4053 5.3938 0.0 0
M  V30 70 C 6.0435 4.0319 0.0 0
M  V30 71 C 15.7187 10.5183 0.0 0
M  V30 72 C 9.1858 4.0435 0.0 0
M  V30 73 C 6.8339 2.6682 0.0 0
M  V30 74 C 14.9391 9.1674 0.0 0
M  V30 75 C 17.2982 10.5340 0.0 0
M  V30 76 C 10.5842 3.6833 0.0 0
M  V30 77 C 8.4102 2.6674 0.0 0
M  V30 78 C 15.7197 7.8169 0.0 0
M  V30 79 C 18.0853 9.1683 0.0 0
M  V30 80 C 11.9823 4.0443 0.0 0
M  V30 81 C 15.3335 6.4254 0.0 0
M  V30 82 C 17.2991 7.8021 0.0 0
M  V30 83 C 12.7621 5.3952 0.0 0
M  V30 84 C 12.7589 2.6688 0.0 0
M  V30 85 C 14.3217 5.3949 0.0 0
M  V30 86 C 14.3351 2.6705 0.0 0
M  V30 87 C 15.1248 4.0347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 47
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 52
M  V30 10 1 10 11
M  V30 11 1 10 55
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 15 1 12 59
M  V30 16 1 16 17
M  V30 17 1 16 60
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 18 21
M  V30 21 1 18 65
M  V30 22 1 22 23
M  V30 23 1 22 69
M  V30 24 1 23 24
M  V30 25 1 24 25
M  V30 26 2 24 26
M  V30 27 1 27 28
M  V30 28 1 27 29
M  V30 29 1 27 30
M  V30 30 1 27 73
M  V30 31 1 31 32
M  V30 32 1 31 74
M  V30 33 1 32 33
M  V30 34 1 33 34
M  V30 35 2 33 35
M  V30 36 1 36 37
M  V30 37 1 36 38
M  V30 38 1 36 39
M  V30 39 1 36 79
M  V30 40 1 40 41
M  V30 41 1 40 83
M  V30 42 1 42 43
M  V30 43 1 42 44
M  V30 44 1 42 45
M  V30 45 1 42 86
M  V30 46 1 46 47
M  V30 47 1 46 48
M  V30 48 2 46 49
M  V30 49 2 47 50
M  V30 50 1 48 51
M  V30 51 1 49 52
M  V30 52 1 50 53
M  V30 53 1 50 54
M  V30 54 1 51 55
M  V30 55 2 51 56
M  V30 56 2 52 54
M  V30 57 1 53 57
M  V30 58 2 55 58
M  V30 59 1 56 59
M  V30 60 1 57 60
M  V30 61 2 57 61
M  V30 62 1 58 62
M  V30 63 1 58 63
M  V30 64 2 59 63
M  V30 65 2 60 64
M  V30 66 1 61 65
M  V30 67 1 62 66
M  V30 68 1 64 67
M  V30 69 1 64 68
M  V30 70 2 65 68
M  V30 71 1 66 69
M  V30 72 2 66 70
M  V30 73 1 67 71
M  V30 74 2 69 72
M  V30 75 1 70 73
M  V30 76 1 71 74
M  V30 77 2 71 75
M  V30 78 1 72 76
M  V30 79 1 72 77
M  V30 80 2 73 77
M  V30 81 2 74 78
M  V30 82 1 75 79
M  V30 83 1 76 80
M  V30 84 1 78 81
M  V30 85 1 78 82
M  V30 86 2 79 82
M  V30 87 1 80 83
M  V30 88 2 80 84
M  V30 89 1 81 85
M  V30 90 2 83 85
M  V30 91 1 84 86
M  V30 92 1 85 87
M  V30 93 2 86 87
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1,1′,1′′-[[5,11,17,23,29,35-hexakis(1,1-dimethylethyl)-38,40,42-...
C87H117N3O9
608129-78-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  99 108 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 11.4243 6.2199 0.0 0
M  V30 2 C 11.4243 4.6799 0.0 0
M  V30 3 C 10.0905 3.9099 0.0 0
M  V30 4 O 8.7568 4.6799 0.0 0
M  V30 5 C 15.1010 2.9314 0.0 0
M  V30 6 C 13.7674 2.1614 0.0 0
M  V30 7 C 15.8710 1.5977 0.0 0
M  V30 8 C 16.4348 3.7014 0.0 0
M  V30 9 O 13.3976 10.7633 0.0 0
M  V30 10 C 12.6267 9.4301 0.0 0
M  V30 11 C 19.6239 10.7594 0.0 0
M  V30 12 C 18.8530 9.4263 0.0 0
M  V30 13 C 20.3930 9.4252 0.0 0
M  V30 14 C 20.3947 12.0926 0.0 0
M  V30 15 O 9.1726 8.3240 0.0 0
M  V30 16 C 8.4031 9.6579 0.0 0
M  V30 17 C 6.0579 2.9329 0.0 0
M  V30 18 C 6.8274 1.5990 0.0 0
M  V30 19 C 5.2874 1.5994 0.0 0
M  V30 20 C 4.5179 2.9334 0.0 0
M  V30 21 O 16.0950 12.6094 0.0 0
M  V30 22 C 17.4290 13.3790 0.0 0
M  V30 23 C 17.4294 14.9190 0.0 0
M  V30 24 O 16.0961 15.6894 0.0 0
M  V30 25 C 15.1059 18.5932 0.0 0
M  V30 26 C 13.5659 18.5937 0.0 0
M  V30 27 C 14.3364 19.9272 0.0 0
M  V30 28 C 16.6459 18.5928 0.0 0
M  V30 29 O 7.8586 9.1292 0.0 0
M  V30 30 C 9.3464 9.5268 0.0 0
M  V30 31 C 10.4347 8.4373 0.0 0
M  V30 32 O 10.0352 6.9500 0.0 0
M  V30 33 C 1.5400 10.7665 0.0 0
M  V30 34 C 1.5389 9.2265 0.0 0
M  V30 35 C 0.0000 10.7676 0.0 0
M  V30 36 C 1.5409 12.3065 0.0 0
M  V30 37 O 9.1759 13.2025 0.0 0
M  V30 38 C 10.7159 13.2025 0.0 0
M  V30 39 C 6.0628 18.5946 0.0 0
M  V30 40 C 5.2928 17.2610 0.0 0
M  V30 41 C 4.5228 18.5948 0.0 0
M  V30 42 C 6.8328 19.9284 0.0 0
M  V30 43 C 14.3177 6.9897 0.0 0
M  V30 44 C 12.7579 6.9899 0.0 0
M  V30 45 C 15.3295 8.0200 0.0 0
M  V30 46 C 15.1207 5.6293 0.0 0
M  V30 47 C 11.9782 5.6388 0.0 0
M  V30 48 C 15.7168 9.4112 0.0 0
M  V30 49 C 14.3310 4.2650 0.0 0
M  V30 50 C 10.5797 5.2780 0.0 0
M  V30 51 C 12.7547 4.2633 0.0 0
M  V30 52 C 14.9376 10.7624 0.0 0
M  V30 53 C 17.2964 9.3949 0.0 0
M  V30 54 C 9.1816 5.6394 0.0 0
M  V30 55 C 15.7185 12.1126 0.0 0
M  V30 56 C 18.0839 10.7604 0.0 0
M  V30 57 C 8.4023 6.9906 0.0 0
M  V30 58 C 8.4046 4.2641 0.0 0
M  V30 59 C 15.3328 13.5043 0.0 0
M  V30 60 C 17.2981 12.1270 0.0 0
M  V30 61 C 6.8425 6.9909 0.0 0
M  V30 62 C 6.8283 4.2662 0.0 0
M  V30 63 C 14.3213 14.5352 0.0 0
M  V30 64 C 5.8310 8.0217 0.0 0
M  V30 65 C 6.0389 5.6308 0.0 0
M  V30 66 C 12.7616 14.5355 0.0 0
M  V30 67 C 15.1249 15.8952 0.0 0
M  V30 68 C 5.4454 9.4133 0.0 0
M  V30 69 C 11.9822 15.8867 0.0 0
M  V30 70 C 14.3356 17.2597 0.0 0
M  V30 71 C 6.2262 10.7636 0.0 0
M  V30 72 C 3.8657 9.3992 0.0 0
M  V30 73 C 10.5840 16.2480 0.0 0
M  V30 74 C 12.7591 17.2621 0.0 0
M  V30 75 C 5.4469 12.1149 0.0 0
M  V30 76 C 3.0800 10.7656 0.0 0
M  V30 77 C 9.1857 15.8871 0.0 0
M  V30 78 C 5.8343 13.5060 0.0 0
M  V30 79 C 3.8675 12.1313 0.0 0
M  V30 80 C 8.4059 14.5361 0.0 0
M  V30 81 C 8.4091 17.2627 0.0 0
M  V30 82 C 6.8460 14.5364 0.0 0
M  V30 83 C 6.8328 17.2610 0.0 0
M  V30 84 C 6.0431 15.8967 0.0 0
M  V30 85 N 10.0905 2.3699 0.0 0
M  V30 86 C 8.8446 1.4647 0.0 0
M  V30 87 C 11.3365 1.4647 0.0 0
M  V30 88 C 9.3205 0.0000 0.0 0
M  V30 89 C 10.8605 0.0000 0.0 0
M  V30 90 N 22.0320 15.3201 0.0 0
M  V30 91 C 23.0419 14.1576 0.0 0
M  V30 92 C 22.8256 16.6399 0.0 0
M  V30 93 C 24.4597 14.7590 0.0 0
M  V30 94 C 24.3260 16.2931 0.0 0
M  V30 95 N 10.0370 9.9251 0.0 0
M  V30 96 C 8.5996 10.4778 0.0 0
M  V30 97 C 11.0069 11.1212 0.0 0
M  V30 98 C 8.6812 12.0156 0.0 0
M  V30 99 C 10.1690 12.4132 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 44
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 85
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 49
M  V30 10 1 9 10
M  V30 11 1 9 52
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 56
M  V30 16 1 15 16
M  V30 17 1 15 57
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 17 62
M  V30 22 1 21 22
M  V30 23 1 21 66
M  V30 24 1 22 23
M  V30 25 2 23 24
M  V30 26 1 23 90
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 1 25 70
M  V30 31 1 29 30
M  V30 32 1 29 71
M  V30 33 1 30 31
M  V30 34 2 31 32
M  V30 35 1 31 95
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 33 36
M  V30 39 1 33 76
M  V30 40 1 37 38
M  V30 41 1 37 80
M  V30 42 1 39 40
M  V30 43 1 39 41
M  V30 44 1 39 42
M  V30 45 1 39 83
M  V30 46 1 43 44
M  V30 47 1 43 45
M  V30 48 2 43 46
M  V30 49 2 44 47
M  V30 50 1 45 48
M  V30 51 1 46 49
M  V30 52 1 47 50
M  V30 53 1 47 51
M  V30 54 1 48 52
M  V30 55 2 48 53
M  V30 56 2 49 51
M  V30 57 1 50 54
M  V30 58 2 52 55
M  V30 59 1 53 56
M  V30 60 1 54 57
M  V30 61 2 54 58
M  V30 62 1 55 59
M  V30 63 1 55 60
M  V30 64 2 56 60
M  V30 65 2 57 61
M  V30 66 1 58 62
M  V30 67 1 59 63
M  V30 68 1 61 64
M  V30 69 1 61 65
M  V30 70 2 62 65
M  V30 71 1 63 66
M  V30 72 2 63 67
M  V30 73 1 64 68
M  V30 74 2 66 69
M  V30 75 1 67 70
M  V30 76 1 68 71
M  V30 77 2 68 72
M  V30 78 1 69 73
M  V30 79 1 69 74
M  V30 80 2 70 74
M  V30 81 2 71 75
M  V30 82 1 72 76
M  V30 83 1 73 77
M  V30 84 1 75 78
M  V30 85 1 75 79
M  V30 86 2 76 79
M  V30 87 1 77 80
M  V30 88 2 77 81
M  V30 89 1 78 82
M  V30 90 2 80 82
M  V30 91 1 81 83
M  V30 92 1 82 84
M  V30 93 2 83 84
M  V30 94 1 85 86
M  V30 95 1 85 87
M  V30 96 1 86 88
M  V30 97 1 87 89
M  V30 98 1 88 89
M  V30 99 1 90 91
M  V30 100 1 90 92
M  V30 101 1 91 93
M  V30 102 1 92 94
M  V30 103 1 93 94
M  V30 104 1 95 96
M  V30 105 1 95 97
M  V30 106 1 96 98
M  V30 107 1 97 99
M  V30 108 1 98 99
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 138709-57-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 608129-78-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9948037
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 5,17,29,11,23,35-Hexa-tert-butyl-38,40,42-trimethoxy-37,39,41-tris[(1-pyrrolidinecarbonyl)methoxy]calix[6]-arene
(4). (COCl)2 (1 mL, 11.45 mmol, 27.2 equiv) was added to a solution of 6
(500 mg, 0.42 mmol) in anhydrous CH2Cl2 (40 mL) under argon. After 4 h at
reflux, the mixture was evaporated under vacuum to dryness. The resulting
crude product was dissolved in anhydrous benzene (40 mL), the mixture was
cooled to 0 °C, and a solution of pyrrolidine (117 μL, 1.39 mmol, 3.3
equiv) and Et3N (538 μL, 3.78 mmol, 9 equiv) in benzene (40 mL) was added
dropwise. After 24 h at room temperature, the organic layer was washed
with water (2 × 50 mL), dried (MgSO4), and evaporated to dryness. The
crude product was purified by crystallization (CHCl3/MeOH) to yield 4 as
a colorless solid (567.8 mg, 100%). Mp 257-259 °C. 1H NMR (250 MHz,
CDCl3) δ 7.21 (s, 6H), 6.61 (s, 6H), 4.55 (s, 6H), 4.46 (d, 6H, J = 8.9
Hz), 3.74 (m, 6H), 3.68 (m, 6H), 3.43 (d, 6H, J = 8.9 Hz), 2.19 (s, 9H),
1.91 (m, 6H), 1.87 (m, 6H), 1.37 (s, 27H), 0.76 (s, 27H). Anal. Calcd for
4•2H2O (C87H117N3O9•2H2O, 1383.90): C 75.45, H 8.81, N 3.03. Found: C
75.54, H 8.31, N 2.78.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Unprecedented Selective ipso-Nitration of Calixarenes Monitored by the
O-Substituents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Redon, Sophie; Li, Yun; Reinaud, Olivia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2003), 68(18), 7004-7008

$RFMT $RIREG SCHEME77 STEP1
$RXN



  2  1
$MOL
4-(5-Oxo-1-phenyl-3-pyrrolidinyl)-2-phenyl-5-pyrimidinecarboxylic acid
C21H17N3O3
1392304-31-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 1.3336 0.0 0
M  V30 2 O 4.6200 0.0000 0.0 0
M  V30 3 O 6.9300 1.3336 0.0 0
M  V30 4 O 10.5457 2.3259 0.0 0
M  V30 5 C 5.3900 4.0011 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 N 4.6200 5.3347 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 3.0800 5.3347 0.0 0
M  V30 10 N 2.3100 4.0011 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 7.8353 5.2470 0.0 0
M  V30 13 C 7.8353 2.7552 0.0 0
M  V30 14 N 9.2998 4.7711 0.0 0
M  V30 15 C 9.2998 3.2311 0.0 0
M  V30 16 C 2.3100 6.6684 0.0 0
M  V30 17 C 3.0800 8.0022 0.0 0
M  V30 18 C 0.7700 6.6684 0.0 0
M  V30 19 C 2.3100 9.3358 0.0 0
M  V30 20 C 0.0000 8.0022 0.0 0
M  V30 21 C 0.7700 9.3358 0.0 0
M  V30 22 C 10.5457 5.6763 0.0 0
M  V30 23 C 10.3847 7.2079 0.0 0
M  V30 24 C 11.9526 5.0498 0.0 0
M  V30 25 C 11.6306 8.1131 0.0 0
M  V30 26 C 13.1985 5.9551 0.0 0
M  V30 27 C 13.0376 7.4866 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 15
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 9 16
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 1 14 22
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Phenyl-4-[2-phenyl-5-(1-pyrrolidinylcarbonyl)-4-pyrimidinyl]-2-pyrrolidinone
C25H24N4O2
1392304-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 9.2401 0.0 0
M  V30 2 O 5.1047 10.0102 0.0 0
M  V30 3 O 8.7322 10.9588 0.0 0
M  V30 4 C 5.1047 6.9301 0.0 0
M  V30 5 C 3.7711 7.7001 0.0 0
M  V30 6 N 5.1047 5.3901 0.0 0
M  V30 7 C 2.4374 6.9301 0.0 0
M  V30 8 C 3.7711 4.6201 0.0 0
M  V30 9 N 2.4374 5.3901 0.0 0
M  V30 10 C 6.4385 7.7001 0.0 0
M  V30 11 C 7.8453 7.0736 0.0 0
M  V30 12 C 6.5995 9.2317 0.0 0
M  V30 13 N 8.8758 8.2182 0.0 0
M  V30 14 C 8.1058 9.5518 0.0 0
M  V30 15 N 2.4374 10.0102 0.0 0
M  V30 16 C 2.2765 11.5417 0.0 0
M  V30 17 C 1.0304 9.3837 0.0 0
M  V30 18 C 0.7700 11.8619 0.0 0
M  V30 19 C 0.0000 10.5282 0.0 0
M  V30 20 C 3.7711 3.0800 0.0 0
M  V30 21 C 2.4374 2.3100 0.0 0
M  V30 22 C 5.1047 2.3100 0.0 0
M  V30 23 C 2.4374 0.7700 0.0 0
M  V30 24 C 5.1047 0.7700 0.0 0
M  V30 25 C 3.7711 0.0000 0.0 0
M  V30 26 C 10.4075 8.0573 0.0 0
M  V30 27 C 11.3126 9.3031 0.0 0
M  V30 28 C 11.0338 6.6503 0.0 0
M  V30 29 C 12.8443 9.1422 0.0 0
M  V30 30 C 12.5654 6.4894 0.0 0
M  V30 31 C 13.4706 7.7352 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 15
M  V30 4 2 3 14
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 10
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 1 8 20
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 14
M  V30 18 1 13 26
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1392304-31-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1392304-52-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-795465
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 59483-84-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Parallel synthesis of 2-substituted
6-(5-oxo-1-phenylpyrrolidin-3-yl)pyrimidine-5-carboxamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Crcek, Bojana; Baskovc, Jernej; Groselj, Uros; Kocar, Drago; Dahmann,
Georg; Stanovnik, Branko; Svete, Jurij
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Molecules (2012), 175363-5384

$RFMT $RIREG SCHEME78 STEP1
$RXN



  2  1
$MOL
rel-(3R,4aS)-1-(1,3-Benzodioxol-5-ylmethyl)-4a-(ethoxycarbonyl)-1,2,3,4,4a,5,...
C22H25NO7
1393934-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 5.3901 0.0 0
M  V30 2 O 2.6673 6.1601 0.0 0
M  V30 3 O 4.0010 3.8501 0.0 0
M  V30 4 C 1.3337 5.3901 0.0 0
M  V30 5 C 0.0000 6.1601 0.0 0
M  V30 6 C 9.3358 6.9302 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 5.3348 1.5400 0.0 0
M  V30 9 O 5.3348 0.0000 0.0 0
M  V30 10 O 4.0010 2.3101 0.0 0
M  V30 11 O 9.3358 3.8501 0.0 0
M  V30 12 C 5.3348 6.1601 0.0 0 CFG=1
M  V30 13 C 6.6685 6.9302 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 4.0010 6.9302 0.0 0
M  V30 16 N 8.0022 6.1601 0.0 0
M  V30 17 C 6.6685 8.4702 0.0 0
M  V30 18 C 6.6685 3.8501 0.0 0 CFG=2
M  V30 19 C 4.0010 8.4702 0.0 0
M  V30 20 C 8.0022 4.6201 0.0 0
M  V30 21 C 5.3348 9.2402 0.0 0
M  V30 22 C 10.6697 6.1601 0.0 0
M  V30 23 C 12.0033 6.9302 0.0 0
M  V30 24 C 10.6697 4.6201 0.0 0
M  V30 25 C 13.3370 6.1601 0.0 0
M  V30 26 C 12.0033 3.8501 0.0 0
M  V30 27 C 13.3370 4.6201 0.0 0
M  V30 28 O 14.8017 6.6360 0.0 0
M  V30 29 O 14.8017 4.1442 0.0 0
M  V30 30 C 15.7068 5.3901 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 12 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 16
M  V30 7 1 6 22
M  V30 8 1 7 8
M  V30 9 1 18 7 CFG=1
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 11 20
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 22 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 25 28
M  V30 30 2 26 27
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 12 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Ethyl (3R,4aS)-1-(1,3-benzodioxol-5-ylmethyl)-1,3,4,5,6,7-hexahydro-2-oxo...
C26H32N2O6
1393935-15-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 7.7599 0.0 0
M  V30 2 O 2.6673 8.5299 0.0 0
M  V30 3 O 4.0010 6.2198 0.0 0
M  V30 4 C 1.3337 7.7599 0.0 0
M  V30 5 C 0.0000 8.5299 0.0 0
M  V30 6 C 9.3358 9.2999 0.0 0
M  V30 7 C 6.6684 4.6798 0.0 0
M  V30 8 C 5.3348 3.9098 0.0 0
M  V30 9 O 4.0010 4.6798 0.0 0
M  V30 10 O 9.3358 6.2198 0.0 0
M  V30 11 C 5.3348 8.5299 0.0 0 CFG=1
M  V30 12 C 6.6684 9.2999 0.0 0
M  V30 13 C 5.3348 6.9898 0.0 0
M  V30 14 C 4.0010 9.2999 0.0 0
M  V30 15 N 8.0021 8.5299 0.0 0
M  V30 16 C 6.6684 10.8399 0.0 0
M  V30 17 C 6.6684 6.2198 0.0 0 CFG=2
M  V30 18 C 4.0010 10.8399 0.0 0
M  V30 19 C 8.0021 6.9898 0.0 0
M  V30 20 C 5.3348 11.6099 0.0 0
M  V30 21 C 10.6696 8.5299 0.0 0
M  V30 22 C 12.0032 9.2999 0.0 0
M  V30 23 C 10.6696 6.9898 0.0 0
M  V30 24 C 13.3369 8.5299 0.0 0
M  V30 25 C 12.0032 6.2198 0.0 0
M  V30 26 C 13.3369 6.9898 0.0 0
M  V30 27 O 14.8016 9.0057 0.0 0
M  V30 28 O 14.8016 6.5140 0.0 0
M  V30 29 C 15.7067 7.7599 0.0 0
M  V30 30 N 5.3348 2.3698 0.0 0
M  V30 31 C 6.5807 1.4646 0.0 0
M  V30 32 C 4.0888 1.4646 0.0 0
M  V30 33 C 6.1048 0.0000 0.0 0
M  V30 34 C 4.5648 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 11 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 15
M  V30 7 1 6 21
M  V30 8 1 7 8
M  V30 9 1 17 7 CFG=1
M  V30 10 2 8 9
M  V30 11 1 8 30
M  V30 12 2 10 19
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 1 14 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 21 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 24 27
M  V30 30 2 25 26
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 11 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1393934-01-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1393935-15-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-843899
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1467-16-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 865-49-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure D: Automated Library
Synthesis. A of solution of a carboxylic acid (7, 8, 26, or 36, 1.25
mmol) in 25 mL of CDCl3 was treated with CDI (16, 212.8 mg, 1.31 mmol,
1.05 equiv). The reaction was stirred at room temperature until NMR
indicated complete conversion of the carboxylic acid to the corresponding
acylimidazole, which typically took 2-4 h. Using a Perkin-Elmer
Multiprobe II liquid handler, the resulting solution was distributed into
24 1-dram glass vials, delivering 0.95 mL of the above solution into each
vial. For reactions involving the coupling with secondary amines, the
glass vials were precharged with imidazole hydrochloride (9.9 mg, 0.095
mmol, 2 equiv). For each vial, a solution of one of the 24 amines 11 (2
M, 2.7 equiv) in 0.065 mL of chloroform was added. The resulting reaction
mixtures were capped and agitated on an orbital shaker at room
temperature for 48 h. The vials were then returned to the deck of the
liquid handler and treated with 1.9 mL of 1.2 N HCl solution followed by
eight cycles of rapid aspiration and dispensing to ensure thorough
mixing. After complete phase separation, which can be accelerated by
centrifugation for 10 min at 500 g (versus ~2 h without centrifugation),
the bottom layers were retrieved by the liquid hander and transferred to
24 empty barcoded, preweighed one-dram vials. The vials containing the
product solutions were placed in a GeneVac centrifugal evaporator to
remove solvent, and were weighed using an automated Mettler Toledo
weigher to determine the yield of each final product. Each of the tips
used for the above material transfer was then washed in another vial
containing 0.5 mL of MeOH in order to dissolve the residual material
present on the tip, which provided sufficient amount of material for
purity analysis of each final compound using LC-MS equipped with an
autosampler. Piperidinone-Containing Amide 13t. Compound 13t was prepared
according to the general procedure D from carboxylic acid 8n and amine
11w. Yield 100.0%. 1H NMR (500 MHz, CDCl3) δ 6.85 (d, J = 1.6 Hz, 1H),
6.80-6.70 (m, 2H), 5.95-5.87 (m, 2H), 5.31 (d, J = 15.9 Hz, 1H), 5.17
(dd, J = 5.2, 2.7 Hz, 1H), 4.42 (d, J = 15.8 Hz, 1H), 4.17 (q, J = 7.1
Hz, 2H), 3.51 (dt, J = 13.0, 6.8 Hz, 1H), 3.41 (p, J = 6.9, 6.3 Hz, 3H),
2.90 (dd, J = 16.5, 6.2 Hz, 1H), 2.73 (dtd, J = 12.4, 5.9, 3.3 Hz, 1H),
2.62 (dd, J = 16.4, 3.3 Hz, 1H), 2.36 (dd, J = 12.8, 5.8 Hz, 1H),
2.28-2.18 (m, 1H), 2.18-1.97 (m, 3H), 1.97-1.89 (m, 2H), 1.87-1.78 (m,
2H), 1.67-1.58 (m, 1H), 1.52 (td, J = 13.6, 2.7 Hz, 1H), 1.42-1.30 (m,
1H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR (126 MHz, CDCl3) δ 174.8, 171.1,
169.1, 148.0, 146.3, 137.6, 132.2, 119.5, 108.3, 108.2, 107.5, 100.9,
61.5, 48.9, 46.8, 46.6, 45.8, 36.7, 36.6, 36.4, 35.1, 26.2, 24.5, 24.5,
18.8, 14.4; MS(ESI) calcd for C26H32N2O6 468.23 (M+), found 469.23 (M +
H)+, 491.22 (M + Na)+. Mass (mg): 25.1.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Assembly of Four Diverse Heterocyclic Libraries Enabled by Prins
Cyclization, Au-Catalyzed Enyne Cycloisomerization, and Automated Amide
Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cui, Jiayue; Chai, David I.; Miller, Christopher; Hao, Jason; Thomas,
Christopher; Wang, JingQi; Scheidt, Karl A.; Kozmin, Sergey A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(17), 7435-7470

$RFMT $RIREG SCHEME79 STEP1
$RXN



  2  1
$MOL
rel-(3R,4aS,5S,7S)-1-(1,3-Benzodioxol-5-ylmethyl)-1,3,4,4a,5,7-hexahydro-4a-(...
C29H31NO9
1393935-89-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.5016 2.4670 0.0 0
M  V30 2 O 10.8974 1.8161 0.0 0
M  V30 3 O 8.2400 1.5836 0.0 0
M  V30 4 C 11.0316 0.2820 0.0 0
M  V30 5 C 11.6774 2.6675 0.0 0
M  V30 6 C 6.2873 6.6685 0.0 0
M  V30 7 C 6.2873 1.3337 0.0 0
M  V30 8 C 4.7473 1.3337 0.0 0
M  V30 9 O 3.9773 0.0000 0.0 0
M  V30 10 O 3.9773 2.6673 0.0 0
M  V30 11 O 4.7473 4.0011 0.0 0
M  V30 12 C 11.6774 8.0023 0.0 0
M  V30 13 O 13.2174 8.0023 0.0 0
M  V30 14 C 13.9874 9.3359 0.0 0
M  V30 15 C 9.3673 4.0011 0.0 0 CFG=1
M  V30 16 C 8.5973 5.3348 0.0 0
M  V30 17 C 8.5973 2.6675 0.0 0
M  V30 18 C 10.9074 4.0011 0.0 0 CFG=2
M  V30 19 N 7.0573 5.3348 0.0 0
M  V30 20 C 9.3673 6.6685 0.0 0
M  V30 21 C 7.0573 2.6673 0.0 0 CFG=2
M  V30 22 O 11.6774 5.3348 0.0 0
M  V30 23 C 6.2873 4.0011 0.0 0
M  V30 24 C 10.9074 6.6685 0.0 0 CFG=1
M  V30 25 C 4.7473 6.6685 0.0 0
M  V30 26 C 3.9773 8.0023 0.0 0
M  V30 27 C 3.9773 5.3348 0.0 0
M  V30 28 C 2.4372 8.0023 0.0 0
M  V30 29 C 2.4372 5.3348 0.0 0
M  V30 30 C 1.6672 6.6685 0.0 0
M  V30 31 O 1.4068 9.1467 0.0 0
M  V30 32 O 0.1609 6.9886 0.0 0
M  V30 33 C 0.0000 8.5203 0.0 0
M  V30 34 C 15.5274 9.3359 0.0 0
M  V30 35 C 16.2974 10.6696 0.0 0
M  V30 36 C 16.2974 8.0023 0.0 0
M  V30 37 C 17.8375 10.6696 0.0 0
M  V30 38 C 17.8375 8.0023 0.0 0
M  V30 39 C 18.6075 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 18 5 CFG=1
M  V30 6 1 6 19
M  V30 7 1 6 25
M  V30 8 1 7 8
M  V30 9 1 21 7 CFG=3
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 2 11 23
M  V30 13 1 12 13
M  V30 14 1 24 12 CFG=1
M  V30 15 1 13 14
M  V30 16 1 14 34
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 16 20
M  V30 22 1 17 21
M  V30 23 1 18 22
M  V30 24 1 19 23
M  V30 25 1 20 24
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 25 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 28 31
M  V30 34 2 29 30
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 15 18 21 24)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-Methyl (3R,4aS,5S,7S)-1-(1,3-benzodioxol-5-ylmethyl)-1,3,4,7-tetrahydro-5...
C33H38N2O8
1393936-58-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4550 9.9932 0.0 0
M  V30 2 O 9.3384 11.2546 0.0 0
M  V30 3 O 6.9209 10.1273 0.0 0
M  V30 4 C 8.6874 12.6504 0.0 0
M  V30 5 C 10.4395 10.9075 0.0 0
M  V30 6 C 7.7722 4.7474 0.0 0
M  V30 7 C 5.1047 9.3675 0.0 0
M  V30 8 C 3.7711 8.5975 0.0 0
M  V30 9 O 3.7711 7.0575 0.0 0
M  V30 10 O 5.1047 6.2874 0.0 0
M  V30 11 C 13.1070 6.2874 0.0 0
M  V30 12 O 14.4406 7.0575 0.0 0
M  V30 13 C 15.7743 6.2874 0.0 0
M  V30 14 C 9.1058 8.5975 0.0 0 CFG=1
M  V30 15 C 9.1058 7.0575 0.0 0
M  V30 16 C 7.7722 9.3675 0.0 0
M  V30 17 C 10.4395 9.3675 0.0 0 CFG=2
M  V30 18 N 7.7722 6.2874 0.0 0
M  V30 19 C 10.4395 6.2874 0.0 0
M  V30 20 C 6.4384 8.5975 0.0 0 CFG=2
M  V30 21 O 11.7733 8.5975 0.0 0
M  V30 22 C 6.4384 7.0575 0.0 0
M  V30 23 C 11.7733 7.0575 0.0 0 CFG=1
M  V30 24 C 6.4385 3.9774 0.0 0
M  V30 25 C 6.4385 2.4374 0.0 0
M  V30 26 C 5.1047 4.7474 0.0 0
M  V30 27 C 5.1047 1.6674 0.0 0
M  V30 28 C 3.7711 3.9774 0.0 0
M  V30 29 C 3.7711 2.4374 0.0 0
M  V30 30 O 4.7845 0.1609 0.0 0
M  V30 31 O 2.6267 1.4068 0.0 0
M  V30 32 C 3.2530 0.0000 0.0 0
M  V30 33 N 2.4374 9.3675 0.0 0
M  V30 34 C 2.2763 10.8990 0.0 0
M  V30 35 C 1.0304 8.7410 0.0 0
M  V30 36 C 0.7700 11.2192 0.0 0
M  V30 37 C 0.0000 9.8856 0.0 0
M  V30 38 C 17.1081 7.0575 0.0 0
M  V30 39 C 17.1081 8.5975 0.0 0
M  V30 40 C 18.4418 6.2874 0.0 0
M  V30 41 C 18.4418 9.3675 0.0 0
M  V30 42 C 19.7754 7.0575 0.0 0
M  V30 43 C 19.7754 8.5975 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=3
M  V30 4 1 2 4
M  V30 5 1 17 5 CFG=3
M  V30 6 1 6 18
M  V30 7 1 6 24
M  V30 8 1 7 8
M  V30 9 1 20 7 CFG=1
M  V30 10 2 8 9
M  V30 11 1 8 33
M  V30 12 2 10 22
M  V30 13 1 11 12
M  V30 14 1 23 11 CFG=3
M  V30 15 1 12 13
M  V30 16 1 13 38
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 1 15 18
M  V30 21 2 15 19
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 1 18 22
M  V30 25 1 19 23
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 1 24 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 27 30
M  V30 34 2 28 29
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 43 2 38 39
M  V30 44 1 38 40
M  V30 45 1 39 41
M  V30 46 2 40 42
M  V30 47 2 41 43
M  V30 48 1 42 43
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(4 14 17 20 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1393935-89-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1393936-58-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14236241
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1467-16-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 865-49-6
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure D: Automated Library
Synthesis. A of solution of a carboxylic acid (7, 8, 26, or 36, 1.25
mmol) in 25 mL of CDCl3 was treated with CDI (16, 212.8 mg, 1.31 mmol,
1.05 equiv). The reaction was stirred at room temperature until NMR
indicated complete conversion of the carboxylic acid to the corresponding
acylimidazole, which typically took 2-4 h. Using a Perkin-Elmer
Multiprobe II liquid handler, the resulting solution was distributed into
24 1-dram glass vials, delivering 0.95 mL of the above solution into each
vial. For reactions involving the coupling with secondary amines, the
glass vials were precharged with imidazole hydrochloride (9.9 mg, 0.095
mmol, 2 equiv). For each vial, a solution of one of the 24 amines 11 (2
M, 2.7 equiv) in 0.065 mL of chloroform was added. The resulting reaction
mixtures were capped and agitated on an orbital shaker at room
temperature for 48 h. The vials were then returned to the deck of the
liquid handler and treated with 1.9 mL of 1.2 N HCl solution followed by
eight cycles of rapid aspiration and dispensing to ensure thorough
mixing. After complete phase separation, which can be accelerated by
centrifugation for 10 min at 500 g (versus ~2 h without centrifugation),
the bottom layers were retrieved by the liquid hander and transferred to
24 empty barcoded, preweighed one-dram vials. The vials containing the
product solutions were placed in a GeneVac centrifugal evaporator to
remove solvent, and were weighed using an automated Mettler Toledo
weigher to determine the yield of each final product. Each of the tips
used for the above material transfer was then washed in another vial
containing 0.5 mL of MeOH in order to dissolve the residual material
present on the tip, which provided sufficient amount of material for
purity analysis of each final compound using LC-MS equipped with an
autosampler. Tetrahydropyran-Fused Piperidinone-Containing Amide 27bb.
Compound 27bb was prepared according to the general procedure D from
carboxylic acid 26ab and amine 11w. Yield 100.0%. 1H NMR (500 MHz, CDCl3)
δ 7.35-7.24 (m, 5H), 6.79 (d, J = 1.1 Hz, 1H), 6.72 (t, J = 1.1 Hz, 2H),
5.90 (d, J = 1.2 Hz, 2H), 5.30 (d, J = 1.7 Hz, 1H), 4.86 (d, J = 15.6 Hz,
1H), 4.79 (d, J = 15.6 Hz, 1H), 4.54 (d, J = 12.0 Hz, 1H), 4.47 (d, J =
12.3 Hz, 1H), 4.42 (td, J = 6.6, 6.2, 1.7 Hz, 1H), 4.12 (q, J = 6.4, 6.0
Hz, 1H), 3.64 (s, 3H), 3.54-3.48 (m, 2H), 3.43 (m, 4H), 3.33 (dd, J =
9.8, 5.7 Hz, 1H), 2.99-2.91 (m, 1H), 2.82 (dd, J = 16.4, 6.6 Hz, 1H),
2.68 (dd, J = 16.5, 3.5 Hz, 1H), 2.33 (dd, J = 12.6, 6.2 Hz, 1H), 2.02
(t, J = 12.3 Hz, 1H), 1.93 (m, 2H), 1.87- 1.80 (m, 2H), 1.21 (d, J = 6.4
Hz, 2H); 13C NMR (126 MHz, CDCl3) δ 173.1, 171.3, 168.9, 147.9, 146.5,
138.2, 136.8, 131.2, 128.5, 127.8, 127.8, 120.3, 108.2, 107.9, 107.0,
101.0, 74.4, 73.5, 73.1, 73.0, 52.8, 51.4, 47.3, 46.6, 45.8, 36.9, 36.7,
29.6, 26.2, 24.5, 17.2; MS(ESI) calcd for C33H38N2O8 590.26 (M+), found
591.38 (M + H)+. Mass (mg): 16.01.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Assembly of Four Diverse Heterocyclic Libraries Enabled by Prins
Cyclization, Au-Catalyzed Enyne Cycloisomerization, and Automated Amide
Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cui, Jiayue; Chai, David I.; Miller, Christopher; Hao, Jason; Thomas,
Christopher; Wang, JingQi; Scheidt, Karl A.; Kozmin, Sergey A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2012), 77(17), 7435-7470

$RFMT $RIREG SCHEME80 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acrylate
C5H8O2
140-88-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-pyrrolidinepropanoate
C9H17NO2
6317-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 C 6.4384 1.5400 0.0 0
M  V30 4 O 7.7722 2.3101 0.0 0
M  V30 5 O 6.4384 0.0000 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4396 2.3101 0.0 0
M  V30 8 N 2.4374 2.3101 0.0 0
M  V30 9 C 1.0304 1.6836 0.0 0
M  V30 10 C 2.2763 3.8416 0.0 0
M  V30 11 C 0.0000 2.8281 0.0 0
M  V30 12 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 140-88-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 6317-35-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-3403340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic Approaches to Two Potential Anticancer Agents: Symmetric
Bis-Benzimidazoles, a New Family of DNA Mino Groove Binders and the
Marine natural Product Eleutherobin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baron, Anne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2000), (20140701), No pp.

$RFMT $RIREG SCHEME81 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2E)-3-(1-pyrrolidinyl)-2-butenoate
C10H17NO2
54716-02-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 3.7711 4.1618 0.0 0
M  V30 4 C 6.4384 2.6218 0.0 0
M  V30 5 O 7.7722 1.8517 0.0 0
M  V30 6 O 6.4384 4.1618 0.0 0
M  V30 7 C 9.1059 2.6218 0.0 0
M  V30 8 C 10.4396 1.8517 0.0 0
M  V30 9 N 2.4374 1.8517 0.0 0
M  V30 10 C 2.2763 0.3202 0.0 0
M  V30 11 C 1.0304 2.4782 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54716-02-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-18440911
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enamines as Surrogates of Alkene Carbanions for the Reductive
Alkenylation of Secondary Amides: An Approach to Allylamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Ai-E.; Yu, Cun-Cun; Chen, Ting-Ting; Liu, Yong-Peng; Huang,
Pei-Qiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2018), 20(4), 999-1002

$RFMT $RIREG SCHEME82 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-2-(3-methyl-2-quinoxalinyl)-N-(tetrahydro-2H-pyran-4-yl)imidazo[1,2-...
C20H19ClN6O
1425298-27-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.0821 5.3347 0.0 0
M  V30 2 Cl 10.0821 0.0000 0.0 0
M  V30 3 C 2.6674 2.9790 0.0 0
M  V30 4 C 7.7721 4.0009 0.0 0
M  V30 5 N 7.0021 2.6673 0.0 0
M  V30 6 C 9.3121 4.0009 0.0 0
M  V30 7 N 6.7417 5.1454 0.0 0
M  V30 8 C 5.4956 2.9874 0.0 0
M  V30 9 N 7.7721 1.3336 0.0 0
M  V30 10 C 10.0821 2.6673 0.0 0
M  V30 11 C 5.3347 4.5190 0.0 0
M  V30 12 C 9.3121 1.3336 0.0 0
M  V30 13 C 11.6221 5.3347 0.0 0
M  V30 14 C 12.3921 6.6684 0.0 0
M  V30 15 C 12.3921 4.0009 0.0 0
M  V30 16 C 13.9321 6.6684 0.0 0
M  V30 17 C 13.9321 4.0009 0.0 0
M  V30 18 O 14.7021 5.3347 0.0 0
M  V30 19 C 4.0011 5.2890 0.0 0
M  V30 20 N 4.0011 6.8290 0.0 0
M  V30 21 C 2.6674 4.5190 0.0 0
M  V30 22 C 2.6674 7.5990 0.0 0
M  V30 23 N 1.3336 5.2890 0.0 0
M  V30 24 C 1.3336 6.8290 0.0 0
M  V30 25 C 2.6674 9.1390 0.0 0
M  V30 26 C 0.0000 7.5990 0.0 0
M  V30 27 C 1.3336 9.9090 0.0 0
M  V30 28 C 0.0000 9.1390 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 13
M  V30 3 1 2 12
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 8 11
M  V30 13 2 9 12
M  V30 14 1 10 12
M  V30 15 1 11 19
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 22 25
M  V30 28 1 23 24
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Methyl-2-quinoxalinyl)-6-(1-pyrrolidinyl)-N-(tetrahydro-2H-pyran-4-yl)im...
C24H27N7O
1425297-60-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1047 3.0800 0.0 0
M  V30 2 C 10.3482 8.8273 0.0 0
M  V30 3 C 6.4385 5.3900 0.0 0
M  V30 4 N 6.4385 6.9300 0.0 0
M  V30 5 C 5.1047 4.6200 0.0 0
M  V30 6 N 7.9030 4.9142 0.0 0
M  V30 7 C 7.9030 7.4059 0.0 0
M  V30 8 N 5.1047 7.7000 0.0 0
M  V30 9 C 3.7710 5.3900 0.0 0
M  V30 10 C 8.8082 6.1600 0.0 0
M  V30 11 C 3.7710 6.9300 0.0 0
M  V30 12 C 3.7710 2.3100 0.0 0
M  V30 13 C 3.7710 0.7700 0.0 0
M  V30 14 C 2.4374 3.0800 0.0 0
M  V30 15 C 2.4374 0.0000 0.0 0
M  V30 16 C 1.1037 2.3100 0.0 0
M  V30 17 O 1.1037 0.7700 0.0 0
M  V30 18 C 10.3482 6.1600 0.0 0
M  V30 19 N 11.1182 4.8264 0.0 0
M  V30 20 C 11.1182 7.4937 0.0 0
M  V30 21 C 12.6582 4.8264 0.0 0
M  V30 22 N 12.6582 7.4937 0.0 0
M  V30 23 C 13.4283 6.1600 0.0 0
M  V30 24 C 13.4283 3.4926 0.0 0
M  V30 25 C 14.9683 6.1600 0.0 0
M  V30 26 C 14.9683 3.4926 0.0 0
M  V30 27 C 15.7383 4.8264 0.0 0
M  V30 28 N 2.4374 7.7000 0.0 0
M  V30 29 C 2.2764 9.2316 0.0 0
M  V30 30 C 1.0304 7.0736 0.0 0
M  V30 31 C 0.7700 9.5517 0.0 0
M  V30 32 C 0.0000 8.2181 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 12
M  V30 3 1 2 20
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 10
M  V30 12 2 8 11
M  V30 13 1 9 11
M  V30 14 1 10 18
M  V30 15 1 11 28
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 21 24
M  V30 28 1 22 23
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1425298-27-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1425297-60-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20596319
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM product further converted to HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a pyrazolo[1,5-a]pyrimidine derivative (MT-3014) as a highly
selective PDE10A inhibitor via core structure transformation from the
stilbene moiety
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koizumi, Yuuki; Tanaka, Yoshihito; Matsumura, Takehiko; Kadoh, Yoichi;
Miyoshi, Haruko; Hongu, Mitsuya; Takedomi, Kei; Kotera, Jun; Sasaki,
Takashi; Taniguchi, Hiroyuki; Watanabe, Yumi; Takakuwa, Misae; Kojima,
Koki; Baba, Nobuyuki; Nakamura, Itsuko; Kawanishi, Eiji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2019), 27(15), 3440-3450

$RFMT $RIREG SCHEME83 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Butynyl)phthalimide
C12H9NO2
14396-90-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6078 0.0000 0.0 0
M  V30 2 O 4.6078 5.4211 0.0 0
M  V30 3 C 6.5770 2.7106 0.0 0
M  V30 4 C 7.3470 4.0442 0.0 0
M  V30 5 C 8.8870 4.0442 0.0 0
M  V30 6 C 10.4270 4.0442 0.0 0
M  V30 7 C 2.6673 1.9406 0.0 0
M  V30 8 C 2.6673 3.4806 0.0 0
M  V30 9 C 4.1320 1.4647 0.0 0
M  V30 10 C 1.3336 1.1706 0.0 0
M  V30 11 C 4.1320 3.9564 0.0 0
M  V30 12 C 1.3336 4.2506 0.0 0
M  V30 13 N 5.0370 2.7106 0.0 0
M  V30 14 C 0.0000 1.9406 0.0 0
M  V30 15 C 0.0000 3.4806 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 3 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[5-(1-Pyrrolidinyl)-3-pentyn-1-yl]-1H-isoindole-1,3(2H)-dione
C17H18N2O2
56766-57-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.0205 5.3182 0.0 0
M  V30 2 O 5.7309 0.6234 0.0 0
M  V30 3 C 6.0811 3.9554 0.0 0
M  V30 4 C 7.4150 3.1854 0.0 0
M  V30 5 C 8.7486 3.9554 0.0 0
M  V30 6 C 10.0823 4.7254 0.0 0
M  V30 7 C 11.4161 5.4955 0.0 0
M  V30 8 C 2.3101 2.6673 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 3.3406 3.8119 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 4.5865 1.6538 0.0 0
M  V30 13 C 2.3101 0.0000 0.0 0
M  V30 14 N 4.7475 3.1854 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 17 N 12.7498 4.7254 0.0 0
M  V30 18 C 12.9107 3.1939 0.0 0
M  V30 19 C 14.1566 5.3519 0.0 0
M  V30 20 C 14.4172 2.8737 0.0 0
M  V30 21 C 15.1872 4.2074 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 10
M  V30 2 2 2 12
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 3 5 6
M  V30 7 1 6 7
M  V30 8 1 7 17
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 14396-90-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 56766-57-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-19529024
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation isoxazolecarboxamide compounds and uses thereof for Atoh1
induction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Beckwith, Rohan Eric John; Jiang, Hua; Wang, Ce
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018172997 A1 2018-09-27

$RFMT $RIREG SCHEME84 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N,N-bis(methylsulfonyl)benzamide
C9H10ClNO5S2
1441987-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 2.6674 0.0 0
M  V30 2 C 3.8500 4.0011 0.0 0
M  V30 3 S 3.8500 1.3338 0.0 0 VAL=6
M  V30 4 S 1.5400 2.6674 0.0 0 VAL=6
M  V30 5 O 3.0800 5.3349 0.0 0
M  V30 6 C 4.6200 0.0000 0.0 0
M  V30 7 O 5.1836 2.1038 0.0 0
M  V30 8 O 2.5164 0.5638 0.0 0
M  V30 9 C 0.0000 2.6674 0.0 0
M  V30 10 O 1.5400 1.1274 0.0 0
M  V30 11 O 1.5400 4.2074 0.0 0
M  V30 12 Cl 10.0100 4.0011 0.0 0
M  V30 13 C 5.3900 4.0011 0.0 0
M  V30 14 C 6.1600 2.6674 0.0 0
M  V30 15 C 6.1600 5.3349 0.0 0
M  V30 16 C 7.7000 2.6674 0.0 0
M  V30 17 C 7.7000 5.3349 0.0 0
M  V30 18 C 8.4700 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 13
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 2 3 8
M  V30 9 1 4 9
M  V30 10 2 4 10
M  V30 11 2 4 11
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Chlorophenyl)-1-pyrrolidinylmethanone
C11H12ClNO
19202-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 Cl 9.1059 4.6201 0.0 0
M  V30 4 C 5.1048 2.3101 0.0 0
M  V30 5 C 5.1048 3.8501 0.0 0
M  V30 6 C 6.4386 1.5400 0.0 0
M  V30 7 C 6.4386 4.6201 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 N 2.4374 2.3101 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1441987-15-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19202-05-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-18179640
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Organocatalytic Amidation and Esterification of Aldehydes with Activating
Reagents by a Cross-coupling Strategy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tan, Bin; Toda, Narihiro; Barbas, Carlos F.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2012), 51(50), 12538-12541

$RFMT $RIREG SCHEME85 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzotriazol-1-yl-4-pyridinylmethanone
C12H8N4O
144223-31-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 3.7710 0.0 0
M  V30 2 O 4.4608 5.1048 0.0 0
M  V30 3 C 2.9292 2.2764 0.0 0
M  V30 4 N 4.4608 2.4374 0.0 0
M  V30 5 C 2.6091 0.7700 0.0 0
M  V30 6 C 1.7849 3.3068 0.0 0
M  V30 7 N 5.0872 1.0306 0.0 0
M  V30 8 N 3.9427 0.0000 0.0 0
M  V30 9 C 1.1444 0.2941 0.0 0
M  V30 10 C 0.3202 2.8310 0.0 0
M  V30 11 C 0.0000 1.3247 0.0 0
M  V30 12 C 6.7708 3.7710 0.0 0
M  V30 13 C 7.5408 2.4374 0.0 0
M  V30 14 C 7.5408 5.1048 0.0 0
M  V30 15 C 9.0808 2.4374 0.0 0
M  V30 16 C 9.0808 5.1048 0.0 0
M  V30 17 N 9.8508 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 12
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pyridinyl-1-pyrrolidinylmethanone
C10H12N2O
86542-83-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 O 4.0011 0.0000 0.0 0
M  V30 3 N 5.3348 2.3100 0.0 0
M  V30 4 C 5.4957 3.8416 0.0 0
M  V30 5 C 6.7417 1.6837 0.0 0
M  V30 6 C 7.0021 4.1617 0.0 0
M  V30 7 C 7.7722 2.8281 0.0 0
M  V30 8 C 2.6675 2.3100 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 1.3337 1.5400 0.0 0
M  V30 11 C 1.3337 4.6201 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 N 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 144223-31-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 86542-83-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-586441
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Reaction of
N-Acylbenzo-triazoles 2 with Primary Amines. The N-acylbenzotriazole 2 (1
mmol) was stirred with the appropriate primary amine (1 mmol) in THF (10
mL) at room temperature for 4 h. After evaporation of solvents in vacuo,
the residue was added to 2 M NaOH (20 mL) and extracted with EtOAc. The
combined organic layers were dried over anhydrous MgSO4. Evaporation of
the solvent gave a secondary amide 4a-j, which was recrystallized from
appropriate solvents. 4-Pyridinyl(tetrahydro-1H-pyrrol-1-yl)methanone
(5i): yield, 100%; Yellow oil. 1H NMR δ 8.73-8.71 (m, 2H), 7.43-7.40 (m,
2H), 3.68 (t,J= 6.9 Hz, 2H), 3.40 (t,J= 6.9 Hz, 2H), 2.05-1.88 (m, 4H);
13C NMR δ 167.1 (C═O), 150.0, 144.5, 121.2, 49.2, 46.3, 26.2, 24.2. HRMS
Calcd for C10H13N2O: 177.1028 (M+1), found: 177.1017.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Acylbenzotriazoles: Neutral Acylating Reagents for the Preparation of
Primary, Secondary, and Tertiary Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Katritzky, Alan R.; He, Hai-Ying; Suzuki, Kazuyuki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2000), 65(24), 8210-8213

$RFMT $RIREG SCHEME86 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N′-Bis(tert-butoxycarbonyl)thiourea
C11H20N2O4S
145013-05-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0010 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 N 5.3348 0.5637 0.0 0
M  V30 8 O 4.0010 2.8737 0.0 0
M  V30 9 C 6.6685 1.3337 0.0 0
M  V30 10 N 8.0022 0.5637 0.0 0
M  V30 11 S 6.6685 2.8737 0.0 0
M  V30 12 C 9.3360 1.3337 0.0 0
M  V30 13 O 10.6697 0.5637 0.0 0
M  V30 14 O 9.3360 2.8737 0.0 0
M  V30 15 C 12.0033 1.3337 0.0 0
M  V30 16 C 12.7733 0.0000 0.0 0
M  V30 17 C 13.3370 2.1037 0.0 0
M  V30 18 C 11.2333 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 13 15
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[[[(1,1-dimethylethoxy)carbonyl]amino]-1-pyrrolidinylmeth...
C15H27N3O4
207857-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 3.7710 0.0 0
M  V30 2 N 5.3900 5.1048 0.0 0
M  V30 3 N 7.7000 3.7710 0.0 0
M  V30 4 C 3.8500 5.1048 0.0 0
M  V30 5 C 8.4700 5.1048 0.0 0
M  V30 6 O 3.0800 6.4384 0.0 0
M  V30 7 O 3.0800 3.7710 0.0 0
M  V30 8 O 10.0100 5.1048 0.0 0
M  V30 9 O 7.7000 6.4384 0.0 0
M  V30 10 C 1.5400 6.4384 0.0 0
M  V30 11 C 10.7800 6.4384 0.0 0
M  V30 12 C 1.5400 4.8984 0.0 0
M  V30 13 C 0.0000 6.4384 0.0 0
M  V30 14 C 1.5400 7.9784 0.0 0
M  V30 15 C 9.4464 7.2084 0.0 0
M  V30 16 C 11.5500 7.7721 0.0 0
M  V30 17 C 12.1136 5.6684 0.0 0
M  V30 18 N 5.3900 2.4374 0.0 0
M  V30 19 C 6.0163 1.0306 0.0 0
M  V30 20 C 3.8585 2.2764 0.0 0
M  V30 21 C 4.8719 0.0000 0.0 0
M  V30 22 C 3.5383 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 11 16
M  V30 17 1 11 17
M  V30 18 1 18 19
M  V30 19 1 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 145013-05-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 207857-31-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5832890
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 12619-90-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of N,N'-bis-tert-butoxycarbonyl
Protected Guanidines Guanylation of Amines Nickel-boride alloy (13 mg,
0.10 mmol, prepared by the reduction of nickel acetate or chloride with
sodium borohydride in ethanol or water) was added to a solution of
N,N'-bis-tert-butoxycarbonylthiourea (28 mg, 0.10 mmol, prepared in Part
1 of Example 1) and an amine (0.15 mmol) in dimethyl formamide (DMF)
contained in a 15 ml screw cap vial. The solution was stirred at room
temperature and the progress of the reaction was monitored by thin layer
chromatography (TLC). The reaction mixture was then diluted with ethyl
acetate (15 ml) and poured into 25 ml of water. The organic layer was
separated, and the aqueous layer was extracted with 10 ml of ethyl
acetate. The combined extracts were washed twice with 15 ml of water
after which they were dried over sodium sulfate, evaporating the solvent.
The residue was passed through a short silica gel column using a gradient
of hexane and ether as eluents. The pure guanidine. Entry 1 Entry 4 Yield
(%) = 89
$DTYPE RXN:VAR(1):NOTES
$DATUM SOLVENT CRITICAL TO REACTION TIME, YIELD
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel-promoted guanylation of amines with (iso)thioureas
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhat, Laxminarayan; Georg, Gunda I.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6100428 A 2000-08-08

$RFMT $RIREG SCHEME87 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-(3-Bromopropoxy)-2,3-dihydro-1H-inden-5-yl]-3,5-dimethylisoxazole
C17H20BrNO2
1455438-18-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.9093 5.5976 0.0 0
M  V30 2 C 9.2430 6.3676 0.0 0
M  V30 3 C 10.5766 5.5976 0.0 0
M  V30 4 C 11.9103 6.3676 0.0 0
M  V30 5 Br 13.2441 5.5976 0.0 0
M  V30 6 C 0.0000 2.9211 0.0 0
M  V30 7 C 5.1558 1.2459 0.0 0
M  V30 8 C 5.1687 5.7411 0.0 0
M  V30 9 C 4.1383 6.8857 0.0 0
M  V30 10 C 6.5755 6.3676 0.0 0
M  V30 11 C 4.6929 4.2766 0.0 0
M  V30 12 C 2.6319 6.5655 0.0 0
M  V30 13 C 4.9083 8.2193 0.0 0
M  V30 14 C 6.4146 7.8992 0.0 0
M  V30 15 C 3.1864 3.9564 0.0 0
M  V30 16 C 2.1560 5.1008 0.0 0
M  V30 17 C 2.7106 2.4917 0.0 0
M  V30 18 C 1.2460 2.0159 0.0 0
M  V30 19 C 3.6158 1.2459 0.0 0
M  V30 20 N 1.2460 0.4759 0.0 0
M  V30 21 O 2.7106 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 18
M  V30 7 1 7 19
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2,3-Dihydro-3-[3-(1-pyrrolidinyl)propoxy]-1H-inden-5-yl]-3,5-dimethylisoxa...
C21H28N2O2
1455438-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.9092 5.5976 0.0 0
M  V30 2 C 9.2429 6.3677 0.0 0
M  V30 3 C 10.5767 5.5976 0.0 0
M  V30 4 C 11.9103 6.3677 0.0 0
M  V30 5 C 5.1558 1.2459 0.0 0
M  V30 6 C 0.0000 2.9211 0.0 0
M  V30 7 C 5.1688 5.7412 0.0 0
M  V30 8 C 4.1382 6.8857 0.0 0
M  V30 9 C 6.5756 6.3677 0.0 0
M  V30 10 C 4.6927 4.2766 0.0 0
M  V30 11 C 2.6319 6.5655 0.0 0
M  V30 12 C 4.9082 8.2194 0.0 0
M  V30 13 C 6.4146 7.8992 0.0 0
M  V30 14 C 3.1864 3.9565 0.0 0
M  V30 15 C 2.1560 5.1008 0.0 0
M  V30 16 C 2.7106 2.4917 0.0 0
M  V30 17 C 3.6158 1.2459 0.0 0
M  V30 18 C 1.2459 2.0159 0.0 0
M  V30 19 N 2.7106 0.0000 0.0 0
M  V30 20 O 1.2459 0.4759 0.0 0
M  V30 21 N 13.2440 5.5976 0.0 0
M  V30 22 C 14.6509 6.2240 0.0 0
M  V30 23 C 13.4051 4.0661 0.0 0
M  V30 24 C 15.6814 5.0796 0.0 0
M  V30 25 C 14.9114 3.7458 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 21
M  V30 6 1 5 17
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 16 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1455438-18-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1455438-25-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-13688371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as
selective inhibitors of the BET bromodomains
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hay, Duncan; Fedorov, Oleg; Filippakopoulos, Panagis; Martin, Sarah;
Philpott, Martin; Picaud, Sarah; Hewings, David S.; Uttakar, Sagar;
Heightman, Tom D.; Conway, Stuart J.; Knapp, Stefan; Brennan, Paul E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM MedChemComm (2013), 4(1), 140-144

$RFMT $RIREG SCHEME88 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-[[4-[2-[(2,2-dimethylpropyl)amino]-2-oxoethyl]phenyl]amino]-5-pyri...
C18H22ClN5O2
1472103-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 5.3347 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 N 2.3100 6.6685 0.0 0
M  V30 4 O 0.0000 5.3347 0.0 0
M  V30 5 Cl 4.6200 0.0000 0.0 0
M  V30 6 C 10.7800 5.3347 0.0 0
M  V30 7 C 11.5500 6.6685 0.0 0
M  V30 8 N 13.0900 6.6685 0.0 0
M  V30 9 O 10.7800 8.0021 0.0 0
M  V30 10 C 13.8600 8.0021 0.0 0
M  V30 11 C 15.4000 8.0021 0.0 0
M  V30 12 C 15.4000 9.5421 0.0 0
M  V30 13 C 16.9400 8.0021 0.0 0
M  V30 14 C 15.4000 6.4621 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 2.3100 4.0011 0.0 0
M  V30 17 N 4.6200 2.6674 0.0 0
M  V30 18 C 1.5400 2.6674 0.0 0
M  V30 19 C 3.8500 1.3336 0.0 0
M  V30 20 N 2.3100 1.3336 0.0 0
M  V30 21 C 6.1600 5.3347 0.0 0
M  V30 22 C 6.9300 6.6685 0.0 0
M  V30 23 C 6.9300 4.0011 0.0 0
M  V30 24 C 8.4700 6.6685 0.0 0
M  V30 25 C 8.4700 4.0011 0.0 0
M  V30 26 C 9.2400 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 16
M  V30 6 1 5 19
M  V30 7 1 6 7
M  V30 8 1 6 26
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 20
M  V30 22 2 21 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 2 23 25
M  V30 26 2 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[4-[2-[(2,2-Dimethylpropyl)amino]-2-oxoethyl]phenyl]amino]-2-(1-pyrrolidin...
C22H30N6O2
1472103-15-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 7.7721 0.0 0
M  V30 2 C 1.5400 7.7721 0.0 0
M  V30 3 N 2.3100 9.1057 0.0 0
M  V30 4 O 0.0000 7.7721 0.0 0
M  V30 5 C 10.7800 7.7721 0.0 0
M  V30 6 C 11.5500 9.1057 0.0 0
M  V30 7 N 13.0900 9.1057 0.0 0
M  V30 8 O 10.7800 10.4394 0.0 0
M  V30 9 C 13.8600 10.4394 0.0 0
M  V30 10 C 15.4000 10.4394 0.0 0
M  V30 11 C 15.4000 11.9794 0.0 0
M  V30 12 C 16.9400 10.4394 0.0 0
M  V30 13 C 15.4000 8.8994 0.0 0
M  V30 14 C 3.8500 6.4383 0.0 0
M  V30 15 C 2.3100 6.4383 0.0 0
M  V30 16 N 4.6200 5.1046 0.0 0
M  V30 17 C 1.5400 5.1046 0.0 0
M  V30 18 C 3.8500 3.7710 0.0 0
M  V30 19 N 2.3100 3.7710 0.0 0
M  V30 20 C 6.1600 7.7721 0.0 0
M  V30 21 C 6.9300 6.4383 0.0 0
M  V30 22 C 6.9300 9.1057 0.0 0
M  V30 23 C 8.4700 6.4383 0.0 0
M  V30 24 C 8.4700 9.1057 0.0 0
M  V30 25 C 9.2400 7.7721 0.0 0
M  V30 26 N 4.6200 2.4374 0.0 0
M  V30 27 C 3.9937 1.0304 0.0 0
M  V30 28 C 6.1515 2.2763 0.0 0
M  V30 29 C 5.1381 0.0000 0.0 0
M  V30 30 C 6.4717 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 5 6
M  V30 7 1 5 25
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 19
M  V30 21 1 18 26
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1472103-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1472103-15-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7080931
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of 5-carbamoyl-2-phenylpyrimidine
derivatives as novel and potent PDE4 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Goto, Taiji; Shiina, Akiko; Yoshino, Toshiharu; Mizukami, Kiyoshi;
Hirahara, Kazuki; Suzuki, Osamu; Sogawa, Yoshitaka; Takahashi, Tomoko;
Mikkaichi, Tsuyoshi; Nakao, Naoki; Takahashi, Mizuki; Hasegawa, Masashi;
Sasaki, Shigeki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2013), 21(22), 7025-7037

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Nitrophenyl)pyrrolidine
C10H12N2O2
40832-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 1.3338 0.0 0 VAL=5
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 4.6200 1.3338 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 C 0.7700 2.6674 0.0 0
M  V30 8 C 0.7700 5.3349 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 N 4.6200 4.0011 0.0 0
M  V30 11 C 5.5252 2.7552 0.0 0
M  V30 12 C 5.5252 5.2469 0.0 0
M  V30 13 C 6.9898 3.2311 0.0 0
M  V30 14 C 6.9898 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 40832-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15612601
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, reactant assumed, exothermic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Formic acid as a sustainable and complementary reductant: an approach to
fused benzimidazoles by molecular iodine-catalyzed reductive redox
cyclization of o-nitro-t-anilines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nguyen, T. B.; Ermolenko, L.; Al-Mourabit, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Green Chemistry (2016), 18(10), 2966-2970

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Nitrophenyl)pyrrolidine
C10H12N2O2
40832-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 1.3338 0.0 0 VAL=5
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 4.6200 1.3338 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 C 0.7700 2.6674 0.0 0
M  V30 8 C 0.7700 5.3349 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 N 4.6200 4.0011 0.0 0
M  V30 11 C 5.5252 2.7552 0.0 0
M  V30 12 C 5.5252 5.2469 0.0 0
M  V30 13 C 6.9898 3.2311 0.0 0
M  V30 14 C 6.9898 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 40832-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-73653
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Compound 158a. 1-(2-Nitro-phenyl)-pyrrolidine A suspension of
2-fluoro-nitrobenzene (1.0 g, 7.09 mmol, 1.0 eq), pyrrolidine (0.5g, 7.09
mmol, 1.0eq), and potassium carbonate (1.t8 g, 8.51 mmol, 1.2 eq) in
acetonitrile was heated at reflux for 3 hours then allowed to cool with
stirring for 18 hours. The reaction was diluted with water (10 ml) and
ethyl acetate (20 ml) and the organic layer removed. The aqueous phase
was then re-extracted twice more with ethyl acetate (2 x 20 ml), the
organics combined, dried over sodium sulphate, and the solvent removed in
vacuo to give the title compound (1.36 g, 7.09 mmol, 100%). . Compound
158a. 1-(2-Nitro-phenyl)-pyrrolidine, yield (1.36 g, 7.09 mmol, 100%). .
1H NMR shows product in >95% purity
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thienopyrimidines for pharmaceutical compositions and their preparation
and use as kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jaekel, Stefan; Murfin, Stefen; Taylor, Steven; Aicher, Babette; Kelter,
Arnd-Rene; Coulter, Thomasstefen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006136402 A1 2006-12-28

$RFMT $RIREG SCHEME89 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-2-nitrobenzene
C6H4FNO2
1493-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 F 2.3101 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 6
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Nitrophenyl)pyrrolidine
C10H12N2O2
40832-79-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 1.3338 0.0 0 VAL=5
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 O 4.6200 1.3338 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 2.3100 5.3349 0.0 0
M  V30 7 C 0.7700 2.6674 0.0 0
M  V30 8 C 0.7700 5.3349 0.0 0
M  V30 9 C 0.0000 4.0011 0.0 0
M  V30 10 N 4.6200 4.0011 0.0 0
M  V30 11 C 5.5252 2.7552 0.0 0
M  V30 12 C 5.5252 5.2469 0.0 0
M  V30 13 C 6.9898 3.2311 0.0 0
M  V30 14 C 6.9898 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1493-27-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 40832-79-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16321228
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Structure-Activity Study of Nickel NNN Pincer Complexes for Alkyl-Alkyl
Kumada and Suzuki-Miyaura Coupling Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Di Franco, Thomas; Stojanovic, Marko; Keller, Sebastien Carlos;
Scopelliti, Rosario; Hu, Xile
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Helvetica Chimica Acta (2016), 99(11), 830-847

$RFMT $RIREG SCHEME90 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Isoxazolo[3,4-b]quinolin-3(1H)-one
C10H6N2O2
1498303-39-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0408 3.1885 0.0 0
M  V30 2 C 5.3901 2.4782 0.0 0
M  V30 3 C 4.6201 1.1444 0.0 0
M  V30 4 C 4.6201 3.8119 0.0 0
M  V30 5 C 6.8964 2.1579 0.0 0
M  V30 6 N 3.0801 1.1444 0.0 0
M  V30 7 N 5.6505 0.0000 0.0 0
M  V30 8 C 3.0801 3.8119 0.0 0
M  V30 9 O 7.0574 0.6263 0.0 0
M  V30 10 C 2.3101 2.4782 0.0 0
M  V30 11 C 2.3101 5.1456 0.0 0
M  V30 12 C 0.7700 2.4782 0.0 0
M  V30 13 C 0.7700 5.1456 0.0 0
M  V30 14 C 0.0000 3.8119 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[pyrrolidine-1,2′(1′H)-[1,2,4]triazolo[4,3-a]quinolin-1-ium], 4′-carboxy...
C15H15N3O2
1498303-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.1047 1.3338 0.0 0
M  V30 2 O 2.5647 1.3338 0.0 0 CHG=-1
M  V30 3 O 4.8747 0.0000 0.0 0
M  V30 4 N 4.8747 5.3347 0.0 0
M  V30 5 C 4.1047 4.0011 0.0 0
M  V30 6 C 6.4147 5.3347 0.0 0
M  V30 7 C 3.8441 6.4792 0.0 0
M  V30 8 N 2.5983 4.3212 0.0 0
M  V30 9 C 4.8747 2.6674 0.0 0
M  V30 10 C 7.1847 4.0011 0.0 0
M  V30 11 C 7.1847 6.6685 0.0 0
M  V30 12 N 2.4374 5.8528 0.0 0 CHG=1 VAL=4
M  V30 13 C 6.4147 2.6674 0.0 0
M  V30 14 C 8.7247 4.0011 0.0 0
M  V30 15 C 8.7247 6.6685 0.0 0
M  V30 16 C 1.0306 5.2265 0.0 0
M  V30 17 C 2.2764 7.3845 0.0 0
M  V30 18 C 9.4947 5.3347 0.0 0
M  V30 19 C 0.0000 6.3708 0.0 0
M  V30 20 C 0.7700 7.7046 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 6 11
M  V30 11 1 7 12
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 13
M  V30 15 2 10 14
M  V30 16 1 11 15
M  V30 17 1 12 16
M  V30 18 1 12 17
M  V30 19 1 14 18
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 17 20
M  V30 23 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1498303-39-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1498303-53-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-4777850
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Tandem Mannich-Electrophilic Amination Reaction: a Versatile Platform
for Fluorescent Probing and Labeling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saczewski, Jaroslaw; Hinc, Krzysztof; Obuchowski, Michal; Gdaniec, Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2013), 19(35), 11531-11535

$RFMT $RIREG SCHEME91 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-2-butenoyl isothiocyanate
C6H7NOS
1504580-88-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 N 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 S 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-N-(1-pyrrolidinylthioxomethyl)-2-butenamide
C10H16N2OS
1504580-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 N 5.1047 1.8517 0.0 0
M  V30 3 S 3.7711 4.1618 0.0 0
M  V30 4 C 6.4384 2.6217 0.0 0
M  V30 5 C 7.7722 1.8517 0.0 0
M  V30 6 O 6.4384 4.1618 0.0 0
M  V30 7 C 9.1059 2.6217 0.0 0
M  V30 8 C 9.1059 4.1618 0.0 0
M  V30 9 C 10.4395 1.8517 0.0 0
M  V30 10 N 2.4374 1.8517 0.0 0
M  V30 11 C 1.0304 2.4782 0.0 0
M  V30 12 C 2.2763 0.3202 0.0 0
M  V30 13 C 0.0000 1.3337 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1504580-88-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1504580-89-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-14975571
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazolo compounds as PDE10 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flohr, Alexander; Groebke Zbinden, Katrin; Kuhn, Bernd; Lerner,
Christian; Rudolph, Markus; Schaffhauser, Herve
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013178572 A1 2013-12-05

$RFMT $RIREG SCHEME92 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2-Dimethyl-N-[2-(2,4,5-trihydroxyphenyl)ethyl]propanamide
C13H19NO4
155592-12-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 N 8.4700 4.0011 0.0 0
M  V30 4 C 9.2400 5.3349 0.0 0
M  V30 5 C 10.7800 5.3349 0.0 0
M  V30 6 O 8.4700 6.6685 0.0 0
M  V30 7 C 10.7800 3.7949 0.0 0
M  V30 8 C 12.3200 5.3349 0.0 0
M  V30 9 C 10.7800 6.8749 0.0 0
M  V30 10 O 4.6200 0.0000 0.0 0
M  V30 11 O 1.5400 5.3349 0.0 0
M  V30 12 O 0.0000 2.6674 0.0 0
M  V30 13 C 4.6200 2.6674 0.0 0
M  V30 14 C 3.8500 1.3338 0.0 0
M  V30 15 C 3.8500 4.0011 0.0 0
M  V30 16 C 2.3100 1.3338 0.0 0
M  V30 17 C 2.3100 4.0011 0.0 0
M  V30 18 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 14
M  V30 11 1 11 17
M  V30 12 1 12 18
M  V30 13 2 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 2 15 17
M  V30 17 2 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-[2,4-Dihydroxy-5-(1-pyrrolidinyl)phenyl]ethyl]-2,2-dimethylpropanamide
C17H26N2O3
178495-36-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.3117 2.6674 0.0 0
M  V30 2 C 6.4717 2.6674 0.0 0
M  V30 3 C 7.2417 4.0011 0.0 0
M  V30 4 N 8.7817 4.0011 0.0 0
M  V30 5 C 9.5517 5.3347 0.0 0
M  V30 6 C 11.0917 5.3347 0.0 0
M  V30 7 O 8.7817 6.6684 0.0 0
M  V30 8 C 11.0917 3.7947 0.0 0
M  V30 9 C 12.6317 5.3347 0.0 0
M  V30 10 C 11.0917 6.8747 0.0 0
M  V30 11 O 4.9317 0.0000 0.0 0
M  V30 12 C 2.6217 4.0011 0.0 0
M  V30 13 C 4.1617 4.0011 0.0 0
M  V30 14 C 1.8517 2.6674 0.0 0
M  V30 15 C 4.9317 2.6674 0.0 0
M  V30 16 C 2.6217 1.3336 0.0 0
M  V30 17 C 4.1617 1.3336 0.0 0
M  V30 18 N 1.8517 5.3347 0.0 0
M  V30 19 C 0.3202 5.4956 0.0 0
M  V30 20 C 2.4782 6.7417 0.0 0
M  V30 21 C 0.0000 7.0021 0.0 0
M  V30 22 C 1.3336 7.7721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 1 2 15
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 155592-12-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 178495-36-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-6389492
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 2206-26-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM "Redox cycling" preparation of pyrrolidinoresorcinols 6a and 6b. To a
solution of 0.06 mmol of 5-(2-pivalamidoethyl)-1,2,4-benzenetriol (2a) or
5-tert-butyl-1,2,4-benzenetriol (2b) in CD3CN (0.5 mL) was added
pyrrolidine (5 μL, 0.06 mmol), and the mixture was allowed to stand
overnight. 4-(Pyrrolidin-1-yl)-6-(2-pivalamidoethyl)resorcinol (6a) or
4-(pyrrolidin-1-yl)-6-tertbutylresorcinol (6b) were obtained
quantitatively, due to redox cycling catalysis by traces of the
corresponding quinone that contaminates the starting triols.(a) 1H NMR
(CD3CN) δ 1.11 (s, 9H), 1.89 (br s, 4H), 2.62 (t, J = 7.08 Hz, 2H), 2.92
(br s, 4H), 3.23 (m, 2H), 6.35 (s, 1H), 6.67 (br s, NH, 1H), 6.82 (s,
1H); 13C NMR (CD3CN) δ 25.0 (2C), 27.7 (3C), 30.7, 39.1, 41.0, 53.7 (2C),
102.7, 117.3, 123.2,130.5, 152.1, 153.2,180.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Pyrrolines Are Mechanism-Based Inactivators of the Quinone-Dependent
Amine Oxidases but Only Substrates of the Flavin-Dependent Amine Oxidases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Younghee; Ling, Ke-Qing; Lu, Xingliang; Silverman, Richard B.;
Shepard, E. M.; Dooley, D. M.; Sayre, Lawrence M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2002), 124(41), 12135-12143

$RFMT $RIREG SCHEME93 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-formylbenzoate
C9H8O3
1571-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 1.3337 2.3101 0.0 0
M  V30 3 O 2.6675 0.0000 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 C 8.0023 4.6201 0.0 0
M  V30 6 O 9.3360 3.8501 0.0 0
M  V30 7 C 4.0012 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 5.3348 1.5400 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 6.6685 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimethylsilyl cyanide
C4H9NSi
7677-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(cyano-1-pyrrolidinylmethyl)benzoate
C14H16N2O2
701054-24-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.0801 0.0 0
M  V30 2 C 3.7711 1.5400 0.0 0
M  V30 3 N 3.7711 0.0000 0.0 0
M  V30 4 C 9.1059 6.1601 0.0 0
M  V30 5 O 10.4396 5.3901 0.0 0
M  V30 6 O 9.1059 7.7002 0.0 0
M  V30 7 C 11.7733 6.1601 0.0 0
M  V30 8 C 5.1048 3.8501 0.0 0
M  V30 9 C 6.4384 3.0801 0.0 0
M  V30 10 C 5.1048 5.3901 0.0 0
M  V30 11 C 7.7722 3.8501 0.0 0
M  V30 12 C 6.4384 6.1601 0.0 0
M  V30 13 C 7.7722 5.3901 0.0 0
M  V30 14 N 2.4373 3.8501 0.0 0
M  V30 15 C 1.0304 3.2238 0.0 0
M  V30 16 C 2.2763 5.3816 0.0 0
M  V30 17 C 0.0000 4.3682 0.0 0
M  V30 18 C 0.7700 5.7018 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 3 2 3
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 13
M  V30 8 1 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1571-08-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 7677-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 701054-24-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-346-CAS-14891174
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 144026-79-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM polymer-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, flow system, Strecker reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of the heterogeneously catalyzed Strecker reaction conducted
under continuous flow
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wiles, Charlotte; Watts, Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2008), (33), 5597-5613

$RFMT $RIREG SCHEME94 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[5-(Chloromethyl)-2-methylphenyl]-4-[[6,7-dihydro-4-[4-(trifluoromethoxy)ph...
C29H24ClF3N4O3
1575815-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 11.5500 6.6684 0.0 0
M  V30 2 O 2.3100 4.0011 0.0 0
M  V30 3 C 1.5400 5.3347 0.0 0
M  V30 4 F 2.3100 6.6684 0.0 0
M  V30 5 F 0.7700 6.6684 0.0 0
M  V30 6 F 0.0000 5.3347 0.0 0
M  V30 7 C 17.7100 6.6684 0.0 0
M  V30 8 N 18.4800 8.0021 0.0 0
M  V30 9 O 18.4800 5.3347 0.0 0
M  V30 10 C 20.0200 10.6694 0.0 0
M  V30 11 C 23.1000 5.3347 0.0 0
M  V30 12 Cl 24.6400 5.3347 0.0 0
M  V30 13 C 8.4700 4.0011 0.0 0
M  V30 14 C 9.2400 2.6673 0.0 0
M  V30 15 N 9.2400 5.3347 0.0 0
M  V30 16 C 10.7800 2.6673 0.0 0
M  V30 17 C 8.4700 1.3336 0.0 0
M  V30 18 C 10.7800 5.3347 0.0 0
M  V30 19 N 11.5500 4.0011 0.0 0
M  V30 20 O 11.5500 1.3336 0.0 0
M  V30 21 C 9.2400 0.0000 0.0 0
M  V30 22 C 10.7800 0.0000 0.0 0
M  V30 23 C 6.9300 4.0011 0.0 0
M  V30 24 C 6.1600 5.3347 0.0 0
M  V30 25 C 6.1600 2.6673 0.0 0
M  V30 26 C 4.6200 5.3347 0.0 0
M  V30 27 C 4.6200 2.6673 0.0 0
M  V30 28 C 3.8500 4.0011 0.0 0
M  V30 29 C 13.0900 6.6684 0.0 0
M  V30 30 C 13.8600 5.3347 0.0 0
M  V30 31 C 13.8600 8.0021 0.0 0
M  V30 32 C 15.4000 5.3347 0.0 0
M  V30 33 C 15.4000 8.0021 0.0 0
M  V30 34 C 16.1700 6.6684 0.0 0
M  V30 35 C 20.0200 8.0021 0.0 0
M  V30 36 C 20.7900 6.6684 0.0 0
M  V30 37 C 20.7900 9.3358 0.0 0
M  V30 38 C 22.3300 6.6684 0.0 0
M  V30 39 C 22.3300 9.3358 0.0 0
M  V30 40 C 23.1000 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 1 29
M  V30 3 1 2 3
M  V30 4 1 2 28
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 34
M  V30 11 1 8 35
M  V30 12 1 10 37
M  V30 13 1 11 12
M  V30 14 1 11 38
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 13 23
M  V30 18 1 14 16
M  V30 19 1 14 17
M  V30 20 2 15 18
M  V30 21 2 16 19
M  V30 22 1 16 20
M  V30 23 1 17 21
M  V30 24 1 18 19
M  V30 25 1 20 22
M  V30 26 1 21 22
M  V30 27 2 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[6,7-Dihydro-4-[4-(trifluoromethoxy)phenyl]-5H-pyrano[2,3-d]pyrimidin-2-yl...
C33H32F3N5O3
1575815-67-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 15.4598 6.6684 0.0 0
M  V30 2 O 24.6998 4.0011 0.0 0
M  V30 3 C 25.4698 5.3347 0.0 0
M  V30 4 F 27.0098 5.3347 0.0 0
M  V30 5 F 26.2398 6.6684 0.0 0
M  V30 6 F 24.6998 6.6684 0.0 0
M  V30 7 C 9.2998 6.6684 0.0 0
M  V30 8 N 8.5298 8.0021 0.0 0
M  V30 9 O 8.5298 5.3347 0.0 0
M  V30 10 C 6.9898 10.6694 0.0 0
M  V30 11 C 3.9098 5.3347 0.0 0
M  V30 12 C 17.7698 2.6673 0.0 0
M  V30 13 C 18.5398 4.0011 0.0 0
M  V30 14 C 16.2298 2.6673 0.0 0
M  V30 15 C 18.5398 1.3336 0.0 0
M  V30 16 N 17.7698 5.3347 0.0 0
M  V30 17 N 15.4598 4.0011 0.0 0
M  V30 18 O 15.4598 1.3336 0.0 0
M  V30 19 C 17.7698 0.0000 0.0 0
M  V30 20 C 16.2298 5.3347 0.0 0
M  V30 21 C 16.2298 0.0000 0.0 0
M  V30 22 C 20.0798 4.0011 0.0 0
M  V30 23 C 20.8498 5.3347 0.0 0
M  V30 24 C 20.8498 2.6673 0.0 0
M  V30 25 C 22.3898 5.3347 0.0 0
M  V30 26 C 22.3898 2.6673 0.0 0
M  V30 27 C 23.1598 4.0011 0.0 0
M  V30 28 C 13.9198 6.6684 0.0 0
M  V30 29 C 13.1498 8.0021 0.0 0
M  V30 30 C 13.1498 5.3347 0.0 0
M  V30 31 C 11.6098 8.0021 0.0 0
M  V30 32 C 11.6098 5.3347 0.0 0
M  V30 33 C 10.8398 6.6684 0.0 0
M  V30 34 C 6.9898 8.0021 0.0 0
M  V30 35 C 6.2198 6.6684 0.0 0
M  V30 36 C 6.2198 9.3358 0.0 0
M  V30 37 C 4.6798 6.6684 0.0 0
M  V30 38 C 4.6798 9.3358 0.0 0
M  V30 39 C 3.9098 8.0021 0.0 0
M  V30 40 N 2.3698 5.3347 0.0 0
M  V30 41 C 1.4645 6.5806 0.0 0
M  V30 42 C 1.4645 4.0889 0.0 0
M  V30 43 C 0.0000 6.1047 0.0 0
M  V30 44 C 0.0000 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 20
M  V30 2 1 1 28
M  V30 3 1 2 3
M  V30 4 1 2 27
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 33
M  V30 11 1 8 34
M  V30 12 1 10 36
M  V30 13 1 11 37
M  V30 14 1 11 40
M  V30 15 2 12 13
M  V30 16 1 12 14
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 1 13 22
M  V30 20 2 14 17
M  V30 21 1 14 18
M  V30 22 1 15 19
M  V30 23 2 16 20
M  V30 24 1 17 20
M  V30 25 1 18 21
M  V30 26 1 19 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 2 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 2 30 32
M  V30 37 2 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 1 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1575815-64-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1575815-67-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5768256
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
N-(2-Methyl-5-((4-methylpiperazin-1-yl)methyl)phenyl)-4-((4-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-pyrano[2,3-d]pyrimidin-2-yl)amino)benzamide
(17). In a 10-mL reaction vial, N-methylpiperazine (44 mg, 5 eq) and
K2CO3 (24 mg, 3 eq) were added to a solution of 16 (50 mg, 1 eq) in DMF
(2 mL). The mixture was stirred at room temperature for 6 h and poured
into ice water (20 mL), extracted by EtOAc. After dried over anhydrous
Na2SO4, the organic layer was concentrated and purified by chromatography
(CH2Cl2 : CH3OH = 20:1) to give the product.
N-(2-Methyl-5-(pyrrolidin-1-ylmethyl)phenyl)-4-((4-(4-(trifluoromethoxy)phenyl)-6,7-dihydro-5H-pyrano[2,3-d]pyrimidin-2-yl)amino)benzamide
(19). Similar procedure of 17 was employed, and the compound 19 (56 mg,
100%) was obtained as a white solid. mp 116-118°C. Rf = 0.16 (CH2Cl2 :
CH3OH = 20:1). 1H-NMR (400 MHz, DMSO-d6) δ 9.86 (s, 1H, CONH), 9.64 (s,
1H, NH), 7.91 (s, 4H, ArH), 7.84 (d, 2H, J = 8.4 Hz, ArH), 7.54 (d, 2H, J
= 8.0 Hz, ArH), 7.30 (s, 1H, ArH), 7.21 (d, 1H, J = 8.0 Hz, ArH), 7.10
(d, 1H, J = 7.6 Hz, ArH), 4.41 (t, 2H, OCH2), 3.58 (s, 2H, PhCH2N), 2.69
(t, 2H, ArCH2), 2.47 (s, 4H, N(CH2)2), 2.21 (s, 3H, CH3), 1.90 (m, 2H,
CH2), 1.70 (s, 4H, CH2CH2) ppm; 13C-NMR (100 MHz, DMSO-d6) δ 167.65,
164.75, 164.19, 157.64, 148.75, 143.89, 136.95, 136.43, 131.99, 130.82,
129.95, 128.34, 126.56, 126.30, 120.65, 117.27, 104.21, 59.01, 53.39,
23.05, 22.06, 21.54, 17.63; MS (ESI) m/z: [M + H]+ = 604.3; HRMS(ESI) m/z
calcd for C33H33N5O3F3 [M + H]+ 604.2543, found 604.2536. IC50: 16.1
(nM).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, synthesis, and biological study of
6,7-dihydro-5H-pyrano[2,3-d]pyrimidine derivatives as novel hedgehog
signaling pathway inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xin, Minhang; Zhang, Liandi; Shen, Han; Wen, Jun; Tu, Chongxing; Liu,
Zhaoyu; Cheng, Lingfei; Zhao, Xinge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Medicinal Chemistry Research (2014), 23(8), 3784-3792

$RFMT $RIREG SCHEME95 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(2-Furanylmethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione
C11H10O5
15875-49-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5177 1.5400 0.0 0
M  V30 2 O 5.5177 4.6200 0.0 0
M  V30 3 O 2.8502 0.0000 0.0 0
M  V30 4 C 0.0000 3.5825 0.0 0
M  V30 5 C 0.9899 5.2970 0.0 0
M  V30 6 C 4.1840 2.3100 0.0 0
M  V30 7 C 4.1840 3.8500 0.0 0
M  V30 8 C 2.8502 1.5400 0.0 0
M  V30 9 O 2.8502 4.6200 0.0 0
M  V30 10 O 1.5166 2.3100 0.0 0
M  V30 11 C 1.5166 3.8500 0.0 0
M  V30 12 C 6.8513 2.3100 0.0 0
M  V30 13 C 7.0122 3.8415 0.0 0
M  V30 14 O 8.2582 1.6835 0.0 0
M  V30 15 C 8.5187 4.1617 0.0 0
M  V30 16 C 9.2887 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 1 12
M  V30 3 2 2 7
M  V30 4 2 3 8
M  V30 5 1 4 11
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[2-Hydroxy-5-(1-pyrrolidinyl)-2,4-pentadien-1-ylidene]-2,2-dimethyl-1,3-dio...
C15H19NO5
337513-86-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7996 2.6674 0.0 0
M  V30 2 C 6.5696 4.0011 0.0 0
M  V30 3 C 8.1096 4.0011 0.0 0
M  V30 4 O 5.7996 5.3349 0.0 0
M  V30 5 C 8.8796 5.3349 0.0 0
M  V30 6 C 10.4196 5.3349 0.0 0
M  V30 7 O 4.2596 0.0000 0.0 0
M  V30 8 O 4.2596 5.3349 0.0 0
M  V30 9 C 0.0000 3.6573 0.0 0
M  V30 10 C 0.0000 1.6775 0.0 0
M  V30 11 C 4.2596 2.6674 0.0 0
M  V30 12 C 3.4896 1.3338 0.0 0
M  V30 13 C 3.4896 4.0011 0.0 0
M  V30 14 O 1.9496 1.3338 0.0 0
M  V30 15 O 1.9496 4.0011 0.0 0
M  V30 16 C 1.1796 2.6674 0.0 0
M  V30 17 N 11.1896 4.0011 0.0 0
M  V30 18 C 10.5633 2.5943 0.0 0
M  V30 19 C 12.7212 3.8401 0.0 0
M  V30 20 C 11.7077 1.5637 0.0 0
M  V30 21 C 13.0413 2.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 11
M  V30 3 2 2 3 CFG=2
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 5 6 CFG=2
M  V30 7 1 6 17
M  V30 8 2 7 12
M  V30 9 2 8 13
M  V30 10 1 9 16
M  V30 11 1 10 16
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 15875-49-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 337513-86-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24017738
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM It's a trap: thiol-Michael chemistry on a DASA photoswitch
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alves, Jessica; Wiedbrauk, Sandra; Graefe, David; Walden, Sarah L.;
Blinco, James P.; Barner-Kowollik, Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2020), 26(4), 809-813

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Vinylbenzyl chloride
C9H9Cl
1592-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 0.0000 0.0 0
M  V30 4 Cl 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Ethenylphenyl)methyl]pyrrolidine
C13H17N
60472-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 0.0000 0.0 0
M  V30 2 C 9.1059 3.0801 0.0 0
M  V30 3 C 10.4396 2.3101 0.0 0
M  V30 4 C 5.1048 0.7700 0.0 0
M  V30 5 C 6.4384 0.0000 0.0 0
M  V30 6 C 5.1048 2.3101 0.0 0
M  V30 7 C 7.7722 0.7700 0.0 0
M  V30 8 C 6.4384 3.0801 0.0 0
M  V30 9 C 7.7722 2.3101 0.0 0
M  V30 10 N 2.4374 0.7700 0.0 0
M  V30 11 C 1.0304 0.1437 0.0 0
M  V30 12 C 2.2763 2.3016 0.0 0
M  V30 13 C 0.0000 1.2881 0.0 0
M  V30 14 C 0.7700 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1592-20-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60472-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11256645
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Functionalized diolefin elastomers having low hysteresis and good
compatibility with fillers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rodewald, Stephan; Henning, Steven Kristofer; Burkhart, Brian Earl
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6790921 B1 2004-09-14

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Vinylbenzyl chloride
C9H9Cl
1592-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 0.0000 0.0 0
M  V30 4 Cl 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Ethenylphenyl)methyl]pyrrolidine
C13H17N
60472-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 0.0000 0.0 0
M  V30 2 C 9.1059 3.0801 0.0 0
M  V30 3 C 10.4396 2.3101 0.0 0
M  V30 4 C 5.1048 0.7700 0.0 0
M  V30 5 C 6.4384 0.0000 0.0 0
M  V30 6 C 5.1048 2.3101 0.0 0
M  V30 7 C 7.7722 0.7700 0.0 0
M  V30 8 C 6.4384 3.0801 0.0 0
M  V30 9 C 7.7722 2.3101 0.0 0
M  V30 10 N 2.4374 0.7700 0.0 0
M  V30 11 C 1.0304 0.1437 0.0 0
M  V30 12 C 2.2763 2.3016 0.0 0
M  V30 13 C 0.0000 1.2881 0.0 0
M  V30 14 C 0.7700 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1592-20-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60472-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14210466
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Functionalized diolefin elastomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rodewald, Stephan; Henning, Steven Kristofer; Burkhart, Brian Earl
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040063890 A1 2004-04-01

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Vinylbenzyl chloride
C9H9Cl
1592-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 0.0000 0.0 0
M  V30 4 Cl 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Ethenylphenyl)methyl]pyrrolidine
C13H17N
60472-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 0.0000 0.0 0
M  V30 2 C 9.1059 3.0801 0.0 0
M  V30 3 C 10.4396 2.3101 0.0 0
M  V30 4 C 5.1048 0.7700 0.0 0
M  V30 5 C 6.4384 0.0000 0.0 0
M  V30 6 C 5.1048 2.3101 0.0 0
M  V30 7 C 7.7722 0.7700 0.0 0
M  V30 8 C 6.4384 3.0801 0.0 0
M  V30 9 C 7.7722 2.3101 0.0 0
M  V30 10 N 2.4374 0.7700 0.0 0
M  V30 11 C 1.0304 0.1437 0.0 0
M  V30 12 C 2.2763 2.3016 0.0 0
M  V30 13 C 0.0000 1.2881 0.0 0
M  V30 14 C 0.7700 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1592-20-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60472-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7841602
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of functionalized styrene monomers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rodewald, Stephan; Henning, Steven Kristofer; Burkhart, Brian Earl
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20040063933 A1 2004-04-01

$RFMT $RIREG SCHEME96 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Vinylbenzyl chloride
C9H9Cl
1592-20-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 C 0.0000 2.3101 0.0 0
M  V30 3 C 6.6687 0.0000 0.0 0
M  V30 4 Cl 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 4.0012 3.0801 0.0 0
M  V30 7 C 2.6675 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Ethenylphenyl)methyl]pyrrolidine
C13H17N
60472-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 0.0000 0.0 0
M  V30 2 C 9.1059 3.0801 0.0 0
M  V30 3 C 10.4396 2.3101 0.0 0
M  V30 4 C 5.1048 0.7700 0.0 0
M  V30 5 C 6.4384 0.0000 0.0 0
M  V30 6 C 5.1048 2.3101 0.0 0
M  V30 7 C 7.7722 0.7700 0.0 0
M  V30 8 C 6.4384 3.0801 0.0 0
M  V30 9 C 7.7722 2.3101 0.0 0
M  V30 10 N 2.4374 0.7700 0.0 0
M  V30 11 C 1.0304 0.1437 0.0 0
M  V30 12 C 2.2763 2.3016 0.0 0
M  V30 13 C 0.0000 1.2881 0.0 0
M  V30 14 C 0.7700 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1592-20-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60472-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14842962
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction mixture cooled with an ice bath
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Functionalized elastomers for tire treads
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rodewald, Stephan; Henning, Steven Kristofer; Burkhart, Brian Earl
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US6664328 B1 2003-12-16

$RFMT $RIREG SCHEME97 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Iodoethyl)-3-[(4-methoxyphenyl)methyl]-2(1H)-quinoxalinone
C18H17IN2O2
1610961-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 4.0011 0.0 0
M  V30 2 C 1.5400 5.3347 0.0 0
M  V30 3 I 0.0000 5.3347 0.0 0
M  V30 4 O 3.8500 6.6685 0.0 0
M  V30 5 C 6.9300 6.6685 0.0 0
M  V30 6 O 13.0900 6.6685 0.0 0
M  V30 7 C 13.8600 8.0021 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 N 3.8500 4.0011 0.0 0
M  V30 10 C 6.1600 2.6674 0.0 0
M  V30 11 C 3.8500 1.3336 0.0 0
M  V30 12 C 4.6200 5.3347 0.0 0
M  V30 13 N 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3336 0.0 0
M  V30 15 C 4.6200 0.0000 0.0 0
M  V30 16 C 6.1600 5.3347 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 18 C 8.4700 6.6685 0.0 0
M  V30 19 C 9.2400 5.3347 0.0 0
M  V30 20 C 9.2400 8.0021 0.0 0
M  V30 21 C 10.7800 5.3347 0.0 0
M  V30 22 C 10.7800 8.0021 0.0 0
M  V30 23 C 11.5500 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 4 12
M  V30 5 1 5 16
M  V30 6 1 5 18
M  V30 7 1 6 7
M  V30 8 1 6 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 2 15 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[(4-Methoxyphenyl)methyl]-1-[2-(1-pyrrolidinyl)ethyl]-2(1H)-quinoxalinone
C22H25N3O2
1610961-23-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 4.0011 0.0 0
M  V30 2 C 3.9098 5.3347 0.0 0
M  V30 3 O 6.2198 6.6685 0.0 0
M  V30 4 C 9.2998 6.6685 0.0 0
M  V30 5 O 15.4598 6.6685 0.0 0
M  V30 6 C 16.2298 8.0021 0.0 0
M  V30 7 C 6.9898 2.6674 0.0 0
M  V30 8 N 6.2198 4.0011 0.0 0
M  V30 9 C 8.5298 2.6674 0.0 0
M  V30 10 C 6.2198 1.3336 0.0 0
M  V30 11 C 6.9898 5.3347 0.0 0
M  V30 12 N 9.2998 4.0011 0.0 0
M  V30 13 C 9.2998 1.3336 0.0 0
M  V30 14 C 6.9898 0.0000 0.0 0
M  V30 15 C 8.5298 5.3347 0.0 0
M  V30 16 C 8.5298 0.0000 0.0 0
M  V30 17 N 2.3698 5.3347 0.0 0
M  V30 18 C 1.4645 6.5806 0.0 0
M  V30 19 C 1.4645 4.0889 0.0 0
M  V30 20 C 0.0000 6.1047 0.0 0
M  V30 21 C 0.0000 4.5647 0.0 0
M  V30 22 C 10.8398 6.6685 0.0 0
M  V30 23 C 11.6098 5.3347 0.0 0
M  V30 24 C 11.6098 8.0021 0.0 0
M  V30 25 C 13.1498 5.3347 0.0 0
M  V30 26 C 13.1498 8.0021 0.0 0
M  V30 27 C 13.9198 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 17
M  V30 4 2 3 11
M  V30 5 1 4 15
M  V30 6 1 4 22
M  V30 7 1 5 6
M  V30 8 1 5 27
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 11
M  V30 13 1 9 12
M  V30 14 2 9 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 2 14 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1610961-35-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1610961-23-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3946352
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 18162-48-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A diversity-oriented synthesis of caroverine derivatives via
TEMPO-promoted aerobic oxidative C-N bond formation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kobayashi, Yusuke; Suzuki, Yusuke; Ogata, Tokutaro; Kimachi, Tetsutaro;
Takemoto, Yoshiji
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(22), 3299-3301

$RFMT $RIREG SCHEME98 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloropropanesulfonyl chloride
C3H6Cl2O2S
1633-82-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.1037 0.0 0
M  V30 2 S 1.3338 1.3337 0.0 0 VAL=6
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 0.0000 0.5637 0.0 0
M  V30 5 O 2.1038 0.0000 0.0 0
M  V30 6 O 0.5638 2.6673 0.0 0
M  V30 7 C 5.3348 2.1037 0.0 0
M  V30 8 Cl 6.6687 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(3-Chloropropyl)sulfonyl]pyrrolidine
C7H14ClNO2S
146475-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 2.6218 0.0 0 VAL=6
M  V30 2 C 5.1048 3.3918 0.0 0
M  V30 3 O 4.5411 1.2881 0.0 0
M  V30 4 O 3.0011 3.9554 0.0 0
M  V30 5 C 6.4386 2.6218 0.0 0
M  V30 6 C 7.7722 3.3918 0.0 0
M  V30 7 Cl 9.1059 2.6218 0.0 0
M  V30 8 N 2.4374 1.8517 0.0 0
M  V30 9 C 1.0304 2.4781 0.0 0
M  V30 10 C 2.2763 0.3202 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1633-82-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 146475-49-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-9581799
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of 1-[(3-chloropropyl)sulfonyl)]pyrrolidine 41: The procedure
for Synthesis of sulfonamides: In a flame-dried two-necked flask equipped
with a magnetical stirrer, 1 eq. of amine and 1 eq. of Et3N were
dissolved in Et2O or CH2Cl2. The solution was stirred and 1 eq. of
sulfonyl chloride was slowly added. The stirring was maintained for 4
hours. After that time the reaction mixture was filtered and the solvent
evaporated. The product was purified by flash chromatography. The titled
compound was followed this procedure with: 2 mL (1.704 g; 23.95 mmol; 1
eq.) of pyrrolidine 3.33 mL (2.424 g; 23.95 mmol; 1 eq.) of Et3N; 2.913
mL (4.241 g; 23.95 mmol; 1 eq.) of 3-chloropropanesulfonyl chloride; 21
mL of CH2Cl2. Flash chromatography: AcOEt:CH2Cl2 1:1, Yield: 5.23 g (100
%). Aspect: white solid. TLC: Rf = 0.29 (CH2Cl2 100 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric cyclopentannulation reactions: scope and limitation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schanen, Patrick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2003), (20140701), No pp.

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N,N-bis[(4-chloro-2-pyridinyl)methyl]-2-pyridinemethanamine
C18H15Cl3N4
1639852-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 C 6.9300 6.6684 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 Cl 0.0000 10.6694 0.0 0
M  V30 6 Cl 11.5500 9.3358 0.0 0
M  V30 7 Cl 4.6200 0.0000 0.0 0
M  V30 8 C 3.0800 8.0021 0.0 0
M  V30 9 C 2.3100 9.3358 0.0 0
M  V30 10 N 2.3100 6.6684 0.0 0
M  V30 11 C 0.7700 9.3358 0.0 0
M  V30 12 C 0.7700 6.6684 0.0 0
M  V30 13 C 0.0000 8.0021 0.0 0
M  V30 14 C 7.7000 8.0021 0.0 0
M  V30 15 C 9.2400 8.0021 0.0 0
M  V30 16 N 6.9300 9.3358 0.0 0
M  V30 17 C 10.0100 9.3358 0.0 0
M  V30 18 C 7.7000 10.6694 0.0 0
M  V30 19 C 9.2400 10.6694 0.0 0
M  V30 20 C 5.3900 4.0011 0.0 0
M  V30 21 C 4.6200 2.6673 0.0 0
M  V30 22 N 6.9300 4.0011 0.0 0
M  V30 23 C 5.3900 1.3336 0.0 0
M  V30 24 C 7.7000 2.6673 0.0 0
M  V30 25 C 6.9300 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 8
M  V30 5 1 3 14
M  V30 6 1 4 20
M  V30 7 1 5 11
M  V30 8 1 6 17
M  V30 9 1 7 23
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1-Pyrrolidinyl)-N,N-bis[[4-(1-pyrrolidinyl)-2-pyridinyl]methyl]-2-pyridine...
C30H39N7
2446735-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5299 9.1059 0.0 0
M  V30 2 C 9.3000 7.7721 0.0 0
M  V30 3 C 6.9899 9.1059 0.0 0
M  V30 4 C 9.3000 10.4396 0.0 0
M  V30 5 C 8.5299 6.4384 0.0 0
M  V30 6 C 9.3000 5.1048 0.0 0
M  V30 7 N 6.9899 6.4384 0.0 0
M  V30 8 C 8.5299 3.7711 0.0 0
M  V30 9 C 6.2199 5.1048 0.0 0
M  V30 10 C 6.9899 3.7711 0.0 0
M  V30 11 C 6.2199 10.4396 0.0 0
M  V30 12 C 4.6799 10.4396 0.0 0
M  V30 13 N 6.9899 11.7733 0.0 0
M  V30 14 C 3.9098 11.7733 0.0 0
M  V30 15 C 6.2199 13.1069 0.0 0
M  V30 16 C 4.6799 13.1069 0.0 0
M  V30 17 C 10.8400 10.4396 0.0 0
M  V30 18 C 11.6100 9.1059 0.0 0
M  V30 19 N 11.6100 11.7733 0.0 0
M  V30 20 C 13.1500 9.1059 0.0 0
M  V30 21 C 13.1500 11.7733 0.0 0
M  V30 22 C 13.9201 10.4396 0.0 0
M  V30 23 N 9.3000 2.4373 0.0 0
M  V30 24 C 8.6736 1.0304 0.0 0
M  V30 25 C 10.8315 2.2763 0.0 0
M  V30 26 C 9.8180 0.0000 0.0 0
M  V30 27 C 11.1517 0.7700 0.0 0
M  V30 28 N 2.3698 11.7733 0.0 0
M  V30 29 C 1.4646 13.0191 0.0 0
M  V30 30 C 1.4646 10.5274 0.0 0
M  V30 31 C 0.0000 12.5433 0.0 0
M  V30 32 C 0.0000 11.0032 0.0 0
M  V30 33 N 15.4601 10.4396 0.0 0
M  V30 34 C 16.3653 9.1937 0.0 0
M  V30 35 C 16.3653 11.6855 0.0 0
M  V30 36 C 17.8299 9.6696 0.0 0
M  V30 37 C 17.8299 11.2096 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 11
M  V30 6 1 4 17
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 8 23
M  V30 13 1 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 14 28
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 1 22 33
M  V30 28 1 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1639852-32-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2446735-20-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-113-CAS-22302138
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM p-Substituted Tris(2-pyridylmethyl)amines as Ligands for Highly Active
ATRP Catalysts: Facile Synthesis and Characterization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Enciso, Alan E.; Lorandi, Francesca; Mehmood, Arshad; Fantin, Marco;
Szczepaniak, Grzegorz; Janesko, Benjamin G.; Matyjaszewski, Krzysztof
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2020), 59(35), 14910-14920

$RFMT $RIREG SCHEME99 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N,N-bis[(4-chloro-2-pyridinyl)methyl]-2-pyridinemethanamine
C18H15Cl3N4
1639852-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 C 6.9300 6.6684 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 Cl 0.0000 10.6694 0.0 0
M  V30 6 Cl 11.5500 9.3358 0.0 0
M  V30 7 Cl 4.6200 0.0000 0.0 0
M  V30 8 C 3.0800 8.0021 0.0 0
M  V30 9 C 2.3100 9.3358 0.0 0
M  V30 10 N 2.3100 6.6684 0.0 0
M  V30 11 C 0.7700 9.3358 0.0 0
M  V30 12 C 0.7700 6.6684 0.0 0
M  V30 13 C 0.0000 8.0021 0.0 0
M  V30 14 C 7.7000 8.0021 0.0 0
M  V30 15 C 9.2400 8.0021 0.0 0
M  V30 16 N 6.9300 9.3358 0.0 0
M  V30 17 C 10.0100 9.3358 0.0 0
M  V30 18 C 7.7000 10.6694 0.0 0
M  V30 19 C 9.2400 10.6694 0.0 0
M  V30 20 C 5.3900 4.0011 0.0 0
M  V30 21 C 4.6200 2.6673 0.0 0
M  V30 22 N 6.9300 4.0011 0.0 0
M  V30 23 C 5.3900 1.3336 0.0 0
M  V30 24 C 7.7000 2.6673 0.0 0
M  V30 25 C 6.9300 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 8
M  V30 5 1 3 14
M  V30 6 1 4 20
M  V30 7 1 5 11
M  V30 8 1 6 17
M  V30 9 1 7 23
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1-Pyrrolidinyl)-N,N-bis[[4-(1-pyrrolidinyl)-2-pyridinyl]methyl]-2-pyridine...
C30H39N7
2446735-20-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5299 9.1059 0.0 0
M  V30 2 C 9.3000 7.7721 0.0 0
M  V30 3 C 6.9899 9.1059 0.0 0
M  V30 4 C 9.3000 10.4396 0.0 0
M  V30 5 C 8.5299 6.4384 0.0 0
M  V30 6 C 9.3000 5.1048 0.0 0
M  V30 7 N 6.9899 6.4384 0.0 0
M  V30 8 C 8.5299 3.7711 0.0 0
M  V30 9 C 6.2199 5.1048 0.0 0
M  V30 10 C 6.9899 3.7711 0.0 0
M  V30 11 C 6.2199 10.4396 0.0 0
M  V30 12 C 4.6799 10.4396 0.0 0
M  V30 13 N 6.9899 11.7733 0.0 0
M  V30 14 C 3.9098 11.7733 0.0 0
M  V30 15 C 6.2199 13.1069 0.0 0
M  V30 16 C 4.6799 13.1069 0.0 0
M  V30 17 C 10.8400 10.4396 0.0 0
M  V30 18 C 11.6100 9.1059 0.0 0
M  V30 19 N 11.6100 11.7733 0.0 0
M  V30 20 C 13.1500 9.1059 0.0 0
M  V30 21 C 13.1500 11.7733 0.0 0
M  V30 22 C 13.9201 10.4396 0.0 0
M  V30 23 N 9.3000 2.4373 0.0 0
M  V30 24 C 8.6736 1.0304 0.0 0
M  V30 25 C 10.8315 2.2763 0.0 0
M  V30 26 C 9.8180 0.0000 0.0 0
M  V30 27 C 11.1517 0.7700 0.0 0
M  V30 28 N 2.3698 11.7733 0.0 0
M  V30 29 C 1.4646 13.0191 0.0 0
M  V30 30 C 1.4646 10.5274 0.0 0
M  V30 31 C 0.0000 12.5433 0.0 0
M  V30 32 C 0.0000 11.0032 0.0 0
M  V30 33 N 15.4601 10.4396 0.0 0
M  V30 34 C 16.3653 9.1937 0.0 0
M  V30 35 C 16.3653 11.6855 0.0 0
M  V30 36 C 17.8299 9.6696 0.0 0
M  V30 37 C 17.8299 11.2096 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 11
M  V30 6 1 4 17
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 8 23
M  V30 13 1 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 14 28
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 21 22
M  V30 27 1 22 33
M  V30 28 1 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1639852-32-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2446735-20-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32525888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dual electrochemical and chemical control in atom transfer radical
polymerization with copper electrodes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De Bon, Francesco; Lorandi, Francesca; Coelho, Jorge F. J.; Serra,
Armenio C.; Matyjaszewski, Krzysztof; Isse, Abdirisak A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2022), 13(20), 6008-6018

$RFMT $RIREG SCHEME100 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N,N-bis[(4-chloro-2-pyridinyl)methyl]-2-pyridinemethanamine
C18H15Cl3N4
1639852-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 6.6684 0.0 0
M  V30 2 C 4.6200 8.0021 0.0 0
M  V30 3 C 6.9300 6.6684 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 Cl 0.0000 10.6694 0.0 0
M  V30 6 Cl 11.5500 9.3358 0.0 0
M  V30 7 Cl 4.6200 0.0000 0.0 0
M  V30 8 C 3.0800 8.0021 0.0 0
M  V30 9 C 2.3100 9.3358 0.0 0
M  V30 10 N 2.3100 6.6684 0.0 0
M  V30 11 C 0.7700 9.3358 0.0 0
M  V30 12 C 0.7700 6.6684 0.0 0
M  V30 13 C 0.0000 8.0021 0.0 0
M  V30 14 C 7.7000 8.0021 0.0 0
M  V30 15 C 9.2400 8.0021 0.0 0
M  V30 16 N 6.9300 9.3358 0.0 0
M  V30 17 C 10.0100 9.3358 0.0 0
M  V30 18 C 7.7000 10.6694 0.0 0
M  V30 19 C 9.2400 10.6694 0.0 0
M  V30 20 C 5.3900 4.0011 0.0 0
M  V30 21 C 4.6200 2.6673 0.0 0
M  V30 22 N 6.9300 4.0011 0.0 0
M  V30 23 C 5.3900 1.3336 0.0 0
M  V30 24 C 7.7000 2.6673 0.0 0
M  V30 25 C 6.9300 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 8
M  V30 5 1 3 14
M  V30 6 1 4 20
M  V30 7 1 5 11
M  V30 8 1 6 17
M  V30 9 1 7 23
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Pyridinemethanamine, 4-(1-pyrrolidinyl)-N,N-bis[[4-(1-pyrrolidinyl)-2-pyrid...
C30H39N7
3050743-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.2417 9.1058 0.0 0
M  V30 2 C 8.7817 9.1058 0.0 0
M  V30 3 C 6.4717 7.7721 0.0 0
M  V30 4 C 6.4717 10.4396 0.0 0
M  V30 5 C 9.5517 10.4396 0.0 0
M  V30 6 C 11.0918 10.4396 0.0 0
M  V30 7 N 8.7817 11.7732 0.0 0
M  V30 8 C 11.8618 11.7732 0.0 0
M  V30 9 C 9.5517 13.1069 0.0 0
M  V30 10 C 11.0918 13.1069 0.0 0
M  V30 11 C 7.2417 6.4385 0.0 0
M  V30 12 C 6.4717 5.1047 0.0 0
M  V30 13 N 8.7817 6.4385 0.0 0
M  V30 14 C 7.2417 3.7710 0.0 0
M  V30 15 C 9.5517 5.1047 0.0 0
M  V30 16 C 8.7817 3.7710 0.0 0
M  V30 17 C 4.9317 10.4396 0.0 0
M  V30 18 C 4.1617 11.7732 0.0 0
M  V30 19 N 4.1617 9.1058 0.0 0
M  V30 20 C 2.6217 11.7732 0.0 0
M  V30 21 C 2.6217 9.1058 0.0 0
M  V30 22 C 1.8517 10.4396 0.0 0
M  V30 23 N 13.4018 11.7732 0.0 0
M  V30 24 C 14.3070 10.5273 0.0 0
M  V30 25 C 14.3070 13.0191 0.0 0
M  V30 26 C 15.7715 11.0032 0.0 0
M  V30 27 C 15.7715 12.5432 0.0 0
M  V30 28 N 6.4717 2.4374 0.0 0
M  V30 29 C 4.9402 2.2764 0.0 0
M  V30 30 C 7.0981 1.0306 0.0 0
M  V30 31 C 4.6200 0.7700 0.0 0
M  V30 32 C 5.9537 0.0000 0.0 0
M  V30 33 N 1.8517 13.1069 0.0 0
M  V30 34 C 2.4780 14.5137 0.0 0
M  V30 35 C 0.3202 13.2678 0.0 0
M  V30 36 C 1.3336 15.5442 0.0 0
M  V30 37 C 0.0000 14.7742 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 11
M  V30 6 1 4 17
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 8 23
M  V30 13 1 9 10
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 14 28
M  V30 20 1 15 16
M  V30 21 2 17 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 21
M  V30 25 2 20 22
M  V30 26 1 20 33
M  V30 27 1 21 22
M  V30 28 1 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1639852-32-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3050743-30-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41445773
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM AceGlass pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Electrochemically Mediated Atom Transfer Radical Polymerization Driven by
Alternating Current
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM De Bon, Francesco; Fantin, Marco; Pereira, Vanessa A.; Lourenco
Bernardino, Teresa J.; Serra, Armenio C.; Matyjaszewski, Krzysztof;
Coelho, Jorge F. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(29), e202406484

$RFMT $RIREG SCHEME101 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(6R,7R)-1-Oxo-2-azaspiro[5.5]undecane-7-acetaldehyde
C12H19NO2
1642129-63-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 3.0800 0.0 0
M  V30 2 C 6.6685 3.8500 0.0 0
M  V30 3 O 8.0021 3.0800 0.0 0
M  V30 4 O 0.0000 3.0800 0.0 0
M  V30 5 C 2.6674 3.0800 0.0 0 CFG=2
M  V30 6 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 7 C 1.3336 2.3100 0.0 0
M  V30 8 C 1.3336 3.8500 0.0 0
M  V30 9 C 4.0011 2.3100 0.0 0
M  V30 10 C 4.0011 5.3900 0.0 0
M  V30 11 N 1.3336 0.7700 0.0 0
M  V30 12 C 1.3336 5.3900 0.0 0
M  V30 13 C 4.0011 0.7700 0.0 0
M  V30 14 C 2.6674 6.1600 0.0 0
M  V30 15 C 2.6674 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 6 1 CFG=3
M  V30 3 2 2 3
M  V30 4 2 4 7
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=1
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(6R,7R)-7-[(1E)-2-(1-Pyrrolidinyl)ethenyl]-2-azaspiro[5.5]undecan-1-one
C16H26N2O
1642129-64-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 0.0000 3.0801 0.0 0
M  V30 4 C 2.6673 3.0801 0.0 0 CFG=2
M  V30 5 C 4.0012 2.3101 0.0 0 CFG=1
M  V30 6 C 1.3337 3.8501 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 4.0012 3.8501 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 N 1.3337 5.3901 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 2.6673 6.1601 0.0 0
M  V30 15 N 8.0022 3.0801 0.0 0
M  V30 16 C 8.1633 4.6116 0.0 0
M  V30 17 C 9.4091 2.4537 0.0 0
M  V30 18 C 9.6696 4.9318 0.0 0
M  V30 19 C 10.4396 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 5 1 CFG=1
M  V30 3 1 2 15
M  V30 4 2 3 6
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7 CFG=1
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 4 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1642129-63-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1642129-64-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13358102
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 7-((E)-2-(Pyrrolidin-1-yl)vinyl)-2-azaspiro[5.5]undecan-1-one (37). To a
stirred solution of aldehyde 36 (50 mg, 0.24 mmol) in CHCl3 (1 mL) at 0
°C was added 4 Å molecular sieves (300 mg) and pyrrolidine (0.29 mmol,
0.024 mL). The reaction mixture was stirred for 1.5 h at 0 °C, filtered
through a Celite pad, and concentrated in vacuo. Pyrrolidinoenamine 37 as
a white solid that was used without further purification (63 mg, 100%). A
small sample (ca. 5 mg) of enamine 37 was recrystallized from Et2O to
afford clear prisms that were suitable for X-ray analysis. 1H NMR (300
MHz, CDCl3) δ 6.08-6.19 (m, 2H), 3.95 (dd, J = 13.8, 7.6 Hz, 1H),
2.85-3.25 (m, 6H), 2.62-2.73 (m, 1H), 1.11-2.05 (m, 16H); 13C NMR (75
MHz, CDCl3) δ 178.6, 136.9, 100.2, 49.6, 47.4, 43.8, 42.7, 34.3, 28.1,
26.3, 25.2, 23.5, 20.8, 20.4; HRMS-ES+ (C16H27N2O) calcd 263.2123 (MH+),
found 263.2131.
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Construction of the Myrioneuron Alkaloids: A Total Synthesis of
(±)-Myrioneurinol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nocket, Anthony J.; Feng, Yiqing; Weinreb, Steven M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(2), 1116-1129

$RFMT $RIREG SCHEME102 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
1694-92-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0009 0.0 0 VAL=6
M  V30 2 Cl 6.1600 4.0009 0.0 0
M  V30 3 O 4.6200 2.4609 0.0 0
M  V30 4 O 4.6200 5.5409 0.0 0
M  V30 5 N 3.0800 1.3336 0.0 0 VAL=5
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 O 4.6200 1.3336 0.0 0
M  V30 8 C 3.0800 4.0009 0.0 0
M  V30 9 C 2.3100 2.6673 0.0 0
M  V30 10 C 2.3100 5.3347 0.0 0
M  V30 11 C 0.7700 2.6673 0.0 0
M  V30 12 C 0.7700 5.3347 0.0 0
M  V30 13 C 0.0000 4.0009 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 9
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(2-Nitrophenyl)sulfonyl]pyrrolidine
C10H12N2O4S
327069-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 4.0009 0.0 0 VAL=6
M  V30 2 O 4.6200 2.4609 0.0 0
M  V30 3 O 4.6200 5.5409 0.0 0
M  V30 4 N 3.0800 1.3336 0.0 0 VAL=5
M  V30 5 O 2.3100 0.0000 0.0 0
M  V30 6 O 4.6200 1.3336 0.0 0
M  V30 7 C 3.0800 4.0009 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 0.7700 2.6673 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 0.0000 4.0009 0.0 0
M  V30 13 N 6.1600 4.0009 0.0 0
M  V30 14 C 7.0652 2.7551 0.0 0
M  V30 15 C 7.0652 5.2469 0.0 0
M  V30 16 C 8.5298 3.2309 0.0 0
M  V30 17 C 8.5298 4.7709 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 1 13
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 8
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-92-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 327069-81-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-5986868
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) 1-(2-Nitro-benzenesulfonyl)-pyrrolidine 2-Nitrobenzenesulfonyl
chloride (4.43 g, 20 mmol) in methylene chloride (20 mL) was added
dropwise to the ice-cooled solution of pyrrolidine (8.4 mL, 100 mmol) in
methylene chloride (100 mL). The reaction mixture was stirred at room
temperature for 2 hours and washed with 3N HCl (2x60 mL) and brine (60
mL). The organic layer was dried (Na2SO4) and concentrated to yield the
intermediate nitrobenzene derivative (5.12 g, 100%).
1-(2-Nitro-benzenesulfonyl)-pyrrolidine, yield (5.12 g, 100%). 1H NMR
(400 MHz, CDCl3) δ: 8.00 (d, 1H), 7.70 (m, 2H), 7.60 (d, 1H), 3.40 (t,
4H), 1.92 (t, 4H), 1.80 (t, 4H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-aminoalkyl amides as agonists of the κ opioid receptor
useful against gastrointestinal disorders, pain, and pruritus
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dolle, Roland E.; Chu, Guo-Hua; Gu, Minghua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20050107355 A1 2005-05-19

$RFMT $RIREG SCHEME103 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(6-Bromo-3-pyridinyl)-3-chloropropanamide
C8H8BrClN2O
1696852-80-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1601 1.3337 0.0 0
M  V30 2 C 6.9302 2.6673 0.0 0
M  V30 3 C 8.4702 2.6673 0.0 0
M  V30 4 O 6.1601 4.0010 0.0 0
M  V30 5 C 9.2402 4.0010 0.0 0
M  V30 6 Cl 10.7802 4.0010 0.0 0
M  V30 7 Br 0.0000 1.3337 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 3.8501 0.0000 0.0 0
M  V30 10 C 3.8501 2.6673 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 N 2.3101 2.6673 0.0 0
M  V30 13 C 1.5400 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 7 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(6-Bromo-3-pyridinyl)-1-pyrrolidinepropanamide
C12H16BrN3O
2166566-48-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.9898 3.9132 0.0 0
M  V30 2 C 6.2198 2.5795 0.0 0
M  V30 3 C 4.6798 2.5795 0.0 0
M  V30 4 O 6.9898 1.2459 0.0 0
M  V30 5 C 3.9098 1.2459 0.0 0
M  V30 6 Br 13.1499 3.9132 0.0 0
M  V30 7 C 8.5299 3.9132 0.0 0
M  V30 8 C 9.2999 5.2469 0.0 0
M  V30 9 C 9.2999 2.5795 0.0 0
M  V30 10 C 10.8399 5.2469 0.0 0
M  V30 11 N 10.8399 2.5795 0.0 0
M  V30 12 C 11.6099 3.9132 0.0 0
M  V30 13 N 2.3698 1.2459 0.0 0
M  V30 14 C 1.4646 2.4918 0.0 0
M  V30 15 C 1.4646 0.0000 0.0 0
M  V30 16 C 0.0000 2.0159 0.0 0
M  V30 17 C 0.0000 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 13
M  V30 7 1 6 12
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1696852-80-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2166566-48-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19599094
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heteroaryl-carboxamides as histone demethylase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carceller Gonzalez, Elena; Ortega Munoz, Alberto; Salas Solana, Jorge
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018219478 A1 2018-12-06

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzoyl chloride
C7H4BrClO
1711-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Br 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Bromophenyl)(pyrrolidin-1-yl)methanone
C11H12BrNO
346721-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 Br 9.1059 1.5400 0.0 0
M  V30 4 C 5.1048 2.3101 0.0 0
M  V30 5 C 6.4386 1.5400 0.0 0
M  V30 6 C 5.1048 3.8501 0.0 0
M  V30 7 C 7.7722 2.3101 0.0 0
M  V30 8 C 6.4386 4.6201 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 N 2.4374 2.3101 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 7
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-09-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 346721-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-6252684
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (3-Bromo-phenyl)-pyrrolidin-1-yl-methanone (Intermediate 81) A solution
of 3-bromo-benzoyl chloride (2.7 g, 12 mmol) in DCM (40 mL) was chilled
to zero degrees and treated with pyrrolidine (3 mL, 36.8 mmol). Reaction
was allowed to come to room temperature and stir for 4 h. Mixture was
then poured onto water and washed once. Organic phase then washed with
brine, dried over sodium sulfate, filtered and evaporated. amber oil,
yield (3.1 g, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine derivatives as JAK kinases inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Noronha, Glenn; Mak, Chi Ching; Cao, Jianguo; Renick, Joel; McPherson,
Andrew; Zeng, Binqi; Pathak, Ved P.; Lohse, Daniel L.; Hood, John D.;
Soll, Richard M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20110212077 A1 2011-09-01

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzoyl chloride
C7H4BrClO
1711-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Br 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Bromophenyl)(pyrrolidin-1-yl)methanone
C11H12BrNO
346721-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 Br 9.1059 1.5400 0.0 0
M  V30 4 C 5.1048 2.3101 0.0 0
M  V30 5 C 6.4386 1.5400 0.0 0
M  V30 6 C 5.1048 3.8501 0.0 0
M  V30 7 C 7.7722 2.3101 0.0 0
M  V30 8 C 6.4386 4.6201 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 N 2.4374 2.3101 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 7
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-09-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 346721-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-2841147
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (3-Bromo-phenyl)-pyrrolidin-1-yl-methanone (Intermediate 81) A solution
of 3-bromo-benzoyl chloride (2.7 g, 12 mmol) in DCM (40 mL) was chilled
to zero degrees and treated with pyrrolidine (3 mL, 36.8 mmol). Reaction
was allowed to come to room temperature and stir for 4 h. Mixture was
then poured onto water and washed once. Organic phase then washed with
brine, dried over sodium sulfate, filtered and evaporated. Amber oil,
yield (3.1 g, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bi-aryl 2,4-pyrimidinediamines as inhibitors of kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hood, John D.; Noronha, Glenn
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090286789 A1 2009-11-19

$RFMT $RIREG SCHEME104 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromobenzoyl chloride
C7H4BrClO
1711-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Br 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Bromophenyl)(pyrrolidin-1-yl)methanone
C11H12BrNO
346721-91-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 Br 9.1059 1.5400 0.0 0
M  V30 4 C 5.1048 2.3101 0.0 0
M  V30 5 C 6.4386 1.5400 0.0 0
M  V30 6 C 5.1048 3.8501 0.0 0
M  V30 7 C 7.7722 2.3101 0.0 0
M  V30 8 C 6.4386 4.6201 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 N 2.4374 2.3101 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 7
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-09-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 346721-91-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-8809506
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 229. (3-Bromo-phenyl)-pyrrolidin-1-yl-methanone (Intermediate 81)
A solution of 3-bromo-benzoyl chloride (2.7 g, 12 mmol) in DCM (40 mL)
was chilled to zero degrees and treated with pyrrolidine (3 mL, 36.8
mmol). Reaction was allowed to come to room temperature and stir for 4 h.
Mixture was then poured onto water and washed once. Organic phase then
washed with brine, dried over sodium sulfate, filtered and evaporated to
amber oil (3.1g, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bi-aryl 2,4-pyrimidinediamines as inhibitors of kinases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cao, Jon Jianguo; Hood, John; Lohse, Dan; Mak, Chi Ching; McPherson,
Andrew; Noronha, Glenn; Pathak, Ved; Renick, Joel; Soll, Richard M.;
Zeng, Binqi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007053452 A1 2007-05-10

$RFMT $RIREG SCHEME105 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,5-Dicyanopyridazine
C6H2N4
17412-15-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.0011 0.0 0
M  V30 2 N 6.1600 4.0011 0.0 0
M  V30 3 C 3.0800 1.3338 0.0 0
M  V30 4 N 3.8500 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 2.3100 5.3349 0.0 0
M  V30 8 C 0.7700 2.6674 0.0 0
M  V30 9 N 0.7700 5.3349 0.0 0
M  V30 10 N 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 3 3 4
M  V30 4 1 3 6
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1-Pyrrolidinyl)-4-pyridazinecarbonitrile
C9H10N4
1428268-39-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 1.3338 0.0 0
M  V30 2 N 3.1398 0.0000 0.0 0
M  V30 3 C 3.9098 4.0011 0.0 0
M  V30 4 C 4.6798 2.6674 0.0 0
M  V30 5 C 4.6798 5.3349 0.0 0
M  V30 6 C 6.2198 2.6674 0.0 0
M  V30 7 N 6.2198 5.3349 0.0 0
M  V30 8 N 6.9898 4.0011 0.0 0
M  V30 9 N 2.3698 4.0011 0.0 0
M  V30 10 C 1.4645 5.2469 0.0 0
M  V30 11 C 1.4645 2.7552 0.0 0
M  V30 12 C 0.0000 4.7711 0.0 0
M  V30 13 C 0.0000 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 9
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 17412-15-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1428268-39-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29270510
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM slow addition of DCP/THF; alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nucleophilic aromatic substitutions on 4,5-dicyanopyridazine. Part 2:
Nitrogen nucleophiles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Alfini, Renzo; Calamai, Elisa; Salvini, Antonella; Giomi, Donatella
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2013), 69(16), 3475-3479

$RFMT $RIREG SCHEME106 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Acetylbenzenesulfonyl chloride
C8H7ClO3S
1788-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 C 0.7700 1.5400 0.0 0
M  V30 6 C 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-(1-Pyrrolidinylsulfonyl)phenyl]ethanone
C12H15NO3S
58722-33-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.9098 1.5400 0.0 0 VAL=6
M  V30 2 O 3.9098 3.0800 0.0 0
M  V30 3 O 3.9098 0.0000 0.0 0
M  V30 4 C 10.0698 1.5400 0.0 0
M  V30 5 C 10.8398 2.8737 0.0 0
M  V30 6 O 10.8398 0.2064 0.0 0
M  V30 7 C 5.4498 1.5400 0.0 0
M  V30 8 C 6.2198 0.2064 0.0 0
M  V30 9 C 6.2198 2.8737 0.0 0
M  V30 10 C 7.7598 0.2064 0.0 0
M  V30 11 C 7.7598 2.8737 0.0 0
M  V30 12 C 8.5298 1.5400 0.0 0
M  V30 13 N 2.3698 1.5400 0.0 0
M  V30 14 C 1.4645 2.7859 0.0 0
M  V30 15 C 1.4645 0.2941 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 1 13
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1788-10-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 58722-33-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-7478512
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM 82-100% yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and structure-activity relationship of aminopyrimidine IKK2
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bingham, Alistair H.; Davenport, Richard J.; Fosbeary, Richard; Gowers,
Lewis; Knight, Roland L.; Lowe, Christopher; Owen, David A.; Parry, David
M.; Pitt, Will R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2008), 18(12), 3622-3627

$RFMT $RIREG SCHEME107 STEP1
$RXN



  3  1
$MOL
cis-1,2-Cyclohexanediol
C6H12O2
1792-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 2.6673 0.0 0
M  V30 2 O 3.0801 0.0000 0.0 0
M  V30 3 C 3.0801 2.6673 0.0 0 CFG=2
M  V30 4 C 2.3101 1.3337 0.0 0 CFG=1
M  V30 5 C 2.3101 4.0010 0.0 0
M  V30 6 C 0.7700 1.3337 0.0 0
M  V30 7 C 0.7700 4.0010 0.0 0
M  V30 8 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 3 1 CFG=1
M  V30 2 1 4 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 3 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Triphosgene
C3Cl6O3
32315-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.5637 0.0 0
M  V30 2 C 6.6687 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 8.0023 2.1037 0.0 0
M  V30 5 Cl 5.8986 2.6673 0.0 0
M  V30 6 Cl 7.4387 0.0000 0.0 0
M  V30 7 O 2.6675 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 Cl 0.0000 2.1037 0.0 0
M  V30 11 Cl 2.1037 2.6673 0.0 0
M  V30 12 Cl 0.5637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2S)-2-Hydroxycyclohexyl 1-pyrrolidinecarboxylate
C11H19NO3
787554-09-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 O 4.6200 5.3349 0.0 0
M  V30 4 O 3.0800 0.0000 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0 CFG=2
M  V30 6 C 2.3100 1.3338 0.0 0 CFG=1
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 0.7700 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.0000 2.6674 0.0 0
M  V30 11 N 6.9300 4.0011 0.0 0
M  V30 12 C 7.8353 5.2470 0.0 0
M  V30 13 C 7.8353 2.7552 0.0 0
M  V30 14 C 9.2998 4.7711 0.0 0
M  V30 15 C 9.2998 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 5 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 11
M  V30 5 1 6 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1792-81-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 787554-09-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-357-CAS-3537659
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of an L-Histidine-Derived Minimal Artificial Acylase for
the Kinetic Resolution of Racemic Alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ishihara, Kazuaki; Kosugi, Yuji; Akakura, Matsujiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2004), 126(39), 12212-12213

$RFMT $RIREG SCHEME108 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dimethyl 3-oxopentanedioate
C7H10O5
1830-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 C 8.0023 1.5400 0.0 0
M  V30 7 O 1.3337 2.3101 0.0 0
M  V30 8 O 2.6673 0.0000 0.0 0
M  V30 9 O 9.3360 2.3101 0.0 0
M  V30 10 O 8.0023 0.0000 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 12 C 10.6697 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Dimethyl (2Z)-3-(1-pyrrolidinyl)-2-pentenedioate
C11H17NO4
1343468-60-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.7710 0.0 0
M  V30 2 C 6.1600 3.7710 0.0 0
M  V30 3 C 3.8500 5.1048 0.0 0
M  V30 4 C 6.9300 5.1048 0.0 0
M  V30 5 C 2.3100 5.1048 0.0 0
M  V30 6 O 8.4700 5.1048 0.0 0
M  V30 7 O 6.1600 6.4384 0.0 0
M  V30 8 O 1.5400 6.4384 0.0 0
M  V30 9 O 1.5400 3.7710 0.0 0
M  V30 10 C 9.2400 6.4384 0.0 0
M  V30 11 C 0.0000 6.4384 0.0 0
M  V30 12 N 3.8500 2.4374 0.0 0
M  V30 13 C 4.4763 1.0306 0.0 0
M  V30 14 C 2.3185 2.2764 0.0 0
M  V30 15 C 3.3319 0.0000 0.0 0
M  V30 16 C 1.9983 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1830-54-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1343468-60-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4315368
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Dimethyl 3-Pyrrolidin-1-yl-pent-2-enedioate (2d) A solution containing
1,3-dimethyl acetonedicarboxylate (5.0 mL, 34.7 mmol) and pyrrolidine
(2.9 mL, 34.7 mmol) in MeOH (30 mL) was stirred at r.t. overnight.
Evaporation of the solvent, Compound 2d (quantitative) as a single
diastereoisomer. 1H NMR (250 MHz, CDCl3): δ = 1.75-1.82 (m, 4 H, 2 x
CH2), 3.02-3.23 (m,4H, 2 x NCH2), 3.39 (s, 3 H, CH3), 3.53 (s, 3 H, CH3),
3.96 (s, 2 H, CH2), 4.39 (s, 1 H, CH). 13C NMR (62.5 MHz, CDCl3): δ =
24.8, 35.2, 47.7, 49.7, 51.8, 84.5, 154.3, 168.9, 169.8.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-bromosuccinimide-promoted cyclization of β-carboxymethyl enamino
esters; synthesis of functionalized 4-amino-2(5H)-furanones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Toum, Valerie; Kadouri-Puchot, Catherine; Hamon, Louis; Lhommet, Gerard;
Mouries-Mansuy, Virginie; Vanucci-Bacque, Corinne; Dechoux, Luc
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2011), (17), 2781-2788

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1H-pyrrolo[2,3-b]pyridine
C7H5BrN2
183208-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 N 3.7036 0.0000 0.0 0
M  V30 5 N 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1-Pyrrolidinyl)-1H-pyrrolo[2,3-b]pyridine
C11H13N3
2098332-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0372 2.6217 0.0 0
M  V30 2 C 3.7036 1.8517 0.0 0
M  V30 3 C 5.0372 4.1617 0.0 0
M  V30 4 C 2.3698 2.6217 0.0 0
M  V30 5 N 3.7036 4.9317 0.0 0
M  V30 6 C 2.3698 4.1617 0.0 0
M  V30 7 C 0.9052 2.1458 0.0 0
M  V30 8 N 0.9052 4.6376 0.0 0
M  V30 9 C 0.0000 3.3917 0.0 0
M  V30 10 N 6.3709 1.8517 0.0 0
M  V30 11 C 7.7778 2.4782 0.0 0
M  V30 12 C 6.5318 0.3202 0.0 0
M  V30 13 C 8.8082 1.3336 0.0 0
M  V30 14 C 8.0382 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 5 6
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 183208-35-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2098332-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18557539
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 4039-32-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 787618-22-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1375325-68-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald-Hartwig coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridonyl azaindoles and their use as ERK kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guichou, Jean-Francois; Bories, Cedric; Geoffroy, Clement; Duquenne,
Charline; Gelin, Muriel; Labesse, Gilles; Bessin, Yannick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017085230 A1 2017-05-26

$RFMT $RIREG SCHEME109 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-1H-pyrrolo[2,3-b]pyridine
C7H5BrN2
183208-35-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 6.3710 3.0800 0.0 0
M  V30 2 C 2.3699 0.7700 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 N 3.7036 0.0000 0.0 0
M  V30 5 N 0.9052 0.2941 0.0 0
M  V30 6 C 3.7036 3.0800 0.0 0
M  V30 7 C 0.9052 2.7859 0.0 0
M  V30 8 C 5.0372 0.7700 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1-Pyrrolidinyl)-1H-pyrrolo[2,3-b]pyridine
C11H13N3
2098332-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0372 2.6217 0.0 0
M  V30 2 C 3.7036 1.8517 0.0 0
M  V30 3 C 5.0372 4.1617 0.0 0
M  V30 4 C 2.3698 2.6217 0.0 0
M  V30 5 N 3.7036 4.9317 0.0 0
M  V30 6 C 2.3698 4.1617 0.0 0
M  V30 7 C 0.9052 2.1458 0.0 0
M  V30 8 N 0.9052 4.6376 0.0 0
M  V30 9 C 0.0000 3.3917 0.0 0
M  V30 10 N 6.3709 1.8517 0.0 0
M  V30 11 C 7.7778 2.4782 0.0 0
M  V30 12 C 6.5318 0.3202 0.0 0
M  V30 13 C 8.8082 1.3336 0.0 0
M  V30 14 C 8.0382 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 5 6
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 183208-35-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2098332-96-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20500963
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 4039-32-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 787618-22-8
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1375325-68-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald-Hartwig coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridonyl azaindoles and their use as ERK kinase
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guichou, Jan- Francois; Bories, Cedric; Geoffroy, Clement; Duquenne,
Charline; Gelin, Muriel; Labesse, Gilles; Bessin, Yannick
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3170822 A1 2017-05-24

$RFMT $RIREG SCHEME110 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-iodopyrimidine
C4H2BrIN2
183438-24-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 1.3337 0.0 0
M  V30 2 I 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 N 3.8500 0.0000 0.0 0
M  V30 7 N 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(1-pyrrolidinyl)pyrimidine
C8H10BrN3
446286-61-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 8.5298 1.3336 0.0 0
M  V30 2 C 3.9098 1.3336 0.0 0
M  V30 3 N 4.6798 2.6673 0.0 0
M  V30 4 N 4.6798 0.0000 0.0 0
M  V30 5 C 6.2198 2.6673 0.0 0
M  V30 6 C 6.2198 0.0000 0.0 0
M  V30 7 C 6.9898 1.3336 0.0 0
M  V30 8 N 2.3698 1.3336 0.0 0
M  V30 9 C 1.4645 2.5795 0.0 0
M  V30 10 C 1.4645 0.0878 0.0 0
M  V30 11 C 0.0000 2.1037 0.0 0
M  V30 12 C 0.0000 0.5636 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 8
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 183438-24-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 446286-61-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35794545
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, sealed microwave vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel heterocyclic compounds for the diagnosis of TDP-43 proteinopathies
and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kroth, Heiko; Darmency, Vincent; Dreyfus, Nicolas; Boudou, Cedric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023285661 A1 2023-01-19

$RFMT $RIREG SCHEME111 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-fluoro-4-nitro-, methyl ester
C8H6FNO4
185629-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6684 4.6201 0.0 0
M  V30 2 O 8.0022 3.8500 0.0 0
M  V30 3 O 6.6684 6.1601 0.0 0
M  V30 4 C 9.3359 4.6201 0.0 0
M  V30 5 F 1.3337 4.6201 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8500 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8500 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 12
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-nitro-3-(1-pyrrolidinyl)benzoate
C12H14N2O4
1914528-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.4374 1.5400 0.0 0 VAL=5
M  V30 2 O 1.1036 2.3101 0.0 0
M  V30 3 O 2.4374 0.0000 0.0 0
M  V30 4 C 7.7722 4.6201 0.0 0
M  V30 5 O 9.1059 3.8501 0.0 0
M  V30 6 O 7.7722 6.1601 0.0 0
M  V30 7 C 10.4396 4.6201 0.0 0
M  V30 8 C 3.7711 3.8501 0.0 0
M  V30 9 C 3.7711 2.3101 0.0 0
M  V30 10 C 5.1047 4.6201 0.0 0
M  V30 11 C 5.1047 1.5400 0.0 0
M  V30 12 C 6.4384 3.8501 0.0 0
M  V30 13 C 6.4384 2.3101 0.0 0
M  V30 14 N 2.4374 4.6201 0.0 0
M  V30 15 C 1.0304 3.9936 0.0 0
M  V30 16 C 2.2763 6.1517 0.0 0
M  V30 17 C 0.0000 5.1382 0.0 0
M  V30 18 C 0.7700 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 1 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 185629-31-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1914528-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21857743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted N-benzo[d]thiazol-2-yl
1H-pyrrole-2-carboxamides as a new class of DNA gyrase and/or
topoisomerase IV inhibitors with activity against gram-positive and
gram-negative bacteria
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tomasic, Tihomir; Zidar, Nace; Durcik, Martina; Ilas, Janez; Zega,
Anamarija; Durante Cruz, Cristina; Tammela, Paeivi; Pal, Csaba; Nyerges,
Akos Jozsef; Kikelj, Danijel; Masic, Lucija Peterlin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020048949 A1 2020-03-12

$RFMT $RIREG SCHEME112 STEP1
$RXN



  2  1
$MOL
(1S,5S,6S)-5-(2,3-Difluorophenyl)-3-[[(1,1-dimethylethoxy)carbonyl][[2-(trime...
C24H34F2N2O5SSi
1874241-01-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 8.8975 0.0 0
M  V30 2 O 0.0000 8.8975 0.0 0
M  V30 3 O 2.3100 10.2312 0.0 0
M  V30 4 C 2.6538 4.0740 0.0 0
M  V30 5 N 6.3112 8.3337 0.0 0
M  V30 6 C 6.3112 9.8737 0.0 0
M  V30 7 C 7.6449 7.5637 0.0 0
M  V30 8 O 7.6449 10.6438 0.0 0
M  V30 9 O 4.9774 10.6438 0.0 0
M  V30 10 O 8.9785 8.3337 0.0 0
M  V30 11 C 7.6449 12.1838 0.0 0
M  V30 12 C 10.3122 7.5637 0.0 0
M  V30 13 C 9.1849 12.1838 0.0 0
M  V30 14 C 7.6449 13.7238 0.0 0
M  V30 15 C 6.1048 12.1838 0.0 0
M  V30 16 C 11.6460 8.3337 0.0 0
M  V30 17 Si 12.9797 7.5637 0.0 0
M  V30 18 C 14.3133 6.7937 0.0 0
M  V30 19 C 12.2097 6.2300 0.0 0
M  V30 20 C 13.7497 8.8975 0.0 0
M  V30 21 F 2.5903 2.3595 0.0 0
M  V30 22 F 4.5700 0.0000 0.0 0
M  V30 23 C 2.3100 7.5637 0.0 0 CFG=2
M  V30 24 C 2.3100 6.0237 0.0 0 CFG=2
M  V30 25 C 0.9764 6.7937 0.0 0
M  V30 26 S 3.6437 8.3337 0.0 0
M  V30 27 C 3.6437 5.2537 0.0 0 CFG=2
M  V30 28 C 4.9774 7.5637 0.0 0
M  V30 29 N 4.9774 6.0237 0.0 0
M  V30 30 C 4.6336 4.0740 0.0 0
M  V30 31 C 4.1069 2.6268 0.0 0
M  V30 32 C 6.1503 4.3413 0.0 0
M  V30 33 C 5.0969 1.4472 0.0 0
M  V30 34 C 7.1402 3.1617 0.0 0
M  V30 35 C 6.6135 1.7145 0.0 0
M  V30 36 H 1.5400 4.6900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 23 1 CFG=1
M  V30 4 1 27 4 CFG=1
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 28
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 17 20
M  V30 21 1 21 31
M  V30 22 1 22 33
M  V30 23 1 23 24
M  V30 24 1 23 25
M  V30 25 1 23 26
M  V30 26 1 24 25
M  V30 27 1 24 27
M  V30 28 1 24 36 CFG=1
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 27 30 CFG=3
M  V30 32 2 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 23 24 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S,5S,6S)-5-(2,3-difluorophenyl)-5-methyl-1-(1-pyrrolid...
C28H41F2N3O4SSi
1874240-88-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 8.8975 0.0 0
M  V30 2 O 4.6798 10.2312 0.0 0
M  V30 3 C 5.0236 4.0740 0.0 0
M  V30 4 N 8.6810 8.3337 0.0 0
M  V30 5 C 8.6810 9.8737 0.0 0
M  V30 6 C 10.0146 7.5637 0.0 0
M  V30 7 O 10.0146 10.6437 0.0 0
M  V30 8 O 7.3473 10.6437 0.0 0
M  V30 9 O 11.3483 8.3337 0.0 0
M  V30 10 C 10.0146 12.1838 0.0 0
M  V30 11 C 12.6821 7.5637 0.0 0
M  V30 12 C 11.5547 12.1838 0.0 0
M  V30 13 C 10.0146 13.7238 0.0 0
M  V30 14 C 8.4746 12.1838 0.0 0
M  V30 15 C 14.0158 8.3337 0.0 0
M  V30 16 Si 15.3494 7.5637 0.0 0
M  V30 17 C 16.6831 6.7937 0.0 0
M  V30 18 C 16.1194 8.8975 0.0 0
M  V30 19 C 14.5794 6.2300 0.0 0
M  V30 20 F 4.9601 2.3595 0.0 0
M  V30 21 F 6.9400 0.0000 0.0 0
M  V30 22 C 4.6798 7.5637 0.0 0 CFG=2
M  V30 23 C 4.6798 6.0237 0.0 0 CFG=2
M  V30 24 C 3.3462 6.7937 0.0 0
M  V30 25 S 6.0135 8.3337 0.0 0
M  V30 26 C 6.0135 5.2536 0.0 0 CFG=2
M  V30 27 C 7.3473 7.5637 0.0 0
M  V30 28 N 7.3473 6.0237 0.0 0
M  V30 29 N 2.3698 8.8975 0.0 0
M  V30 30 C 1.4646 7.6515 0.0 0
M  V30 31 C 1.4646 10.1434 0.0 0
M  V30 32 C 0.0000 8.1275 0.0 0
M  V30 33 C 0.0000 9.6675 0.0 0
M  V30 34 C 7.0034 4.0740 0.0 0
M  V30 35 C 6.4767 2.6268 0.0 0
M  V30 36 C 8.5200 4.3413 0.0 0
M  V30 37 C 7.4667 1.4472 0.0 0
M  V30 38 C 9.5100 3.1617 0.0 0
M  V30 39 C 8.9833 1.7145 0.0 0
M  V30 40 H 3.9098 4.6900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 22 1 CFG=1
M  V30 3 1 1 29
M  V30 4 1 26 3 CFG=1
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 27
M  V30 8 1 5 7
M  V30 9 2 5 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 16 19
M  V30 21 1 20 35
M  V30 22 1 21 37
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 22 25
M  V30 26 1 23 24
M  V30 27 1 23 26
M  V30 28 1 23 40 CFG=1
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 26 34 CFG=3
M  V30 32 2 27 28
M  V30 33 1 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 22 23 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1874241-01-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1874240-88-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24220826
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 530-62-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclopropathiazin-2-amine compounds as beta-secretase inhibitors and
their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Allen, Jennifer R.; Amegadzie, Albert; Bourbeau, Matthew P.; Brown, James
A.; Chen, Jian J.; Cheng, Yuan; Frohn, Michael J.; Guzman-Perez, Angel;
Harrington, Paul E.; Liu, Longbin; Liu, Qingyian; Low, Jonathan D.; Ma,
Vu Van; Manning, James; Minatti, Ana Elena; Nguyen, Thomas T.; Nishmura,
Nobuko; Norman, Mark H.; Pettus, Liping H.; Pickrell, Alexander J.; Qian,
Wenyuan; Rumfelt, Shannon; Rzasa, Robert M.; Siegmund, Aaron C.; Stec,
Markian M.; White, Ryan; Xue, Qiufen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016022724 A1 2016-02-11

$RFMT $RIREG SCHEME113 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Piperidinedicarboxylic acid, 4-methyl-, 1-(1,1-dimethylethyl) ester
C12H21NO4
189321-63-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.2469 2.8736 0.0 0
M  V30 2 O 8.0169 1.5400 0.0 0
M  V30 3 O 8.0169 4.2073 0.0 0
M  V30 4 C 9.5569 1.5400 0.0 0
M  V30 5 C 9.5569 0.0000 0.0 0
M  V30 6 C 11.0969 1.5400 0.0 0
M  V30 7 C 9.5569 3.0800 0.0 0
M  V30 8 C 1.4471 3.8636 0.0 0
M  V30 9 O 0.0000 3.3369 0.0 0
M  V30 10 O 1.7146 5.3801 0.0 0
M  V30 11 C 1.4471 1.8837 0.0 0
M  V30 12 N 5.7069 2.8736 0.0 0
M  V30 13 C 4.9369 1.5400 0.0 0
M  V30 14 C 4.9369 4.2073 0.0 0
M  V30 15 C 3.3969 1.5400 0.0 0
M  V30 16 C 3.3969 4.2073 0.0 0
M  V30 17 C 2.6269 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 17
M  V30 11 1 11 17
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-methyl-4-(1-pyrrolidinylcarbonyl)-1-piperidinecarboxylate
C16H28N2O3
1257293-58-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9373 3.8636 0.0 0
M  V30 2 O 4.2048 5.3801 0.0 0
M  V30 3 C 3.9373 1.8837 0.0 0
M  V30 4 C 9.7371 2.8736 0.0 0
M  V30 5 O 10.5071 1.5400 0.0 0
M  V30 6 O 10.5071 4.2073 0.0 0
M  V30 7 C 12.0471 1.5400 0.0 0
M  V30 8 C 12.0471 0.0000 0.0 0
M  V30 9 C 13.5871 1.5400 0.0 0
M  V30 10 C 12.0471 3.0800 0.0 0
M  V30 11 C 5.1171 2.8736 0.0 0
M  V30 12 C 5.8871 4.2073 0.0 0
M  V30 13 C 5.8871 1.5400 0.0 0
M  V30 14 C 7.4271 4.2073 0.0 0
M  V30 15 C 7.4271 1.5400 0.0 0
M  V30 16 N 8.1971 2.8736 0.0 0
M  V30 17 N 2.4903 3.3369 0.0 0
M  V30 18 C 2.0658 1.8565 0.0 0
M  V30 19 C 1.2135 4.1980 0.0 0
M  V30 20 C 0.5267 1.8027 0.0 0
M  V30 21 C 0.0000 3.2499 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 1 17
M  V30 4 1 3 11
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 16
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 189321-63-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1257293-58-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-3776610
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 1: 4-Methyl-4-(pyrrolidine-1-carbonyl)piperidine-1-carboxylic acid
tert-butyl ester To a solution of 4-methylpiperidine-1,4-dicarboxylic
acid mono-tert-butyl ester (229 mg, 0.94 mmol) in DMF (10 mL) were added
DIPEA (0.493 mL, 2.83 mmol), pyrrolidine (0.118 mL, 1.41 mmol) and HATU
(537 mg, 1.41 mmol). The reaction mixture was stirred at room temperature
for 18 hours and then partitioned between water and EtOAc. The organic
layer was separated and washed with a 0.1N aqueous HCl solution and
brine, dried over Na2SO4, filtered and concentrated to give
4-Methyl-4-(pyrrolidine-1-carbonyl)piperidine-1-carboxylic acid
tert-butyl ester as a white solid (279 mg, 100 %).
4-Methyl-4-(pyrrolidine-1-carbonyl)piperidine-1-carboxylic acid
tert-butyl ester, yield 279 mg, 100 % LCMS (Method H): RT 4.00 min;
[M+Na]+ 319
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic pyrimidines as selective inhibitors of the p110
delta isoform of PI3K for treating inflammation, immune diseases and
cancers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castanedo, Georgette; Chan, Bryan; Goldstein, David Michael; Kondru, Rama
K.; Lucas, Matthew C.; Palmer, Wylie Solang; Price, Stephen; Safina,
Brian; Savy, Pascal Pierre Alexandre; Seward, Eileen Mary; Sutherlin,
Daniel P.; Sweeney, Zachary Kevin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010138589 A1 2010-12-02

$RFMT $RIREG SCHEME114 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1S)-2-[2-(2,6-Dichlorophenyl)acetyl]-2,3-dihydro-1-methyl-1H-isoindole-4-sul...
C17H14Cl3NO3S
1900707-42-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 1.3337 4.0010 0.0 0 VAL=6
M  V30 2 Cl 0.5637 5.3348 0.0 0
M  V30 3 O 0.0000 3.2310 0.0 0
M  V30 4 O 2.6673 4.7710 0.0 0
M  V30 5 C 7.0646 0.6234 0.0 0
M  V30 6 C 7.4148 3.9554 0.0 0
M  V30 7 C 8.7485 3.1854 0.0 0
M  V30 8 O 7.4148 5.4955 0.0 0
M  V30 9 Cl 8.7485 6.2655 0.0 0
M  V30 10 Cl 11.4160 1.6454 0.0 0
M  V30 11 C 3.6437 2.6673 0.0 0
M  V30 12 C 4.4137 1.3337 0.0 0
M  V30 13 C 2.1037 2.6673 0.0 0
M  V30 14 C 4.6742 3.8119 0.0 0
M  V30 15 C 5.9202 1.6538 0.0 0 CFG=2
M  V30 16 C 3.6437 0.0000 0.0 0
M  V30 17 C 1.3337 1.3337 0.0 0
M  V30 18 N 6.0811 3.1854 0.0 0
M  V30 19 C 2.1037 0.0000 0.0 0
M  V30 20 C 10.0823 3.9554 0.0 0
M  V30 21 C 10.0823 5.4955 0.0 0
M  V30 22 C 11.4160 3.1854 0.0 0
M  V30 23 C 11.4160 6.2655 0.0 0
M  V30 24 C 12.7496 3.9554 0.0 0
M  V30 25 C 12.7496 5.4955 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 13
M  V30 5 1 15 5 CFG=1
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 18
M  V30 9 1 7 20
M  V30 10 1 9 21
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 18
M  V30 19 1 15 18
M  V30 20 1 16 19
M  V30 21 2 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Ethanone, 2-(2,6-dichlorophenyl)-1-[(1S)-1,3-dihydro-1-methyl-4-(1-pyrrolidin...
C21H22Cl2N2O3S
1900706-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 2.6217 3.7710 0.0 0 VAL=6
M  V30 2 O 1.2881 4.5410 0.0 0
M  V30 3 O 3.9554 3.0010 0.0 0
M  V30 4 C 8.3526 7.1488 0.0 0
M  V30 5 C 8.7028 3.8166 0.0 0
M  V30 6 C 10.0364 4.5866 0.0 0
M  V30 7 O 8.7028 2.2766 0.0 0
M  V30 8 Cl 10.0364 1.5066 0.0 0
M  V30 9 Cl 12.7039 6.1266 0.0 0
M  V30 10 C 4.9317 5.1047 0.0 0
M  V30 11 C 3.3917 5.1047 0.0 0
M  V30 12 C 5.7018 6.4385 0.0 0
M  V30 13 C 5.9622 3.9603 0.0 0
M  V30 14 C 2.6217 6.4385 0.0 0
M  V30 15 C 7.2082 6.1183 0.0 0 CFG=2
M  V30 16 C 4.9317 7.7722 0.0 0
M  V30 17 N 7.3691 4.5866 0.0 0
M  V30 18 C 3.3917 7.7722 0.0 0
M  V30 19 N 1.8517 2.4374 0.0 0
M  V30 20 C 0.3202 2.2765 0.0 0
M  V30 21 C 2.4782 1.0304 0.0 0
M  V30 22 C 0.0000 0.7700 0.0 0
M  V30 23 C 1.3337 0.0000 0.0 0
M  V30 24 C 11.3703 3.8166 0.0 0
M  V30 25 C 11.3703 2.2766 0.0 0
M  V30 26 C 12.7039 4.5866 0.0 0
M  V30 27 C 12.7039 1.5066 0.0 0
M  V30 28 C 14.0376 3.8166 0.0 0
M  V30 29 C 14.0376 2.2766 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 19
M  V30 5 1 15 4 CFG=3
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 17
M  V30 9 1 6 24
M  V30 10 1 8 25
M  V30 11 1 9 26
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 2 12 16
M  V30 18 1 13 17
M  V30 19 2 14 18
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1900707-42-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1900706-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-15797177
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of isoindoline derivatives D1 pos. allosteric modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Skolc, David; Ates, Ali; Jnoff, Eric; Valade, Anne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016055482 A1 2016-04-14

$RFMT $RIREG SCHEME115 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Isothiocyanato-1,3-dimethylbenzene
C9H9NS
19241-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 3.0800 0.0 0
M  V30 4 C 4.0011 4.6200 0.0 0
M  V30 5 C 1.3338 0.0000 0.0 0
M  V30 6 C 2.6674 2.3100 0.0 0
M  V30 7 C 2.6674 3.8500 0.0 0
M  V30 8 C 1.3338 1.5400 0.0 0
M  V30 9 C 1.3338 4.6200 0.0 0
M  V30 10 C 0.0000 2.3100 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 7
M  V30 5 1 5 8
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2,6-Dimethylphenyl)-1-pyrrolidinecarbothioamide
C13H18N2S
80762-27-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 2.6674 0.0 0
M  V30 2 C 5.3900 4.0011 0.0 0
M  V30 3 S 4.6200 5.3349 0.0 0
M  V30 4 C 3.0800 5.3349 0.0 0
M  V30 5 C 3.0800 0.0000 0.0 0
M  V30 6 C 3.0800 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 0.7700 1.3338 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 12 N 6.9300 4.0011 0.0 0
M  V30 13 C 7.8353 5.2470 0.0 0
M  V30 14 C 7.8353 2.7552 0.0 0
M  V30 15 C 9.2998 4.7711 0.0 0
M  V30 16 C 9.2998 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 2 12
M  V30 5 1 4 7
M  V30 6 1 5 8
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19241-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 80762-27-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-18878333
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thiourea-Group IV transition metal catalysts and polymerization systems
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krasovskiy, Arkady L.; Szuromi, Endre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018063799 A1 2018-04-05

$RFMT $RIREG SCHEME116 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-(4-nitrophenyl)propanamide
C9H9ClN2O3
19313-88-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 O 8.0022 2.3101 0.0 0
M  V30 5 C 10.6697 3.8501 0.0 0
M  V30 6 Cl 12.0033 4.6201 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0012 4.6201 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6673 3.8501 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Nitrophenyl)-1-pyrrolidinepropanamide
C13H17N3O3
851651-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 O 8.0023 2.3100 0.0 0
M  V30 5 C 10.6698 3.8501 0.0 0
M  V30 6 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 2.6675 3.8501 0.0 0
M  V30 13 C 4.0011 1.5400 0.0 0
M  V30 14 C 2.6675 2.3100 0.0 0
M  V30 15 N 12.0034 4.6201 0.0 0
M  V30 16 C 13.4103 3.9936 0.0 0
M  V30 17 C 12.1644 6.1516 0.0 0
M  V30 18 C 14.4409 5.1382 0.0 0
M  V30 19 C 13.6708 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 14
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19313-88-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 851651-95-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14666961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Click chemistry assembly of G-quadruplex ligands incorporating a
diarylurea scaffold and triazole linkers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Drewe, William C.; Neidle, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2008), (42),
5295-5297

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chlorohexanoyl chloride
C6H10Cl2O
19347-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 Cl 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 9 Cl 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1-(1-pyrrolidinyl)-1-hexanone
C10H18ClNO
1629156-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4384 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4396 2.3101 0.0 0
M  V30 8 Cl 11.7733 1.5400 0.0 0
M  V30 9 N 2.4373 2.3101 0.0 0
M  V30 10 C 1.0304 1.6836 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 0.0000 2.8281 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19347-73-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1629156-37-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20314450
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM α-Fluorination of carbonyls with nucleophilic fluorine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adler, Pauline; Teskey, Christopher J.; Kaiser, Daniel; Holy, Marion;
Sitte, Harald H.; Maulide, Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Chemistry (2019), 11(4), 329-334

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chlorohexanoyl chloride
C6H10Cl2O
19347-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 Cl 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 9 Cl 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1-(1-pyrrolidinyl)-1-hexanone
C10H18ClNO
1629156-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4384 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4396 2.3101 0.0 0
M  V30 8 Cl 11.7733 1.5400 0.0 0
M  V30 9 N 2.4373 2.3101 0.0 0
M  V30 10 C 1.0304 1.6836 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 0.0000 2.8281 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19347-73-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1629156-37-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-17876112
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective Intermolecular Cross-Enolate-Type Coupling of Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaiser, Daniel; Teskey, Christopher J.; Adler, Pauline; Maulide, Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(45), 16040-16043

$RFMT $RIREG SCHEME117 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chlorohexanoyl chloride
C6H10Cl2O
19347-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 2.6675 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 1.3337 1.5400 0.0 0
M  V30 5 C 6.6685 1.5400 0.0 0
M  V30 6 Cl 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 9 Cl 9.3360 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-1-(1-pyrrolidinyl)-1-hexanone
C10H18ClNO
1629156-37-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4384 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4396 2.3101 0.0 0
M  V30 8 Cl 11.7733 1.5400 0.0 0
M  V30 9 N 2.4373 2.3101 0.0 0
M  V30 10 C 1.0304 1.6836 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 0.0000 2.8281 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19347-73-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1629156-37-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-17175634
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Flexible and Chemoselective Oxidation of Amides to α-Keto Amides and
α-Hydroxy Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de la Torre, Aurelien; Kaiser, Daniel; Maulide, Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(19), 6578-6581

$RFMT $RIREG SCHEME118 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Wortmannin
C23H24O8
19545-26-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5420 3.9646 0.0 0
M  V30 2 O 5.7309 2.6673 0.0 0
M  V30 3 C 4.9609 1.3337 0.0 0
M  V30 4 C 3.4208 1.3337 0.0 0
M  V30 5 O 5.7309 0.0000 0.0 0
M  V30 6 C 7.4324 2.6471 0.0 0
M  V30 7 O 8.2694 1.3546 0.0 0
M  V30 8 C 9.8074 1.4331 0.0 0
M  V30 9 O 4.9989 9.3307 0.0 0
M  V30 10 C 1.7456 4.0889 0.0 0
M  V30 11 O 11.8951 5.5522 0.0 0
M  V30 12 O 0.0000 4.6245 0.0 0
M  V30 13 C 5.7309 5.3348 0.0 0
M  V30 14 C 7.2820 5.3152 0.0 0 CFG=2
M  V30 15 C 4.9609 6.6684 0.0 0
M  V30 16 C 4.9609 4.0011 0.0 0 CFG=2
M  V30 17 C 8.0121 6.6476 0.0 0
M  V30 18 C 8.1333 4.0184 0.0 0 CFG=1
M  V30 19 C 3.4208 6.6684 0.0 0 CFG=2
M  V30 20 C 5.7532 7.9881 0.0 0
M  V30 21 C 3.4208 4.0011 0.0 0
M  V30 22 C 7.3072 7.9784 0.0 0
M  V30 23 C 9.5130 6.7699 0.0 0
M  V30 24 O 9.6715 4.0874 0.0 0
M  V30 25 C 2.6508 5.3348 0.0 0 CFG=2
M  V30 26 C 2.3904 7.8130 0.0 0
M  V30 27 O 8.4482 9.0441 0.0 0
M  V30 28 C 10.3575 5.4654 0.0 0
M  V30 29 C 9.7970 8.3052 0.0 0
M  V30 30 C 1.1445 5.6549 0.0 0
M  V30 31 C 0.9835 7.1865 0.0 0
M  V30 32 H 4.0472 8.0754 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 14 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 16 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 18 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 9 20
M  V30 10 1 25 10 CFG=1
M  V30 11 2 11 28
M  V30 12 2 12 30
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 15 20
M  V30 20 1 16 21
M  V30 21 2 17 22
M  V30 22 1 17 23
M  V30 23 1 18 24
M  V30 24 1 19 25
M  V30 25 1 19 26
M  V30 26 1 19 32 CFG=3
M  V30 27 1 20 22
M  V30 28 1 21 25
M  V30 29 1 22 27
M  V30 30 1 23 28
M  V30 31 2 23 29
M  V30 32 1 24 28
M  V30 33 1 25 30
M  V30 34 1 26 31
M  V30 35 1 27 29
M  V30 36 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 14 16 18 19 25)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Cyclopenta[5,6]naphtho[1,2-c]pyran-2,7,10(1H)-trione, 5-(acetyloxy)-4,4a,5,6,...
C27H33NO8
502844-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3184 3.8501 0.0 0
M  V30 2 O 3.9845 3.0801 0.0 0
M  V30 3 C 2.6509 2.3101 0.0 0
M  V30 4 C 2.6509 0.7700 0.0 0
M  V30 5 O 1.3172 3.0801 0.0 0
M  V30 6 C 5.3184 2.3101 0.0 0
M  V30 7 O 5.3184 0.7700 0.0 0
M  V30 8 C 6.6520 0.0000 0.0 0
M  V30 9 O 6.6520 9.2402 0.0 0
M  V30 10 C 10.6532 5.3901 0.0 0
M  V30 11 O 9.3194 7.7002 0.0 0
M  V30 12 C 1.2440 6.3037 0.0 0
M  V30 13 O 10.6532 2.3101 0.0 0
M  V30 14 O 0.0000 7.6404 0.0 0
M  V30 15 C 5.3184 5.3901 0.0 0
M  V30 16 C 6.6520 4.6201 0.0 0 CFG=2
M  V30 17 C 5.3184 6.9302 0.0 0
M  V30 18 C 3.9845 4.6201 0.0 0 CFG=2
M  V30 19 C 7.9857 5.3901 0.0 0
M  V30 20 C 6.6520 3.0801 0.0 0 CFG=1
M  V30 21 C 3.9845 7.7002 0.0 0 CFG=2
M  V30 22 C 6.6520 7.7002 0.0 0
M  V30 23 C 2.6509 5.3901 0.0 0
M  V30 24 C 9.3194 4.6201 0.0 0
M  V30 25 C 7.9857 6.9302 0.0 0
M  V30 26 O 7.9857 2.3101 0.0 0
M  V30 27 C 2.6509 6.9302 0.0 0 CFG=2
M  V30 28 C 3.6644 9.2065 0.0 0
M  V30 29 C 9.3194 3.0801 0.0 0
M  V30 30 C 1.5065 7.9606 0.0 0
M  V30 31 C 2.1328 9.3674 0.0 0
M  V30 32 N 11.9869 4.6201 0.0 0
M  V30 33 C 13.3937 5.2464 0.0 0
M  V30 34 C 12.1478 3.0884 0.0 0
M  V30 35 C 14.4243 4.1020 0.0 0
M  V30 36 C 13.6542 2.7682 0.0 0
M  V30 37 H 5.2306 8.6052 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 16 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 18 2 CFG=3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 1 20 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 9 22
M  V30 10 2 10 24 CFG=2
M  V30 11 1 10 32
M  V30 12 1 11 25
M  V30 13 1 27 12 CFG=1
M  V30 14 2 13 29
M  V30 15 2 14 30
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 1 17 21
M  V30 22 1 17 22
M  V30 23 1 18 23
M  V30 24 1 19 24
M  V30 25 2 19 25
M  V30 26 1 20 26
M  V30 27 1 21 27
M  V30 28 1 21 28
M  V30 29 1 21 37 CFG=3
M  V30 30 1 22 25
M  V30 31 1 23 27
M  V30 32 1 24 29
M  V30 33 1 26 29
M  V30 34 1 27 30
M  V30 35 1 28 31
M  V30 36 1 30 31
M  V30 37 1 32 33
M  V30 38 1 32 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19545-26-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 502844-52-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30872741
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and biological evaluation of synthetic viridins derived from
C(20)-heteroalkylation of the steroidal PI-3-kinase inhibitor wortmannin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wipf, Peter; Minion, Daniel J.; Halter, Robert J.; Berggren, Margareta
I.; Ho, Caroline B.; Chiang, Gary G.; Kirkpatrick, Lynn; Abraham, Robert;
Powis, Garth
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2004), 2(13), 1911-1920

$RFMT $RIREG SCHEME119 STEP1
$RXN



  2  1
$MOL
2-[(1E)-3-Oxo-3-phenyl-1-propen-1-yl]-1H-pyrrole-1-propanoic acid
C16H15NO3
1985631-96-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 3.7710 0.0 0
M  V30 2 C 5.3900 3.7710 0.0 0
M  V30 3 C 4.6200 5.1048 0.0 0
M  V30 4 O 5.3900 6.4384 0.0 0
M  V30 5 C 10.2619 3.4208 0.0 0
M  V30 6 C 11.7684 3.1006 0.0 0
M  V30 7 C 12.7988 4.2450 0.0 0
M  V30 8 O 14.3051 3.9248 0.0 0
M  V30 9 O 12.3229 5.7097 0.0 0
M  V30 10 C 7.7000 2.4374 0.0 0
M  V30 11 N 9.2315 2.2764 0.0 0
M  V30 12 C 7.0735 1.0306 0.0 0
M  V30 13 C 9.5517 0.7700 0.0 0
M  V30 14 C 8.2181 0.0000 0.0 0
M  V30 15 C 3.0800 5.1048 0.0 0
M  V30 16 C 2.3100 6.4384 0.0 0
M  V30 17 C 2.3100 3.7710 0.0 0
M  V30 18 C 0.7700 6.4384 0.0 0
M  V30 19 C 0.7700 3.7710 0.0 0
M  V30 20 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 15
M  V30 6 1 5 6
M  V30 7 1 5 11
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 2 7 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1S,2R)-2,3-Dihydro-2-(1-pyrrolidinylcarbonyl)-1H-pyrrolizin-1-yl]-1-pheny...
C20H22N2O2
1985632-22-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0170 4.7797 0.0 0
M  V30 2 C 8.3508 4.0097 0.0 0
M  V30 3 O 8.3508 2.4697 0.0 0
M  V30 4 C 3.9564 6.1425 0.0 0
M  V30 5 O 5.1008 7.1729 0.0 0
M  V30 6 C 5.6834 4.0097 0.0 0 CFG=2
M  V30 7 C 4.2766 4.6360 0.0 0 CFG=1
M  V30 8 C 5.5225 2.4780 0.0 0
M  V30 9 C 3.2460 3.4917 0.0 0
M  V30 10 N 4.0160 2.1579 0.0 0
M  V30 11 C 6.2925 1.1444 0.0 0
M  V30 12 C 3.8551 0.6263 0.0 0
M  V30 13 C 5.2621 0.0000 0.0 0
M  V30 14 N 2.4917 6.6183 0.0 0
M  V30 15 C 1.2459 5.7131 0.0 0
M  V30 16 C 2.0159 8.0829 0.0 0
M  V30 17 C 0.0000 6.6183 0.0 0
M  V30 18 C 0.4759 8.0829 0.0 0
M  V30 19 C 9.6845 4.7797 0.0 0
M  V30 20 C 9.6845 6.3197 0.0 0
M  V30 21 C 11.0181 4.0097 0.0 0
M  V30 22 C 11.0181 7.0897 0.0 0
M  V30 23 C 12.3518 4.7797 0.0 0
M  V30 24 C 12.3518 6.3197 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 6 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 19
M  V30 5 2 4 5
M  V30 6 1 7 4 CFG=3
M  V30 7 1 4 14
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 9 10
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 6 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1985631-96-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1985632-22-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-254-CAS-16015498
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 3282-30-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 885051-07-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, >95:5 dr, >99:1 er and >99% ee, Michael
addition followed by lactonisation and then ring-opening reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Isothiourea-catalysed enantioselective pyrrolizine synthesis: synthetic
and computational studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stark, Daniel G.; Williamson, Patrick; Gayner, Emma R.; Musolino,
Stefania F.; Kerr, Ryan W. F.; Taylor, James E.; Slawin, Alexandra M. Z.;
O'Riordan, Timothy J. C.; Macgregor, Stuart A.; Smith, Andrew D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2016), 14(38), 8957-8965

$RFMT $RIREG SCHEME120 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Phenylmethyl)-1-oxa-6-azaspiro[2.5]octane
C13H17NO
19867-34-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.6436 0.0 0
M  V30 2 C 8.0021 1.3336 0.0 0
M  V30 3 C 9.5421 1.3336 0.0 0
M  V30 4 O 8.7721 0.0000 0.0 0
M  V30 5 C 8.0021 2.8736 0.0 0
M  V30 6 C 6.6685 0.5636 0.0 0
M  V30 7 C 6.6685 3.6436 0.0 0
M  V30 8 C 5.3347 1.3336 0.0 0
M  V30 9 N 5.3347 2.8736 0.0 0
M  V30 10 C 2.6674 2.8736 0.0 0
M  V30 11 C 2.6674 1.3336 0.0 0
M  V30 12 C 1.3336 3.6436 0.0 0
M  V30 13 C 1.3336 0.5636 0.0 0
M  V30 14 C 0.0000 2.8736 0.0 0
M  V30 15 C 0.0000 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 3 4
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Phenylmethyl)-4-(1-pyrrolidinylmethyl)-4-piperidinol
C17H26N2O
889952-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.8798 4.9910 0.0 0
M  V30 2 O 8.8798 3.0112 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 7.7000 4.0011 0.0 0
M  V30 5 C 6.9300 5.3349 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 5.3900 5.3349 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 N 4.6200 4.0011 0.0 0
M  V30 10 N 10.3268 4.4643 0.0 0
M  V30 11 C 10.7514 2.9839 0.0 0
M  V30 12 C 11.6036 5.3255 0.0 0
M  V30 13 C 12.2904 2.9302 0.0 0
M  V30 14 C 12.8171 4.3773 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0
M  V30 16 C 0.7700 2.6674 0.0 0
M  V30 17 C 3.0800 1.3338 0.0 0
M  V30 18 C 0.0000 1.3338 0.0 0
M  V30 19 C 2.3100 0.0000 0.0 0
M  V30 20 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 1 2 4
M  V30 4 1 3 9
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 9
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 19867-34-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 889952-46-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-15808632
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(hetero)aryl substituted heterocycle derivatives useful
as dopamine transporter inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cremonesi, Susanna; Micheli, Fabrizio; Semeraro, Teresa; Tarsi, Luca;
Luker, Tim; Leslie, Colin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016042453 A1 2016-03-24

$RFMT $RIREG SCHEME121 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 7-chloro-2-(4-nitrophenyl)pyrazolo[1,5-a]pyrimidine-5-carboxylate
C14H9ClN4O4
2035421-82-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 10.6336 0.0000 0.0 0
M  V30 2 C 13.3009 4.6200 0.0 0
M  V30 3 O 14.6347 3.8500 0.0 0
M  V30 4 O 13.3009 6.1600 0.0 0
M  V30 5 C 15.9683 4.6200 0.0 0
M  V30 6 N 0.7700 3.0800 0.0 0 VAL=5
M  V30 7 O 0.0000 4.4137 0.0 0
M  V30 8 O 0.0000 1.7464 0.0 0
M  V30 9 C 9.3000 3.8500 0.0 0
M  V30 10 N 9.3000 2.3100 0.0 0
M  V30 11 C 7.8353 4.3259 0.0 0
M  V30 12 N 10.6336 4.6200 0.0 0
M  V30 13 N 7.8353 1.8341 0.0 0
M  V30 14 C 10.6336 1.5400 0.0 0
M  V30 15 C 6.9300 3.0800 0.0 0
M  V30 16 C 11.9672 3.8500 0.0 0
M  V30 17 C 11.9672 2.3100 0.0 0
M  V30 18 C 5.3900 3.0800 0.0 0
M  V30 19 C 4.6200 1.7464 0.0 0
M  V30 20 C 4.6200 4.4137 0.0 0
M  V30 21 C 3.0800 1.7464 0.0 0
M  V30 22 C 3.0800 4.4137 0.0 0
M  V30 23 C 2.3100 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 16
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 23
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 12
M  V30 12 1 10 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 2 13 15
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(4-nitrophenyl)-7-(1-pyrrolidinyl)pyrazolo[1,5-a]pyrimidine-5-carbox...
C18H17N5O4
2035417-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.9559 5.1047 0.0 0
M  V30 2 O 13.7260 6.4385 0.0 0
M  V30 3 O 13.7260 3.7711 0.0 0
M  V30 4 C 15.2660 6.4385 0.0 0
M  V30 5 N 1.3337 10.0367 0.0 0 VAL=5
M  V30 6 O 1.3337 11.5767 0.0 0
M  V30 7 O 0.0000 9.2667 0.0 0
M  V30 8 N 8.3359 5.1047 0.0 0
M  V30 9 C 9.1059 3.7711 0.0 0
M  V30 10 C 9.1059 6.4385 0.0 0
M  V30 11 N 6.8296 5.4251 0.0 0
M  V30 12 C 10.6459 3.7711 0.0 0
M  V30 13 C 8.0754 7.5829 0.0 0
M  V30 14 N 10.6459 6.4385 0.0 0
M  V30 15 C 6.6685 6.9566 0.0 0
M  V30 16 C 11.4159 5.1047 0.0 0
M  V30 17 N 8.3359 2.4374 0.0 0
M  V30 18 C 6.8043 2.2765 0.0 0
M  V30 19 C 8.9622 1.0304 0.0 0
M  V30 20 C 6.4841 0.7700 0.0 0
M  V30 21 C 7.8178 0.0000 0.0 0
M  V30 22 C 5.3348 7.7266 0.0 0
M  V30 23 C 5.3348 9.2667 0.0 0
M  V30 24 C 4.0011 6.9566 0.0 0
M  V30 25 C 4.0011 10.0367 0.0 0
M  V30 26 C 2.6675 7.7266 0.0 0
M  V30 27 C 2.6675 9.2667 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 27
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 2 9 12
M  V30 12 1 9 17
M  V30 13 2 10 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 2 14 16
M  V30 19 1 15 22
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2035421-82-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2035417-70-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16673049
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrazolo- and triazolo-pyrimidine compounds as RSV
antiviral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lancois, David Francis Alain; Guillemont, Jerome Emile Georges;
Raboisson, Pierre Jean-Marie Bernard; Roymans, Dirk Andre Emmy; Rogovoy,
Boris; Bichko, Vadim; Lardeau, Delphine Yvonne Raymonde; Michaut, Antoine
Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016174079 A1 2016-11-03

$RFMT $RIREG SCHEME122 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanecarboxaldehyde
C7H12O
2043-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Cyclohexyl-3-phenyl-2-propyn-1-yl)pyrrolidine
C19H25N
615253-68-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 3.7710 0.0 0
M  V30 2 C 4.6201 3.7710 0.0 0
M  V30 3 C 6.1601 3.7710 0.0 0
M  V30 4 N 2.3100 2.4374 0.0 0
M  V30 5 C 0.7785 2.2765 0.0 0
M  V30 6 C 2.9364 1.0304 0.0 0
M  V30 7 C 0.4583 0.7700 0.0 0
M  V30 8 C 1.7920 0.0000 0.0 0
M  V30 9 C 2.3100 5.1047 0.0 0
M  V30 10 C 0.7700 5.1047 0.0 0
M  V30 11 C 3.0800 6.4385 0.0 0
M  V30 12 C 0.0000 6.4385 0.0 0
M  V30 13 C 2.3100 7.7722 0.0 0
M  V30 14 C 0.7700 7.7722 0.0 0
M  V30 15 C 7.7001 3.7710 0.0 0
M  V30 16 C 8.4701 5.1047 0.0 0
M  V30 17 C 8.4701 2.4374 0.0 0
M  V30 18 C 10.0101 5.1047 0.0 0
M  V30 19 C 10.0101 2.4374 0.0 0
M  V30 20 C 10.7801 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 9
M  V30 4 3 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2043-61-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 615253-68-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-17160472
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2093105-70-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, sealed tube used, catalyst prepared and used,
aerobic, optimization study, optimized on catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu(II) Coordination Polymers as Vehicles in the A3 Coupling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Loukopoulos, Edward; Kallitsakis, Michael; Tsoureas, Nikolaos;
Abdul-Sada, Alaa; Chilton, Nicholas F.; Lykakis, Ioannis N.; Kostakis,
George E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2017), 56(9), 4898-4910

$RFMT $RIREG SCHEME123 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)phenylacetylene
C9H5F3
705-31-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 3.0800 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 0.0000 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 C 9.2400 1.5400 0.0 0
M  V30 7 C 3.0800 1.5400 0.0 0
M  V30 8 C 3.8500 0.2064 0.0 0
M  V30 9 C 3.8500 2.8736 0.0 0
M  V30 10 C 5.3900 0.2064 0.0 0
M  V30 11 C 5.3900 2.8736 0.0 0
M  V30 12 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 3 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanecarboxaldehyde
C7H12O
2043-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-Cyclohexyl-3-[4-(trifluoromethyl)phenyl]-2-propyn-1-yl]pyrrolidine
C20H24F3N
2093105-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 3.7710 0.0 0
M  V30 2 C 4.6200 3.7710 0.0 0
M  V30 3 C 6.1600 3.7710 0.0 0
M  V30 4 C 12.3200 3.7710 0.0 0
M  V30 5 F 12.3200 5.3110 0.0 0
M  V30 6 F 13.8600 3.7710 0.0 0
M  V30 7 F 12.3200 2.2310 0.0 0
M  V30 8 N 2.3100 2.4374 0.0 0
M  V30 9 C 0.7785 2.2764 0.0 0
M  V30 10 C 2.9363 1.0304 0.0 0
M  V30 11 C 0.4583 0.7700 0.0 0
M  V30 12 C 1.7919 0.0000 0.0 0
M  V30 13 C 2.3100 5.1046 0.0 0
M  V30 14 C 0.7700 5.1046 0.0 0
M  V30 15 C 3.0800 6.4384 0.0 0
M  V30 16 C 0.0000 6.4384 0.0 0
M  V30 17 C 2.3100 7.7721 0.0 0
M  V30 18 C 0.7700 7.7721 0.0 0
M  V30 19 C 7.7000 3.7710 0.0 0
M  V30 20 C 8.4700 5.1046 0.0 0
M  V30 21 C 8.4700 2.4374 0.0 0
M  V30 22 C 10.0100 5.1046 0.0 0
M  V30 23 C 10.0100 2.4374 0.0 0
M  V30 24 C 10.7800 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 13
M  V30 4 3 2 3
M  V30 5 1 3 19
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 4 24
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 705-31-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2043-61-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2093105-82-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-17160522
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2093105-70-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-63-0
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, sealed tube used, catalyst prepared and used,
aerobic
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu(II) Coordination Polymers as Vehicles in the A3 Coupling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Loukopoulos, Edward; Kallitsakis, Michael; Tsoureas, Nikolaos;
Abdul-Sada, Alaa; Chilton, Nicholas F.; Lykakis, Ioannis N.; Kostakis,
George E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganic Chemistry (2017), 56(9), 4898-4910

$RFMT $RIREG SCHEME124 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[Bis[(4-methoxyphenyl)methyl]amino]sulfonyl]propanoic acid
C19H23NO6S
2050018-57-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 5.3347 0.0 0
M  V30 2 S 6.9300 4.0011 0.0 0 VAL=6
M  V30 3 C 6.9300 6.6684 0.0 0
M  V30 4 C 4.6200 5.3347 0.0 0
M  V30 5 C 7.7000 2.6673 0.0 0
M  V30 6 O 8.2636 4.7711 0.0 0
M  V30 7 O 5.5964 3.2311 0.0 0
M  V30 8 C 6.9300 1.3336 0.0 0
M  V30 9 C 9.2400 2.6673 0.0 0
M  V30 10 O 7.7000 0.0000 0.0 0
M  V30 11 O 5.3900 1.3336 0.0 0
M  V30 12 O 13.0900 6.6684 0.0 0
M  V30 13 C 13.8600 8.0021 0.0 0
M  V30 14 O 1.5400 10.6694 0.0 0
M  V30 15 C 0.0000 10.6694 0.0 0
M  V30 16 C 8.4700 6.6684 0.0 0
M  V30 17 C 9.2400 5.3347 0.0 0
M  V30 18 C 9.2400 8.0021 0.0 0
M  V30 19 C 10.7800 5.3347 0.0 0
M  V30 20 C 10.7800 8.0021 0.0 0
M  V30 21 C 11.5500 6.6684 0.0 0
M  V30 22 C 3.8500 6.6684 0.0 0
M  V30 23 C 4.6200 8.0021 0.0 0
M  V30 24 C 2.3100 6.6684 0.0 0
M  V30 25 C 3.8500 9.3358 0.0 0
M  V30 26 C 1.5400 8.0021 0.0 0
M  V30 27 C 2.3100 9.3358 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 2 7
M  V30 7 1 3 16
M  V30 8 1 4 22
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 1 12 13
M  V30 14 1 12 21
M  V30 15 1 14 15
M  V30 16 1 14 27
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Bis[(4-methoxyphenyl)methyl]-α-methyl-β-oxo-1-pyrrolidineethanesulfonamide
C23H30N2O5S
2050018-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7598 8.0022 0.0 0
M  V30 2 S 6.2198 8.0022 0.0 0 VAL=6
M  V30 3 C 8.5298 6.6684 0.0 0
M  V30 4 C 8.5298 9.3358 0.0 0
M  V30 5 C 4.6798 8.0022 0.0 0
M  V30 6 O 6.2198 6.4622 0.0 0
M  V30 7 O 6.2198 9.5422 0.0 0
M  V30 8 C 3.9098 9.3358 0.0 0
M  V30 9 C 3.9098 6.6684 0.0 0
M  V30 10 O 4.6798 10.6695 0.0 0
M  V30 11 O 5.4498 1.3336 0.0 0
M  V30 12 C 6.2198 0.0000 0.0 0
M  V30 13 O 14.6898 9.3358 0.0 0
M  V30 14 C 15.4598 10.6695 0.0 0
M  V30 15 C 7.7598 5.3347 0.0 0
M  V30 16 C 6.2198 5.3347 0.0 0
M  V30 17 C 8.5298 4.0011 0.0 0
M  V30 18 C 5.4498 4.0011 0.0 0
M  V30 19 C 7.7598 2.6673 0.0 0
M  V30 20 C 6.2198 2.6673 0.0 0
M  V30 21 C 10.0698 9.3358 0.0 0
M  V30 22 C 10.8398 8.0022 0.0 0
M  V30 23 C 10.8398 10.6695 0.0 0
M  V30 24 C 12.3798 8.0022 0.0 0
M  V30 25 C 12.3798 10.6695 0.0 0
M  V30 26 C 13.1498 9.3358 0.0 0
M  V30 27 N 2.3698 9.3358 0.0 0
M  V30 28 C 1.4645 8.0900 0.0 0
M  V30 29 C 1.4645 10.5817 0.0 0
M  V30 30 C 0.0000 8.5658 0.0 0
M  V30 31 C 0.0000 10.1058 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 2 2 7
M  V30 7 1 3 15
M  V30 8 1 4 21
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 2 8 10
M  V30 12 1 8 27
M  V30 13 1 11 12
M  V30 14 1 11 20
M  V30 15 1 13 14
M  V30 16 1 13 26
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2050018-57-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2050018-61-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17173227
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 68957-94-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Triazoles as agonists of the APJ receptor and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Ning; Chen, Xiaoqi; Chen, Yinhong; Cheng, Alan C.; Connors, Richard
V.; Deignan, Jeffrey; Dransfield, Paul John; Du, Xiaohui; Fu, Zice;
Heath, Julie Anne; Horne, Daniel B.; Houze, Jonathan; Kaller, Matthew R.;
Khakoo, Aarif Yusuf; Kopecky, David John; Lai, Su-Jen; Ma, Zhihua; Mcgee,
Lawrence R.; Medina, Julio C.; Mihalic, Jeffrey T.; Nishimura, Nobuko;
Olson, Steven H.; Pattaropong, Vatee; Swaminath, Gayathri; Wang,
Xiaodong; Yang, Kevin; Yeh, Wen-Chen; Debenedetto, Mikkel V.; Farrell,
Robert P.; Hedley, Simon J.; Judd, Ted C.; Kayser, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016187308 A1 2016-11-24

$RFMT $RIREG SCHEME125 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Acetyl-5-phenyl-1,3-cyclohexanedione
C14H14O3
2057-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3101 0.0000 0.0 0
M  V30 2 O 2.3101 5.3350 0.0 0
M  V30 3 C 0.7700 2.6675 0.0 0
M  V30 4 C 0.0000 4.0012 0.0 0
M  V30 5 O 0.0000 1.3338 0.0 0
M  V30 6 C 5.3901 2.6675 0.0 0
M  V30 7 C 4.6201 1.3338 0.0 0
M  V30 8 C 4.6201 4.0012 0.0 0
M  V30 9 C 3.0801 1.3338 0.0 0
M  V30 10 C 3.0801 4.0012 0.0 0
M  V30 11 C 2.3101 2.6675 0.0 0
M  V30 12 C 6.9302 2.6675 0.0 0
M  V30 13 C 7.7002 4.0012 0.0 0
M  V30 14 C 7.7002 1.3338 0.0 0
M  V30 15 C 9.2402 4.0012 0.0 0
M  V30 16 C 9.2402 1.3338 0.0 0
M  V30 17 C 10.0102 2.6675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Phenyl-2-[1-(1-pyrrolidinyl)ethylidene]-1,3-cyclohexanedione
C18H21NO2
18930-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6217 3.7710 0.0 0
M  V30 2 C 1.8517 5.1048 0.0 0
M  V30 3 O 4.1617 1.1037 0.0 0
M  V30 4 O 4.1617 6.4384 0.0 0
M  V30 5 C 4.1617 3.7710 0.0 0
M  V30 6 C 4.9317 2.4374 0.0 0
M  V30 7 C 4.9317 5.1048 0.0 0
M  V30 8 C 6.4717 2.4374 0.0 0
M  V30 9 C 6.4717 5.1048 0.0 0
M  V30 10 C 7.2417 3.7710 0.0 0
M  V30 11 N 1.8517 2.4374 0.0 0
M  V30 12 C 0.3202 2.2764 0.0 0
M  V30 13 C 2.4782 1.0306 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 1.3336 0.0000 0.0 0
M  V30 16 C 8.7817 3.7710 0.0 0
M  V30 17 C 9.5517 5.1048 0.0 0
M  V30 18 C 9.5517 2.4374 0.0 0
M  V30 19 C 11.0917 5.1048 0.0 0
M  V30 20 C 11.0917 2.4374 0.0 0
M  V30 21 C 11.8617 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 5
M  V30 3 1 1 11
M  V30 4 2 3 6
M  V30 5 2 4 7
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 10 16
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2057-01-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18930-30-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1115161
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Fragment-based Identification of Hsp90 Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barker, John J.; Barker, Oliver; Boggio, Roberto; Chauhan, Viddhata;
Cheng, Robert K. Y.; Corden, Vincent; Courtney, Stephen M.; Edwards,
Neil; Falque, Virginie M.; Fusar, Fulvia; Gardiner, Mihaly; Hamelin,
Estelle M. N.; Hesterkamp, Thomas; Ichihara, Osamu; Jones, Richard S.;
Mather, Owen; Mercurio, Ciro; Minucci, Saverio; Montalbetti, Christian A.
G. N.; Muller, Annett; Patel, Deepti; Phillips, Banu G.; Varasi, Mario;
Whittaker, Mark; Winkler, Dirk; Yarnold, Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemMedChem (2009), 4(6), 963-966

$RFMT $RIREG SCHEME126 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S,5R)-1-(2-Bromo-1-oxopropyl)-3,4-dimethyl-5-phenyl-2-imidazolidinone
C14H17BrN2O2
206358-45-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.1864 2.6091 0.0 0
M  V30 2 C 2.1559 1.4647 0.0 0 CFG=3
M  V30 3 O 4.6927 2.2889 0.0 0
M  V30 4 Br 2.6317 0.0000 0.0 0
M  V30 5 C 0.6496 1.7849 0.0 0
M  V30 6 C 3.1864 8.0302 0.0 0
M  V30 7 O 0.0000 3.6444 0.0 0
M  V30 8 C 0.0000 6.9949 0.0 0
M  V30 9 C 3.6156 5.3196 0.0 0 CFG=2
M  V30 10 N 2.7104 4.0738 0.0 0
M  V30 11 C 2.7104 6.5655 0.0 0 CFG=2
M  V30 12 C 1.2459 4.5496 0.0 0
M  V30 13 N 1.2459 6.0897 0.0 0
M  V30 14 C 5.1556 5.3196 0.0 0
M  V30 15 C 5.9256 6.6533 0.0 0
M  V30 16 C 5.9256 3.9860 0.0 0
M  V30 17 C 7.4656 6.6533 0.0 0
M  V30 18 C 7.4656 3.9860 0.0 0
M  V30 19 C 8.2357 5.3196 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 11 6 CFG=1
M  V30 7 2 7 12
M  V30 8 1 8 13
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 14 CFG=1
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 9 11)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4R,5S)-1,5-Dimethyl-3-[(2R)-1-oxo-2-(1-pyrrolidinyl)propyl]-4-phenyl-2-imida...
C18H25N3O2
206358-49-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.4211 5.0492 0.0 0
M  V30 2 C 6.5655 6.0798 0.0 0 CFG=2
M  V30 3 O 5.7413 3.5429 0.0 0
M  V30 4 C 6.2453 7.5861 0.0 0
M  V30 5 C 0.0000 5.0492 0.0 0
M  V30 6 O 4.3858 8.2357 0.0 0
M  V30 7 C 1.0353 8.2357 0.0 0
M  V30 8 C 2.7106 4.6200 0.0 0 CFG=2
M  V30 9 N 3.9564 5.5252 0.0 0
M  V30 10 C 1.4647 5.5252 0.0 0 CFG=2
M  V30 11 C 3.4806 6.9898 0.0 0
M  V30 12 N 1.9406 6.9898 0.0 0
M  V30 13 C 2.7106 3.0800 0.0 0
M  V30 14 C 4.0442 2.3100 0.0 0
M  V30 15 C 1.3769 2.3100 0.0 0
M  V30 16 C 4.0442 0.7700 0.0 0
M  V30 17 C 1.3769 0.7700 0.0 0
M  V30 18 C 2.7106 0.0000 0.0 0
M  V30 19 N 8.0302 5.6039 0.0 0
M  V30 20 C 8.5061 4.1392 0.0 0
M  V30 21 C 9.2761 6.5090 0.0 0
M  V30 22 C 10.0461 4.1392 0.0 0
M  V30 23 C 10.5219 5.6039 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4 CFG=1
M  V30 5 1 2 19
M  V30 6 1 10 5 CFG=3
M  V30 7 2 6 11
M  V30 8 1 7 12
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 13 CFG=3
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 2 8 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 206358-45-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 206358-49-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-240234
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 311-28-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of α-amino esters by dynamic kinetic resolution of α-haloacyl
imidazolidinones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Caddick, S.; Afonso, C. A. M.; Candeias, S. X.; Hitchcock, P. B.;
Jenkins, K.; Murtagh, L.; Pardoe, D.; Santos, A. G.; Treweeke, N. R.;
Weaving, R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2001), 57(30), 6589-6605

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Difluorooxido-λ4-sulfanylidene)-4-ethynylbenzenamine
C8H5F2NOS
2081093-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.1037 2.6673 0.0 0
M  V30 2 S 1.3337 1.3337 0.0 0 VAL=6
M  V30 3 F 0.5637 0.0000 0.0 0
M  V30 4 F 0.0000 2.1037 0.0 0
M  V30 5 O 2.6673 0.5637 0.0 0
M  V30 6 C 8.2638 2.6673 0.0 0
M  V30 7 C 9.8039 2.6673 0.0 0
M  V30 8 C 3.6437 2.6673 0.0 0
M  V30 9 C 4.4137 1.3337 0.0 0
M  V30 10 C 4.4137 4.0010 0.0 0
M  V30 11 C 5.9538 1.3337 0.0 0
M  V30 12 C 5.9538 4.0010 0.0 0
M  V30 13 C 6.7238 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Ethynylphenyl)-1-pyrrolidinesulfonimidoyl fluoride
C12H13FN2OS
2081093-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 1.3337 0.0 0 VAL=6
M  V30 2 N 5.1048 0.5637 0.0 0
M  V30 3 F 3.0011 0.0000 0.0 0
M  V30 4 O 4.5411 2.6673 0.0 0
M  V30 5 C 10.4396 3.6437 0.0 0
M  V30 6 C 11.7733 4.4137 0.0 0
M  V30 7 N 2.4373 2.1037 0.0 0
M  V30 8 C 2.2763 3.6352 0.0 0
M  V30 9 C 1.0304 1.4774 0.0 0
M  V30 10 C 0.7700 3.9554 0.0 0
M  V30 11 C 0.0000 2.6218 0.0 0
M  V30 12 C 6.4384 1.3337 0.0 0
M  V30 13 C 6.4384 2.8737 0.0 0
M  V30 14 C 7.7722 0.5637 0.0 0
M  V30 15 C 7.7722 3.6437 0.0 0
M  V30 16 C 9.1059 1.3337 0.0 0
M  V30 17 C 9.1059 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 12
M  V30 6 3 5 6
M  V30 7 1 5 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2081093-53-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2081093-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27076741
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of thionyl tetrafluoride modified compounds and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sharpless, K. Barry; Wu, Peng; Li, Suhua; Liu, Zilei; Gao, Bing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018102433 A1 2018-06-07

$RFMT $RIREG SCHEME127 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(Difluorooxido-λ4-sulfanylidene)-4-ethynylbenzenamine
C8H5F2NOS
2081093-53-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.1037 2.6673 0.0 0
M  V30 2 S 1.3337 1.3337 0.0 0 VAL=6
M  V30 3 F 0.5637 0.0000 0.0 0
M  V30 4 F 0.0000 2.1037 0.0 0
M  V30 5 O 2.6673 0.5637 0.0 0
M  V30 6 C 8.2638 2.6673 0.0 0
M  V30 7 C 9.8039 2.6673 0.0 0
M  V30 8 C 3.6437 2.6673 0.0 0
M  V30 9 C 4.4137 1.3337 0.0 0
M  V30 10 C 4.4137 4.0010 0.0 0
M  V30 11 C 5.9538 1.3337 0.0 0
M  V30 12 C 5.9538 4.0010 0.0 0
M  V30 13 C 6.7238 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Ethynylphenyl)-1-pyrrolidinesulfonimidoyl fluoride
C12H13FN2OS
2081093-85-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 1.3337 0.0 0 VAL=6
M  V30 2 N 5.1048 0.5637 0.0 0
M  V30 3 F 3.0011 0.0000 0.0 0
M  V30 4 O 4.5411 2.6673 0.0 0
M  V30 5 C 10.4396 3.6437 0.0 0
M  V30 6 C 11.7733 4.4137 0.0 0
M  V30 7 N 2.4373 2.1037 0.0 0
M  V30 8 C 2.2763 3.6352 0.0 0
M  V30 9 C 1.0304 1.4774 0.0 0
M  V30 10 C 0.7700 3.9554 0.0 0
M  V30 11 C 0.0000 2.6218 0.0 0
M  V30 12 C 6.4384 1.3337 0.0 0
M  V30 13 C 6.4384 2.8737 0.0 0
M  V30 14 C 7.7722 0.5637 0.0 0
M  V30 15 C 7.7722 3.6437 0.0 0
M  V30 16 C 9.1059 1.3337 0.0 0
M  V30 17 C 9.1059 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 1 2 12
M  V30 6 3 5 6
M  V30 7 1 5 17
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2081093-53-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2081093-85-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29820190
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multidimensional SuFEx Click Chemistry: Sequential Sulfur(VI) Fluoride
Exchange Connections of Diverse Modules Launched From An SOF4 Hub
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Suhua; Wu, Peng; Moses, John E.; Sharpless, K. Barry
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2017), 56(11), 2903-2908

$RFMT $RIREG SCHEME128 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(2R,4S,6S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]tetrahydro-6-phenyl-2H-...
C18H25NO5
2089106-81-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 6.9302 0.0 0
M  V30 2 C 9.3360 6.1601 0.0 0
M  V30 3 O 10.6697 6.9302 0.0 0
M  V30 4 O 9.3360 4.6201 0.0 0
M  V30 5 C 12.0033 6.1601 0.0 0
M  V30 6 C 11.2333 4.8265 0.0 0
M  V30 7 C 13.3370 5.3901 0.0 0
M  V30 8 C 12.7733 7.4938 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0010 1.5400 0.0 0
M  V30 11 O 4.0010 0.0000 0.0 0
M  V30 12 O 2.6673 2.3101 0.0 0
M  V30 13 C 4.0010 6.1601 0.0 0 CFG=1
M  V30 14 C 5.3348 6.9302 0.0 0
M  V30 15 O 4.0010 4.6201 0.0 0
M  V30 16 C 6.6685 6.1601 0.0 0 CFG=1
M  V30 17 C 5.3348 3.8501 0.0 0 CFG=1
M  V30 18 C 6.6685 4.6201 0.0 0
M  V30 19 C 2.6673 6.9302 0.0 0
M  V30 20 C 2.6673 8.4702 0.0 0
M  V30 21 C 1.3337 6.1601 0.0 0
M  V30 22 C 1.3337 9.2402 0.0 0
M  V30 23 C 0.0000 6.9302 0.0 0
M  V30 24 C 0.0000 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=1
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 10
M  V30 10 1 17 9 CFG=3
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 19 CFG=3
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 13 16 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl N-[(2R,4S,6S)-tetrahydro-2-[2-oxo-2-(1-pyrrolidinyl)eth...
C22H32N2O4
2089106-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.2084 7.7000 0.0 0
M  V30 2 C 9.5420 6.9300 0.0 0
M  V30 3 O 9.5420 5.3900 0.0 0
M  V30 4 N 2.8736 7.7000 0.0 0
M  V30 5 C 2.8736 9.2400 0.0 0
M  V30 6 O 1.5400 10.0100 0.0 0
M  V30 7 O 4.2073 10.0100 0.0 0
M  V30 8 C 1.5400 11.5500 0.0 0
M  V30 9 C 3.0800 11.5500 0.0 0
M  V30 10 C 1.5400 13.0900 0.0 0
M  V30 11 C 0.0000 11.5500 0.0 0
M  V30 12 C 5.5409 4.6200 0.0 0 CFG=2
M  V30 13 O 6.8747 5.3900 0.0 0
M  V30 14 C 4.2073 5.3900 0.0 0
M  V30 15 C 6.8747 6.9300 0.0 0 CFG=1
M  V30 16 C 4.2073 6.9300 0.0 0 CFG=1
M  V30 17 C 5.5409 7.7000 0.0 0
M  V30 18 C 5.5411 3.0800 0.0 0
M  V30 19 C 4.2073 2.3100 0.0 0
M  V30 20 C 6.8747 2.3100 0.0 0
M  V30 21 C 4.2073 0.7700 0.0 0
M  V30 22 C 6.8747 0.7700 0.0 0
M  V30 23 C 5.5411 0.0000 0.0 0
M  V30 24 N 10.8758 7.7000 0.0 0
M  V30 25 C 12.2826 7.0737 0.0 0
M  V30 26 C 11.0367 9.2315 0.0 0
M  V30 27 C 13.3130 8.2181 0.0 0
M  V30 28 C 12.5430 9.5517 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 1 16 4 CFG=1
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 18 CFG=3
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 12 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2089106-81-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2089106-82-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-16969095
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 4-aminotetrahydropyran scaffolds for drug discovery
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nortcliffe, Andrew; Milne, Gavin D. S.; Hamza, Daniel; Moody, Christopher
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(7), 2218-2225

$RFMT $RIREG SCHEME129 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-Chloro-2-methyl-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]py...
C18H24ClN5OSi
2092672-69-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 1.2896 3.9644 0.0 0
M  V30 2 C 7.8084 5.2890 0.0 0
M  V30 3 O 8.5784 6.6226 0.0 0
M  V30 4 C 10.1184 6.6226 0.0 0
M  V30 5 C 10.8884 7.9564 0.0 0
M  V30 6 Si 12.4284 7.9564 0.0 0
M  V30 7 C 13.9684 7.9564 0.0 0
M  V30 8 C 12.4284 6.4164 0.0 0
M  V30 9 C 12.4284 9.4964 0.0 0
M  V30 10 C 4.8592 0.0000 0.0 0
M  V30 11 N 1.7288 10.9325 0.0 0
M  V30 12 C 3.8987 4.5190 0.0 0
M  V30 13 C 3.8987 6.0590 0.0 0
M  V30 14 C 5.3632 4.0431 0.0 0
M  V30 15 C 2.7541 3.4886 0.0 0
M  V30 16 C 5.3632 6.5348 0.0 0
M  V30 17 N 6.2684 5.2890 0.0 0
M  V30 18 N 5.6834 2.5367 0.0 0
M  V30 19 N 3.0743 1.9821 0.0 0
M  V30 20 C 4.5390 1.5063 0.0 0
M  V30 21 C 2.6528 6.9642 0.0 0
M  V30 22 C 2.8137 8.4957 0.0 0
M  V30 23 C 1.2459 6.3379 0.0 0
M  V30 24 C 1.5679 9.4009 0.0 0
M  V30 25 C 0.0000 7.2429 0.0 0
M  V30 26 N 0.1609 8.7746 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 15
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 20
M  V30 11 1 11 24
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 2 13 16
M  V30 16 1 13 21
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 17
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-Methyl-4-(1-pyrrolidinyl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrol...
C22H32N6OSi
2092672-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.0105 5.2890 0.0 0
M  V30 2 O 9.7805 6.6226 0.0 0
M  V30 3 C 11.3205 6.6226 0.0 0
M  V30 4 C 12.0905 7.9564 0.0 0
M  V30 5 Si 13.6305 7.9564 0.0 0
M  V30 6 C 15.1705 7.9564 0.0 0
M  V30 7 C 13.6305 9.4964 0.0 0
M  V30 8 C 13.6305 6.4164 0.0 0
M  V30 9 C 6.0613 0.0000 0.0 0
M  V30 10 N 2.9309 10.9325 0.0 0
M  V30 11 C 5.1008 4.5190 0.0 0
M  V30 12 C 5.1008 6.0590 0.0 0
M  V30 13 C 6.5655 4.0431 0.0 0
M  V30 14 C 3.9564 3.4886 0.0 0
M  V30 15 C 6.5655 6.5348 0.0 0
M  V30 16 N 7.4705 5.2890 0.0 0
M  V30 17 N 6.8856 2.5367 0.0 0
M  V30 18 N 4.2766 1.9821 0.0 0
M  V30 19 C 5.7411 1.5063 0.0 0
M  V30 20 C 3.8549 6.9642 0.0 0
M  V30 21 C 4.0159 8.4957 0.0 0
M  V30 22 C 2.4480 6.3379 0.0 0
M  V30 23 C 2.7700 9.4009 0.0 0
M  V30 24 C 1.2021 7.2429 0.0 0
M  V30 25 N 1.3631 8.7746 0.0 0
M  V30 26 N 2.4917 3.9644 0.0 0
M  V30 27 C 2.0159 5.4291 0.0 0
M  V30 28 C 1.2459 3.0592 0.0 0
M  V30 29 C 0.4759 5.4291 0.0 0
M  V30 30 C 0.0000 3.9644 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 19
M  V30 10 1 10 23
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 2 12 15
M  V30 15 1 12 20
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 14 26
M  V30 20 1 15 16
M  V30 21 1 17 19
M  V30 22 2 18 19
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2092672-69-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2092672-97-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20501324
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM microwave irradiation, regioselective, thermal
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of new pyrrolo[2,3-d]pyrimidine derivatives as dual
DYRK1/CLK1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fiumana, Andrea; Foloppe, Nicolas; Ray, Stuart; Walmsley, David; Kotschy,
Andras; Burbridge, Michael Frank; Cruzalegui, Francisco Humberto
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017055533 A1 2017-04-06

$RFMT $RIREG SCHEME130 STEP1
$RXN



  2  1
$MOL
rel-(5aR,6S,7R,8R,8aS)-5a-(4-Bromophenyl)-3-chloro-5a,7,8,8a-tetrahydro-8,8a-...
C24H19BrClNO6
2098196-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 37 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.4389 3.8782 0.0 0
M  V30 2 O 8.0156 1.9426 0.0 0
M  V30 3 C 4.7383 1.2459 0.0 0
M  V30 4 O 5.6435 0.0000 0.0 0
M  V30 5 O 3.2068 1.0849 0.0 0
M  V30 6 O 10.3726 4.3153 0.0 0
M  V30 7 C 11.9126 4.3153 0.0 0
M  V30 8 Br 1.5839 9.7800 0.0 0
M  V30 9 Cl 10.3726 9.6500 0.0 0
M  V30 10 C 5.6252 5.1308 0.0 0 CFG=1
M  V30 11 C 7.0321 4.5045 0.0 0 CFG=2
M  V30 12 C 4.5948 3.9865 0.0 0 CFG=2
M  V30 13 O 5.7861 6.6625 0.0 0
M  V30 14 C 8.0626 5.6491 0.0 0
M  V30 15 C 6.8711 2.9730 0.0 0 CFG=2
M  V30 16 C 5.3648 2.6528 0.0 0 CFG=1
M  V30 17 C 7.2926 6.9827 0.0 0
M  V30 18 C 9.6026 5.6491 0.0 0
M  V30 19 C 8.0626 8.3164 0.0 0
M  V30 20 N 10.3726 6.9827 0.0 0
M  V30 21 C 9.6026 8.3164 0.0 0
M  V30 22 C 4.6149 6.2932 0.0 0
M  V30 23 C 3.1031 5.9993 0.0 0
M  V30 24 C 5.1162 7.7493 0.0 0
M  V30 25 C 2.0929 7.1617 0.0 0
M  V30 26 C 4.1060 8.9116 0.0 0
M  V30 27 C 2.5941 8.6177 0.0 0
M  V30 28 C 3.0632 4.1474 0.0 0
M  V30 29 C 2.1580 2.9015 0.0 0
M  V30 30 C 2.4368 5.5543 0.0 0
M  V30 31 C 0.6265 3.0625 0.0 0
M  V30 32 C 0.9052 5.7153 0.0 0
M  V30 33 C 0.0000 4.4694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 11 1 CFG=1
M  V30 2 1 15 2 CFG=3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 16 3 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 18
M  V30 8 1 8 27
M  V30 9 1 9 21
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 10 13
M  V30 13 1 10 22 CFG=1
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 12 28 CFG=1
M  V30 18 1 13 17
M  V30 19 1 14 17
M  V30 20 2 14 18
M  V30 21 1 15 16
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 2 22 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 26
M  V30 30 2 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 10 11 12 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-[(5aR,6S,7R,8R,8aS)-5a-(4-Bromophenyl)-3-chloro-5a,7,8,8a-tetrahydro-8,8a...
C28H26BrClN2O5
2098196-43-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.3983 4.5606 0.0 0
M  V30 2 O 2.9337 5.8950 0.0 0
M  V30 3 C 3.9689 9.0814 0.0 0
M  V30 4 O 4.5954 10.4884 0.0 0
M  V30 5 O 3.8100 2.6674 0.0 0
M  V30 6 C 3.0400 1.3336 0.0 0
M  V30 7 Br 12.9370 7.5463 0.0 0
M  V30 8 Cl 8.4300 0.0000 0.0 0
M  V30 9 C 6.8900 6.3708 0.0 0 CFG=1
M  V30 10 C 5.6441 5.4658 0.0 0 CFG=2
M  V30 11 C 6.4141 7.8355 0.0 0 CFG=2
M  V30 12 O 8.1360 5.4658 0.0 0
M  V30 13 C 6.1200 4.0011 0.0 0
M  V30 14 C 4.3983 6.3708 0.0 0 CFG=2
M  V30 15 C 4.8741 7.8355 0.0 0 CFG=1
M  V30 16 C 7.6600 4.0011 0.0 0
M  V30 17 C 5.3500 2.6674 0.0 0
M  V30 18 C 8.4300 2.6674 0.0 0
M  V30 19 N 6.1200 1.3336 0.0 0
M  V30 20 C 7.6600 1.3336 0.0 0
M  V30 21 C 8.4018 6.6647 0.0 0
M  V30 22 C 9.4120 5.5024 0.0 0
M  V30 23 C 8.9031 8.1209 0.0 0
M  V30 24 C 10.9239 5.7963 0.0 0
M  V30 25 C 10.4149 8.4147 0.0 0
M  V30 26 C 11.4251 7.2525 0.0 0
M  V30 27 C 7.3193 9.0814 0.0 0
M  V30 28 C 6.6930 10.4884 0.0 0
M  V30 29 C 8.8509 8.9205 0.0 0
M  V30 30 C 7.5982 11.7342 0.0 0
M  V30 31 C 9.7561 10.1663 0.0 0
M  V30 32 C 9.1298 11.5731 0.0 0
M  V30 33 N 2.4374 8.9205 0.0 0
M  V30 34 C 1.4069 10.0648 0.0 0
M  V30 35 C 1.6674 7.5868 0.0 0
M  V30 36 C 0.0000 9.4385 0.0 0
M  V30 37 C 0.1611 7.9070 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 10 1 CFG=1
M  V30 2 1 14 2 CFG=3
M  V30 3 2 3 4
M  V30 4 1 15 3 CFG=3
M  V30 5 1 3 33
M  V30 6 1 5 6
M  V30 7 1 5 17
M  V30 8 1 7 26
M  V30 9 1 8 20
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 21 CFG=1
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 1 11 15
M  V30 17 1 11 27 CFG=1
M  V30 18 1 12 16
M  V30 19 1 13 16
M  V30 20 2 13 17
M  V30 21 1 14 15
M  V30 22 2 16 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 2 19 20
M  V30 26 2 21 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 2 23 25
M  V30 30 2 24 26
M  V30 31 1 25 26
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(5 9 10 11 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 2098196-09-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2098196-43-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18672859
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heterocyclic derivatives as eIF4A inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ernst, Justin T.; Reich, Siegfried H.; Sprengeler, Paul A.; Tran, Chinh
Viet; Packard, Garrick Kenneth; Xiang, Alan X.; Nilewski, Christian;
Michels, Theo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20170145026 A1 2017-05-25

$RFMT $RIREG SCHEME131 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-chloro-5-methyl-4-oxazolecarboxylate
C6H6ClNO3
2114330-60-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1556 2.7104 0.0 0
M  V30 2 O 5.9256 4.0442 0.0 0
M  V30 3 O 5.9256 1.3768 0.0 0
M  V30 4 C 7.4656 4.0442 0.0 0
M  V30 5 C 3.1864 0.0000 0.0 0
M  V30 6 Cl 0.0000 4.3856 0.0 0
M  V30 7 C 3.6156 2.7104 0.0 0
M  V30 8 N 2.7104 3.9564 0.0 0
M  V30 9 C 2.7104 1.4645 0.0 0
M  V30 10 C 1.2459 3.4804 0.0 0
M  V30 11 O 1.2459 1.9404 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 9
M  V30 6 1 6 10
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-methyl-2-(1-pyrrolidinyl)-4-oxazolecarboxylate
C10H14N2O3
2106704-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5257 2.7104 0.0 0
M  V30 2 O 8.2957 4.0442 0.0 0
M  V30 3 O 8.2957 1.3768 0.0 0
M  V30 4 C 9.8357 4.0442 0.0 0
M  V30 5 C 5.5563 0.0000 0.0 0
M  V30 6 C 3.6158 3.4804 0.0 0
M  V30 7 N 5.0805 3.9564 0.0 0
M  V30 8 O 3.6158 1.9404 0.0 0
M  V30 9 C 5.9857 2.7104 0.0 0
M  V30 10 C 5.0805 1.4645 0.0 0
M  V30 11 N 2.3699 4.3856 0.0 0
M  V30 12 C 2.3699 5.9256 0.0 0
M  V30 13 C 0.9052 3.9098 0.0 0
M  V30 14 C 0.9052 6.4015 0.0 0
M  V30 15 C 0.0000 5.1556 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 5 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2114330-60-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2106704-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24527163
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of a novel series of
2,7-substituted-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline derivatives
as selective peroxisome proliferator-activated receptor γ partial
agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Morishita, Ko; Ito, Yuma; Otake, Kazuya; Takahashi, Kenji; Yamamoto,
Megumi; Kitao, Tatsuya; Ozawa, Shin-ichiro; Hirono, Shuichi; Shirahase,
Hiroaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical & Pharmaceutical Bulletin (2021), 69(4), 333-351

$RFMT $RIREG SCHEME132 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S,5Z)-5-[[1-[(Benzoyloxy)methyl]-5-nitro-1H-pyrrol-3-yl]methylene]-4-[(3E)-...
C28H32N2O7
2131834-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.8320 5.6122 0.0 0
M  V30 2 C 13.8763 5.2714 0.0 0
M  V30 3 C 15.2100 6.0414 0.0 0
M  V30 4 C 16.5437 5.2714 0.0 0
M  V30 5 C 17.8773 6.0414 0.0 0
M  V30 6 C 19.2111 5.2714 0.0 0
M  V30 7 C 17.8773 7.5814 0.0 0
M  V30 8 C 20.5448 6.0414 0.0 0
M  V30 9 C 21.8785 5.2714 0.0 0
M  V30 10 C 23.2122 6.0414 0.0 0
M  V30 11 C 24.5460 5.2714 0.0 0
M  V30 12 C 23.2122 7.5814 0.0 0
M  V30 13 C 11.9162 4.6346 0.0 0
M  V30 14 O 13.0184 9.9979 0.0 0
M  V30 15 C 4.4405 6.1788 0.0 0
M  V30 16 O 3.9647 4.7142 0.0 0
M  V30 17 C 2.4582 4.3939 0.0 0
M  V30 18 O 1.4278 5.5384 0.0 0
M  V30 19 N 5.8033 9.2396 0.0 0 VAL=5
M  V30 20 O 6.5733 10.5733 0.0 0
M  V30 21 O 4.2633 9.2396 0.0 0
M  V30 22 C 11.0779 6.5173 0.0 0
M  V30 23 C 12.5425 6.0414 0.0 0 CFG=2
M  V30 24 O 11.0779 8.0573 0.0 0
M  V30 25 O 13.4477 7.2873 0.0 0
M  V30 26 C 12.5425 8.5333 0.0 0
M  V30 27 C 8.4251 6.2385 0.0 0
M  V30 28 C 7.0914 5.4685 0.0 0
M  V30 29 C 8.1049 7.7448 0.0 0
M  V30 30 N 5.9468 6.4989 0.0 0
M  V30 31 C 6.5733 7.9059 0.0 0
M  V30 32 C 1.9823 2.9293 0.0 0
M  V30 33 C 0.4760 2.6091 0.0 0
M  V30 34 C 3.0128 1.7847 0.0 0
M  V30 35 C 0.0000 1.1444 0.0 0
M  V30 36 C 2.5369 0.3202 0.0 0
M  V30 37 C 1.0306 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 23 2 CFG=1
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 23 13 CFG=3
M  V30 15 2 14 26
M  V30 16 1 15 16
M  V30 17 1 15 30
M  V30 18 1 16 17
M  V30 19 2 17 18
M  V30 20 1 17 32
M  V30 21 2 19 20
M  V30 22 2 19 21
M  V30 23 1 19 31
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(4R,5Z)-5-[[1-[(Benzoyloxy)methyl]-5-nitro-1H-pyrrol-3-yl]methylene]-4-[(3E)-...
C28H32N2O7
2131834-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 9.8320 5.6122 0.0 0
M  V30 2 C 13.8763 5.2714 0.0 0
M  V30 3 C 15.2100 6.0414 0.0 0
M  V30 4 C 16.5437 5.2714 0.0 0
M  V30 5 C 17.8773 6.0414 0.0 0
M  V30 6 C 19.2111 5.2714 0.0 0
M  V30 7 C 17.8773 7.5814 0.0 0
M  V30 8 C 20.5448 6.0414 0.0 0
M  V30 9 C 21.8785 5.2714 0.0 0
M  V30 10 C 23.2122 6.0414 0.0 0
M  V30 11 C 24.5460 5.2714 0.0 0
M  V30 12 C 23.2122 7.5814 0.0 0
M  V30 13 C 11.9162 4.6346 0.0 0
M  V30 14 O 13.0184 9.9979 0.0 0
M  V30 15 C 4.4405 6.1788 0.0 0
M  V30 16 O 3.9647 4.7142 0.0 0
M  V30 17 C 2.4582 4.3939 0.0 0
M  V30 18 O 1.4278 5.5384 0.0 0
M  V30 19 N 5.8033 9.2396 0.0 0 VAL=5
M  V30 20 O 4.2633 9.2396 0.0 0
M  V30 21 O 6.5733 10.5733 0.0 0
M  V30 22 C 11.0779 6.5173 0.0 0
M  V30 23 C 12.5425 6.0414 0.0 0 CFG=1
M  V30 24 O 11.0779 8.0573 0.0 0
M  V30 25 O 13.4477 7.2873 0.0 0
M  V30 26 C 12.5425 8.5333 0.0 0
M  V30 27 C 8.4251 6.2385 0.0 0
M  V30 28 C 7.0914 5.4685 0.0 0
M  V30 29 C 8.1049 7.7448 0.0 0
M  V30 30 N 5.9468 6.4989 0.0 0
M  V30 31 C 6.5733 7.9059 0.0 0
M  V30 32 C 1.9823 2.9293 0.0 0
M  V30 33 C 0.4760 2.6091 0.0 0
M  V30 34 C 3.0128 1.7847 0.0 0
M  V30 35 C 0.0000 1.1444 0.0 0
M  V30 36 C 2.5369 0.3202 0.0 0
M  V30 37 C 1.0306 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 22
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 23 2 CFG=3
M  V30 5 1 3 4
M  V30 6 2 4 5
M  V30 7 1 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 23 13 CFG=1
M  V30 15 2 14 26
M  V30 16 1 15 16
M  V30 17 1 15 30
M  V30 18 1 16 17
M  V30 19 2 17 18
M  V30 20 1 17 32
M  V30 21 2 19 20
M  V30 22 2 19 21
M  V30 23 1 19 31
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinecarboxylic acid, (1S,4E)-1-[2-[1-[(benzoyloxy)methyl]-5-nitro-1H...
C32H41N3O7
2131834-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.4917 9.2288 0.0 0
M  V30 2 O 2.6527 10.7603 0.0 0
M  V30 3 C 1.4068 11.6655 0.0 0
M  V30 4 O 0.0000 11.0392 0.0 0
M  V30 5 N 2.4917 5.8783 0.0 0 VAL=5
M  V30 6 O 1.0848 6.5048 0.0 0
M  V30 7 O 2.6527 4.3468 0.0 0
M  V30 8 C 7.6474 7.5536 0.0 0
M  V30 9 C 8.4174 6.2199 0.0 0
M  V30 10 C 9.9574 6.2199 0.0 0 CFG=2
M  V30 11 O 7.6474 4.8863 0.0 0
M  V30 12 O 9.9574 4.6799 0.0 0
M  V30 13 C 11.4974 6.2199 0.0 0
M  V30 14 C 9.9574 7.7599 0.0 0
M  V30 15 C 11.2912 3.9099 0.0 0
M  V30 16 C 12.2674 7.5536 0.0 0
M  V30 17 O 12.6248 4.6799 0.0 0
M  V30 18 C 13.8074 7.5536 0.0 0
M  V30 19 C 14.5774 8.8872 0.0 0
M  V30 20 C 16.1174 8.8872 0.0 0
M  V30 21 C 13.8074 10.2210 0.0 0
M  V30 22 C 16.8874 10.2210 0.0 0
M  V30 23 C 18.4274 10.2210 0.0 0
M  V30 24 C 19.1974 11.5547 0.0 0
M  V30 25 C 20.7374 11.5547 0.0 0
M  V30 26 C 18.4274 12.8883 0.0 0
M  V30 27 N 3.7376 8.3236 0.0 0
M  V30 28 C 3.7376 6.7836 0.0 0
M  V30 29 C 5.2023 8.7994 0.0 0
M  V30 30 C 5.2023 6.3077 0.0 0
M  V30 31 C 6.1073 7.5536 0.0 0
M  V30 32 C 1.5677 13.1971 0.0 0
M  V30 33 C 0.3219 14.1023 0.0 0
M  V30 34 C 2.9747 13.8235 0.0 0
M  V30 35 C 0.4828 15.6338 0.0 0
M  V30 36 C 3.1356 15.3551 0.0 0
M  V30 37 C 1.8897 16.2603 0.0 0
M  V30 38 N 11.2912 2.3699 0.0 0
M  V30 39 C 12.5370 1.4647 0.0 0
M  V30 40 C 10.0453 1.4647 0.0 0
M  V30 41 C 12.0612 0.0000 0.0 0
M  V30 42 C 10.5212 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 32
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 28
M  V30 9 1 8 9
M  V30 10 1 8 31
M  V30 11 1 10 9 CFG=3
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 10 14 CFG=1
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 2 15 17
M  V30 19 1 15 38
M  V30 20 1 16 18
M  V30 21 2 18 19
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 22 23
M  V30 26 2 23 24
M  V30 27 1 24 25
M  V30 28 1 24 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 34 2 32 33
M  V30 35 1 32 34
M  V30 36 1 33 35
M  V30 37 2 34 36
M  V30 38 2 35 37
M  V30 39 1 36 37
M  V30 40 1 38 39
M  V30 41 1 38 40
M  V30 42 1 39 41
M  V30 43 1 40 42
M  V30 44 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2131834-05-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2131834-12-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2131834-06-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17826772
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM General Synthesis of the Nitropyrrolin Family of Natural Products via
Regioselective CO2-Mediated Alkyne Hydration
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ding, Xiao-Bo; Furkert, Daniel P.; Brimble, Margaret A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(19), 5418-5421

$RFMT $RIREG SCHEME133 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-[8-(Dimethylamino)-5,7-quinolinediyl]bis[2,2,2-trifluoroethanone]
C15H10F6N2O2
221636-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 3.6437 0.0 0
M  V30 2 C 1.3337 2.1037 0.0 0
M  V30 3 C 0.0000 4.4137 0.0 0
M  V30 4 C 6.6685 6.7238 0.0 0
M  V30 5 C 8.0023 5.9538 0.0 0
M  V30 6 O 6.6685 8.2638 0.0 0
M  V30 7 F 8.7723 7.2874 0.0 0
M  V30 8 F 9.3360 5.1838 0.0 0
M  V30 9 F 7.2323 4.6201 0.0 0
M  V30 10 C 4.0012 2.1037 0.0 0
M  V30 11 C 5.3348 1.3337 0.0 0
M  V30 12 O 2.6675 1.3337 0.0 0
M  V30 13 F 6.1048 2.6673 0.0 0
M  V30 14 F 6.6685 0.5637 0.0 0
M  V30 15 F 4.5648 0.0000 0.0 0
M  V30 16 C 2.6675 5.9538 0.0 0
M  V30 17 C 4.0012 6.7238 0.0 0
M  V30 18 C 2.6675 4.4137 0.0 0
M  V30 19 N 1.3337 6.7238 0.0 0
M  V30 20 C 5.3348 5.9538 0.0 0
M  V30 21 C 4.0012 8.2638 0.0 0
M  V30 22 C 4.0012 3.6437 0.0 0
M  V30 23 C 1.3337 8.2638 0.0 0
M  V30 24 C 5.3348 4.4137 0.0 0
M  V30 25 C 2.6675 9.0338 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 18
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 20
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 10 22
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 2 16 17
M  V30 17 1 16 18
M  V30 18 1 16 19
M  V30 19 1 17 20
M  V30 20 1 17 21
M  V30 21 2 18 22
M  V30 22 2 19 23
M  V30 23 2 20 24
M  V30 24 2 21 25
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-[8-(1-Pyrrolidinyl)-5,7-quinolinediyl]bis[2,2,2-trifluoroethanone]
C17H12F6N2O2
221636-62-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.6675 0.0 0
M  V30 2 C 4.6799 1.3337 0.0 0
M  V30 3 O 2.3698 2.6675 0.0 0
M  V30 4 F 3.3462 0.5637 0.0 0
M  V30 5 F 5.4499 0.0000 0.0 0
M  V30 6 F 6.0135 2.1037 0.0 0
M  V30 7 C 8.5299 5.3348 0.0 0
M  V30 8 C 9.3000 4.0012 0.0 0
M  V30 9 O 9.3000 6.6685 0.0 0
M  V30 10 F 10.6336 4.7712 0.0 0
M  V30 11 F 10.0700 2.6675 0.0 0
M  V30 12 F 7.9663 3.2311 0.0 0
M  V30 13 C 3.9098 5.3348 0.0 0
M  V30 14 C 4.6799 6.6685 0.0 0
M  V30 15 C 4.6799 4.0012 0.0 0
M  V30 16 C 6.2199 6.6685 0.0 0
M  V30 17 N 3.9098 8.0023 0.0 0
M  V30 18 C 6.2199 4.0012 0.0 0
M  V30 19 C 6.9899 5.3348 0.0 0
M  V30 20 C 6.9899 8.0023 0.0 0
M  V30 21 C 4.6799 9.3360 0.0 0
M  V30 22 C 6.2199 9.3360 0.0 0
M  V30 23 N 2.3698 5.3348 0.0 0
M  V30 24 C 1.4646 4.0889 0.0 0
M  V30 25 C 1.4646 6.5807 0.0 0
M  V30 26 C 0.0000 4.5648 0.0 0
M  V30 27 C 0.0000 6.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 19
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 23
M  V30 16 2 14 16
M  V30 17 1 14 17
M  V30 18 1 15 18
M  V30 19 1 16 19
M  V30 20 1 16 20
M  V30 21 2 17 21
M  V30 22 2 18 19
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 221636-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 221636-62-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-033-CAS-2532740
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N-N Exchange Reaction of 3 with Amines;
General Procedures. To a solution of 3 (1.10 g, 3 mmol) in MeCN (21 mL)
were added the appropriate amines (3-15 mmol) and the mixture was stirred
at 0 °C-reflux temperature for 0.5-96 h. The solvent was evaporated in
vacuo to give the practically pure products 4a-l. In the case of 4m, PrCN
was used as a solvent, and separation and purification were carried out
by recrystallization from n-hexane/EtOAc. Compound 4i, yield 100%. Mp
157-158°C. Molecular Formula: C17H12F6N2O2. IR (KBr) ν (cm-1): 1653. 1H
NMR (CDCl3/TMS) J (Hz): 1.84-2.25 (m, 4 H, CH2), 3.70-4.09 (m, 4 H, CH2),
7.48 (dd, 1 H, J = 4, 9, H-3), 8.60-8.75 (m, 2 H, H-2, H-6), 9.30 (dd, 1
H, J = 2, 9, H-4).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aromatic nucleophilic N-N, N-S and N-O exchange reactions: efficient
synthesis of 5,7-Bis(trifluoroacetyl)-8-quinolyl amines, sulfides, and
ethers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Okada, Etsuji; Tsukushi, Norikado; Shimomura, Naofumi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2000), (2), 237-242

$RFMT $RIREG SCHEME134 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-methyl (2R,4R)-1,2,4-pyrrolidinetricarboxylate
C12H19NO6
2227199-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.5626 5.3196 0.0 0
M  V30 2 O 7.3326 6.6533 0.0 0
M  V30 3 O 7.3326 3.9860 0.0 0
M  V30 4 C 8.8726 6.6533 0.0 0
M  V30 5 C 8.8726 8.1933 0.0 0
M  V30 6 C 10.4126 6.6533 0.0 0
M  V30 7 C 8.8726 5.1133 0.0 0
M  V30 8 C 4.5932 2.6091 0.0 0
M  V30 9 O 3.5628 1.4647 0.0 0
M  V30 10 O 6.0996 2.2889 0.0 0
M  V30 11 C 4.0387 0.0000 0.0 0
M  V30 12 C 1.4068 6.9948 0.0 0
M  V30 13 O 0.0000 6.3684 0.0 0
M  V30 14 O 1.5679 8.5264 0.0 0
M  V30 15 N 5.0226 5.3196 0.0 0
M  V30 16 C 4.1173 4.0738 0.0 0 CFG=1
M  V30 17 C 4.1173 6.5655 0.0 0
M  V30 18 C 2.6528 4.5496 0.0 0
M  V30 19 C 2.6528 6.0896 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 16 8 CFG=1
M  V30 11 1 9 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 19 12 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 16 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-methyl (2R,4R)-4-(1-pyrrolidinylcarbonyl)-1,2-pyrroli...
C16H26N2O5
2377903-34-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 5.3196 0.0 0
M  V30 2 O 3.0800 6.6533 0.0 0
M  V30 3 O 3.0800 3.9860 0.0 0
M  V30 4 C 1.5400 6.6533 0.0 0
M  V30 5 C 1.5400 5.1133 0.0 0
M  V30 6 C 0.0000 6.6533 0.0 0
M  V30 7 C 1.5400 8.1933 0.0 0
M  V30 8 C 5.8194 2.6091 0.0 0
M  V30 9 O 6.8498 1.4647 0.0 0
M  V30 10 O 4.3129 2.2889 0.0 0
M  V30 11 C 6.3739 0.0000 0.0 0
M  V30 12 C 9.0058 6.9949 0.0 0
M  V30 13 O 8.8447 8.5264 0.0 0
M  V30 14 N 5.3900 5.3196 0.0 0
M  V30 15 C 6.2952 4.0738 0.0 0 CFG=1
M  V30 16 C 6.2952 6.5655 0.0 0
M  V30 17 C 7.7599 4.5496 0.0 0
M  V30 18 C 7.7599 6.0896 0.0 0 CFG=2
M  V30 19 N 10.4126 6.3684 0.0 0
M  V30 20 C 11.7462 7.1384 0.0 0
M  V30 21 C 10.7328 4.8621 0.0 0
M  V30 22 C 12.8908 6.1080 0.0 0
M  V30 23 C 12.2643 4.7012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 15 8 CFG=3
M  V30 11 1 9 11
M  V30 12 2 12 13
M  V30 13 1 18 12 CFG=3
M  V30 14 1 12 19
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2227199-04-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2377903-34-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21493101
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted pyrrolidinecarboxamides as Factor XIIa
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Philippou, Helen; Foster, Richard; Fishwick, Colin; Revill, Charlotte;
Yule, Ian; Taylor, Roger; Naylor, Alan; Fallon, Philip Spencer; Crosby,
Stuart; Hopkins, Anna; Guetzoyan, Lucie Juliette; Macnair, Alistair
James; Stewart, Mark Richard; Winfield, Natalie Louise
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019186164 A1 2019-10-03

$RFMT $RIREG SCHEME135 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-methyl-5-nitropyridine
C6H5ClN2O2
22280-56-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 N 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 9
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methyl-6-(1-pyrrolidinyl)-3-pyridinamine
C10H15N3
1215985-49-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 0.0000 0.0 0
M  V30 2 N 8.5299 2.6673 0.0 0
M  V30 3 N 2.3698 2.6673 0.0 0
M  V30 4 C 1.4646 1.4214 0.0 0
M  V30 5 C 1.4646 3.9132 0.0 0
M  V30 6 C 0.0000 1.8973 0.0 0
M  V30 7 C 0.0000 3.4373 0.0 0
M  V30 8 C 3.9098 2.6673 0.0 0
M  V30 9 C 4.6798 1.3337 0.0 0
M  V30 10 N 4.6798 4.0010 0.0 0
M  V30 11 C 6.2198 1.3337 0.0 0
M  V30 12 C 6.2198 4.0010 0.0 0
M  V30 13 C 6.9898 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 22280-56-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1215985-49-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11333308
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 1 To a solution of
2-chloro-5-nitropyridine (LXV) (5.0 g, 31.5 mmol) in DMF (50 mL) was
added piperidin-4-ol (LXXXIX) (3.5 g, 34.65 mmol) and K2CO3 (8.7 g, 63.0
mmol). The reaction was headed at 85°C overnight. The solution was poured
into ice water, stirred for 15 min and then filtered. The solid was
washed with cold water and dried under vacuum to produce
1-(5-aminopyridin-2-yl)piperidin-4-ol (XC) as a yellow solid (6.62 g,
29.67 mmol, 94.2% yield). Step 2 10% Palladium on carbon (0.095g) was
added to a solution of 3'-fluoro-3-nitrobiphenyl (L) (0.63 g, 2.88 mmol)
in EtOH (20.0 mL). The flask was evacuated and replaced with a hydrogen
atmosphere. The solution was stirred at room temperature for 5 h under
hydrogen. The catalyst was filtered through a pad of Celite, and the
solvent was removed under reduced pressure. The residue was purified by
flash chromatography using a 40 g Thomson normal phase silica gel
cartridge (100% hexanes → 15:85 EtOAc:hexanes) to afford
3'-fluorobiphenyl-3-amine (LI) (0.34 g, 1.81 mmol, 63% yield) as a light
yellow oil. 5-Methyl-6-(pyrrolidin-1-yl)pyridin-3-amine (XCIII): Dark
blue viscous oil (2.06 g, 12.62 mmol, 100% yield). 1H NMR (DMSO-d6) δ ppm
1.76-1.82 (m, 4H), 2.13 (s, 3H), 3.15-3.20 (m, 4H), 4.53 (brs, 2H), 6.74
(d, J=3.5Hz, 1H), 7.42 (d, J=2.7Hz, 1H); ESIMS found for C10H15N3 m/z
178.1 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indazolecarboxamide derivatives for use as Wnt β-catenin
signaling pathway inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hood, John; Kumar, Sunil K. C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013040215 A1 2013-03-21

$RFMT $RIREG SCHEME136 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(6aR,7R,10aR)-4-Chloro-5,6a,7,9,10,10a-hexahydro-7,10a-dimethyl-2-(4-quinolin...
C25H26ClN3O2
2230762-90-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 37 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.3698 8.0022 0.0 0
M  V30 2 C 6.2198 4.0011 0.0 0
M  V30 3 Cl 10.0698 8.0022 0.0 0
M  V30 4 C 2.3698 5.3347 0.0 0
M  V30 5 C 3.1398 6.6685 0.0 0 CFG=2
M  V30 6 C 3.1398 4.0011 0.0 0
M  V30 7 O 1.4645 6.5806 0.0 0
M  V30 8 O 1.4645 4.0889 0.0 0
M  V30 9 C 4.6798 6.6685 0.0 0 CFG=1
M  V30 10 C 4.6798 4.0011 0.0 0
M  V30 11 C 0.0000 6.1047 0.0 0
M  V30 12 C 0.0000 4.5647 0.0 0
M  V30 13 C 5.4498 5.3347 0.0 0 CFG=1
M  V30 14 C 5.4498 8.0022 0.0 0
M  V30 15 C 6.9898 5.3347 0.0 0
M  V30 16 C 6.9898 8.0022 0.0 0
M  V30 17 C 7.7598 6.6685 0.0 0
M  V30 18 N 7.7598 4.0011 0.0 0
M  V30 19 C 9.2998 6.6685 0.0 0
M  V30 20 C 9.2998 4.0011 0.0 0
M  V30 21 N 10.0698 5.3347 0.0 0
M  V30 22 C 10.0698 2.6674 0.0 0
M  V30 23 C 11.6098 2.6674 0.0 0
M  V30 24 C 9.2998 1.3336 0.0 0
M  V30 25 C 12.3798 1.3336 0.0 0
M  V30 26 C 12.3798 4.0011 0.0 0
M  V30 27 C 10.0698 0.0000 0.0 0
M  V30 28 N 11.6098 0.0000 0.0 0
M  V30 29 C 13.9198 1.3336 0.0 0
M  V30 30 C 13.9198 4.0011 0.0 0
M  V30 31 C 14.6898 2.6674 0.0 0
M  V30 32 H 3.9098 8.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 5 1 CFG=3
M  V30 2 1 13 2 CFG=1
M  V30 3 1 3 19
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 9 14
M  V30 14 1 9 32 CFG=3
M  V30 15 1 10 13
M  V30 16 1 11 12
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 1 16 17
M  V30 22 2 17 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 21
M  V30 26 1 20 22
M  V30 27 1 22 23
M  V30 28 2 22 24
M  V30 29 2 23 25
M  V30 30 1 23 26
M  V30 31 1 24 27
M  V30 32 1 25 28
M  V30 33 1 25 29
M  V30 34 2 26 30
M  V30 35 2 27 28
M  V30 36 2 29 31
M  V30 37 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 5 9 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(6aR,7R,10aR)-5,6a,7,9,10,10a-Hexahydro-7,10a-dimethyl-4-(1-pyrrolidinyl)-2-(...
C29H34N4O2
2230767-29-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 42 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 8.4702 6.4384 0.0 0
M  V30 2 C 12.3203 2.4374 0.0 0
M  V30 3 C 7.7002 5.1048 0.0 0
M  V30 4 C 9.2402 5.1048 0.0 0 CFG=1
M  V30 5 C 6.9302 3.7711 0.0 0
M  V30 6 N 6.9302 6.4384 0.0 0
M  V30 7 C 10.0102 3.7711 0.0 0 CFG=2
M  V30 8 C 10.0102 6.4384 0.0 0
M  V30 9 C 5.3901 3.7711 0.0 0
M  V30 10 C 7.7002 2.4374 0.0 0
M  V30 11 C 5.3901 6.4384 0.0 0
M  V30 12 C 11.5503 3.7711 0.0 0 CFG=1
M  V30 13 C 9.2402 2.4374 0.0 0
M  V30 14 C 11.5503 6.4384 0.0 0
M  V30 15 N 4.6201 5.1048 0.0 0
M  V30 16 C 12.3203 5.1048 0.0 0
M  V30 17 O 13.2255 3.8589 0.0 0
M  V30 18 O 13.2255 6.3506 0.0 0
M  V30 19 C 14.6901 4.3347 0.0 0
M  V30 20 C 14.6901 5.8748 0.0 0
M  V30 21 N 4.6201 2.4374 0.0 0
M  V30 22 C 3.0885 2.2763 0.0 0
M  V30 23 C 5.2464 1.0304 0.0 0
M  V30 24 C 2.7682 0.7700 0.0 0
M  V30 25 C 4.1020 0.0000 0.0 0
M  V30 26 C 4.6201 7.7722 0.0 0
M  V30 27 C 3.0801 7.7722 0.0 0
M  V30 28 C 5.3901 9.1059 0.0 0
M  V30 29 C 2.3101 9.1059 0.0 0
M  V30 30 C 2.3101 6.4384 0.0 0
M  V30 31 C 4.6201 10.4396 0.0 0
M  V30 32 N 3.0801 10.4396 0.0 0
M  V30 33 C 0.7700 9.1059 0.0 0
M  V30 34 C 0.7700 6.4384 0.0 0
M  V30 35 C 0.0000 7.7722 0.0 0
M  V30 36 H 10.7802 2.4374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 4 1 CFG=1
M  V30 2 1 12 2 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 1 7 13
M  V30 13 1 7 36 CFG=3
M  V30 14 1 8 14
M  V30 15 1 9 15
M  V30 16 1 9 21
M  V30 17 1 10 13
M  V30 18 2 11 15
M  V30 19 1 11 26
M  V30 20 1 12 16
M  V30 21 1 14 16
M  V30 22 1 16 17
M  V30 23 1 16 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 1 19 20
M  V30 27 1 21 22
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 1 23 25
M  V30 31 1 24 25
M  V30 32 1 26 27
M  V30 33 2 26 28
M  V30 34 2 27 29
M  V30 35 1 27 30
M  V30 36 1 28 31
M  V30 37 1 29 32
M  V30 38 1 29 33
M  V30 39 2 30 34
M  V30 40 2 31 32
M  V30 41 2 33 35
M  V30 42 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 4 7 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2230762-90-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2230767-29-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-20681104
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidine tricyclic enone derivatives as RORγ inhibitors
for the treatment and prevention of inflammation or autoimmune disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Xin; Bender, Christopher F.; Visnick, Melean; Hotema, Martha R.;
Sheldon, Zachary S.; Lee, Chitase; Caprathe, Bradley William; Bolton,
Gary; Kornberg, Brian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018111315 A1 2018-06-21

$RFMT $RIREG SCHEME137 STEP1
$RXN



  4  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4,6-Trichloropyrimidine
C4HCl3N2
3764-01-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 0.0000 4.6200 0.0 0
M  V30 2 Cl 5.3349 4.6200 0.0 0
M  V30 3 Cl 2.6674 0.0000 0.0 0
M  V30 4 C 2.6674 4.6200 0.0 0
M  V30 5 C 1.3338 3.8500 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 N 1.3338 2.3100 0.0 0
M  V30 8 N 4.0011 2.3100 0.0 0
M  V30 9 C 2.6674 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 6
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-hydroxy-α-methyl-α-phenoxybenzenepropanoate
C18H20O4
223126-69-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 6.9302 0.0 0
M  V30 2 C 4.0564 6.1601 0.0 0
M  V30 3 O 4.6201 8.2638 0.0 0
M  V30 4 C 6.7239 7.7002 0.0 0
M  V30 5 C 6.1601 5.5963 0.0 0
M  V30 6 O 8.0576 6.9302 0.0 0
M  V30 7 O 6.7239 9.2402 0.0 0
M  V30 8 C 9.3913 7.7002 0.0 0
M  V30 9 C 10.7251 6.9302 0.0 0
M  V30 10 O 4.0564 0.0000 0.0 0
M  V30 11 C 4.0564 4.6201 0.0 0
M  V30 12 C 2.7228 3.8501 0.0 0
M  V30 13 C 5.3901 3.8501 0.0 0
M  V30 14 C 2.7228 2.3101 0.0 0
M  V30 15 C 5.3901 2.3101 0.0 0
M  V30 16 C 4.0564 1.5400 0.0 0
M  V30 17 C 3.0801 8.2638 0.0 0
M  V30 18 C 2.3101 6.9302 0.0 0
M  V30 19 C 2.3101 9.5975 0.0 0
M  V30 20 C 0.7700 6.9302 0.0 0
M  V30 21 C 0.7700 9.5975 0.0 0
M  V30 22 C 0.0000 8.2638 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 11
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 2 4 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 16
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzylpiperazine
C11H16N2
2759-28-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 C 1.3336 3.0800 0.0 0
M  V30 4 C 2.6674 0.7700 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 C 1.3336 0.0000 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 N 5.3347 2.3100 0.0 0
M  V30 9 C 6.6685 3.0800 0.0 0
M  V30 10 C 5.3347 0.7700 0.0 0
M  V30 11 C 8.0021 2.3100 0.0 0
M  V30 12 C 6.6685 0.0000 0.0 0
M  V30 13 N 8.0021 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-Methyl-α-phenoxy-4-[[6-[4-(phenylmethyl)-1-piperazinyl]-2-(1-pyrrolidinyl)-...
C35H39N5O4
1141923-81-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.9784 6.9899 0.0 0
M  V30 2 C 18.3142 9.3000 0.0 0
M  V30 3 C 3.6437 3.9099 0.0 0
M  V30 4 C 2.3100 4.6799 0.0 0
M  V30 5 O 3.0800 6.0136 0.0 0
M  V30 6 C 1.5400 3.3461 0.0 0
M  V30 7 C 0.9764 5.4499 0.0 0
M  V30 8 O 0.0000 3.3461 0.0 0
M  V30 9 O 2.3100 2.0125 0.0 0
M  V30 10 C 12.9795 6.2199 0.0 0
M  V30 11 N 12.9795 4.6799 0.0 0
M  V30 12 C 11.6458 6.9899 0.0 0
M  V30 13 C 11.6458 3.9099 0.0 0
M  V30 14 C 10.3122 6.2199 0.0 0
M  V30 15 N 10.3122 4.6799 0.0 0
M  V30 16 N 14.3131 6.9899 0.0 0
M  V30 17 C 15.6469 6.2199 0.0 0
M  V30 18 C 14.3131 8.5299 0.0 0
M  V30 19 C 16.9806 6.9899 0.0 0
M  V30 20 C 15.6469 9.3000 0.0 0
M  V30 21 N 16.9806 8.5299 0.0 0
M  V30 22 N 11.6458 2.3699 0.0 0
M  V30 23 C 10.4000 1.4647 0.0 0
M  V30 24 C 12.8917 1.4647 0.0 0
M  V30 25 C 10.8758 0.0000 0.0 0
M  V30 26 C 12.4159 0.0000 0.0 0
M  V30 27 C 7.6448 6.2199 0.0 0
M  V30 28 C 6.3111 6.9899 0.0 0
M  V30 29 C 7.6448 4.6799 0.0 0
M  V30 30 C 4.9775 6.2199 0.0 0
M  V30 31 C 6.3111 3.9099 0.0 0
M  V30 32 C 4.9775 4.6799 0.0 0
M  V30 33 C 19.6479 8.5299 0.0 0
M  V30 34 C 20.9817 9.3000 0.0 0
M  V30 35 C 19.6479 6.9899 0.0 0
M  V30 36 C 22.3153 8.5299 0.0 0
M  V30 37 C 20.9817 6.2199 0.0 0
M  V30 38 C 22.3153 6.9899 0.0 0
M  V30 39 C 2.3100 7.3472 0.0 0
M  V30 40 C 0.7700 7.3472 0.0 0
M  V30 41 C 3.0800 8.6809 0.0 0
M  V30 42 C 0.0000 8.6809 0.0 0
M  V30 43 C 2.3100 10.0147 0.0 0
M  V30 44 C 0.7700 10.0147 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 27
M  V30 3 1 2 21
M  V30 4 1 2 33
M  V30 5 1 3 4
M  V30 6 1 3 32
M  V30 7 1 4 5
M  V30 8 1 4 6
M  V30 9 1 4 7
M  V30 10 1 5 39
M  V30 11 1 6 8
M  V30 12 2 6 9
M  V30 13 2 10 11
M  V30 14 1 10 12
M  V30 15 1 10 16
M  V30 16 1 11 13
M  V30 17 2 12 14
M  V30 18 2 13 15
M  V30 19 1 13 22
M  V30 20 1 14 15
M  V30 21 1 16 17
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 1 19 21
M  V30 26 1 20 21
M  V30 27 1 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 26
M  V30 32 2 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 31
M  V30 36 2 30 32
M  V30 37 1 31 32
M  V30 38 2 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 2 35 37
M  V30 42 2 36 38
M  V30 43 1 37 38
M  V30 44 2 39 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 2 41 43
M  V30 48 2 42 44
M  V30 49 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3764-01-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 223126-69-0
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 2759-28-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1141923-81-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-170-CAS-1720023
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 5
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7693-26-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 12408-02-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example 48
3-{4-[6-(4-Benzyl-piperazin-1-yl)-2-methylamino-pyrimidin-4-yloxy]-phenyl}-2-methyl-2-phenoxy-propionic
acid This compound was prepared by means of a procedure similar to that
used for Example 47. Benzylamine (0.53 g, 0.54 ml, 5 mmol) and
triethylamine (0.50 g, 0.69 ml, 5 mmol) in tetrahydrofuran (20 ml) were
added to 2,4,6-trichloropyrimidine (0.917 g, 5 mmol) in tetrahydrofuran
(20 ml) at 0&#x00B0; C. The mixture was stirred for several hours. The
precipitate then filtered through celite, then the most of the methanol
was removed in vacuo. The residue was purified in silica to provide a
colorless oil. 3-(4-Hydroxyphenyl)-2-methyl-2-phenoxypropionic acid ethyl
ester (60 mg, 0.2 mmol), benzyl-(4,6-dichloro-pyrimidin-2-yl)-amine (50
mg, 0.2 mmol) and Cs2CO3 (76 mg, 0.22 mmol) were combined in anhydrous
N,N-dimethylformamide (DMF) (5 mL) and stirred at 90&#x00B0; C. in dry
atmosphere for 5 h. The DMF was removed in vacuo, the residue was
purified in silica to provide a white oil.
3-[4-(2-Benzylamino-6-chloro-pyrimidin-4-yloxy)-phenyl]-2-methyl-2-phenoxy-propionic
acid ethyl ester (60 mg, 0.1 mmol), 1-Benzyl-piperazine (25 mg, 0.25 ml,
0.15 mmol) and Cs2CO3 (35 mg, 0.11 mmol) were combined in anhydrous
N,N-dimethylformamide (DMF) (5 mL) and stirred at 90&#x00B0; C. in dry
atmosphere overnight. The DMF was removed in vacuo, the residue was
purified in silica to provide a white oil. Example 54
3-{4-[6-(4-Benzyl-piperazin-1-yl)-2-pyrrolidin-1-yl-pyrimidin-4-yloxy]-phenyl}-2-methyl-2-phenoxy-propionic
acid This compound was prepared by means of a procedure similar to that
used for Example 47. mp 126-127&#x00B0; C; 1HNMR (300 MHz, CD3OD):
&#x03B4; 1.40 (s, 3H), 1.91 (m, 4H), 2.78 (m, 4H), 3.15 (d, 1H, J=13.5
Hz), 3.33 (d, 1H, J=13.5 Hz), 3.41 (m, 4H), 3.62 (m, 4H), 3.87 (s, 2H),
5.09 (s, 1H), 6.87~6.93 (m, 3H), 7.02 (d, 211, J=8.4 Hz), 7.18 (t, 2H,
J=8.4 Hz), 7.32 (d, 2H, J=8.4 Hz), 7.37~7.41 (m, 5H); EI-MS: m/e 593
(M+), 94 (100%).
$DTYPE RXN:VAR(1):NOTES
$DATUM Alcohol solvent was assumed
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidinyl-propionic acid derivatives as PPAR agonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shen, Jianhua; Mei, Changlin; Jiang, Hualiang; Dai, Bin; Ye, Yangliang;
Xiong, Xishan; Tang, Jing; Fu, Lili
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009046606 A1 2009-04-16

$RFMT $RIREG SCHEME138 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-3-(1,3-benzodioxol-5-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborola...
C17H21BO6
2232215-49-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0169 4.6200 0.0 0
M  V30 2 C 5.0169 3.0800 0.0 0
M  V30 3 C 3.6833 2.3100 0.0 0
M  V30 4 O 3.6833 0.7700 0.0 0
M  V30 5 O 2.3494 3.0800 0.0 0
M  V30 6 C 2.3494 0.0000 0.0 0
M  V30 7 C 0.6091 7.8681 0.0 0
M  V30 8 C 2.4917 8.7063 0.0 0
M  V30 9 C 0.2154 4.7636 0.0 0
M  V30 10 C 0.0000 6.8132 0.0 0
M  V30 11 B 3.6833 5.3901 0.0 0
M  V30 12 O 3.5222 6.9216 0.0 0
M  V30 13 O 2.2763 4.7636 0.0 0
M  V30 14 C 2.0159 7.2418 0.0 0
M  V30 15 C 1.2459 5.9081 0.0 0
M  V30 16 C 6.3506 5.3901 0.0 0
M  V30 17 C 7.6844 4.6200 0.0 0
M  V30 18 C 6.3506 6.9301 0.0 0
M  V30 19 C 9.0180 5.3901 0.0 0
M  V30 20 C 7.6844 7.7001 0.0 0
M  V30 21 C 9.0180 6.9301 0.0 0
M  V30 22 O 10.4826 4.9140 0.0 0
M  V30 23 O 10.4826 7.4059 0.0 0
M  V30 24 C 11.3878 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 1 16
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 1 7 14
M  V30 9 1 8 14
M  V30 10 1 9 15
M  V30 11 1 10 15
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 19 22
M  V30 23 2 20 21
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-3-(1,3-Benzodioxol-5-yl)-1-(1-pyrrolidinyl)-3-(4,4,5,5-tetramethyl-1,3,2...
C20H26BNO5
2376716-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1454 5.4413 0.0 0
M  V30 2 C 6.4792 6.2113 0.0 0
M  V30 3 C 7.8129 5.4413 0.0 0
M  V30 4 O 7.8129 3.9013 0.0 0
M  V30 5 C 4.5365 0.0000 0.0 0
M  V30 6 C 2.8692 1.2114 0.0 0
M  V30 7 C 7.4219 1.2114 0.0 0
M  V30 8 C 5.7545 0.0000 0.0 0
M  V30 9 B 5.1454 3.9013 0.0 0
M  V30 10 O 3.8996 2.9962 0.0 0
M  V30 11 O 6.3915 2.9962 0.0 0
M  V30 12 C 4.3754 1.5315 0.0 0
M  V30 13 C 5.9154 1.5315 0.0 0
M  V30 14 C 3.8118 6.2113 0.0 0
M  V30 15 C 3.8118 7.7513 0.0 0
M  V30 16 C 2.4782 5.4413 0.0 0
M  V30 17 C 2.4782 8.5213 0.0 0
M  V30 18 C 1.1445 6.2113 0.0 0
M  V30 19 C 1.1445 7.7513 0.0 0
M  V30 20 O 2.1580 10.0277 0.0 0
M  V30 21 O 0.0000 8.7819 0.0 0
M  V30 22 C 0.6263 10.1886 0.0 0
M  V30 23 N 9.1465 6.2113 0.0 0
M  V30 24 C 9.3075 7.7430 0.0 0
M  V30 25 C 10.5535 5.5850 0.0 0
M  V30 26 C 10.8139 8.0631 0.0 0
M  V30 27 C 11.5839 6.7295 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 1 14
M  V30 4 1 2 3
M  V30 5 2 3 4
M  V30 6 1 3 23
M  V30 7 1 5 12
M  V30 8 1 6 12
M  V30 9 1 7 13
M  V30 10 1 8 13
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 22 2 18 19
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2232215-49-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376716-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20624108
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Route to Air and Moisture Stable β-Difluoroboryl Acrylamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fritzemeier, Russell G.; Medici, Eric J.; Szwetkowski, Connor;
Wonilowicz, Laura G.; Sibley, Christopher D.; Slebodnick, Carla; Santos,
Webster L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(19), 8053-8057

$RFMT $RIREG SCHEME139 STEP1
$RXN



  2  1
$MOL
tert-Butoxycarbonyl-D-valine
C10H19NO4
22838-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0 CFG=1
M  V30 2 N 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 2.6675 3.8501 0.0 0
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 C 0.0000 2.3101 0.0 0
M  V30 7 C 1.3337 0.0000 0.0 0
M  V30 8 O 1.3337 4.6201 0.0 0
M  V30 9 O 4.0012 4.6201 0.0 0
M  V30 10 O 6.6685 1.5400 0.0 0
M  V30 11 O 5.3348 3.8501 0.0 0
M  V30 12 C 8.0023 2.3101 0.0 0
M  V30 13 C 8.7723 0.9764 0.0 0
M  V30 14 C 9.3360 3.0801 0.0 0
M  V30 15 C 7.2323 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 2 4 9
M  V30 9 1 5 10
M  V30 10 2 5 11
M  V30 11 1 10 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 12 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-2-methyl-1-(1-pyrrolidinylcarbonyl)propyl]carbamate
C14H26N2O3
298704-77-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.1617 2.6674 0.0 0 CFG=1
M  V30 2 C 2.6217 2.6674 0.0 0
M  V30 3 N 4.9317 4.0011 0.0 0
M  V30 4 C 4.9317 1.3338 0.0 0
M  V30 5 O 1.8517 1.3338 0.0 0
M  V30 6 C 6.4717 4.0011 0.0 0
M  V30 7 C 6.4717 1.3338 0.0 0
M  V30 8 C 4.1617 0.0000 0.0 0
M  V30 9 O 7.2417 5.3349 0.0 0
M  V30 10 O 7.2417 2.6674 0.0 0
M  V30 11 C 8.7817 5.3349 0.0 0
M  V30 12 C 8.7817 3.7949 0.0 0
M  V30 13 C 10.3217 5.3349 0.0 0
M  V30 14 C 8.7817 6.8749 0.0 0
M  V30 15 N 1.8517 4.0011 0.0 0
M  V30 16 C 0.3202 4.1622 0.0 0
M  V30 17 C 2.4782 5.4080 0.0 0
M  V30 18 C 0.0000 5.6684 0.0 0
M  V30 19 C 1.3336 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 2 2 5
M  V30 5 1 2 15
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 6 9
M  V30 10 2 6 10
M  V30 11 1 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 22838-58-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 298704-77-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31072861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 77-92-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Process for the preparation of pyrazolopyrimidine derivative as WEE1
inhibitor useful in treatment of proliferative diseases such as cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Huang, Peter Qinhua; Hopkins, Chad Daniel; Boren, Brant Clayton; Abraham,
Sunny; Bunker, Kevin Duane; Boga, Sobhana Babu; Zhu, Shuguang; Wu, Tao;
Pratt, Benjamin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2021252667 A1 2021-12-16

$RFMT $RIREG SCHEME140 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (4Z)-5-(1,2-dihydro-6-methoxy-1,1,2-trimethyl-2-naphthalenyl)-4-pentenoate
C21H28O3
2304514-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3771 3.1940 0.0 0
M  V30 2 C 6.6627 4.1839 0.0 0
M  V30 3 C 8.8798 0.3437 0.0 0
M  V30 4 C 10.3269 0.8704 0.0 0
M  V30 5 C 10.5943 2.3870 0.0 0
M  V30 6 C 12.0414 2.9138 0.0 0
M  V30 7 C 13.2211 1.9239 0.0 0
M  V30 8 O 14.6682 2.4506 0.0 0
M  V30 9 O 12.9537 0.4073 0.0 0
M  V30 10 C 15.8480 1.4607 0.0 0
M  V30 11 C 17.2951 1.9874 0.0 0
M  V30 12 C 8.8798 2.3236 0.0 0
M  V30 13 O 0.7700 2.6673 0.0 0
M  V30 14 C 0.0000 4.0009 0.0 0
M  V30 15 C 5.3900 2.6673 0.0 0
M  V30 16 C 4.6200 1.3336 0.0 0
M  V30 17 C 6.9300 2.6673 0.0 0
M  V30 18 C 4.6200 4.0009 0.0 0
M  V30 19 C 5.3900 0.0000 0.0 0
M  V30 20 C 3.0800 1.3336 0.0 0
M  V30 21 C 7.7000 1.3336 0.0 0 CFG=3
M  V30 22 C 3.0800 4.0009 0.0 0
M  V30 23 C 6.9300 0.0000 0.0 0
M  V30 24 C 2.3100 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 17
M  V30 2 1 2 17
M  V30 3 2 3 4
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 12 21
M  V30 13 1 13 14
M  V30 14 1 13 24
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 2 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-5-(1,2-Dihydro-6-methoxy-1,1,2-trimethyl-2-naphthalenyl)-1-(1-pyrrolidin...
C23H31NO2
2304514-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.3771 3.1940 0.0 0
M  V30 2 C 6.6625 4.1839 0.0 0
M  V30 3 C 8.8796 0.3437 0.0 0
M  V30 4 C 10.3268 0.8704 0.0 0
M  V30 5 C 10.5943 2.3870 0.0 0
M  V30 6 C 12.0413 2.9138 0.0 0
M  V30 7 C 13.2211 1.9239 0.0 0
M  V30 8 O 12.9536 0.4073 0.0 0
M  V30 9 C 8.8796 2.3236 0.0 0
M  V30 10 O 0.7700 2.6673 0.0 0
M  V30 11 C 0.0000 4.0009 0.0 0
M  V30 12 C 5.3900 2.6673 0.0 0
M  V30 13 C 4.6200 1.3336 0.0 0
M  V30 14 C 6.9300 2.6673 0.0 0
M  V30 15 C 4.6200 4.0009 0.0 0
M  V30 16 C 5.3900 0.0000 0.0 0
M  V30 17 C 3.0800 1.3336 0.0 0
M  V30 18 C 7.7000 1.3336 0.0 0 CFG=3
M  V30 19 C 3.0800 4.0009 0.0 0
M  V30 20 C 6.9300 0.0000 0.0 0
M  V30 21 C 2.3100 2.6673 0.0 0
M  V30 22 N 14.6682 2.4506 0.0 0
M  V30 23 C 15.0926 3.9310 0.0 0
M  V30 24 C 15.9449 1.5894 0.0 0
M  V30 25 C 16.6317 3.9847 0.0 0
M  V30 26 C 17.1584 2.5376 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 14
M  V30 3 2 3 4
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 7 8
M  V30 9 1 7 22
M  V30 10 1 9 18
M  V30 11 1 10 11
M  V30 12 1 10 21
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 1 15 19
M  V30 20 2 16 20
M  V30 21 1 17 21
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2304514-28-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2304514-29-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20265477
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ring-expansion approaches for the total synthesis of salimabromide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schmid, Matthias; Grossmann, Adriana S.; Mayer, Peter; Mueller, Thomas;
Magauer, Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2019), 75(24), 3195-3215

$RFMT $RIREG SCHEME141 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-methyl-5-nitropyridine
C6H5ClN2O2
23056-33-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 C 2.3101 0.0000 0.0 0
M  V30 5 Cl 6.9302 2.6673 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 3.0801 1.3337 0.0 0
M  V30 8 C 3.0801 4.0010 0.0 0
M  V30 9 C 4.6201 1.3337 0.0 0
M  V30 10 N 4.6201 4.0010 0.0 0
M  V30 11 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 7
M  V30 5 1 5 11
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-5-nitro-2-(1-pyrrolidinyl)pyridine
C10H13N3O2
850172-53-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 0.0000 0.0 0
M  V30 2 N 0.7700 2.6673 0.0 0 VAL=5
M  V30 3 O 0.0000 1.3337 0.0 0
M  V30 4 O 0.0000 4.0010 0.0 0
M  V30 5 C 5.3901 2.6673 0.0 0
M  V30 6 C 4.6201 1.3337 0.0 0
M  V30 7 N 4.6201 4.0010 0.0 0
M  V30 8 C 3.0801 1.3337 0.0 0
M  V30 9 C 3.0801 4.0010 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 N 6.9302 2.6673 0.0 0
M  V30 12 C 7.8354 3.9132 0.0 0
M  V30 13 C 7.8354 1.4215 0.0 0
M  V30 14 C 9.3000 3.4374 0.0 0
M  V30 15 C 9.3000 1.8973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 2 2 4
M  V30 4 1 2 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23056-33-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 850172-53-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14553351
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reference Example 45. 4-Methyl-1-nitro-2-pyrrolidin-1-ylpyridine. A
solution of 2-chloro-4-methyl-5-nitropyridine (3.0 g, 17.3 mmol) in
pyrrolidine (50 mL) was stirred at 80°C. for 12 hr. The mixture was
concentrated in vacuo to give a residue which was poured into water and
extracted with ethyl acetate. Organic layer was washed with brine, dried
over anhydrous sodium sulfate and concentrated in vacuo to give the title
compound (3.6 g, 17.3 mmol, 100%) as a yellow solid. 1H NMR (CDCl3) δ
2.05 (br, 4H), 2.60 (s, 3H), 3.54 (br, 4H), 6.09 (s, 1H), 9.00 (s, 1H).
MS Calcd.: 207; Found: 208 (M+H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of tricyclic compounds as CRF receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aso, Kazuyoshi; Kobayashi, Katsumi; Takai, Takafumi; Kojima, Takuto;
Tokumaru, Kazuyuki; Mochizuki, Michiyo; Hoashi, Yasutaka
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20090186879 A1 2009-07-23

$RFMT $RIREG SCHEME142 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Butyl-4-piperidinone
C9H17NO
23081-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 C 8.0023 3.0801 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 O 0.0000 0.0000 0.0 0
M  V30 6 N 4.0012 2.3101 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 4.0012 0.7700 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 2.6675 0.0000 0.0 0
M  V30 11 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 5 11
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Butyl-1,2,3,6-tetrahydro-4-(1-pyrrolidinyl)pyridine
C13H24N2
285547-62-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7722 4.9318 0.0 0
M  V30 2 C 9.1059 4.1618 0.0 0
M  V30 3 C 10.4396 4.9318 0.0 0
M  V30 4 C 11.7733 4.1618 0.0 0
M  V30 5 C 3.7711 2.6218 0.0 0
M  V30 6 C 3.7711 4.1618 0.0 0
M  V30 7 C 5.1048 1.8517 0.0 0
M  V30 8 C 5.1048 4.9318 0.0 0
M  V30 9 C 6.4384 2.6218 0.0 0
M  V30 10 N 6.4384 4.1618 0.0 0
M  V30 11 N 2.4373 1.8517 0.0 0
M  V30 12 C 1.0304 2.4782 0.0 0
M  V30 13 C 2.2763 0.3202 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 11
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 23081-86-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 285547-62-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-20647340
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 9037-24-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark trap used,Amberlyst 15 used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of furopyridines and related compounds with neurotrophic
activity.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peters, Dan; Gronborg, Mette; Moller, Arne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000043397 A1 2000-07-27

$RFMT $RIREG SCHEME143 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3,4-dihydro-5-iodo-7-nitro-2(1H)-isoquinolinecarboxylate
C14H17IN2O4
2361055-24-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 I 4.0010 0.0000 0.0 0
M  V30 2 C 9.3360 4.6201 0.0 0
M  V30 3 O 10.6697 3.8501 0.0 0
M  V30 4 O 9.3360 6.1601 0.0 0
M  V30 5 C 12.0033 4.6201 0.0 0
M  V30 6 C 11.2333 5.9538 0.0 0
M  V30 7 C 13.3370 5.3901 0.0 0
M  V30 8 C 12.7733 3.2864 0.0 0
M  V30 9 N 1.3337 4.6201 0.0 0 VAL=5
M  V30 10 O 1.3337 6.1601 0.0 0
M  V30 11 O 0.0000 3.8501 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 5.3348 2.3101 0.0 0
M  V30 14 C 6.6685 4.6201 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 4.0010 1.5400 0.0 0
M  V30 17 C 6.6685 1.5400 0.0 0
M  V30 18 N 8.0022 3.8501 0.0 0
M  V30 19 C 2.6673 3.8501 0.0 0
M  V30 20 C 2.6673 2.3101 0.0 0
M  V30 21 C 8.0022 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 16
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 18
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 9 10
M  V30 10 2 9 11
M  V30 11 1 9 19
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 2 13 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 21
M  V30 22 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3,4-dihydro-7-nitro-5-(1-pyrrolidinyl)-2(1H)-isoquinolineca...
C18H25N3O4
2361055-33-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 6.9899 0.0 0 VAL=5
M  V30 2 O 1.3337 8.5299 0.0 0
M  V30 3 O 0.0000 6.2199 0.0 0
M  V30 4 C 9.3360 6.9899 0.0 0
M  V30 5 O 10.6697 6.2199 0.0 0
M  V30 6 O 9.3360 8.5299 0.0 0
M  V30 7 C 12.0033 6.9899 0.0 0
M  V30 8 C 11.2333 8.3236 0.0 0
M  V30 9 C 13.3370 7.7599 0.0 0
M  V30 10 C 12.7733 5.6562 0.0 0
M  V30 11 C 4.0010 3.9098 0.0 0
M  V30 12 C 5.3348 4.6799 0.0 0
M  V30 13 C 2.6673 4.6799 0.0 0
M  V30 14 C 5.3348 6.2199 0.0 0
M  V30 15 C 6.6685 3.9098 0.0 0
M  V30 16 C 2.6673 6.2199 0.0 0
M  V30 17 C 6.6685 6.9899 0.0 0
M  V30 18 C 4.0010 6.9899 0.0 0
M  V30 19 C 8.0022 4.6799 0.0 0
M  V30 20 N 8.0022 6.2199 0.0 0
M  V30 21 N 4.0010 2.3698 0.0 0
M  V30 22 C 5.2470 1.4646 0.0 0
M  V30 23 C 2.7551 1.4646 0.0 0
M  V30 24 C 4.7710 0.0000 0.0 0
M  V30 25 C 3.2311 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 20
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 11 21
M  V30 14 1 12 14
M  V30 15 1 12 15
M  V30 16 2 13 16
M  V30 17 1 14 17
M  V30 18 2 14 18
M  V30 19 1 15 19
M  V30 20 1 16 18
M  V30 21 1 17 20
M  V30 22 1 19 20
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2361055-24-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2361055-33-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21530459
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 564483-18-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald-Hartwig cross coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of triazolophthalazine compounds, use as human
immunodeficiency virus inhibitors of HIV Vif-dependent degradation of
APOBEC3
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ananthan, Subramaniam; Augelli-Szafran, Corinne E.; Bennett, Ryan P.;
Smith, Harold C.; Venukadasula, Phanindra Krishna Mohan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019133666 A1 2019-07-04

$RFMT $RIREG SCHEME144 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-(trans-4-formylcyclohexyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole...
C20H24BrN3O3
2375253-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8085 5.2892 0.0 0
M  V30 2 N 8.5785 6.6228 0.0 0
M  V30 3 O 8.5785 3.9554 0.0 0
M  V30 4 Br 4.8592 0.0000 0.0 0
M  V30 5 C 14.7385 6.6228 0.0 0
M  V30 6 O 15.5085 7.9565 0.0 0
M  V30 7 C 5.3632 4.0433 0.0 0
M  V30 8 C 3.8987 4.5192 0.0 0
M  V30 9 C 6.2684 5.2892 0.0 0
M  V30 10 C 5.6834 2.5369 0.0 0
M  V30 11 N 3.8987 6.0592 0.0 0
M  V30 12 C 2.7542 3.4886 0.0 0
M  V30 13 N 5.3632 6.5350 0.0 0
M  V30 14 C 4.5390 1.5064 0.0 0
M  V30 15 C 3.0743 1.9823 0.0 0
M  V30 16 C 2.6528 6.9644 0.0 0 CFG=3
M  V30 17 C 1.2459 6.3379 0.0 0
M  V30 18 O 2.8137 8.4959 0.0 0
M  V30 19 C 0.0000 7.2431 0.0 0
M  V30 20 C 1.5679 9.4011 0.0 0
M  V30 21 C 0.1609 8.7747 0.0 0
M  V30 22 C 10.1185 6.6228 0.0 0 CFG=1
M  V30 23 C 10.8885 5.2892 0.0 0
M  V30 24 C 10.8885 7.9565 0.0 0
M  V30 25 C 12.4285 5.2892 0.0 0
M  V30 26 C 12.4285 7.9565 0.0 0
M  V30 27 C 13.1985 6.6228 0.0 0 CFG=1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 22 2 CFG=1
M  V30 5 1 4 14
M  V30 6 2 5 6
M  V30 7 1 27 5 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 11 16
M  V30 17 1 12 15
M  V30 18 2 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 22 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
5-Bromo-N-[trans-4-(1-pyrrolidinylmethyl)cyclohexyl]-1-(tetrahydro-2H-pyran-2...
C24H33BrN4O2
2375253-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.8085 5.2892 0.0 0
M  V30 2 N 8.5785 6.6228 0.0 0
M  V30 3 O 8.5785 3.9554 0.0 0
M  V30 4 Br 4.8592 0.0000 0.0 0
M  V30 5 C 14.7385 6.6228 0.0 0
M  V30 6 C 3.8987 4.5192 0.0 0
M  V30 7 N 3.8987 6.0592 0.0 0
M  V30 8 C 5.3632 4.0431 0.0 0
M  V30 9 C 2.7542 3.4886 0.0 0
M  V30 10 N 5.3632 6.5350 0.0 0
M  V30 11 C 6.2684 5.2892 0.0 0
M  V30 12 C 5.6834 2.5369 0.0 0
M  V30 13 C 3.0743 1.9823 0.0 0
M  V30 14 C 4.5390 1.5064 0.0 0
M  V30 15 C 2.6527 6.9642 0.0 0 CFG=3
M  V30 16 C 2.8137 8.4959 0.0 0
M  V30 17 O 1.2459 6.3379 0.0 0
M  V30 18 C 1.5677 9.4011 0.0 0
M  V30 19 C 0.0000 7.2431 0.0 0
M  V30 20 C 0.1609 8.7747 0.0 0
M  V30 21 C 10.1185 6.6228 0.0 0 CFG=1
M  V30 22 C 10.8885 7.9565 0.0 0
M  V30 23 C 10.8885 5.2892 0.0 0
M  V30 24 C 12.4285 7.9565 0.0 0
M  V30 25 C 12.4285 5.2892 0.0 0
M  V30 26 C 13.1985 6.6228 0.0 0 CFG=1
M  V30 27 N 15.5085 7.9565 0.0 0
M  V30 28 C 17.0400 8.1174 0.0 0
M  V30 29 C 14.8822 9.3634 0.0 0
M  V30 30 C 17.3602 9.6238 0.0 0
M  V30 31 C 16.0266 10.3938 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 21 2 CFG=3
M  V30 5 1 4 14
M  V30 6 1 26 5 CFG=1
M  V30 7 1 5 27
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 7 15
M  V30 13 1 8 11
M  V30 14 2 8 12
M  V30 15 1 9 13
M  V30 16 2 10 11
M  V30 17 1 12 14
M  V30 18 2 13 14
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 1 19 20
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 21 26)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2375253-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2375253-86-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-21014919
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-heteroaryl substituted indazole-3-carboxamides fo
treating disorders characterized by the activation of Wnt pathway
signaling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kc, Sunil Kumar; Mak, Chi Ching; Mittapalli, Gopi Kumar; Hofilena, Brian
Joseph; Eastman, Brian Walter; Cao, Jianguo; Chiruta, Chandramouli;
Bollu, Venkataiah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019165192 A1 2019-08-29

$RFMT $RIREG SCHEME145 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C16H25NO6S
2376439-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0 CFG=1
M  V30 2 N 5.3900 8.0021 0.0 0
M  V30 3 C 5.3900 5.3347 0.0 0
M  V30 4 C 3.8500 8.0021 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 O 3.0800 9.3358 0.0 0
M  V30 7 O 3.0800 6.6684 0.0 0
M  V30 8 O 5.3900 2.6674 0.0 0
M  V30 9 C 1.5400 9.3358 0.0 0
M  V30 10 S 6.1600 1.3336 0.0 0 VAL=6
M  V30 11 C 1.5400 10.8758 0.0 0
M  V30 12 C 0.0000 9.3358 0.0 0
M  V30 13 C 1.5400 7.7958 0.0 0
M  V30 14 C 7.4936 2.1036 0.0 0
M  V30 15 O 6.9300 0.0000 0.0 0
M  V30 16 O 4.8264 0.5636 0.0 0
M  V30 17 O 10.7800 9.3358 0.0 0
M  V30 18 C 12.3200 9.3358 0.0 0
M  V30 19 C 7.7000 6.6684 0.0 0
M  V30 20 C 8.4700 8.0021 0.0 0
M  V30 21 C 8.4700 5.3347 0.0 0
M  V30 22 C 10.0100 8.0021 0.0 0
M  V30 23 C 10.0100 5.3347 0.0 0
M  V30 24 C 10.7800 6.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 2 10 15
M  V30 16 2 10 16
M  V30 17 1 17 18
M  V30 18 1 17 22
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1R)-1-(3-methoxyphenyl)-3-(1-pyrrolidinyl)propyl]carbamate
C19H30N2O3
2376439-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6684 0.0 0 CFG=2
M  V30 2 C 7.7000 6.6684 0.0 0
M  V30 3 N 5.3900 8.0021 0.0 0
M  V30 4 C 8.4700 8.0021 0.0 0
M  V30 5 C 3.8500 8.0021 0.0 0
M  V30 6 O 3.0800 9.3358 0.0 0
M  V30 7 O 3.0800 6.6684 0.0 0
M  V30 8 C 1.5400 9.3358 0.0 0
M  V30 9 C 1.5400 7.7958 0.0 0
M  V30 10 C 0.0000 9.3358 0.0 0
M  V30 11 C 1.5400 10.8758 0.0 0
M  V30 12 O 6.1600 1.3336 0.0 0
M  V30 13 C 5.3900 0.0000 0.0 0
M  V30 14 C 5.3900 5.3347 0.0 0
M  V30 15 C 6.1600 4.0011 0.0 0
M  V30 16 C 3.8500 5.3347 0.0 0
M  V30 17 C 5.3900 2.6674 0.0 0
M  V30 18 C 3.0800 4.0011 0.0 0
M  V30 19 C 3.8500 2.6674 0.0 0
M  V30 20 N 10.0100 8.0021 0.0 0
M  V30 21 C 10.9152 6.7561 0.0 0
M  V30 22 C 10.9152 9.2480 0.0 0
M  V30 23 C 12.3798 7.2321 0.0 0
M  V30 24 C 12.3798 8.7721 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 20
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 1 12 17
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376439-11-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376439-50-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-20693504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of Selective Dual ROCK1 and ROCK2 Inhibitors Using
Structure-Based Drug Design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hobson, Adrian D.; Judge, Russell A.; Aguirre, Ana L.; Brown, Brian S.;
Cui, Yifang; Ding, Ping; Dominguez, Eric; DiGiammarino, Enrico; Egan,
David A.; Freiberg, Gail M.; Gopalakrishnan, Sujatha M.; Harris,
Christopher M.; Honore, Marie P.; Kage, Karen L.; Kapecki, Nicolas J.;
Ling, Christopher; Ma, Junli; Mack, Helmut; Mamo, Mulugeta; Maurus,
Stefan; McRae, Bradford; Moore, Nigel S.; Mueller, Bernhard K.; Mueller,
Reinhold; Namovic, Marian T.; Patel, Kaushal; Pratt, Steve D.; Putman, C.
Brent; Queeney, Kara L.; Sarris, Kathy K.; Schaffter, Lisa M.; Stoll,
Vincent; Vasudevan, Anil; Wang, Lei; Wang, Lu; Wirthl, William; Yach,
Kimberly
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2018), 61(24), 11074-11100

$RFMT $RIREG SCHEME146 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[5-[1-[(2E)-4-Bromo-1-oxo-2-buten-1-yl]-1,2,3,6-tetrahydro-4-pyridinyl]-...
C38H43BrFN5O3Si
2376723-64-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 54 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 18.8616 11.3622 0.0 0
M  V30 2 O 19.8922 10.2178 0.0 0
M  V30 3 C 21.3985 10.5380 0.0 0
M  V30 4 C 22.4289 9.3936 0.0 0
M  V30 5 Si 23.9354 9.7138 0.0 0
M  V30 6 C 25.4417 10.0339 0.0 0
M  V30 7 C 23.6152 11.2201 0.0 0
M  V30 8 C 24.2555 8.2073 0.0 0
M  V30 9 C 10.8759 13.6127 0.0 0
M  V30 10 N 8.2085 12.0726 0.0 0
M  V30 11 C 6.8749 11.3026 0.0 0
M  V30 12 O 6.8749 9.7626 0.0 0
M  V30 13 F 10.8759 7.4525 0.0 0
M  V30 14 C 11.0753 5.2183 0.0 0
M  V30 15 C 11.5512 3.7537 0.0 0
M  V30 16 O 9.5690 5.5384 0.0 0
M  V30 17 C 10.5207 2.6091 0.0 0
M  V30 18 C 10.9966 1.1446 0.0 0
M  V30 19 Br 9.9662 0.0000 0.0 0
M  V30 20 C 14.8770 11.3025 0.0 0
M  V30 21 C 15.1972 9.7962 0.0 0
M  V30 22 C 13.5434 12.0725 0.0 0
M  V30 23 C 16.2107 12.0725 0.0 0
M  V30 24 C 16.7288 9.6352 0.0 0
M  V30 25 N 13.5434 13.6125 0.0 0
M  V30 26 N 17.3553 11.0420 0.0 0
M  V30 27 N 16.2107 13.6125 0.0 0
M  V30 28 C 14.8770 14.3825 0.0 0
M  V30 29 C 14.1668 8.6518 0.0 0
M  V30 30 C 12.6603 8.9719 0.0 0
M  V30 31 C 14.6426 7.1870 0.0 0
M  V30 32 C 11.6299 7.8274 0.0 0
M  V30 33 C 13.6122 6.0426 0.0 0
M  V30 34 N 12.1057 6.3628 0.0 0
M  V30 35 C 12.2097 11.3026 0.0 0
M  V30 36 C 10.8759 12.0726 0.0 0
M  V30 37 C 12.2097 9.7626 0.0 0
M  V30 38 C 9.5422 11.3026 0.0 0
M  V30 39 C 10.8759 8.9926 0.0 0
M  V30 40 C 9.5422 9.7626 0.0 0
M  V30 41 C 5.5410 12.0726 0.0 0
M  V30 42 C 5.5410 13.6127 0.0 0
M  V30 43 C 4.2074 11.3026 0.0 0
M  V30 44 C 4.2074 14.3827 0.0 0
M  V30 45 C 2.8737 12.0726 0.0 0
M  V30 46 C 2.8737 13.6127 0.0 0
M  V30 47 C 1.5400 14.3827 0.0 0
M  V30 48 C 0.7700 15.7164 0.0 0
M  V30 49 C 0.0000 14.3827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 26
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 36
M  V30 10 1 10 11
M  V30 11 1 10 38
M  V30 12 2 11 12
M  V30 13 1 11 41
M  V30 14 1 13 39
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 34
M  V30 18 2 15 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 2 20 22
M  V30 23 1 20 23
M  V30 24 2 21 24
M  V30 25 1 21 29
M  V30 26 1 22 25
M  V30 27 1 22 35
M  V30 28 1 23 26
M  V30 29 2 23 27
M  V30 30 1 24 26
M  V30 31 2 25 28
M  V30 32 1 27 28
M  V30 33 1 29 30
M  V30 34 2 29 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 51 1 46 47
M  V30 52 1 47 48
M  V30 53 1 47 49
M  V30 54 1 48 49
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyclopropyl-N-[5-fluoro-2-methyl-3-[5-[1,2,3,6-tetrahydro-1-[(2E)-1-oxo-4-(...
C42H51FN6O3Si
2376726-04-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  53 59 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 18.8612 13.6384 0.0 0
M  V30 2 O 19.8917 12.4940 0.0 0
M  V30 3 C 21.3980 12.8142 0.0 0
M  V30 4 C 22.4284 11.6697 0.0 0
M  V30 5 Si 23.9348 11.9898 0.0 0
M  V30 6 C 25.4411 12.3100 0.0 0
M  V30 7 C 23.6147 13.4963 0.0 0
M  V30 8 C 24.2550 10.4836 0.0 0
M  V30 9 C 10.8756 15.8886 0.0 0
M  V30 10 N 8.2084 14.3486 0.0 0
M  V30 11 C 6.8747 13.5786 0.0 0
M  V30 12 O 6.8747 12.0386 0.0 0
M  V30 13 F 10.8756 9.7286 0.0 0
M  V30 14 C 11.0751 7.4946 0.0 0
M  V30 15 C 11.5509 6.0299 0.0 0
M  V30 16 O 9.5688 7.8147 0.0 0
M  V30 17 C 10.5205 4.8855 0.0 0
M  V30 18 C 10.9964 3.4208 0.0 0
M  V30 19 C 14.8767 13.5786 0.0 0
M  V30 20 C 15.1969 12.0724 0.0 0
M  V30 21 C 13.5431 14.3486 0.0 0
M  V30 22 C 16.2104 14.3486 0.0 0
M  V30 23 C 16.7284 11.9113 0.0 0
M  V30 24 N 13.5431 15.8886 0.0 0
M  V30 25 N 17.3549 13.3182 0.0 0
M  V30 26 N 16.2104 15.8886 0.0 0
M  V30 27 C 14.8767 16.6586 0.0 0
M  V30 28 C 14.1665 10.9278 0.0 0
M  V30 29 C 14.6423 9.4633 0.0 0
M  V30 30 C 12.6600 11.2480 0.0 0
M  V30 31 C 13.6119 8.3188 0.0 0
M  V30 32 C 11.6296 10.1036 0.0 0
M  V30 33 N 12.1055 8.6389 0.0 0
M  V30 34 C 12.2094 13.5786 0.0 0
M  V30 35 C 10.8756 14.3486 0.0 0
M  V30 36 C 12.2094 12.0386 0.0 0
M  V30 37 C 9.5420 13.5786 0.0 0
M  V30 38 C 10.8756 11.2686 0.0 0
M  V30 39 C 9.5420 12.0386 0.0 0
M  V30 40 C 5.5409 14.3486 0.0 0
M  V30 41 C 4.2073 13.5786 0.0 0
M  V30 42 C 5.5409 15.8886 0.0 0
M  V30 43 C 2.8736 14.3486 0.0 0
M  V30 44 C 4.2073 16.6586 0.0 0
M  V30 45 C 2.8736 15.8886 0.0 0
M  V30 46 N 9.9660 2.2764 0.0 0
M  V30 47 C 10.2861 0.7700 0.0 0
M  V30 48 C 8.4344 2.4374 0.0 0
M  V30 49 C 8.9525 0.0000 0.0 0
M  V30 50 C 7.8080 1.0306 0.0 0
M  V30 51 C 1.5400 16.6586 0.0 0
M  V30 52 C 0.0000 16.6586 0.0 0
M  V30 53 C 0.7700 17.9924 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 25
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 9 35
M  V30 10 1 10 11
M  V30 11 1 10 37
M  V30 12 2 11 12
M  V30 13 1 11 40
M  V30 14 1 13 38
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 14 33
M  V30 18 2 15 17
M  V30 19 1 17 18
M  V30 20 1 18 46
M  V30 21 1 19 20
M  V30 22 2 19 21
M  V30 23 1 19 22
M  V30 24 2 20 23
M  V30 25 1 20 28
M  V30 26 1 21 24
M  V30 27 1 21 34
M  V30 28 1 22 25
M  V30 29 2 22 26
M  V30 30 1 23 25
M  V30 31 2 24 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 2 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 39 2 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 2 36 38
M  V30 43 2 37 39
M  V30 44 1 38 39
M  V30 45 2 40 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 2 42 44
M  V30 49 2 43 45
M  V30 50 1 44 45
M  V30 51 1 45 51
M  V30 52 1 46 47
M  V30 53 1 46 48
M  V30 54 1 47 49
M  V30 55 1 48 50
M  V30 56 1 49 50
M  V30 57 1 51 52
M  V30 58 1 51 53
M  V30 59 1 52 53
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2376723-64-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2376726-04-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21471707
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design of Potent and Selective Covalent Inhibitors of Bruton's Tyrosine
Kinase Targeting an Inactive Conformation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pulz, Robert; Angst, Daniela; Dawson, Janet; Gessier, Francois; Gutmann,
Sascha; Hersperger, Rene; Hinniger, Alexandra; Janser, Philipp; Koch,
Guido; Revesz, Laszlo; Vulpetti, Anna; Waelchli, Rudolf; Zimmerlin,
Alfred; Cenni, Bruno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2019), 10(10), 1467-1472

$RFMT $RIREG SCHEME147 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[(1R,2R)-2-Isoselenocyanatocyclohexyl]-1H-isoindole-1,3(2H)-dione
C15H14N2O2Se
2412906-51-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.3513 5.6420 0.0 0
M  V30 2 O 7.0619 0.9473 0.0 0
M  V30 3 N 2.6675 4.6201 0.0 0
M  V30 4 C 1.3337 5.3901 0.0 0
M  V30 5 Se 0.0000 6.1601 0.0 0
M  V30 6 N 5.3348 3.0800 0.0 0
M  V30 7 C 5.4957 4.6116 0.0 0
M  V30 8 C 6.7417 2.4536 0.0 0
M  V30 9 C 7.0021 4.9317 0.0 0
M  V30 10 C 7.7722 3.5981 0.0 0
M  V30 11 C 7.7722 6.2654 0.0 0
M  V30 12 C 9.3122 3.5981 0.0 0
M  V30 13 C 9.3122 6.2654 0.0 0
M  V30 14 C 10.0822 4.9317 0.0 0
M  V30 15 C 4.0011 2.3100 0.0 0 CFG=2
M  V30 16 C 2.6675 3.0800 0.0 0 CFG=2
M  V30 17 C 4.0011 0.7700 0.0 0
M  V30 18 C 1.3337 2.3100 0.0 0
M  V30 19 C 2.6675 0.0000 0.0 0
M  V30 20 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 8
M  V30 3 2 3 4
M  V30 4 1 16 3 CFG=1
M  V30 5 2 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 15 6 CFG=3
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1R,2R)-2-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)cyclohexyl]-1-pyrrolidin...
C19H23N3O2Se
2412906-52-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.4211 4.6079 0.0 0
M  V30 2 O 0.0000 4.6079 0.0 0
M  V30 3 N 5.3779 6.5772 0.0 0
M  V30 4 C 6.7116 7.3472 0.0 0
M  V30 5 Se 6.7116 8.8872 0.0 0
M  V30 6 N 2.7104 5.0371 0.0 0
M  V30 7 C 3.9565 4.1320 0.0 0
M  V30 8 C 1.4646 4.1320 0.0 0
M  V30 9 C 3.4805 2.6673 0.0 0
M  V30 10 C 1.9404 2.6673 0.0 0
M  V30 11 C 4.2505 1.3337 0.0 0
M  V30 12 C 1.1704 1.3337 0.0 0
M  V30 13 C 3.4805 0.0000 0.0 0
M  V30 14 C 1.9404 0.0000 0.0 0
M  V30 15 C 2.7104 6.5772 0.0 0 CFG=2
M  V30 16 C 4.0443 7.3472 0.0 0 CFG=2
M  V30 17 C 1.3768 7.3472 0.0 0
M  V30 18 C 4.0443 8.8872 0.0 0
M  V30 19 C 1.3768 8.8872 0.0 0
M  V30 20 C 2.7104 9.6572 0.0 0
M  V30 21 N 8.0453 6.5772 0.0 0
M  V30 22 C 8.2063 5.0456 0.0 0
M  V30 23 C 9.4522 7.2036 0.0 0
M  V30 24 C 9.7126 4.7254 0.0 0
M  V30 25 C 10.4827 6.0591 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 16 3 CFG=1
M  V30 5 2 4 5
M  V30 6 1 4 21
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 15 6 CFG=3
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2412906-51-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2412906-52-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25891460
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Selenourea-Thiourea Bronsted Acid Catalyst Facilitates Asymmetric
Conjugate Additions of Amines to α,β-Unsaturated Esters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lin, Yingfu; Hirschi, William J.; Kunadia, Anuj; Paul, Anirudra;
Ghiviriga, Ion; Abboud, Khalil A.; Karugu, Rachael W.; Vetticatt, Mathew
J.; Hirschi, Jennifer S.; Seidel, Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2020), 142(12), 5627-5635

$RFMT $RIREG SCHEME148 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-2-phenyl-5,8-quinolinedione
C16H11NO3
246862-42-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 0.0000 0.0 0
M  V30 2 O 10.0100 5.3349 0.0 0
M  V30 3 O 11.5500 2.6674 0.0 0
M  V30 4 C 12.3200 1.3338 0.0 0
M  V30 5 C 6.9300 2.6674 0.0 0
M  V30 6 C 7.7000 4.0011 0.0 0
M  V30 7 N 5.3900 2.6674 0.0 0
M  V30 8 C 7.7000 1.3338 0.0 0
M  V30 9 C 9.2400 4.0011 0.0 0
M  V30 10 C 6.9300 5.3349 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0
M  V30 12 C 9.2400 1.3338 0.0 0
M  V30 13 C 10.0100 2.6674 0.0 0
M  V30 14 C 5.3900 5.3349 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 2.3100 2.6674 0.0 0
M  V30 17 C 2.3100 5.3349 0.0 0
M  V30 18 C 0.7700 2.6674 0.0 0
M  V30 19 C 0.7700 5.3349 0.0 0
M  V30 20 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 1 11 15
M  V30 16 2 12 13
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Phenyl-6-(1-pyrrolidinyl)-5,8-quinolinedione
C19H16N2O2
687637-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.9098 5.3349 0.0 0
M  V30 2 O 6.9898 0.0000 0.0 0
M  V30 3 C 6.2198 4.0011 0.0 0
M  V30 4 C 6.9898 2.6674 0.0 0
M  V30 5 C 4.6798 4.0011 0.0 0
M  V30 6 C 6.9898 5.3349 0.0 0
M  V30 7 N 8.5298 2.6674 0.0 0
M  V30 8 C 6.2198 1.3338 0.0 0
M  V30 9 C 3.9098 2.6674 0.0 0
M  V30 10 C 8.5298 5.3349 0.0 0
M  V30 11 C 9.2998 4.0011 0.0 0
M  V30 12 C 4.6798 1.3338 0.0 0
M  V30 13 N 2.3698 2.6674 0.0 0
M  V30 14 C 1.4645 1.4216 0.0 0
M  V30 15 C 1.4645 3.9133 0.0 0
M  V30 16 C 0.0000 1.8974 0.0 0
M  V30 17 C 0.0000 3.4374 0.0 0
M  V30 18 C 10.8398 4.0011 0.0 0
M  V30 19 C 11.6098 2.6674 0.0 0
M  V30 20 C 11.6098 5.3349 0.0 0
M  V30 21 C 13.1498 2.6674 0.0 0
M  V30 22 C 13.1498 5.3349 0.0 0
M  V30 23 C 13.9198 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 2 10 11
M  V30 15 1 11 18
M  V30 16 1 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 2 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 2 20 22
M  V30 25 2 21 23
M  V30 26 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 246862-42-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 687637-71-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2865576
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel quinolinequinone antitumor agents: structure-metabolism studies
with NAD(P)H:quinone oxidoreductase (NQO1)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fryatt, Tara; Pettersson, Hanna I.; Gardipee, Walter T.; Bray, Kurtis C.;
Green, Stephen J.; Slawin, Alexandra M. Z.; Beall, Howard D.; Moody,
Christopher J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2004), 12(7), 1667-1687

$RFMT $RIREG SCHEME149 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Methoxy-2-tetralone
C11H12O2
2472-22-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.0023 3.0801 0.0 0
M  V30 2 C 9.3360 2.3101 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 4.0012 0.7700 0.0 0
M  V30 6 C 5.3348 3.0801 0.0 0
M  V30 7 C 2.6675 3.0801 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 5.3348 0.0000 0.0 0
M  V30 10 C 6.6685 2.3101 0.0 0
M  V30 11 C 1.3337 2.3101 0.0 0
M  V30 12 C 1.3337 0.7700 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 3 12
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 13
M  V30 14 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3,4-Dihydro-6-methoxy-2-naphthalenyl)pyrrolidine
C15H19NO
20915-80-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.4396 4.9318 0.0 0
M  V30 2 C 11.7733 4.1618 0.0 0
M  V30 3 C 6.4384 2.6218 0.0 0
M  V30 4 C 6.4384 4.1618 0.0 0
M  V30 5 C 5.1048 1.8517 0.0 0
M  V30 6 C 7.7722 1.8517 0.0 0
M  V30 7 C 7.7722 4.9318 0.0 0
M  V30 8 C 5.1048 4.9318 0.0 0
M  V30 9 C 3.7711 2.6218 0.0 0
M  V30 10 C 9.1059 2.6218 0.0 0
M  V30 11 C 9.1059 4.1618 0.0 0
M  V30 12 C 3.7711 4.1618 0.0 0
M  V30 13 N 2.4373 1.8517 0.0 0
M  V30 14 C 2.2763 0.3202 0.0 0
M  V30 15 C 1.0304 2.4782 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 17 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 2 10 11
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2472-22-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20915-80-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9773443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A. 6-Methoxy--tetralone 1 (3.0 g, 17.0 mmol) was placed in a 250 mL
round-bottom flask and dissolved in benzene (90 mL). Pyrrolidine (2.4 mL,
28.8 mmol) was added with stirring and the flask was flushed with argon.
A Dean-Stark trap and a reflux condenser were attached and the solution
was heated at reflux for 67 hours. After cooling, the solvent was removed
in vacuo to yield enamine 2 as a solid which was used in subsequent
reactions without further purification. Orange glassy solid. MS (MH+)
230; 1H NMR (CDCl3) 1.92 (m, 4 H), 2.45 (t, 2H), 2.84 (t, 2H), 3.26 (m,
4H), 3.79 (s, 3H), 5.11 (s, 1H), 6.65 (m, 2H), 6.81 (m, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-aralkyl-2-tetralinamines as neuropeptide Y Y5 receptor
ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Dax, Scott L.; Lovenberg, Timothy W.; Baxter, Ellen W.; Carson, John R.;
Ludovici, Donald W.; Youngman, Mark A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000020376 A1 2000-04-13

$RFMT $RIREG SCHEME150 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(tetrahydro-2H-pyran-4-yl)benzaldehyde
C12H13BrO2
2495165-11-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 1.3338 0.0 0
M  V30 2 O 5.3900 0.0000 0.0 0
M  V30 3 Br 9.2400 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 5.3900 2.6674 0.0 0
M  V30 6 C 5.3900 5.3349 0.0 0
M  V30 7 C 6.9300 2.6674 0.0 0
M  V30 8 C 6.9300 5.3349 0.0 0
M  V30 9 C 7.7000 4.0011 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3349 0.0 0
M  V30 13 C 0.7700 2.6674 0.0 0
M  V30 14 C 0.7700 5.3349 0.0 0
M  V30 15 O 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[5-Bromo-2-(tetrahydro-2H-pyran-4-yl)phenyl]methyl]pyrrolidine
C16H22BrNO
2857816-60-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.3347 0.0 0
M  V30 2 Br 5.3900 0.0000 0.0 0
M  V30 3 C 3.0800 4.0011 0.0 0
M  V30 4 C 4.6200 4.0011 0.0 0
M  V30 5 C 2.3100 2.6674 0.0 0
M  V30 6 C 5.3900 2.6674 0.0 0
M  V30 7 C 3.0800 1.3336 0.0 0
M  V30 8 C 4.6200 1.3336 0.0 0
M  V30 9 C 2.3100 5.3347 0.0 0
M  V30 10 C 3.0800 6.6685 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 C 2.3100 8.0022 0.0 0
M  V30 13 C 0.0000 6.6685 0.0 0
M  V30 14 O 0.7700 8.0022 0.0 0
M  V30 15 N 6.9300 5.3347 0.0 0
M  V30 16 C 7.8353 4.0889 0.0 0
M  V30 17 C 7.8353 6.5806 0.0 0
M  V30 18 C 9.2998 4.5647 0.0 0
M  V30 19 C 9.2998 6.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 15
M  V30 3 1 2 8
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 3 9
M  V30 7 1 4 6
M  V30 8 2 5 7
M  V30 9 2 6 8
M  V30 10 1 7 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2495165-11-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2857816-60-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35228671
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of halo-substituted amino aza-heteroaryl compounds as
inhibitors of the hematopoietic progenitor kinase 1 (HPK1)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chau, Anh; Isaac, Methvin; Joseph, Babu; Laufer, Radek; Poda, Gennady;
Prakesch, Michael; Uehling, David; Watson, Iain; Wilson, Brian; Xin, Tao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022226665 A1 2022-11-03

$RFMT $RIREG SCHEME151 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Isothiocyanato-1,3-bis(1-methylethyl)benzene
C13H17NS
25343-70-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 0.7700 0.0 0
M  V30 3 S 1.3336 0.0000 0.0 0
M  V30 4 C 6.6685 3.0800 0.0 0
M  V30 5 C 8.0021 3.8500 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 1.3336 3.0800 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 4.0011 3.0800 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 2.6674 3.8500 0.0 0
M  V30 13 C 5.3347 5.3900 0.0 0
M  V30 14 C 2.6674 5.3900 0.0 0
M  V30 15 C 4.0011 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 11
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 7 12
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2,6-Bis(1-methylethyl)phenyl]-1-pyrrolidinecarbothioamide
C17H26N2S
2218495-01-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0009 0.0 0
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 S 4.6200 6.6684 0.0 0
M  V30 4 C 3.0800 1.3336 0.0 0
M  V30 5 C 4.6200 1.3336 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 C 2.4441 6.8689 0.0 0
M  V30 8 C 1.1827 7.7521 0.0 0
M  V30 9 C 3.8398 7.5197 0.0 0
M  V30 10 C 3.0800 4.0009 0.0 0
M  V30 11 C 2.3100 2.6673 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 0.7700 5.3347 0.0 0
M  V30 15 C 0.0000 4.0009 0.0 0
M  V30 16 N 6.9300 5.3347 0.0 0
M  V30 17 C 7.8352 6.5806 0.0 0
M  V30 18 C 7.8352 4.0887 0.0 0
M  V30 19 C 9.2998 6.1047 0.0 0
M  V30 20 C 9.2998 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 2 2 3
M  V30 4 1 2 16
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 11
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 12
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 25343-70-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2218495-01-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-18878334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Thiourea-Group IV transition metal catalysts and polymerization systems
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Krasovskiy, Arkady L.; Szuromi, Endre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018063799 A1 2018-04-05

$RFMT $RIREG SCHEME152 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-4-fluoro-5-formyl-N-methylbenzamide
C9H7BrFNO2
2640353-02-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0011 0.0 0
M  V30 2 N 6.9301 5.3348 0.0 0
M  V30 3 O 6.9301 2.6675 0.0 0
M  V30 4 C 8.4701 5.3348 0.0 0
M  V30 5 C 1.5400 1.3338 0.0 0
M  V30 6 O 2.3100 0.0000 0.0 0
M  V30 7 Br 1.5400 6.6686 0.0 0
M  V30 8 F 0.0000 4.0011 0.0 0
M  V30 9 C 4.6201 4.0011 0.0 0
M  V30 10 C 3.8500 2.6675 0.0 0
M  V30 11 C 3.8500 5.3348 0.0 0
M  V30 12 C 2.3100 2.6675 0.0 0
M  V30 13 C 2.3100 5.3348 0.0 0
M  V30 14 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 5 12
M  V30 7 1 7 13
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-4-fluoro-N-methyl-5-(1-pyrrolidinylmethyl)benzamide
C13H16BrFN2O
2664901-23-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 2.6674 0.0 0
M  V30 2 F 5.3900 0.0000 0.0 0
M  V30 3 C 2.3100 5.3347 0.0 0
M  V30 4 N 0.7700 5.3347 0.0 0
M  V30 5 O 3.0800 6.6685 0.0 0
M  V30 6 C 0.0000 6.6685 0.0 0
M  V30 7 Br 2.3100 0.0000 0.0 0
M  V30 8 C 5.3900 2.6674 0.0 0
M  V30 9 C 4.6200 4.0011 0.0 0
M  V30 10 C 4.6200 1.3338 0.0 0
M  V30 11 C 3.0800 4.0011 0.0 0
M  V30 12 C 3.0800 1.3338 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 N 7.7000 4.0011 0.0 0
M  V30 15 C 7.0735 5.4080 0.0 0
M  V30 16 C 9.2315 4.1620 0.0 0
M  V30 17 C 8.2181 6.4384 0.0 0
M  V30 18 C 9.5517 5.6684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 10
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 1 4 6
M  V30 8 1 7 12
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2640353-02-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2664901-23-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24010581
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridine derivatives as FGFR inhibitors for
treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Roach, Jeremy; Shvartsbart, Artem; Witten, Michael; Yao, Wenqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20210214366 A1 2021-07-15

$RFMT $RIREG SCHEME153 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R,6S)-7-Oxabicyclo[4.1.0]heptan-2-ol
C6H10O2
26828-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0801 0.0 0
M  V30 2 C 2.6673 3.0801 0.0 0 CFG=2
M  V30 3 C 4.0010 2.3101 0.0 0 CFG=2
M  V30 4 C 1.3337 2.3101 0.0 0 CFG=2
M  V30 5 O 4.0010 3.8501 0.0 0
M  V30 6 C 4.0010 0.7700 0.0 0
M  V30 7 C 1.3337 0.7700 0.0 0
M  V30 8 C 2.6673 0.0000 0.0 0
M  V30 9 H 1.8973 4.4137 0.0 0
M  V30 10 H 5.5410 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 4 1 CFG=1
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 9 CFG=3
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 10 CFG=3
M  V30 9 1 4 7
M  V30 10 1 6 8
M  V30 11 1 7 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 2 3 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
rel-(1R,2S,3R)-3-(1-Pyrrolidinyl)-1,2-cyclohexanediol
C10H19NO2
1779533-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.1046 4.6200 0.0 0
M  V30 2 O 7.7721 3.0800 0.0 0
M  V30 3 C 3.7710 2.3100 0.0 0 CFG=2
M  V30 4 C 5.1046 3.0800 0.0 0 CFG=2
M  V30 5 C 3.7710 0.7700 0.0 0
M  V30 6 C 6.4384 2.3100 0.0 0 CFG=2
M  V30 7 C 5.1046 0.0000 0.0 0
M  V30 8 C 6.4384 0.7700 0.0 0
M  V30 9 N 2.4374 3.0800 0.0 0
M  V30 10 C 2.2764 4.6115 0.0 0
M  V30 11 C 1.0304 2.4535 0.0 0
M  V30 12 C 0.7700 4.9317 0.0 0
M  V30 13 C 0.0000 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 4 1 CFG=3
M  V30 2 1 6 2 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9 CFG=1
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 3 4 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 26828-72-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1779533-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-15944965
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective Synthesis of cis,cis-Configured
Perhydroquinoxaline-5-Carbonitrile from Cyclohex-2-en-1-ol
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Schulte, Adrian; Saito, Susumu; Wuensch, Bernhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2016), 53(2), 533-536

$RFMT $RIREG SCHEME154 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-methyl (2R,3S)-1,2,3-piperidinetricarboxylate
C13H21NO6
2719004-20-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 20 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 2.3100 0.0 0
M  V30 2 O 2.6673 1.5400 0.0 0
M  V30 3 O 5.3348 1.5400 0.0 0
M  V30 4 C 2.6673 0.0000 0.0 0
M  V30 5 C 6.6684 3.8500 0.0 0
M  V30 6 O 8.0022 4.6201 0.0 0
M  V30 7 O 6.6684 2.3100 0.0 0
M  V30 8 C 9.3359 3.8500 0.0 0
M  V30 9 C 10.1059 5.1837 0.0 0
M  V30 10 C 10.6695 3.0800 0.0 0
M  V30 11 C 8.5659 2.5164 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 13 O 0.0000 4.6201 0.0 0
M  V30 14 O 1.3337 2.3100 0.0 0
M  V30 15 C 4.0011 3.8500 0.0 0 CFG=1
M  V30 16 N 5.3348 4.6201 0.0 0
M  V30 17 C 2.6673 4.6201 0.0 0 CFG=1
M  V30 18 C 5.3348 6.1601 0.0 0
M  V30 19 C 2.6673 6.1601 0.0 0
M  V30 20 C 4.0011 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 15 1 CFG=1
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 16
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 13
M  V30 13 2 12 14
M  V30 14 1 17 12 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 19
M  V30 19 1 18 20
M  V30 20 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 15 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-(1,1-Dimethylethyl) 2-methyl (2R,3S)-3-(1-pyrrolidinylcarbonyl)-1,2-piperid...
C17H28N2O5
2873532-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4384 2.3101 0.0 0
M  V30 2 O 5.1048 1.5400 0.0 0
M  V30 3 O 7.7721 1.5400 0.0 0
M  V30 4 C 5.1048 0.0000 0.0 0
M  V30 5 C 3.7711 3.8501 0.0 0
M  V30 6 O 3.7711 2.3101 0.0 0
M  V30 7 C 9.1059 3.8501 0.0 0
M  V30 8 O 10.4396 4.6201 0.0 0
M  V30 9 O 9.1059 2.3101 0.0 0
M  V30 10 C 11.7733 3.8501 0.0 0
M  V30 11 C 12.5433 5.1838 0.0 0
M  V30 12 C 13.1069 3.0801 0.0 0
M  V30 13 C 11.0032 2.5164 0.0 0
M  V30 14 C 6.4384 3.8501 0.0 0 CFG=2
M  V30 15 C 5.1048 4.6201 0.0 0 CFG=1
M  V30 16 N 7.7721 4.6201 0.0 0
M  V30 17 C 5.1048 6.1601 0.0 0
M  V30 18 C 7.7721 6.1601 0.0 0
M  V30 19 C 6.4384 6.9302 0.0 0
M  V30 20 N 2.4373 4.6201 0.0 0
M  V30 21 C 1.0304 3.9938 0.0 0
M  V30 22 C 2.2763 6.1517 0.0 0
M  V30 23 C 0.0000 5.1382 0.0 0
M  V30 24 C 0.7700 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 14 1 CFG=1
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 1 15 5 CFG=1
M  V30 7 1 5 20
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 16
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2719004-20-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2873532-34-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35592864
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of peptidomimetics as Factor XIIa inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Foster, Richard James; Abas Prades, Sonia; Ayres, James Nigel; Philippou,
Helen; Perrior, Trevor; Naylor, Alan; Fallon, Philip Spencer; Hopkins,
Anna; Galvan Alvarez, Alicia; Negoita-Giras, Gabriel; May, John Joseph;
Brough, Daniel John; Ricci, Paolo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022248883 A1 2022-12-01

$RFMT $RIREG SCHEME155 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxybenzyl bromide
C8H9BrO
2746-25-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 Br 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Methoxyphenyl)methyl]pyrrolidine
C12H17NO
122439-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 0.0000 0.0 0
M  V30 2 O 9.1059 3.0801 0.0 0
M  V30 3 C 10.4396 2.3101 0.0 0
M  V30 4 C 5.1048 0.7700 0.0 0
M  V30 5 C 6.4384 0.0000 0.0 0
M  V30 6 C 5.1048 2.3101 0.0 0
M  V30 7 C 7.7722 0.7700 0.0 0
M  V30 8 C 6.4384 3.0801 0.0 0
M  V30 9 C 7.7722 2.3101 0.0 0
M  V30 10 N 2.4374 0.7700 0.0 0
M  V30 11 C 1.0304 0.1437 0.0 0
M  V30 12 C 2.2763 2.3016 0.0 0
M  V30 13 C 0.0000 1.2881 0.0 0
M  V30 14 C 0.7700 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 2 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2746-25-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 122439-15-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15725746
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of Aldehydes by Oxidation of Benzylic Amines with Selectfluor
(F-TEDA-BF4)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hauser, Anett; Bohlmann, Rolf
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synlett (2016), 27(12), 1870-1872

$RFMT $RIREG SCHEME156 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-2-[4-[[(2,4-dimethoxyphenyl)methyl]amino]-7-cinnolinyl]benzoic acid
C24H20ClN3O4
2759951-80-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 6.1601 0.0 0
M  V30 2 C 5.3348 6.9302 0.0 0
M  V30 3 C 12.0035 1.5400 0.0 0
M  V30 4 O 10.6697 2.3101 0.0 0
M  V30 5 O 12.0035 0.0000 0.0 0
M  V30 6 O 2.6675 8.4702 0.0 0
M  V30 7 C 1.3338 9.2402 0.0 0
M  V30 8 Cl 17.3383 4.6201 0.0 0
M  V30 9 O 0.0000 3.8501 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 9.3360 6.1601 0.0 0
M  V30 12 C 10.6697 6.9302 0.0 0
M  V30 13 C 8.0023 6.9302 0.0 0
M  V30 14 C 9.3360 4.6201 0.0 0
M  V30 15 C 12.0035 6.1601 0.0 0
M  V30 16 N 10.6697 8.4702 0.0 0
M  V30 17 C 8.0023 8.4702 0.0 0
M  V30 18 C 10.6697 3.8501 0.0 0
M  V30 19 C 12.0035 4.6201 0.0 0
M  V30 20 N 9.3360 9.2402 0.0 0
M  V30 21 C 13.3372 3.8501 0.0 0
M  V30 22 C 13.3372 2.3101 0.0 0
M  V30 23 C 14.6708 4.6201 0.0 0
M  V30 24 C 14.6708 1.5400 0.0 0
M  V30 25 C 16.0045 3.8501 0.0 0
M  V30 26 C 16.0045 2.3101 0.0 0
M  V30 27 C 4.0012 6.1601 0.0 0
M  V30 28 C 2.6675 6.9302 0.0 0
M  V30 29 C 4.0012 4.6201 0.0 0
M  V30 30 C 1.3338 6.1601 0.0 0
M  V30 31 C 2.6675 3.8501 0.0 0
M  V30 32 C 1.3338 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 27
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 22
M  V30 7 1 6 7
M  V30 8 1 6 28
M  V30 9 1 8 25
M  V30 10 1 9 10
M  V30 11 1 9 32
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 2 14 18
M  V30 19 2 15 19
M  V30 20 2 16 20
M  V30 21 1 17 20
M  V30 22 1 18 19
M  V30 23 1 19 21
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[4-Chloro-2-[4-[[(2,4-dimethoxyphenyl)methyl]amino]-7-cinnolinyl]phenyl]-1-py...
C28H27ClN4O3
2759951-86-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.9098 0.0 0
M  V30 2 O 6.6684 4.6798 0.0 0
M  V30 3 Cl 0.0000 6.9898 0.0 0
M  V30 4 N 10.6696 8.5299 0.0 0
M  V30 5 C 12.0034 9.2999 0.0 0
M  V30 6 O 14.6707 10.8399 0.0 0
M  V30 7 C 16.0044 11.6099 0.0 0
M  V30 8 O 17.3382 6.2198 0.0 0
M  V30 9 C 18.6718 6.9898 0.0 0
M  V30 10 C 4.0011 6.2198 0.0 0
M  V30 11 C 4.0011 4.6798 0.0 0
M  V30 12 C 2.6675 6.9898 0.0 0
M  V30 13 C 2.6675 3.9098 0.0 0
M  V30 14 C 1.3337 6.2198 0.0 0
M  V30 15 C 1.3337 4.6798 0.0 0
M  V30 16 C 5.3348 6.9898 0.0 0
M  V30 17 C 5.3348 8.5299 0.0 0
M  V30 18 C 6.6684 6.2198 0.0 0
M  V30 19 C 6.6684 9.2999 0.0 0
M  V30 20 C 8.0023 6.9898 0.0 0
M  V30 21 C 8.0023 8.5299 0.0 0
M  V30 22 N 6.6684 10.8399 0.0 0
M  V30 23 C 9.3359 9.2999 0.0 0
M  V30 24 N 8.0023 11.6099 0.0 0
M  V30 25 C 9.3359 10.8399 0.0 0
M  V30 26 N 5.3348 2.3698 0.0 0
M  V30 27 C 4.0889 1.4646 0.0 0
M  V30 28 C 6.5807 1.4646 0.0 0
M  V30 29 C 4.5648 0.0000 0.0 0
M  V30 30 C 6.1048 0.0000 0.0 0
M  V30 31 C 13.3370 8.5299 0.0 0
M  V30 32 C 14.6707 9.2999 0.0 0
M  V30 33 C 13.3370 6.9898 0.0 0
M  V30 34 C 16.0044 8.5299 0.0 0
M  V30 35 C 14.6707 6.2198 0.0 0
M  V30 36 C 16.0044 6.9898 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 11
M  V30 3 1 1 26
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 4 23
M  V30 7 1 5 31
M  V30 8 1 6 7
M  V30 9 1 6 32
M  V30 10 1 8 9
M  V30 11 1 8 36
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 10 16
M  V30 15 1 11 13
M  V30 16 2 12 14
M  V30 17 2 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 19 22
M  V30 25 1 20 21
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2759951-80-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2759951-86-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31475642
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of complement factors and uses thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Artis, Dean R.; Leslie, Colin Philip; Mileo, Luca Biagio; Beato, Claudia;
Sorana, Federico; Di Guglielmo, Bruno; Padroni, Chiara
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022020244 A1 2022-01-27

$RFMT $RIREG SCHEME157 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Quinoline, 4-chloro-6-(3-chloropropoxy)-2-methyl-
C13H13Cl2NO
2761539-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.6673 0.0000 0.0 0
M  V30 2 C 0.0000 4.6201 0.0 0
M  V30 3 O 8.0022 1.5400 0.0 0
M  V30 4 C 9.3360 2.3101 0.0 0
M  V30 5 C 10.6697 1.5400 0.0 0
M  V30 6 C 12.0033 2.3101 0.0 0
M  V30 7 Cl 13.3370 1.5400 0.0 0
M  V30 8 C 4.0010 3.8501 0.0 0
M  V30 9 C 4.0010 2.3101 0.0 0
M  V30 10 C 5.3348 4.6201 0.0 0
M  V30 11 N 2.6673 4.6201 0.0 0
M  V30 12 C 5.3348 1.5400 0.0 0
M  V30 13 C 2.6673 1.5400 0.0 0
M  V30 14 C 6.6685 3.8501 0.0 0
M  V30 15 C 1.3337 3.8501 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 2 15
M  V30 3 1 3 4
M  V30 4 1 3 16
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 2 12 16
M  V30 16 2 13 17
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Quinoline, 4-chloro-2-methyl-6-[3-(1-pyrrolidinyl)propoxy]-
C17H21ClN2O
2761539-12-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.6675 0.3117 0.0 0
M  V30 2 C 0.0000 4.9318 0.0 0
M  V30 3 O 8.0023 1.8517 0.0 0
M  V30 4 C 9.3360 2.6218 0.0 0
M  V30 5 C 10.6697 1.8517 0.0 0
M  V30 6 C 12.0035 2.6218 0.0 0
M  V30 7 C 4.0012 4.1618 0.0 0
M  V30 8 C 4.0012 2.6218 0.0 0
M  V30 9 C 5.3348 4.9318 0.0 0
M  V30 10 N 2.6675 4.9318 0.0 0
M  V30 11 C 5.3348 1.8517 0.0 0
M  V30 12 C 2.6675 1.8517 0.0 0
M  V30 13 C 6.6687 4.1618 0.0 0
M  V30 14 C 1.3338 4.1618 0.0 0
M  V30 15 C 6.6687 2.6218 0.0 0
M  V30 16 C 1.3338 2.6218 0.0 0
M  V30 17 N 13.3372 1.8517 0.0 0
M  V30 18 C 13.4981 0.3202 0.0 0
M  V30 19 C 14.7440 2.4782 0.0 0
M  V30 20 C 15.0045 0.0000 0.0 0
M  V30 21 C 15.7746 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 14
M  V30 3 1 3 4
M  V30 4 1 3 15
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 17
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 2 11 15
M  V30 16 2 12 16
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2761539-11-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2761539-12-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31592615
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-11-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of AL-GDa62 as a Potential Synthetic Lethal Lead for the
Treatment of Gastric Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Luxenburger, Andreas; Bougen-Zhukov, Nicola; Fraser, Michael G.; Beetham,
Henry; Harris, Lawrence D.; Schmidt, Dorian; Cameron, Scott A.; Guilford,
Parry J.; Evans, Gary B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(24), 18114-18142

$RFMT $RIREG SCHEME158 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(-)-Methyl lactate
C4H8O3
27871-49-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0 CFG=1
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 O 1.3338 0.0000 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 6 1 3 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-2-Hydroxy-1-(1-pyrrolidinyl)-1-propanone
C7H13NO2
122151-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 C 5.1048 2.3100 0.0 0 CFG=1
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 5.1048 3.8500 0.0 0
M  V30 5 O 6.4385 1.5400 0.0 0
M  V30 6 N 2.4374 2.3100 0.0 0
M  V30 7 C 1.0306 1.6835 0.0 0
M  V30 8 C 2.2764 3.8416 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 10 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 27871-49-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 122151-38-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6673003
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 14
[00455]N-((1S,2S)-1-(2-fluoro-3-(trifluoromethyl)phenyl)-2-hydroxypropyl)-2-(isopropylamino)-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxamide
(I-18) [00456]step 1: (S)-Methyl 2-hydroxypropanoate (30.0 g, 288 mmol)
and pyrrolidine (22.5 g, 317 mmol) were stirred at RT for 3 d. The crude
product was purified by passing through a SiO2 plug eluting with 80%
EtOAc/hexane to afford 41.1 g (99.6%)
(S)-2-hydroxy-1-(pyrrolidin-1-yl)propan-1-one (108) 41.1 g (99.6%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridopyrimidine derivatives as ERK inhibitors and their preparation and
use for the treatment of hyperproliferative diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blake, James F.; Chen, Huifen; Chicarelli, Mark Joseph; Demeese, Jason;
Garrey, Rustam; Gaudino, John J.; Kaus, Robert J.; Kolakowski, Gabrielle
R.; Marlow, Allison L.; Mohr, Peter J.; Ren, Li; Schwarz, Jacob; Siedem,
Christopher S.; Thomas, Allen A.; Wallace, Eli; Wenglowsky, Steven Mark
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012118850 A1 2012-09-07

$RFMT $RIREG SCHEME159 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,3R,5R)-2-Chloro-2-methyl-5-(1-methylethenyl)-3-[[(4-methylphenyl)sulfonyl...
C17H21ClO4S
2846064-02-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6200 0.0 0
M  V30 2 S 6.6685 6.1600 0.0 0 VAL=6
M  V30 3 O 6.6685 7.7000 0.0 0
M  V30 4 O 5.1285 6.1600 0.0 0
M  V30 5 C 6.8513 2.5773 0.0 0
M  V30 6 Cl 5.8615 0.8629 0.0 0
M  V30 7 C 1.3338 4.6200 0.0 0
M  V30 8 C 1.3338 6.1600 0.0 0
M  V30 9 C 0.0000 3.8500 0.0 0
M  V30 10 O 4.0011 0.0000 0.0 0
M  V30 11 C 12.8285 6.1600 0.0 0
M  V30 12 C 5.3347 3.8500 0.0 0 CFG=1
M  V30 13 C 4.0011 4.6200 0.0 0
M  V30 14 C 5.3347 2.3100 0.0 0 CFG=1
M  V30 15 C 2.6674 3.8500 0.0 0 CFG=1
M  V30 16 C 4.0011 1.5400 0.0 0
M  V30 17 C 2.6674 2.3100 0.0 0
M  V30 18 C 8.2085 6.1600 0.0 0
M  V30 19 C 8.9785 4.8264 0.0 0
M  V30 20 C 8.9785 7.4936 0.0 0
M  V30 21 C 10.5185 4.8264 0.0 0
M  V30 22 C 10.5185 7.4936 0.0 0
M  V30 23 C 11.2885 6.1600 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 18
M  V30 6 1 14 5 CFG=1
M  V30 7 1 14 6 CFG=3
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 15 7 CFG=3
M  V30 11 2 10 16
M  V30 12 1 11 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 12 14 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[(1R,5R)-2-Methyl-5-(1-methylethenyl)-2-cyclopenten-1-yl]-1-pyrrolidinylmetha...
C14H21NO
2846064-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 3.7710 0.0 0
M  V30 2 O 4.6798 5.1048 0.0 0
M  V30 3 C 7.2418 3.4208 0.0 0
M  V30 4 C 6.7660 4.8855 0.0 0
M  V30 5 C 8.7481 3.1006 0.0 0
M  V30 6 C 2.5470 0.7104 0.0 0
M  V30 7 C 4.6798 2.4374 0.0 0 CFG=1
M  V30 8 C 6.2113 2.2764 0.0 0 CFG=2
M  V30 9 C 4.0534 1.0306 0.0 0
M  V30 10 C 6.5316 0.7700 0.0 0
M  V30 11 C 5.1978 0.0000 0.0 0
M  V30 12 N 2.3698 3.7710 0.0 0
M  V30 13 C 1.4645 5.0170 0.0 0
M  V30 14 C 1.4645 2.5251 0.0 0
M  V30 15 C 0.0000 4.5410 0.0 0
M  V30 16 C 0.0000 3.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 1 1 12
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 8 3 CFG=3
M  V30 7 1 6 9
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2846064-02-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2846064-06-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35231756
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM Favorskii rearrangement-elimination,alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Total Synthesis of Eupalinilide E, a Promoter of Human HSPC
Expansion
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maity, Ramkrishna; Hajra, Saumen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(26), 4745-4749

$RFMT $RIREG SCHEME160 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,3R,5R)-3-(Acetyloxy)-2-chloro-2-methyl-5-(1-methylethenyl)cyclohexanone
C12H17ClO3
2846064-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 2.6674 0.0 0
M  V30 3 C 6.1600 1.3338 0.0 0
M  V30 4 O 8.4700 2.6674 0.0 0
M  V30 5 C 3.5827 6.8515 0.0 0
M  V30 6 Cl 5.2971 5.8615 0.0 0
M  V30 7 O 1.5400 6.6685 0.0 0
M  V30 8 C 1.5400 1.3338 0.0 0
M  V30 9 C 0.0000 1.3338 0.0 0
M  V30 10 C 2.3100 0.0000 0.0 0
M  V30 11 C 4.6200 4.0011 0.0 0 CFG=2
M  V30 12 C 3.8500 5.3347 0.0 0 CFG=1
M  V30 13 C 3.8500 2.6674 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 2.3100 2.6674 0.0 0 CFG=1
M  V30 16 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 11 1 CFG=3
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 12 5 CFG=3
M  V30 6 1 12 6 CFG=1
M  V30 7 2 7 14
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 15 8 CFG=1
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 11 12 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[(1R,5R)-2-Methyl-5-(1-methylethenyl)-2-cyclopenten-1-yl]-1-pyrrolidinylmetha...
C14H21NO
2846064-06-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 3.7710 0.0 0
M  V30 2 O 4.6798 5.1048 0.0 0
M  V30 3 C 7.2418 3.4208 0.0 0
M  V30 4 C 6.7660 4.8855 0.0 0
M  V30 5 C 8.7481 3.1006 0.0 0
M  V30 6 C 2.5470 0.7104 0.0 0
M  V30 7 C 4.6798 2.4374 0.0 0 CFG=1
M  V30 8 C 6.2113 2.2764 0.0 0 CFG=2
M  V30 9 C 4.0534 1.0306 0.0 0
M  V30 10 C 6.5316 0.7700 0.0 0
M  V30 11 C 5.1978 0.0000 0.0 0
M  V30 12 N 2.3698 3.7710 0.0 0
M  V30 13 C 1.4645 5.0170 0.0 0
M  V30 14 C 1.4645 2.5251 0.0 0
M  V30 15 C 0.0000 4.5410 0.0 0
M  V30 16 C 0.0000 3.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 7 1 CFG=3
M  V30 3 1 1 12
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 8 3 CFG=3
M  V30 7 1 6 9
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 7 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2846064-03-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2846064-06-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35231793
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM Favorskii rearrangement-elimination,alternative preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric Total Synthesis of Eupalinilide E, a Promoter of Human HSPC
Expansion
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maity, Ramkrishna; Hajra, Saumen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(26), 4745-4749

$RFMT $RIREG SCHEME161 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl α-bromobenzeneacetate
C10H11BrO2
2882-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 Br 4.0011 0.0000 0.0 0
M  V30 4 O 6.6684 1.5400 0.0 0
M  V30 5 O 5.3347 3.8500 0.0 0
M  V30 6 C 8.0021 2.3100 0.0 0
M  V30 7 C 9.3358 1.5400 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 2.6674 3.8500 0.0 0
M  V30 10 C 1.3336 1.5400 0.0 0
M  V30 11 C 1.3336 4.6200 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl α-phenyl-1-pyrrolidineacetate
C14H19NO2
22083-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.9098 0.0 0
M  V30 2 C 5.3347 4.6798 0.0 0
M  V30 3 O 6.6684 3.9098 0.0 0
M  V30 4 O 5.3347 6.2198 0.0 0
M  V30 5 C 8.0022 4.6798 0.0 0
M  V30 6 C 9.3358 3.9098 0.0 0
M  V30 7 C 2.6674 4.6798 0.0 0
M  V30 8 C 1.3336 3.9098 0.0 0
M  V30 9 C 2.6674 6.2198 0.0 0
M  V30 10 C 0.0000 4.6798 0.0 0
M  V30 11 C 1.3336 6.9898 0.0 0
M  V30 12 C 0.0000 6.2198 0.0 0
M  V30 13 N 4.0011 2.3698 0.0 0
M  V30 14 C 2.7552 1.4645 0.0 0
M  V30 15 C 5.2470 1.4645 0.0 0
M  V30 16 C 3.2311 0.0000 0.0 0
M  V30 17 C 4.7711 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2882-19-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22083-21-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12864937
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of ethyl 2-pheny2-(pyrrolidin-1-yl)acetate (134). Ethyl
2-bromo-2-phenylacetate (0.22 ml, 1.23 mmol) was dissolved in
acetonitrile (4.0 ml). DIPEA (0.26 ml, 1.48 mmol) and pyrrolidine (0.12
ml, 1.48 mmol) were sequentially added and the solution was stirred at
room temperature for 1.5 h. Acetonitrile was evaporated and the residue
was purified by flash chromatography (petroleum ether/EtOAc = 9/1) to
obtain ethyl 2-pheny2-(pyrrolidin-1-yl)acetate. Colorless oil, yield (315
mg, quantitative). 1H NMR (300 MHz, DMSO-d6) ppm 7.39 - 7.47 (m, 2 H),
7.26 - 7.39 (m, 3 H), 4.09 (dq, 1 H), 4.03 (dq, 1 H), 3.98 (s, 1 H), 2.24
- 2.48 (m, 4 H), 1.58 - 1.82 (m, 4 H), 1.11 (t, 3 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinuclidine esters of 1-azaheterocyclylacetic acid
derivatives as antimuscarinic agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Amari, Gabriele; Pesenti, Cristina; Bossolo, Stefano
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013098145 A1 2013-07-04

$RFMT $RIREG SCHEME162 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[[2-(3-Bromopropoxy)phenyl]methyl]-4-chloro-N-phenylbenzenesulfonamide
C22H21BrClNO3S
290325-90-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 6.9302 0.0 0
M  V30 2 C 5.3348 6.1601 0.0 0
M  V30 3 S 8.0022 6.1601 0.0 0 VAL=6
M  V30 4 O 8.7722 7.4938 0.0 0
M  V30 5 O 7.2322 4.8265 0.0 0
M  V30 6 O 2.6673 4.6201 0.0 0
M  V30 7 C 1.3337 3.8501 0.0 0
M  V30 8 C 1.3337 2.3101 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 Br 0.0000 0.0000 0.0 0
M  V30 11 Cl 13.3370 3.0801 0.0 0
M  V30 12 C 6.6685 8.4702 0.0 0
M  V30 13 C 8.0022 9.2402 0.0 0
M  V30 14 C 5.3348 9.2402 0.0 0
M  V30 15 C 8.0022 10.7802 0.0 0
M  V30 16 C 5.3348 10.7802 0.0 0
M  V30 17 C 6.6685 11.5503 0.0 0
M  V30 18 C 4.0010 6.9302 0.0 0
M  V30 19 C 2.6673 6.1601 0.0 0
M  V30 20 C 4.0010 8.4702 0.0 0
M  V30 21 C 1.3337 6.9302 0.0 0
M  V30 22 C 2.6673 9.2402 0.0 0
M  V30 23 C 1.3337 8.4702 0.0 0
M  V30 24 C 9.3360 5.3901 0.0 0
M  V30 25 C 9.3360 3.8501 0.0 0
M  V30 26 C 10.6697 6.1601 0.0 0
M  V30 27 C 10.6697 3.0801 0.0 0
M  V30 28 C 12.0033 5.3901 0.0 0
M  V30 29 C 12.0033 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 18
M  V30 5 2 3 4
M  V30 6 2 3 5
M  V30 7 1 3 24
M  V30 8 1 6 7
M  V30 9 1 6 19
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 9 10
M  V30 13 1 11 29
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-phenyl-N-[[2-[3-(1-pyrrolidinyl)propoxy]phenyl]methyl]benzenesulfo...
C26H29ClN2O3S
769909-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 7.7000 0.0 0
M  V30 2 C 5.3347 8.4700 0.0 0
M  V30 3 S 4.0011 6.1600 0.0 0 VAL=6
M  V30 4 O 5.5411 6.1600 0.0 0
M  V30 5 O 2.4611 6.1600 0.0 0
M  V30 6 O 8.0021 10.0100 0.0 0
M  V30 7 C 9.3358 10.7800 0.0 0
M  V30 8 C 10.6694 10.0100 0.0 0
M  V30 9 C 12.0032 10.7800 0.0 0
M  V30 10 Cl 4.0011 0.0000 0.0 0
M  V30 11 C 2.6674 8.4700 0.0 0
M  V30 12 C 2.6674 10.0100 0.0 0
M  V30 13 C 1.3338 7.7000 0.0 0
M  V30 14 C 1.3338 10.7800 0.0 0
M  V30 15 C 0.0000 8.4700 0.0 0
M  V30 16 C 0.0000 10.0100 0.0 0
M  V30 17 C 5.3347 10.0100 0.0 0
M  V30 18 C 6.6685 10.7800 0.0 0
M  V30 19 C 4.0011 10.7800 0.0 0
M  V30 20 C 6.6685 12.3200 0.0 0
M  V30 21 C 4.0011 12.3200 0.0 0
M  V30 22 C 5.3347 13.0900 0.0 0
M  V30 23 C 4.0011 4.6200 0.0 0
M  V30 24 C 5.3347 3.8500 0.0 0
M  V30 25 C 2.6674 3.8500 0.0 0
M  V30 26 C 5.3347 2.3100 0.0 0
M  V30 27 C 2.6674 2.3100 0.0 0
M  V30 28 C 4.0011 1.5400 0.0 0
M  V30 29 N 13.3369 10.0100 0.0 0
M  V30 30 C 13.4978 8.4785 0.0 0
M  V30 31 C 14.7437 10.6363 0.0 0
M  V30 32 C 15.0042 8.1583 0.0 0
M  V30 33 C 15.7742 9.4919 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 17
M  V30 5 2 3 4
M  V30 6 2 3 5
M  V30 7 1 3 23
M  V30 8 1 6 7
M  V30 9 1 6 18
M  V30 10 1 7 8
M  V30 11 1 8 9
M  V30 12 1 9 29
M  V30 13 1 10 28
M  V30 14 2 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 2 13 15
M  V30 18 2 14 16
M  V30 19 1 15 16
M  V30 20 2 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 21
M  V30 24 2 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 290325-90-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 769909-76-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14400697
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM product also isolated as HCl salt, analogs prepared similarly
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of sulfonamide derivatives as amyloid β production inhibitors
useful in treating or preventing diseases related to Aβ
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Smith, David W.; Munoz, Benito; Srinivasan, Kumar; Bergstrom, Carl P.;
Chaturvedula, Prasad V.; Deshpande, Milind S.; Keavy, Daniel J.; Lau, Wai
Yu; Parker, Michael F.; Sloan, Charles P.; Wallace, Owen B.; Wang, Henry
Hui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000050391 A1 2000-08-31

$RFMT $RIREG SCHEME163 STEP1
$RXN



  3  1
$MOL
3-Bromo-1-propanol
C3H7BrO
627-18-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 C 4.0010 0.0000 0.0 0
M  V30 4 Br 0.0000 0.7700 0.0 0
M  V30 5 O 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-(2,5-difluorophenyl)-N-[(2-hydroxyphenyl)methyl]benzenesulfonamide
C19H14ClF2NO3S
290326-02-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.0800 5.3347 0.0 0
M  V30 2 S 4.6200 5.3347 0.0 0 VAL=6
M  V30 3 C 2.3100 6.6684 0.0 0
M  V30 4 O 4.6200 6.8747 0.0 0
M  V30 5 O 4.6200 3.7947 0.0 0
M  V30 6 F 0.0000 5.3347 0.0 0
M  V30 7 F 3.0800 0.0000 0.0 0
M  V30 8 O 0.7700 9.3358 0.0 0
M  V30 9 Cl 10.7800 5.3347 0.0 0
M  V30 10 C 2.3100 4.0011 0.0 0
M  V30 11 C 0.7700 4.0011 0.0 0
M  V30 12 C 3.0800 2.6673 0.0 0
M  V30 13 C 0.0000 2.6673 0.0 0
M  V30 14 C 2.3100 1.3336 0.0 0
M  V30 15 C 0.7700 1.3336 0.0 0
M  V30 16 C 6.1600 5.3347 0.0 0
M  V30 17 C 6.9300 6.6684 0.0 0
M  V30 18 C 6.9300 4.0011 0.0 0
M  V30 19 C 8.4700 6.6684 0.0 0
M  V30 20 C 8.4700 4.0011 0.0 0
M  V30 21 C 9.2400 5.3347 0.0 0
M  V30 22 C 3.0800 8.0021 0.0 0
M  V30 23 C 2.3100 9.3358 0.0 0
M  V30 24 C 4.6200 8.0021 0.0 0
M  V30 25 C 3.0800 10.6694 0.0 0
M  V30 26 C 5.3900 9.3358 0.0 0
M  V30 27 C 4.6200 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 2 16
M  V30 7 1 3 22
M  V30 8 1 6 11
M  V30 9 1 7 14
M  V30 10 1 8 23
M  V30 11 1 9 21
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-(2,5-difluorophenyl)-N-[[2-[3-(1-pyrrolidinyl)propoxy]phenyl]methy...
C26H27ClF2N2O3S
757930-56-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0023 5.3901 0.0 0
M  V30 3 S 5.3348 5.3901 0.0 0 VAL=6
M  V30 4 O 4.5648 4.0564 0.0 0
M  V30 5 O 6.1048 6.7238 0.0 0
M  V30 6 F 9.3360 3.0801 0.0 0
M  V30 7 F 4.0012 0.0000 0.0 0
M  V30 8 O 10.6697 6.9302 0.0 0
M  V30 9 C 12.0033 7.7002 0.0 0
M  V30 10 C 13.3372 6.9302 0.0 0
M  V30 11 C 14.6708 7.7002 0.0 0
M  V30 12 Cl 0.0000 8.4702 0.0 0
M  V30 13 C 6.6685 3.0801 0.0 0
M  V30 14 C 8.0023 2.3101 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 16 C 8.0023 0.7700 0.0 0
M  V30 17 C 5.3348 0.7700 0.0 0
M  V30 18 C 6.6685 0.0000 0.0 0
M  V30 19 C 8.0023 6.9302 0.0 0
M  V30 20 C 9.3360 7.7002 0.0 0
M  V30 21 C 6.6685 7.7002 0.0 0
M  V30 22 C 9.3360 9.2402 0.0 0
M  V30 23 C 6.6685 9.2402 0.0 0
M  V30 24 C 8.0023 10.0102 0.0 0
M  V30 25 C 4.0012 6.1601 0.0 0
M  V30 26 C 4.0012 7.7002 0.0 0
M  V30 27 C 2.6675 5.3901 0.0 0
M  V30 28 C 2.6675 8.4702 0.0 0
M  V30 29 C 1.3337 6.1601 0.0 0
M  V30 30 C 1.3337 7.7002 0.0 0
M  V30 31 N 16.0045 6.9302 0.0 0
M  V30 32 C 17.4115 7.5565 0.0 0
M  V30 33 C 16.1654 5.3986 0.0 0
M  V30 34 C 18.4419 6.4121 0.0 0
M  V30 35 C 17.6719 5.0784 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 19
M  V30 5 2 3 4
M  V30 6 2 3 5
M  V30 7 1 3 25
M  V30 8 1 6 14
M  V30 9 1 7 17
M  V30 10 1 8 9
M  V30 11 1 8 20
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 11 31
M  V30 15 1 12 30
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 627-18-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 290326-02-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 757930-56-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-008-CAS-322214
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM Mitsunobu reaction in stage 1, no experimental detail in stage 1, product
also isolated as HCl salt, analogs prepared similarly
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of sulfonamide derivatives as amyloid β production inhibitors
useful in treating or preventing diseases related to Aβ
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Smith, David W.; Munoz, Benito; Srinivasan, Kumar; Bergstrom, Carl P.;
Chaturvedula, Prasad V.; Deshpande, Milind S.; Keavy, Daniel J.; Lau, Wai
Yu; Parker, Michael F.; Sloan, Charles P.; Wallace, Owen B.; Wang, Henry
Hui
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000050391 A1 2000-08-31

$RFMT $RIREG SCHEME164 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Benzenediamine, N1-(2-chloro-5-fluoro-4-pyrimidinyl)-
C10H8ClFN4
2922209-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 4.6200 0.0 0
M  V30 2 F 1.3336 6.1600 0.0 0
M  V30 3 Cl 1.3336 0.0000 0.0 0
M  V30 4 N 9.3358 1.5400 0.0 0
M  V30 5 C 2.6674 3.8500 0.0 0
M  V30 6 C 1.3336 4.6200 0.0 0
M  V30 7 N 2.6674 2.3100 0.0 0
M  V30 8 C 0.0000 3.8500 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 N 0.0000 2.3100 0.0 0
M  V30 11 C 5.3347 3.8500 0.0 0
M  V30 12 C 6.6684 4.6200 0.0 0
M  V30 13 C 5.3347 2.3100 0.0 0
M  V30 14 C 8.0021 3.8500 0.0 0
M  V30 15 C 6.6684 1.5400 0.0 0
M  V30 16 C 8.0021 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 2 6
M  V30 4 1 3 9
M  V30 5 1 4 16
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Benzenediamine, N1-[5-fluoro-2-(1-pyrrolidinyl)-4-pyrimidinyl]-
C14H16FN5
2922209-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.4717 2.6675 0.0 0
M  V30 2 F 4.9317 0.0000 0.0 0
M  V30 3 N 9.5518 8.0022 0.0 0
M  V30 4 C 2.6217 4.0011 0.0 0
M  V30 5 N 4.1617 4.0011 0.0 0
M  V30 6 N 1.8517 2.6675 0.0 0
M  V30 7 C 4.9317 2.6675 0.0 0
M  V30 8 C 2.6217 1.3336 0.0 0
M  V30 9 C 4.1617 1.3336 0.0 0
M  V30 10 N 1.8517 5.3348 0.0 0
M  V30 11 C 2.4782 6.7417 0.0 0
M  V30 12 C 0.3202 5.4958 0.0 0
M  V30 13 C 1.3336 7.7721 0.0 0
M  V30 14 C 0.0000 7.0021 0.0 0
M  V30 15 C 7.2417 4.0011 0.0 0
M  V30 16 C 8.7818 4.0011 0.0 0
M  V30 17 C 6.4717 5.3348 0.0 0
M  V30 18 C 9.5518 5.3348 0.0 0
M  V30 19 C 7.2417 6.6686 0.0 0
M  V30 20 C 8.7818 6.6686 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 15
M  V30 3 1 2 9
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 10
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 9
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2922209-72-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2922209-74-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39885320
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and Biological Evaluation of the First Inhibitors of
Oncogenic CHD1L
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Prigaro, Brett J.; Esquer, Hector; Zhou, Qiong; Pike, Laura A.; Awolade,
Paul; Lai, Xin-He; Abraham, Adedoyin D.; Abbott, Joshua M.; Matter,
Brock; Kompella, Uday B.; Messersmith, Wells A.; Gustafson, Daniel L.;
LaBarbera, Daniel V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(5), 3943-3961

$RFMT $RIREG SCHEME165 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5a(3H)-Acenaphthyleneacetaldehyde, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-...
C23H40O2Si
2933872-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 1.4431 4.9215 0.0 0
M  V30 2 C 1.6561 6.4467 0.0 0
M  V30 3 O 0.4418 7.3938 0.0 0
M  V30 4 C 0.0000 4.2541 0.0 0
M  V30 5 C 3.7889 0.0000 0.0 0
M  V30 6 O 6.3109 6.3882 0.0 0
M  V30 7 Si 7.8509 6.3882 0.0 0
M  V30 8 C 9.3909 6.3882 0.0 0
M  V30 9 C 7.8509 4.8482 0.0 0
M  V30 10 C 7.8509 7.9282 0.0 0
M  V30 11 C 9.3909 7.9282 0.0 0
M  V30 12 C 10.9309 6.3882 0.0 0
M  V30 13 C 9.3909 4.8482 0.0 0
M  V30 14 C 6.9899 4.5330 0.0 0
M  V30 15 C 2.6576 3.9744 0.0 0 CFG=2
M  V30 16 C 3.8555 3.0401 0.0 0 CFG=1
M  V30 17 C 2.9257 5.5024 0.0 0
M  V30 18 C 1.2409 3.3423 0.0 0
M  V30 19 C 5.2820 3.5223 0.0 0 CFG=2
M  V30 20 C 3.7354 1.5391 0.0 0 CFG=1
M  V30 21 C 4.3653 6.0484 0.0 0
M  V30 22 C 1.0621 1.8129 0.0 0
M  V30 23 C 5.5409 5.0546 0.0 0 CFG=1
M  V30 24 C 6.1509 2.2250 0.0 0
M  V30 25 C 5.2052 1.0124 0.0 0
M  V30 26 C 2.3123 0.9148 0.0 0
M  V30 27 H 2.4458 2.4203 0.0 0
M  V30 28 H 6.7879 3.8454 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 4 18
M  V30 5 1 20 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 23 6 CFG=3
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 8 11
M  V30 12 1 8 12
M  V30 13 1 8 13
M  V30 14 1 23 14 CFG=1
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 1 16 20
M  V30 20 1 16 27 CFG=1
M  V30 21 1 17 21
M  V30 22 2 18 22
M  V30 23 1 19 23
M  V30 24 1 19 24
M  V30 25 1 19 28 CFG=3
M  V30 26 1 20 25
M  V30 27 1 20 26
M  V30 28 1 21 23
M  V30 29 1 22 26
M  V30 30 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 15 16 19 20 23)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1-[(1E)-2-[(2aS,3S,5aS,8aS,8bR)-3-[[(1,1-dimethylethyl)dimethyls...
C27H47NOSi
2933872-27-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.3435 4.9215 0.0 0
M  V30 2 C 3.5565 6.4467 0.0 0
M  V30 3 C 5.6892 0.0000 0.0 0
M  V30 4 C 1.9004 4.2541 0.0 0
M  V30 5 O 8.2113 6.3882 0.0 0
M  V30 6 Si 9.7513 6.3882 0.0 0
M  V30 7 C 11.2913 6.3882 0.0 0
M  V30 8 C 9.7513 7.9282 0.0 0
M  V30 9 C 9.7513 4.8482 0.0 0
M  V30 10 C 11.2913 4.8482 0.0 0
M  V30 11 C 12.8313 6.3882 0.0 0
M  V30 12 C 11.2913 7.9282 0.0 0
M  V30 13 C 8.8903 4.5330 0.0 0
M  V30 14 C 5.7559 3.0401 0.0 0 CFG=1
M  V30 15 C 4.5579 3.9744 0.0 0 CFG=2
M  V30 16 C 7.1824 3.5223 0.0 0 CFG=2
M  V30 17 C 5.6358 1.5391 0.0 0 CFG=1
M  V30 18 C 4.8261 5.5024 0.0 0
M  V30 19 C 3.1413 3.3423 0.0 0
M  V30 20 C 7.4413 5.0546 0.0 0 CFG=1
M  V30 21 C 8.0513 2.2250 0.0 0
M  V30 22 C 7.1056 1.0124 0.0 0
M  V30 23 C 4.2127 0.9148 0.0 0
M  V30 24 C 6.2656 6.0484 0.0 0
M  V30 25 C 2.9625 1.8129 0.0 0
M  V30 26 N 2.3422 7.3938 0.0 0
M  V30 27 C 0.8622 6.9680 0.0 0
M  V30 28 C 2.3945 8.9329 0.0 0
M  V30 29 C 0.0000 8.2441 0.0 0
M  V30 30 C 0.9471 9.4584 0.0 0
M  V30 31 H 4.3462 2.4203 0.0 0
M  V30 32 H 8.6882 3.8454 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 15 1 CFG=3
M  V30 3 1 2 26
M  V30 4 1 17 3 CFG=3
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 1 20 5 CFG=3
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 1 20 13 CFG=1
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 31 CFG=1
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 1 16 20
M  V30 22 1 16 21
M  V30 23 1 16 32 CFG=3
M  V30 24 1 17 22
M  V30 25 1 17 23
M  V30 26 1 18 24
M  V30 27 2 19 25
M  V30 28 1 20 24
M  V30 29 1 21 22
M  V30 30 1 23 25
M  V30 31 1 26 27
M  V30 32 1 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 14 15 16 17 20)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2933872-25-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2933872-27-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37110195
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, molecular sieves used,no experimental detail
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Syntheses of Wickerols A and B
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chung, Jonathan; Capani, Joseph S. Jr.; Gohl, Matthias; Roosen, Philipp
C.; Vanderwal, Christopher D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2023), 145(11), 6486-6497

$RFMT $RIREG SCHEME166 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylformamide dimethyl acetal
C5H13NO2
4637-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C8H6D3NO3
2939743-59-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 O 6.6685 1.5400 0.0 0
M  V30 6 C 8.0023 2.3101 0.0 0
M  V30 7 C 2.6675 2.3101 0.0 0
M  V30 8 C 4.0012 1.5400 0.0 0
M  V30 9 C 2.6675 3.8501 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 H 9.3360 1.5400 0.0 0 MASS=2
M  V30 14 H 9.3360 3.0801 0.0 0 MASS=2
M  V30 15 H 8.0023 3.8501 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 1 5 6
M  V30 6 1 5 10
M  V30 7 1 6 13
M  V30 8 1 6 14
M  V30 9 1 6 15
M  V30 10 2 7 8
M  V30 11 1 7 9
M  V30 12 1 8 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C13H13D3N2O3
2939743-60-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 4.0011 0.0 0
M  V30 2 C 3.9098 5.3347 0.0 0
M  V30 3 N 6.2198 1.3338 0.0 0 VAL=5
M  V30 4 O 6.9898 0.0000 0.0 0
M  V30 5 O 4.6798 1.3338 0.0 0
M  V30 6 O 10.8398 4.0011 0.0 0
M  V30 7 C 11.6098 5.3347 0.0 0
M  V30 8 C 6.2198 4.0011 0.0 0
M  V30 9 C 6.9898 2.6674 0.0 0
M  V30 10 C 6.9898 5.3347 0.0 0
M  V30 11 C 8.5298 2.6674 0.0 0
M  V30 12 C 8.5298 5.3347 0.0 0
M  V30 13 C 9.2998 4.0011 0.0 0
M  V30 14 N 2.3698 5.3347 0.0 0
M  V30 15 C 1.4645 6.5807 0.0 0
M  V30 16 C 1.4645 4.0889 0.0 0
M  V30 17 C 0.0000 6.1047 0.0 0
M  V30 18 C 0.0000 4.5647 0.0 0
M  V30 19 H 10.8398 6.6685 0.0 0 MASS=2
M  V30 20 H 12.3798 6.6685 0.0 0 MASS=2
M  V30 21 H 13.1498 5.3347 0.0 0 MASS=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 1 6 7
M  V30 8 1 6 13
M  V30 9 1 7 19
M  V30 10 1 7 20
M  V30 11 1 7 21
M  V30 12 2 8 9
M  V30 13 1 8 10
M  V30 14 1 9 11
M  V30 15 2 10 12
M  V30 16 2 11 13
M  V30 17 1 12 13
M  V30 18 1 14 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4637-24-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 2939743-59-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2939743-60-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-36815880
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Analogs of 6-methoxy- N, N-dimethyltryptamine for debilitating
neuropsychiatric diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duncton, Matthew; Clark, Samuel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2023108174 A1 2023-06-15

$RFMT $RIREG SCHEME167 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethyl)benzenesulfonyl chloride
C7H4ClF3O2S
2991-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 F 1.5400 0.0000 0.0 0
M  V30 3 F 0.0000 1.5400 0.0 0
M  V30 4 F 1.5400 3.0800 0.0 0
M  V30 5 S 7.7000 1.5400 0.0 0 VAL=6
M  V30 6 Cl 9.2400 1.5400 0.0 0
M  V30 7 O 7.7000 0.0000 0.0 0
M  V30 8 O 7.7000 3.0800 0.0 0
M  V30 9 C 3.0800 1.5400 0.0 0
M  V30 10 C 3.8500 0.2064 0.0 0
M  V30 11 C 3.8500 2.8736 0.0 0
M  V30 12 C 5.3900 0.2064 0.0 0
M  V30 13 C 5.3900 2.8736 0.0 0
M  V30 14 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 9
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[[4-(Trifluoromethyl)phenyl]sulfonyl]pyrrolidine
C11H12F3NO2S
1455280-81-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.9098 1.5400 0.0 0 VAL=6
M  V30 2 O 3.9098 3.0800 0.0 0
M  V30 3 O 3.9098 0.0000 0.0 0
M  V30 4 C 10.0698 1.5400 0.0 0
M  V30 5 F 10.0698 3.0800 0.0 0
M  V30 6 F 11.6098 1.5400 0.0 0
M  V30 7 F 10.0698 0.0000 0.0 0
M  V30 8 C 5.4498 1.5400 0.0 0
M  V30 9 C 6.2198 0.2064 0.0 0
M  V30 10 C 6.2198 2.8736 0.0 0
M  V30 11 C 7.7598 0.2064 0.0 0
M  V30 12 C 7.7598 2.8736 0.0 0
M  V30 13 C 8.5298 1.5400 0.0 0
M  V30 14 N 2.3698 1.5400 0.0 0
M  V30 15 C 1.4645 2.7859 0.0 0
M  V30 16 C 1.4645 0.2941 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 18 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 1 14
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2991-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1455280-81-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-18010449
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective Single C(sp3)-F Bond Cleavage in Trifluoromethylarenes: Merging
Visible-Light Catalysis with Lewis Acid Activation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chen, Kang; Berg, Nele; Gschwind, Ruth; Koenig, Burkhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(51), 18444-18447

$RFMT $RIREG SCHEME168 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Pyrrolo[2,3-c]pyridin-7-one, 3,4-dichloro-6,7-dihydro-2-[[(methylsulfonyl)...
C30H37Cl2N5O5SSi
3038777-85-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 19.0940 6.6245 0.0 0
M  V30 2 O 9.0935 4.6647 0.0 0
M  V30 3 Cl 9.0935 10.8248 0.0 0
M  V30 4 C 5.8193 5.0343 0.0 0
M  V30 5 O 4.3130 4.7140 0.0 0
M  V30 6 C 3.8371 3.2494 0.0 0
M  V30 7 C 2.3307 2.9293 0.0 0
M  V30 8 Si 1.8548 1.4646 0.0 0
M  V30 9 C 1.3789 0.0000 0.0 0
M  V30 10 C 0.3902 1.9404 0.0 0
M  V30 11 C 3.3195 0.9887 0.0 0
M  V30 12 Cl 5.8193 10.4553 0.0 0
M  V30 13 C 3.8500 7.7447 0.0 0
M  V30 14 O 3.0800 9.0785 0.0 0
M  V30 15 S 1.5400 9.0785 0.0 0 VAL=6
M  V30 16 C 1.5400 10.6186 0.0 0
M  V30 17 O 0.0000 9.0785 0.0 0
M  V30 18 O 1.5400 7.5385 0.0 0
M  V30 19 C 15.7621 6.9747 0.0 0
M  V30 20 C 14.9920 8.3085 0.0 0
M  V30 21 C 17.0957 7.7447 0.0 0
M  V30 22 C 16.3257 9.0785 0.0 0
M  V30 23 C 17.4146 10.1675 0.0 0
M  V30 24 C 15.9271 10.5660 0.0 0
M  V30 25 C 14.4282 6.2047 0.0 0
M  V30 26 C 13.0946 6.9747 0.0 0
M  V30 27 C 14.4282 4.6647 0.0 0
M  V30 28 C 11.7609 6.2047 0.0 0
M  V30 29 C 13.0946 3.8947 0.0 0
M  V30 30 C 11.7609 4.6647 0.0 0
M  V30 31 C 16.5321 5.6411 0.0 0
M  V30 32 N 18.0636 5.4801 0.0 0
M  V30 33 N 15.9056 4.2343 0.0 0
M  V30 34 C 18.3838 3.9737 0.0 0
M  V30 35 N 17.0501 3.2037 0.0 0
M  V30 36 N 10.4273 6.9747 0.0 0
M  V30 37 C 9.0935 6.2047 0.0 0
M  V30 38 C 10.4273 8.5147 0.0 0
M  V30 39 C 7.7598 6.9747 0.0 0
M  V30 40 C 9.0935 9.2847 0.0 0
M  V30 41 C 7.7598 8.5147 0.0 0
M  V30 42 N 6.2953 6.4989 0.0 0
M  V30 43 C 6.2953 8.9908 0.0 0
M  V30 44 C 5.3901 7.7447 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 32
M  V30 2 2 2 37
M  V30 3 1 3 40
M  V30 4 1 4 5
M  V30 5 1 4 42
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 43
M  V30 13 1 13 14
M  V30 14 1 13 44
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 2 15 17
M  V30 18 2 15 18
M  V30 19 1 19 20
M  V30 20 1 19 21
M  V30 21 1 19 25
M  V30 22 1 19 31
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 28 2 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 29
M  V30 32 2 28 30
M  V30 33 1 28 36
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 2 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 35
M  V30 40 1 36 37
M  V30 41 1 36 38
M  V30 42 1 37 39
M  V30 43 2 38 40
M  V30 44 2 39 41
M  V30 45 1 39 42
M  V30 46 1 40 41
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 2 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7H-Pyrrolo[2,3-c]pyridin-7-one, 3,4-dichloro-1,6-dihydro-6-[3-[5-(4-methyl-4H...
C33H42Cl2N6O2Si
3038777-87-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 18.7037 6.6247 0.0 0
M  V30 2 O 8.7034 4.6648 0.0 0
M  V30 3 Cl 8.7034 10.8249 0.0 0
M  V30 4 C 5.4292 5.0343 0.0 0
M  V30 5 O 3.9227 4.7141 0.0 0
M  V30 6 C 3.4469 3.2494 0.0 0
M  V30 7 C 1.9404 2.9293 0.0 0
M  V30 8 Si 1.4646 1.4647 0.0 0
M  V30 9 C 0.9887 0.0000 0.0 0
M  V30 10 C 0.0000 1.9406 0.0 0
M  V30 11 C 2.9293 0.9888 0.0 0
M  V30 12 C 3.4598 7.7449 0.0 0
M  V30 13 Cl 5.4292 10.4554 0.0 0
M  V30 14 C 15.3718 6.9749 0.0 0
M  V30 15 C 14.6018 8.3085 0.0 0
M  V30 16 C 16.7054 7.7449 0.0 0
M  V30 17 C 15.9354 9.0785 0.0 0
M  V30 18 C 17.0244 10.1675 0.0 0
M  V30 19 C 15.5369 10.5660 0.0 0
M  V30 20 C 14.0381 6.2049 0.0 0
M  V30 21 C 12.7043 6.9749 0.0 0
M  V30 22 C 14.0381 4.6648 0.0 0
M  V30 23 C 11.3707 6.2049 0.0 0
M  V30 24 C 12.7043 3.8948 0.0 0
M  V30 25 C 11.3707 4.6648 0.0 0
M  V30 26 C 16.1418 5.6412 0.0 0
M  V30 27 N 17.6733 5.4801 0.0 0
M  V30 28 N 15.5153 4.2343 0.0 0
M  V30 29 C 17.9935 3.9738 0.0 0
M  V30 30 N 16.6598 3.2038 0.0 0
M  V30 31 N 10.0370 6.9749 0.0 0
M  V30 32 C 8.7034 6.2049 0.0 0
M  V30 33 C 10.0370 8.5149 0.0 0
M  V30 34 C 7.3696 6.9749 0.0 0
M  V30 35 C 8.7034 9.2849 0.0 0
M  V30 36 N 5.9050 6.4990 0.0 0
M  V30 37 C 7.3696 8.5149 0.0 0
M  V30 38 C 4.9998 7.7449 0.0 0
M  V30 39 C 5.9050 8.9907 0.0 0
M  V30 40 N 2.6898 9.0785 0.0 0
M  V30 41 C 1.1582 9.2395 0.0 0
M  V30 42 C 3.3161 10.4855 0.0 0
M  V30 43 C 0.8381 10.7459 0.0 0
M  V30 44 C 2.1717 11.5159 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 27
M  V30 2 2 2 32
M  V30 3 1 3 35
M  V30 4 1 4 5
M  V30 5 1 4 36
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 38
M  V30 13 1 12 40
M  V30 14 1 13 39
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20
M  V30 18 1 14 26
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 23 31
M  V30 30 1 24 25
M  V30 31 1 26 27
M  V30 32 2 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 30
M  V30 36 1 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 1 34 36
M  V30 41 2 34 37
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 2 38 39
M  V30 46 1 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3038777-85-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3038777-87-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40752124
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted bicyclic pyridone derivatives as CBL-B
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bock, William Jeremy; Cho-Schultz, Sujin; Deal, Judith Gail; Donaldson,
Joyann Susan; Jalaie, Mehran; Jeffreys, Matthew Scott; Kaiser, Stephen
Elliott; Kath, John Charles; Montgomery, Timothy Patrick; Nair, Sajiv
Krishnan; Patman, Ryan Lloyd; Tran, Khanh Tuan; Wisniewska, Hanna Maria;
Zhou, Ru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024105563 A1 2024-05-23

$RFMT $RIREG SCHEME169 STEP1
$RXN



  2  1
$MOL
7H-Pyrrolo[2,3-c]pyridin-7-one, 4-chloro-3-fluoro-1,6-dihydro-2-(hydroxymethy...
C29H35ClFN5O3Si
3038777-99-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 45 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 6.6245 0.0 0
M  V30 2 O 10.0004 4.6647 0.0 0
M  V30 3 Cl 10.0004 10.8248 0.0 0
M  V30 4 C 13.2746 5.0343 0.0 0
M  V30 5 O 14.7811 4.7140 0.0 0
M  V30 6 C 15.2569 3.2494 0.0 0
M  V30 7 C 16.7634 2.9293 0.0 0
M  V30 8 Si 17.2392 1.4646 0.0 0
M  V30 9 C 17.7151 0.0000 0.0 0
M  V30 10 C 15.7745 0.9887 0.0 0
M  V30 11 C 18.7038 1.9404 0.0 0
M  V30 12 F 13.2746 10.4553 0.0 0
M  V30 13 C 15.2440 7.7447 0.0 0
M  V30 14 O 16.0140 9.0785 0.0 0
M  V30 15 C 3.3320 6.9747 0.0 0
M  V30 16 C 1.9983 7.7447 0.0 0
M  V30 17 C 4.1020 8.3085 0.0 0
M  V30 18 C 2.7683 9.0785 0.0 0
M  V30 19 C 3.1669 10.5660 0.0 0
M  V30 20 C 1.6794 10.1675 0.0 0
M  V30 21 C 4.6656 6.2047 0.0 0
M  V30 22 C 5.9994 6.9747 0.0 0
M  V30 23 C 4.6656 4.6647 0.0 0
M  V30 24 C 7.3331 6.2047 0.0 0
M  V30 25 C 5.9994 3.8947 0.0 0
M  V30 26 C 7.3331 4.6647 0.0 0
M  V30 27 C 2.5620 5.6411 0.0 0
M  V30 28 N 3.1884 4.2343 0.0 0
M  V30 29 N 1.0304 5.4801 0.0 0
M  V30 30 N 2.0439 3.2037 0.0 0
M  V30 31 C 0.7103 3.9737 0.0 0
M  V30 32 N 8.6667 6.9747 0.0 0
M  V30 33 C 10.0004 6.2047 0.0 0
M  V30 34 C 8.6667 8.5147 0.0 0
M  V30 35 C 11.3342 6.9747 0.0 0
M  V30 36 C 10.0004 9.2847 0.0 0
M  V30 37 C 11.3342 8.5147 0.0 0
M  V30 38 N 12.7988 6.4989 0.0 0
M  V30 39 C 12.7988 8.9908 0.0 0
M  V30 40 C 13.7040 7.7447 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 29
M  V30 2 2 2 33
M  V30 3 1 3 36
M  V30 4 1 4 5
M  V30 5 1 4 38
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 39
M  V30 13 1 13 14
M  V30 14 1 13 40
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 21
M  V30 18 1 15 27
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 24 32
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 31
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 35 38
M  V30 42 1 36 37
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 40
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7H-Pyrrolo[2,3-c]pyridin-7-one, 4-chloro-3-fluoro-1,6-dihydro-6-[3-[5-(4-meth...
C33H42ClFN6O2Si
3038778-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  44 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 18.7037 6.6247 0.0 0
M  V30 2 O 8.7034 4.6648 0.0 0
M  V30 3 Cl 8.7034 10.8249 0.0 0
M  V30 4 C 5.4292 5.0343 0.0 0
M  V30 5 O 3.9227 4.7141 0.0 0
M  V30 6 C 3.4469 3.2494 0.0 0
M  V30 7 C 1.9404 2.9293 0.0 0
M  V30 8 Si 1.4646 1.4647 0.0 0
M  V30 9 C 0.9887 0.0000 0.0 0
M  V30 10 C 0.0000 1.9406 0.0 0
M  V30 11 C 2.9293 0.9888 0.0 0
M  V30 12 C 3.4598 7.7449 0.0 0
M  V30 13 F 5.4292 10.4554 0.0 0
M  V30 14 C 15.3718 6.9749 0.0 0
M  V30 15 C 14.6018 8.3085 0.0 0
M  V30 16 C 16.7054 7.7449 0.0 0
M  V30 17 C 15.9354 9.0785 0.0 0
M  V30 18 C 17.0244 10.1675 0.0 0
M  V30 19 C 15.5369 10.5660 0.0 0
M  V30 20 C 14.0381 6.2049 0.0 0
M  V30 21 C 12.7043 6.9749 0.0 0
M  V30 22 C 14.0381 4.6648 0.0 0
M  V30 23 C 11.3707 6.2049 0.0 0
M  V30 24 C 12.7043 3.8948 0.0 0
M  V30 25 C 11.3707 4.6648 0.0 0
M  V30 26 C 16.1418 5.6412 0.0 0
M  V30 27 N 17.6733 5.4801 0.0 0
M  V30 28 N 15.5153 4.2343 0.0 0
M  V30 29 C 17.9935 3.9738 0.0 0
M  V30 30 N 16.6598 3.2038 0.0 0
M  V30 31 N 10.0370 6.9749 0.0 0
M  V30 32 C 8.7034 6.2049 0.0 0
M  V30 33 C 10.0370 8.5149 0.0 0
M  V30 34 C 7.3696 6.9749 0.0 0
M  V30 35 C 8.7034 9.2849 0.0 0
M  V30 36 N 5.9050 6.4990 0.0 0
M  V30 37 C 7.3696 8.5149 0.0 0
M  V30 38 C 4.9998 7.7449 0.0 0
M  V30 39 C 5.9050 8.9907 0.0 0
M  V30 40 N 2.6898 9.0785 0.0 0
M  V30 41 C 1.1582 9.2395 0.0 0
M  V30 42 C 3.3161 10.4855 0.0 0
M  V30 43 C 0.8381 10.7459 0.0 0
M  V30 44 C 2.1717 11.5159 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 27
M  V30 2 2 2 32
M  V30 3 1 3 35
M  V30 4 1 4 5
M  V30 5 1 4 36
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 12 38
M  V30 13 1 12 40
M  V30 14 1 13 39
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 20
M  V30 18 1 14 26
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 1 17 18
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 23 31
M  V30 30 1 24 25
M  V30 31 1 26 27
M  V30 32 2 26 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 2 29 30
M  V30 36 1 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 1 34 36
M  V30 41 2 34 37
M  V30 42 1 35 37
M  V30 43 1 36 38
M  V30 44 1 37 39
M  V30 45 2 38 39
M  V30 46 1 40 41
M  V30 47 1 40 42
M  V30 48 1 41 43
M  V30 49 1 42 44
M  V30 50 1 43 44
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3038777-99-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3038778-00-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40752149
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7143-01-3
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of DIPEA and mesic anhydride in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted bicyclic pyridone derivatives as CBL-B
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bock, William Jeremy; Cho-Schultz, Sujin; Deal, Judith Gail; Donaldson,
Joyann Susan; Jalaie, Mehran; Jeffreys, Matthew Scott; Kaiser, Stephen
Elliott; Kath, John Charles; Montgomery, Timothy Patrick; Nair, Sajiv
Krishnan; Patman, Ryan Lloyd; Tran, Khanh Tuan; Wisniewska, Hanna Maria;
Zhou, Ru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024105563 A1 2024-05-23

$RFMT $RIREG SCHEME170 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-(3-nitrophenyl)butanamide
C10H11ClN2O3
304684-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 O 8.0022 3.8501 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 C 12.0033 1.5400 0.0 0
M  V30 7 Cl 13.3370 2.3101 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 O 1.3337 0.0000 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 4.0010 1.5400 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 C 4.0010 4.6201 0.0 0
M  V30 16 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Nitrophenyl)-1-pyrrolidinebutanamide
C14H19N3O3
851651-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 1.5400 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 O 8.0023 3.8501 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 C 12.0035 1.5400 0.0 0
M  V30 7 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6675 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6675 3.8501 0.0 0
M  V30 16 N 13.3372 2.3101 0.0 0
M  V30 17 C 14.7440 1.6837 0.0 0
M  V30 18 C 13.4981 3.8416 0.0 0
M  V30 19 C 15.7746 2.8281 0.0 0
M  V30 20 C 15.0045 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 13
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 304684-54-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 851651-88-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12525485
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Click chemistry assembly of G-quadruplex ligands incorporating a
diarylurea scaffold and triazole linkers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Drewe, William C.; Neidle, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2008), (42),
5295-5297

$RFMT $RIREG SCHEME171 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(3aR,7R,7aS)-3a-Chloro-5-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-...
C35H39ClO5Si
310889-32-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 46 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.0010 8.0408 0.0 0
M  V30 2 O 5.3348 7.2708 0.0 0
M  V30 3 C 4.7710 9.3746 0.0 0
M  V30 4 C 5.3348 5.7308 0.0 0
M  V30 5 C 3.4374 10.1447 0.0 0
M  V30 6 C 5.5410 10.7083 0.0 0
M  V30 7 C 6.1048 8.6046 0.0 0
M  V30 8 C 6.1418 1.9737 0.0 0
M  V30 9 C 5.1519 3.6882 0.0 0
M  V30 10 Cl 6.7563 1.7456 0.0 0
M  V30 11 O 10.6697 5.7308 0.0 0
M  V30 12 C 10.6697 7.2708 0.0 0
M  V30 13 C 10.7428 4.0472 0.0 0
M  V30 14 O 7.2919 0.0000 0.0 0
M  V30 15 O 11.9867 2.7105 0.0 0
M  V30 16 C 2.6673 8.8108 0.0 0
M  V30 17 C 2.6673 10.3509 0.0 0
M  V30 18 C 1.3337 8.0408 0.0 0
M  V30 19 C 1.3337 11.1209 0.0 0
M  V30 20 C 0.0000 8.8108 0.0 0
M  V30 21 C 0.0000 10.3509 0.0 0
M  V30 22 C 3.2310 6.7072 0.0 0
M  V30 23 C 4.0010 5.3735 0.0 0
M  V30 24 C 1.6910 6.7072 0.0 0
M  V30 25 C 3.2310 4.0398 0.0 0
M  V30 26 C 0.9209 5.3735 0.0 0
M  V30 27 C 1.6910 4.0398 0.0 0
M  V30 28 C 6.6685 4.9608 0.0 0
M  V30 29 C 6.6685 3.4207 0.0 0
M  V30 30 C 8.0022 5.7308 0.0 0
M  V30 31 C 8.0022 2.6507 0.0 0 CFG=2
M  V30 32 C 9.3358 4.9608 0.0 0 CFG=2
M  V30 33 C 9.3358 3.4207 0.0 0 CFG=2
M  V30 34 C 8.3223 1.1444 0.0 0
M  V30 35 C 10.4804 2.3903 0.0 0
M  V30 36 O 9.8539 0.9835 0.0 0
M  V30 37 C 12.0033 8.0408 0.0 0
M  V30 38 C 12.0033 9.5809 0.0 0
M  V30 39 C 13.3370 7.2708 0.0 0
M  V30 40 C 13.3370 10.3509 0.0 0
M  V30 41 C 14.6707 8.0408 0.0 0
M  V30 42 C 14.6707 9.5809 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 16
M  V30 4 1 1 22
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 28
M  V30 10 1 8 29
M  V30 11 1 9 29
M  V30 12 1 31 10 CFG=1
M  V30 13 1 11 12
M  V30 14 1 32 11 CFG=3
M  V30 15 1 12 37
M  V30 16 1 33 13 CFG=1
M  V30 17 2 14 34
M  V30 18 2 15 35
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 1 28 29
M  V30 32 2 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 31 34
M  V30 37 1 32 33
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 41 2 37 38
M  V30 42 1 37 39
M  V30 43 1 38 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 42
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(3 31 32 33)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[5-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-2,6,6-trimethyl-3-(phenylm...
C38H47NO3Si
310889-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  43 47 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 4.0012 10.0102 0.0 0
M  V30 2 O 5.3348 9.2402 0.0 0
M  V30 3 C 3.2311 8.6764 0.0 0
M  V30 4 C 6.6687 10.0102 0.0 0
M  V30 5 C 1.8975 9.4464 0.0 0
M  V30 6 C 2.4611 7.3427 0.0 0
M  V30 7 C 4.5648 7.9064 0.0 0
M  V30 8 C 10.3259 11.1899 0.0 0
M  V30 9 C 8.3461 11.1899 0.0 0
M  V30 10 C 12.0035 10.0102 0.0 0
M  V30 11 O 12.0035 11.5503 0.0 0
M  V30 12 O 9.3360 5.3901 0.0 0
M  V30 13 C 8.0023 4.6201 0.0 0
M  V30 14 C 12.0035 6.9302 0.0 0
M  V30 15 C 2.6675 10.7802 0.0 0
M  V30 16 C 1.3338 10.0102 0.0 0
M  V30 17 C 2.6675 12.3203 0.0 0
M  V30 18 C 0.0000 10.7802 0.0 0
M  V30 19 C 1.3338 13.0903 0.0 0
M  V30 20 C 0.0000 12.3203 0.0 0
M  V30 21 C 4.7712 11.3439 0.0 0
M  V30 22 C 6.3112 11.3439 0.0 0
M  V30 23 C 4.0012 12.6776 0.0 0
M  V30 24 C 7.0812 12.6776 0.0 0
M  V30 25 C 4.7712 14.0112 0.0 0
M  V30 26 C 6.3112 14.0112 0.0 0
M  V30 27 C 8.0023 9.2402 0.0 0
M  V30 28 C 9.3360 10.0102 0.0 0
M  V30 29 C 8.0023 7.7002 0.0 0
M  V30 30 C 10.6697 9.2402 0.0 0
M  V30 31 C 9.3360 6.9302 0.0 0
M  V30 32 C 10.6697 7.7002 0.0 0
M  V30 33 N 13.3372 9.2402 0.0 0
M  V30 34 C 14.7440 9.8665 0.0 0
M  V30 35 C 13.4981 7.7085 0.0 0
M  V30 36 C 15.7746 8.7221 0.0 0
M  V30 37 C 15.0045 7.3883 0.0 0
M  V30 38 C 8.0023 3.0801 0.0 0
M  V30 39 C 9.3360 2.3101 0.0 0
M  V30 40 C 6.6687 2.3101 0.0 0
M  V30 41 C 9.3360 0.7700 0.0 0
M  V30 42 C 6.6687 0.7700 0.0 0
M  V30 43 C 8.0023 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 15
M  V30 4 1 1 21
M  V30 5 1 2 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 4 27
M  V30 10 1 8 28
M  V30 11 1 9 28
M  V30 12 2 10 11
M  V30 13 1 10 30
M  V30 14 1 10 33
M  V30 15 1 12 13
M  V30 16 1 12 31
M  V30 17 1 13 38
M  V30 18 1 14 32
M  V30 19 2 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 1 27 28
M  V30 32 2 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 37
M  V30 42 2 38 39
M  V30 43 1 38 40
M  V30 44 1 39 41
M  V30 45 2 40 42
M  V30 46 2 41 43
M  V30 47 1 42 43
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 310889-32-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 310889-34-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-11282928
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7226-23-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Paclitaxel synthetic studies. A Diels-Alder approach to the A-ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Carballares, Santiago; Craig, Donald; Lane, Charlotte A. L.; Mitchell,
William P.; MacKenzie, A. Roderick; Wood, Anthony
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge) (2000), (18), 1767-1768

$RFMT $RIREG SCHEME172 STEP1
$RXN



  3  1
$MOL
3-Bromobenzaldehyde
C7H5BrO
3132-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0801 0.0 0
M  V30 2 O 6.6687 2.3101 0.0 0
M  V30 3 Br 0.0000 3.0801 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 0.7700 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 9 C 1.3338 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[[(4-Hydroxyphenyl)methyl]thio]-4(5H)-thiazolone
C10H9NO2S2
851428-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.1556 1.6752 0.0 0
M  V30 2 C 5.9256 3.0089 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 O 12.0857 3.0089 0.0 0
M  V30 5 C 3.6156 1.6752 0.0 0
M  V30 6 S 2.7104 2.9211 0.0 0
M  V30 7 N 2.7104 0.4294 0.0 0
M  V30 8 C 1.2459 2.4452 0.0 0
M  V30 9 C 1.2459 0.9052 0.0 0
M  V30 10 C 7.4657 3.0089 0.0 0
M  V30 11 C 8.2357 4.3425 0.0 0
M  V30 12 C 8.2357 1.6752 0.0 0
M  V30 13 C 9.7757 4.3425 0.0 0
M  V30 14 C 9.7757 1.6752 0.0 0
M  V30 15 C 10.5457 3.0089 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 10
M  V30 4 2 3 9
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5Z)-5-[(3-Bromophenyl)methylene]-2-(1-pyrrolidinyl)-4(5H)-thiazolone
C14H13BrN2OS
851428-80-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.5257 2.7106 0.0 0
M  V30 2 O 5.5563 0.0000 0.0 0
M  V30 3 Br 12.1457 5.3778 0.0 0
M  V30 4 C 3.6158 3.4806 0.0 0
M  V30 5 S 5.0805 3.9564 0.0 0
M  V30 6 N 3.6158 1.9406 0.0 0
M  V30 7 C 5.9857 2.7106 0.0 0
M  V30 8 C 5.0805 1.4647 0.0 0
M  V30 9 N 2.3699 4.3858 0.0 0
M  V30 10 C 2.3699 5.9258 0.0 0
M  V30 11 C 0.9052 3.9099 0.0 0
M  V30 12 C 0.9052 6.4016 0.0 0
M  V30 13 C 0.0000 5.1558 0.0 0
M  V30 14 C 8.2957 4.0442 0.0 0
M  V30 15 C 9.8357 4.0442 0.0 0
M  V30 16 C 7.5257 5.3778 0.0 0
M  V30 17 C 10.6057 5.3778 0.0 0
M  V30 18 C 8.2957 6.7116 0.0 0
M  V30 19 C 9.8357 6.7116 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 1 14
M  V30 3 2 2 8
M  V30 4 1 3 17
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 9
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 3132-99-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 851428-65-4
$DTYPE RXN:RCT(2):AMD
$DATUM Wang resin-supported
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 851428-80-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-333-CAS-4529469
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-89-8
$DTYPE RXN:VAR(1):NOTES
$DATUM Knoevenagel condensation stage 1, solid-supported reactant
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Traceless solid-phase synthesis of 2-amino-5-alkylidene-thiazol-4-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pulici, Maurizio; Quartieri, Francesca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2005), 46(14), 2387-2391

$RFMT $RIREG SCHEME173 STEP1
$RXN



  3  1
$MOL
Triphosgene
C3Cl6O3
32315-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.5637 0.0 0
M  V30 2 C 6.6687 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 8.0023 2.1037 0.0 0
M  V30 5 Cl 5.8986 2.6673 0.0 0
M  V30 6 Cl 7.4387 0.0000 0.0 0
M  V30 7 O 2.6675 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 Cl 0.0000 2.1037 0.0 0
M  V30 11 Cl 2.1037 2.6673 0.0 0
M  V30 12 Cl 0.5637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-[(phenylamino)methyl]-, methyl ester
C15H15NO2
39126-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5503 2.6673 0.0 0
M  V30 2 O 12.3203 4.0010 0.0 0
M  V30 3 O 12.3203 1.3337 0.0 0
M  V30 4 C 13.8603 4.0010 0.0 0
M  V30 5 C 5.3901 2.6673 0.0 0
M  V30 6 N 4.6201 1.3337 0.0 0
M  V30 7 C 10.0102 2.6673 0.0 0
M  V30 8 C 9.2402 1.3337 0.0 0
M  V30 9 C 9.2402 4.0010 0.0 0
M  V30 10 C 7.7002 1.3337 0.0 0
M  V30 11 C 7.7002 4.0010 0.0 0
M  V30 12 C 6.9302 2.6673 0.0 0
M  V30 13 C 3.0801 1.3337 0.0 0
M  V30 14 C 2.3101 0.0000 0.0 0
M  V30 15 C 2.3101 2.6673 0.0 0
M  V30 16 C 0.7700 0.0000 0.0 0
M  V30 17 C 0.7700 2.6673 0.0 0
M  V30 18 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 1 6 13
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[[phenyl(1-pyrrolidinylcarbonyl)amino]methyl]benzoate
C20H22N2O3
2080358-46-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.1618 4.0012 0.0 0
M  V30 2 C 2.6218 4.0012 0.0 0
M  V30 3 C 4.9318 5.3348 0.0 0
M  V30 4 O 1.8517 2.6675 0.0 0
M  V30 5 C 11.0919 5.3348 0.0 0
M  V30 6 O 11.8620 6.6685 0.0 0
M  V30 7 O 11.8620 4.0012 0.0 0
M  V30 8 C 13.4020 6.6685 0.0 0
M  V30 9 C 4.9318 2.6675 0.0 0
M  V30 10 C 4.1618 1.3337 0.0 0
M  V30 11 C 6.4718 2.6675 0.0 0
M  V30 12 C 4.9318 0.0000 0.0 0
M  V30 13 C 7.2419 1.3337 0.0 0
M  V30 14 C 6.4718 0.0000 0.0 0
M  V30 15 N 1.8517 5.3348 0.0 0
M  V30 16 C 2.4782 6.7418 0.0 0
M  V30 17 C 0.3202 5.4958 0.0 0
M  V30 18 C 1.3337 7.7722 0.0 0
M  V30 19 C 0.0000 7.0022 0.0 0
M  V30 20 C 6.4718 5.3348 0.0 0
M  V30 21 C 7.2419 6.6685 0.0 0
M  V30 22 C 7.2419 4.0012 0.0 0
M  V30 23 C 8.7819 6.6685 0.0 0
M  V30 24 C 8.7819 4.0012 0.0 0
M  V30 25 C 9.5519 5.3348 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 3 20
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 5 25
M  V30 10 1 6 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39126-16-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2080358-46-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-17404531
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of oxadiazole derivatives for use as histone deacetylase 6
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Jaekwang; Kim, Yuntae; Lee, Chang Sik; Song, Hyeseung; Gwak,
Dal-Yong; Lee, Jaeyoung; Oh, Jung Taek; Lee, Chang Gon; Kim, Hyang, II
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017023133 A2 2017-02-09

$RFMT $RIREG SCHEME174 STEP1
$RXN



  3  1
$MOL
Triphosgene
C3Cl6O3
32315-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.5637 0.0 0
M  V30 2 C 6.6687 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 8.0023 2.1037 0.0 0
M  V30 5 Cl 5.8986 2.6673 0.0 0
M  V30 6 Cl 7.4387 0.0000 0.0 0
M  V30 7 O 2.6675 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 Cl 0.0000 2.1037 0.0 0
M  V30 11 Cl 2.1037 2.6673 0.0 0
M  V30 12 Cl 0.5637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(1R,2S)-1-Phenyl-1,2-propanediol
C9H12O2
40421-52-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0 CFG=1
M  V30 2 C 5.3901 1.3337 0.0 0 CFG=1
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 C 4.6201 0.0000 0.0 0
M  V30 5 O 6.9302 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.7700 1.3337 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=1
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2R)-2-Hydroxy-1-methyl-2-phenylethyl 1-pyrrolidinecarboxylate
C14H19NO3
871478-56-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.0801 0.0 0 CFG=1
M  V30 2 C 5.3348 2.3101 0.0 0 CFG=1
M  V30 3 O 4.0010 4.6201 0.0 0
M  V30 4 O 6.6685 3.0801 0.0 0
M  V30 5 C 5.3348 0.7700 0.0 0
M  V30 6 C 8.0022 2.3101 0.0 0
M  V30 7 O 8.0022 0.7700 0.0 0
M  V30 8 C 2.6673 2.3101 0.0 0
M  V30 9 C 2.6673 0.7700 0.0 0
M  V30 10 C 1.3337 3.0801 0.0 0
M  V30 11 C 1.3337 0.0000 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 0.0000 0.7700 0.0 0
M  V30 14 N 9.3360 3.0801 0.0 0
M  V30 15 C 9.4969 4.6116 0.0 0
M  V30 16 C 10.7428 2.4536 0.0 0
M  V30 17 C 11.0032 4.9318 0.0 0
M  V30 18 C 11.7732 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 4 6
M  V30 7 2 6 7
M  V30 8 1 6 14
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 40421-52-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 871478-56-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-357-CAS-1758990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of an L-Histidine-Derived Minimal Artificial Acylase for
the Kinetic Resolution of Racemic Alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ishihara, Kazuaki; Kosugi, Yuji; Akakura, Matsujiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2004), 126(39), 12212-12213

$RFMT $RIREG SCHEME175 STEP1
$RXN



  3  1
$MOL
cis-1,2-Cyclopentanediol
C5H10O2
5057-98-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.2459 0.0000 0.0 0
M  V30 2 O 3.9563 1.9692 0.0 0
M  V30 3 C 1.2459 1.5400 0.0 0 CFG=2
M  V30 4 C 2.4917 2.4452 0.0 0 CFG=1
M  V30 5 C 0.0000 2.4452 0.0 0
M  V30 6 C 2.0159 3.9098 0.0 0
M  V30 7 C 0.4759 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 3 1 CFG=3
M  V30 2 1 4 2 CFG=3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 3 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Triphosgene
C3Cl6O3
32315-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.5637 0.0 0
M  V30 2 C 6.6687 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 8.0023 2.1037 0.0 0
M  V30 5 Cl 5.8986 2.6673 0.0 0
M  V30 6 Cl 7.4387 0.0000 0.0 0
M  V30 7 O 2.6675 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 Cl 0.0000 2.1037 0.0 0
M  V30 11 Cl 2.1037 2.6673 0.0 0
M  V30 12 Cl 0.5637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2S)-2-Hydroxycyclopentyl 1-pyrrolidinecarboxylate
C10H17NO3
787554-14-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.7711 1.8517 0.0 0
M  V30 2 C 5.1048 2.6218 0.0 0
M  V30 3 O 5.1048 4.1618 0.0 0
M  V30 4 O 0.7103 0.4890 0.0 0
M  V30 5 C 2.4374 2.6218 0.0 0 CFG=2
M  V30 6 C 1.0304 1.9954 0.0 0 CFG=1
M  V30 7 C 2.2763 4.1533 0.0 0
M  V30 8 C 0.0000 3.1398 0.0 0
M  V30 9 C 0.7700 4.4735 0.0 0
M  V30 10 N 6.4384 1.8517 0.0 0
M  V30 11 C 6.5995 0.3202 0.0 0
M  V30 12 C 7.8454 2.4781 0.0 0
M  V30 13 C 8.1058 0.0000 0.0 0
M  V30 14 C 8.8758 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 5 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 10
M  V30 5 1 6 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5057-98-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 787554-14-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-357-CAS-5686293
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of an L-Histidine-Derived Minimal Artificial Acylase for
the Kinetic Resolution of Racemic Alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ishihara, Kazuaki; Kosugi, Yuji; Akakura, Matsujiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2004), 126(39), 12212-12213

$RFMT $RIREG SCHEME176 STEP1
$RXN



  3  1
$MOL
meso-2,3-Butanediol
C4H10O2
5341-95-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0 CFG=2
M  V30 2 C 1.3337 2.3101 0.0 0 CFG=1
M  V30 3 C 4.0010 2.3101 0.0 0
M  V30 4 O 2.6673 0.0000 0.0 0
M  V30 5 C 1.3337 3.8501 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 1 2 6 CFG=1
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Triphosgene
C3Cl6O3
32315-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.5637 0.0 0
M  V30 2 C 6.6687 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 8.0023 2.1037 0.0 0
M  V30 5 Cl 5.8986 2.6673 0.0 0
M  V30 6 Cl 7.4387 0.0000 0.0 0
M  V30 7 O 2.6675 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 Cl 0.0000 2.1037 0.0 0
M  V30 11 Cl 2.1037 2.6673 0.0 0
M  V30 12 Cl 0.5637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,2S)-2-Hydroxy-1-methylpropyl 1-pyrrolidinecarboxylate
C9H17NO3
787554-16-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 5.1047 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0 CFG=2
M  V30 5 C 7.7722 2.3100 0.0 0 CFG=1
M  V30 6 C 6.4385 0.0000 0.0 0
M  V30 7 C 9.1058 1.5400 0.0 0
M  V30 8 O 7.7722 3.8501 0.0 0
M  V30 9 N 2.4374 2.3100 0.0 0
M  V30 10 C 1.0304 1.6836 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 0.0000 2.8281 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6 CFG=1
M  V30 7 1 5 7
M  V30 8 1 5 8 CFG=1
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 4 5)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 5341-95-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 787554-16-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-357-CAS-3882027
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of an L-Histidine-Derived Minimal Artificial Acylase for
the Kinetic Resolution of Racemic Alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ishihara, Kazuaki; Kosugi, Yuji; Akakura, Matsujiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2004), 126(39), 12212-12213

$RFMT $RIREG SCHEME177 STEP1
$RXN



  3  1
$MOL
Triphosgene
C3Cl6O3
32315-10-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 0.5637 0.0 0
M  V30 2 C 6.6687 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 Cl 8.0023 2.1037 0.0 0
M  V30 5 Cl 5.8986 2.6673 0.0 0
M  V30 6 Cl 7.4387 0.0000 0.0 0
M  V30 7 O 2.6675 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 1.3337 1.3337 0.0 0
M  V30 10 Cl 0.0000 2.1037 0.0 0
M  V30 11 Cl 2.1037 2.6673 0.0 0
M  V30 12 Cl 0.5637 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Allothreonine, methyl ester
C5H11NO3
68331-48-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0 CFG=1
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0 CFG=1
M  V30 4 N 2.6674 0.0000 0.0 0
M  V30 5 O 5.3347 1.5400 0.0 0
M  V30 6 O 4.0011 3.8500 0.0 0
M  V30 7 C 0.0000 1.5400 0.0 0
M  V30 8 O 1.3338 3.8500 0.0 0
M  V30 9 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 8 CFG=3
M  V30 8 1 5 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Pyrrolidinylcarbonyl)allothreonine methyl ester
C10H18N2O4
787554-19-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 2.3101 0.0 0 CFG=1
M  V30 2 N 4.0012 3.0801 0.0 0
M  V30 3 C 1.3337 3.0801 0.0 0
M  V30 4 C 2.6673 0.7700 0.0 0 CFG=1
M  V30 5 C 5.3348 2.3101 0.0 0
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 O 0.0000 2.3101 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 5.3348 0.7700 0.0 0
M  V30 11 C 0.0000 5.3901 0.0 0
M  V30 12 N 6.6685 3.0801 0.0 0
M  V30 13 C 6.8296 4.6116 0.0 0
M  V30 14 C 8.0755 2.4537 0.0 0
M  V30 15 C 8.3359 4.9318 0.0 0
M  V30 16 C 9.1059 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9 CFG=3
M  V30 9 2 5 10
M  V30 10 1 5 12
M  V30 11 1 6 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 32315-10-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 68331-48-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 787554-19-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-15095370
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of an L-Histidine-Derived Minimal Artificial Acylase for
the Kinetic Resolution of Racemic Alcohols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ishihara, Kazuaki; Kosugi, Yuji; Akakura, Matsujiro
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2004), 126(39), 12212-12213

$RFMT $RIREG SCHEME178 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[(2R)-4-[[5-(5-Chloro-2-thienyl)-3-isoxazolyl]methyl]-2-[[(methylsulfonyl)...
C35H30ClN5O5S2
323594-47-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 53 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 8.0020 0.0 0
M  V30 2 N 5.3900 9.3358 0.0 0
M  V30 3 C 6.9300 12.0031 0.0 0
M  V30 4 N 6.1600 13.3367 0.0 0
M  V30 5 C 10.0100 6.6684 0.0 0
M  V30 6 C 11.5500 4.0009 0.0 0
M  V30 7 O 12.3200 2.6673 0.0 0
M  V30 8 S 11.5500 1.3336 0.0 0 VAL=6
M  V30 9 C 12.8836 0.5636 0.0 0
M  V30 10 O 10.7800 0.0000 0.0 0
M  V30 11 O 10.2162 2.1036 0.0 0
M  V30 12 O 11.5500 9.3358 0.0 0
M  V30 13 C 16.1700 6.6684 0.0 0
M  V30 14 Cl 24.1829 10.2361 0.0 0
M  V30 15 C 5.3900 6.6684 0.0 0
M  V30 16 C 4.6200 5.3347 0.0 0
M  V30 17 C 6.9300 6.6684 0.0 0
M  V30 18 C 5.3900 4.0009 0.0 0
M  V30 19 C 7.7000 5.3347 0.0 0
M  V30 20 C 6.9300 4.0009 0.0 0
M  V30 21 C 3.0800 8.0020 0.0 0
M  V30 22 C 2.3100 9.3358 0.0 0
M  V30 23 C 2.3100 6.6684 0.0 0
M  V30 24 C 0.7700 9.3358 0.0 0
M  V30 25 C 0.7700 6.6684 0.0 0
M  V30 26 C 0.0000 8.0020 0.0 0
M  V30 27 C 6.9300 9.3358 0.0 0
M  V30 28 C 7.7000 10.6694 0.0 0
M  V30 29 C 7.7000 8.0020 0.0 0
M  V30 30 C 9.2400 10.6694 0.0 0
M  V30 31 C 9.2400 8.0020 0.0 0
M  V30 32 C 10.0100 9.3358 0.0 0
M  V30 33 N 11.5500 6.6684 0.0 0
M  V30 34 C 12.3200 5.3347 0.0 0 CFG=1
M  V30 35 C 12.3200 8.0020 0.0 0
M  V30 36 C 13.8600 5.3347 0.0 0
M  V30 37 C 13.8600 8.0020 0.0 0
M  V30 38 N 14.6300 6.6684 0.0 0
M  V30 39 C 16.9400 8.0020 0.0 0
M  V30 40 C 18.4715 8.1631 0.0 0
M  V30 41 N 16.3135 9.4089 0.0 0
M  V30 42 C 18.7917 9.6694 0.0 0
M  V30 43 O 17.4581 10.4394 0.0 0
M  V30 44 C 20.1985 10.2957 0.0 0
M  V30 45 S 21.5323 9.5257 0.0 0
M  V30 46 C 20.5187 11.8021 0.0 0
M  V30 47 C 22.6767 10.5562 0.0 0
M  V30 48 C 22.0503 11.9630 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 15
M  V30 3 1 1 21
M  V30 4 1 2 27
M  V30 5 3 3 4
M  V30 6 1 3 28
M  V30 7 1 5 31
M  V30 8 1 5 33
M  V30 9 1 6 7
M  V30 10 1 34 6 CFG=3
M  V30 11 1 7 8
M  V30 12 1 8 9
M  V30 13 2 8 10
M  V30 14 2 8 11
M  V30 15 2 12 35
M  V30 16 1 13 38
M  V30 17 1 13 39
M  V30 18 1 14 47
M  V30 19 2 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 25 2 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 2 23 25
M  V30 29 2 24 26
M  V30 30 1 25 26
M  V30 31 2 27 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 31
M  V30 35 2 30 32
M  V30 36 1 31 32
M  V30 37 1 33 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 1 37 38
M  V30 43 1 39 40
M  V30 44 2 39 41
M  V30 45 2 40 42
M  V30 46 1 41 43
M  V30 47 1 42 43
M  V30 48 1 42 44
M  V30 49 1 44 45
M  V30 50 2 44 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 2 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 34)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
4-[[(6S)-4-[[5-(5-Chloro-2-thienyl)-3-isoxazolyl]methyl]-2-oxo-6-(1-pyrrolidi...
C38H35ClN6O2S
323594-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  48 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 7.7721 0.0 0
M  V30 2 N 5.3901 9.1059 0.0 0
M  V30 3 C 6.9301 11.7732 0.0 0
M  V30 4 N 6.1601 13.1069 0.0 0
M  V30 5 C 10.0102 6.4384 0.0 0
M  V30 6 C 11.5502 3.7711 0.0 0
M  V30 7 O 11.5502 9.1059 0.0 0
M  V30 8 C 16.1703 6.4384 0.0 0
M  V30 9 Cl 24.1834 10.0062 0.0 0
M  V30 10 C 3.0801 7.7721 0.0 0
M  V30 11 C 2.3100 9.1059 0.0 0
M  V30 12 C 2.3100 6.4384 0.0 0
M  V30 13 C 0.7700 9.1059 0.0 0
M  V30 14 C 0.7700 6.4384 0.0 0
M  V30 15 C 0.0000 7.7721 0.0 0
M  V30 16 C 5.3901 6.4384 0.0 0
M  V30 17 C 4.6201 5.1047 0.0 0
M  V30 18 C 6.9301 6.4384 0.0 0
M  V30 19 C 5.3901 3.7711 0.0 0
M  V30 20 C 7.7001 5.1047 0.0 0
M  V30 21 C 6.9301 3.7711 0.0 0
M  V30 22 C 6.9301 9.1059 0.0 0
M  V30 23 C 7.7001 10.4395 0.0 0
M  V30 24 C 7.7001 7.7721 0.0 0
M  V30 25 C 9.2402 10.4395 0.0 0
M  V30 26 C 9.2402 7.7721 0.0 0
M  V30 27 C 10.0102 9.1059 0.0 0
M  V30 28 N 11.5502 6.4384 0.0 0
M  V30 29 C 12.3202 5.1047 0.0 0 CFG=1
M  V30 30 C 12.3202 7.7721 0.0 0
M  V30 31 C 13.8603 5.1047 0.0 0
M  V30 32 C 13.8603 7.7721 0.0 0
M  V30 33 N 14.6303 6.4384 0.0 0
M  V30 34 N 12.3202 2.4373 0.0 0
M  V30 35 C 11.6937 1.0304 0.0 0
M  V30 36 C 13.8518 2.2763 0.0 0
M  V30 37 C 12.8383 0.0000 0.0 0
M  V30 38 C 14.1720 0.7700 0.0 0
M  V30 39 C 16.9403 7.7721 0.0 0
M  V30 40 C 18.4719 7.9332 0.0 0
M  V30 41 N 16.3138 9.1790 0.0 0
M  V30 42 C 18.7921 9.4395 0.0 0
M  V30 43 O 17.4584 10.2095 0.0 0
M  V30 44 C 20.1989 10.0659 0.0 0
M  V30 45 S 21.5327 9.2959 0.0 0
M  V30 46 C 20.5190 11.5722 0.0 0
M  V30 47 C 22.6771 10.3264 0.0 0
M  V30 48 C 22.0508 11.7332 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16
M  V30 4 1 2 22
M  V30 5 3 3 4
M  V30 6 1 3 23
M  V30 7 1 5 26
M  V30 8 1 5 28
M  V30 9 1 29 6 CFG=3
M  V30 10 1 6 34
M  V30 11 2 7 30
M  V30 12 1 8 33
M  V30 13 1 8 39
M  V30 14 1 9 47
M  V30 15 2 10 11
M  V30 16 1 10 12
M  V30 17 1 11 13
M  V30 18 2 12 14
M  V30 19 2 13 15
M  V30 20 1 14 15
M  V30 21 2 16 17
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 2 18 20
M  V30 25 2 19 21
M  V30 26 1 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 38
M  V30 44 1 39 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 43
M  V30 48 1 42 43
M  V30 49 1 42 44
M  V30 50 1 44 45
M  V30 51 2 44 46
M  V30 52 1 45 47
M  V30 53 1 46 48
M  V30 54 2 47 48
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 323594-47-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 323594-48-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8502247
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM B:
(S)-2-(Benzhydrylidene-amino)-4-{4-[5-(5-chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-2-oxo-6-pyrrolidin-1-ylmethyl-piperazin-1-ylmethyl}-benzonitrile.
A mixture of (R)-methanesulfonic acid
1-[3-(benzhydrylidene-amino)-4-cyano-benzyl]-4-[5-(5-chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-6-oxo-piperazin-2-ylmethyl
ester (1.5 g, 2.14 mmol), pyrrolidine (2 mL, 24 mmol), and K2CO3 (1.55 g,
11.2 mmol) was heated to 8000 for 2 h. The reaction was diluted with
EtOAc which was then washed with water, followed by brine, dried over
Na2SO4, filtered and concentrated. 1.5 g (> 100%) as an oil. Mass
Spectrum: (ESI) m/z 675 (M+H)+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted piperazinone derivatives and other oxoazaheterocyclyl
compounds useful as factor Xa/IIa inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ewing, William R.; Becker, Michael R.; Choi-Sledeski, Yong Mi; Pauls,
Heinz W.; He, Wei; Condon, Stephen M.; Davis, Roderick S.; Hanney,
Barbara A.; Spada, Alfred P.; Burns, Christopher J.; Jiang, John Z.; Li,
Aiwen; Myers, Michael R.; Lau, Wan F.; Poli, Gregory B.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001007436 A2 2001-02-01

$RFMT $RIREG SCHEME179 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Propanoic acid, 2-isocyano-, methyl ester
C5H7NO2
33115-74-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 N 1.3338 2.3100 0.0 0 CHG=1 VAL=4
M  V30 4 C 2.6674 0.0000 0.0 0
M  V30 5 O 5.3347 1.5400 0.0 0
M  V30 6 O 4.0011 3.8500 0.0 0
M  V30 7 C 0.0000 3.0800 0.0 0 CHG=-1
M  V30 8 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 3 3 7
M  V30 7 1 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Isocyano-1-(1-pyrrolidinyl)-1-propanone
C8H12N2O
1277169-07-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 C 5.1046 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 N 6.4384 1.5400 0.0 0 CHG=1 VAL=4
M  V30 5 C 5.1046 3.8500 0.0 0
M  V30 6 C 7.7721 0.7700 0.0 0 CHG=-1
M  V30 7 N 2.4374 2.3100 0.0 0
M  V30 8 C 1.0304 1.6835 0.0 0
M  V30 9 C 2.2764 3.8415 0.0 0
M  V30 10 C 0.0000 2.8281 0.0 0
M  V30 11 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 3 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 33115-74-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1277169-07-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39574712
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl sulfonium salt electron donor-acceptor complexes for halogen atom
transfer: Isocyanides as tunable coupling partners
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Huaibo; Cuomo, Valentina D.; Rossi-Ashton, James A.; Procter, David
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chem (2024), 10(4), 1240-1251

$RFMT $RIREG SCHEME180 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine, N-(2,6-dichloro-4-pyrimidinyl-2,4,6-13C3-1,3-15N2)-, ethyl ester
C8H9Cl2N3O2
331736-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 4.6201 0.0 0
M  V30 2 C 6.6685 3.8501 0.0 0
M  V30 3 C 8.0022 4.6201 0.0 0
M  V30 4 O 9.3360 3.8501 0.0 0
M  V30 5 O 8.0022 6.1601 0.0 0
M  V30 6 C 10.6697 4.6201 0.0 0
M  V30 7 C 12.0033 3.8501 0.0 0
M  V30 8 Cl 0.0000 4.6201 0.0 0
M  V30 9 Cl 2.6673 0.0000 0.0 0
M  V30 10 C 4.0012 3.8501 0.0 0 MASS=13
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 N 4.0012 2.3101 0.0 0 MASS=15
M  V30 13 C 1.3337 3.8501 0.0 0 MASS=13
M  V30 14 C 2.6673 1.5400 0.0 0 MASS=13
M  V30 15 N 1.3337 2.3101 0.0 0 MASS=15
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 13
M  V30 9 1 9 14
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1-[[(2,6-di-1-pyrrolidinyl-4-pyrimidinyl-2,4,6-13C3-1,3-15N2)ami...
C18H28N6O
331736-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7722 6.9898 0.0 0
M  V30 2 C 9.1058 6.2198 0.0 0
M  V30 3 C 10.4396 6.9898 0.0 0
M  V30 4 O 10.4396 8.5299 0.0 0
M  V30 5 C 3.7710 6.2198 0.0 0 MASS=13
M  V30 6 N 3.7710 4.6798 0.0 0 MASS=15
M  V30 7 C 5.1049 6.9898 0.0 0
M  V30 8 C 5.1049 3.9098 0.0 0 MASS=13
M  V30 9 C 6.4385 6.2198 0.0 0 MASS=13
M  V30 10 N 6.4385 4.6798 0.0 0 MASS=15
M  V30 11 N 2.4374 6.9898 0.0 0
M  V30 12 C 2.2765 8.5214 0.0 0
M  V30 13 C 1.0306 6.3635 0.0 0
M  V30 14 C 0.7700 8.8416 0.0 0
M  V30 15 C 0.0000 7.5079 0.0 0
M  V30 16 N 5.1049 2.3698 0.0 0
M  V30 17 C 6.3507 1.4646 0.0 0
M  V30 18 C 3.8588 1.4646 0.0 0
M  V30 19 C 5.8749 0.0000 0.0 0
M  V30 20 C 4.3349 0.0000 0.0 0
M  V30 21 N 11.7733 6.2198 0.0 0
M  V30 22 C 11.9342 4.6883 0.0 0
M  V30 23 C 13.1801 6.8462 0.0 0
M  V30 24 C 13.4407 4.3681 0.0 0
M  V30 25 C 14.2107 5.7018 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 21
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 11
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 8 16
M  V30 13 1 9 10
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 331736-19-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 331736-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-14442617
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of several isotopically labeled pyrrolo[1,3-d]pyrimidine
analogs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Easter, John A.; Stolle, Wayne T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Labelled Compounds & Radiopharmaceuticals (2001), 44(11),
797-810

$RFMT $RIREG SCHEME181 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[1-(2,2,2-Trifluoroacetyl)-4-piperidinyl]thio]benzenesulfonyl chloride
C13H13ClF3NO3S2
333988-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 1.5400 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 O 2.6673 0.0000 0.0 0
M  V30 4 F 0.5637 0.9764 0.0 0
M  V30 5 F 0.0000 3.0801 0.0 0
M  V30 6 F 2.1037 3.6437 0.0 0
M  V30 7 S 8.0022 4.6201 0.0 0
M  V30 8 S 13.3370 1.5400 0.0 0 VAL=6
M  V30 9 Cl 14.6707 0.7700 0.0 0
M  V30 10 O 12.5670 0.2064 0.0 0
M  V30 11 O 14.1070 2.8737 0.0 0
M  V30 12 N 4.0010 2.3101 0.0 0
M  V30 13 C 4.0010 3.8501 0.0 0
M  V30 14 C 5.3348 1.5400 0.0 0
M  V30 15 C 5.3348 4.6201 0.0 0
M  V30 16 C 6.6685 2.3101 0.0 0
M  V30 17 C 6.6685 3.8501 0.0 0
M  V30 18 C 9.3358 3.8501 0.0 0
M  V30 19 C 10.6697 4.6201 0.0 0
M  V30 20 C 9.3358 2.3101 0.0 0
M  V30 21 C 12.0033 3.8501 0.0 0
M  V30 22 C 10.6697 1.5400 0.0 0
M  V30 23 C 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 2 6
M  V30 7 1 7 17
M  V30 8 1 7 18
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 8 11
M  V30 12 1 8 23
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,2,2-Trifluoro-1-[4-[[4-(1-pyrrolidinylsulfonyl)phenyl]thio]-1-piperidinyl]e...
C17H21F3N2O3S2
333988-20-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 2.6218 0.0 0 VAL=6
M  V30 2 O 4.5411 1.2881 0.0 0
M  V30 3 O 3.0011 3.9554 0.0 0
M  V30 4 S 9.1059 5.7018 0.0 0
M  V30 5 C 14.4407 2.6218 0.0 0
M  V30 6 C 15.7746 3.3918 0.0 0
M  V30 7 O 14.4407 1.0817 0.0 0
M  V30 8 F 15.0045 4.7254 0.0 0
M  V30 9 F 17.1082 4.1618 0.0 0
M  V30 10 F 16.5446 2.0581 0.0 0
M  V30 11 C 5.1047 3.3918 0.0 0
M  V30 12 C 6.4386 2.6218 0.0 0
M  V30 13 C 5.1047 4.9318 0.0 0
M  V30 14 C 7.7722 3.3918 0.0 0
M  V30 15 C 6.4386 5.7018 0.0 0
M  V30 16 C 7.7722 4.9318 0.0 0
M  V30 17 N 2.4374 1.8517 0.0 0
M  V30 18 C 1.0306 2.4782 0.0 0
M  V30 19 C 2.2765 0.3202 0.0 0
M  V30 20 C 0.0000 1.3337 0.0 0
M  V30 21 C 0.7700 0.0000 0.0 0
M  V30 22 C 10.4397 4.9318 0.0 0
M  V30 23 C 10.4397 3.3918 0.0 0
M  V30 24 C 11.7734 5.7018 0.0 0
M  V30 25 C 11.7734 2.6218 0.0 0
M  V30 26 C 13.1071 4.9318 0.0 0
M  V30 27 N 13.1071 3.3918 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 1 17
M  V30 5 1 4 16
M  V30 6 1 4 22
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 5 27
M  V30 10 1 6 8
M  V30 11 1 6 9
M  V30 12 1 6 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 333988-10-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 333988-20-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-10885085
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-aryl-N-(heterocyclylalkyl)piperidinecarboxamides as CCR5
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Imamura, Shinichi; Baba, Masanori; Sugihara, Yoshihiro; Kanzaki, Naoyuki;
Nishimura, Osamu; Hattori, Taeko; Hashiguchi, Shohei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Canada, CA2608807 A1 2001-04-12

$RFMT $RIREG SCHEME182 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2R)-2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)[(phenylmethoxy)carbon...
C23H24N2O6
339201-14-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 6.5772 0.0 0
M  V30 2 C 4.0010 7.3472 0.0 0 CFG=2
M  V30 3 C 6.6685 7.3472 0.0 0
M  V30 4 C 4.0010 8.8872 0.0 0
M  V30 5 C 2.6673 6.5772 0.0 0
M  V30 6 O 8.0022 6.5772 0.0 0
M  V30 7 O 6.6685 8.8872 0.0 0
M  V30 8 O 2.6673 9.6572 0.0 0
M  V30 9 O 5.3348 9.6572 0.0 0
M  V30 10 C 1.3337 7.3472 0.0 0
M  V30 11 C 9.3360 7.3472 0.0 0
M  V30 12 C 2.6673 11.1973 0.0 0
M  V30 13 C 1.3337 8.8872 0.0 0
M  V30 14 C 0.0000 6.5772 0.0 0
M  V30 15 O 8.0453 4.6079 0.0 0
M  V30 16 O 2.6242 4.6079 0.0 0
M  V30 17 N 5.3348 5.0371 0.0 0
M  V30 18 C 6.5807 4.1321 0.0 0
M  V30 19 C 4.0889 4.1321 0.0 0
M  V30 20 C 6.1048 2.6673 0.0 0
M  V30 21 C 4.5648 2.6673 0.0 0
M  V30 22 C 6.8749 1.3337 0.0 0
M  V30 23 C 3.7948 1.3337 0.0 0
M  V30 24 C 6.1048 0.0000 0.0 0
M  V30 25 C 4.5648 0.0000 0.0 0
M  V30 26 C 10.6697 6.5772 0.0 0
M  V30 27 C 12.0033 7.3472 0.0 0
M  V30 28 C 10.6697 5.0371 0.0 0
M  V30 29 C 13.3370 6.5772 0.0 0
M  V30 30 C 12.0033 4.2671 0.0 0
M  V30 31 C 13.3370 5.0371 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 3 6
M  V30 7 2 3 7
M  V30 8 1 4 8
M  V30 9 2 4 9
M  V30 10 1 5 10
M  V30 11 1 6 11
M  V30 12 1 8 12
M  V30 13 1 10 13
M  V30 14 1 10 14
M  V30 15 1 11 26
M  V30 16 2 15 18
M  V30 17 2 16 19
M  V30 18 1 17 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 1-[(1R)-1-(methoxycarbonyl)-3-methylbutyl]-2-[2-(1-pyrrolidinylc...
C27H33N3O6
929720-00-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.6696 5.3900 0.0 0
M  V30 2 O 9.3358 4.6200 0.0 0
M  V30 3 C 8.0021 6.9300 0.0 0
M  V30 4 N 6.6685 7.7000 0.0 0
M  V30 5 O 8.0021 5.3900 0.0 0
M  V30 6 N 5.3347 6.9300 0.0 0
M  V30 7 C 4.0011 7.7000 0.0 0 CFG=2
M  V30 8 C 5.3347 5.3900 0.0 0
M  V30 9 C 4.0011 9.2400 0.0 0
M  V30 10 C 2.6674 6.9300 0.0 0
M  V30 11 O 6.6685 4.6200 0.0 0
M  V30 12 O 4.0011 4.6200 0.0 0
M  V30 13 O 2.6674 10.0100 0.0 0
M  V30 14 O 5.3347 10.0100 0.0 0
M  V30 15 C 1.3338 7.7000 0.0 0
M  V30 16 C 6.6685 3.0800 0.0 0
M  V30 17 C 2.6674 11.5500 0.0 0
M  V30 18 C 1.3338 9.2400 0.0 0
M  V30 19 C 0.0000 6.9300 0.0 0
M  V30 20 C 10.6696 6.9300 0.0 0
M  V30 21 C 9.3358 7.7000 0.0 0
M  V30 22 C 12.0032 7.7000 0.0 0
M  V30 23 C 9.3358 9.2400 0.0 0
M  V30 24 C 12.0032 9.2400 0.0 0
M  V30 25 C 10.6696 10.0100 0.0 0
M  V30 26 N 12.0032 4.6200 0.0 0
M  V30 27 C 12.1642 3.0885 0.0 0
M  V30 28 C 13.4100 5.2463 0.0 0
M  V30 29 C 13.6706 2.7683 0.0 0
M  V30 30 C 14.4406 4.1019 0.0 0
M  V30 31 C 5.3347 2.3100 0.0 0
M  V30 32 C 5.3347 0.7700 0.0 0
M  V30 33 C 4.0011 3.0800 0.0 0
M  V30 34 C 4.0011 0.0000 0.0 0
M  V30 35 C 2.6674 2.3100 0.0 0
M  V30 36 C 2.6674 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 20
M  V30 3 1 1 26
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 21
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 7 10 CFG=3
M  V30 12 1 8 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 2 9 14
M  V30 16 1 10 15
M  V30 17 1 11 16
M  V30 18 1 13 17
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 1 16 31
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 33 2 31 32
M  V30 34 1 31 33
M  V30 35 1 32 34
M  V30 36 2 33 35
M  V30 37 2 34 36
M  V30 38 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 7)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 339201-14-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 929720-00-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-655156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Nα-Z, Nβ-Fmoc or Boc protected α-hydrazinoacids and study of
the coupling reaction in solution of Nα-Z-α-hydrazinoesters
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bouillon, Isabelle; Brosse, Nicolas; Vanderesse, Regis; Jamart-Gregoire,
Brigitte
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2007), 63(10), 2223-2234

$RFMT $RIREG SCHEME183 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,6-Dimethylisoxazolo[3,4-b]pyridin-3(1H)-one
C8H8N2O2
339365-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6507 0.0000 0.0 0
M  V30 2 O 0.0000 1.9571 0.0 0
M  V30 3 C 7.2708 2.6673 0.0 0
M  V30 4 C 3.4207 4.0012 0.0 0
M  V30 5 C 2.6507 2.6673 0.0 0
M  V30 6 N 4.9608 4.0012 0.0 0
M  V30 7 N 2.3903 5.1456 0.0 0
M  V30 8 C 3.4207 1.3337 0.0 0
M  V30 9 C 1.1444 2.9877 0.0 0
M  V30 10 C 5.7308 2.6673 0.0 0
M  V30 11 O 0.9835 4.5192 0.0 0
M  V30 12 C 4.9608 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 9
M  V30 3 1 3 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Spiro[pyrrolidine-1,2′(3′H)-[1,2,4]triazolo[4,3-a]pyridinium], 8′-carboxy-5′,...
C13H17N3O2
1498303-45-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 6.1600 0.0 0
M  V30 2 O 4.0011 6.9300 0.0 0 CHG=-1
M  V30 3 O 1.3336 6.9300 0.0 0
M  V30 4 C 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 4.6200 0.0 0
M  V30 6 N 6.3708 3.0800 0.0 0 CHG=1 VAL=4
M  V30 7 N 5.4658 4.3259 0.0 0
M  V30 8 C 5.4658 1.8341 0.0 0
M  V30 9 C 7.2760 4.3259 0.0 0
M  V30 10 C 7.2760 1.8341 0.0 0
M  V30 11 C 4.0011 3.8500 0.0 0
M  V30 12 N 4.0011 2.3100 0.0 0
M  V30 13 C 8.7407 3.8500 0.0 0
M  V30 14 C 8.7407 2.3100 0.0 0
M  V30 15 C 2.6674 4.6200 0.0 0
M  V30 16 C 2.6674 1.5400 0.0 0
M  V30 17 C 1.3336 3.8500 0.0 0
M  V30 18 C 1.3336 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 15
M  V30 4 1 4 16
M  V30 5 1 5 17
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 339365-49-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1498303-45-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-573-CAS-1558443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The Tandem Mannich-Electrophilic Amination Reaction: a Versatile Platform
for Fluorescent Probing and Labeling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saczewski, Jaroslaw; Hinc, Krzysztof; Obuchowski, Michal; Gdaniec, Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2013), 19(35), 11531-11535

$RFMT $RIREG SCHEME184 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Phenylmethyl) hydrogen N-[(1,1-dimethylethoxy)carbonyl]-D-glutamate
C17H23NO6
34404-30-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 5.3347 0.0 0 CFG=1
M  V30 2 C 5.3900 5.3347 0.0 0
M  V30 3 N 7.7000 6.6684 0.0 0
M  V30 4 C 7.7000 4.0011 0.0 0
M  V30 5 O 4.6200 6.6684 0.0 0
M  V30 6 O 4.6200 4.0011 0.0 0
M  V30 7 C 9.2400 6.6684 0.0 0
M  V30 8 C 6.9300 2.6673 0.0 0
M  V30 9 C 3.0800 6.6684 0.0 0
M  V30 10 O 10.0100 8.0021 0.0 0
M  V30 11 O 10.0100 5.3347 0.0 0
M  V30 12 C 7.7000 1.3336 0.0 0
M  V30 13 C 11.5500 8.0021 0.0 0
M  V30 14 O 9.2400 1.3336 0.0 0
M  V30 15 O 6.9300 0.0000 0.0 0
M  V30 16 C 11.5500 9.5421 0.0 0
M  V30 17 C 13.0900 8.0021 0.0 0
M  V30 18 C 11.5500 6.4621 0.0 0
M  V30 19 C 2.3100 8.0021 0.0 0
M  V30 20 C 0.7700 8.0021 0.0 0
M  V30 21 C 3.0800 9.3358 0.0 0
M  V30 22 C 0.0000 9.3358 0.0 0
M  V30 23 C 2.3100 10.6694 0.0 0
M  V30 24 C 0.7700 10.6694 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 19
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 16
M  V30 17 1 13 17
M  V30 18 1 13 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 2 21 23
M  V30 23 2 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (αR)-α-[[(1,1-dimethylethoxy)carbonyl]amino]-δ-oxo-1-pyrrolidine...
C21H30N2O5
1821257-67-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.4718 6.6685 0.0 0 CFG=1
M  V30 2 C 4.9318 6.6685 0.0 0
M  V30 3 C 7.2418 8.0021 0.0 0
M  V30 4 N 7.2418 5.3348 0.0 0
M  V30 5 C 4.1618 8.0021 0.0 0
M  V30 6 O 8.7818 8.0021 0.0 0
M  V30 7 O 6.4718 9.3359 0.0 0
M  V30 8 C 6.4718 4.0010 0.0 0
M  V30 9 C 2.6217 8.0021 0.0 0
M  V30 10 C 9.5518 9.3359 0.0 0
M  V30 11 O 7.2418 2.6673 0.0 0
M  V30 12 O 4.9318 4.0010 0.0 0
M  V30 13 O 1.8517 6.6685 0.0 0
M  V30 14 C 6.4718 1.3337 0.0 0
M  V30 15 C 5.1381 2.1037 0.0 0
M  V30 16 C 5.7018 0.0000 0.0 0
M  V30 17 C 7.8055 0.5636 0.0 0
M  V30 18 N 1.8517 9.3359 0.0 0
M  V30 19 C 2.4782 10.7427 0.0 0
M  V30 20 C 0.3202 9.4969 0.0 0
M  V30 21 C 1.3337 11.7732 0.0 0
M  V30 22 C 0.0000 11.0032 0.0 0
M  V30 23 C 11.0919 9.3359 0.0 0
M  V30 24 C 11.8619 8.0021 0.0 0
M  V30 25 C 11.8619 10.6696 0.0 0
M  V30 26 C 13.4019 8.0021 0.0 0
M  V30 27 C 13.4019 10.6696 0.0 0
M  V30 28 C 14.1719 9.3359 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 9 18
M  V30 14 1 10 23
M  V30 15 1 11 14
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 14 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 22
M  V30 24 2 23 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 2 25 27
M  V30 28 2 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 34404-30-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1821257-67-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-21739042
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 94790-37-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM alternate reaction conditions also shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazine-carboxamide derivatives as factor XIIa
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Philippou, Helen; Foster, Richard; Fishwick, Colin; Revill, Charlotte;
Yule, Ian; Taylor, Roger; Naylor, Alan; Fallon, Philip Spencer; Crosby,
Stuart; Hopkins, Anna; Stewart, Mark Richard; Winfield, Natalie Louise
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019211585 A1 2019-11-07

$RFMT $RIREG SCHEME185 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[(Benzoylamino)methyl]cyclohexyl]-5-chloro-3-(2-chloro-6-fluorophenyl)-4...
C24H22Cl2FN3O3
347186-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6699 4.3755 0.0 0
M  V30 2 N 7.0036 5.1456 0.0 0
M  V30 3 O 5.6699 2.8355 0.0 0
M  V30 4 Cl 5.3197 7.7076 0.0 0
M  V30 5 Cl 0.0000 3.5673 0.0 0
M  V30 6 F 5.2183 2.4582 0.0 0
M  V30 7 C 12.3384 5.1456 0.0 0
M  V30 8 N 13.6723 4.3755 0.0 0
M  V30 9 C 15.0059 5.1456 0.0 0
M  V30 10 O 15.0059 6.6856 0.0 0
M  V30 11 C 2.9293 4.5191 0.0 0
M  V30 12 C 4.3363 5.1456 0.0 0
M  V30 13 N 1.8989 5.6636 0.0 0
M  V30 14 C 4.1753 6.6771 0.0 0
M  V30 15 O 2.6689 6.9973 0.0 0
M  V30 16 C 2.6091 3.0128 0.0 0
M  V30 17 C 1.1446 2.5369 0.0 0
M  V30 18 C 3.7537 1.9822 0.0 0
M  V30 19 C 0.8244 1.0304 0.0 0
M  V30 20 C 3.4335 0.4759 0.0 0
M  V30 21 C 1.9688 0.0000 0.0 0
M  V30 22 C 8.3374 4.3755 0.0 0
M  V30 23 C 9.6711 5.1456 0.0 0
M  V30 24 C 8.3374 2.8355 0.0 0
M  V30 25 C 11.0048 4.3755 0.0 0
M  V30 26 C 9.6711 2.0655 0.0 0
M  V30 27 C 11.0048 2.8355 0.0 0
M  V30 28 C 16.3396 4.3755 0.0 0
M  V30 29 C 17.6733 5.1456 0.0 0
M  V30 30 C 16.3396 2.8355 0.0 0
M  V30 31 C 19.0071 4.3755 0.0 0
M  V30 32 C 17.6733 2.0655 0.0 0
M  V30 33 C 19.0071 2.8355 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 22
M  V30 5 1 4 14
M  V30 6 1 5 17
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 1 7 25
M  V30 10 1 8 9
M  V30 11 2 9 10
M  V30 12 1 9 28
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 11 16
M  V30 16 2 12 14
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-[(Benzoylamino)methyl]cyclohexyl]-3-(2-chloro-6-fluorophenyl)-5-(1-pyrro...
C28H30ClFN4O3
347186-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.6699 5.4901 0.0 0
M  V30 2 N 7.0036 4.7200 0.0 0
M  V30 3 O 5.6699 7.0301 0.0 0
M  V30 4 Cl 5.2183 7.4074 0.0 0
M  V30 5 F 0.0000 6.2981 0.0 0
M  V30 6 C 12.3384 4.7200 0.0 0
M  V30 7 N 13.6723 5.4901 0.0 0
M  V30 8 C 15.0059 4.7200 0.0 0
M  V30 9 O 15.0059 3.1800 0.0 0
M  V30 10 C 4.3363 4.7200 0.0 0
M  V30 11 C 2.9293 5.3464 0.0 0
M  V30 12 C 4.1753 3.1883 0.0 0
M  V30 13 N 1.8989 4.2020 0.0 0
M  V30 14 O 2.6689 2.8682 0.0 0
M  V30 15 C 2.6091 6.8528 0.0 0
M  V30 16 C 3.7537 7.8833 0.0 0
M  V30 17 C 1.1446 7.3287 0.0 0
M  V30 18 C 3.4335 9.3896 0.0 0
M  V30 19 C 0.8244 8.8350 0.0 0
M  V30 20 C 1.9688 9.8655 0.0 0
M  V30 21 N 5.3197 2.1579 0.0 0
M  V30 22 C 5.1588 0.6263 0.0 0
M  V30 23 C 6.8262 2.4781 0.0 0
M  V30 24 C 6.5656 0.0000 0.0 0
M  V30 25 C 7.5962 1.1444 0.0 0
M  V30 26 C 8.3374 5.4901 0.0 0
M  V30 27 C 9.6711 4.7200 0.0 0
M  V30 28 C 8.3374 7.0301 0.0 0
M  V30 29 C 11.0048 5.4901 0.0 0
M  V30 30 C 9.6711 7.8001 0.0 0
M  V30 31 C 11.0048 7.0301 0.0 0
M  V30 32 C 16.3396 5.4901 0.0 0
M  V30 33 C 16.3396 7.0301 0.0 0
M  V30 34 C 17.6733 4.7200 0.0 0
M  V30 35 C 17.6733 7.8001 0.0 0
M  V30 36 C 19.0071 5.4901 0.0 0
M  V30 37 C 19.0071 7.0301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 26
M  V30 5 1 4 16
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 1 6 29
M  V30 9 1 7 8
M  V30 10 2 8 9
M  V30 11 1 8 32
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 12 21
M  V30 18 1 13 14
M  V30 19 2 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 2 17 19
M  V30 23 2 18 20
M  V30 24 1 19 20
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 30 1 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 31
M  V30 36 2 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 2 34 36
M  V30 40 2 35 37
M  V30 41 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 347186-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 347186-45-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10374035
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
[5-(Diethylamino)-3-(6-chloro-2-fluorophenyl)isoxazo4-yl]-N-{3-[(phenylcarbonylamino)methyl]cyclohexyl}carboxamide
To a solution of a compound from preparation 278 (0.1 g, 0.2 mmol) in DMF
(2.5 ml) under N2 was added diethylamine (0.065 ml, 0.63 mmol)j and
stirred for 2 h. The reaction was diluted with EtOAc, washed (H2O then
brine), dried (MgSO4, filtered, and concentrated. (0.1 N HCl and brine),
dried (MgSO4), filtered, and concentrated. Flash chromatography (silica
gel, acetone/CH2Cl2 gradient) gave the title compound.
[3-(6-Chloro-2-fluorophenyl)-5-pyrrolidinylisoxazo4-yl]-N-{3-[(phenylcarbonylamino)methyl]cyclohexyl}carboxamide
In a fashion similar to that described for preparation 280, a compound
from preparation 279 (0.085 g, 0.17 mmol), DMF (2.5 ml), pyrrolidine
(0.14 ml, 1.7 mmol) gave the title compound (0.089 g, 100%) which was
taken on as a crude residue. Mass Spectrum (ES+) (m/z) 525.2 [M+1].
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-(isoxazoloquinolinylcyclohexyl)carboxamides and analogs
as MRP1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bonjouklian, Rosanne; Cohen, Jeffrey Daniel; Gruber, Joseph Michael;
Johnson, Douglas Webb; Jungheim, Louis Nickolaus; Kroin, Julian Stanley;
Lander, Peter Ambrose; Lin, Ho-shen; Lohman, Mark Christopher; Muehl,
Brian Stephen; Norman, Bryan Hurst; Patel, Vinod Francis; Richett,
Michael Enrico; Thrasher, Kenneth Jeff; Vepachedu, Sreenivasarao; White,
Wesley Todd; Xie, Yongping; York, Jeremy Schulenburg; Parkhurst, Brandon
Lee
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2001046199 A1 2001-06-28

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
349-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 F 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Fluorophenyl)sulfonyl]pyrrolidine
C10H12FNO2S
157187-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.9098 1.5400 0.0 0 VAL=6
M  V30 2 O 3.9098 3.0800 0.0 0
M  V30 3 O 3.9098 0.0000 0.0 0
M  V30 4 F 10.0698 1.5400 0.0 0
M  V30 5 C 5.4498 1.5400 0.0 0
M  V30 6 C 6.2198 2.8736 0.0 0
M  V30 7 C 6.2198 0.2064 0.0 0
M  V30 8 C 7.7598 2.8736 0.0 0
M  V30 9 C 7.7598 0.2064 0.0 0
M  V30 10 C 8.5298 1.5400 0.0 0
M  V30 11 N 2.3698 1.5400 0.0 0
M  V30 12 C 1.4645 0.2941 0.0 0
M  V30 13 C 1.4645 2.7859 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 1 11
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 349-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 157187-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-20264591
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and
Structure-Activity Relationships
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leung, Leo; Niculescu-Duvaz, Dan; Smithen, Deborah; Lopes, Filipa;
Callens, Cedric; McLeary, Robert; Saturno, Grazia; Davies, Lawrence;
Aljarah, Mohammed; Brown, Michael; Johnson, Louise; Zambon, Alfonso;
Chambers, Tim; Menard, Delphine; Bayliss, Natasha; Knight, Ruth; Fish,
Laura; Lawrence, Rae; Challinor, Mairi; Tang, HaoRan; Marais, Richard;
Springer, Caroline
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(12), 5863-5884

$RFMT $RIREG SCHEME186 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
349-88-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 Cl 0.0000 1.5400 0.0 0
M  V30 3 O 1.5400 3.0800 0.0 0
M  V30 4 O 1.5400 0.0000 0.0 0
M  V30 5 F 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Fluorophenyl)sulfonyl]pyrrolidine
C10H12FNO2S
157187-14-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.9098 1.5400 0.0 0 VAL=6
M  V30 2 O 3.9098 3.0800 0.0 0
M  V30 3 O 3.9098 0.0000 0.0 0
M  V30 4 F 10.0698 1.5400 0.0 0
M  V30 5 C 5.4498 1.5400 0.0 0
M  V30 6 C 6.2198 2.8736 0.0 0
M  V30 7 C 6.2198 0.2064 0.0 0
M  V30 8 C 7.7598 2.8736 0.0 0
M  V30 9 C 7.7598 0.2064 0.0 0
M  V30 10 C 8.5298 1.5400 0.0 0
M  V30 11 N 2.3698 1.5400 0.0 0
M  V30 12 C 1.4645 0.2941 0.0 0
M  V30 13 C 1.4645 2.7859 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 15 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 1 11
M  V30 5 1 4 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 349-88-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 157187-14-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-19060892
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroarylmethylamine derivatives as lysyl oxidase inhibitors for the
treatment of cancer and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Springer, Caroline; Marais, Richard; Niculescu-Duvaz, Dan; Leung, Leo;
Smithen, Deborah; Callens, Cedric; Tang, Haoran
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017141049 A1 2017-08-24

$RFMT $RIREG SCHEME187 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Bromo-5-(trifluoromethyl)benzenesulfonyl chloride
C7H3BrClF3O2S
351003-46-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 4.6201 0.0 0
M  V30 2 F 2.1037 5.9538 0.0 0
M  V30 3 F 0.0000 5.3901 0.0 0
M  V30 4 F 0.5637 3.2864 0.0 0
M  V30 5 S 6.6687 4.6201 0.0 0 VAL=6
M  V30 6 Cl 8.0023 5.3901 0.0 0
M  V30 7 O 7.4387 3.2864 0.0 0
M  V30 8 O 5.8986 5.9538 0.0 0
M  V30 9 Br 4.0012 0.0000 0.0 0
M  V30 10 C 2.6675 3.8501 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 2.6675 2.3101 0.0 0
M  V30 13 C 5.3348 3.8501 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 5.3348 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 5 8
M  V30 8 1 5 13
M  V30 9 1 9 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1-[[3-bromo-5-(trifluoromethyl)phenyl]sulfonyl]-
C11H11BrF3NO2S
951884-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6685 4.6201 0.0 0 VAL=6
M  V30 2 O 7.4385 3.2864 0.0 0
M  V30 3 O 5.8985 5.9538 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 F 0.5637 3.2864 0.0 0
M  V30 6 F 0.0000 5.3901 0.0 0
M  V30 7 F 2.1037 5.9538 0.0 0
M  V30 8 Br 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 3.8501 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 3.8501 0.0 0
M  V30 13 C 4.0012 1.5400 0.0 0
M  V30 14 C 2.6673 2.3101 0.0 0
M  V30 15 N 8.0022 5.3901 0.0 0
M  V30 16 C 9.4091 4.7636 0.0 0
M  V30 17 C 8.1633 6.9217 0.0 0
M  V30 18 C 10.4396 5.9082 0.0 0
M  V30 19 C 9.6696 7.2419 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 15
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 12
M  V30 9 1 8 13
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 351003-46-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 951884-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-19060971
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroarylmethylamine derivatives as lysyl oxidase inhibitors for the
treatment of cancer and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Springer, Caroline; Marais, Richard; Niculescu-Duvaz, Dan; Leung, Leo;
Smithen, Deborah; Callens, Cedric; Tang, Haoran
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017141049 A1 2017-08-24

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzyl-4-piperidone
C12H15NO
3612-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 O 9.3358 0.0000 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 0.7700 0.0 0
M  V30 5 C 6.6684 3.0800 0.0 0
M  V30 6 C 6.6684 0.0000 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 0.7700 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3336 3.0800 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3336 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 2 2 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,6-Tetrahydro-1-(phenylmethyl)-4-(1-pyrrolidinyl)pyridine
C16H22N2
16675-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.9318 0.0 0
M  V30 2 C 8.0022 2.6218 0.0 0
M  V30 3 C 6.6685 1.8517 0.0 0
M  V30 4 C 8.0022 4.1618 0.0 0
M  V30 5 C 5.3348 2.6218 0.0 0
M  V30 6 C 6.6685 4.9318 0.0 0
M  V30 7 N 5.3348 4.1618 0.0 0
M  V30 8 N 9.3360 1.8517 0.0 0
M  V30 9 C 9.4969 0.3202 0.0 0
M  V30 10 C 10.7428 2.4782 0.0 0
M  V30 11 C 11.0032 0.0000 0.0 0
M  V30 12 C 11.7733 1.3337 0.0 0
M  V30 13 C 2.6673 4.1618 0.0 0
M  V30 14 C 1.3337 4.9318 0.0 0
M  V30 15 C 2.6673 2.6218 0.0 0
M  V30 16 C 0.0000 4.1618 0.0 0
M  V30 17 C 1.3337 1.8517 0.0 0
M  V30 18 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 8
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3612-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16675-58-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6623747
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark apparatus used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A concise one-pot synthesis of trifluoromethyl-containing
2,6-disubstituted 5,6,7,8-tetrahydroquinolines and
5,6,7,8-tetrahydronaphthyridines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Johnson, Russell J.; O'Mahony, Donogh J. R.; Edwards, William T.;
Duncton, Matthew A. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2013), 11(8), 1358-1366

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzyl-4-piperidone
C12H15NO
3612-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 O 9.3358 0.0000 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 0.7700 0.0 0
M  V30 5 C 6.6684 3.0800 0.0 0
M  V30 6 C 6.6684 0.0000 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 0.7700 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3336 3.0800 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3336 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 2 2 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,6-Tetrahydro-1-(phenylmethyl)-4-(1-pyrrolidinyl)pyridine
C16H22N2
16675-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.9318 0.0 0
M  V30 2 C 8.0022 2.6218 0.0 0
M  V30 3 C 6.6685 1.8517 0.0 0
M  V30 4 C 8.0022 4.1618 0.0 0
M  V30 5 C 5.3348 2.6218 0.0 0
M  V30 6 C 6.6685 4.9318 0.0 0
M  V30 7 N 5.3348 4.1618 0.0 0
M  V30 8 N 9.3360 1.8517 0.0 0
M  V30 9 C 9.4969 0.3202 0.0 0
M  V30 10 C 10.7428 2.4782 0.0 0
M  V30 11 C 11.0032 0.0000 0.0 0
M  V30 12 C 11.7733 1.3337 0.0 0
M  V30 13 C 2.6673 4.1618 0.0 0
M  V30 14 C 1.3337 4.9318 0.0 0
M  V30 15 C 2.6673 2.6218 0.0 0
M  V30 16 C 0.0000 4.1618 0.0 0
M  V30 17 C 1.3337 1.8517 0.0 0
M  V30 18 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 8
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3612-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16675-58-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-118628
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark apparatus used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combinations of atorvastatin and α1-adrenergic receptor antagonists for
the treatment of benign prostatic hyperplasia
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pullen, Nicholas; Thurlow, Richard James
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004026300 A1 2004-04-01

$RFMT $RIREG SCHEME188 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Benzyl-4-piperidone
C12H15NO
3612-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 O 9.3358 0.0000 0.0 0
M  V30 3 N 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 0.7700 0.0 0
M  V30 5 C 6.6684 3.0800 0.0 0
M  V30 6 C 6.6684 0.0000 0.0 0
M  V30 7 C 8.0021 2.3100 0.0 0
M  V30 8 C 8.0021 0.7700 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 1.3336 3.0800 0.0 0
M  V30 11 C 2.6674 0.7700 0.0 0
M  V30 12 C 0.0000 2.3100 0.0 0
M  V30 13 C 1.3336 0.0000 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 2 2 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,3,6-Tetrahydro-1-(phenylmethyl)-4-(1-pyrrolidinyl)pyridine
C16H22N2
16675-58-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 4.9318 0.0 0
M  V30 2 C 8.0022 2.6218 0.0 0
M  V30 3 C 6.6685 1.8517 0.0 0
M  V30 4 C 8.0022 4.1618 0.0 0
M  V30 5 C 5.3348 2.6218 0.0 0
M  V30 6 C 6.6685 4.9318 0.0 0
M  V30 7 N 5.3348 4.1618 0.0 0
M  V30 8 N 9.3360 1.8517 0.0 0
M  V30 9 C 9.4969 0.3202 0.0 0
M  V30 10 C 10.7428 2.4782 0.0 0
M  V30 11 C 11.0032 0.0000 0.0 0
M  V30 12 C 11.7733 1.3337 0.0 0
M  V30 13 C 2.6673 4.1618 0.0 0
M  V30 14 C 1.3337 4.9318 0.0 0
M  V30 15 C 2.6673 2.6218 0.0 0
M  V30 16 C 0.0000 4.1618 0.0 0
M  V30 17 C 1.3337 1.8517 0.0 0
M  V30 18 C 0.0000 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 8
M  V30 6 1 3 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3612-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 16675-58-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-2112156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark apparatus used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of alkoxy quinazolinone compounds as α1L adrenoceptors
antagonists useful in therapy
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Blagg, Julian; Fray, Michael Jonathan; Lewis, Mark Llewellyn; Mathias,
John Paul; Stefaniak, Mark Henryk; Stobie, Alan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003076427 A1 2003-09-18

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dinitro-5-fluoroaniline
C6H4FN3O4
367-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 N 6.6685 4.6200 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 4.0011 4.6200 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dinitro-5-(1-pyrrolidinyl)benzenamine
C10H12N4O4
1259926-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.9098 1.3338 0.0 0 VAL=5
M  V30 2 O 2.3698 1.3338 0.0 0
M  V30 3 O 4.6798 0.0000 0.0 0
M  V30 4 N 6.9898 6.6685 0.0 0
M  V30 5 N 8.5298 4.0011 0.0 0 VAL=5
M  V30 6 O 9.2998 2.6674 0.0 0
M  V30 7 O 9.2998 5.3347 0.0 0
M  V30 8 C 3.9098 4.0011 0.0 0
M  V30 9 C 4.6798 2.6674 0.0 0
M  V30 10 C 4.6798 5.3347 0.0 0
M  V30 11 C 6.2198 2.6674 0.0 0
M  V30 12 C 6.2198 5.3347 0.0 0
M  V30 13 C 6.9898 4.0011 0.0 0
M  V30 14 N 2.3698 4.0011 0.0 0
M  V30 15 C 1.4645 5.2470 0.0 0
M  V30 16 C 1.4645 2.7552 0.0 0
M  V30 17 C 0.0000 4.7711 0.0 0
M  V30 18 C 0.0000 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 367-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1259926-71-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-7714016
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted benzimidazoles and their use in the treatment
of tuberculosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ojima, Iwao; Awasthi, Divya
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2015077276 A1 2015-05-28

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dinitro-5-fluoroaniline
C6H4FN3O4
367-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 N 6.6685 4.6200 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 4.0011 4.6200 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dinitro-5-(1-pyrrolidinyl)benzenamine
C10H12N4O4
1259926-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.9098 1.3338 0.0 0 VAL=5
M  V30 2 O 2.3698 1.3338 0.0 0
M  V30 3 O 4.6798 0.0000 0.0 0
M  V30 4 N 6.9898 6.6685 0.0 0
M  V30 5 N 8.5298 4.0011 0.0 0 VAL=5
M  V30 6 O 9.2998 2.6674 0.0 0
M  V30 7 O 9.2998 5.3347 0.0 0
M  V30 8 C 3.9098 4.0011 0.0 0
M  V30 9 C 4.6798 2.6674 0.0 0
M  V30 10 C 4.6798 5.3347 0.0 0
M  V30 11 C 6.2198 2.6674 0.0 0
M  V30 12 C 6.2198 5.3347 0.0 0
M  V30 13 C 6.9898 4.0011 0.0 0
M  V30 14 N 2.3698 4.0011 0.0 0
M  V30 15 C 1.4645 5.2470 0.0 0
M  V30 16 C 1.4645 2.7552 0.0 0
M  V30 17 C 0.0000 4.7711 0.0 0
M  V30 18 C 0.0000 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 367-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1259926-71-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3741501
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzimidazole-based antibacterial agents against Francisella tularensis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Kunal; Awasthi, Divya; Lee, Seung-Yub; Cummings, Jason E.;
Knudson, Susan E.; Slayden, Richard A.; Ojima, Iwao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2013), 21(11), 3318-3326

$RFMT $RIREG SCHEME189 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dinitro-5-fluoroaniline
C6H4FN3O4
367-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3336 0.0000 0.0 0
M  V30 4 F 1.3336 4.6200 0.0 0
M  V30 5 N 6.6685 1.5400 0.0 0 VAL=5
M  V30 6 O 6.6685 0.0000 0.0 0
M  V30 7 O 8.0021 2.3100 0.0 0
M  V30 8 N 6.6685 4.6200 0.0 0
M  V30 9 C 2.6674 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 2.6674 3.8500 0.0 0
M  V30 12 C 5.3347 2.3100 0.0 0
M  V30 13 C 4.0011 4.6200 0.0 0
M  V30 14 C 5.3347 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 11
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 12
M  V30 8 1 8 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,4-Dinitro-5-(1-pyrrolidinyl)benzenamine
C10H12N4O4
1259926-71-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.9098 1.3338 0.0 0 VAL=5
M  V30 2 O 2.3698 1.3338 0.0 0
M  V30 3 O 4.6798 0.0000 0.0 0
M  V30 4 N 6.9898 6.6685 0.0 0
M  V30 5 N 8.5298 4.0011 0.0 0 VAL=5
M  V30 6 O 9.2998 2.6674 0.0 0
M  V30 7 O 9.2998 5.3347 0.0 0
M  V30 8 C 3.9098 4.0011 0.0 0
M  V30 9 C 4.6798 2.6674 0.0 0
M  V30 10 C 4.6798 5.3347 0.0 0
M  V30 11 C 6.2198 2.6674 0.0 0
M  V30 12 C 6.2198 5.3347 0.0 0
M  V30 13 C 6.9898 4.0011 0.0 0
M  V30 14 N 2.3698 4.0011 0.0 0
M  V30 15 C 1.4645 5.2470 0.0 0
M  V30 16 C 1.4645 2.7552 0.0 0
M  V30 17 C 0.0000 4.7711 0.0 0
M  V30 18 C 0.0000 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 12
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 367-81-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1259926-71-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1858576
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 5-(4-Methylpiperazin-1-yl)-2,4-dinitroaniline
(4b-G): A solution of N-methylpiperazine (1.19 g, 11.94 mmol) in
tetrahydrofuran (50 mL) was added dropwise to a magnetically stirred
solution of 3 (2 g, 9.95 mmol) and DIPEA (2.01 mL, 11.94 mmol) in
tetrahydrofuran (50 mL). The mixture was stirred at room temperature for
4 h. The reaction mixture was diluted with dichloromethane, washed with
water (30 mL x 3) and dried over anhydrous magnesium sulfate. The solvent
was evaporated to afford 4b-G as a yellow solid (1.40 g, 98% yield):
2,4-Dinitro-5-(pyrrolidin-1-yl)aniline (4c-G) Yellow solid; quantitative
yield; mp 169-171°C; 1H NMR (500 MHz, CDCl3) δ 2.0 (m, 4 H), 3.27 (m, 4
H), 5.91 (s, 1 H), 6.30 (broad s, NH), 8.71 (s, 1 H); 13C NMR (125 MHz,
CDCl3) δ 25.63, 50.96, 98.26, 122.8, 127.9, 130.1, 146.7, 147.2. MS (ESI)
m/z 255.1 (M+1)+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel Trisubstituted Benzimidazoles, Targeting Mtb FtsZ, as a New Class
of Antitubercular Agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kumar, Kunal; Awasthi, Divya; Lee, Seung-Yub; Zanardi, Ilaria; Ruzsicska,
Bela; Knudson, Susan; Tonge, Peter J.; Slayden, Richard A.; Ojima, Iwao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2011), 54(1), 374-381

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Phenylmethyl) hydrogen N-[(phenylmethoxy)carbonyl]-L-glutamate
C20H21NO6
3705-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 5.3348 0.0 0 CFG=2
M  V30 2 C 9.2402 5.3348 0.0 0
M  V30 3 N 6.9302 6.6685 0.0 0
M  V30 4 C 6.9302 4.0012 0.0 0
M  V30 5 O 10.0102 6.6685 0.0 0
M  V30 6 O 10.0102 4.0012 0.0 0
M  V30 7 C 5.3901 6.6685 0.0 0
M  V30 8 C 7.7002 2.6673 0.0 0
M  V30 9 C 11.5503 6.6685 0.0 0
M  V30 10 O 4.6201 8.0022 0.0 0
M  V30 11 O 4.6201 5.3348 0.0 0
M  V30 12 C 6.9302 1.3337 0.0 0
M  V30 13 C 3.0801 8.0022 0.0 0
M  V30 14 O 7.7002 0.0000 0.0 0
M  V30 15 O 5.3901 1.3337 0.0 0
M  V30 16 C 12.3203 8.0022 0.0 0
M  V30 17 C 13.8603 8.0022 0.0 0
M  V30 18 C 11.5503 9.3360 0.0 0
M  V30 19 C 14.6303 9.3360 0.0 0
M  V30 20 C 12.3203 10.6697 0.0 0
M  V30 21 C 13.8603 10.6697 0.0 0
M  V30 22 C 2.3101 9.3360 0.0 0
M  V30 23 C 0.7700 9.3360 0.0 0
M  V30 24 C 3.0801 10.6697 0.0 0
M  V30 25 C 0.0000 10.6697 0.0 0
M  V30 26 C 2.3101 12.0033 0.0 0
M  V30 27 C 0.7700 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 16
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 22
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (αS)-δ-oxo-α-[[(phenylmethoxy)carbonyl]amino]-1-pyrrolidinepenta...
C24H28N2O5
2559759-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 7.7722 0.0 0 CFG=2
M  V30 2 C 6.9302 6.4384 0.0 0
M  V30 3 C 6.9302 9.1059 0.0 0
M  V30 4 N 9.2402 7.7722 0.0 0
M  V30 5 C 7.7002 5.1048 0.0 0
M  V30 6 O 5.3901 9.1059 0.0 0
M  V30 7 O 7.7002 10.4396 0.0 0
M  V30 8 C 10.0102 9.1059 0.0 0
M  V30 9 C 6.9302 3.7711 0.0 0
M  V30 10 C 4.6201 10.4396 0.0 0
M  V30 11 O 11.5503 9.1059 0.0 0
M  V30 12 O 9.2402 10.4396 0.0 0
M  V30 13 O 5.3901 3.7711 0.0 0
M  V30 14 C 12.3203 10.4396 0.0 0
M  V30 15 N 7.7002 2.4373 0.0 0
M  V30 16 C 9.2317 2.2763 0.0 0
M  V30 17 C 7.0738 1.0304 0.0 0
M  V30 18 C 9.5519 0.7700 0.0 0
M  V30 19 C 8.2182 0.0000 0.0 0
M  V30 20 C 3.0801 10.4396 0.0 0
M  V30 21 C 2.3101 9.1059 0.0 0
M  V30 22 C 2.3101 11.7733 0.0 0
M  V30 23 C 0.7700 9.1059 0.0 0
M  V30 24 C 0.7700 11.7733 0.0 0
M  V30 25 C 0.0000 10.4396 0.0 0
M  V30 26 C 13.8603 10.4396 0.0 0
M  V30 27 C 14.6303 11.7733 0.0 0
M  V30 28 C 14.6303 9.1059 0.0 0
M  V30 29 C 16.1704 11.7733 0.0 0
M  V30 30 C 16.1704 9.1059 0.0 0
M  V30 31 C 16.9404 10.4396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 9 15
M  V30 14 1 10 20
M  V30 15 1 11 14
M  V30 16 1 14 26
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3705-42-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2559759-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-37376185
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Metabolism-guided development of Ko143 analogs as ABCG2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Junjie; Lei, Saifei; Lu, Jie; Hao, Yixuan; Qian, Qi; Devanathan,
Aaron S.; Feng, Zhiwei; Xie, Xiang-Qun; Wipf, Peter; Ma, Xiaochao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2023), 259115666

$RFMT $RIREG SCHEME190 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(Phenylmethyl) hydrogen N-[(phenylmethoxy)carbonyl]-L-glutamate
C20H21NO6
3705-42-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 5.3348 0.0 0 CFG=2
M  V30 2 C 9.2402 5.3348 0.0 0
M  V30 3 N 6.9302 6.6685 0.0 0
M  V30 4 C 6.9302 4.0012 0.0 0
M  V30 5 O 10.0102 6.6685 0.0 0
M  V30 6 O 10.0102 4.0012 0.0 0
M  V30 7 C 5.3901 6.6685 0.0 0
M  V30 8 C 7.7002 2.6673 0.0 0
M  V30 9 C 11.5503 6.6685 0.0 0
M  V30 10 O 4.6201 8.0022 0.0 0
M  V30 11 O 4.6201 5.3348 0.0 0
M  V30 12 C 6.9302 1.3337 0.0 0
M  V30 13 C 3.0801 8.0022 0.0 0
M  V30 14 O 7.7002 0.0000 0.0 0
M  V30 15 O 5.3901 1.3337 0.0 0
M  V30 16 C 12.3203 8.0022 0.0 0
M  V30 17 C 13.8603 8.0022 0.0 0
M  V30 18 C 11.5503 9.3360 0.0 0
M  V30 19 C 14.6303 9.3360 0.0 0
M  V30 20 C 12.3203 10.6697 0.0 0
M  V30 21 C 13.8603 10.6697 0.0 0
M  V30 22 C 2.3101 9.3360 0.0 0
M  V30 23 C 0.7700 9.3360 0.0 0
M  V30 24 C 3.0801 10.6697 0.0 0
M  V30 25 C 0.0000 10.6697 0.0 0
M  V30 26 C 2.3101 12.0033 0.0 0
M  V30 27 C 0.7700 12.0033 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=3
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 7 10
M  V30 10 2 7 11
M  V30 11 1 8 12
M  V30 12 1 9 16
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 2 12 15
M  V30 16 1 13 22
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Phenylmethyl (αS)-δ-oxo-α-[[(phenylmethoxy)carbonyl]amino]-1-pyrrolidinepenta...
C24H28N2O5
2559759-51-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7002 7.7722 0.0 0 CFG=2
M  V30 2 C 6.9302 6.4384 0.0 0
M  V30 3 C 6.9302 9.1059 0.0 0
M  V30 4 N 9.2402 7.7722 0.0 0
M  V30 5 C 7.7002 5.1048 0.0 0
M  V30 6 O 5.3901 9.1059 0.0 0
M  V30 7 O 7.7002 10.4396 0.0 0
M  V30 8 C 10.0102 9.1059 0.0 0
M  V30 9 C 6.9302 3.7711 0.0 0
M  V30 10 C 4.6201 10.4396 0.0 0
M  V30 11 O 11.5503 9.1059 0.0 0
M  V30 12 O 9.2402 10.4396 0.0 0
M  V30 13 O 5.3901 3.7711 0.0 0
M  V30 14 C 12.3203 10.4396 0.0 0
M  V30 15 N 7.7002 2.4373 0.0 0
M  V30 16 C 9.2317 2.2763 0.0 0
M  V30 17 C 7.0738 1.0304 0.0 0
M  V30 18 C 9.5519 0.7700 0.0 0
M  V30 19 C 8.2182 0.0000 0.0 0
M  V30 20 C 3.0801 10.4396 0.0 0
M  V30 21 C 2.3101 9.1059 0.0 0
M  V30 22 C 2.3101 11.7733 0.0 0
M  V30 23 C 0.7700 9.1059 0.0 0
M  V30 24 C 0.7700 11.7733 0.0 0
M  V30 25 C 0.0000 10.4396 0.0 0
M  V30 26 C 13.8603 10.4396 0.0 0
M  V30 27 C 14.6303 11.7733 0.0 0
M  V30 28 C 14.6303 9.1059 0.0 0
M  V30 29 C 16.1704 11.7733 0.0 0
M  V30 30 C 16.1704 9.1059 0.0 0
M  V30 31 C 16.9404 10.4396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=1
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 9 15
M  V30 14 1 10 20
M  V30 15 1 11 14
M  V30 16 1 14 26
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 28 2 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 2 28 30
M  V30 32 2 29 31
M  V30 33 1 30 31
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3705-42-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2559759-51-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23616841
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel therapy for erythropoietic protoporphyria (EPP) and X-linked
protoporphyria (XLP) and treating multidrug resistance in cancer
comprising an ABCG2 inhibitor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ma, Xiaochao; Zhu, Junjie; Lu, Jie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020236901 A1 2020-11-26

$RFMT $RIREG SCHEME191 STEP1
$RXN



  2  1
$MOL
Cyanoacetic acid
C3H3NO2
372-09-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 2.6673 0.0 0
M  V30 2 C 1.5400 1.3336 0.0 0
M  V30 3 C 3.8500 2.6673 0.0 0
M  V30 4 O 2.3100 0.0000 0.0 0
M  V30 5 O 0.0000 1.3336 0.0 0
M  V30 6 N 5.3900 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 3 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Oxo-1-pyrrolidinepropanenitrile
C7H10N2O
14227-95-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 C 5.1047 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 N 7.7722 0.7700 0.0 0
M  V30 6 N 2.4374 2.3100 0.0 0
M  V30 7 C 1.0304 1.6835 0.0 0
M  V30 8 C 2.2765 3.8416 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 10 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 3 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 372-09-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14227-95-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-17077822
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM α-Diazo-β-oxo-1-pyrrolidinepropanenitrile
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Marcoux, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM e-EROS Encyclopedia of Reagents for Organic Synthesis (2011), 1-2

$RFMT $RIREG SCHEME192 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoropyridine
C5H4FN
372-48-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Pyrrolidinyl)pyridine
C9H12N2
54660-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3698 1.3337 0.0 0
M  V30 2 C 1.4646 0.0878 0.0 0
M  V30 3 C 1.4646 2.5795 0.0 0
M  V30 4 C 0.0000 0.5636 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 3.9098 1.3337 0.0 0
M  V30 7 C 4.6798 0.0000 0.0 0
M  V30 8 N 4.6798 2.6673 0.0 0
M  V30 9 C 6.2198 0.0000 0.0 0
M  V30 10 C 6.2198 2.6673 0.0 0
M  V30 11 C 6.9898 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 372-48-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54660-06-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39567725
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a pressure tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper-catalyzed direct α-peroxidation of nitrogen heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gerard, Phideline; Guissart, Celine; Evano, Gwilherm
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2024), (5), 202312154

$RFMT $RIREG SCHEME193 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Tungsten, carbonyl(η5-2,4-cyclopentadien-1-yl)[[(1,1-dimethylethyl)dimethylsi...
C14H21NO2SiW
380373-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.5094 1.5414 0.0 0 CHG=-2 VAL=4
M  V30 2 C 4.1761 1.1550 0.0 0
M  V30 3 Si 4.8427 1.5414 0.0 0
M  V30 4 C 5.5094 1.1550 0.0 0
M  V30 5 C 4.8427 2.6793 0.0 0
M  V30 6 C 5.5667 1.9596 0.0 0
M  V30 7 C 6.1760 1.5414 0.0 0
M  V30 8 C 5.8958 0.4883 0.0 0
M  V30 9 C 5.1251 0.4883 0.0 0
M  V30 10 C 0.8429 1.5414 0.0 0
M  V30 11 O 0.0722 1.5414 0.0 0 VAL=3
M  V30 12 N 2.1761 0.7707 0.0 0 VAL=4
M  V30 13 O 2.1761 0.0000 0.0 0 CHG=1 VAL=3
M  V30 14 W 2.1761 2.3120 0.0 0 CHG=2 VAL=9
M  V30 15 C 2.1761 6.4308 0.0 0 CHG=-1 VAL=4
M  V30 16 C 1.3758 4.3714 0.0 0 VAL=5
M  V30 17 C 2.9765 4.3714 0.0 0 VAL=5
M  V30 18 C 4.3502 5.1718 0.0 0 VAL=5
M  V30 19 C 0.0000 5.1718 0.0 0 VAL=5
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 2 1 14 CFG=2
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 4 9
M  V30 10 3 10 11
M  V30 11 1 10 14
M  V30 12 3 12 13
M  V30 13 1 12 14
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 14 17
M  V30 17 1 14 18
M  V30 18 1 14 19
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 1 16 17
M  V30 22 2 16 19
M  V30 23 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbonyl(η5-2,4-cyclopentadien-1-yl)[2-[(1,1-dimethylethyl)dimethylsilyl]-1-(...
C18H30N2O2SiW
380373-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2922 3.6979 0.0 0 CHG=-2 VAL=4
M  V30 2 C 7.4831 4.3882 0.0 0
M  V30 3 Si 8.6740 3.6979 0.0 0
M  V30 4 C 9.8650 4.3882 0.0 0
M  V30 5 C 8.6740 1.6650 0.0 0
M  V30 6 C 9.9863 2.9735 0.0 0
M  V30 7 C 11.0673 3.7207 0.0 0
M  V30 8 C 10.5515 5.5791 0.0 0
M  V30 9 C 9.1785 5.5791 0.0 0
M  V30 10 C 1.5057 3.6562 0.0 0
M  V30 11 O 0.1290 3.6562 0.0 0 VAL=3
M  V30 12 N 3.8876 2.2794 0.0 0 VAL=4
M  V30 13 O 3.8876 0.9027 0.0 0 CHG=1 VAL=3
M  V30 14 W 3.8876 5.0330 0.0 0 CHG=2 VAL=9
M  V30 15 C 3.8876 12.3909 0.0 0 CHG=-1 VAL=4
M  V30 16 C 2.4577 8.7120 0.0 0 VAL=5
M  V30 17 C 5.3174 8.7120 0.0 0 VAL=5
M  V30 18 C 7.7714 10.1418 0.0 0 VAL=5
M  V30 19 C 0.0000 10.1418 0.0 0 VAL=5
M  V30 20 N 6.2922 2.3250 0.0 0
M  V30 21 C 5.0557 1.4830 0.0 0
M  V30 22 C 7.4679 1.4337 0.0 0
M  V30 23 C 5.5450 0.0228 0.0 0
M  V30 24 C 7.0052 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 14 CFG=2
M  V30 3 1 1 20
M  V30 4 1 2 3
M  V30 5 1 3 4
M  V30 6 1 3 5
M  V30 7 1 3 6
M  V30 8 1 4 7
M  V30 9 1 4 8
M  V30 10 1 4 9
M  V30 11 3 10 11
M  V30 12 1 10 14
M  V30 13 3 12 13
M  V30 14 1 12 14
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 17
M  V30 18 1 14 18
M  V30 19 1 14 19
M  V30 20 1 15 18
M  V30 21 1 15 19
M  V30 22 1 16 17
M  V30 23 2 16 19
M  V30 24 2 17 18
M  V30 25 1 20 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 380373-59-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 380373-66-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-239-CAS-895438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Synthesis of the Aminocarbene Complexes
[W{=C-(NR1R2)CH2Si(CH3)2C(CH3)3}(η5-C5H5)(CO)(NO)] (R1= H, R2= n-C4H9
(5a); R1= H, R2= CH(CH3)2 (5b); R1= H, R2 = C(CH3)3 (5c); R1= R2= (CH2)4
(5d)). General Procedure. A 20-fold excess of the appropriate primary
amine (NH2R; R = n-C4H9, CH(CH3)2, C(CH3)3) or secondary amine
(pyrrolidine) was syringed at room temperature into a stirred solution of
the vinylidene complex 4 (0.50 g, 1.29 mmol) in 25 mL of THF. The color
of the reaction mixture changed from orange to red. When the reaction was
complete, the volatile components were removed under reduced pressure and
dried under vacuum. The samples were spetroscopically pure, and no effort
was made for any further purification.
[W{=C(cyclo-NC4H8)CH2Si(CH3)2C(CH3)3}(η5-C5H5)(CO)(NO)] (5d): reaction
time 1 h, dark red viscous oil (100% yield). Anal. Calcd for
C18H30N2O2SiW: C, 41.71; H, 5.83, N, 5.40. Found: C, 41.21; H, 5.80; N,
5.22. 1H NMR (CDCl3, 400.13 MHz): δ 5.49 (2JH-W = 8.9 Hz) (s, 5H, Cp),
3.77, 3.60- 3.53, and 3.48-3.41 (br s and 2 m, 4H, CH2CH2CH2CH2), 2.78
(2JH-H = 10.8 Hz) and 2.69 [br d and br s, AB system, 2H,
CH2Si(CH3)2C(CH3)3], 2.10-1.90 (m, 4H, CH2CH2CH2CH2), 0.89 [s, 9H,
Si(CH3)2C(CH3)3], 0.12 and 0.04 [2 s, diastereotopic methyl groups, 6H,
Si(CH3)2C(CH3)3]. 13C NMR (CDCl3, 100.61 MHz): δ 252.4 (1JC-W = 158.1 Hz)
(carbene C), 237.1 (CO), 93.7 (Cp), 60.3 and 51.8 (CH2CH2CH2CH2), 40.8
[CH2Si(CH3)2C(CH3)3], 26.4 [Si(CH3)2C(CH3)3], 25.9 and 25.3
(CH2CH2CH2CH2), 17.6 [Si(CH3)2C(CH3)3], -3.9 and -6.2 [Si(CH3)2C(CH3)3].
IR (KBr; ν˜ (cm-1)): 1889 (s, C=O), 1576 (s, N≡O). MS (70 eV) m/e 518
(M+, 184W), 488 (M+ - NO). Highresolution mass spectrum: m/e calcd for
C18H30N2O2Si182W (M+) 516.1559, found 516.1554.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM η2-Alkynyl and Vinylidene Transition Metal Complexes. 7. Hydroamination
of Neutral Tungsten-Vinylidene Complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ipaktschi, Junes; Uhlig, Sascha; Duelmer, Ansgar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organometallics (2001), 20(23), 4840-4846

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Undecenoyl chloride
C11H19ClO
38460-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 13.3370 2.3101 0.0 0
M  V30 11 Cl 0.0000 2.3101 0.0 0
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Pyrrolidinyl)-10-undecen-1-one
C15H27NO
95018-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1047 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4397 2.3101 0.0 0
M  V30 8 C 11.7734 1.5400 0.0 0
M  V30 9 C 13.1071 2.3101 0.0 0
M  V30 10 C 14.4407 1.5400 0.0 0
M  V30 11 C 15.7746 2.3101 0.0 0
M  V30 12 C 17.1082 1.5400 0.0 0
M  V30 13 N 2.4374 2.3101 0.0 0
M  V30 14 C 1.0306 1.6836 0.0 0
M  V30 15 C 2.2765 3.8416 0.0 0
M  V30 16 C 0.0000 2.8281 0.0 0
M  V30 17 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38460-95-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95018-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-22211365
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amines via hydroaminoalkylation reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maulide, Nuno; Shaaban, Saad; Goncalves, Carlos; Tona, Veronica; Kaiser,
Daniel; Hsu, Che-Sheng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019219942 A1 2019-11-21

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Undecenoyl chloride
C11H19ClO
38460-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 13.3370 2.3101 0.0 0
M  V30 11 Cl 0.0000 2.3101 0.0 0
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Pyrrolidinyl)-10-undecen-1-one
C15H27NO
95018-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1047 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4397 2.3101 0.0 0
M  V30 8 C 11.7734 1.5400 0.0 0
M  V30 9 C 13.1071 2.3101 0.0 0
M  V30 10 C 14.4407 1.5400 0.0 0
M  V30 11 C 15.7746 2.3101 0.0 0
M  V30 12 C 17.1082 1.5400 0.0 0
M  V30 13 N 2.4374 2.3101 0.0 0
M  V30 14 C 1.0306 1.6836 0.0 0
M  V30 15 C 2.2765 3.8416 0.0 0
M  V30 16 C 0.0000 2.8281 0.0 0
M  V30 17 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38460-95-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95018-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-23239181
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of amines via hydroaminomethylation reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Maulide, Nuno; Shaaban, Saad; Goncalves, Carlos; Tona, Veronica; Kaiser,
Daniel
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP3569593 A1 2019-11-20

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Undecenoyl chloride
C11H19ClO
38460-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 13.3370 2.3101 0.0 0
M  V30 11 Cl 0.0000 2.3101 0.0 0
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Pyrrolidinyl)-10-undecen-1-one
C15H27NO
95018-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1047 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4397 2.3101 0.0 0
M  V30 8 C 11.7734 1.5400 0.0 0
M  V30 9 C 13.1071 2.3101 0.0 0
M  V30 10 C 14.4407 1.5400 0.0 0
M  V30 11 C 15.7746 2.3101 0.0 0
M  V30 12 C 17.1082 1.5400 0.0 0
M  V30 13 N 2.4374 2.3101 0.0 0
M  V30 14 C 1.0306 1.6836 0.0 0
M  V30 15 C 2.2765 3.8416 0.0 0
M  V30 16 C 0.0000 2.8281 0.0 0
M  V30 17 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38460-95-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95018-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20314447
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM α-Fluorination of carbonyls with nucleophilic fluorine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Adler, Pauline; Teskey, Christopher J.; Kaiser, Daniel; Holy, Marion;
Sitte, Harald H.; Maulide, Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Chemistry (2019), 11(4), 329-334

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Undecenoyl chloride
C11H19ClO
38460-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 13.3370 2.3101 0.0 0
M  V30 11 Cl 0.0000 2.3101 0.0 0
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Pyrrolidinyl)-10-undecen-1-one
C15H27NO
95018-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1047 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4397 2.3101 0.0 0
M  V30 8 C 11.7734 1.5400 0.0 0
M  V30 9 C 13.1071 2.3101 0.0 0
M  V30 10 C 14.4407 1.5400 0.0 0
M  V30 11 C 15.7746 2.3101 0.0 0
M  V30 12 C 17.1082 1.5400 0.0 0
M  V30 13 N 2.4374 2.3101 0.0 0
M  V30 14 C 1.0306 1.6836 0.0 0
M  V30 15 C 2.2765 3.8416 0.0 0
M  V30 16 C 0.0000 2.8281 0.0 0
M  V30 17 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38460-95-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95018-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-20699534
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A General Acid-Mediated Hydroaminomethylation of Unactivated Alkenes and
Alkynes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaiser, Daniel; Tona, Veronica; Goncalves, Carlos R.; Shaaban, Saad;
Oppedisano, Alberto; Maulide, Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2019), 58(41), 14639-14643

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Undecenoyl chloride
C11H19ClO
38460-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 13.3370 2.3101 0.0 0
M  V30 11 Cl 0.0000 2.3101 0.0 0
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Pyrrolidinyl)-10-undecen-1-one
C15H27NO
95018-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1047 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4397 2.3101 0.0 0
M  V30 8 C 11.7734 1.5400 0.0 0
M  V30 9 C 13.1071 2.3101 0.0 0
M  V30 10 C 14.4407 1.5400 0.0 0
M  V30 11 C 15.7746 2.3101 0.0 0
M  V30 12 C 17.1082 1.5400 0.0 0
M  V30 13 N 2.4374 2.3101 0.0 0
M  V30 14 C 1.0306 1.6836 0.0 0
M  V30 15 C 2.2765 3.8416 0.0 0
M  V30 16 C 0.0000 2.8281 0.0 0
M  V30 17 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38460-95-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95018-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-17876108
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemoselective Intermolecular Cross-Enolate-Type Coupling of Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaiser, Daniel; Teskey, Christopher J.; Adler, Pauline; Maulide, Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(45), 16040-16043

$RFMT $RIREG SCHEME194 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
10-Undecenoyl chloride
C11H19ClO
38460-95-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 C 9.3358 1.5400 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 10.6697 2.3101 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 12.0033 1.5400 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 13.3370 2.3101 0.0 0
M  V30 11 Cl 0.0000 2.3101 0.0 0
M  V30 12 O 1.3337 0.0000 0.0 0
M  V30 13 C 14.6707 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 2 10 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Pyrrolidinyl)-10-undecen-1-one
C15H27NO
95018-99-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1047 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4397 2.3101 0.0 0
M  V30 8 C 11.7734 1.5400 0.0 0
M  V30 9 C 13.1071 2.3101 0.0 0
M  V30 10 C 14.4407 1.5400 0.0 0
M  V30 11 C 15.7746 2.3101 0.0 0
M  V30 12 C 17.1082 1.5400 0.0 0
M  V30 13 N 2.4374 2.3101 0.0 0
M  V30 14 C 1.0306 1.6836 0.0 0
M  V30 15 C 2.2765 3.8416 0.0 0
M  V30 16 C 0.0000 2.8281 0.0 0
M  V30 17 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 38460-95-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 95018-99-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-17175123
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Flexible and Chemoselective Oxidation of Amides to α-Keto Amides and
α-Hydroxy Amides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de la Torre, Aurelien; Kaiser, Daniel; Maulide, Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2017), 139(19), 6578-6581

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-(trifluoromethyl)-3-pyridinecarbonitrile
C7H2ClF3N2
386704-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 4.2073 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 1.1273 0.0 0
M  V30 5 Cl 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 N 9.2400 2.6673 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 N 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 11
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Pyrrolidinyl)-6-(trifluoromethyl)-3-pyridinecarbonitrile
C11H10F3N3
166451-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.1048 0.0 0
M  V30 2 N 0.0000 5.1048 0.0 0
M  V30 3 C 7.7000 5.1048 0.0 0
M  V30 4 F 7.7000 6.6448 0.0 0
M  V30 5 F 9.2400 5.1048 0.0 0
M  V30 6 F 7.7000 3.5648 0.0 0
M  V30 7 C 3.8500 3.7710 0.0 0
M  V30 8 C 3.0800 5.1048 0.0 0
M  V30 9 N 5.3900 3.7710 0.0 0
M  V30 10 C 3.8500 6.4384 0.0 0
M  V30 11 C 6.1600 5.1048 0.0 0
M  V30 12 C 5.3900 6.4384 0.0 0
M  V30 13 N 3.0800 2.4374 0.0 0
M  V30 14 C 3.7063 1.0306 0.0 0
M  V30 15 C 1.5485 2.2764 0.0 0
M  V30 16 C 2.5619 0.0000 0.0 0
M  V30 17 C 1.2283 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 386704-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 166451-04-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16727961
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic heteroaryl ureas and amides as TRPV1 vanilloid
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Napoletano, Mauro; Trevisani, Marcello; Pavani, Maria Giovanna;
Fruttarolo, Francesca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2377850 A1 2011-10-19

$RFMT $RIREG SCHEME195 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-(trifluoromethyl)-3-pyridinecarbonitrile
C7H2ClF3N2
386704-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 F 1.5400 4.2073 0.0 0
M  V30 3 F 0.0000 2.6673 0.0 0
M  V30 4 F 1.5400 1.1273 0.0 0
M  V30 5 Cl 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 N 9.2400 2.6673 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 N 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 11
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Pyrrolidinyl)-6-(trifluoromethyl)-3-pyridinecarbonitrile
C11H10F3N3
166451-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.1048 0.0 0
M  V30 2 N 0.0000 5.1048 0.0 0
M  V30 3 C 7.7000 5.1048 0.0 0
M  V30 4 F 7.7000 6.6448 0.0 0
M  V30 5 F 9.2400 5.1048 0.0 0
M  V30 6 F 7.7000 3.5648 0.0 0
M  V30 7 C 3.8500 3.7710 0.0 0
M  V30 8 C 3.0800 5.1048 0.0 0
M  V30 9 N 5.3900 3.7710 0.0 0
M  V30 10 C 3.8500 6.4384 0.0 0
M  V30 11 C 6.1600 5.1048 0.0 0
M  V30 12 C 5.3900 6.4384 0.0 0
M  V30 13 N 3.0800 2.4374 0.0 0
M  V30 14 C 3.7063 1.0306 0.0 0
M  V30 15 C 1.5485 2.2764 0.0 0
M  V30 16 C 2.5619 0.0000 0.0 0
M  V30 17 C 1.2283 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 386704-06-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 166451-04-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13928509
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of
2-(1-pyrrolidin)-6-(trifluoromethyl)-pyridine-3-carbonitrile 28e (Scheme
14). To 2-chloro-6-trifluoromethyl-nicotinonitrile (0.5g, 2.4 mmol) was
added pyrrolidine (4 mol eq) and the mixture was heated in neat at 90°C
for 3 h. The mixture was concentrated, water was added and the mixture
was extracted with EtOAc (3×20 mL). The recombined organic phases were
anhydrified and evaporated to dryness to obtain
2-(1-pyrrolidin)-6-(trifluoromethyl)nicotinonitrile as pale yellow oil
(0.88 g, quantitative yield). 1HNMR (DMSO, 200 MHz) δ 1.44 (m, 4H), 2.10
(m, 4H), 7.25 (d, 1H, J=8), 7.54 (d, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic heteroaryl ureas and amides as TRPV1 vanilloid
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Napoletano, Mauro; Trevisani, Marcello; Pavani, Maria Giovanna;
Fruttarolo, Francesca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011120604 A1 2011-10-06

$RFMT $RIREG SCHEME196 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluorobenzonitrile
C7H4FN
394-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 6.1601 2.6673 0.0 0
M  V30 3 F 3.0801 0.0000 0.0 0
M  V30 4 C 3.0801 2.6673 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 2.3101 4.0010 0.0 0
M  V30 7 C 0.7700 1.3337 0.0 0
M  V30 8 C 0.7700 4.0010 0.0 0
M  V30 9 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 5
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Pyrrolidinyl)benzonitrile
C11H12N2
20925-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 1.3338 0.0 0
M  V30 2 N 3.1398 0.0000 0.0 0
M  V30 3 C 3.9098 4.0011 0.0 0
M  V30 4 C 4.6798 2.6674 0.0 0
M  V30 5 C 4.6798 5.3349 0.0 0
M  V30 6 C 6.2198 2.6674 0.0 0
M  V30 7 C 6.2198 5.3349 0.0 0
M  V30 8 C 6.9898 4.0011 0.0 0
M  V30 9 N 2.3698 4.0011 0.0 0
M  V30 10 C 1.4645 5.2469 0.0 0
M  V30 11 C 1.4645 2.7552 0.0 0
M  V30 12 C 0.0000 4.7711 0.0 0
M  V30 13 C 0.0000 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 394-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 20925-25-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3414552
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, sealed pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amination of aryl chlorides and fluorides toward the synthesis of
aromatic amines by palladium-catalyzed route or transition metal free
way: Scopes and limitations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kleist, Wolfgang; Proeckl, Sandra S.; Drees, Markus; Koehler, Klaus;
Djakovitch, Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2009), 303(1-2), 15-22

$RFMT $RIREG SCHEME197 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzeneacetic acid, α-isocyano-, methyl ester
C10H9NO2
39533-32-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 3.8500 0.0 0
M  V30 3 N 4.0011 1.5400 0.0 0 CHG=1 VAL=4
M  V30 4 O 6.6685 3.0800 0.0 0
M  V30 5 O 5.3347 5.3900 0.0 0
M  V30 6 C 4.0011 0.0000 0.0 0 CHG=-1
M  V30 7 C 8.0021 3.8500 0.0 0
M  V30 8 C 2.6674 3.8500 0.0 0
M  V30 9 C 1.3336 3.0800 0.0 0
M  V30 10 C 2.6674 5.3900 0.0 0
M  V30 11 C 0.0000 3.8500 0.0 0
M  V30 12 C 1.3336 6.1600 0.0 0
M  V30 13 C 0.0000 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 3 3 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Isocyano-2-phenyl-1-(1-pyrrolidinyl)ethanone
C13H14N2O
943030-27-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 2.6674 0.0 0
M  V30 2 C 3.9098 4.0011 0.0 0
M  V30 3 N 3.9098 1.3338 0.0 0 CHG=1 VAL=4
M  V30 4 O 4.6798 5.3349 0.0 0
M  V30 5 C 3.1398 0.0000 0.0 0 CHG=-1
M  V30 6 C 6.2198 2.6674 0.0 0
M  V30 7 C 6.9898 4.0011 0.0 0
M  V30 8 C 6.9898 1.3338 0.0 0
M  V30 9 C 8.5298 4.0011 0.0 0
M  V30 10 C 8.5298 1.3338 0.0 0
M  V30 11 C 9.2998 2.6674 0.0 0
M  V30 12 N 2.3698 4.0011 0.0 0
M  V30 13 C 1.4645 2.7552 0.0 0
M  V30 14 C 1.4645 5.2470 0.0 0
M  V30 15 C 0.0000 3.2311 0.0 0
M  V30 16 C 0.0000 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 2 2 4
M  V30 5 1 2 12
M  V30 6 3 3 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39533-32-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 943030-27-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39574717
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl sulfonium salt electron donor-acceptor complexes for halogen atom
transfer: Isocyanides as tunable coupling partners
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Huaibo; Cuomo, Valentina D.; Rossi-Ashton, James A.; Procter, David
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chem (2024), 10(4), 1240-1251

$RFMT $RIREG SCHEME198 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitrobenzyl bromide
C7H6BrNO2
3958-57-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 Br 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(3-Nitrophenyl)methyl]pyrrolidine
C11H14N2O2
415931-07-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 N 9.1059 1.5400 0.0 0 VAL=5
M  V30 3 O 9.1059 0.0000 0.0 0
M  V30 4 O 10.4396 2.3101 0.0 0
M  V30 5 C 5.1048 2.3101 0.0 0
M  V30 6 C 6.4384 1.5400 0.0 0
M  V30 7 C 5.1048 3.8501 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 6.4384 4.6201 0.0 0
M  V30 10 C 7.7722 3.8501 0.0 0
M  V30 11 N 2.4374 2.3101 0.0 0
M  V30 12 C 2.2763 3.8416 0.0 0
M  V30 13 C 1.0304 1.6837 0.0 0
M  V30 14 C 0.7700 4.1618 0.0 0
M  V30 15 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 8
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 3958-57-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 415931-07-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19550885
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preapration of diarylureas as allosteric modulators of cannabinoid CB1
receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Yanan; Nguyen, Thuy; German, Nadezhda
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018209030 A1 2018-11-15

$RFMT $RIREG SCHEME199 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl isocyanoacetate
C4H5NO2
39687-95-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 O 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 N 5.3348 1.5400 0.0 0 CHG=1 VAL=4
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 0.7700 0.0 0 CHG=-1
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 3 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Isocyano-1-(1-pyrrolidinyl)ethanone
C7H10N2O
67434-30-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 C 5.1047 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 N 6.4385 1.5400 0.0 0 CHG=1 VAL=4
M  V30 5 C 7.7722 0.7700 0.0 0 CHG=-1
M  V30 6 N 2.4374 2.3100 0.0 0
M  V30 7 C 1.0304 1.6835 0.0 0
M  V30 8 C 2.2765 3.8416 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 10 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 3 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39687-95-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 67434-30-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39574714
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Aryl sulfonium salt electron donor-acceptor complexes for halogen atom
transfer: Isocyanides as tunable coupling partners
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhao, Huaibo; Cuomo, Valentina D.; Rossi-Ashton, James A.; Procter, David
J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chem (2024), 10(4), 1240-1251

$RFMT $RIREG SCHEME200 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Pentenoyl chloride
C5H7ClO
39716-58-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 C 4.0011 1.5400 0.0 0
M  V30 4 Cl 0.0000 2.3100 0.0 0
M  V30 5 O 1.3338 0.0000 0.0 0
M  V30 6 C 5.3348 2.3100 0.0 0
M  V30 7 C 6.6686 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Pyrrolidinyl)-4-penten-1-one
C9H15NO
81911-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4386 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 N 2.4374 2.3101 0.0 0
M  V30 8 C 1.0304 1.6836 0.0 0
M  V30 9 C 2.2763 3.8416 0.0 0
M  V30 10 C 0.0000 2.8281 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39716-58-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 81911-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-15908171
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chemo- and Stereoselective Transition-Metal-Free Amination of Amides with
Azides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tona, Veronica; de la Torre, Aurelien; Padmanaban, Mohan; Ruider, Stefan;
Gonzalez, Leticia; Maulide, Nuno
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2016), 138(27), 8348-8351

$RFMT $RIREG SCHEME201 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-4-oxo-2-(1-pyrrolidinylcarbonyl)-1-pyrrolidinecarboxylate
C14H22N2O4
401564-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0170 4.0287 0.0 0
M  V30 2 O 8.3508 3.2587 0.0 0
M  V30 3 O 7.0170 5.5687 0.0 0
M  V30 4 C 9.6845 4.0287 0.0 0
M  V30 5 C 8.9145 5.3623 0.0 0
M  V30 6 C 11.0181 4.7987 0.0 0
M  V30 7 C 10.4545 2.6950 0.0 0
M  V30 8 C 3.9564 5.3914 0.0 0
M  V30 9 O 5.1008 6.4218 0.0 0
M  V30 10 O 3.3897 0.0000 0.0 0
M  V30 11 N 5.6834 3.2587 0.0 0
M  V30 12 C 4.2766 3.8850 0.0 0 CFG=2
M  V30 13 C 5.5225 1.7271 0.0 0
M  V30 14 C 3.2460 2.7406 0.0 0
M  V30 15 C 4.0160 1.4070 0.0 0
M  V30 16 N 2.4917 5.8673 0.0 0
M  V30 17 C 1.2459 4.9621 0.0 0
M  V30 18 C 2.0159 7.3320 0.0 0
M  V30 19 C 0.0000 5.8673 0.0 0
M  V30 20 C 0.4759 7.3320 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 12 8 CFG=1
M  V30 10 1 8 16
M  V30 11 2 10 15
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
[(2S)-2,5-Dihydro-4-(1-pyrrolidinyl)-1H-pyrrol-2-yl]-1-pyrrolidinylmethanone
C13H21N3O
874448-86-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 C 7.5421 2.8281 0.0 0
M  V30 4 C 6.5117 1.6836 0.0 0
M  V30 5 C 6.7721 4.1618 0.0 0
M  V30 6 C 5.1047 2.3100 0.0 0 CFG=1
M  V30 7 N 5.2658 3.8416 0.0 0
M  V30 8 N 9.0737 2.6672 0.0 0
M  V30 9 C 9.8437 1.3334 0.0 0
M  V30 10 C 10.1042 3.8116 0.0 0
M  V30 11 C 11.3501 1.6535 0.0 0
M  V30 12 C 11.5110 3.1852 0.0 0
M  V30 13 N 2.4374 2.3100 0.0 0
M  V30 14 C 2.2763 3.8416 0.0 0
M  V30 15 C 1.0304 1.6836 0.0 0
M  V30 16 C 0.7700 4.1618 0.0 0
M  V30 17 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 6 1 CFG=1
M  V30 3 1 1 13
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 3 8
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 7
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 401564-40-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 874448-86-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-15174005
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 6
2-{4-[(3S,4R,5S)-4-Methyl-5-(pyrrolidine-1-carbonyl)-pyrrolidin-3-yl]-piperazin-1-yl}-nicotinonitrile
Step 1
(S)-(2,3.4.5,2',5'-Hexahydro-1'-[1,3']bipyrroyl-5'-yl)-pyrrolidin-1-yl-methanone
The title compound of Preparation 1 (5.6 g, 20 mmol) was dissolved in
benzene (50 mL) containing 4 A molecular sieves (7.9 g) and treated with
pyrrolidine (2.0 mL, 24 mmol). The solution was filtered and concentrated
to dryness, leaving an orange foam (7.0 g, 100% yield).
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieve used, reaction from p. 15 in patent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of piperazinyl pyrrolidinyl compounds for treating diabetes
and other disorders regulated by dipeptidyl peptidase IV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cabral, Shawn; Hulin, Bernard; Piotrowski, David Walter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006008644 A1 2006-01-26

$RFMT $RIREG SCHEME202 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Fluoro-3-nitrobenzene
C6H4FNO2
402-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 F 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Nitrophenyl)pyrrolidine
C10H12N2O2
132993-20-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7722 3.0800 0.0 0 VAL=5
M  V30 2 O 7.7722 4.6201 0.0 0
M  V30 3 O 9.1058 2.3100 0.0 0
M  V30 4 C 3.7711 2.3100 0.0 0
M  V30 5 C 5.1047 3.0800 0.0 0
M  V30 6 C 3.7711 0.7700 0.0 0
M  V30 7 C 6.4385 2.3100 0.0 0
M  V30 8 C 5.1047 0.0000 0.0 0
M  V30 9 C 6.4385 0.7700 0.0 0
M  V30 10 N 2.4374 3.0800 0.0 0
M  V30 11 C 1.0304 2.4536 0.0 0
M  V30 12 C 2.2763 4.6116 0.0 0
M  V30 13 C 0.0000 3.5981 0.0 0
M  V30 14 C 0.7700 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 402-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 132993-20-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5768363
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-(3-Nitrophenyl)pyrrolidine. A mixture of 3-fluoronitrobenzene (21.2ml,
0.20mol) and pyrrolidine (33.4ml, 0.40mol) was stirred at reflux over
night. The cooled mixture was poured into water and the precipitate was
filtered off, washed with water and air-dried to afford to desired
product. Yield quantitative.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of arylbenzimidazole derivatives and their use for modulating
the GABA-a receptor complex to combat anxiety and related diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Teuber, Lene; Larsen, Janus S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004087690 A2 2004-10-14

$RFMT $RIREG SCHEME203 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4′-Fluoroacetophenone
C8H7FO
403-42-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4-(1-Pyrrolidinyl)phenyl]ethanone
C12H15NO
21557-09-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 5.3901 1.3337 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 4.6201 0.0000 0.0 0
M  V30 7 C 3.0801 2.6673 0.0 0
M  V30 8 C 3.0801 0.0000 0.0 0
M  V30 9 C 2.3101 1.3337 0.0 0
M  V30 10 N 6.9302 1.3337 0.0 0
M  V30 11 C 7.8354 0.0878 0.0 0
M  V30 12 C 7.8354 2.5796 0.0 0
M  V30 13 C 9.3000 0.5637 0.0 0
M  V30 14 C 9.3000 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 10
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-42-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 21557-09-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-12544063
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 872-50-4
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, alternative preparation decreased yield, sealed pressure
tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amination of aryl chlorides and fluorides toward the synthesis of
aromatic amines by palladium-catalyzed route or transition metal free
way: Scopes and limitations
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kleist, Wolfgang; Proeckl, Sandra S.; Drees, Markus; Koehler, Klaus;
Djakovitch, Laurent
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2009), 303(1-2), 15-22

$RFMT $RIREG SCHEME204 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzoyl chloride
C7H4ClFO
403-43-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 F 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Fluorophenyl)-1-pyrrolidinylmethanone
C11H12FNO
349644-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 F 9.1059 4.6201 0.0 0
M  V30 4 C 5.1048 2.3101 0.0 0
M  V30 5 C 5.1048 3.8501 0.0 0
M  V30 6 C 6.4386 1.5400 0.0 0
M  V30 7 C 6.4386 4.6201 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 N 2.4374 2.3101 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403-43-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 349644-07-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42762430
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photoredox-Catalyzed [3+2] annulation of Aromatic Amides with Olefins via
Iminium Intermediates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Zhanyong; Yao, Zhenying; Yu, Yueyang; Huang, Jialin; Ma, Xiaoqiang;
Zhao, Xingda; Chang, Zhe; Zhao, Depeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(52), e202412152

$RFMT $RIREG SCHEME205 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-4-chloro-2-methylquinazoline
C9H6BrClN2
403850-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 2.6674 0.0000 0.0 0
M  V30 2 C 0.0000 4.6200 0.0 0
M  V30 3 Br 8.0021 4.6200 0.0 0
M  V30 4 C 4.0011 3.8500 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 N 2.6674 4.6200 0.0 0
M  V30 7 C 5.3347 4.6200 0.0 0
M  V30 8 C 2.6674 1.5400 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 1.3336 3.8500 0.0 0
M  V30 11 C 6.6685 3.8500 0.0 0
M  V30 12 N 1.3336 2.3100 0.0 0
M  V30 13 C 6.6685 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 2 10
M  V30 3 1 3 11
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Bromo-2-methyl-4-(1-pyrrolidinyl)quinazoline
C13H14BrN3
403850-79-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 0.0000 0.0 0
M  V30 2 Br 0.0000 6.9301 0.0 0
M  V30 3 C 4.0011 4.6201 0.0 0
M  V30 4 C 5.3348 3.8501 0.0 0
M  V30 5 C 2.6673 3.8501 0.0 0
M  V30 6 C 4.0011 6.1601 0.0 0
M  V30 7 N 5.3348 2.3100 0.0 0
M  V30 8 N 2.6673 2.3100 0.0 0
M  V30 9 C 1.3337 4.6201 0.0 0
M  V30 10 C 2.6673 6.9301 0.0 0
M  V30 11 C 4.0011 1.5400 0.0 0
M  V30 12 C 1.3337 6.1601 0.0 0
M  V30 13 N 6.6684 4.6201 0.0 0
M  V30 14 C 8.0754 3.9937 0.0 0
M  V30 15 C 6.8295 6.1516 0.0 0
M  V30 16 C 9.1058 5.1381 0.0 0
M  V30 17 C 8.3358 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 13
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 2 6 10
M  V30 11 1 7 11
M  V30 12 2 8 11
M  V30 13 2 9 12
M  V30 14 1 10 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 403850-84-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 403850-79-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11540402
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: d) A solution of 0.8 g (3.1 mmol) of
7-bromo-4-chloro-2-methyl-quinazoline in 2 ml of pyrrolidine was heated
at reflux for 12 h. The reaction mixture was concentrated in vacuo, the
residue applied to a silica gel column with CH2Cl2/MeOH (95:5) as eluant.
Combination of the purified fractions and concentration in vacuo. Yield:
1g (100 %) of the desired of
7-bromo-2-methyl-4-pyrrolidin-1-yl-quinazoline as a yellow solid. Mp.
120-122°C. ISP mass spectrum, m/e: 292.2 (M+1 calculated for C13H14BrN3:
292).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Quinazoline derivatives useful as neuropeptide Y (NPY) receptor ligands,
particularly antagonists, their preparation and pharmaceutical
compositions, and their use in the treatment of, e.g. obesity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mattei, Patrizio; Mueller, Werner; Neidhart, Werner; Nettekoven, Matthias
Heinrich; Pflieger, Philippe
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004005265 A1 2004-01-15

$RFMT $RIREG SCHEME206 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-N-methyl-1,8-naphthalimide
C13H8BrNO2
4116-90-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 Br 8.4700 4.0011 0.0 0
M  V30 4 C 0.0000 2.6674 0.0 0
M  V30 5 C 4.6200 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.1600 2.6674 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 1.3338 0.0 0
M  V30 12 C 4.6200 0.0000 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 C 6.9300 1.3338 0.0 0
M  V30 15 N 1.5400 2.6674 0.0 0
M  V30 16 C 6.1600 5.3349 0.0 0
M  V30 17 C 6.1600 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 13
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 2 7 12
M  V30 12 1 8 13
M  V30 13 1 8 14
M  V30 14 1 9 15
M  V30 15 1 10 16
M  V30 16 1 11 15
M  V30 17 1 12 17
M  V30 18 2 13 16
M  V30 19 2 14 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-6-(1-pyrrolidinyl)-1H-benz[de]isoquinoline-1,3(2H)-dione
C17H16N2O2
824957-35-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.5400 5.3349 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 3 C 0.0000 2.6674 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 6.1600 2.6674 0.0 0
M  V30 6 C 3.8500 4.0011 0.0 0
M  V30 7 C 3.8500 1.3338 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 6.9300 1.3338 0.0 0
M  V30 10 C 4.6200 5.3349 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 2.3100 1.3338 0.0 0
M  V30 13 C 4.6200 0.0002 0.0 0
M  V30 14 C 6.1600 5.3349 0.0 0
M  V30 15 C 6.1600 0.0000 0.0 0
M  V30 16 N 1.5400 2.6674 0.0 0
M  V30 17 N 8.4700 4.0011 0.0 0
M  V30 18 C 9.3752 5.2469 0.0 0
M  V30 19 C 9.3752 2.7552 0.0 0
M  V30 20 C 10.8398 4.7711 0.0 0
M  V30 21 C 10.8398 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 11
M  V30 2 2 2 12
M  V30 3 1 3 16
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 6 11
M  V30 11 1 7 12
M  V30 12 2 7 13
M  V30 13 2 8 14
M  V30 14 1 8 17
M  V30 15 2 9 15
M  V30 16 1 10 14
M  V30 17 1 11 16
M  V30 18 1 12 16
M  V30 19 1 13 15
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4116-90-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 824957-35-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-11034081
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Fluorescence Properties of New Enaminenaphthalimides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM McAdam, C. John; Morgan, Joy L.; Murray, R. Eva; Robinson, Brian H.;
Simpson, Jim
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Australian Journal of Chemistry (2004), 57(6), 525-530

$RFMT $RIREG SCHEME207 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,5-Dibromothiazole
C3HBr2NS
4175-78-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 2.6218 0.0 0
M  V30 2 Br 5.3026 1.4946 0.0 0
M  V30 3 S 2.7406 2.4782 0.0 0
M  V30 4 C 1.3337 1.8517 0.0 0
M  V30 5 C 3.7711 1.3337 0.0 0
M  V30 6 C 1.4946 0.3202 0.0 0
M  V30 7 N 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Bromo-2-(1-pyrrolidinyl)thiazole
C7H9BrN2S
933696-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 7.7399 2.6217 0.0 0
M  V30 2 C 3.9688 1.3337 0.0 0
M  V30 3 S 4.9994 2.4782 0.0 0
M  V30 4 N 4.7388 0.0000 0.0 0
M  V30 5 C 6.4062 1.8517 0.0 0
M  V30 6 C 6.2453 0.3202 0.0 0
M  V30 7 N 2.4373 1.4948 0.0 0
M  V30 8 C 1.6672 2.8284 0.0 0
M  V30 9 C 1.4068 0.3502 0.0 0
M  V30 10 C 0.1609 2.5082 0.0 0
M  V30 11 C 0.0000 0.9767 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 7
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4175-78-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 933696-74-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27638771
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, pressure tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Stereoselective and Modular Assembly Method for Heterocycle-Fused Daucane
Sesquiterpenoids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Christiaens, Mien; Hullaert, Jan; Van Hecke, Kristof; Laplace, Duchan;
Winne, Johan M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2018), 24(52), 13783-13787

$RFMT $RIREG SCHEME208 STEP1
$RXN



  3  1
$MOL
Carbon disulfide
CS2
75-15-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 S 0.0000 0.0000 0.0 0
M  V30 3 S 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Vinylpyrazine
C6H6N2
4177-16-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 N 2.3101 0.0000 0.0 0
M  V30 6 N 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Pyrazinyl)ethyl 1-pyrrolidinecarbodithioate
C11H15N3S2
1939165-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 2.3101 0.0 0
M  V30 2 S 6.6685 3.0801 0.0 0
M  V30 3 S 8.0022 0.7700 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 C 4.0010 3.0801 0.0 0
M  V30 6 N 9.3360 3.0801 0.0 0
M  V30 7 C 9.4969 4.6116 0.0 0
M  V30 8 C 10.7428 2.4536 0.0 0
M  V30 9 C 11.0032 4.9318 0.0 0
M  V30 10 C 11.7732 3.5981 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 3.0801 0.0 0
M  V30 13 N 2.6673 0.7700 0.0 0
M  V30 14 N 0.0000 2.3101 0.0 0
M  V30 15 C 1.3337 0.0000 0.0 0
M  V30 16 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 75-15-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 4177-16-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1939165-00-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26181890
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial, green chemistry, regioselective, no solvent (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A one-pot three-component synthesis of dithiocarbamates starting from
vinyl pyridines and vinyl pyrazine under solvent- and catalyst-free
conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Halimehjani, Azim Ziyaei; Martens, Jurgen; Schluter, Torben
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2016), 72(27-28), 3958-3965

$RFMT $RIREG SCHEME209 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-3-nitrobenzaldehyde
C7H4FNO3
42564-51-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3100 0.0 0
M  V30 4 F 1.3337 4.6201 0.0 0
M  V30 5 C 6.6686 1.5400 0.0 0
M  V30 6 O 8.0022 2.3100 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 4.0011 1.5400 0.0 0
M  V30 9 C 2.6675 3.8500 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 4.0011 4.6201 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 10
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Nitro-4-(1-pyrrolidinyl)benzaldehyde
C11H12N2O3
284679-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.9098 1.3338 0.0 0 VAL=5
M  V30 2 O 4.6798 0.0000 0.0 0
M  V30 3 O 2.3698 1.3338 0.0 0
M  V30 4 C 8.5298 4.0011 0.0 0
M  V30 5 O 9.2998 5.3349 0.0 0
M  V30 6 C 3.9098 4.0011 0.0 0
M  V30 7 C 4.6798 2.6674 0.0 0
M  V30 8 C 4.6798 5.3349 0.0 0
M  V30 9 C 6.2198 2.6674 0.0 0
M  V30 10 C 6.2198 5.3349 0.0 0
M  V30 11 C 6.9898 4.0011 0.0 0
M  V30 12 N 2.3698 4.0011 0.0 0
M  V30 13 C 1.4645 2.7552 0.0 0
M  V30 14 C 1.4645 5.2469 0.0 0
M  V30 15 C 0.0000 3.2311 0.0 0
M  V30 16 C 0.0000 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 42564-51-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 284679-97-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32019639
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Expansion of the 4-(Diethylamino)benzaldehyde Scaffold to Explore the
Impact on Aldehyde Dehydrogenase Activity and Antiproliferative Activity
in Prostate Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ibrahim, Ali I. M.; Batlle, Elisabet; Sneha, Smarakan; Jimenez, Rafael;
Pequerul, Raquel; Pares, Xavier; Rungeler, Till; Jha, Vibhu; Tuccinardi,
Tiziano; Sadiq, Maria; Frame, Fiona; Maitland, Norman J.; Farres, Jaume;
Pors, Klaus
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2022), 65(5), 3833-3848

$RFMT $RIREG SCHEME210 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3aR,6aS)-3,3a,6,6a-Tetrahydro-2H-cyclopenta[b]furan-2-one
C7H8O2
43119-28-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.2795 2.3100 0.0 0
M  V30 2 C 2.3698 3.0800 0.0 0 CFG=1
M  V30 3 C 2.3698 1.5400 0.0 0 CFG=2
M  V30 4 C 3.8344 3.5559 0.0 0
M  V30 5 C 0.9051 3.5559 0.0 0
M  V30 6 O 3.8344 1.0641 0.0 0
M  V30 7 C 0.9051 1.0641 0.0 0
M  V30 8 C 4.7395 2.3100 0.0 0
M  V30 9 C 0.0000 2.3100 0.0 0
M  V30 10 H 2.3698 4.6200 0.0 0
M  V30 11 H 2.3698 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 10 CFG=3
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 11 CFG=3
M  V30 9 1 4 8
M  V30 10 2 5 9
M  V30 11 1 6 8
M  V30 12 1 7 9
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
2-[(1R,5S)-5-Hydroxy-2-cyclopenten-1-yl]-1-(1-pyrrolidinyl)ethanone
C11H17NO2
783345-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.8517 0.0 0
M  V30 2 C 5.1048 2.6218 0.0 0
M  V30 3 O 5.1048 4.1618 0.0 0
M  V30 4 O 0.7103 0.4890 0.0 0
M  V30 5 C 2.4374 2.6218 0.0 0 CFG=2
M  V30 6 C 1.0304 1.9954 0.0 0 CFG=1
M  V30 7 C 2.2763 4.1533 0.0 0
M  V30 8 C 0.0000 3.1398 0.0 0
M  V30 9 C 0.7700 4.4735 0.0 0
M  V30 10 N 6.4384 1.8517 0.0 0
M  V30 11 C 6.5995 0.3202 0.0 0
M  V30 12 C 7.8454 2.4781 0.0 0
M  V30 13 C 8.1058 0.0000 0.0 0
M  V30 14 C 8.8758 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 5 1 CFG=1
M  V30 3 2 2 3
M  V30 4 1 2 10
M  V30 5 1 6 4 CFG=1
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 5 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 43119-28-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 783345-17-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-14783355
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective syntheses of bicyclo[3.1.0]hexane carboxylic acid
derivatives by intramolecular cyclopropanation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yoshikawa, Naoki; Tan, Lushi; Yasuda, Nobuyoshi; Volante, Ralph P.;
Tillyer, Richard D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2004), 45(39), 7261-7264

$RFMT $RIREG SCHEME211 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Bis(benzotriazol-1-yl)methanethione
C13H8N6S
4314-19-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5242 2.5872 0.0 0
M  V30 2 S 5.8443 1.0809 0.0 0
M  V30 3 N 6.6687 3.6176 0.0 0
M  V30 4 C 8.1750 3.2975 0.0 0
M  V30 5 N 6.5078 5.1493 0.0 0
M  V30 6 C 8.9450 4.6313 0.0 0
M  V30 7 C 8.9450 1.9638 0.0 0
M  V30 8 N 7.9146 5.7756 0.0 0
M  V30 9 C 10.4850 4.6313 0.0 0
M  V30 10 C 10.4850 1.9638 0.0 0
M  V30 11 C 11.2550 3.2975 0.0 0
M  V30 12 N 4.0596 3.0631 0.0 0
M  V30 13 C 2.8137 2.1580 0.0 0
M  V30 14 N 3.5838 4.5278 0.0 0
M  V30 15 C 1.5677 3.0631 0.0 0
M  V30 16 C 2.6527 0.6263 0.0 0
M  V30 17 N 2.0437 4.5278 0.0 0
M  V30 18 C 0.1609 2.4368 0.0 0
M  V30 19 C 1.2459 0.0000 0.0 0
M  V30 20 C 0.0000 0.9052 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 2 5 8
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 2 14 17
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Pyrrolidinylthioxomethyl)-1H-benzotriazole
C11H12N4S
690634-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 1.5064 0.0 0
M  V30 2 S 5.4106 0.0000 0.0 0
M  V30 3 C 3.0800 2.2167 0.0 0
M  V30 4 N 4.5864 2.5368 0.0 0
M  V30 5 C 2.3100 3.5503 0.0 0
M  V30 6 C 2.3100 0.8830 0.0 0
M  V30 7 N 4.7474 4.0684 0.0 0
M  V30 8 N 3.3404 4.6948 0.0 0
M  V30 9 C 0.7700 3.5503 0.0 0
M  V30 10 C 0.7700 0.8830 0.0 0
M  V30 11 C 0.0000 2.2167 0.0 0
M  V30 12 N 7.1955 1.9823 0.0 0
M  V30 13 C 7.6714 3.4470 0.0 0
M  V30 14 C 8.4414 1.0771 0.0 0
M  V30 15 C 9.2114 3.4470 0.0 0
M  V30 16 C 9.6872 1.9823 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 12
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 2 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4314-19-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 690634-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-21322387
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Free Radical Synthetic Protocol for Benzothiazoles via Ring Opening of
Benzotriazole: A Two-step Organic Chemistry Experiment for Undergraduate
and Postgraduate Students
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Singh, Anoop S.; Mishra, Nidhi; Yadav, Mangal S.; Tiwari, Vinod K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Heterocyclic Chemistry (2019), 56(1), 275-280

$RFMT $RIREG SCHEME212 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[3-(3-chloropropyl)-2,3-dihydro-2-oxo-1H-benzimidazol-1-y...
C20H28ClN3O3
442688-36-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.4394 6.4933 0.0 0
M  V30 2 C 13.6258 5.4579 0.0 0
M  V30 3 C 15.0326 4.8316 0.0 0
M  V30 4 C 16.2784 5.7368 0.0 0
M  V30 5 Cl 17.6854 5.1103 0.0 0
M  V30 6 C 3.8500 3.7827 0.0 0
M  V30 7 O 3.0800 5.1165 0.0 0
M  V30 8 O 3.0800 2.4491 0.0 0
M  V30 9 C 1.5400 5.1165 0.0 0
M  V30 10 C 1.5400 3.5765 0.0 0
M  V30 11 C 0.0000 5.1165 0.0 0
M  V30 12 C 1.5400 6.6565 0.0 0
M  V30 13 N 10.0100 3.7827 0.0 0
M  V30 14 C 10.9152 2.5368 0.0 0
M  V30 15 C 10.9152 5.0287 0.0 0
M  V30 16 C 12.3799 3.0127 0.0 0
M  V30 17 C 10.5950 1.0306 0.0 0
M  V30 18 N 12.3799 4.5527 0.0 0
M  V30 19 C 13.5243 1.9823 0.0 0
M  V30 20 C 11.7394 0.0000 0.0 0
M  V30 21 C 13.2041 0.4760 0.0 0
M  V30 22 C 8.4700 3.7827 0.0 0
M  V30 23 C 7.7000 2.4491 0.0 0
M  V30 24 C 7.7000 5.1165 0.0 0
M  V30 25 C 6.1600 2.4491 0.0 0
M  V30 26 C 6.1600 5.1165 0.0 0
M  V30 27 N 5.3900 3.7827 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 2 3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 27
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 13 22
M  V30 16 1 14 16
M  V30 17 2 14 17
M  V30 18 1 15 18
M  V30 19 1 16 18
M  V30 20 2 16 19
M  V30 21 1 17 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2,3-dihydro-2-oxo-3-[3-(1-pyrrolidinyl)propyl]-1H-benzim...
C24H36N4O3
442689-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 10.4394 6.4933 0.0 0
M  V30 2 C 13.6258 5.4579 0.0 0
M  V30 3 C 15.0326 4.8316 0.0 0
M  V30 4 C 16.2786 5.7368 0.0 0
M  V30 5 C 3.8500 3.7827 0.0 0
M  V30 6 O 3.0800 5.1165 0.0 0
M  V30 7 O 3.0800 2.4491 0.0 0
M  V30 8 C 1.5400 5.1165 0.0 0
M  V30 9 C 1.5400 6.6565 0.0 0
M  V30 10 C 0.0000 5.1165 0.0 0
M  V30 11 C 1.5400 3.5765 0.0 0
M  V30 12 N 10.0100 3.7827 0.0 0
M  V30 13 C 10.9152 2.5368 0.0 0
M  V30 14 C 10.9152 5.0287 0.0 0
M  V30 15 C 12.3799 3.0127 0.0 0
M  V30 16 C 10.5950 1.0306 0.0 0
M  V30 17 N 12.3799 4.5527 0.0 0
M  V30 18 C 13.5243 1.9823 0.0 0
M  V30 19 C 11.7396 0.0000 0.0 0
M  V30 20 C 13.2041 0.4760 0.0 0
M  V30 21 C 8.4700 3.7827 0.0 0
M  V30 22 C 7.7000 5.1165 0.0 0
M  V30 23 C 7.7000 2.4491 0.0 0
M  V30 24 C 6.1600 5.1165 0.0 0
M  V30 25 C 6.1600 2.4491 0.0 0
M  V30 26 N 5.3900 3.7827 0.0 0
M  V30 27 N 17.6854 5.1103 0.0 0
M  V30 28 C 19.0190 5.8803 0.0 0
M  V30 29 C 18.0055 3.6041 0.0 0
M  V30 30 C 20.1635 4.8499 0.0 0
M  V30 31 C 19.5371 3.4431 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 1 2 3
M  V30 3 1 2 17
M  V30 4 1 3 4
M  V30 5 1 4 27
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 26
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 21
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 442688-36-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 442689-67-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3449118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A mixture of Compound 70 (2.26 g, 5.7 mM), prepared in Example 70,
pyrrolidine (1.0 ml, 10.4 mM), potassium carbonate (1.6 g, 11.5 mM) and a
catalytic amount of sodium iodide in DMF (40 ml) was heated in a 70° C.
oil bath for 16 hours. The mixture was allowed to cool to RT then diluted
with water (200 ml). The aqueous mixture was extracted with EtOAc (2×250
ml). The combined EtOAc extracts were dried over MgSO4 and evaporated in
vacuo. The product as an oil (2.4 g, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel substituted benzimidazol-2-ones as vasopressin receptor antagonists
and neuropeptide y modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Urbanski, Maud J.; Gunnet, Joseph W., Jr.; Demarest, Keith T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002055514 A2 2002-07-18

$RFMT $RIREG SCHEME213 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(8aS)-Tetrahydro-8-methyl-5,7(1H,6H)-indolizinedione
C9H13NO2
443984-06-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7036 6.1600 0.0 0
M  V30 2 O 3.7036 0.0000 0.0 0
M  V30 3 O 6.3710 4.6200 0.0 0
M  V30 4 C 2.3699 3.8500 0.0 0 CFG=1
M  V30 5 N 2.3699 2.3100 0.0 0
M  V30 6 C 3.7036 4.6200 0.0 0 CFG=3
M  V30 7 C 0.9052 4.3259 0.0 0
M  V30 8 C 3.7036 1.5400 0.0 0
M  V30 9 C 0.9052 1.8341 0.0 0
M  V30 10 C 5.0372 3.8500 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 C 5.0372 2.3100 0.0 0
M  V30 13 H 2.2090 5.3815 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 2 2 8
M  V30 3 2 3 10
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 4 7
M  V30 7 1 4 13 CFG=3
M  V30 8 1 5 8
M  V30 9 1 5 9
M  V30 10 1 6 10
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 4)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(8aS)-2,3,8,8a-Tetrahydro-8-methyl-7-(1-pyrrolidinyl)-5(1H)-indolizinone
C13H20N2O
443984-07-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7036 6.1600 0.0 0
M  V30 2 O 3.7036 0.0000 0.0 0
M  V30 3 C 5.0372 3.8500 0.0 0
M  V30 4 C 3.7036 4.6200 0.0 0 CFG=3
M  V30 5 C 5.0372 2.3100 0.0 0
M  V30 6 C 2.3698 3.8500 0.0 0 CFG=2
M  V30 7 C 3.7036 1.5400 0.0 0
M  V30 8 N 2.3698 2.3100 0.0 0
M  V30 9 C 0.9052 4.3259 0.0 0
M  V30 10 C 0.9052 1.8341 0.0 0
M  V30 11 C 0.0000 3.0800 0.0 0
M  V30 12 N 6.3709 4.6200 0.0 0
M  V30 13 C 7.7778 3.9935 0.0 0
M  V30 14 C 6.5318 6.1516 0.0 0
M  V30 15 C 8.8082 5.1381 0.0 0
M  V30 16 C 8.0382 6.4717 0.0 0
M  V30 17 H 2.2088 5.3816 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 7
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 12
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 6 17 CFG=3
M  V30 11 1 7 8
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 1 10 11
M  V30 15 1 12 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 443984-06-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 443984-07-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1743449
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 9(iv)
(8aS)-8-Methyl-7-(1-pyrrolidinyl)-1,2,3,5,8,8a-hexahydroindolizin-5-one.
2.62 ml (31.4 mmol) of pyrrolidine were added to a solution of 2.62 g
(15.7 mmol) of
(8aS)-8-methyl-1,2,3,5,6,7,8,8a-octahydroindolizine-5,7-dione [obtained
as described in Preparative Example 9(iii) above] in 30 ml of ethanol and
the resulting mixture was stirred for 30 minutes at 80°C. After the
reaction was completed, the solvent and excess pyrrolidine were removed
from the reaction mixture by evaporation under reduced pressure to afford
of the title compound as a brown oil. Yield: 3.67 g, (quantitative).
1H-NMR spectrum (500 MHz, CDCl3) δ ppm: 4.52 (1H, singlet); 3.80-3.65
(2H, multiplet); 3.44-3.34 (1H, multiplet); 3.33-3.17 (4H, multiplet);
2.61-2.43 (1H, multiplet); 2.02-1.89 (6 H, multiplet); 1.88-1.72 (4H,
multiplet); 1.01 (3H, doublet, J=7 Hz).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolizinylpyrrole derivates for treating cytokine
mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kimura, Tomio; Ohkawa, Nobuyuki; Nakao, Akira; Nagasaki, Takayoshi;
Yamazki, Takanori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002057264 A1 2002-07-25

$RFMT $RIREG SCHEME214 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-nitropyridine
C5H3ClN2O2
4548-45-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 N 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(Pyrrolidin-1-yl)pyridin-3-amine
C9H13N3
92808-19-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.5298 1.3336 0.0 0
M  V30 2 C 3.9098 1.3336 0.0 0
M  V30 3 C 4.6798 2.6673 0.0 0
M  V30 4 N 4.6798 0.0000 0.0 0
M  V30 5 C 6.2198 2.6673 0.0 0
M  V30 6 C 6.2198 0.0000 0.0 0
M  V30 7 C 6.9898 1.3336 0.0 0
M  V30 8 N 2.3698 1.3336 0.0 0
M  V30 9 C 1.4645 2.5795 0.0 0
M  V30 10 C 1.4645 0.0878 0.0 0
M  V30 11 C 0.0000 2.1037 0.0 0
M  V30 12 C 0.0000 0.5636 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4548-45-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 92808-19-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21014879
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM ultrasound (stage 1)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-heteroaryl substituted indazole-3-carboxamides fo
treating disorders characterized by the activation of Wnt pathway
signaling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kc, Sunil Kumar; Mak, Chi Ching; Mittapalli, Gopi Kumar; Hofilena, Brian
Joseph; Eastman, Brian Walter; Cao, Jianguo; Chiruta, Chandramouli;
Bollu, Venkataiah
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019165192 A1 2019-08-29

$RFMT $RIREG SCHEME215 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 3-bromo-4-(trifluoromethyl)-, methyl ester
C9H6BrF3O2
455941-82-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6673 0.0 0
M  V30 2 O 8.4700 4.0011 0.0 0
M  V30 3 O 8.4700 1.3336 0.0 0
M  V30 4 C 10.0100 4.0011 0.0 0
M  V30 5 Br 3.0800 0.0000 0.0 0
M  V30 6 C 1.5400 2.6673 0.0 0
M  V30 7 F 1.5400 4.2073 0.0 0
M  V30 8 F 0.0000 2.6673 0.0 0
M  V30 9 F 1.5400 1.1273 0.0 0
M  V30 10 C 6.1600 2.6673 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 3.8500 1.3336 0.0 0
M  V30 14 C 3.8500 4.0011 0.0 0
M  V30 15 C 3.0800 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 5 13
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 6 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-(1-pyrrolidinyl)-4-(trifluoromethyl)benzoate
C13H14F3NO2
2411969-54-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.4374 1.3337 0.0 0
M  V30 2 F 3.2074 0.0000 0.0 0
M  V30 3 F 1.1036 0.5637 0.0 0
M  V30 4 F 1.6674 2.6673 0.0 0
M  V30 5 C 7.7722 4.4137 0.0 0
M  V30 6 O 9.1059 3.6437 0.0 0
M  V30 7 O 7.7722 5.9538 0.0 0
M  V30 8 C 10.4396 4.4137 0.0 0
M  V30 9 C 3.7711 3.6437 0.0 0
M  V30 10 C 3.7711 2.1037 0.0 0
M  V30 11 C 5.1048 4.4137 0.0 0
M  V30 12 C 5.1048 1.3337 0.0 0
M  V30 13 C 6.4384 3.6437 0.0 0
M  V30 14 C 6.4384 2.1037 0.0 0
M  V30 15 N 2.4374 4.4137 0.0 0
M  V30 16 C 2.2763 5.9453 0.0 0
M  V30 17 C 1.0304 3.7874 0.0 0
M  V30 18 C 0.7700 6.2655 0.0 0
M  V30 19 C 0.0000 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 1 6 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 455941-82-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2411969-54-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21816740
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 98327-87-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Inhibitors of secreted carboxy esterase, Notum, and their use in
increasing Wnt protein signalling and treatment of central nervous system
and other disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fish, Paul Vincent; Mahy, William; Willis, Nicky John; Woodward, Hannah;
Atkinson, Benjamin N.; Bayle, Elliott D.; Sipthorp, James; Jones, Edith
Yvonne; Zhao, Yuguang; Vecchia, Luca; Ruza, Reinis Reinholds
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2020043866 A1 2020-03-05

$RFMT $RIREG SCHEME216 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 5,6,7,8-tetrahydro-2-methyl-6-oxo-1H-benz[f]indole-3-carboxylate
C21H19NO3
459451-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5013 3.8899 0.0 0
M  V30 2 O 4.9950 3.5697 0.0 0
M  V30 3 O 7.5317 2.7454 0.0 0
M  V30 4 C 4.5190 2.1050 0.0 0
M  V30 5 C 4.5319 6.6004 0.0 0
M  V30 6 O 15.1102 5.0604 0.0 0
M  V30 7 C 8.4418 5.8304 0.0 0
M  V30 8 C 8.4418 7.3704 0.0 0
M  V30 9 C 6.9771 5.3544 0.0 0
M  V30 10 C 9.7755 5.0604 0.0 0
M  V30 11 C 9.7755 8.1404 0.0 0
M  V30 12 N 6.9771 7.8463 0.0 0
M  V30 13 C 6.0719 6.6004 0.0 0
M  V30 14 C 11.1091 5.8304 0.0 0
M  V30 15 C 11.1091 7.3704 0.0 0
M  V30 16 C 12.4429 5.0604 0.0 0
M  V30 17 C 12.4429 8.1404 0.0 0
M  V30 18 C 13.7765 5.8304 0.0 0
M  V30 19 C 13.7765 7.3704 0.0 0
M  V30 20 C 3.0127 1.7849 0.0 0
M  V30 21 C 1.9823 2.9294 0.0 0
M  V30 22 C 2.5368 0.3202 0.0 0
M  V30 23 C 0.4759 2.6091 0.0 0
M  V30 24 C 1.0304 0.0000 0.0 0
M  V30 25 C 0.0000 1.1445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 20
M  V30 6 1 5 13
M  V30 7 2 6 18
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 2 8 11
M  V30 12 1 8 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 1 11 15
M  V30 16 1 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylmethyl 5,6,7,8-tetrahydro-2-methyl-6-(1-pyrrolidinyl)-1H-benz[f]indole-...
C25H28N2O2
724700-31-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5013 3.8899 0.0 0
M  V30 2 O 4.9949 3.5697 0.0 0
M  V30 3 O 7.5317 2.7454 0.0 0
M  V30 4 C 4.5190 2.1050 0.0 0
M  V30 5 C 4.5319 6.6005 0.0 0
M  V30 6 C 8.4417 5.8305 0.0 0
M  V30 7 C 8.4417 7.3705 0.0 0
M  V30 8 C 6.9772 5.3545 0.0 0
M  V30 9 C 9.7755 5.0605 0.0 0
M  V30 10 C 9.7755 8.1405 0.0 0
M  V30 11 N 6.9772 7.8463 0.0 0
M  V30 12 C 6.0719 6.6005 0.0 0
M  V30 13 C 11.1092 5.8305 0.0 0
M  V30 14 C 11.1092 7.3705 0.0 0
M  V30 15 C 12.4428 5.0605 0.0 0
M  V30 16 C 12.4428 8.1405 0.0 0
M  V30 17 C 13.7764 5.8305 0.0 0
M  V30 18 C 13.7764 7.3705 0.0 0
M  V30 19 C 3.0127 1.7849 0.0 0
M  V30 20 C 2.5367 0.3202 0.0 0
M  V30 21 C 1.9821 2.9294 0.0 0
M  V30 22 C 1.0304 0.0000 0.0 0
M  V30 23 C 0.4759 2.6091 0.0 0
M  V30 24 C 0.0000 1.1445 0.0 0
M  V30 25 N 15.1102 5.0605 0.0 0
M  V30 26 C 15.2712 3.5288 0.0 0
M  V30 27 C 16.5170 5.6868 0.0 0
M  V30 28 C 16.7775 3.2086 0.0 0
M  V30 29 C 17.5475 4.5424 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 19
M  V30 6 1 5 12
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 1 17 25
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 459451-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 724700-31-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-10704577
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: To a solution of bent indole ketone (80 mg,
0.24 mg) in dichloroethane (3 mL), was added pyrrolidine (25 ]xL, 0.28
mmol), sodium triacetoxyborohydride (81 mg, 0.38 mmol), and acetic acid
(14 mg, 0.24 mmol). The reaction mixture was stirred at room temperature
for overnight. The mixture was diluted with dichloromethane and washed
with saturated sodium bicarbonate. The organic phases were dried over
Na2SO4. After removing the solvent, the residue was loaded on silica gel
and chromatographed, eluting with ethyl acetate/methanol/ triethyl amine
(10:1:0.1). bent indole amine was obtained. This amine was converted into
a hydrochloride salt. Following the above procedure, linear indole amine
was generated in 100% yield. LC/MS (ESI+) 389 (M+1); Anal.
C25H28O2N2·HCl): C, N, H.
$DTYPE RXN:VAR(1):NOTES
$DATUM product isolated also as HCl salt
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of functionalized indoles, benzimidazolones and related
heterocycles as modulators of CCR-5 chemokine receptor and use in
treating patients with HIV
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harriman, Geraldine C. B.; Carson, Kenneth G.; Flynn, Daniel L.; Solomon,
Michael E.; Song, Yuntao; Trivedi, Bharat K.; Roth, Bruce D.; Kolz,
Christine N.; Pham, Ly; Sun, Kuai-Lin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2002072549 A1 2002-09-19

$RFMT $RIREG SCHEME217 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylformamide dimethyl acetal
C5H13NO2
4637-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methyl-4-nitroanisole
C8H9NO3
5367-32-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 1.3337 4.6201 0.0 0
M  V30 5 O 6.6686 4.6201 0.0 0
M  V30 6 C 8.0022 3.8500 0.0 0
M  V30 7 C 2.6675 2.3100 0.0 0
M  V30 8 C 2.6675 3.8500 0.0 0
M  V30 9 C 4.0011 1.5400 0.0 0
M  V30 10 C 4.0011 4.6201 0.0 0
M  V30 11 C 5.3348 2.3100 0.0 0
M  V30 12 C 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 1 5 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1-[2-(5-methoxy-2-nitrophenyl)ethenyl]-, (E)-
C13H16N2O3
61293-32-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 N 4.6200 1.3338 0.0 0 VAL=5
M  V30 4 O 3.8500 0.0000 0.0 0
M  V30 5 O 6.1600 1.3338 0.0 0
M  V30 6 O 1.5400 6.6685 0.0 0
M  V30 7 C 0.0000 6.6685 0.0 0
M  V30 8 C 4.6200 4.0011 0.0 0
M  V30 9 C 3.8500 2.6674 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 2.3100 2.6674 0.0 0
M  V30 12 C 2.3100 5.3347 0.0 0
M  V30 13 C 1.5400 4.0011 0.0 0
M  V30 14 N 8.4700 5.3347 0.0 0
M  V30 15 C 9.3752 4.0889 0.0 0
M  V30 16 C 9.3752 6.5807 0.0 0
M  V30 17 C 10.8398 4.5647 0.0 0
M  V30 18 C 10.8398 6.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 14
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 1 6 7
M  V30 8 1 6 12
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4637-24-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 5367-32-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 61293-32-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10932473
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step A: Preparation of
(E)-1-(4-bromo-2-nitrostyryl)pyrrolidine: A solution of
4-bromo-2-nitrotoluene (100 g, 463 mmol), pyrrolidine (46.2 mL, 565
mmol), and N,N-dimethylformamide dimethylacetal (75.6 mL, 565 mmol) was
refluxed for 4 hours at 110 °C. The reaction mixture was cooled to room
temperature and concentrated under reduced pressure. The crude
(E)-1-(4-bromo-2-nitrostyryl)pyrrolidine that was used directly without
further purification. Step A: (E)-1-(5-Methoxy-2-nitrostyryl)pyrrolidine
(100%) was prepared according to Synthesis of Compound 47, Step A,
substituting 4-methoxy-2-methyl-1-nitrobenzene for
4-bromo-2-nitrotoluene, and used without further purification.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted benzoazepines as toll-like receptor modulators and their
preparation and use for the treatment of TLR7- and TLR8-mediated diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Howbert, James Jeffry; Hershberg, Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2012097177 A2 2012-07-19

$RFMT $RIREG SCHEME218 STEP1
$RXN



  3  1
$MOL
p-Chloroacetophenone
C8H7ClO
99-91-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 Cl 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Dimethylformamide dimethyl acetal
C5H13NO2
4637-24-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 N 1.3338 1.5400 0.0 0
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 8 C 4.0011 4.6200 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-1-(4-Chlorophenyl)-3-(1-pyrrolidinyl)-2-propen-1-one
C13H14ClNO
2426642-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 6.6685 2.3101 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 Cl 0.0000 4.6201 0.0 0
M  V30 6 C 4.0010 2.3101 0.0 0
M  V30 7 C 4.0010 3.8501 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 2.6673 4.6201 0.0 0
M  V30 10 C 1.3337 2.3101 0.0 0
M  V30 11 C 1.3337 3.8501 0.0 0
M  V30 12 N 9.3360 2.3101 0.0 0
M  V30 13 C 9.4969 3.8416 0.0 0
M  V30 14 C 10.7428 1.6837 0.0 0
M  V30 15 C 11.0032 4.1618 0.0 0
M  V30 16 C 11.7733 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 2 4
M  V30 5 1 4 12
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 99-91-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 4637-24-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2426642-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28508805
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM One-pot synthesis, X-ray single crystal and molecular insight of
enaminone-based
β-morpholino-/N-methylpiperazinyl-/pyrrolidinylpropiophenone
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barakat, Assem; Soliman, Saied M.; Haukka, Matti; Al-Majid, Abdullah
Mohammed; Islam, Mohammad Shahidul; Ali, M.; Shaik, Mohammed Rafi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Crystals (2020), 10(4), 282

$RFMT $RIREG SCHEME219 STEP1
$RXN



  2  1
$MOL
5-Bromo-2-thiophenecarboxaldehyde
C5H3BrOS
4701-17-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3026 2.6218 0.0 0
M  V30 2 O 6.6363 1.8517 0.0 0
M  V30 3 Br 0.0000 1.4946 0.0 0
M  V30 4 C 3.9690 1.8517 0.0 0
M  V30 5 S 2.5620 2.4782 0.0 0
M  V30 6 C 3.8079 0.3202 0.0 0
M  V30 7 C 1.5316 1.3337 0.0 0
M  V30 8 C 2.3016 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 7
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(5-Bromo-2-thienyl)methyl]pyrrolidine
C9H12BrNS
1065184-86-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 Br 9.0738 1.4946 0.0 0
M  V30 3 C 5.1049 1.8517 0.0 0
M  V30 4 S 6.5117 2.4782 0.0 0
M  V30 5 C 5.2658 0.3202 0.0 0
M  V30 6 C 7.5421 1.3337 0.0 0
M  V30 7 C 6.7721 0.0000 0.0 0
M  V30 8 N 2.4374 1.8517 0.0 0
M  V30 9 C 1.0306 2.4782 0.0 0
M  V30 10 C 2.2765 0.3202 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 8
M  V30 3 1 2 6
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 4701-17-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1065184-86-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4385570
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 1-[(5-Bromo-2-thienyl)methyl]pyrrolidine 5-Bromo-2-thiophenecarbaldehyde
(191 mg, 1.0 mmol) was diluted in a mixture of dichloromethane (6 mL) and
N,N-dimethylformamide (2 mL), and cooled to 0 °C. Pyrrolidine (107 mg,
1.5 mmol)) was added, followed by sodium triacetoxyborohydride (1.04 g,
4.9 mmol, 4.9 eq) and glacial acetic acid (2 drops). The reaction mixture
was stirred at 23 °C for 2h, then carefully quenched with saturated aq
sodium bicarbonate (fizzing!). The reaction mixture was extracted with
dichloromethane (2 X10 mL), then the combined organic layers were
filtered through a SCX cartridge (5 grams), eluting with methanol (10
mL). The first fraction was discarded if no product was present by tic,
and the desired product was eluted from the resin with methanol in
ammonia (2M, Aldrich, 25 mL). The latter fraction was concentrated to
afford 349 mg (> 100%) of the title compound.
1-[(5-Bromo-2-thienyl)methyl]pyrrolidine, yield 349 mg (> 100%) 1H NMR
(400 MHz, CDCl3) δ 6.88 (d, 1 H), 6.69 (d, 1H), 3.77(s, 2H), 2.57 (m,
4H), 1.81(m, 4H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of indolecarboxamide derivatives for use as IKK2 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Boehm, Jeffrey Charles; Busch-Petersen, Jakob; Fu, Wei; Jin, Qi; Kerns,
Jeffrey K.; Li, Huijie; Lin, Guoliang; Lin, Xichen; Neipp, Christopher E.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008118724 A1 2008-10-02

$RFMT $RIREG SCHEME220 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Naphthazarin
C10H6O4
475-38-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.0000 3.0801 0.0 0
M  V30 2 O 1.3338 5.3901 0.0 0
M  V30 3 O 6.6687 2.3101 0.0 0
M  V30 4 O 5.3348 0.0000 0.0 0
M  V30 5 C 2.6675 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 C 1.3338 2.3101 0.0 0
M  V30 8 C 2.6675 4.6201 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 4.0012 0.7700 0.0 0
M  V30 11 C 1.3338 0.7700 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 5.3348 4.6201 0.0 0
M  V30 14 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 1 3 9
M  V30 4 2 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 14
M  V30 15 2 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5,8-Dihydroxy-2-(1-pyrrolidinyl)-1,4-naphthalenedione
C14H13NO4
129961-63-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 1.3338 0.0 0
M  V30 2 O 3.0801 0.0000 0.0 0
M  V30 3 O 2.3101 6.6687 0.0 0
M  V30 4 O 0.0000 5.3348 0.0 0
M  V30 5 C 3.0801 2.6675 0.0 0
M  V30 6 C 2.3101 4.0012 0.0 0
M  V30 7 C 4.6201 2.6675 0.0 0
M  V30 8 C 2.3101 1.3338 0.0 0
M  V30 9 C 3.0801 5.3348 0.0 0
M  V30 10 C 0.7700 4.0012 0.0 0
M  V30 11 C 5.3901 4.0012 0.0 0
M  V30 12 C 0.7700 1.3338 0.0 0
M  V30 13 C 4.6201 5.3348 0.0 0
M  V30 14 C 0.0000 2.6675 0.0 0
M  V30 15 N 6.9302 4.0012 0.0 0
M  V30 16 C 7.8354 5.2470 0.0 0
M  V30 17 C 7.8354 2.7553 0.0 0
M  V30 18 C 9.3000 4.7712 0.0 0
M  V30 19 C 9.3000 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 1 2 8
M  V30 3 2 3 9
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 1 11 15
M  V30 16 2 12 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 475-38-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 129961-63-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-6241697
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM "On water": unprecedented nucleophilic substitution and addition
reactions with 1,4-quinones in aqueous suspension
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tandon, Vishnu K.; Maurya, Hardesh K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2009), 50(43), 5896-5902

$RFMT $RIREG SCHEME221 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenenitrile
C4H5N
4786-20-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3100 1.3336 0.0 0
M  V30 2 C 1.5400 0.0000 0.0 0
M  V30 3 C 3.8500 1.3336 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 N 5.3900 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 3 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
β-Methyl-1-pyrrolidinepropanenitrile
C8H14N2
90152-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 C 5.1047 2.3100 0.0 0
M  V30 3 C 3.7710 0.0000 0.0 0
M  V30 4 C 6.4385 1.5400 0.0 0
M  V30 5 N 7.7722 0.7700 0.0 0
M  V30 6 N 2.4374 2.3100 0.0 0
M  V30 7 C 1.0304 1.6835 0.0 0
M  V30 8 C 2.2765 3.8416 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 10 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 3 4 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4786-20-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 90152-61-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-20560951
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2122312-62-1
$DTYPE RXN:VAR(1):NOTES
$DATUM glovebox used, oxa-aza-Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Template catalysis by manganese pincer complexes: oxa- and aza-Michael
additions to unsaturated nitriles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Shan; Milstein, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Science (2019), 10(39), 8990-8994

$RFMT $RIREG SCHEME222 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1,1-Dimethylethyl)-1,2,4-benzenetriol
C10H14O3
4857-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6674 0.0 0
M  V30 2 C 0.7700 4.0011 0.0 0
M  V30 3 C 0.0000 2.6674 0.0 0
M  V30 4 C 0.7700 1.3338 0.0 0
M  V30 5 O 3.0800 0.0000 0.0 0
M  V30 6 O 6.1600 5.3349 0.0 0
M  V30 7 O 7.7000 2.6674 0.0 0
M  V30 8 C 3.0800 2.6674 0.0 0
M  V30 9 C 3.8500 1.3338 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3338 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 9
M  V30 6 1 6 12
M  V30 7 1 7 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl)-6-(1-pyrrolidinyl)-1,3-benzenediol
C14H21NO2
178495-37-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.9318 0.0 0
M  V30 2 C 1.3337 1.8517 0.0 0
M  V30 3 C 1.3337 0.3117 0.0 0
M  V30 4 C 0.0000 1.0817 0.0 0
M  V30 5 C 0.0000 2.6218 0.0 0
M  V30 6 O 1.3337 4.9318 0.0 0
M  V30 7 C 5.3348 2.6218 0.0 0
M  V30 8 C 4.0012 1.8517 0.0 0
M  V30 9 C 5.3348 4.1618 0.0 0
M  V30 10 C 2.6673 2.6218 0.0 0
M  V30 11 C 4.0012 4.9318 0.0 0
M  V30 12 C 2.6673 4.1618 0.0 0
M  V30 13 N 6.6685 1.8517 0.0 0
M  V30 14 C 8.0755 2.4782 0.0 0
M  V30 15 C 6.8296 0.3202 0.0 0
M  V30 16 C 9.1059 1.3337 0.0 0
M  V30 17 C 8.3359 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 10
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 4857-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 178495-37-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-4549359
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 2206-26-0
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: "Redox cycling" preparation of
pyrrolidinoresorcinols 6a and 6b. To a solution of 0.06 mmol of
5-(2-pivalamidoethyl)-1,2,4-benzenetriol (2a) or
5-tert-butyl-1,2,4-benzenetriol (2b) in CD3CN (0.5 mL) was added
pyrrolidine (5 μL, 0.06 mmol), and the mixture was allowed to stand
overnight. 4-(pyrrolidin-1-yl)-6-tertbutylresorcinol (6b) 1H NMR (CD3CN)
δ 1.31 (s, 9H), 1.90 (br s, 4H), 2.92 (br s, 4H), 6.28 (s, 1H), 7.00 (s,
1H); 13C NMR (CD3CN) δ 25.03 (2C), 30.08 (3C), 34.90, 53.91 (2C), 103.28,
120.03, 128.09, 129.67, 151.50, 153.30; HRMS calcd for C14H21NO2 m/z (rel
intensity) 235.1573, found 235.1579 (56.7%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Pyrrolines Are Mechanism-Based Inactivators of the Quinone-Dependent
Amine Oxidases but Only Substrates of the Flavin-Dependent Amine Oxidases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Younghee; Ling, Ke-Qing; Lu, Xingliang; Silverman, Richard B.;
Shepard, E. M.; Dooley, D. M.; Sayre, Lawrence M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2002), 124(41), 12135-12143

$RFMT $RIREG SCHEME223 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Phenyl-2-propyn-1-yl)pyrrolidine
C13H15N
1015-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 4.6201 0.0 0
M  V30 2 C 5.3348 3.8501 0.0 0
M  V30 3 C 4.0012 3.0801 0.0 0
M  V30 4 N 8.0022 3.8501 0.0 0
M  V30 5 C 8.1633 2.3185 0.0 0
M  V30 6 C 9.4091 4.4764 0.0 0
M  V30 7 C 9.6696 1.9983 0.0 0
M  V30 8 C 10.4396 3.3320 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 3 2 3
M  V30 4 1 3 9
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1015-02-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-14646867
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1833884-09-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM catalyst prepared and used, Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic Activity of Cationic and Neutral Silver(I)-XPhos Complexes with
Nitrogen Ligands or Tolylsulfonate for Mannich and Aza-Diels-Alder
Coupling Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grirrane, Abdessamad; Alvarez, Eleuterio; Garcia, Hermenegildo; Corma,
Avelino
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2016), 22(1), 340-354

$RFMT $RIREG SCHEME224 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Podophyllotoxin
C22H22O8
518-28-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 7.7964 1.7270 0.0 0
M  V30 2 O 1.1446 1.6672 0.0 0
M  V30 3 O 7.8131 8.5974 0.0 0
M  V30 4 C 6.4794 9.3674 0.0 0
M  V30 5 O 10.4804 3.9773 0.0 0
M  V30 6 C 11.8142 4.7473 0.0 0
M  V30 7 O 10.4804 7.0574 0.0 0
M  V30 8 C 10.4804 8.5974 0.0 0
M  V30 9 C 5.1456 3.9773 0.0 0 CFG=1
M  V30 10 C 3.8119 4.7473 0.0 0
M  V30 11 C 5.1456 2.4373 0.0 0 CFG=1
M  V30 12 C 2.4782 3.9773 0.0 0
M  V30 13 C 3.8119 6.2873 0.0 0
M  V30 14 C 3.8119 1.6672 0.0 0 CFG=2
M  V30 15 C 6.2901 1.4068 0.0 0
M  V30 16 C 2.4782 2.4373 0.0 0 CFG=2
M  V30 17 C 1.1446 4.7473 0.0 0
M  V30 18 C 2.4782 7.0574 0.0 0
M  V30 19 C 4.1321 0.1609 0.0 0
M  V30 20 O 5.6638 0.0000 0.0 0
M  V30 21 C 1.1446 6.2873 0.0 0
M  V30 22 O 2.1580 8.5638 0.0 0
M  V30 23 O 0.0000 7.3179 0.0 0
M  V30 24 C 0.6265 8.7248 0.0 0
M  V30 25 C 6.4794 4.7473 0.0 0
M  V30 26 C 6.4794 6.2873 0.0 0
M  V30 27 C 7.8131 3.9773 0.0 0
M  V30 28 C 7.8131 7.0574 0.0 0
M  V30 29 C 9.1467 4.7473 0.0 0
M  V30 30 C 9.1467 6.2873 0.0 0
M  V30 31 H 6.5525 3.0637 0.0 0
M  V30 32 H 2.5660 0.7622 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 15
M  V30 2 1 16 2 CFG=1
M  V30 3 1 3 4
M  V30 4 1 3 28
M  V30 5 1 5 6
M  V30 6 1 5 29
M  V30 7 1 7 8
M  V30 8 1 7 30
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 9 25 CFG=1
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 11 31 CFG=3
M  V30 17 1 12 16
M  V30 18 2 12 17
M  V30 19 1 13 18
M  V30 20 1 14 16
M  V30 21 1 14 19
M  V30 22 1 14 32 CFG=1
M  V30 23 1 15 20
M  V30 24 1 17 21
M  V30 25 2 18 21
M  V30 26 1 18 22
M  V30 27 1 19 20
M  V30 28 1 21 23
M  V30 29 1 22 24
M  V30 30 1 23 24
M  V30 31 2 25 26
M  V30 32 1 25 27
M  V30 33 1 26 28
M  V30 34 2 27 29
M  V30 35 2 28 30
M  V30 36 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 9 11 14 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinyl[(5R,6S,7R,8R)-5,6,7,8-tetrahydro-8-hydroxy-7-(hydroxymethyl)-5...
C26H31NO8
291272-81-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 6.9302 0.0 0
M  V30 2 O 3.7711 5.3901 0.0 0
M  V30 3 C 3.7711 10.0102 0.0 0
M  V30 4 O 3.7711 11.5503 0.0 0
M  V30 5 O 6.4384 11.5503 0.0 0
M  V30 6 O 9.1059 2.3101 0.0 0
M  V30 7 C 10.4396 3.0801 0.0 0
M  V30 8 O 3.7711 2.3101 0.0 0
M  V30 9 C 3.7711 0.7700 0.0 0
M  V30 10 O 6.4384 0.7700 0.0 0
M  V30 11 C 7.7721 0.0000 0.0 0
M  V30 12 C 6.4384 6.9302 0.0 0 CFG=1
M  V30 13 C 7.7721 7.7002 0.0 0
M  V30 14 C 5.1048 7.7002 0.0 0 CFG=2
M  V30 15 C 7.7721 9.2402 0.0 0
M  V30 16 C 9.1059 6.9302 0.0 0
M  V30 17 C 5.1048 9.2402 0.0 0 CFG=2
M  V30 18 C 6.4384 10.0102 0.0 0 CFG=2
M  V30 19 C 9.1059 10.0102 0.0 0
M  V30 20 C 10.4396 7.7002 0.0 0
M  V30 21 C 10.4396 9.2402 0.0 0
M  V30 22 O 11.9043 7.2243 0.0 0
M  V30 23 O 11.9042 9.7161 0.0 0
M  V30 24 C 12.8094 8.4702 0.0 0
M  V30 25 C 6.4384 5.3901 0.0 0
M  V30 26 C 7.7721 4.6201 0.0 0
M  V30 27 C 5.1048 4.6201 0.0 0
M  V30 28 C 7.7721 3.0801 0.0 0
M  V30 29 C 5.1048 3.0801 0.0 0
M  V30 30 C 6.4384 2.3101 0.0 0
M  V30 31 N 2.4373 7.7002 0.0 0
M  V30 32 C 2.2763 9.2317 0.0 0
M  V30 33 C 1.0304 7.0738 0.0 0
M  V30 34 C 0.7700 9.5519 0.0 0
M  V30 35 C 0.0000 8.2182 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 1 1 31
M  V30 4 1 3 4
M  V30 5 1 17 3 CFG=3
M  V30 6 1 18 5 CFG=1
M  V30 7 1 6 7
M  V30 8 1 6 28
M  V30 9 1 8 9
M  V30 10 1 8 29
M  V30 11 1 10 11
M  V30 12 1 10 30
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 12 25 CFG=1
M  V30 16 2 13 15
M  V30 17 1 13 16
M  V30 18 1 14 17
M  V30 19 1 15 18
M  V30 20 1 15 19
M  V30 21 2 16 20
M  V30 22 1 17 18
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 2 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 29
M  V30 33 2 28 30
M  V30 34 1 29 30
M  V30 35 1 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 12 14 17 18)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 518-28-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 291272-81-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-3631
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Picropodophyllic Acid Pyrrolidinyl Amide (17). Pyrrolidine (0.8 mL, 9.6
mmol) was added to a solution of 1 (200 mg, 0.48 mmol) in dry benzene (20
mL), and the mixture was stirred at 50 °C under argon atmosphere during
46 h. Solvent and residual amine were evaporated in vacuum to give the
corresponding dihydroxyamide 17 in quantitative yield. Picropodophyllic
Acid Pyrrolidinyl Amide (17), quantitative yield 1H NMR (CDCl3): δ
1.50-1.90 (m, 4H, C9'-N-(CH2)4-), 3.20-3.50 (m, 4H, C9'- N-(CH2)4-). 13C
NMR (CDCl3): δ 24.2, 25.9, 46.0, 46.8 (C9'- N-(CH2)4-), 173.9 (C9'). IR
(film) cm-1: 3380, 1126, 1038 (OH), 1611 (CON-(CH2)4-). HRMS: calcd for
C26H31NO8 + H, 486.2122; found, 486.2127.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Biological Evaluation of New Podophyllic Aldehyde
Derivatives with Cytotoxic and Apoptosis-Inducing Activities
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castro, Ma Angeles; Miguel del Corral, Jose Ma; Garcia, Pablo A.; Rojo,
Ma Victoria; de la Iglesia-Vicente, Janis; Mollinedo, Faustino; Cuevas,
Carmen; San Feliciano, Arturo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2010), 53(3), 983-993

$RFMT $RIREG SCHEME225 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Thiophenecarbonyl chloride
C5H3ClOS
5271-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 Cl 5.1048 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 2.4374 2.3100 0.0 0
M  V30 5 C 1.0306 1.6835 0.0 0
M  V30 6 S 2.2764 3.8416 0.0 0
M  V30 7 C 0.0000 2.8281 0.0 0
M  V30 8 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinyl-2-thienylmethanone
C9H11NOS
69340-21-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 C 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 S 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 C 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 C 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5271-67-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 69340-21-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42762438
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photoredox-Catalyzed [3+2] annulation of Aromatic Amides with Olefins via
Iminium Intermediates
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tang, Zhanyong; Yao, Zhenying; Yu, Yueyang; Huang, Jialin; Ma, Xiaoqiang;
Zhao, Xingda; Chang, Zhe; Zhao, Depeng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2024), 63(52), e202412152

$RFMT $RIREG SCHEME226 STEP1
$RXN



  3  1
$MOL
Hexanal
C6H12O
66-25-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6687 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 O 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-(2-Phenylethynyl)hexyl]pyrrolidine
C18H25N
955387-89-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 3.7711 0.0 0
M  V30 2 C 3.8501 5.1048 0.0 0
M  V30 3 C 6.1601 3.7711 0.0 0
M  V30 4 C 3.0801 6.4384 0.0 0
M  V30 5 C 6.9302 5.1048 0.0 0
M  V30 6 C 8.4702 5.1048 0.0 0
M  V30 7 C 9.2402 6.4384 0.0 0
M  V30 8 C 10.7802 6.4384 0.0 0
M  V30 9 N 3.8501 2.4374 0.0 0
M  V30 10 C 2.3185 2.2763 0.0 0
M  V30 11 C 4.4764 1.0304 0.0 0
M  V30 12 C 1.9983 0.7700 0.0 0
M  V30 13 C 3.3320 0.0000 0.0 0
M  V30 14 C 2.3101 7.7722 0.0 0
M  V30 15 C 3.0801 9.1059 0.0 0
M  V30 16 C 0.7700 7.7722 0.0 0
M  V30 17 C 2.3101 10.4396 0.0 0
M  V30 18 C 0.0000 9.1059 0.0 0
M  V30 19 C 0.7700 10.4396 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 3 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 66-25-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 955387-89-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-4400429
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 13453-07-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 141432-50-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, solid-supported catalyst, reusable catalyst,
Poly (NIPAM-co-4-VP) used as support, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Au(III) catalyst supported on a thermoresponsive hydrogel and its
application to the A-3 coupling reaction in water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shabbir, Saira; Lee, Youngeun; Rhee, Hakjune
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Catalysis (2015), 322104-108

$RFMT $RIREG SCHEME227 STEP1
$RXN



  3  1
$MOL
2-Naphthalenecarboxaldehyde
C11H8O
66-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6687 3.0801 0.0 0
M  V30 2 O 8.0023 2.3101 0.0 0
M  V30 3 C 2.6675 2.3101 0.0 0
M  V30 4 C 2.6675 0.7700 0.0 0
M  V30 5 C 4.0012 3.0801 0.0 0
M  V30 6 C 1.3337 3.0801 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 C 1.3337 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-(2-Naphthalenyl)-3-phenyl-2-propyn-1-yl]pyrrolidine
C23H21N
955387-42-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.9098 0.0 0
M  V30 2 C 8.0022 4.6799 0.0 0
M  V30 3 C 9.3360 5.4499 0.0 0
M  V30 4 C 5.3348 4.6799 0.0 0
M  V30 5 C 4.0010 3.9098 0.0 0
M  V30 6 C 5.3348 6.2199 0.0 0
M  V30 7 C 2.6673 4.6799 0.0 0
M  V30 8 C 4.0010 6.9899 0.0 0
M  V30 9 C 2.6673 6.2199 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 1.3337 6.9899 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 0.0000 6.2199 0.0 0
M  V30 14 N 6.6685 2.3698 0.0 0
M  V30 15 C 7.9144 1.4646 0.0 0
M  V30 16 C 5.4226 1.4646 0.0 0
M  V30 17 C 7.4385 0.0000 0.0 0
M  V30 18 C 5.8985 0.0000 0.0 0
M  V30 19 C 10.6697 6.2199 0.0 0
M  V30 20 C 12.0033 5.4499 0.0 0
M  V30 21 C 10.6697 7.7599 0.0 0
M  V30 22 C 13.3370 6.2199 0.0 0
M  V30 23 C 12.0033 8.5299 0.0 0
M  V30 24 C 13.3370 7.7599 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 14
M  V30 4 3 2 3
M  V30 5 1 3 19
M  V30 6 2 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 6 8
M  V30 10 2 7 9
M  V30 11 1 7 10
M  V30 12 1 8 9
M  V30 13 1 9 11
M  V30 14 2 10 12
M  V30 15 2 11 13
M  V30 16 1 12 13
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 66-99-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 955387-42-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-16680617
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 14167-15-8
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent, sealed flask used, aerobic, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu(II) salen complex catalyzed synthesis of propargylamines by a
three-component coupling reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tajbaksh, Mahmood; Farhang, Maryam; Mardani, Hamid Reza; Hosseinzadeh,
Rahman; Sarrafi, Yaghoub
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Cuihua Xuebao (2013), 34(12), 2217-2222

$RFMT $RIREG SCHEME228 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyphenyl isocyanate
C8H7NO2
5416-93-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 0.0000 0.0 0
M  V30 2 C 8.0023 0.7700 0.0 0
M  V30 3 O 9.3360 1.5400 0.0 0
M  V30 4 O 1.3337 3.0801 0.0 0
M  V30 5 C 0.0000 2.3101 0.0 0
M  V30 6 C 5.3348 0.7700 0.0 0
M  V30 7 C 4.0012 0.0000 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 2.6675 0.7700 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 2.6675 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Methoxyphenyl)-1-pyrrolidinecarboxamide
C12H16N2O2
35799-27-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.1047 1.8517 0.0 0
M  V30 2 C 3.7711 2.6218 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 O 10.4396 4.9318 0.0 0
M  V30 5 C 11.7732 4.1618 0.0 0
M  V30 6 C 6.4384 2.6218 0.0 0
M  V30 7 C 7.7722 1.8517 0.0 0
M  V30 8 C 6.4384 4.1618 0.0 0
M  V30 9 C 9.1059 2.6218 0.0 0
M  V30 10 C 7.7722 4.9318 0.0 0
M  V30 11 C 9.1059 4.1618 0.0 0
M  V30 12 N 2.4373 1.8517 0.0 0
M  V30 13 C 2.2763 0.3202 0.0 0
M  V30 14 C 1.0304 2.4782 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 16 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 2 12
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5416-93-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35799-27-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33519645
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-54-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convergent Synthesis of Dihydrobenzofurans via Urea Ligand-Enabled
Heteroannulation of 2-Bromophenols with 1,3-Dienes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Houghtling, Kaitlyn E.; Canfield, Amanda M.; Paradine, Shauna M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(31), 5787-5790

$RFMT $RIREG SCHEME229 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Bromopropyl)phthalimide
C11H10BrNO2
5460-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7308 4.6948 0.0 0
M  V30 2 O 3.0202 0.0000 0.0 0
M  V30 3 C 6.0810 1.3627 0.0 0
M  V30 4 C 7.4146 2.1327 0.0 0
M  V30 5 C 8.7484 1.3627 0.0 0
M  V30 6 Br 10.0821 2.1327 0.0 0
M  V30 7 C 3.0800 3.9844 0.0 0
M  V30 8 C 2.3100 2.6508 0.0 0
M  V30 9 C 4.5864 3.6643 0.0 0
M  V30 10 C 2.3100 5.3182 0.0 0
M  V30 11 C 3.3404 1.5064 0.0 0
M  V30 12 C 0.7700 2.6508 0.0 0
M  V30 13 N 4.7474 2.1327 0.0 0
M  V30 14 C 0.7700 5.3182 0.0 0
M  V30 15 C 0.0000 3.9844 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 9
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 13
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 8 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 13
M  V30 15 1 12 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[3-(1-Pyrrolidinyl)propyl]-1H-isoindole-1,3(2H)-dione
C15H18N2O2
76277-39-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.7309 4.6949 0.0 0
M  V30 2 O 3.0203 0.0000 0.0 0
M  V30 3 C 6.0811 1.3628 0.0 0
M  V30 4 C 7.4148 2.1328 0.0 0
M  V30 5 C 8.7485 1.3628 0.0 0
M  V30 6 C 3.0801 3.9845 0.0 0
M  V30 7 C 2.3101 2.6509 0.0 0
M  V30 8 C 4.5864 3.6644 0.0 0
M  V30 9 C 2.3101 5.3184 0.0 0
M  V30 10 C 3.3405 1.5065 0.0 0
M  V30 11 C 0.7700 2.6509 0.0 0
M  V30 12 N 4.7473 2.1328 0.0 0
M  V30 13 C 0.7700 5.3184 0.0 0
M  V30 14 C 0.0000 3.9845 0.0 0
M  V30 15 N 10.0823 2.1328 0.0 0
M  V30 16 C 11.4891 1.5065 0.0 0
M  V30 17 C 10.2432 3.6644 0.0 0
M  V30 18 C 12.5196 2.6509 0.0 0
M  V30 19 C 11.7495 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 1 3 4
M  V30 4 1 3 12
M  V30 5 1 4 5
M  V30 6 1 5 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5460-29-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 76277-39-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19710028
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors:
synthesis, biological evaluation and binding mode analysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tazarki, Helmi; Zeinyeh, Wael; Esvan, Yannick J.; Knapp, Stefan;
Chatterjee, Deep; Schroder, Martin; Joerger, Andreas C.; Khiari,
Jameleddine; Josselin, Beatrice; Baratte, Blandine; Bach, Stephane;
Ruchaud, Sandrine; Anizon, Fabrice; Giraud, Francis; Moreau, Pascale
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2019), 166304-317

$RFMT $RIREG SCHEME230 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pseudopelletierine
C9H15NO
552-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.8995 1.7098 0.0 0
M  V30 2 O 0.0000 1.7098 0.0 0
M  V30 3 C 4.1374 2.0692 0.0 0
M  V30 4 N 5.3607 1.6499 0.0 0
M  V30 5 C 2.7199 1.0263 0.0 0
M  V30 6 C 3.2226 3.4944 0.0 0
M  V30 7 C 3.9835 1.0543 0.0 0
M  V30 8 C 1.4089 1.0879 0.0 0
M  V30 9 C 1.8521 2.8938 0.0 0
M  V30 10 C 2.4991 0.0000 0.0 0
M  V30 11 C 3.0122 2.5331 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-Methyl-3-(1-pyrrolidinyl)-9-azabicyclo[3.3.1]non-2-ene
C13H22N2
926659-04-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2966 1.2257 0.0 0
M  V30 2 C 3.7711 1.1989 0.0 0
M  V30 3 C 5.0678 0.9964 0.0 0
M  V30 4 C 4.7376 0.0000 0.0 0
M  V30 5 C 6.5893 1.8807 0.0 0
M  V30 6 C 6.3271 0.8883 0.0 0
M  V30 7 N 7.7602 1.3320 0.0 0
M  V30 8 C 5.8333 3.3959 0.0 0
M  V30 9 C 5.5207 2.4630 0.0 0
M  V30 10 C 4.4062 2.9465 0.0 0
M  V30 11 N 2.4373 1.9689 0.0 0
M  V30 12 C 2.2763 3.5007 0.0 0
M  V30 13 C 1.0304 1.3426 0.0 0
M  V30 14 C 0.7700 3.8208 0.0 0
M  V30 15 C 0.0000 2.4872 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 11
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 7
M  V30 10 1 6 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 552-70-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 926659-04-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-6636132
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7550-45-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 9-Methyl-3-(pyrrolidin-1-yl)-9-azabicyclo[3.3.1]non-3-ene. To
pseudo-pelletierine (1.5 g, 9.8 mmol) in toluene (75 mL) was added
pyrrolidine (4.9 mL, 58.75 mmol). TiCl4 (0.66 mL, 6.0 mmol ) in toluene
(10 mL) was then added to the mixture at -5 °C. The reaction mixture was
left to warm up to rt and stirred for 2 days. The mixture was filtered
and the filtrate was concentrated to a residue and toluene (100 mL) was
added and the mixture was filtered again. The filtrate was concentrated
to a residue to afford the product (2.0 g, 100%) as yellow oil.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bridged N-cyclic sulfonamide compounds as inhibitors of
gamma secretase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bowers, Simeon; Garofalo, Albert W.; Hom, Roy K.; Konradi, Andrei W.;
Mattson, Matthew N.; Neitzel, Martin L.; Semko, Chris M.; Truong, Anh P.;
Wu, Jing; Xu, Ying-Zi
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2007022502 A2 2007-02-22

$RFMT $RIREG SCHEME231 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenyl vinyl sulfone
C8H8O2S
5535-48-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 1.5400 0.0 0 VAL=6
M  V30 2 C 6.1600 1.5400 0.0 0
M  V30 3 O 4.6200 3.0800 0.0 0
M  V30 4 O 4.6200 0.0000 0.0 0
M  V30 5 C 6.9300 2.8736 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 2.3100 0.2064 0.0 0
M  V30 8 C 2.3100 2.8736 0.0 0
M  V30 9 C 0.7700 0.2064 0.0 0
M  V30 10 C 0.7700 2.8736 0.0 0
M  V30 11 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 2 2 5
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-(Phenylsulfonyl)ethyl]pyrrolidine
C12H17NO2S
649760-40-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 2.5795 0.0 0 VAL=6
M  V30 2 C 6.1600 2.5795 0.0 0
M  V30 3 O 4.6200 4.1195 0.0 0
M  V30 4 O 4.6200 1.0395 0.0 0
M  V30 5 C 6.9300 1.2459 0.0 0
M  V30 6 C 3.0800 2.5795 0.0 0
M  V30 7 C 2.3100 3.9132 0.0 0
M  V30 8 C 2.3100 1.2459 0.0 0
M  V30 9 C 0.7700 3.9132 0.0 0
M  V30 10 C 0.7700 1.2459 0.0 0
M  V30 11 C 0.0000 2.5795 0.0 0
M  V30 12 N 8.4700 1.2459 0.0 0
M  V30 13 C 9.3753 2.4917 0.0 0
M  V30 14 C 9.3753 0.0000 0.0 0
M  V30 15 C 10.8398 2.0159 0.0 0
M  V30 16 C 10.8398 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 2 5
M  V30 6 1 5 12
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5535-48-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 649760-40-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8354755
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N 1 ,N 1 ,N
2-Trimethyl-N2-[2-(phenylsulfonyl)ethyl]-1,2-ethanediamine (18a).
(Vinylsulfonyl)benzene (commercially available) (100 mg, 0.60 mmol) was
dissolved in DCM (4 mL, dry) to which N 1,N 1,N
2-trimethyl-1,2-ethanediamine (61 mg, 0.062 mL, 0.60 mmol) was added at
room temperature with stirring. Stirring was continued at room
temperature overnight. The solvent was removed under reduced pressure.
1-[2-(Phenylsulfonyl)ethyl]pyrrolidine (18d) Colourless oil, 100% yield.
1H-NMR (CDCl3): 7.93-7.96 (2H, m), 7.69 (1H, t, J = 7.2 Hz), 7.60 (2H, t,
J = 7.2 Hz), 3.43 (2H, br, s), 2.97 (2H, br, s), 2.57 (4H, br, s), 1.80
(4H, br, s). IR: 1452, 1308, 1293, 1252, 1144, 1086, 745, 725, 389 cm-1.
HRESIMS: calculated for C12H18NO2S 240.1053 Found: 240.1049.
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small
Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents
Development of Collagen-Induced Arthritis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Al-Riyami, Lamyaa; Pineda, Miguel A.; Rzepecka, Justyna; Huggan, Judith
K.; Khalaf, Abedawn I.; Suckling, Colin J.; Scott, Fraser J.; Rodgers,
David T.; Harnett, Margaret M.; Harnett, William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2013), 56(24), 9982-10002

$RFMT $RIREG SCHEME232 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Nitrophenyl)-1-pyrrolidinylmethanone
C11H12N2O3
53578-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 N 9.1059 4.6201 0.0 0 VAL=5
M  V30 4 O 9.1059 6.1601 0.0 0
M  V30 5 O 10.4396 3.8501 0.0 0
M  V30 6 C 5.1048 2.3101 0.0 0
M  V30 7 C 6.4384 1.5400 0.0 0
M  V30 8 C 5.1048 3.8501 0.0 0
M  V30 9 C 7.7722 2.3101 0.0 0
M  V30 10 C 6.4384 4.6201 0.0 0
M  V30 11 C 7.7722 3.8501 0.0 0
M  V30 12 N 2.4374 2.3101 0.0 0
M  V30 13 C 1.0304 1.6837 0.0 0
M  V30 14 C 2.2763 3.8416 0.0 0
M  V30 15 C 0.0000 2.8281 0.0 0
M  V30 16 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 53578-11-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41356629
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1313-99-1
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1314-13-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 7440-02-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 112-40-3
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, catalyst prepared and used, reusable catalyst, 90% isolated
yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A cooperative nanoscale ZnO-NiO-Ni heterojunction for sustainable
catalytic amidation of aldehydes with secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shelte, Amishwar Raysing; Patil, Rahul Daga; Pratihar, Sanjay
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Sustainability (2024), 2(9), 2615-2625

$RFMT $RIREG SCHEME233 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrobenzaldehyde
C7H5NO3
555-16-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 O 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-[(4-Nitrophenyl)methylene]bis[pyrrolidine]
C15H21N3O2
55591-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 3.9098 0.0 0
M  V30 2 N 9.1058 6.9898 0.0 0 VAL=5
M  V30 3 O 9.1058 8.5298 0.0 0
M  V30 4 O 10.4395 6.2198 0.0 0
M  V30 5 C 5.1047 4.6798 0.0 0
M  V30 6 C 6.4383 3.9098 0.0 0
M  V30 7 C 5.1047 6.2198 0.0 0
M  V30 8 C 7.7721 4.6798 0.0 0
M  V30 9 C 6.4383 6.9898 0.0 0
M  V30 10 C 7.7721 6.2198 0.0 0
M  V30 11 N 2.4374 4.6798 0.0 0
M  V30 12 C 1.0304 4.0535 0.0 0
M  V30 13 C 2.2763 6.2113 0.0 0
M  V30 14 C 0.0000 5.1979 0.0 0
M  V30 15 C 0.7700 6.5317 0.0 0
M  V30 16 N 3.7710 2.3698 0.0 0
M  V30 17 C 2.5252 1.4646 0.0 0
M  V30 18 C 5.0169 1.4646 0.0 0
M  V30 19 C 3.0010 0.0000 0.0 0
M  V30 20 C 4.5410 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 1 1 16
M  V30 4 2 2 3
M  V30 5 2 2 4
M  V30 6 1 2 10
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 555-16-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 55591-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-23959658
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 2206-26-0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amide bond formation via aerobic photooxidative coupling of aldehydes
with amines catalyzed by a riboflavin derivative
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hassan Tolba, Amal; Krupicka, Martin; Chudoba, Josef; Cibulka, Radek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2021), 23(17), 6825-6830

$RFMT $RIREG SCHEME234 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Bromophenyl)-5-(chloromethyl)-1,3,4-oxadiazole
C9H6BrClN2O
568544-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.7758 3.0089 0.0 0
M  V30 2 Cl 11.1826 2.3825 0.0 0
M  V30 3 Br 0.0000 1.3336 0.0 0
M  V30 4 C 6.1600 1.3336 0.0 0
M  V30 5 O 7.0652 2.5795 0.0 0
M  V30 6 N 7.0652 0.0878 0.0 0
M  V30 7 C 8.5298 2.1037 0.0 0
M  V30 8 N 8.5298 0.5636 0.0 0
M  V30 9 C 4.6200 1.3336 0.0 0
M  V30 10 C 3.8500 0.0000 0.0 0
M  V30 11 C 3.8500 2.6673 0.0 0
M  V30 12 C 2.3100 0.0000 0.0 0
M  V30 13 C 2.3100 2.6673 0.0 0
M  V30 14 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 14
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3,4-Oxadiazole, 2-(4-bromophenyl)-5-(1-pyrrolidinylmethyl)-
C13H14BrN3O
911062-01-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8850 0.1435 0.0 0
M  V30 2 Br 13.6608 1.8187 0.0 0
M  V30 3 C 7.5008 1.8187 0.0 0
M  V30 4 O 6.5955 0.5729 0.0 0
M  V30 5 N 6.5955 3.0646 0.0 0
M  V30 6 C 5.1308 1.0487 0.0 0
M  V30 7 N 5.1308 2.5888 0.0 0
M  V30 8 C 9.0408 1.8187 0.0 0
M  V30 9 C 9.8108 0.4851 0.0 0
M  V30 10 C 9.8108 3.1524 0.0 0
M  V30 11 C 11.3508 0.4851 0.0 0
M  V30 12 C 11.3508 3.1524 0.0 0
M  V30 13 C 12.1208 1.8187 0.0 0
M  V30 14 N 2.4782 0.7700 0.0 0
M  V30 15 C 1.1445 0.0000 0.0 0
M  V30 16 C 2.1580 2.2763 0.0 0
M  V30 17 C 0.0000 1.0304 0.0 0
M  V30 18 C 0.6263 2.4372 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 14
M  V30 3 1 2 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 8
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 2 6 7
M  V30 10 2 8 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 15 1 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 568544-04-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 911062-01-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12674529
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Preparation 13.
2-(4-Bromophenyl)-5-(1H-pyrazol-1-ylmethyl)-1,3,4-oxadiazole. Potassium
carbonate (860mg, 6.24mmol) was added to a mixture of the product of
preparation 6 (1g, 3,63mmol) and pyrazole (299mg, 4.40mmol) in
dimethylsulfoxide (5mL) and the mixture was heated at 55°C for 18 hours.
The reaction mixture was then diluted with ethyl acetate and washed with
water and brine. The organic solution was dried over sodium sulfate,
concentrated in vacuo and the residue was re-dissolved in methanol,
treated with charcoal and triturated with diethyl ether to afford the
title compound as a pale brown solid in 73% yield, 804mg. Preparation 15.
2-(4-Bromophenyl)-5-(pyrrolidin-1-ylmethyl)-1,3,4-oxadiazole. The title
compound was prepared from the product of preparation 6 and pyrrolidine,
using a similar method to that described for preparation 13. The crude
compound was purified by column chromatography on silica gel, eluting
with dichloromethane:methanol, 99:1 to 98:2 to afford the title compound
in quantitative yield. 1HNMR(400MHz, CDCl3) δ: 1.90(m, 4H), 2.70(m, 4H),
4.00(s, 2H), 7.65(d, 2H), 8.00(d, 2H); LRMS APCl m/z 310[M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Substituted triazole derivatives as oxytocin antagonists and their
preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brown, Alan Daniel; Ellis, David; Smith, Christopher Ronald
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006100588 A1 2006-09-28

$RFMT $RIREG SCHEME235 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxyphenylacetaldehyde
C9H10O2
5703-26-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 1.3337 0.0000 0.0 0
M  V30 5 C 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1E)-2-(4-Methoxyphenyl)ethenyl]pyrrolidine
C13H17NO
2374729-49-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1047 1.8517 0.0 0
M  V30 2 C 3.7711 2.6218 0.0 0
M  V30 3 O 10.4396 4.9318 0.0 0
M  V30 4 C 11.7733 4.1618 0.0 0
M  V30 5 C 6.4384 2.6218 0.0 0
M  V30 6 C 6.4384 4.1618 0.0 0
M  V30 7 C 7.7722 1.8517 0.0 0
M  V30 8 C 7.7722 4.9318 0.0 0
M  V30 9 C 9.1059 2.6218 0.0 0
M  V30 10 C 9.1059 4.1618 0.0 0
M  V30 11 N 2.4373 1.8517 0.0 0
M  V30 12 C 1.0304 2.4782 0.0 0
M  V30 13 C 2.2763 0.3202 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 15 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 2 11
M  V30 4 1 3 4
M  V30 5 1 3 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5703-26-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2374729-49-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39317590
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7757-82-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Schlenk tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Regio- and Enantioselective Synthesis of 1,2-Diamines by Formal
Hydroamination of Enamines: Scope, Mechanism, and Asymmetric Synthesis of
Orthogonally Protected Bis-Piperazines as a Privileged Scaffold
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mohiti, Maziar; Lu, Yu; He, Hui; Ni, Shao-Fei; Somfai, Peter
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2024), 30(16), e202303078

$RFMT $RIREG SCHEME236 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-fluorobenzaldehyde
C7H4BrFO
57848-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 2.6673 0.0 0
M  V30 2 O 0.0000 4.0010 0.0 0
M  V30 3 F 2.3101 0.0000 0.0 0
M  V30 4 Br 6.9302 2.6673 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Bromo-2-fluorophenyl)methyl]pyrrolidine
C11H13BrFN
283173-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 F 2.6673 0.0000 0.0 0
M  V30 3 Br 0.0000 4.6201 0.0 0
M  V30 4 C 4.0012 2.3101 0.0 0
M  V30 5 C 2.6673 1.5400 0.0 0
M  V30 6 C 4.0012 3.8501 0.0 0
M  V30 7 C 1.3337 2.3101 0.0 0
M  V30 8 C 2.6673 4.6201 0.0 0
M  V30 9 C 1.3337 3.8501 0.0 0
M  V30 10 N 6.6685 2.3101 0.0 0
M  V30 11 C 8.0755 1.6837 0.0 0
M  V30 12 C 6.8296 3.8416 0.0 0
M  V30 13 C 9.1059 2.8281 0.0 0
M  V30 14 C 8.3359 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 1 2 5
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 57848-46-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 283173-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-34336023
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of GSK251: A Highly Potent, Highly Selective, Orally
Bioavailable Inhibitor of PI3Kδ with a Novel Binding Mode
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Down, Kenneth; Amour, Augustin; Anderson, Niall A.; Barton, Nick; Campos,
Sebastien; Cannons, Edward P.; Clissold, Cole; Convery, Maire A.; Coward,
John J.; Doyle, Kevin; Duempelfeld, Birgit; Edwards, Christopher D.;
Goldsmith, Michael D.; Krause, Jana; Mallett, David N.; McGonagle, Grant
A.; Patel, Vipulkumar K.; Rowedder, James; Rowland, Paul; Sharpe, Andrew;
Sriskantharajah, Srividya; Thomas, Daniel A.; Thomson, Douglas W.; Uddin,
Sorif; Hamblin, J. Nicole; Hessel, Edith M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2021), 64(18), 13780-13792

$RFMT $RIREG SCHEME237 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[2-[4-[(3-Bromophenyl)methylene]-1-piperidinyl]ethoxy]-2-methylquinoline
C24H25BrN2O
584554-91-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.9300 5.3347 0.0 0
M  V30 2 C 8.4700 5.3347 0.0 0
M  V30 3 C 9.2400 4.0011 0.0 0
M  V30 4 C 0.0000 6.6684 0.0 0
M  V30 5 C 15.4000 4.0011 0.0 0
M  V30 6 Br 20.0200 1.3336 0.0 0
M  V30 7 C 4.6200 6.6684 0.0 0
M  V30 8 C 3.8500 8.0021 0.0 0
M  V30 9 C 6.1600 6.6684 0.0 0
M  V30 10 C 3.8500 5.3347 0.0 0
M  V30 11 C 4.6200 9.3358 0.0 0
M  V30 12 N 2.3100 8.0021 0.0 0
M  V30 13 C 6.9300 8.0021 0.0 0
M  V30 14 C 2.3100 5.3347 0.0 0
M  V30 15 C 6.1600 9.3358 0.0 0
M  V30 16 C 1.5400 6.6684 0.0 0
M  V30 17 N 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 2.6674 0.0 0
M  V30 19 C 11.5500 5.3347 0.0 0
M  V30 20 C 13.0900 2.6674 0.0 0
M  V30 21 C 13.0900 5.3347 0.0 0
M  V30 22 C 13.8600 4.0011 0.0 0
M  V30 23 C 16.1700 2.6674 0.0 0
M  V30 24 C 17.7100 2.6674 0.0 0
M  V30 25 C 15.4000 1.3336 0.0 0
M  V30 26 C 18.4800 1.3336 0.0 0
M  V30 27 C 16.1700 0.0000 0.0 0
M  V30 28 C 17.7100 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 1 3 17
M  V30 5 1 4 16
M  V30 6 2 5 22
M  V30 7 1 5 23
M  V30 8 1 6 26
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 8 12
M  V30 14 2 9 13
M  V30 15 2 10 14
M  V30 16 2 11 15
M  V30 17 2 12 16
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-5-[2-[4-[[3-(1-pyrrolidinyl)phenyl]methylene]-1-piperidinyl]ethoxy]q...
C28H33N3O
1123543-92-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 2.3101 0.0 0
M  V30 2 C 8.0022 3.0801 0.0 0
M  V30 3 C 9.3358 2.3101 0.0 0
M  V30 4 C 0.0000 0.0000 0.0 0
M  V30 5 C 14.6708 5.3901 0.0 0
M  V30 6 C 4.0010 2.3101 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 5.3348 3.0801 0.0 0
M  V30 9 C 4.0010 0.7700 0.0 0
M  V30 10 C 2.6673 4.6201 0.0 0
M  V30 11 N 1.3337 2.3101 0.0 0
M  V30 12 C 5.3348 4.6201 0.0 0
M  V30 13 C 2.6673 0.0000 0.0 0
M  V30 14 C 4.0010 5.3901 0.0 0
M  V30 15 C 1.3337 0.7700 0.0 0
M  V30 16 N 10.6697 3.0801 0.0 0
M  V30 17 C 12.0033 2.3101 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 19 C 13.3370 3.0801 0.0 0
M  V30 20 C 12.0033 5.3901 0.0 0
M  V30 21 C 13.3370 4.6201 0.0 0
M  V30 22 C 16.0045 4.6201 0.0 0
M  V30 23 C 17.3382 5.3901 0.0 0
M  V30 24 C 16.0045 3.0801 0.0 0
M  V30 25 C 18.6718 4.6201 0.0 0
M  V30 26 C 17.3382 2.3101 0.0 0
M  V30 27 C 18.6718 3.0801 0.0 0
M  V30 28 N 20.0057 5.3901 0.0 0
M  V30 29 C 20.1666 6.9217 0.0 0
M  V30 30 C 21.4125 4.7636 0.0 0
M  V30 31 C 21.6729 7.2419 0.0 0
M  V30 32 C 22.4429 5.9082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 16
M  V30 5 1 4 15
M  V30 6 2 5 21
M  V30 7 1 5 22
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 2 8 12
M  V30 14 2 9 13
M  V30 15 2 10 14
M  V30 16 2 11 15
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 25 28
M  V30 31 1 26 27
M  V30 32 1 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 584554-91-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1123543-92-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-3985750
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3375-31-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 98327-87-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Studies on a series of potent, orally bioavailable, 5-HT1 receptor
ligands-Part II
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ward, Simon E.; Eddershaw, Peter; Flynn, Sean T.; Gordon, Laurie; Lovell,
Peter J.; Moore, Susan H.; Scott, Claire M.; Smith, Paul W.; Thewlis,
Kevin M.; Wyman, Paul A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2009), 19(2), 428-432

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzoic acid
C8H8O3
586-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 6.6687 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Methoxyphenyl)-1-pyrrolidinylmethanone
C12H15NO2
207558-39-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 O 9.1059 1.5400 0.0 0
M  V30 4 C 10.4396 2.3101 0.0 0
M  V30 5 C 5.1048 2.3101 0.0 0
M  V30 6 C 6.4384 1.5400 0.0 0
M  V30 7 C 5.1048 3.8501 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 6.4384 4.6201 0.0 0
M  V30 10 C 7.7722 3.8501 0.0 0
M  V30 11 N 2.4374 2.3101 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 2.2763 3.8416 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 15 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-38-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 207558-39-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14244200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of biarylpropionic acid derivatives as cathepsin A inhibitors
for use in atherosclerosis, heart failure, renal diseases, liver diseases
or inflammatory diseases Biaryl-propionic acid derivatives and their use
as pharmaceuticals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ruf, Sven; Sadowski, Thorsten; Wirth, Klaus; Schreuder, Herman; Buning,
Christian; Kallus, Christopher; Strobel, Hartmut; Wehlan, Hermut
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014154726 A1 2014-10-02

$RFMT $RIREG SCHEME238 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzoic acid
C8H8O3
586-38-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 6.6687 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Methoxyphenyl)-1-pyrrolidinylmethanone
C12H15NO2
207558-39-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 O 9.1059 1.5400 0.0 0
M  V30 4 C 10.4396 2.3101 0.0 0
M  V30 5 C 5.1048 2.3101 0.0 0
M  V30 6 C 6.4384 1.5400 0.0 0
M  V30 7 C 5.1048 3.8501 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 6.4384 4.6201 0.0 0
M  V30 10 C 7.7722 3.8501 0.0 0
M  V30 11 N 2.4374 2.3101 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 2.2763 3.8416 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 15 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586-38-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 207558-39-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-10134844
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of biarylpropionic acid derivatives as cathepsin A inhibitors
for use in atherosclerosis, heart failure, renal diseases, liver diseases
or inflammatory diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ruf, Sven; Sadowski, Thorsten; Wirth, Klaus; Schreuder, Herman; Buning,
Christian; Kallus, Christopher; Strobel, Hartmut; Wehlan, Hermut
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014154727 A1 2014-10-02

$RFMT $RIREG SCHEME239 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,4,5,6-Pentafluorophenyl (αR,4S)-α-[3-(4-ethoxyphenyl)propyl]-2,2-dimethyl...
C24H23F5O6
586972-84-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0623 8.0020 0.0 0 CFG=1
M  V30 2 C 5.8323 6.6684 0.0 0
M  V30 3 C 5.8323 9.3358 0.0 0
M  V30 4 O 5.0623 5.3347 0.0 0
M  V30 5 O 7.3723 6.6684 0.0 0
M  V30 6 C 7.3723 9.3358 0.0 0
M  V30 7 C 8.1423 10.6695 0.0 0
M  V30 8 O 5.0169 10.3037 0.0 0
M  V30 9 C 0.0000 8.1104 0.0 0
M  V30 10 C 0.2154 10.1600 0.0 0
M  V30 11 F 8.1423 5.3347 0.0 0
M  V30 12 F 3.5223 2.6673 0.0 0
M  V30 13 F 9.6823 2.6673 0.0 0
M  V30 14 F 5.0623 0.0000 0.0 0
M  V30 15 F 8.1423 0.0000 0.0 0
M  V30 16 O 14.3023 10.6695 0.0 0
M  V30 17 C 15.0723 12.0031 0.0 0
M  V30 18 C 16.6123 12.0031 0.0 0
M  V30 19 C 3.5223 8.0020 0.0 0 CFG=2
M  V30 20 C 3.6832 9.5337 0.0 0
M  V30 21 O 2.0159 7.6818 0.0 0
M  V30 22 O 2.2764 10.1600 0.0 0
M  V30 23 C 1.2459 9.0156 0.0 0
M  V30 24 C 5.8323 4.0011 0.0 0
M  V30 25 C 7.3723 4.0011 0.0 0
M  V30 26 C 5.0623 2.6673 0.0 0
M  V30 27 C 8.1423 2.6673 0.0 0
M  V30 28 C 5.8323 1.3336 0.0 0
M  V30 29 C 7.3723 1.3336 0.0 0
M  V30 30 C 9.6823 10.6695 0.0 0
M  V30 31 C 10.4523 12.0031 0.0 0
M  V30 32 C 10.4523 9.3358 0.0 0
M  V30 33 C 11.9923 12.0031 0.0 0
M  V30 34 C 11.9923 9.3358 0.0 0
M  V30 35 C 12.7623 10.6695 0.0 0
M  V30 36 H 3.6832 6.4705 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 19
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 4 24
M  V30 8 1 6 7
M  V30 9 1 7 30
M  V30 10 2 8 20
M  V30 11 1 9 23
M  V30 12 1 10 23
M  V30 13 1 11 25
M  V30 14 1 12 26
M  V30 15 1 13 27
M  V30 16 1 14 28
M  V30 17 1 15 29
M  V30 18 1 16 17
M  V30 19 1 16 35
M  V30 20 1 17 18
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 19 36 CFG=1
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 19)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(5S)-5-[(1R)-4-(4-Ethoxyphenyl)-1-(1-pyrrolidinylcarbonyl)butyl]-2,2-dimethyl...
C22H31NO5
847039-01-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.0624 5.1047 0.0 0 CFG=1
M  V30 2 C 5.8324 3.7711 0.0 0
M  V30 3 C 5.8324 6.4385 0.0 0
M  V30 4 O 7.3724 3.7711 0.0 0
M  V30 5 C 7.3724 6.4385 0.0 0
M  V30 6 C 8.1424 7.7722 0.0 0
M  V30 7 O 5.0169 7.4063 0.0 0
M  V30 8 C 0.0000 5.2131 0.0 0
M  V30 9 C 0.2154 7.2628 0.0 0
M  V30 10 O 14.3025 7.7722 0.0 0
M  V30 11 C 15.0725 9.1059 0.0 0
M  V30 12 C 16.6125 9.1059 0.0 0
M  V30 13 C 3.5223 5.1047 0.0 0 CFG=2
M  V30 14 C 3.6833 6.6363 0.0 0
M  V30 15 O 2.0159 4.7845 0.0 0
M  V30 16 O 2.2765 7.2628 0.0 0
M  V30 17 C 1.2459 6.1182 0.0 0
M  V30 18 N 5.0624 2.4374 0.0 0
M  V30 19 C 5.6887 1.0304 0.0 0
M  V30 20 C 3.5308 2.2763 0.0 0
M  V30 21 C 4.5443 0.0000 0.0 0
M  V30 22 C 3.2105 0.7700 0.0 0
M  V30 23 C 9.6824 7.7722 0.0 0
M  V30 24 C 10.4525 9.1059 0.0 0
M  V30 25 C 10.4525 6.4385 0.0 0
M  V30 26 C 11.9925 9.1059 0.0 0
M  V30 27 C 11.9925 6.4385 0.0 0
M  V30 28 C 12.7625 7.7722 0.0 0
M  V30 29 H 3.6833 3.5732 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 13
M  V30 4 2 2 4
M  V30 5 1 2 18
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 6 23
M  V30 9 2 7 14
M  V30 10 1 8 17
M  V30 11 1 9 17
M  V30 12 1 10 11
M  V30 13 1 10 28
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 13 29 CFG=1
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 17
M  V30 21 1 18 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 2 23 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 2 25 27
M  V30 30 2 26 28
M  V30 31 1 27 28
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 586972-84-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 847039-01-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-2817541
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step G. 5- (4-Ethoxy-phenyl)-2R- [ (2, 2-dimethyl-5-oxo- [1, 3]
dioxolan-4S-yl)]-1- pyrrolidin-1-yl-pentan-1-one. To a solution of 2R-
(2, 2-dimethyl-5-oxo- [1, 3] dioxolan-4S-yi)-5- (4-ethoxy-
phenyl)-pentanoic acid pentafluorophenyl ester (150 mg, 0.30 mmol) in
CH2Cl2 (10 ml) was added pyrrolidine (30 I, 0.36 mmol, 1.2 eq. ). The
reaction mixture was stirred for 16 hrs and the solvent was removed under
vacuo. The crude was taken-up in AcOEt (70 ml) and washed with water (10
ml), then with NaHCO3 sat (10 ml) and finally with brine (10 ml). The
solvent was dried over MgSO4 and removed under reduced pressure to give
the desired 5- (4- Ethoxy-phenyl)-2R- [ (2, 2-dimethyl-5-oxo- [1, 3]
dioxolan-4S-yl)]-1-pyrrolidin-1-yl- pentan-1-one, yield 116 mg, 100%.
1H-NMR ; δ (CDCl3) : 7.05 (2H, d, J= 8.6Hz), 6.8 (2H, d, J= 8.6Hz), 4.55
(1 H, d, J= 8.4Hz), 3.99 (2H, m), 3.8-3. 3 (1 OH, m), 3.05 (1 H, m), 2.55
(2H, t, J= 7.6Hz), 2.1-1. 7 (2H, m), 1.6 (3H, s), 1.5 (3H, s), 1.4 (3H,
t, J= 7. 0Hz). LRMS: +ve ion 405 (M+H), 428 (M+Na).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydroxamates as matrix metalloproteinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Pain, Gilles; Davies, Stephen John; Bombrun, Agnes
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005019194 A1 2005-03-03

$RFMT $RIREG SCHEME240 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Methoxyphenyl)-2-oxazoleacetic acid
C12H11NO4
595544-46-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6528 0.2787 0.0 0
M  V30 2 C 1.2459 0.9052 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 O 1.0849 2.4368 0.0 0
M  V30 5 O 12.4285 1.9540 0.0 0
M  V30 6 C 13.1985 3.2876 0.0 0
M  V30 7 C 6.2684 1.9540 0.0 0
M  V30 8 N 5.3632 0.7081 0.0 0
M  V30 9 C 5.3632 3.1998 0.0 0
M  V30 10 C 3.8987 1.1840 0.0 0
M  V30 11 O 3.8987 2.7240 0.0 0
M  V30 12 C 7.8085 1.9540 0.0 0
M  V30 13 C 8.5785 3.2876 0.0 0
M  V30 14 C 8.5785 0.6203 0.0 0
M  V30 15 C 10.1185 3.2876 0.0 0
M  V30 16 C 10.1185 0.6203 0.0 0
M  V30 17 C 10.8885 1.9540 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 6
M  V30 6 1 5 17
M  V30 7 1 7 8
M  V30 8 2 7 9
M  V30 9 1 7 12
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-[4-(4-Methoxyphenyl)-2-oxazolyl]-1-(1-pyrrolidinyl)ethanone
C16H18N2O3
595544-47-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.0226 2.2946 0.0 0
M  V30 2 C 3.6156 2.9211 0.0 0
M  V30 3 O 3.4547 4.4526 0.0 0
M  V30 4 O 14.7982 3.9698 0.0 0
M  V30 5 C 15.5683 5.3035 0.0 0
M  V30 6 C 8.6382 3.9698 0.0 0
M  V30 7 N 7.7330 2.7240 0.0 0
M  V30 8 C 7.7330 5.2157 0.0 0
M  V30 9 C 6.2684 3.1998 0.0 0
M  V30 10 O 6.2684 4.7398 0.0 0
M  V30 11 C 10.1782 3.9698 0.0 0
M  V30 12 C 10.9482 5.3035 0.0 0
M  V30 13 C 10.9482 2.6362 0.0 0
M  V30 14 C 12.4882 5.3035 0.0 0
M  V30 15 C 12.4882 2.6362 0.0 0
M  V30 16 C 13.2582 3.9698 0.0 0
M  V30 17 N 2.3698 2.0159 0.0 0
M  V30 18 C 0.9052 2.4917 0.0 0
M  V30 19 C 2.3698 0.4759 0.0 0
M  V30 20 C 0.0000 1.2459 0.0 0
M  V30 21 C 0.9052 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 2 2 3
M  V30 4 1 2 17
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 11
M  V30 10 2 7 9
M  V30 11 1 8 10
M  V30 12 1 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 595544-46-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 595544-47-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-11177445
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1892-57-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM key intermediate
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyridylethylaminoethoxyphenylazoleacetamides as
β3-adrenergic receptor agonists.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lafontaine, Jennifer Anne; Morgan, Bradley Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003072572 A1 2003-09-04

$RFMT $RIREG SCHEME241 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-6-nitro-1H-benzimidazole
C7H4ClN3O2
5955-72-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 9.2446 3.0800 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 5.3347 3.8500 0.0 0
M  V30 7 C 4.0011 1.5400 0.0 0
M  V30 8 N 6.7994 1.8341 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 N 6.7994 4.3259 0.0 0
M  V30 11 C 2.6674 2.3100 0.0 0
M  V30 12 C 7.7046 3.0800 0.0 0
M  V30 13 C 2.6674 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Nitro-2-(1-pyrrolidinyl)-1H-benzimidazole
C11H12N4O2
832102-68-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 10.2807 1.5400 0.0 0 VAL=5
M  V30 2 O 11.6144 2.3100 0.0 0
M  V30 3 O 10.2807 0.0000 0.0 0
M  V30 4 C 6.2797 2.3100 0.0 0
M  V30 5 C 6.2797 3.8500 0.0 0
M  V30 6 N 4.8150 1.8341 0.0 0
M  V30 7 C 7.6133 1.5400 0.0 0
M  V30 8 N 4.8150 4.3259 0.0 0
M  V30 9 C 7.6133 4.6200 0.0 0
M  V30 10 C 3.9098 3.0800 0.0 0
M  V30 11 C 8.9469 2.3100 0.0 0
M  V30 12 C 8.9469 3.8500 0.0 0
M  V30 13 N 2.3698 3.0800 0.0 0
M  V30 14 C 1.4647 4.3259 0.0 0
M  V30 15 C 1.4647 1.8341 0.0 0
M  V30 16 C 0.0000 3.8500 0.0 0
M  V30 17 C 0.0000 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 11
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 10
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 2 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 5955-72-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 832102-68-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-13920572
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 6-(4-chlorophenyl)-3-[2-(1-pyrrolidinyl)-1H-benzimidazol-5-yl]thieno[3,2-d]pyrimidin-4(3H)-one
trifluoroacetate Step A: 5-nitro-2-(1-pyrroidinyl)-1H-benzimidazole A
mixture of 2-chloro-5-nitro-1H-benzimidazole (Example 75, Step A; 100
mg,0.6 mmol), pyrrolidine (2 mL), and EtOH (10 mL) stirred in a pressure
tube at 160°C for 18 h. The reaction was and concentrated to dryness to
afford the title compound as a brown oil (213 mg, quantitative yield).
5-nitro-2-(1-pyrroidinyl)-1H-benzimidazole, yield 213 mg, quantitative 1H
NMR (400 MHz, DMSO-d6) δ 2.0 (m, 4H) 3.5 (m, 4H) 7.2 (dd, J=8.6, 0.5 Hz,
1H) 7.9 (m, 2H). APCI-LCMS m/z 233 (100), (M+H).
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, reaction in a pressure tube, reaction from p.156,157 in patent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrimidinones as melanin concentrating hormone receptor 1
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barvian, Kevin K.; Carpenter, Andrew J.; Cooper, Joel P.; Feldman, Paul
L.; Guo, Yu C.; Handlon, Anthony L.; Hertzog, Donald L.; Hyman, Clifton
E.; Peat, Andrew J.; Peckham, Gregory E.; Speake, Jason D.; Swain,
William R.; Tavares, Francis X.; Zhou, Huiqiang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004092181 A1 2004-10-28

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-(3-nitrophenyl)propanamide
C9H9ClN2O3
60284-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 O 8.0022 3.8501 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 Cl 12.0033 1.5400 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Nitrophenyl)-1-pyrrolidinepropanamide
C13H17N3O3
851651-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.0801 0.0 0
M  V30 2 C 8.0023 2.3100 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 10.6698 2.3100 0.0 0
M  V30 6 N 1.3338 3.0801 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 N 12.0034 3.0801 0.0 0
M  V30 16 C 12.1644 4.6116 0.0 0
M  V30 17 C 13.4103 2.4536 0.0 0
M  V30 18 C 13.6708 4.9318 0.0 0
M  V30 19 C 14.4409 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 12
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 60284-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 851651-86-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-1775066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Method 2 (2a-i and 13a-c). 1a,b/d-e/g-i or
12a-c were dissolved in MeOH/THF (5-100 mL), and the required amine base
(2-3.6 equiv) was added. The mixture was either (a) stirred overnight at
room temperature prior to the solvent being removed (5% NH3 (aq) (50 mL)
was added and the product extracted with EtOAc (50 mL), washed with brine
(25 mL), and dried over MgSO4), (b) heated under reflux for 4 h prior to
workup as above, or (c) stirred at 30 °C overnight prior to workup as
above. 1c/f was reacted with neat pyrrolidine (20 mL, 0.240 mol) at room
temperature overnight, followed by evaporation of the excess pyrrolidine
and workup as described above.
N-(3-nitrophenyl)-3-(pyrrolidin-1-yl)propanamide (2e). Following method
2c, 1e (20.60g, 0.090 mol) was reacted with pyrrolidine (20 ml, 0.240
mol) to yield a brown oil (23.72g, 0.090 mol, quant.). 1H NMR (400MHz,
d6-DMSO) δ 10.59 (1H, s), 8.70 (1H, t, J=2.2 Hz), 7.95 (2H, m), 7.65 (1H,
t, J=8.2 Hz), 2.78 (2H, t, J=7.1 Hz), 2.58 (2H, t, J=6.9 Hz), 2.52 (4H,
m), 1.74 (4H, m) ppm. 13C NMR (100MHz, d6-DMSO) δ 170.9, 147.9, 140.3,
130.1, 124.9, 117.5, 113.0, 53.4, 51.3, 36.2, 23.1 ppm. MS m/z calc.
C13H17N3O3 263.1, found [MH]- found 262.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of Substituted Diarylureas: A Scaffold for Binding to
G-Quadruplex Motifs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Drewe, William C.; Nanjunda, Rupesh; Gunaratnam, Mekala; Beltran, Monica;
Parkinson, Gary N.; Reszka, Anthony P.; Wilson, W. David; Neidle, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(24), 7751-7767

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-(3-nitrophenyl)propanamide
C9H9ClN2O3
60284-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 O 8.0022 3.8501 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 Cl 12.0033 1.5400 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Nitrophenyl)-1-pyrrolidinepropanamide
C13H17N3O3
851651-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.0801 0.0 0
M  V30 2 C 8.0023 2.3100 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 10.6698 2.3100 0.0 0
M  V30 6 N 1.3338 3.0801 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 N 12.0034 3.0801 0.0 0
M  V30 16 C 12.1644 4.6116 0.0 0
M  V30 17 C 13.4103 2.4536 0.0 0
M  V30 18 C 13.6708 4.9318 0.0 0
M  V30 19 C 14.4409 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 12
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 60284-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 851651-86-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10408095
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Click chemistry assembly of G-quadruplex ligands incorporating a
diarylurea scaffold and triazole linkers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Drewe, William C.; Neidle, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2008), (42),
5295-5297

$RFMT $RIREG SCHEME242 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-(3-nitrophenyl)propanamide
C9H9ClN2O3
60284-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3360 1.5400 0.0 0
M  V30 4 O 8.0022 3.8501 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 Cl 12.0033 1.5400 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3337 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0012 1.5400 0.0 0
M  V30 12 C 5.3348 3.8501 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0012 4.6201 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 13
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Nitrophenyl)-1-pyrrolidinepropanamide
C13H17N3O3
851651-86-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6686 3.0801 0.0 0
M  V30 2 C 8.0023 2.3100 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 10.6698 2.3100 0.0 0
M  V30 6 N 1.3338 3.0801 0.0 0 VAL=5
M  V30 7 O 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 4.6201 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 3.0801 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 12 C 2.6675 2.3100 0.0 0
M  V30 13 C 4.0011 0.0000 0.0 0
M  V30 14 C 2.6675 0.7700 0.0 0
M  V30 15 N 12.0034 3.0801 0.0 0
M  V30 16 C 12.1644 4.6116 0.0 0
M  V30 17 C 13.4103 2.4536 0.0 0
M  V30 18 C 13.6708 4.9318 0.0 0
M  V30 19 C 14.4409 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 15
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 12
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 60284-53-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 851651-86-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14779685
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The synthesis of N-(3-nitrophenyl)-3-(pyrrolidin-1-yl)propanamide (12)
3-chloro-N-(3-nitrophenyl)propanamide (11) (20.60 g, 0.0901 mol) was
dissolved in pyrrolidine (20 ml, 0.330 mol) prior to the addition of THF
(50 ml) and the mixture stirred at 30 °C overnight. The THF and
pyrrolidine was removed in vacuo and the resulting oil suspended in 5%
NH3 (aq.) (200 ml) and extracted into chloroform (300 ml), washed with
brine (100 ml) and dried over MgSO4 prior to evaporation to yield a brown
oil (23.7224 g, 0.0901 mol, quant.). Rf 0.30 [MeOH]. 1H NMR (400 MHz,
d6-DMSO) δ 10.59 (1H, s, NH), 8.70 (1H, t, J=2.2 Hz, ArH), 7.95 (2H, dt,
J=8.2, 2.4 Hz, 2ArH), 7.65 (1H, t, J=8.2 Hz, ArH), 2.78 (2H, t, J=7.1 Hz,
CH2), 2.58 (2H, t, J=6.9 Hz, CH2), 2.52 (4H, m, 2CH2), 1.74 (4H, m, 2CH2)
ppm. 13C NMR (100 MHz, d6-DMSO) δ 170.9 (C=O), 147.9 (ArC), 140.3 (ArC),
130.1 (ArCH), 124.9 (ArCH), 117.5 (ArCH), 113.0 (ArCH), 53.4 (2CH2), 51.3
(CH2), 36.2 (CH2), 23.1 (2CH2) ppm. IR (neat) υmax 2969, 2806, 1738,
1527, 1351, 1217 cm-1. MS m/z calc. C13H17N3O3 [M] 263.1, found [M-1]
found 262.0.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ureylene derivatives as DNA oligonucleotide ligands and their
preparation, pharmaceutical compositions and use in the treatment of
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moses, John Edward; Neidle, Stephen; Moorhouse, Adam Donald; Moore,
Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008122667 A2 2008-10-16

$RFMT $RIREG SCHEME243 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-iodobenzoate
C8H7IO2
610-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 O 5.3901 4.0010 0.0 0
M  V30 3 O 5.3901 1.3337 0.0 0
M  V30 4 C 6.9302 4.0010 0.0 0
M  V30 5 I 3.0801 0.0000 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 C 2.3101 4.0010 0.0 0
M  V30 9 C 0.7700 1.3337 0.0 0
M  V30 10 C 0.7700 4.0010 0.0 0
M  V30 11 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 7
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Carbon monoxide
CO
630-08-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0 CHG=-1
M  V30 2 O 1.5400 0.0000 0.0 0 CHG=1 VAL=3
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 2-(1-pyrrolidinylcarbonyl)benzoate
C13H15NO3
2222512-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 4.0011 0.0 0
M  V30 2 O 4.6798 5.3349 0.0 0
M  V30 3 C 6.9898 4.0011 0.0 0
M  V30 4 O 8.5298 4.0011 0.0 0
M  V30 5 O 6.2198 5.3349 0.0 0
M  V30 6 C 9.2998 5.3349 0.0 0
M  V30 7 C 4.6798 2.6674 0.0 0
M  V30 8 C 6.2198 2.6674 0.0 0
M  V30 9 C 3.9098 1.3338 0.0 0
M  V30 10 C 6.9898 1.3338 0.0 0
M  V30 11 C 4.6798 0.0000 0.0 0
M  V30 12 C 6.2198 0.0000 0.0 0
M  V30 13 N 2.3698 4.0011 0.0 0
M  V30 14 C 1.4645 2.7552 0.0 0
M  V30 15 C 1.4645 5.2469 0.0 0
M  V30 16 C 0.0000 3.2311 0.0 0
M  V30 17 C 0.0000 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 8
M  V30 7 1 4 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 610-97-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 630-08-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2222512-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-182-CAS-22157499
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 83252-49-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM conversion (100%)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The aminocarbonylation of 1,2-diiodoarenes with primary and secondary
amines catalyzed by palladium complexes with imidazole ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wojcik, Przemyslaw; Trzeciak, Anna M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Applied Catalysis, A: General (2018), 56073-83

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl propiolate
C5H6O2
623-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 3.0800 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 3 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2E)-3-(1-pyrrolidinyl)-2-propenoate
C9H15NO2
65651-80-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 C 6.4384 1.5400 0.0 0
M  V30 4 O 7.7722 2.3101 0.0 0
M  V30 5 O 6.4384 0.0000 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4396 2.3101 0.0 0
M  V30 8 N 2.4374 2.3101 0.0 0
M  V30 9 C 2.2763 3.8416 0.0 0
M  V30 10 C 1.0304 1.6836 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 12 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-47-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65651-80-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-21603272
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of ethanediamine-heterocycle derivatives as inhibitors of
protein arginine methyltransferases for treatment of cancers, metabolic,
and immune disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Di Francesco, Maria Emilia; Jones, Philip; McAfoos, Timothy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019169326 A1 2019-09-06

$RFMT $RIREG SCHEME244 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl propiolate
C5H6O2
623-47-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 3.0800 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 3 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl (2E)-3-(1-pyrrolidinyl)-2-propenoate
C9H15NO2
65651-80-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 C 6.4384 1.5400 0.0 0
M  V30 4 O 7.7722 2.3101 0.0 0
M  V30 5 O 6.4384 0.0000 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4396 2.3101 0.0 0
M  V30 8 N 2.4374 2.3101 0.0 0
M  V30 9 C 2.2763 3.8416 0.0 0
M  V30 10 C 1.0304 1.6836 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 12 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 623-47-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 65651-80-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18365285
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A field-based disparity analysis of new 1,2,5-oxadiazole derivatives
endowed with antiproliferative activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Porta, Federica; Gelain, Arianna; Barlocco, Daniela; Ferri, Nicola;
Marchiano, Silvia; Cappello, Valentina; Basile, Livia; Guccione,
Salvatore; Meneghetti, Fiorella; Villa, Stefania
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Biology & Drug Design (2017), 90(5), 820-839

$RFMT $RIREG SCHEME245 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Dibromopyridine
C5H3Br2N
626-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.0800 0.0 0
M  V30 2 Br 5.3349 3.0800 0.0 0
M  V30 3 N 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Bromo-6-(1-pyrrolidinyl)pyridine
C9H11BrN2
230618-41-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 7.7721 3.0800 0.0 0
M  V30 2 C 3.7710 2.3100 0.0 0
M  V30 3 N 5.1046 3.0800 0.0 0
M  V30 4 C 3.7710 0.7700 0.0 0
M  V30 5 C 6.4384 2.3100 0.0 0
M  V30 6 C 5.1046 0.0000 0.0 0
M  V30 7 C 6.4384 0.7700 0.0 0
M  V30 8 N 2.4374 3.0800 0.0 0
M  V30 9 C 2.2764 4.6115 0.0 0
M  V30 10 C 1.0304 2.4535 0.0 0
M  V30 11 C 0.7700 4.9317 0.0 0
M  V30 12 C 0.0000 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 8
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 626-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 230618-41-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31932299
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds and compositions as modulators of
TLR signaling
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Natala, Srinivasa Reddy; Wrasidlo, Wolfgang J.; Stocking, Emily M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022067114 A1 2022-03-31

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethynylbenzaldehyde
C9H6O
63697-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 C 8.4701 1.3337 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Ethynylphenyl)methyl]pyrrolidine
C13H15N
858677-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.8501 0.0 0
M  V30 2 C 9.1059 0.7700 0.0 0
M  V30 3 C 10.4396 0.0000 0.0 0
M  V30 4 C 5.1048 3.0801 0.0 0
M  V30 5 C 5.1048 1.5400 0.0 0
M  V30 6 C 6.4384 3.8501 0.0 0
M  V30 7 C 6.4384 0.7700 0.0 0
M  V30 8 C 7.7722 3.0801 0.0 0
M  V30 9 C 7.7722 1.5400 0.0 0
M  V30 10 N 2.4374 3.0801 0.0 0
M  V30 11 C 2.2763 1.5485 0.0 0
M  V30 12 C 1.0304 3.7064 0.0 0
M  V30 13 C 0.7700 1.2283 0.0 0
M  V30 14 C 0.0000 2.5620 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 3 2 3
M  V30 4 1 2 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63697-96-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858677-32-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-9130653
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Glacial acetic acid (0.2 mL) was added to a mixture of
4-ethynylbenzaldehyde (1 g, 7.5 mmol), pyrrolidine (1.2 mL, 15 mmol) and
NaBH(OAc)3 (2.5 g, 11.5 mmol) in DCE (35 mL). The resulting mixture was
stirred for 2 h at rt. The reaction was quenched with saturated aqueous
NaHCO3 (50 mL). The product was extracted into CH2Cl2 (2 x 100 mL), and
the combined organic layer was washed with brine (25 mL), dried (MgSO4)
and evaporated in vacuo to give 1-(4-ethynylphenyl)pyrrolidine,
quantitative yield. 1H NMR (CDCl3) δ 7.45 (d, J= 7.8 Hz, 2H), 7.30 (d, J=
8.3 Hz, 2H), 3.62 (s, 2H), 3.06 (s, 1H), 2.51 (bs, 4H), 1.80 (bs, 4H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM (1H-Indazol-6-yl)spiro[cyclopropane-1,3'-indolin]-2'-one derivatives as
protein kinase inhibitors and their preparation and use for the treatment
of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sampson, Peter Brent; Liu, Yong; Li, Sze-Wan; Forrest, Bryan T.; Pauls,
Heinz W.; Edwards, Louise G.; Feher, Miklos; Patel, Narendra Kumar B.;
Laufer, Radoslaw; Pan, Guohua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011123946 A1 2011-10-13

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethynylbenzaldehyde
C9H6O
63697-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 C 8.4701 1.3337 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Ethynylphenyl)methyl]pyrrolidine
C13H15N
858677-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.8501 0.0 0
M  V30 2 C 9.1059 0.7700 0.0 0
M  V30 3 C 10.4396 0.0000 0.0 0
M  V30 4 C 5.1048 3.0801 0.0 0
M  V30 5 C 5.1048 1.5400 0.0 0
M  V30 6 C 6.4384 3.8501 0.0 0
M  V30 7 C 6.4384 0.7700 0.0 0
M  V30 8 C 7.7722 3.0801 0.0 0
M  V30 9 C 7.7722 1.5400 0.0 0
M  V30 10 N 2.4374 3.0801 0.0 0
M  V30 11 C 2.2763 1.5485 0.0 0
M  V30 12 C 1.0304 3.7064 0.0 0
M  V30 13 C 0.7700 1.2283 0.0 0
M  V30 14 C 0.0000 2.5620 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 3 2 3
M  V30 4 1 2 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63697-96-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858677-32-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-5590252
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A. 1-(4-ethynylphenyl)pyrrolidine Glacial acetic acid (0.2 mL) was added
to a mixture of 4-ethynylbenzaldehyde (1 g, 7.5 mmol), pyrrolidine (1.2
mL, 15 mmol) and NaBH(OAc)3 (2.5 g, 11.5 mmol) in DCE (35 mL). The
resulting mixture was stirred for 2 h at rt. The reaction was quenched
with saturated aqueous NaHCO3 (50 mL). The product was extracted into
CH2Cl2 (2 x 100 mL), and the combined organic layer was washed with brine
(25 mL), dried (MgSO4) and evaporated in vacuo to give
1-(4-ethynylphenyl)pyrrolidine. Quantitative yield. 1H NMR (CDCl3) δ:
7.45 (d, J = 7.8 Hz, 2H), 7.30 (d, J = 8.3 Hz, 2H), 3.62 (s, 2H), 3.06
(s, 1H), 2.51 (bs, 4H), 1.80 (bs, 4H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of chiral
2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3'-indolin]-2'-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cummings, Graham; Patel, Narenda Kumar B.; Forrest, Bryan T.; Liu, Yong;
Li, Sze-Wan; Sampson, Peter Brent; Edwards, Louise G.; Pauls, Heinz W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011123947 A1 2011-10-13

$RFMT $RIREG SCHEME246 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethynylbenzaldehyde
C9H6O
63697-96-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 C 8.4701 1.3337 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Ethynylphenyl)methyl]pyrrolidine
C13H15N
858677-32-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.8501 0.0 0
M  V30 2 C 9.1059 0.7700 0.0 0
M  V30 3 C 10.4396 0.0000 0.0 0
M  V30 4 C 5.1048 3.0801 0.0 0
M  V30 5 C 5.1048 1.5400 0.0 0
M  V30 6 C 6.4384 3.8501 0.0 0
M  V30 7 C 6.4384 0.7700 0.0 0
M  V30 8 C 7.7722 3.0801 0.0 0
M  V30 9 C 7.7722 1.5400 0.0 0
M  V30 10 N 2.4374 3.0801 0.0 0
M  V30 11 C 2.2763 1.5485 0.0 0
M  V30 12 C 1.0304 3.7064 0.0 0
M  V30 13 C 0.7700 1.2283 0.0 0
M  V30 14 C 0.0000 2.5620 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 10
M  V30 3 3 2 3
M  V30 4 1 2 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 63697-96-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858677-32-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-8985935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Glacial acetic acid (0.2 mL) was added to a mixture of
4-ethynylbenzaldehyde (1 g, 7.5 mmol), pyrrolidine (1.2 mL, 15 mmol) and
NaBH(OAc)3 (2.5 g, 11.5 mmol) in DCE (35 mL). The resulting mixture was
stirred for 2 h at rt. The reaction was quenched with saturated aqueous
NaHCO3 (50 mL). The product was extracted into CH2Cl2 (2 x 100 mL), and
the combined organic layer was washed with brine (25 mL), dried (MgSO4)
and evaporated in vacuo to give 1-(4-ethynylphenyl)pyrrolidine in
quantitative yield. 1-(4-ethynylphenyl)pyrrolidine, quantitative yield.
1H NMR (CDCl3) δ 7.45 (d, J= 7.8 Hz, 2H), 7.30 (d, J= 8.3 Hz, 2H), 3.62
(s, 2H), 3.06 (s, 1H), 2.51 (bs, 4H), 1.80 (bs, 4H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of spiro cyclopropylindolinone compounds as Kinase inhibitors
for treating cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Sampson, Peter Brent; Li, Sze-Wan; Liu, Yong; Pauls, Heinz W.; Edwards,
Louise G.; Forrest, Bryan T.; Feher, Miklos; Patel, Narendra Kumar B.;
Pan, Guohua
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010115279 A1 2010-10-14

$RFMT $RIREG SCHEME247 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2E)-2-(Acetylamino)-N-[2-(4-hydroxyphenyl)ethyl]-2-butenamide
C14H18N2O3
646072-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 5.3347 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 N 5.3900 4.0011 0.0 0
M  V30 4 C 4.6200 2.6674 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 O 5.3900 1.3338 0.0 0
M  V30 7 N 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 0.7700 4.0011 0.0 0
M  V30 10 C 3.0800 0.0000 0.0 0
M  V30 11 C 0.0000 2.6674 0.0 0
M  V30 12 O 0.0000 5.3347 0.0 0
M  V30 13 O 13.8600 5.3347 0.0 0
M  V30 14 C 9.2400 5.3347 0.0 0
M  V30 15 C 10.0100 4.0011 0.0 0
M  V30 16 C 10.0100 6.6685 0.0 0
M  V30 17 C 11.5500 4.0011 0.0 0
M  V30 18 C 11.5500 6.6685 0.0 0
M  V30 19 C 12.3200 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 13 19
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(Benzoylamino)-N-[2-(4-hydroxyphenyl)ethyl]-β-methyl-1-pyrrolidinepropanamide
C23H29N3O3
646071-92-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 4.1618 0.0 0
M  V30 2 C 5.3348 2.6217 0.0 0
M  V30 3 N 4.0011 4.9318 0.0 0
M  V30 4 C 6.6686 4.9318 0.0 0
M  V30 5 C 6.6686 1.8517 0.0 0
M  V30 6 C 4.0011 6.4718 0.0 0
M  V30 7 N 8.0023 4.1618 0.0 0
M  V30 8 O 6.6686 6.4718 0.0 0
M  V30 9 O 5.3348 7.2418 0.0 0
M  V30 10 C 9.3359 4.9318 0.0 0
M  V30 11 C 10.6697 4.1618 0.0 0
M  V30 12 O 16.0045 7.2418 0.0 0
M  V30 13 N 4.0011 1.8517 0.0 0
M  V30 14 C 3.8402 0.3202 0.0 0
M  V30 15 C 2.5943 2.4782 0.0 0
M  V30 16 C 2.3338 0.0000 0.0 0
M  V30 17 C 1.5637 1.3337 0.0 0
M  V30 18 C 2.6675 7.2418 0.0 0
M  V30 19 C 2.6675 8.7818 0.0 0
M  V30 20 C 1.3338 6.4718 0.0 0
M  V30 21 C 1.3338 9.5518 0.0 0
M  V30 22 C 0.0000 7.2418 0.0 0
M  V30 23 C 0.0000 8.7818 0.0 0
M  V30 24 C 12.0034 4.9318 0.0 0
M  V30 25 C 12.0034 6.4718 0.0 0
M  V30 26 C 13.3371 4.1618 0.0 0
M  V30 27 C 13.3371 7.2418 0.0 0
M  V30 28 C 14.6707 4.9318 0.0 0
M  V30 29 C 14.6707 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 2 13
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 2 6 9
M  V30 10 1 6 18
M  V30 11 1 7 10
M  V30 12 1 10 11
M  V30 13 1 11 24
M  V30 14 1 12 29
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 26 2 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 2 26 28
M  V30 30 2 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 646072-01-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 646071-92-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-15042632
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-{1-[2-(4-Hydroxyphenyl)ethylcarbamoyl]-2-pyrrolidin-1-ylpropyl}benzamide
(2v). To a suspension of 1d (0.10 g, 0.31 mmol) in MeOH (2 mL) was added
pyrrolidine (1.3 mL, 15.5 mmol) followed by water (2.0 mL). The resulting
solution was stirred at room temperature for 6 days and concentrated to
yield 2v as a white powder (0.122.5 g, 100%, 85-90% purity): 1H NMR (300
MHz CDCl3) δ 8.61 (1H, t, J = 4.8 Hz), 7.83-7.78 (2H, m), 7.53-7.39 (4H,
m), 7.02-6.96 (2H, m), 6.79-6.71 (3H, m), 4.69 (1H, t, J = 3.7 Hz),
3.60-3.47 (2H, m), 3.06-2.97 (1H, m), 2.93 (1H, dd, J = 6.6, 3.66 Hz),
2.74 (2H, t, J = 6.6 Hz), 2.67-2.57 (3H, m), 1.68-1.59 (4H, m), 1.05
(0.9H, d, J = 6.8 Hz), 0.93 (2.1H, d, J = 6.8 Hz); HRMS calcd for
C23H30N3O3 (M + H) 396.2287, found 396.2287.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent, Michael addn. reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Michael addition of amines and thiols to dehydroalanine amides: a
remarkable rate acceleration in water
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Naidu, B. Narasimhulu; Sorenson, Margaret E.; Connolly, Timothy P.; Ueda,
Yasutsugu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2003), 68(26), 10098-10102

$RFMT $RIREG SCHEME248 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-pyridinecarbonyl chloride
C6H3Cl2NO
65287-34-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3338 1.5400 0.0 0
M  V30 2 Cl 0.0000 2.3100 0.0 0
M  V30 3 O 1.3338 0.0000 0.0 0
M  V30 4 Cl 6.6686 1.5400 0.0 0
M  V30 5 C 2.6675 2.3100 0.0 0
M  V30 6 C 4.0011 1.5400 0.0 0
M  V30 7 C 2.6675 3.8500 0.0 0
M  V30 8 C 5.3348 2.3100 0.0 0
M  V30 9 C 4.0011 4.6201 0.0 0
M  V30 10 N 5.3348 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 8
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2-Chloro-4-pyridinyl)-1-pyrrolidinylmethanone
C10H11ClN2O
720693-06-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 Cl 9.1059 1.5400 0.0 0
M  V30 4 C 5.1048 2.3101 0.0 0
M  V30 5 C 6.4386 1.5400 0.0 0
M  V30 6 C 5.1048 3.8501 0.0 0
M  V30 7 C 7.7722 2.3101 0.0 0
M  V30 8 C 6.4386 4.6201 0.0 0
M  V30 9 N 7.7722 3.8501 0.0 0
M  V30 10 N 2.4374 2.3101 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 7
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 65287-34-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 720693-06-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-7308580
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Neat 2-chloro-isonicotinoyl chloride (500 mg, 2.84 mmol) was added
dropwise to a solution of pyrrolidine (1.18 mL, 14.2 mmol) in
dichloromethane (20 mL) at 0 °C. After 30 min the ice bath was removed
and the reaction was allowed to warm to room temperature. The reaction
mixture was evaporated to dryness and the residue was partitioned between
ethyl ether and sat. NaHCO3 The aqueous layer was separated, extracted
with ethyl ether and the combined organic layers were washed with brine,
dried over Na2SO4 and concentrated to provide the product as a viscous
oil (614 mg, quantitative). Use in the next step without further
purification,
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of 5-(substituted
ethynyl)-3-[[(4-methylcyclohexyl)carbonyl](heteroaryloxy)amino]thiophene-2-carboxylic
acids and variants as inhibitors of flaviviridae viruses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Canales, Eda; Chong, Lee S.; Clarke, Michael O'Neil Hanrahan; Doerffler,
Edward; Lazerwith, Scott E.; Lew, Willard; Liu, Qi; Mertzman, Michael;
Morganelli, Philip A.; Watkins, William J.; Ye, Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011011303 A1 2011-01-27

$RFMT $RIREG SCHEME249 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(4-Nitrophenyl)-4H-3,1-benzoxazin-4-ylidene]-2-propanamine
C17H15N3O3
660425-88-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3100 2.6674 0.0 0
M  V30 2 C 3.0800 1.3336 0.0 0
M  V30 3 C 2.3100 0.0000 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 N 11.5500 5.3347 0.0 0 VAL=5
M  V30 6 O 12.3200 6.6685 0.0 0
M  V30 7 O 12.3200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 3.0800 4.0011 0.0 0
M  V30 11 C 0.7700 5.3347 0.0 0
M  V30 12 N 4.6200 6.6685 0.0 0
M  V30 13 C 2.3100 8.0021 0.0 0
M  V30 14 O 4.6200 4.0011 0.0 0
M  V30 15 C 0.0000 6.6685 0.0 0
M  V30 16 C 5.3900 5.3347 0.0 0
M  V30 17 C 0.7700 8.0021 0.0 0
M  V30 18 C 6.9300 5.3347 0.0 0
M  V30 19 C 7.7000 6.6685 0.0 0
M  V30 20 C 7.7000 4.0011 0.0 0
M  V30 21 C 9.2400 6.6684 0.0 0
M  V30 22 C 9.2400 4.0011 0.0 0
M  V30 23 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 10 CFG=2
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 23
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Methylethyl)-2-[[(4-nitrophenyl)-1-pyrrolidinylmethylene]amino]benzamide
C21H24N4O3
660425-93-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.9098 0.0 0
M  V30 2 N 5.3348 4.6799 0.0 0
M  V30 3 C 2.6673 6.2199 0.0 0
M  V30 4 N 1.3337 6.9899 0.0 0
M  V30 5 O 4.0010 6.9899 0.0 0
M  V30 6 C 1.3337 8.5299 0.0 0
M  V30 7 C 2.6673 9.3000 0.0 0
M  V30 8 C 0.0000 9.3000 0.0 0
M  V30 9 N 12.0033 6.9899 0.0 0 VAL=5
M  V30 10 O 13.3370 6.2199 0.0 0
M  V30 11 O 12.0033 8.5299 0.0 0
M  V30 12 C 8.0022 4.6799 0.0 0
M  V30 13 C 8.0022 6.2199 0.0 0
M  V30 14 C 9.3360 3.9098 0.0 0
M  V30 15 C 9.3360 6.9899 0.0 0
M  V30 16 C 10.6697 4.6799 0.0 0
M  V30 17 C 10.6697 6.2199 0.0 0
M  V30 18 N 6.6685 2.3698 0.0 0
M  V30 19 C 5.4226 1.4646 0.0 0
M  V30 20 C 7.9144 1.4646 0.0 0
M  V30 21 C 5.8985 0.0000 0.0 0
M  V30 22 C 7.4385 0.0000 0.0 0
M  V30 23 C 4.0010 3.9098 0.0 0
M  V30 24 C 2.6673 4.6799 0.0 0
M  V30 25 C 4.0010 2.3698 0.0 0
M  V30 26 C 1.3337 3.9098 0.0 0
M  V30 27 C 2.6673 1.5998 0.0 0
M  V30 28 C 1.3337 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 12
M  V30 3 1 1 18
M  V30 4 1 2 23
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 3 24
M  V30 8 1 4 6
M  V30 9 1 6 7
M  V30 10 1 6 8
M  V30 11 2 9 10
M  V30 12 2 9 11
M  V30 13 1 9 17
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 660425-88-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 660425-93-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-27040825
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amine-induced rearrangement of 4-imino-4H-3,1-benzoxazines to
4-quinazolinones via amidine carboxamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Snider, Barry B.; Zeng, Hongbo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2003), 61173-182

$RFMT $RIREG SCHEME250 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenanthridinium, 5-ethyl-3,8-bis[(phenoxycarbonyl)amino]-6-phenyl-, phosphat...
C35H28N3O4.H2O4P
660836-58-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  47 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 12.3203 7.2873 0.0 0
M  V30 2 C 13.8603 7.2873 0.0 0
M  V30 3 N 5.3901 11.2885 0.0 0
M  V30 4 C 4.6201 12.6222 0.0 0
M  V30 5 O 3.0801 12.6222 0.0 0
M  V30 6 O 5.3901 13.9560 0.0 0
M  V30 7 N 16.1704 11.2885 0.0 0
M  V30 8 C 16.9404 12.6222 0.0 0
M  V30 9 O 18.4804 12.6222 0.0 0
M  V30 10 O 16.1704 13.9560 0.0 0
M  V30 11 C 9.2402 9.9548 0.0 0
M  V30 12 C 10.0102 8.6212 0.0 0
M  V30 13 C 10.0102 11.2885 0.0 0
M  V30 14 C 7.7002 9.9548 0.0 0
M  V30 15 N 11.5503 8.6212 0.0 0 CHG=1 VAL=4
M  V30 16 C 11.5503 11.2885 0.0 0
M  V30 17 C 9.2402 12.6222 0.0 0
M  V30 18 C 6.9302 11.2885 0.0 0
M  V30 19 C 12.3203 9.9548 0.0 0
M  V30 20 C 12.3203 12.6222 0.0 0
M  V30 21 C 7.7002 12.6222 0.0 0
M  V30 22 C 13.8603 9.9548 0.0 0
M  V30 23 C 13.8603 12.6222 0.0 0
M  V30 24 C 14.6303 11.2885 0.0 0
M  V30 25 C 9.2402 7.2873 0.0 0
M  V30 26 C 7.7002 7.2873 0.0 0
M  V30 27 C 10.0102 5.9537 0.0 0
M  V30 28 C 6.9302 5.9537 0.0 0
M  V30 29 C 9.2402 4.6200 0.0 0
M  V30 30 C 7.7002 4.6200 0.0 0
M  V30 31 C 2.3101 13.9560 0.0 0
M  V30 32 C 3.0801 15.2897 0.0 0
M  V30 33 C 0.7700 13.9560 0.0 0
M  V30 34 C 2.3101 16.6233 0.0 0
M  V30 35 C 0.0000 15.2897 0.0 0
M  V30 36 C 0.7700 16.6233 0.0 0
M  V30 37 C 19.2504 13.9560 0.0 0
M  V30 38 C 18.4804 15.2897 0.0 0
M  V30 39 C 20.7905 13.9560 0.0 0
M  V30 40 C 19.2504 16.6233 0.0 0
M  V30 41 C 21.5605 15.2897 0.0 0
M  V30 42 C 20.7905 16.6233 0.0 0
M  V30 43 P 10.7802 1.5400 0.0 0 VAL=5
M  V30 44 O 9.2402 1.5400 0.0 0
M  V30 45 O 12.3202 1.5400 0.0 0 CHG=-1
M  V30 46 O 10.7802 0.0000 0.0 0
M  V30 47 O 10.7802 3.0800 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 15
M  V30 3 1 3 4
M  V30 4 1 3 18
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 31
M  V30 8 1 7 8
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 37
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 12 15
M  V30 17 1 12 25
M  V30 18 2 13 16
M  V30 19 1 13 17
M  V30 20 2 14 18
M  V30 21 2 15 19
M  V30 22 1 16 19
M  V30 23 1 16 20
M  V30 24 2 17 21
M  V30 25 1 18 21
M  V30 26 1 19 22
M  V30 27 2 20 23
M  V30 28 2 22 24
M  V30 29 1 23 24
M  V30 30 2 25 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 2 27 29
M  V30 34 2 28 30
M  V30 35 1 29 30
M  V30 36 2 31 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 2 33 35
M  V30 40 2 34 36
M  V30 41 1 35 36
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 38 40
M  V30 45 2 39 41
M  V30 46 2 40 42
M  V30 47 1 41 42
M  V30 48 2 43 44
M  V30 49 1 43 45
M  V30 50 1 43 46
M  V30 51 1 43 47
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trifluoroacetic acid
C2HF3O2
76-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 2.3101 0.0 0
M  V30 2 C 2.6673 1.5400 0.0 0
M  V30 3 F 2.1037 3.6437 0.0 0
M  V30 4 F 0.0000 3.0801 0.0 0
M  V30 5 F 0.5637 0.9764 0.0 0
M  V30 6 O 4.0010 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 2 2 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenanthridinium, 5-ethyl-6-phenyl-3,8-bis[(1-pyrrolidinylcarbonyl)amino]-, 2...
C31H34N5O2.C2F3O2
660836-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.6098 7.8512 0.0 0
M  V30 2 C 13.1498 7.8512 0.0 0
M  V30 3 N 4.6798 11.8521 0.0 0
M  V30 4 C 3.9098 13.1859 0.0 0
M  V30 5 O 4.6798 14.5195 0.0 0
M  V30 6 N 15.4598 11.8521 0.0 0
M  V30 7 C 16.2298 13.1859 0.0 0
M  V30 8 O 15.4598 14.5195 0.0 0
M  V30 9 C 9.2998 9.1848 0.0 0
M  V30 10 C 8.5298 10.5184 0.0 0
M  V30 11 N 10.8398 9.1848 0.0 0 CHG=1 VAL=4
M  V30 12 C 9.2998 11.8521 0.0 0
M  V30 13 C 6.9898 10.5184 0.0 0
M  V30 14 C 11.6098 10.5184 0.0 0
M  V30 15 C 10.8398 11.8521 0.0 0
M  V30 16 C 8.5298 13.1859 0.0 0
M  V30 17 C 6.2198 11.8521 0.0 0
M  V30 18 C 13.1498 10.5184 0.0 0
M  V30 19 C 11.6098 13.1859 0.0 0
M  V30 20 C 6.9898 13.1859 0.0 0
M  V30 21 C 13.9198 11.8521 0.0 0
M  V30 22 C 13.1498 13.1859 0.0 0
M  V30 23 C 8.5298 7.8512 0.0 0
M  V30 24 C 6.9898 7.8512 0.0 0
M  V30 25 C 9.2998 6.5174 0.0 0
M  V30 26 C 6.2198 6.5174 0.0 0
M  V30 27 C 8.5298 5.1837 0.0 0
M  V30 28 C 6.9898 5.1837 0.0 0
M  V30 29 N 2.3698 13.1859 0.0 0
M  V30 30 C 1.4645 14.4317 0.0 0
M  V30 31 C 1.4645 11.9399 0.0 0
M  V30 32 C 0.0000 13.9559 0.0 0
M  V30 33 C 0.0000 12.4159 0.0 0
M  V30 34 N 17.7698 13.1859 0.0 0
M  V30 35 C 18.6750 11.9399 0.0 0
M  V30 36 C 18.6750 14.4317 0.0 0
M  V30 37 C 20.1395 12.4159 0.0 0
M  V30 38 C 20.1395 13.9559 0.0 0
M  V30 39 C 9.4029 2.3101 0.0 0
M  V30 40 C 10.7366 1.5400 0.0 0
M  V30 41 F 10.1729 3.6437 0.0 0
M  V30 42 F 8.0692 3.0801 0.0 0
M  V30 43 F 8.6329 0.9764 0.0 0
M  V30 44 O 12.0703 2.3101 0.0 0 CHG=-1
M  V30 45 O 10.7366 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 2 4 5
M  V30 6 1 4 29
M  V30 7 1 6 7
M  V30 8 1 6 21
M  V30 9 2 7 8
M  V30 10 1 7 34
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 9 23
M  V30 14 1 10 12
M  V30 15 1 10 13
M  V30 16 2 11 14
M  V30 17 2 12 15
M  V30 18 1 12 16
M  V30 19 2 13 17
M  V30 20 1 14 15
M  V30 21 1 14 18
M  V30 22 1 15 19
M  V30 23 2 16 20
M  V30 24 1 17 20
M  V30 25 2 18 21
M  V30 26 2 19 22
M  V30 27 1 21 22
M  V30 28 2 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 2 25 27
M  V30 32 2 26 28
M  V30 33 1 27 28
M  V30 34 1 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 39 1 34 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 1 37 38
M  V30 44 1 39 40
M  V30 45 1 39 41
M  V30 46 1 39 42
M  V30 47 1 39 43
M  V30 48 1 40 44
M  V30 49 2 40 45
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 660836-58-8
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 660836-61-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-6714718
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 3, 8-Bis-urea-pyrrolidine-ethidium-TFAc (16).
3,8-Bis-phenoxycarbamate-ethidium-H2PO4 (14) (12 mg, 19 μmoles), DMSO (1
mL) and pyrrolidine (40 μL, 460 μmoles, 27 equiv) were combined and
heated for 5 min (90 °C). The reaction was then diluted into water (9 mL,
0.1% TFA) and loaded onto an activated Water's"Sep-pack"C-18 reversed
phase column (activated with 10 mL acetonitrile, 10 mL water). The column
was washed with water (10 mL, 0.1% TFA), then 10% acetonitrile (10 mL, in
water with 0.1% TFA). The product was then eluted with 35% acetonitrile
(10 mL, in water with 0.1% TFA) and lyophilized. Yield 12 mg, 100%, as a
yellow solid. 1H NMR (400 MHz, d6-DMSO, 21 °C) : δ 9.01 (d, J = 9.6 Hz,
1H), δ 8.98 (s, 1H), δ 8.94 (d, J = 9.6 Hz, 1H), δ 8.89 (d, J = 2.0 Hz,
1H), δ 8. 72 (s, 1H), δ 8. 40 (dd J = 9.2 Hz, Jp = 2.4 Hz, 1H), δ 8. 26
(dd J = 9. 2 Hz, J2 = 1. 6 Hz, 1H), δ 7. 34-7. 80 (m, 6H), δ 4. 56 (4, J
= 6. 4 Hz, 2H), δ 3. 46 (t, J = 6.4 Hz, 2H), δ 3.15 (t, J = 6.6 Hz, 2H),
δ 1.91 (t, J = 6.4 Hz, 2H), δ 2.81 (t, J = 6.6 Hz, 2H), δ 1.48 (t, J =
7.2 Hz, 3H). ESI MS calculated for C31H34N5O2 : 508, found 508 [M]+.
W-vis (50 mM sodium phosphate pH 7.5) : λmax (nm) and ε (cm-1M-1) : 288
(4.7 x 104), 438 (4.5 x 103).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of phenanthridine derivatives as anti-viral agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tor, Yitzhak; Luedtke, Nathan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005016343 A1 2005-02-24

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-(1,1-dimethylethyl)benzonitrile
C11H12ClN
67740-14-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 C 1.5400 1.1273 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 C 1.5400 4.2073 0.0 0
M  V30 5 Cl 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 N 9.2400 2.6673 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 11
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl)-2-(1-pyrrolidinyl)benzonitrile
C15H20N2
1338065-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.1048 0.0 0
M  V30 2 N 0.0000 5.1048 0.0 0
M  V30 3 C 7.7000 5.1048 0.0 0
M  V30 4 C 8.4700 6.4384 0.0 0
M  V30 5 C 9.2400 5.1048 0.0 0
M  V30 6 C 8.4700 3.7710 0.0 0
M  V30 7 C 3.8500 3.7710 0.0 0
M  V30 8 C 3.0800 5.1048 0.0 0
M  V30 9 C 5.3900 3.7710 0.0 0
M  V30 10 C 3.8500 6.4384 0.0 0
M  V30 11 C 6.1600 5.1048 0.0 0
M  V30 12 C 5.3900 6.4384 0.0 0
M  V30 13 N 3.0800 2.4374 0.0 0
M  V30 14 C 3.7063 1.0306 0.0 0
M  V30 15 C 1.5485 2.2764 0.0 0
M  V30 16 C 2.5619 0.0000 0.0 0
M  V30 17 C 1.2283 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67740-14-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1338065-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-16728090
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic heteroaryl ureas and amides as TRPV1 vanilloid
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Napoletano, Mauro; Trevisani, Marcello; Pavani, Maria Giovanna;
Fruttarolo, Francesca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Patent Organization, EP2377850 A1 2011-10-19

$RFMT $RIREG SCHEME251 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-(1,1-dimethylethyl)benzonitrile
C11H12ClN
67740-14-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 2.6673 0.0 0
M  V30 2 C 1.5400 1.1273 0.0 0
M  V30 3 C 0.0000 2.6673 0.0 0
M  V30 4 C 1.5400 4.2073 0.0 0
M  V30 5 Cl 6.1600 0.0000 0.0 0
M  V30 6 C 7.7000 2.6673 0.0 0
M  V30 7 N 9.2400 2.6673 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.8500 1.3336 0.0 0
M  V30 10 C 3.8500 4.0011 0.0 0
M  V30 11 C 5.3900 1.3336 0.0 0
M  V30 12 C 5.3900 4.0011 0.0 0
M  V30 13 C 6.1600 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 5 11
M  V30 6 3 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1,1-Dimethylethyl)-2-(1-pyrrolidinyl)benzonitrile
C15H20N2
1338065-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.1048 0.0 0
M  V30 2 N 0.0000 5.1048 0.0 0
M  V30 3 C 7.7000 5.1048 0.0 0
M  V30 4 C 8.4700 6.4384 0.0 0
M  V30 5 C 9.2400 5.1048 0.0 0
M  V30 6 C 8.4700 3.7710 0.0 0
M  V30 7 C 3.8500 3.7710 0.0 0
M  V30 8 C 3.0800 5.1048 0.0 0
M  V30 9 C 5.3900 3.7710 0.0 0
M  V30 10 C 3.8500 6.4384 0.0 0
M  V30 11 C 6.1600 5.1048 0.0 0
M  V30 12 C 5.3900 6.4384 0.0 0
M  V30 13 N 3.0800 2.4374 0.0 0
M  V30 14 C 3.7063 1.0306 0.0 0
M  V30 15 C 1.5485 2.2764 0.0 0
M  V30 16 C 2.5619 0.0000 0.0 0
M  V30 17 C 1.2283 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 3 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 67740-14-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1338065-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1957993
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation of 4-tert-butyl-2-pyrrolidin-1-yl-benzonitrile 10a
(Multi-steps reaction) (Scheme 4). The nitrile 9 (2.2g, 11.3 mmol) was
heated in a steel-bomb with pyrrolidine (3.75 mL, 4 mol eq) at 200°C for
12h. The reaction mixture was concentrated, water and brine was added and
the mixture was extracted three times with EtOAc. The recombined organic
phases were dried under sodium sulfate and evaporated to dryness to
furnish 10a as a red oil (2.6g, quantitative yield), used for the next
step of reaction without further purifications.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of bicyclic heteroaryl ureas and amides as TRPV1 vanilloid
receptor antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Napoletano, Mauro; Trevisani, Marcello; Pavani, Maria Giovanna;
Fruttarolo, Francesca
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011120604 A1 2011-10-06

$RFMT $RIREG SCHEME252 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 3-oxo-4-(2-propen-1-yloxy)butanoate
C8H12O4
680973-42-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 2.6673 1.5400 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 O 1.3337 2.3101 0.0 0
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 8 O 8.0022 1.5400 0.0 0
M  V30 9 C 0.0000 1.5400 0.0 0
M  V30 10 C 9.3360 2.3101 0.0 0
M  V30 11 C 10.6697 1.5400 0.0 0
M  V30 12 C 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 10 11
M  V30 11 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(2-propen-1-yloxy)-3-(1-pyrrolidinyl)-2-butenoate
C12H19NO3
680973-52-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.7710 0.0 0
M  V30 2 C 3.8500 5.1048 0.0 0
M  V30 3 C 6.1600 3.7710 0.0 0
M  V30 4 C 2.3100 5.1048 0.0 0
M  V30 5 O 6.9300 5.1048 0.0 0
M  V30 6 O 1.5400 6.4384 0.0 0
M  V30 7 O 1.5400 3.7710 0.0 0
M  V30 8 C 8.4700 5.1048 0.0 0
M  V30 9 C 0.0000 6.4384 0.0 0
M  V30 10 C 9.2400 6.4384 0.0 0
M  V30 11 C 10.7800 6.4384 0.0 0
M  V30 12 N 3.8500 2.4374 0.0 0
M  V30 13 C 4.4763 1.0306 0.0 0
M  V30 14 C 2.3185 2.2764 0.0 0
M  V30 15 C 3.3319 0.0000 0.0 0
M  V30 16 C 1.9983 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 2 10 11
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 680973-42-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 680973-52-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-5885626
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [2,3]-Wittig rearrangement of methyl
β-pyrrolidinyl-γ-allyloxy-(E)-2-butenoate. Expeditious synthesis of
5-alkenyl-4-pyrrolidin-1-yl-5H-furan-2-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Yu-Jang; Lee, Pei-Ting; Yang, Chuen-Mei; Chang, Yuan-Kang; Weng,
Ying-Chieh; Liu, Yi-Hung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2004), 45(9), 1865-1868

$RFMT $RIREG SCHEME253 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(2-methyl-2-propen-1-yl)oxy]-3-oxobutanoate
C9H14O4
680973-43-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 5.3348 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 9.3360 1.5400 0.0 0
M  V30 6 O 4.0012 1.5400 0.0 0
M  V30 7 O 10.6697 2.3101 0.0 0
M  V30 8 O 9.3360 0.0000 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 12.0033 1.5400 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 0.0000 2.3101 0.0 0
M  V30 13 C 1.3337 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 12 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(2-methyl-2-propen-1-yl)oxy]-3-(1-pyrrolidinyl)-2-butenoate
C13H21NO3
680973-53-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.7710 0.0 0
M  V30 2 C 3.8500 5.1046 0.0 0
M  V30 3 C 6.1600 3.7710 0.0 0
M  V30 4 C 2.3100 5.1046 0.0 0
M  V30 5 O 6.9300 5.1046 0.0 0
M  V30 6 O 1.5400 6.4384 0.0 0
M  V30 7 O 1.5400 3.7710 0.0 0
M  V30 8 C 8.4700 5.1046 0.0 0
M  V30 9 C 0.0000 6.4384 0.0 0
M  V30 10 C 9.2400 6.4384 0.0 0
M  V30 11 C 10.7800 6.4384 0.0 0
M  V30 12 C 8.4700 7.7721 0.0 0
M  V30 13 N 3.8500 2.4374 0.0 0
M  V30 14 C 4.4763 1.0304 0.0 0
M  V30 15 C 2.3185 2.2764 0.0 0
M  V30 16 C 3.3319 0.0000 0.0 0
M  V30 17 C 1.9983 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 680973-43-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 680973-53-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8008203
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [2,3]-Wittig rearrangement of methyl
β-pyrrolidinyl-γ-allyloxy-(E)-2-butenoate. Expeditious synthesis of
5-alkenyl-4-pyrrolidin-1-yl-5H-furan-2-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Yu-Jang; Lee, Pei-Ting; Yang, Chuen-Mei; Chang, Yuan-Kang; Weng,
Ying-Chieh; Liu, Yi-Hung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2004), 45(9), 1865-1868

$RFMT $RIREG SCHEME254 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(1-methyl-2-propen-1-yl)oxy]-3-oxobutanoate
C9H14O4
680973-44-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 5.3348 3.8501 0.0 0
M  V30 6 O 1.3337 1.5400 0.0 0
M  V30 7 O 2.6673 3.8501 0.0 0
M  V30 8 O 8.0022 2.3101 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 9.3360 1.5400 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 9.3360 0.0000 0.0 0
M  V30 13 C 12.0033 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(1-methyl-2-propen-1-yl)oxy]-3-(1-pyrrolidinyl)-2-butenoate
C13H21NO3
680973-54-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 3.7710 0.0 0
M  V30 2 C 3.8500 5.1048 0.0 0
M  V30 3 C 6.1600 3.7710 0.0 0
M  V30 4 C 2.3100 5.1048 0.0 0
M  V30 5 O 6.9300 5.1048 0.0 0
M  V30 6 O 1.5400 6.4384 0.0 0
M  V30 7 O 1.5400 3.7710 0.0 0
M  V30 8 C 8.4700 5.1048 0.0 0
M  V30 9 C 0.0000 6.4384 0.0 0
M  V30 10 C 9.2400 6.4384 0.0 0
M  V30 11 C 9.2400 3.7710 0.0 0
M  V30 12 C 10.7800 6.4384 0.0 0
M  V30 13 N 3.8500 2.4374 0.0 0
M  V30 14 C 4.4763 1.0306 0.0 0
M  V30 15 C 2.3185 2.2764 0.0 0
M  V30 16 C 3.3319 0.0000 0.0 0
M  V30 17 C 1.9983 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 2 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 680973-44-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 680973-54-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-10144031
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [2,3]-Wittig rearrangement of methyl
β-pyrrolidinyl-γ-allyloxy-(E)-2-butenoate. Expeditious synthesis of
5-alkenyl-4-pyrrolidin-1-yl-5H-furan-2-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Yu-Jang; Lee, Pei-Ting; Yang, Chuen-Mei; Chang, Yuan-Kang; Weng,
Ying-Chieh; Liu, Yi-Hung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2004), 45(9), 1865-1868

$RFMT $RIREG SCHEME255 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(1,1-dimethyl-2-propen-1-yl)oxy]-3-oxobutanoate
C10H16O4
680973-45-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3112 2.1037 0.0 0
M  V30 2 C 4.9775 1.3337 0.0 0
M  V30 3 C 7.6449 1.3337 0.0 0
M  V30 4 O 6.3112 3.6437 0.0 0
M  V30 5 O 3.6437 2.1037 0.0 0
M  V30 6 C 8.9786 2.1037 0.0 0
M  V30 7 C 2.3101 1.3337 0.0 0
M  V30 8 O 10.3124 1.3337 0.0 0
M  V30 9 O 8.9786 3.6437 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 11 C 0.9764 0.5637 0.0 0
M  V30 12 C 3.0801 0.0000 0.0 0
M  V30 13 C 11.6460 2.1037 0.0 0
M  V30 14 C 0.0000 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 1 7 12
M  V30 12 1 8 13
M  V30 13 2 10 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(1,1-dimethyl-2-propen-1-yl)oxy]-3-(1-pyrrolidinyl)-2-butenoate
C14H23NO3
680973-55-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 4.6201 0.0 0
M  V30 2 C 5.1048 5.3901 0.0 0
M  V30 3 C 3.7711 3.0801 0.0 0
M  V30 4 O 6.4386 4.6201 0.0 0
M  V30 5 C 2.4374 2.3101 0.0 0
M  V30 6 C 7.7722 5.3901 0.0 0
M  V30 7 O 2.4374 0.7700 0.0 0
M  V30 8 O 1.1037 3.0801 0.0 0
M  V30 9 C 8.5423 4.0564 0.0 0
M  V30 10 C 9.1059 6.1601 0.0 0
M  V30 11 C 7.0022 6.7238 0.0 0
M  V30 12 C 1.1037 0.0000 0.0 0
M  V30 13 C 10.0823 4.0564 0.0 0
M  V30 14 N 2.4374 5.3901 0.0 0
M  V30 15 C 1.0304 4.7636 0.0 0
M  V30 16 C 2.2765 6.9217 0.0 0
M  V30 17 C 0.0000 5.9082 0.0 0
M  V30 18 C 0.7700 7.2419 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 11
M  V30 12 1 7 12
M  V30 13 2 9 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 680973-45-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 680973-55-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-12269649
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [2,3]-Wittig rearrangement of methyl
β-pyrrolidinyl-γ-allyloxy-(E)-2-butenoate. Expeditious synthesis of
5-alkenyl-4-pyrrolidin-1-yl-5H-furan-2-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Yu-Jang; Lee, Pei-Ting; Yang, Chuen-Mei; Chang, Yuan-Kang; Weng,
Ying-Chieh; Liu, Yi-Hung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2004), 45(9), 1865-1868

$RFMT $RIREG SCHEME260 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(3-methyl-2-buten-1-yl)oxy]-3-oxobutanoate
C10H16O4
680973-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 2.6673 2.3101 0.0 0
M  V30 4 C 6.6685 1.5400 0.0 0
M  V30 5 O 5.3348 3.8501 0.0 0
M  V30 6 O 1.3337 1.5400 0.0 0
M  V30 7 O 2.6673 3.8501 0.0 0
M  V30 8 O 8.0022 2.3101 0.0 0
M  V30 9 C 0.0000 2.3101 0.0 0
M  V30 10 C 9.3360 1.5400 0.0 0
M  V30 11 C 10.6697 2.3101 0.0 0
M  V30 12 C 12.0033 1.5400 0.0 0
M  V30 13 C 12.0033 0.0000 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 6 9
M  V30 9 1 8 10
M  V30 10 1 10 11
M  V30 11 2 11 12
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-[(3-methyl-2-buten-1-yl)oxy]-3-(1-pyrrolidinyl)-2-butenoate
C14H23NO3
680973-60-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 4.6201 0.0 0
M  V30 2 C 5.1047 5.3901 0.0 0
M  V30 3 C 3.7711 3.0801 0.0 0
M  V30 4 O 6.4384 4.6201 0.0 0
M  V30 5 C 2.4373 2.3101 0.0 0
M  V30 6 C 7.7722 5.3901 0.0 0
M  V30 7 O 2.4373 0.7700 0.0 0
M  V30 8 O 1.1036 3.0801 0.0 0
M  V30 9 C 9.1059 4.6201 0.0 0
M  V30 10 C 1.1036 0.0000 0.0 0
M  V30 11 C 10.4396 5.3901 0.0 0
M  V30 12 C 10.4396 6.9302 0.0 0
M  V30 13 C 11.7733 4.6201 0.0 0
M  V30 14 N 2.4373 5.3901 0.0 0
M  V30 15 C 2.2763 6.9217 0.0 0
M  V30 16 C 1.0304 4.7636 0.0 0
M  V30 17 C 0.7700 7.2419 0.0 0
M  V30 18 C 0.0000 5.9082 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 9 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 680973-50-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 680973-60-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-14680536
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-43-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM [2,3]-Wittig rearrangement of methyl
β-pyrrolidinyl-γ-allyloxy-(E)-2-butenoate. Expeditious synthesis of
5-alkenyl-4-pyrrolidin-1-yl-5H-furan-2-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Yu-Jang; Lee, Pei-Ting; Yang, Chuen-Mei; Chang, Yuan-Kang; Weng,
Ying-Chieh; Liu, Yi-Hung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2004), 45(9), 1865-1868

$RFMT $RIREG SCHEME262 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-6-(4-methoxyphenyl)-1-methyl-4-(methylthio)-2-oxo-3-pyridinecarbo...
C15H14N2O2S
68464-74-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 6.6685 0.0 0
M  V30 2 S 3.0800 1.3338 0.0 0
M  V30 3 C 3.8500 0.0000 0.0 0
M  V30 4 O 3.0800 6.6685 0.0 0
M  V30 5 C 1.5400 4.0011 0.0 0
M  V30 6 N 0.0000 4.0011 0.0 0
M  V30 7 O 12.3200 4.0011 0.0 0
M  V30 8 C 13.0900 2.6674 0.0 0
M  V30 9 C 6.1600 4.0011 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 N 5.3900 5.3347 0.0 0
M  V30 12 C 3.8500 2.6674 0.0 0
M  V30 13 C 3.8500 5.3347 0.0 0
M  V30 14 C 3.0800 4.0011 0.0 0
M  V30 15 C 7.7000 4.0011 0.0 0
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 C 8.4700 5.3347 0.0 0
M  V30 18 C 10.0100 2.6674 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 20 C 10.7800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 2 4 13
M  V30 5 3 5 6
M  V30 6 1 5 14
M  V30 7 1 7 8
M  V30 8 1 7 20
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 9 15
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-6-(4-methoxyphenyl)-1-methyl-2-oxo-4-(1-pyrrolidinyl)-3-pyridinec...
C18H19N3O2
1482518-69-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 5.1046 0.0 0
M  V30 2 N 0.0000 5.1046 0.0 0
M  V30 3 O 3.0800 7.7721 0.0 0
M  V30 4 C 6.1600 7.7721 0.0 0
M  V30 5 O 12.3200 5.1046 0.0 0
M  V30 6 C 13.0900 6.4384 0.0 0
M  V30 7 C 3.8500 3.7710 0.0 0
M  V30 8 C 3.0800 5.1046 0.0 0
M  V30 9 C 5.3900 3.7710 0.0 0
M  V30 10 C 3.8500 6.4384 0.0 0
M  V30 11 C 6.1600 5.1046 0.0 0
M  V30 12 N 5.3900 6.4384 0.0 0
M  V30 13 N 3.0800 2.4374 0.0 0
M  V30 14 C 1.5485 2.2764 0.0 0
M  V30 15 C 3.7063 1.0304 0.0 0
M  V30 16 C 1.2283 0.7700 0.0 0
M  V30 17 C 2.5619 0.0000 0.0 0
M  V30 18 C 7.7000 5.1046 0.0 0
M  V30 19 C 8.4700 6.4384 0.0 0
M  V30 20 C 8.4700 3.7710 0.0 0
M  V30 21 C 10.0100 6.4384 0.0 0
M  V30 22 C 10.0100 3.7710 0.0 0
M  V30 23 C 10.7800 5.1046 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 2 3 10
M  V30 4 1 4 12
M  V30 5 1 5 6
M  V30 6 1 5 23
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 13
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 1 11 18
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 68464-74-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1482518-69-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-10699105
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Theoretical interpretations of electronic and fluorescence spectra of new
2(1H)-pyridone derivatives in solution and solid state
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Shigemitsu, Yasuhiro; Hagimori, Masayori; Mizuyama, Naoko; Wang,
Bo-Cheng; Tominaga, Yoshinori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dyes and Pigments (2013), 99(3), 940-949

$RFMT $RIREG SCHEME263 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl L-lactate
C5H10O3
687-47-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 O 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0 CFG=1
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 5.3347 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 8 C 6.6685 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7 CFG=1
M  V30 7 1 5 8
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(2S)-2-Hydroxy-1-(1-pyrrolidinyl)-1-propanone
C7H13NO2
122151-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 C 5.1048 2.3100 0.0 0 CFG=1
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 5.1048 3.8500 0.0 0
M  V30 5 O 6.4385 1.5400 0.0 0
M  V30 6 N 2.4374 2.3100 0.0 0
M  V30 7 C 1.0306 1.6835 0.0 0
M  V30 8 C 2.2764 3.8416 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 10 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 2 5 CFG=3
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 687-47-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 122151-38-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-20734521
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Toward Chromanes by de Novo Construction of the Benzene Ring
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Geist, Egor; Berneaud-Koetz, Helge; Baikstis, Tomas; Draeger, Gerald;
Kirschning, Andreas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2019), 21(22), 8930-8933

$RFMT $RIREG SCHEME264 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(2-Formyl-4-nitrophenoxy)acetic acid
C9H7NO6
6965-69-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6684 4.6201 0.0 0
M  V30 2 C 8.0022 3.8500 0.0 0
M  V30 3 C 9.3359 4.6201 0.0 0
M  V30 4 O 9.3359 6.1601 0.0 0
M  V30 5 O 10.6695 3.8500 0.0 0
M  V30 6 C 4.0011 6.1601 0.0 0
M  V30 7 O 2.6673 6.9301 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3100 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 4.0011 4.6201 0.0 0
M  V30 13 C 5.3348 2.3100 0.0 0
M  V30 14 C 2.6675 3.8500 0.0 0
M  V30 15 C 4.0011 1.5400 0.0 0
M  V30 16 C 2.6675 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 6 7
M  V30 7 1 6 12
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Nitro-2-[2-oxo-2-(1-pyrrolidinyl)ethoxy]benzaldehyde
C13H14N2O5
1156670-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3358 4.6201 0.0 0
M  V30 4 O 9.3358 6.1601 0.0 0
M  V30 5 C 4.0010 6.1601 0.0 0
M  V30 6 O 2.6673 6.9302 0.0 0
M  V30 7 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 8 O 0.0000 2.3101 0.0 0
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0010 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 4.0010 1.5400 0.0 0
M  V30 15 C 2.6673 2.3101 0.0 0
M  V30 16 N 10.6697 3.8501 0.0 0
M  V30 17 C 12.0765 4.4764 0.0 0
M  V30 18 C 10.8306 2.3185 0.0 0
M  V30 19 C 13.1069 3.3320 0.0 0
M  V30 20 C 12.3369 1.9983 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 16
M  V30 6 2 5 6
M  V30 7 1 5 11
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6965-69-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1156670-01-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8093932
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: But-3-enoic Acid
[3-(2-Chloropyrimidin-4-yl)phenyl]amide (14a). To a mixture of 12e (0.2
g, 0.852 mmol) and vinylacetic acid (81 μL, 0.942 mmol) in CH2Cl2 (4 mL)
at room temperature were added HOBt (0.184 g, 1.36 mmol) and EDCI (0.26
g, 1.36 mmol). The resulting mixture was stirred for 4 h. The reaction
mixture was cooled to 0 °C and quenched with H2O. The aqueous layer was
extracted with CH2Cl2 thrice and the combined organic extracts were
washed with saturated NaHCO3 followed by brine, dried over Na2SO4 and
concentrated under reduced pressure to give 14a which was taken for the
next step without further purification.
5-Nitro-2-(2-oxo-2-pyrrolidin-1-ylethoxy)benzaldehyde (16s). Following a
procedure similar to that of 14a, the title compound was synthesized from
16r. (yield, quantitative). LC/MS (ESI positive mode) m/z 279 ([M + H]+)
C13H14N2O5.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of Kinase Spectrum Selective Macrocycle
(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene
(SB1317/TG02), a Potent Inhibitor of Cyclin Dependent Kinases (CDKs),
Janus Kinase 2 (JAK2), and Fms-like Tyrosine Kinase-3 (FLT3) for the
Treatment of Cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM William, Anthony D.; Lee, Angeline C.-H.; Goh, Kee Chuan; Blanchard,
Stephanie; Poulsen, Anders; Teo, Ee Ling; Nagaraj, Harish; Lee, Chai
Ping; Wang, Haishan; Williams, Meredith; Sun, Eric T.; Hu, Changyong;
Jayaraman, Ramesh; Pasha, Mohammed Khalid; Ethirajulu, Kantharaj; Wood,
Jeanette M.; Dymock, Brian W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2012), 55(1), 169-196

$RFMT $RIREG SCHEME265 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Iodoanisole
C7H7IO
696-62-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 I 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Methoxyphenyl)pyrrolidine
C11H15NO
54660-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.5299 1.3337 0.0 0
M  V30 2 C 9.2999 2.6673 0.0 0
M  V30 3 C 3.9098 1.3337 0.0 0
M  V30 4 C 4.6798 2.6673 0.0 0
M  V30 5 C 4.6798 0.0000 0.0 0
M  V30 6 C 6.2198 2.6673 0.0 0
M  V30 7 C 6.2198 0.0000 0.0 0
M  V30 8 C 6.9898 1.3337 0.0 0
M  V30 9 N 2.3698 1.3337 0.0 0
M  V30 10 C 1.4646 2.5795 0.0 0
M  V30 11 C 1.4646 0.0878 0.0 0
M  V30 12 C 0.0000 2.1037 0.0 0
M  V30 13 C 0.0000 0.5636 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 696-62-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54660-04-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-2969696
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 147-85-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Coupling Reaction of
Aryl Halides with Alkylamines Catalyzed by CuI and Amino Acid. A mixture
of aryl halide (5 mmol), alkylamine (7.5 mmol, or 15 mmol for the amines
with low boiling points), K2CO3 (10 mmol, for aryl iodide) or K3PO4 (10
mmol, for aryl bromide), CuI (0.5 mmol), and the appropriate amino acid
(1 mmol) in 3 mL of DMSO was heated at the indicated temperature. The
cooled mixture was partitioned between water and ethylacetate. The
organic layer was separated, and the aqueous layer was extracted with
ethyl acetate. The combined organic layers were washed with brine, dried
over Na2SO4, and concentrated in vacuo. The residual oil was loaded on a
silica gel column and eluted with 1/10 to 1/8 ethyl acetate/petroleum
ether to afford the corresponding aniline. Yield 100%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Amino Acid Promoted CuI-Catalyzed C-N Bond Formation between Aryl Halides
and Amines or N-Containing Heterocycles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Hui; Cai, Qian; Ma, Dawei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2005), 70(13), 5164-5173

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
701-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5638 1.7464 0.0 0
M  V30 4 O 2.1038 4.4137 0.0 0
M  V30 5 F 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1-[(3-fluorophenyl)sulfonyl]-
C10H12FNO2S
670272-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 3.0801 0.0 0 VAL=6
M  V30 2 O 4.5411 4.4137 0.0 0
M  V30 3 O 3.0011 1.7464 0.0 0
M  V30 4 F 9.1059 3.0801 0.0 0
M  V30 5 C 5.1048 2.3101 0.0 0
M  V30 6 C 6.4386 3.0801 0.0 0
M  V30 7 C 5.1048 0.7700 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 6.4386 0.0000 0.0 0
M  V30 10 C 7.7722 0.7700 0.0 0
M  V30 11 N 2.4374 3.8501 0.0 0
M  V30 12 C 1.0304 3.2236 0.0 0
M  V30 13 C 2.2763 5.3816 0.0 0
M  V30 14 C 0.0000 4.3682 0.0 0
M  V30 15 C 0.7700 5.7018 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 1 11
M  V30 5 1 4 8
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 701-27-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 670272-02-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-20264593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and
Structure-Activity Relationships
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Leung, Leo; Niculescu-Duvaz, Dan; Smithen, Deborah; Lopes, Filipa;
Callens, Cedric; McLeary, Robert; Saturno, Grazia; Davies, Lawrence;
Aljarah, Mohammed; Brown, Michael; Johnson, Louise; Zambon, Alfonso;
Chambers, Tim; Menard, Delphine; Bayliss, Natasha; Knight, Ruth; Fish,
Laura; Lawrence, Rae; Challinor, Mairi; Tang, HaoRan; Marais, Richard;
Springer, Caroline
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(12), 5863-5884

$RFMT $RIREG SCHEME266 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Fluorobenzenesulfonyl chloride
C6H4ClFO2S
701-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.3338 3.0801 0.0 0 VAL=6
M  V30 2 Cl 0.0000 3.8501 0.0 0
M  V30 3 O 0.5638 1.7464 0.0 0
M  V30 4 O 2.1038 4.4137 0.0 0
M  V30 5 F 6.6687 3.0801 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 2.6675 0.7700 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 0.0000 0.0 0
M  V30 11 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 5 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1-[(3-fluorophenyl)sulfonyl]-
C10H12FNO2S
670272-02-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.7711 3.0801 0.0 0 VAL=6
M  V30 2 O 4.5411 4.4137 0.0 0
M  V30 3 O 3.0011 1.7464 0.0 0
M  V30 4 F 9.1059 3.0801 0.0 0
M  V30 5 C 5.1048 2.3101 0.0 0
M  V30 6 C 6.4386 3.0801 0.0 0
M  V30 7 C 5.1048 0.7700 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 6.4386 0.0000 0.0 0
M  V30 10 C 7.7722 0.7700 0.0 0
M  V30 11 N 2.4374 3.8501 0.0 0
M  V30 12 C 1.0304 3.2236 0.0 0
M  V30 13 C 2.2763 5.3816 0.0 0
M  V30 14 C 0.0000 4.3682 0.0 0
M  V30 15 C 0.7700 5.7018 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 1 11
M  V30 5 1 4 8
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 701-27-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 670272-02-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-19060887
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroarylmethylamine derivatives as lysyl oxidase inhibitors for the
treatment of cancer and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Springer, Caroline; Marais, Richard; Niculescu-Duvaz, Dan; Leung, Leo;
Smithen, Deborah; Callens, Cedric; Tang, Haoran
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2017141049 A1 2017-08-24

$RFMT $RIREG SCHEME267 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-(chloromethyl)pyridine
C6H5Cl2N
70258-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 Cl 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 N 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-5-(1-pyrrolidinylmethyl)pyridine
C10H13ClN2
230617-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.0801 0.0 0
M  V30 2 Cl 9.1059 0.0000 0.0 0
M  V30 3 C 5.1048 2.3101 0.0 0
M  V30 4 C 6.4386 3.0801 0.0 0
M  V30 5 C 5.1048 0.7700 0.0 0
M  V30 6 C 7.7722 2.3101 0.0 0
M  V30 7 N 6.4386 0.0000 0.0 0
M  V30 8 C 7.7722 0.7700 0.0 0
M  V30 9 N 2.4374 2.3101 0.0 0
M  V30 10 C 1.0304 2.9364 0.0 0
M  V30 11 C 2.2763 0.7785 0.0 0
M  V30 12 C 0.0000 1.7920 0.0 0
M  V30 13 C 0.7700 0.4583 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 1 9
M  V30 3 1 2 8
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 70258-18-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 230617-66-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19368743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Heteroaromatic electrophiles for reactivating or realkylating aged
acetylcholinesterase inhibited by or conjugated to organophosphorus
compounds and methods of using thereof
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hadad, Christopher; Callam, Christopher; Beck, Jeremy; Zhuang, Qinggeng;
Franjesevic, Andrew; Corrigan, Thomas; McElroy, Craig
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018152329 A1 2018-08-23

$RFMT $RIREG SCHEME268 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1H-Benzimidazole-1-propanol, 6-[5,6-dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]...
C22H23N5O3S
705263-44-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.5620 6.8435 0.0 0
M  V30 2 C 11.8958 7.6135 0.0 0
M  V30 3 C 13.2294 6.8435 0.0 0
M  V30 4 O 14.5631 7.6135 0.0 0
M  V30 5 S 15.8967 6.8435 0.0 0 VAL=6
M  V30 6 C 15.1267 5.5098 0.0 0
M  V30 7 O 17.2305 6.0735 0.0 0
M  V30 8 O 16.6667 8.1771 0.0 0
M  V30 9 C 5.3634 3.7376 0.0 0
M  V30 10 C 3.8987 3.2617 0.0 0
M  V30 11 C 6.2686 2.4917 0.0 0
M  V30 12 N 3.8987 1.7217 0.0 0
M  V30 13 N 5.3634 1.2459 0.0 0
M  V30 14 C 7.7331 2.0159 0.0 0
M  V30 15 C 6.2686 0.0000 0.0 0
M  V30 16 C 7.7331 0.4759 0.0 0
M  V30 17 C 5.8392 5.2023 0.0 0
M  V30 18 C 7.3455 5.5225 0.0 0
M  V30 19 C 4.8088 6.3467 0.0 0
M  V30 20 C 7.8215 6.9872 0.0 0
M  V30 21 C 5.2847 7.8114 0.0 0
M  V30 22 C 6.7910 8.1315 0.0 0
M  V30 23 N 9.2283 7.6135 0.0 0
M  V30 24 N 7.5610 9.4652 0.0 0
M  V30 25 C 9.0674 9.1450 0.0 0
M  V30 26 C 2.6528 4.1670 0.0 0
M  V30 27 C 2.8137 5.6985 0.0 0
M  V30 28 N 1.2460 3.5406 0.0 0
M  V30 29 C 1.5679 6.6037 0.0 0
M  V30 30 C 0.0000 4.4457 0.0 0
M  V30 31 C 0.1611 5.9774 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 23
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 5 8
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 17
M  V30 12 2 10 12
M  V30 13 1 10 26
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 1 12 13
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 20 23
M  V30 26 2 21 22
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 2 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-[5,6-Dihydro-2-(2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-1-[3-(1-pyrroli...
C25H28N6
883214-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.8298 5.8012 0.0 0
M  V30 2 C 12.2943 6.2771 0.0 0
M  V30 3 C 13.4388 5.2466 0.0 0
M  V30 4 C 5.0990 3.8442 0.0 0
M  V30 5 C 3.5674 3.6832 0.0 0
M  V30 6 C 5.7253 2.4374 0.0 0
M  V30 7 N 3.2471 2.1768 0.0 0
M  V30 8 N 4.5809 1.4068 0.0 0
M  V30 9 C 7.0589 1.6674 0.0 0
M  V30 10 C 5.2072 0.0000 0.0 0
M  V30 11 C 6.7387 0.1609 0.0 0
M  V30 12 C 5.8690 5.1778 0.0 0
M  V30 13 C 7.4090 5.1778 0.0 0
M  V30 14 C 5.0990 6.5116 0.0 0
M  V30 15 C 8.1790 6.5116 0.0 0
M  V30 16 C 5.8690 7.8452 0.0 0
M  V30 17 C 7.4090 7.8452 0.0 0
M  V30 18 N 9.6852 6.8318 0.0 0
M  V30 19 N 8.4394 8.9896 0.0 0
M  V30 20 C 9.8462 8.3633 0.0 0
M  V30 21 C 2.5368 4.8276 0.0 0
M  V30 22 C 3.0127 6.2923 0.0 0
M  V30 23 N 1.0306 4.5074 0.0 0
M  V30 24 C 1.9823 7.4367 0.0 0
M  V30 25 C 0.0000 5.6518 0.0 0
M  V30 26 C 0.4760 7.1165 0.0 0
M  V30 27 N 14.9034 5.7225 0.0 0
M  V30 28 C 15.3792 7.1872 0.0 0
M  V30 29 C 16.1493 4.8173 0.0 0
M  V30 30 C 16.9193 7.1872 0.0 0
M  V30 31 C 17.3953 5.7225 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 18
M  V30 3 1 2 3
M  V30 4 1 3 27
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 2 5 7
M  V30 9 1 5 21
M  V30 10 1 6 8
M  V30 11 1 6 9
M  V30 12 1 7 8
M  V30 13 1 8 10
M  V30 14 1 9 11
M  V30 15 1 10 11
M  V30 16 1 12 13
M  V30 17 2 12 14
M  V30 18 2 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 15 18
M  V30 22 2 16 17
M  V30 23 1 17 19
M  V30 24 1 18 20
M  V30 25 2 19 20
M  V30 26 2 21 22
M  V30 27 1 21 23
M  V30 28 1 22 24
M  V30 29 2 23 25
M  V30 30 2 24 26
M  V30 31 1 25 26
M  V30 32 1 27 28
M  V30 33 1 27 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 705263-44-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 883214-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7413807
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
Dimethyl-(3-{6-[2-(6-methyl-pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-
yl]-benzoimidazol-1-yl}-propyl)-amine (17a). To 2 mL dimethylamine in THF
(2M) was added compound 16a (22 mg, 0.048 mmol) in a 10 mL Flask. After
heating the mixture at 80 °C for 30 minutes, the amine and solvent were
removed in vacuo. The residue without work-up was purified by ISCO column
chromatography on silica gel eluted gradually from dichloromethane to 10%
methanol in dichloromethane (20 mins) to give the desired product as a
white foam (18.5 mg, 95%).
6-(2-Pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)-1-(3-pyrrolidin-1-ylpropyl)-
1H-benzoimidazole (17g). Compound 17g were obtained according to the
procedure described for compound 17c by using 16b with a yield of 100%
(18.1 mg). TOF MS ES+ (m/z ) 429.2 (M+1)+. 1H NMR (400 MHz, CDCl3): δ
8.61 (bd, J= 4.0 Hz, 1H), 7.88 (s, 1H), 7.72 (d, J = 8.4 Hz, 1H), 7.52
(t, J = 7.2 Hz, 1H), 7.37 (d, J = 8.0 Hz, 1H), 7.33 (s, 1H), 7.20 (dd, J
= 8.4, 1.2 Hz, 1H), 7.14 (t, J = 7.6 Hz, 1H), 4.29 (t, J = 7.2 Hz, 2H),
4.17 (t, J = 6.8 Hz, 2H), 3.05 (t, J = 7.2 Hz, 1H), 2.47 (m, 2H), 2.40
(t, J = 7.2 Hz, 1H), 1.95 (m, 2H), 1.79 (m, 2H). HPLC Method A: >99%;
HPLC Method B: >99%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Dihydropyrrolopyrazole Transforming Growth Factor-β Type I Receptor
Kinase Domain Inhibitors: A Novel Benzimidazole Series with Selectivity
versus Transforming Growth Factor-β Type II Receptor Kinase and Mixed
Lineage Kinase-7
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Hong-Yu; Wang, Yan; Heap, Charles R.; King, Chi-Hsin R.; Mundla,
Sreenivasa R.; Voss, Matthew; Clawson, David K.; Yan, Lei; Campbell,
Robert M.; Anderson, Bryan D.; Wagner, Jill R.; Britt, Karen; Lu, Ku X.;
McMillen, William T.; Yingling, Jonathan M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2006), 49(6), 2138-2142

$RFMT $RIREG SCHEME269 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2:3,4-Bis-O-(1-methylethylidene)-6-O-(2-oxiranylmethyl)-α-D-galactopyranose
C15H24O7
70969-90-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.7937 4.8480 0.0 0
M  V30 2 O 8.5638 6.1816 0.0 0
M  V30 3 C 10.1038 6.1816 0.0 0
M  V30 4 C 3.6833 0.0000 0.0 0
M  V30 5 C 5.7441 0.0000 0.0 0
M  V30 6 C 1.0304 8.1644 0.0 0
M  V30 7 C 0.0000 6.3795 0.0 0
M  V30 8 C 3.9437 3.5143 0.0 0 CFG=1
M  V30 9 C 3.1737 4.8480 0.0 0 CFG=1
M  V30 10 C 5.4837 3.5143 0.0 0 CFG=1
M  V30 11 O 3.4678 2.0496 0.0 0
M  V30 12 C 3.9437 6.1816 0.0 0 CFG=1
M  V30 13 O 1.6674 5.1682 0.0 0
M  V30 14 C 6.2537 4.8480 0.0 0 CFG=1
M  V30 15 O 5.9596 2.0496 0.0 0
M  V30 16 C 4.7137 1.1444 0.0 0
M  V30 17 O 5.4837 6.1816 0.0 0
M  V30 18 O 2.9133 7.3262 0.0 0
M  V30 19 C 1.5063 6.6997 0.0 0
M  V30 20 C 10.8738 7.5153 0.0 0 CFG=3
M  V30 21 C 12.2074 8.2853 0.0 0
M  V30 22 O 10.8738 9.0553 0.0 0
M  V30 23 H 2.5059 2.9624 0.0 0
M  V30 24 H 1.8268 4.1014 0.0 0
M  V30 25 H 7.0153 3.3532 0.0 0
M  V30 26 H 4.5700 7.5886 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 20
M  V30 5 1 4 16
M  V30 6 1 5 16
M  V30 7 1 6 19
M  V30 8 1 7 19
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 8 11
M  V30 12 1 8 23 CFG=1
M  V30 13 1 9 12
M  V30 14 1 9 13
M  V30 15 1 9 24 CFG=3
M  V30 16 1 10 14
M  V30 17 1 10 15
M  V30 18 1 10 25 CFG=1
M  V30 19 1 11 16
M  V30 20 1 12 17
M  V30 21 1 12 18
M  V30 22 1 12 26 CFG=3
M  V30 23 1 13 19
M  V30 24 1 14 17
M  V30 25 1 15 16
M  V30 26 1 18 19
M  V30 27 1 20 21
M  V30 28 1 20 22
M  V30 29 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 8 9 10 12 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
6-O-[2-Hydroxy-3-(1-pyrrolidinyl)propyl]-1,2:3,4-bis-O-(1-methylethylidene)-α...
C19H33NO7
676442-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.9839 6.2537 0.0 0
M  V30 2 O 7.3175 5.4837 0.0 0
M  V30 3 C 8.6512 6.2537 0.0 0
M  V30 4 C 9.9848 5.4837 0.0 0 CFG=3
M  V30 5 C 11.3186 6.2537 0.0 0
M  V30 6 O 9.9848 3.9437 0.0 0
M  V30 7 C 0.0000 8.3969 0.0 0
M  V30 8 C 1.7849 9.4274 0.0 0
M  V30 9 C 1.7849 0.0000 0.0 0
M  V30 10 C 0.0000 1.0304 0.0 0
M  V30 11 C 1.9828 5.4837 0.0 0 CFG=1
M  V30 12 C 1.9828 3.9437 0.0 0 CFG=1
M  V30 13 C 3.3164 6.2537 0.0 0 CFG=1
M  V30 14 O 0.8382 6.5141 0.0 0
M  V30 15 C 3.3164 3.1737 0.0 0 CFG=1
M  V30 16 O 0.8382 2.9132 0.0 0
M  V30 17 C 4.6501 5.4837 0.0 0 CFG=1
M  V30 18 O 2.9963 7.7600 0.0 0
M  V30 19 C 1.4647 7.9211 0.0 0
M  V30 20 O 4.6501 3.9437 0.0 0
M  V30 21 O 2.9963 1.6674 0.0 0
M  V30 22 C 1.4647 1.5063 0.0 0
M  V30 23 N 12.6523 5.4837 0.0 0
M  V30 24 C 12.8132 3.9521 0.0 0
M  V30 25 C 14.0591 6.1100 0.0 0
M  V30 26 C 14.3197 3.6320 0.0 0
M  V30 27 C 15.0897 4.9656 0.0 0
M  V30 28 H 0.4617 5.2428 0.0 0
M  V30 29 H 0.4429 3.9167 0.0 0
M  V30 30 H 4.5623 7.1589 0.0 0
M  V30 31 H 4.5623 2.2684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 17 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 23
M  V30 8 1 7 19
M  V30 9 1 8 19
M  V30 10 1 9 22
M  V30 11 1 10 22
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 11 28 CFG=3
M  V30 16 1 12 15
M  V30 17 1 12 16
M  V30 18 1 12 29 CFG=1
M  V30 19 1 13 17
M  V30 20 1 13 18
M  V30 21 1 13 30 CFG=3
M  V30 22 1 14 19
M  V30 23 1 15 20
M  V30 24 1 15 21
M  V30 25 1 15 31 CFG=1
M  V30 26 1 16 22
M  V30 27 1 17 20
M  V30 28 1 18 19
M  V30 29 1 21 22
M  V30 30 1 23 24
M  V30 31 1 23 25
M  V30 32 1 24 26
M  V30 33 1 25 27
M  V30 34 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 11 12 13 15 17)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 70969-90-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 676442-48-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-035-CAS-10042866
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1643-19-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of galactopyranosyl amino alcohols as a new class of
antitubercular and antifungal agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tewari, Neetu; Tiwari, V. K.; Tripathi, R. P.; Chaturvedi, V.;
Srivastava, A.; Srivastava, R.; Shukla, P. K.; Chaturvedi, A. K.;
Gaikwad, A.; Sinha, S.; Srivastava, B. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2004), 14(2), 329-332

$RFMT $RIREG SCHEME270 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dimethoxybenzaldehyde
C9H10O3
7311-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 4.0011 0.0 0
M  V30 2 O 6.9301 5.3348 0.0 0
M  V30 3 O 1.5400 6.6686 0.0 0
M  V30 4 C 0.0000 6.6686 0.0 0
M  V30 5 O 1.5400 1.3338 0.0 0
M  V30 6 C 2.3100 0.0000 0.0 0
M  V30 7 C 4.6201 4.0011 0.0 0
M  V30 8 C 3.8500 5.3348 0.0 0
M  V30 9 C 3.8500 2.6675 0.0 0
M  V30 10 C 2.3100 5.3348 0.0 0
M  V30 11 C 2.3100 2.6675 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Trimethylsilyl cyanide
C4H9NSi
7677-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 N 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
α-(3,5-Dimethoxyphenyl)-1-pyrrolidineacetonitrile
C14H18N2O2
1108730-66-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.0800 0.0 0
M  V30 2 C 3.7711 1.5400 0.0 0
M  V30 3 N 3.7711 0.0000 0.0 0
M  V30 4 O 9.1058 3.0800 0.0 0
M  V30 5 C 10.4395 3.8501 0.0 0
M  V30 6 O 6.4384 7.7001 0.0 0
M  V30 7 C 7.7722 8.4701 0.0 0
M  V30 8 C 5.1047 3.8501 0.0 0
M  V30 9 C 6.4384 3.0800 0.0 0
M  V30 10 C 5.1047 5.3901 0.0 0
M  V30 11 C 7.7722 3.8501 0.0 0
M  V30 12 C 6.4384 6.1601 0.0 0
M  V30 13 C 7.7722 5.3901 0.0 0
M  V30 14 N 2.4374 3.8501 0.0 0
M  V30 15 C 1.0304 3.2237 0.0 0
M  V30 16 C 2.2763 5.3816 0.0 0
M  V30 17 C 0.0000 4.3681 0.0 0
M  V30 18 C 0.7700 5.7018 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 14
M  V30 4 3 2 3
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 7
M  V30 8 1 6 12
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7311-34-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 7677-24-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1108730-66-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-346-CAS-1832510
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 144026-79-9
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM polymer-supported
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst, flow system, Strecker reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Evaluation of the heterogeneously catalyzed Strecker reaction conducted
under continuous flow
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wiles, Charlotte; Watts, Paul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2008), (33), 5597-5613

$RFMT $RIREG SCHEME271 STEP1
$RXN



  2  1
$MOL
L-Tryptophan
C11H12N2O2
73-22-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 5.2308 0.0 0
M  V30 2 C 2.6675 6.7708 0.0 0 CFG=2
M  V30 3 C 1.3337 7.5408 0.0 0
M  V30 4 N 4.0011 7.5408 0.0 0
M  V30 5 O 0.0000 6.7708 0.0 0
M  V30 6 O 1.3337 9.0808 0.0 0
M  V30 7 C 4.1620 2.9293 0.0 0
M  V30 8 C 4.0011 4.4608 0.0 0
M  V30 9 C 5.6685 2.6091 0.0 0
M  V30 10 C 3.1316 1.7849 0.0 0
M  V30 11 C 5.4079 5.0873 0.0 0
M  V30 12 N 6.4385 3.9427 0.0 0
M  V30 13 C 6.1443 1.1444 0.0 0
M  V30 14 C 3.6075 0.3202 0.0 0
M  V30 15 C 5.1139 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=1
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 12
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-[2-(1-Pyrrolidinyl)ethyl]-1H-indole
C14H18N2
14008-96-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 2.7126 0.0 0
M  V30 2 C 7.1954 3.1885 0.0 0
M  V30 3 C 3.0800 3.4229 0.0 0
M  V30 4 C 4.5863 3.7430 0.0 0
M  V30 5 C 2.3100 4.7565 0.0 0
M  V30 6 C 2.3100 2.0892 0.0 0
M  V30 7 C 4.7474 5.2746 0.0 0
M  V30 8 N 3.3405 5.9011 0.0 0
M  V30 9 C 0.7700 4.7565 0.0 0
M  V30 10 C 0.7700 2.0892 0.0 0
M  V30 11 C 0.0000 3.4229 0.0 0
M  V30 12 N 8.3400 2.1580 0.0 0
M  V30 13 C 8.1789 0.6265 0.0 0
M  V30 14 C 9.8463 2.4782 0.0 0
M  V30 15 C 9.5859 0.0000 0.0 0
M  V30 16 C 10.6163 1.1445 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 7 8
M  V30 12 1 9 11
M  V30 13 2 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 73-22-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 14008-96-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33004442
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7558-79-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7681-52-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 134-03-2
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM biphasic system
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Method of synthesizing indole compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hein, Jason Ellis; Sanz, Corey; Chen, Shao-Kai; Cao, Blessing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022140844 A1 2022-07-07

$RFMT $RIREG SCHEME272 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(bromomethyl)benzeneacetate
C10H11BrO2
7398-42-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 O 9.3360 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 10.6697 2.3101 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 Br 0.0000 0.7700 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 5.3348 0.7700 0.0 0
M  V30 10 C 4.0012 3.0801 0.0 0
M  V30 11 C 4.0012 0.0000 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 2.6673 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(1-pyrrolidinylmethyl)benzeneacetate
C14H19NO2
878139-91-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 0.0000 0.0 0
M  V30 2 C 9.1059 3.0801 0.0 0
M  V30 3 C 10.4396 2.3101 0.0 0
M  V30 4 O 11.7733 3.0801 0.0 0
M  V30 5 O 10.4396 0.7700 0.0 0
M  V30 6 C 13.1069 2.3101 0.0 0
M  V30 7 C 5.1048 0.7700 0.0 0
M  V30 8 C 5.1048 2.3101 0.0 0
M  V30 9 C 6.4384 0.0000 0.0 0
M  V30 10 C 6.4384 3.0801 0.0 0
M  V30 11 C 7.7721 0.7700 0.0 0
M  V30 12 C 7.7721 2.3101 0.0 0
M  V30 13 N 2.4373 0.7700 0.0 0
M  V30 14 C 1.0304 0.1437 0.0 0
M  V30 15 C 2.2763 2.3016 0.0 0
M  V30 16 C 0.0000 1.2881 0.0 0
M  V30 17 C 0.7700 2.6218 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 1 2 12
M  V30 5 1 3 4
M  V30 6 2 3 5
M  V30 7 1 4 6
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7398-42-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 878139-91-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11217676
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) Methyl 2-[4-(pyrrolidin-1-ylmethyl)phenyl]acetate (I-85) Pyrrolidine
(866 μL; 12.3 mmol; 3 eq) was added to a solution of methyl
2-[4-(bromomethyl)phenyl]acetate (I-72) (1.0 g; 4.11 mmol; 1 eq) in
methanol (6 mL). The reaction mixture was stirred at room temperature for
3 hours, then, concentrated to dryness. The residue was taken up in water
(20 mL) and the resulting aqueous layer was extracted with
dichloromethane (3 x 20 mL). The combined organic layers were washed with
saturated sodium chloride (60 mL), dried over sodium sulfate, filtered
and concentrated under reduced pressure. The title compound, methyl
2-[4-(pyrrolidin-1-ylmethyl)phenyl]acetate was obtained in a quantitative
yield (1.1 g) as a yellow oil. 1H NMR (CDCl3): δ (ppm) 1.84 (m, 4H), 2.56
(m, 4H), 3.66 (m, 4H), 3.74 (s, 3H), 7.31 (m, 4H); MS (ESI+): m/z =
234.10 [M+H]+.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydantoin and thiohydantoin derivatives as antiviral drugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guedat, Philippe; Berecibar, Amaya; Ciapetti, Paola; Venkata Pithani,
Subhash; Trouche, Nathalie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013171281 A1 2013-11-21

$RFMT $RIREG SCHEME273 STEP1
$RXN



  2  1
$MOL
3-Iodo-4-methoxybenzenamine
C7H8INO
74587-12-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 2.6673 0.0 0
M  V30 2 C 0.0000 4.0010 0.0 0
M  V30 3 I 2.3101 0.0000 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 3.0801 1.3337 0.0 0
M  V30 7 C 3.0801 4.0010 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 9 C 4.6201 4.0010 0.0 0
M  V30 10 C 5.3901 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 3 6
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-(3-Iodo-4-methoxyphenyl)diazenyl]pyrrolidine
C11H14IN3O
1394130-77-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6799 2.6673 0.0 0
M  V30 2 N 3.9098 4.0010 0.0 0
M  V30 3 I 9.3000 0.0000 0.0 0
M  V30 4 O 10.8400 2.6673 0.0 0
M  V30 5 C 11.6100 4.0010 0.0 0
M  V30 6 C 6.2199 2.6673 0.0 0
M  V30 7 C 6.9899 1.3337 0.0 0
M  V30 8 C 6.9899 4.0010 0.0 0
M  V30 9 C 8.5299 1.3337 0.0 0
M  V30 10 C 8.5299 4.0010 0.0 0
M  V30 11 C 9.3000 2.6673 0.0 0
M  V30 12 N 2.3698 4.0010 0.0 0
M  V30 13 C 1.4646 2.7551 0.0 0
M  V30 14 C 1.4646 5.2469 0.0 0
M  V30 15 C 0.0000 3.2310 0.0 0
M  V30 16 C 0.0000 4.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 9
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 74587-12-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1394130-77-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-078-CAS-2812384
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7632-00-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the preparation of
aryltriazene 1b, 1c, 1d, 1e, 1h, 1i, 1l, 1r, 1t, 1u and 1v.A solution of
corresponding aniline (5.0 mmol) in 2.0 mL of conc. HCl was cooled in an
ice bath while a solution of NaNO2 (366 mg, 5.3 mmol) in cold water (10
mL) was added dropwise. The resulting solution of the diazonium salt was
stirred at 0 °C for 30 min and then added to a solution of pyrrolidine
(2.57 g, 36.2 mmol) and K2CO3 (12.51 g, 90.5 mmol) in 1:2
acetonitrile/water (25 mL) by one portion. The reaction mixture was
allowed to warm to room temperature and stirred for 30 min. The aqueous
phase was extracted with EtOAc (3 × 15 mL). The organic phase was washed
twice with brine, dried with MgSO4, and concentrated under reduced
pressure. The crude product was purified by flash column chromatography
over silica gel giving the corresponding aryltriazene.
1-[2-(3-iodo-4-methoxyphenyl)diazen-1-yl]pyrrolidine (1u) Pale yellow
solid; Yield: 100% (1.65 g); mp 69-70 °C; 1H NMR (400 MHz, CDCl3) δ =
7.89 (d, J = 2.4 Hz, 1H), 7.35 (dd, J = 8.4, 2.4 Hz, 1H), 6.77 (d, J =
8.4 Hz, 1H), 3.86 (s, 3H), 3.75 (br, 4H), 2.00 (t, J = 7.6 Hz, 4H); 13C
NMR (100MHz, CDCl3) δ = 155.6, 146.3, 130.4, 121.8, 110.7, 86.1, 56.6,
23.7; IR (neat) cm-1 3051, 2978, 2874, 1485, 1422, 1391, 1337, 1265;
ESI-HRMS: Found: m/z 332.0263. Calcd for C11H15IN3O: (M+H)+ 332.0260.
$DTYPE RXN:VAR(1):NOTES
$DATUM dropwise addition of NaNO2 (1st stage)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transition-Metal-Free Borylation of Aryltriazene Mediated by BF3·OEt2
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhu, Chuan; Yamane, Motoki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2012), 14(17), 4560-4563

$RFMT $RIREG SCHEME274 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-pyrimidinamine
C4H4ClN3
7461-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 3.0800 0.0 0
M  V30 2 Cl 5.3349 3.0800 0.0 0
M  V30 3 N 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 N 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Pyrrolidinyl)-4-pyrimidinamine
C8H12N4
33851-99-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7721 3.0800 0.0 0
M  V30 2 C 3.7710 2.3100 0.0 0
M  V30 3 N 5.1046 3.0800 0.0 0
M  V30 4 N 3.7710 0.7700 0.0 0
M  V30 5 C 6.4384 2.3100 0.0 0
M  V30 6 C 5.1046 0.0000 0.0 0
M  V30 7 C 6.4384 0.7700 0.0 0
M  V30 8 N 2.4374 3.0800 0.0 0
M  V30 9 C 2.2764 4.6115 0.0 0
M  V30 10 C 1.0304 2.4535 0.0 0
M  V30 11 C 0.7700 4.9317 0.0 0
M  V30 12 C 0.0000 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 8
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 7461-50-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 33851-99-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21711959
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of uracil derivatives as Mer-Axl inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tarby, Christine M.; Norris, Derek J.; Lo, Julian C.; Ahuja, Vijay T.;
Seitz, Steven P.; Gavai, Ashvinikumar V.; Tokarski, John S.; Rajasagi,
Mohini; Wichroski, Michael; Broekema, Matthias
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2019213340 A1 2019-11-07

$RFMT $RIREG SCHEME275 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,3,5-Tribromopyridine
C5H2Br3N
75806-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 1.5400 0.0000 0.0 0
M  V30 2 Br 0.0000 2.6673 0.0 0
M  V30 3 Br 6.1601 2.6673 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 1.5400 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 N 2.3101 4.0010 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 3.8501 4.0010 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 8
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,5-Dibromo-2-(1-pyrrolidinyl)pyridine
C9H10Br2N2
1259313-59-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 3.9098 0.0000 0.0 0
M  V30 2 Br 8.5299 2.6673 0.0 0
M  V30 3 N 2.3698 2.6673 0.0 0
M  V30 4 C 1.4646 1.4214 0.0 0
M  V30 5 C 1.4646 3.9132 0.0 0
M  V30 6 C 0.0000 1.8973 0.0 0
M  V30 7 C 0.0000 3.4373 0.0 0
M  V30 8 C 3.9098 2.6673 0.0 0
M  V30 9 C 4.6798 1.3337 0.0 0
M  V30 10 N 4.6798 4.0010 0.0 0
M  V30 11 C 6.2198 1.3337 0.0 0
M  V30 12 C 6.2198 4.0010 0.0 0
M  V30 13 C 6.9898 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 8
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 75806-85-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1259313-59-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9608698
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cross-coupling reaction on N-(3,5-dibromo-2-pyridyl)piperazines:
regioselective synthesis of 3,5-disubstituted pyridylpiperazines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hikawa, Hidemasa; Yokoyama, Yuusaku
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2010), 66(49), 9552-9559

$RFMT $RIREG SCHEME276 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Diethyl acetylenedicarboxylate
C8H10O4
762-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.8501 0.0 0
M  V30 2 C 5.3348 3.0801 0.0 0
M  V30 3 O 2.6673 3.0801 0.0 0
M  V30 4 O 4.0012 5.3901 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 C 1.3337 3.8501 0.0 0
M  V30 7 C 8.0022 1.5400 0.0 0
M  V30 8 C 0.0000 3.0801 0.0 0
M  V30 9 O 9.3360 2.3101 0.0 0
M  V30 10 O 8.0022 0.0000 0.0 0
M  V30 11 C 10.6697 1.5400 0.0 0
M  V30 12 C 12.0033 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 3 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 7 10
M  V30 10 1 9 11
M  V30 11 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,4-Diethyl (2Z)-2-(1-pyrrolidinyl)-2-butenedioate
C12H19NO4
2170557-73-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 3.7711 0.0 0
M  V30 2 C 4.6201 5.1048 0.0 0
M  V30 3 C 6.9302 3.7711 0.0 0
M  V30 4 C 3.0801 5.1048 0.0 0
M  V30 5 O 7.7002 5.1048 0.0 0
M  V30 6 O 7.7002 2.4374 0.0 0
M  V30 7 O 2.3101 6.4386 0.0 0
M  V30 8 O 2.3101 3.7711 0.0 0
M  V30 9 C 9.2402 5.1048 0.0 0
M  V30 10 C 0.7700 6.4386 0.0 0
M  V30 11 C 10.0102 6.4386 0.0 0
M  V30 12 C 0.0000 7.7722 0.0 0
M  V30 13 N 4.6201 2.4374 0.0 0
M  V30 14 C 5.2464 1.0304 0.0 0
M  V30 15 C 3.0885 2.2765 0.0 0
M  V30 16 C 4.1020 0.0000 0.0 0
M  V30 17 C 2.7684 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 7 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 13 14
M  V30 14 1 13 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 762-21-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2170557-73-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-18510793
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, aza-Michael reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Multilayered film microreactors fabricated by a one-step thermal bonding
technique with high reproducibility and their applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Min, Kyoung-Ik; Kim, Jin-Oh; Kim, Heejin; Im, Do Jin; Kim, Dong-Pyo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Lab on a Chip (2016), 16(6), 977-983

$RFMT $RIREG SCHEME277 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hexynyl tosylate
C13H16O3S
76911-01-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.3349 1.3338 0.0 0 VAL=6
M  V30 2 O 6.1049 2.6674 0.0 0
M  V30 3 O 4.5649 0.0000 0.0 0
M  V30 4 O 6.6685 0.5638 0.0 0
M  V30 5 C 7.6449 2.6674 0.0 0
M  V30 6 C 8.4149 4.0011 0.0 0
M  V30 7 C 9.9549 4.0011 0.0 0
M  V30 8 C 10.7249 5.3349 0.0 0
M  V30 9 C 12.2649 5.3349 0.0 0
M  V30 10 C 13.8049 5.3349 0.0 0
M  V30 11 C 0.0000 4.4138 0.0 0
M  V30 12 C 4.0011 2.1038 0.0 0
M  V30 13 C 4.0011 3.6438 0.0 0
M  V30 14 C 2.6674 1.3338 0.0 0
M  V30 15 C 2.6674 4.4138 0.0 0
M  V30 16 C 1.3338 2.1038 0.0 0
M  V30 17 C 1.3338 3.6438 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 12
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 3 9 10
M  V30 11 1 11 17
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(5-Hexyn-1-yl)pyrrolidine
C10H17N
2229209-62-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4384 2.6218 0.0 0
M  V30 4 C 7.7722 1.8517 0.0 0
M  V30 5 C 9.1059 2.6218 0.0 0
M  V30 6 C 10.4396 3.3918 0.0 0
M  V30 7 N 2.4374 1.8517 0.0 0
M  V30 8 C 2.2763 0.3202 0.0 0
M  V30 9 C 1.0304 2.4782 0.0 0
M  V30 10 C 0.7700 0.0000 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 3 5 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76911-01-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2229209-62-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24756837
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and Characterization of Bis-Triazolyl-Pyridine Derivatives as
Noncanonical DNA-Interacting Compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Di Porzio, Anna; Galli, Ubaldina; Amato, Jussara; Zizza, Pasquale;
Iachettini, Sara; Iaccarino, Nunzia; Marzano, Simona; Santoro, Federica;
Brancaccio, Diego; Carotenuto, Alfonso; De Tito, Stefano; Biroccio,
Annamaria; Pagano, Bruno; Tron, Gian Cesare; Randazzo, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM International Journal of Molecular Sciences (2021), 22(21), 11959

$RFMT $RIREG SCHEME278 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl N-(1-phenylethyl)carbamodithioate
C11H15NS2
76926-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.0801 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 C 4.0012 4.6201 0.0 0
M  V30 4 C 6.6685 3.0801 0.0 0
M  V30 5 S 8.0023 2.3101 0.0 0
M  V30 6 S 6.6685 4.6201 0.0 0
M  V30 7 C 9.3360 3.0801 0.0 0
M  V30 8 C 10.6697 2.3101 0.0 0
M  V30 9 C 2.6673 2.3101 0.0 0
M  V30 10 C 2.6673 0.7700 0.0 0
M  V30 11 C 1.3337 3.0801 0.0 0
M  V30 12 C 1.3337 0.0000 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(1-Phenylethyl)-1-pyrrolidinecarbothioamide
C13H18N2S
887090-45-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 N 5.3348 2.3101 0.0 0
M  V30 3 S 6.6685 0.0000 0.0 0
M  V30 4 C 4.0012 1.5400 0.0 0
M  V30 5 C 4.0012 0.0000 0.0 0
M  V30 6 N 8.0022 2.3101 0.0 0
M  V30 7 C 9.4091 1.6837 0.0 0
M  V30 8 C 8.1633 3.8416 0.0 0
M  V30 9 C 10.4396 2.8281 0.0 0
M  V30 10 C 9.6696 4.1618 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 1.3337 1.5400 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 C 0.0000 2.3101 0.0 0
M  V30 15 C 1.3337 4.6201 0.0 0
M  V30 16 C 0.0000 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 76926-65-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 887090-45-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-10948163
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly efficient and catalyst-free synthesis of unsymmetrical thioureas
under solvent-free conditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Halimehjani, Azim Ziyaei; Pourshojaei, Yaghoub; Saidi, Mohammad R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2009), 50(1), 32-34

$RFMT $RIREG SCHEME279 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,9,11,18-Tetraoxo-1,10-dioxa-4,7,13,16-tetraazacyclooctadecane-4,7,13,16-tet...
C20H28N4O14
77145-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 9.2400 0.0 0
M  V30 2 C 1.3338 8.4700 0.0 0
M  V30 3 O 1.3338 6.9300 0.0 0
M  V30 4 O 0.0000 9.2400 0.0 0
M  V30 5 O 6.6685 6.9300 0.0 0
M  V30 6 C 6.6685 13.0900 0.0 0
M  V30 7 C 5.3347 13.8600 0.0 0
M  V30 8 O 5.3347 15.4000 0.0 0
M  V30 9 O 4.0011 13.0900 0.0 0
M  V30 10 O 6.6685 2.3100 0.0 0
M  V30 11 O 9.3358 13.0900 0.0 0
M  V30 12 C 9.3358 2.3100 0.0 0
M  V30 13 C 10.6696 1.5400 0.0 0
M  V30 14 O 10.6696 0.0000 0.0 0
M  V30 15 O 12.0032 2.3100 0.0 0
M  V30 16 O 9.3358 8.4700 0.0 0
M  V30 17 C 13.3369 6.1600 0.0 0
M  V30 18 C 14.6705 6.9300 0.0 0
M  V30 19 O 14.6705 8.4700 0.0 0
M  V30 20 O 16.0043 6.1600 0.0 0
M  V30 21 N 4.0011 8.4700 0.0 0
M  V30 22 C 4.0011 6.9300 0.0 0
M  V30 23 C 5.3347 9.2400 0.0 0
M  V30 24 C 5.3347 6.1600 0.0 0
M  V30 25 C 5.3347 10.7800 0.0 0
M  V30 26 O 5.3347 4.6200 0.0 0
M  V30 27 N 6.6685 11.5500 0.0 0
M  V30 28 C 6.6685 3.8500 0.0 0
M  V30 29 C 8.0021 10.7800 0.0 0
M  V30 30 C 8.0021 4.6200 0.0 0
M  V30 31 C 9.3358 11.5500 0.0 0
M  V30 32 N 9.3358 3.8500 0.0 0
M  V30 33 O 10.6696 10.7800 0.0 0
M  V30 34 C 10.6696 4.6200 0.0 0
M  V30 35 C 10.6696 9.2400 0.0 0
M  V30 36 C 10.6696 6.1600 0.0 0
M  V30 37 C 12.0032 8.4700 0.0 0
M  V30 38 N 12.0032 6.9300 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 21
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 24
M  V30 6 1 6 7
M  V30 7 1 6 27
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 10 28
M  V30 11 2 11 31
M  V30 12 1 12 13
M  V30 13 1 12 32
M  V30 14 1 13 14
M  V30 15 2 13 15
M  V30 16 2 16 35
M  V30 17 1 17 18
M  V30 18 1 17 38
M  V30 19 1 18 19
M  V30 20 2 18 20
M  V30 21 1 21 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 25
M  V30 25 1 24 26
M  V30 26 1 25 27
M  V30 27 1 26 28
M  V30 28 1 27 29
M  V30 29 1 28 30
M  V30 30 1 29 31
M  V30 31 1 30 32
M  V30 32 1 31 33
M  V30 33 1 32 34
M  V30 34 1 33 35
M  V30 35 1 34 36
M  V30 36 1 35 37
M  V30 37 1 36 38
M  V30 38 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Glycine, N,N′-1,2-ethanediylbis[N-[2-oxo-2-(1-pyrrolidinyl)ethyl]-
C18H30N4O6
294646-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.8500 6.4383 0.0 0
M  V30 2 C 4.6200 5.1047 0.0 0
M  V30 3 C 4.6200 7.7720 0.0 0
M  V30 4 C 2.3100 6.4383 0.0 0
M  V30 5 C 3.8500 3.7710 0.0 0
M  V30 6 C 6.1600 7.7720 0.0 0
M  V30 7 C 1.5400 7.7720 0.0 0
M  V30 8 O 2.3100 3.7710 0.0 0
M  V30 9 N 6.9300 9.1058 0.0 0
M  V30 10 O 2.3100 9.1058 0.0 0
M  V30 11 O 0.0000 7.7720 0.0 0
M  V30 12 C 8.4700 9.1058 0.0 0
M  V30 13 C 6.1600 10.4394 0.0 0
M  V30 14 C 9.2400 7.7720 0.0 0
M  V30 15 C 6.9300 11.7731 0.0 0
M  V30 16 O 8.4700 6.4383 0.0 0
M  V30 17 O 6.1600 13.1067 0.0 0
M  V30 18 O 8.4700 11.7731 0.0 0
M  V30 19 N 4.6200 2.4372 0.0 0
M  V30 20 C 3.9935 1.0304 0.0 0
M  V30 21 C 6.1516 2.2763 0.0 0
M  V30 22 C 5.1381 0.0000 0.0 0
M  V30 23 C 6.4717 0.7700 0.0 0
M  V30 24 N 10.7801 7.7720 0.0 0
M  V30 25 C 11.6853 9.0180 0.0 0
M  V30 26 C 11.6853 6.5261 0.0 0
M  V30 27 C 13.1498 8.5420 0.0 0
M  V30 28 C 13.1498 7.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 5 8
M  V30 8 1 5 19
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 9 12
M  V30 13 1 9 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 1 14 24
M  V30 18 1 15 17
M  V30 19 2 15 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 25 1 24 25
M  V30 26 1 24 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 77145-29-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 294646-54-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-366-CAS-12316553
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM EXAMPLE 53. AMD8849: Ruthenium (III) complex
N,N'-bis[2-(N-acetylpyrrolidine)] ethylenediamine-N,N'-diacetic acid
(bpedda). N,N'-bis[2-(N-acetylpyrrolidine)]ethylenediamine-N,N'-diacetic
acid (bpedda). A solution of pyrrolidine (0.56 g, 3.90 mmol) in anhydrous
THF (20 mL) was added dropwise to a stirred solution of
ethylenediamine-N,N,N',N'-tetraacetic acid dianhydride (1.0 g, 7.81 mmol)
in anhydrous THF (20 mL) under nitrogen and the mixture was stirred for
15.5 hours. The precipitate which formed was collected by filtration and
dried in vacuo overnight to give the product. White solid (1.59 g, ∼
100%). 1H NMR (D2O) δ 1.90 (m, 8H), 3.40 (q, 8H, J= 7.2 Hz), 3.52 (s,
4H), 3.83 (s, 4H), 4.13 (s, 4H). ES-MS m/z 399 [M+H]+, 421 [M+Na]+. Anal.
Calcd. for C18H30N4O6·0.2 H2O: C, 53.77; H, 7.62; N, 13.93. Found: C,
53.68; H, 7.54; N, 13.71.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pharmaceutical compositions comprising metal complexes for removal of
excess nitric oxide and other reactive oxygen species in mammals
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fricker, Simon; Abrams, Michael J.; Bridger, Gary; Skerlj, Renato; Baird,
Ian; Cameron, Beth R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000056743 A1 2000-09-28

$RFMT $RIREG SCHEME280 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3aS,4S,5S,7aS)-5-[(1R,2S,4S)-2,4-Bis(acetyloxy)-1-methylcyclohexyl]octahydro...
C24H36O5
782488-89-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7308 8.9919 0.0 0
M  V30 2 C 4.9608 10.3257 0.0 0
M  V30 3 O 5.7308 11.6593 0.0 0
M  V30 4 C 5.7308 4.3448 0.0 0
M  V30 5 O 6.9106 2.6674 0.0 0
M  V30 6 C 7.6806 1.3336 0.0 0
M  V30 7 C 6.9106 0.0000 0.0 0
M  V30 8 O 9.2206 1.3336 0.0 0
M  V30 9 C 1.7456 5.0788 0.0 0
M  V30 10 C 0.0000 5.6144 0.0 0
M  V30 11 O 11.5306 5.3347 0.0 0
M  V30 12 C 12.3006 6.6684 0.0 0
M  V30 13 C 11.5306 8.0021 0.0 0
M  V30 14 O 13.8406 6.6684 0.0 0
M  V30 15 C 5.7308 6.3246 0.0 0 CFG=1
M  V30 16 C 4.9608 7.6583 0.0 0 CFG=1
M  V30 17 C 4.9608 4.9910 0.0 0
M  V30 18 C 3.4208 7.6583 0.0 0 CFG=2
M  V30 19 C 3.4208 4.9910 0.0 0
M  V30 20 C 2.6508 6.3246 0.0 0 CFG=2
M  V30 21 C 2.3904 8.8028 0.0 0
M  V30 22 C 1.1445 6.6448 0.0 0
M  V30 23 C 0.9834 8.1763 0.0 0
M  V30 24 C 6.9106 5.3347 0.0 0 CFG=2
M  V30 25 C 7.6806 4.0011 0.0 0 CFG=1
M  V30 26 C 7.6806 6.6684 0.0 0
M  V30 27 C 9.2206 4.0011 0.0 0
M  V30 28 C 9.2206 6.6684 0.0 0
M  V30 29 C 9.9906 5.3347 0.0 0 CFG=1
M  V30 30 H 6.9106 7.3145 0.0 0
M  V30 31 H 4.0473 9.0652 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 16 1 CFG=3
M  V30 3 2 2 3
M  V30 4 1 24 4 CFG=3
M  V30 5 1 5 6
M  V30 6 1 25 5 CFG=3
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 20 9 CFG=1
M  V30 10 2 10 22
M  V30 11 1 11 12
M  V30 12 1 29 11 CFG=3
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 15 16
M  V30 16 1 15 17
M  V30 17 1 15 24
M  V30 18 1 15 30 CFG=3
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 23 1 18 31 CFG=3
M  V30 24 1 19 20
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 15 16 18 20 24 25 29)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,3-Cyclohexanediol, 4-methyl-4-[(3aS,4S,5S,7aS)-octahydro-7a-methyl-1-methyl...
C28H45NO4
782490-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.9372 5.8615 0.0 0
M  V30 2 C 3.4901 6.3882 0.0 0
M  V30 3 C 7.5640 4.3448 0.0 0
M  V30 4 C 8.0990 10.4657 0.0 0
M  V30 5 O 8.7438 2.6674 0.0 0
M  V30 6 C 9.5138 1.3338 0.0 0
M  V30 7 C 11.0538 1.3338 0.0 0
M  V30 8 O 8.7438 0.0000 0.0 0
M  V30 9 C 7.2683 12.0918 0.0 0
M  V30 10 O 13.3638 5.3347 0.0 0
M  V30 11 C 14.1338 6.6685 0.0 0
M  V30 12 C 13.3638 8.0021 0.0 0
M  V30 13 O 15.6738 6.6685 0.0 0
M  V30 14 C 6.1169 6.8513 0.0 0 CFG=1
M  V30 15 C 7.5640 6.3246 0.0 0 CFG=1
M  V30 16 C 5.8495 8.3679 0.0 0 CFG=2
M  V30 17 C 8.7438 7.3145 0.0 0
M  V30 18 C 7.0292 9.3578 0.0 0 CFG=2
M  V30 19 C 4.5435 9.1841 0.0 0
M  V30 20 C 8.4763 8.8311 0.0 0
M  V30 21 C 6.4523 10.7857 0.0 0
M  V30 22 C 4.9161 10.6784 0.0 0
M  V30 23 C 8.7438 5.3347 0.0 0 CFG=2
M  V30 24 C 9.5138 4.0011 0.0 0 CFG=1
M  V30 25 C 9.5138 6.6685 0.0 0
M  V30 26 C 11.0538 4.0011 0.0 0
M  V30 27 C 11.0538 6.6685 0.0 0
M  V30 28 C 11.8238 5.3347 0.0 0 CFG=1
M  V30 29 N 2.3103 5.3983 0.0 0
M  V30 30 C 0.8162 5.7708 0.0 0
M  V30 31 C 2.4178 3.8620 0.0 0
M  V30 32 C 0.0000 4.4649 0.0 0
M  V30 33 C 0.9899 3.2851 0.0 0
M  V30 34 H 6.7940 4.9910 0.0 0
M  V30 35 H 4.5727 7.5069 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=1
M  V30 3 1 2 29
M  V30 4 1 23 3 CFG=3
M  V30 5 1 18 4 CFG=3
M  V30 6 1 5 6
M  V30 7 1 24 5 CFG=3
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 2 9 21
M  V30 11 1 10 11
M  V30 12 1 28 10 CFG=3
M  V30 13 1 11 12
M  V30 14 2 11 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 15 23
M  V30 19 1 15 34 CFG=1
M  V30 20 1 16 18
M  V30 21 1 16 19
M  V30 22 1 16 35 CFG=1
M  V30 23 1 17 20
M  V30 24 1 18 20
M  V30 25 1 18 21
M  V30 26 1 19 22
M  V30 27 1 21 22
M  V30 28 1 23 24
M  V30 29 1 23 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 28
M  V30 34 1 29 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(7 14 15 16 18 23 24 28)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 782488-89-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 782490-07-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-7233853
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Synthesis of compound 307. A mixture of compound 217 (0.20 g, 0.49 mmol),
pyrrolidine (0.18 mL, 2.2 mmol) and 4 A molecular sieves (0.20 g) in DCE
(5 mL) was stirred at ambient temperature for 30 minutes. NaB(OAc)3H
(0.297 g, 1.33 mmol) was added, rinsing with DCE (2 mL), and the mixture
was stirred at ambient temperature overnight. The reaction mixture was
diluted with MeOH (3 mL) and filtered through a celite bed, rinsing with
EtOAc (25 mL). The filtrate was washed with saturated NaHCO3 solution (10
mL), then brine (2x5 mL), dried over anhydrous MgSO4 and concentrated to
give compound 307 as a glass that was used in the next reaction without
further purification. Colourless glass, yield 0.235 g, quantitative.
$DTYPE RXN:VAR(1):NOTES
$DATUM molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of seco-steroidal indene derivatives for use as
antiinflammatory pharmaceutical agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raymond, Jeffery R.; Han, Kang; Zhou, Yuanlin; He, Yuehua; Noren,
Bradley; Yee, James Gee Ken
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2004092100 A1 2004-10-28

$RFMT $RIREG SCHEME281 STEP1
$RXN



  2  1
$MOL
2-[1-[(1,1-Dimethylethoxy)carbonyl]-3-piperidinyl]-1H-indole-1-propanoic acid
C21H28N2O4
785795-15-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0431 5.7308 0.0 0
M  V30 2 C 2.5367 5.4106 0.0 0
M  V30 3 C 1.5063 6.5550 0.0 0
M  V30 4 O 0.0000 6.2348 0.0 0
M  V30 5 O 1.9821 8.0197 0.0 0
M  V30 6 C 11.2251 7.4148 0.0 0
M  V30 7 O 11.9951 8.7484 0.0 0
M  V30 8 O 11.9951 6.0810 0.0 0
M  V30 9 C 13.5351 8.7484 0.0 0
M  V30 10 C 13.5351 7.2084 0.0 0
M  V30 11 C 15.0751 8.7484 0.0 0
M  V30 12 C 13.5351 10.2884 0.0 0
M  V30 13 C 6.6051 4.7474 0.0 0
M  V30 14 N 5.0735 4.5864 0.0 0
M  V30 15 C 7.2315 3.3406 0.0 0
M  V30 16 C 4.7534 3.0800 0.0 0
M  V30 17 C 6.0870 2.3100 0.0 0
M  V30 18 C 3.4197 2.3100 0.0 0
M  V30 19 C 6.0870 0.7700 0.0 0
M  V30 20 C 3.4197 0.7700 0.0 0
M  V30 21 C 4.7534 0.0000 0.0 0
M  V30 22 C 7.3751 6.0810 0.0 0
M  V30 23 C 8.9151 6.0810 0.0 0
M  V30 24 C 6.6051 7.4146 0.0 0
M  V30 25 N 9.6851 7.4148 0.0 0
M  V30 26 C 7.3751 8.7484 0.0 0
M  V30 27 C 8.9151 8.7484 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 25
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 2 13 15
M  V30 15 1 13 22
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3-[1-[3-oxo-3-(1-pyrrolidinyl)propyl]-1H-indol-2-yl]-1-pipe...
C25H35N3O3
785795-18-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.5213 5.7308 0.0 0
M  V30 2 C 5.0149 5.4106 0.0 0
M  V30 3 C 3.9844 6.5550 0.0 0
M  V30 4 O 4.4603 8.0197 0.0 0
M  V30 5 C 13.7032 7.4148 0.0 0
M  V30 6 O 14.4732 8.7484 0.0 0
M  V30 7 O 14.4732 6.0810 0.0 0
M  V30 8 C 16.0132 8.7484 0.0 0
M  V30 9 C 16.0132 10.2884 0.0 0
M  V30 10 C 17.5532 8.7484 0.0 0
M  V30 11 C 16.0132 7.2084 0.0 0
M  V30 12 C 9.0832 4.7474 0.0 0
M  V30 13 N 7.5517 4.5864 0.0 0
M  V30 14 C 9.7097 3.3406 0.0 0
M  V30 15 C 7.2315 3.0800 0.0 0
M  V30 16 C 8.5652 2.3100 0.0 0
M  V30 17 C 5.8979 2.3100 0.0 0
M  V30 18 C 8.5652 0.7700 0.0 0
M  V30 19 C 5.8979 0.7700 0.0 0
M  V30 20 C 7.2315 0.0000 0.0 0
M  V30 21 C 9.8532 6.0810 0.0 0
M  V30 22 C 11.3932 6.0810 0.0 0
M  V30 23 C 9.0832 7.4148 0.0 0
M  V30 24 N 12.1632 7.4148 0.0 0
M  V30 25 C 9.8532 8.7484 0.0 0
M  V30 26 C 11.3932 8.7484 0.0 0
M  V30 27 N 2.4780 6.2348 0.0 0
M  V30 28 C 1.3336 7.2654 0.0 0
M  V30 29 C 1.8517 4.8281 0.0 0
M  V30 30 C 0.0000 6.4954 0.0 0
M  V30 31 C 0.3202 4.9890 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 2 3
M  V30 4 2 3 4
M  V30 5 1 3 27
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 5 24
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 8 10
M  V30 12 1 8 11
M  V30 13 1 12 13
M  V30 14 2 12 14
M  V30 15 1 12 21
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 785795-15-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 785795-18-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13813423
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Combinatorial synthesis of substituted 3-(2-indolyl)piperidines and
2-phenyl indoles as inhibitors of ZipA-FtsZ interaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jennings, Lee D.; Foreman, Kenneth W.; Rush, Thomas S.; Tsao, Desiree H.
H.; Mosyak, Lidia; Kincaid, Scott L.; Sukhdeo, Mohani N.; Sutherland,
Alan G.; Ding, Weidong; Kenny, Cynthia Hess; Sabus, Chantel L.; Liu,
Hanlan; Dushin, Elizabeth G.; Moghazeh, Soraya L.; Labthavikul, Pornpen;
Petersen, Peter J.; Tuckman, Margareta; Ruzin, Alexey V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2004), 12(19), 5115-5131

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3,6-dihydro-4-(1-pyrrolidinyl)-1(2H)-pyridinecarboxylate
C14H24N2O2
207691-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5298 2.8737 0.0 0
M  V30 2 O 9.2998 1.5400 0.0 0
M  V30 3 O 9.2998 4.2073 0.0 0
M  V30 4 C 10.8398 1.5400 0.0 0
M  V30 5 C 10.8398 0.0000 0.0 0
M  V30 6 C 12.3798 1.5400 0.0 0
M  V30 7 C 10.8398 3.0800 0.0 0
M  V30 8 C 3.9098 2.8737 0.0 0
M  V30 9 C 4.6798 1.5400 0.0 0
M  V30 10 C 4.6798 4.2073 0.0 0
M  V30 11 C 6.2198 1.5400 0.0 0
M  V30 12 C 6.2198 4.2073 0.0 0
M  V30 13 N 6.9898 2.8737 0.0 0
M  V30 14 N 2.3698 2.8737 0.0 0
M  V30 15 C 1.4645 1.6278 0.0 0
M  V30 16 C 1.4645 4.1195 0.0 0
M  V30 17 C 0.0000 2.1037 0.0 0
M  V30 18 C 0.0000 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 207691-65-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-16246355
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark apparatus used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of heterocyclic compounds as antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ombrato, Rosella; Garofalo, Barbara; Mangano, Giorgina; Capezzone de
Joannon, Alessandra; Corso, Gaia; Magaro', Gabriele; Furlotti, Guido;
Iacoangeli, Tommaso
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016096631 A1 2016-06-23

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3,6-dihydro-4-(1-pyrrolidinyl)-1(2H)-pyridinecarboxylate
C14H24N2O2
207691-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5298 2.8737 0.0 0
M  V30 2 O 9.2998 1.5400 0.0 0
M  V30 3 O 9.2998 4.2073 0.0 0
M  V30 4 C 10.8398 1.5400 0.0 0
M  V30 5 C 10.8398 0.0000 0.0 0
M  V30 6 C 12.3798 1.5400 0.0 0
M  V30 7 C 10.8398 3.0800 0.0 0
M  V30 8 C 3.9098 2.8737 0.0 0
M  V30 9 C 4.6798 1.5400 0.0 0
M  V30 10 C 4.6798 4.2073 0.0 0
M  V30 11 C 6.2198 1.5400 0.0 0
M  V30 12 C 6.2198 4.2073 0.0 0
M  V30 13 N 6.9898 2.8737 0.0 0
M  V30 14 N 2.3698 2.8737 0.0 0
M  V30 15 C 1.4645 1.6278 0.0 0
M  V30 16 C 1.4645 4.1195 0.0 0
M  V30 17 C 0.0000 2.1037 0.0 0
M  V30 18 C 0.0000 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 207691-65-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13867734
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Intermediate 31 : 1,1-Dimethylethyl
4-(1-pyrrolidinyl)-3,6-dihydro-1(2H)-pyridinecarboxylate A solution of
1,1-dimethylethyl 4-oxo-1-piperidinecarboxylate (10 g, 0.05 mol) and
pyrrolidine (5.33 g, 0.075 mol) in toluene (40 ml.) was heated under
reflux with a Dean-stark apparatus for 6 hours. The mixture was then
concentrated under vacuum to give the title compound which was used in
the next step without further purification (13 g, quantitative yield).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted 1,6-naphthyridines as SCD inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Daugan, Alain Claude-Marie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009056556 A1 2009-05-07

$RFMT $RIREG SCHEME282 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 4-oxopiperidine-1-carboxylate
C10H17NO3
79099-07-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 2.8736 0.0 0
M  V30 2 O 3.0800 1.5400 0.0 0
M  V30 3 O 3.0800 4.2073 0.0 0
M  V30 4 C 1.5400 1.5400 0.0 0
M  V30 5 C 1.5400 0.0000 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 1.5400 3.0800 0.0 0
M  V30 8 O 10.0100 2.8736 0.0 0
M  V30 9 N 5.3900 2.8736 0.0 0
M  V30 10 C 6.1600 1.5400 0.0 0
M  V30 11 C 6.1600 4.2073 0.0 0
M  V30 12 C 7.7000 1.5400 0.0 0
M  V30 13 C 7.7000 4.2073 0.0 0
M  V30 14 C 8.4700 2.8736 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 14
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 3,6-dihydro-4-(1-pyrrolidinyl)-1(2H)-pyridinecarboxylate
C14H24N2O2
207691-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5298 2.8737 0.0 0
M  V30 2 O 9.2998 1.5400 0.0 0
M  V30 3 O 9.2998 4.2073 0.0 0
M  V30 4 C 10.8398 1.5400 0.0 0
M  V30 5 C 10.8398 0.0000 0.0 0
M  V30 6 C 12.3798 1.5400 0.0 0
M  V30 7 C 10.8398 3.0800 0.0 0
M  V30 8 C 3.9098 2.8737 0.0 0
M  V30 9 C 4.6798 1.5400 0.0 0
M  V30 10 C 4.6798 4.2073 0.0 0
M  V30 11 C 6.2198 1.5400 0.0 0
M  V30 12 C 6.2198 4.2073 0.0 0
M  V30 13 N 6.9898 2.8737 0.0 0
M  V30 14 N 2.3698 2.8737 0.0 0
M  V30 15 C 1.4645 1.6278 0.0 0
M  V30 16 C 1.4645 4.1195 0.0 0
M  V30 17 C 0.0000 2.1037 0.0 0
M  V30 18 C 0.0000 3.6437 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 79099-07-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 207691-65-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-3274060
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (a) tert-Butyl 4-pyrrolidin-1-yl-3,6-dihydropyridine-1(2H)-carboxylate
Pyrrolidine (5 mL, 60.5 mmol) was added to a solution of tert-butyl
4-oxopiperidine-1-carboxylate (11.3 g, 56.7 mmol) and p-TsOH (57 mg, 0.16
mmol) in dry toluene(75 mL) and the reaction mixture was heated during 20
hours using a Deans & Stark trap remove s the water liberated in the
reaction. Evaporation of the solvent gave the desired product which was
used without further purification in the next step. Yield: 14.9 g (104
%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyridine compounds and their use as P2Y12 antagonists and their
preparation, pharmaceutical compositions and use in the treatment of
platelet aggregation disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Antonsson, Thomas; Bach, Peter; Brickmann, Kay; Bylund, Ruth;
Giordanetto, Fabrizio; Johansson, Johan; Zetterberg, Fredrik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008085118 A1 2008-07-17

$RFMT $RIREG SCHEME283 STEP1
$RXN



  2  1
$MOL
2-Propenoic acid, 2-methyl-, methyl ester
C5H8O2
80-62-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 1.3338 1.5400 0.0 0
M  V30 3 O 4.0011 1.5400 0.0 0
M  V30 4 O 2.6674 3.8500 0.0 0
M  V30 5 C 0.0000 2.3100 0.0 0
M  V30 6 C 1.3338 0.0000 0.0 0
M  V30 7 C 5.3349 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl α-methyl-1-pyrrolidinepropanoate
C9H17NO2
4151-03-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1047 2.3100 0.0 0
M  V30 3 C 6.4385 1.5400 0.0 0
M  V30 4 C 5.1047 3.8501 0.0 0
M  V30 5 O 7.7722 2.3100 0.0 0
M  V30 6 O 6.4385 0.0000 0.0 0
M  V30 7 C 9.1059 1.5400 0.0 0
M  V30 8 N 2.4374 2.3100 0.0 0
M  V30 9 C 1.0304 1.6836 0.0 0
M  V30 10 C 2.2763 3.8416 0.0 0
M  V30 11 C 0.0000 2.8281 0.0 0
M  V30 12 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 80-62-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4151-03-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-2692687
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydroamination of methyl methacrylate catalyzed by cationic palladium
diphosphinoazine complexes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vcelak, J.; Cermak, J.; Czakoova, M.; Storch, J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Molecular Catalysis A: Chemical (2006), 259(1-2), 41-45

$RFMT $RIREG SCHEME284 STEP1
$RXN



  2  1
$MOL
3-Bromo-α,α-dimethylbenzeneacetic acid
C10H11BrO2
81606-47-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3336 2.3100 0.0 0
M  V30 3 C 1.3336 0.7700 0.0 0
M  V30 4 C 2.6674 0.0000 0.0 0
M  V30 5 O 1.3336 3.8500 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 Br 8.0021 1.5400 0.0 0
M  V30 8 C 4.0011 2.3100 0.0 0
M  V30 9 C 5.3347 1.5400 0.0 0
M  V30 10 C 4.0011 3.8500 0.0 0
M  V30 11 C 6.6685 2.3100 0.0 0
M  V30 12 C 5.3347 4.6200 0.0 0
M  V30 13 C 6.6685 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 8
M  V30 5 1 2 5
M  V30 6 2 2 6
M  V30 7 1 7 11
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Propanone, 2-(3-bromophenyl)-2-methyl-1-(1-pyrrolidinyl)-
C14H18BrNO
1225280-53-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1047 3.0801 0.0 0
M  V30 2 C 3.7711 2.3100 0.0 0
M  V30 3 C 3.7711 3.8501 0.0 0
M  V30 4 C 5.1047 4.6201 0.0 0
M  V30 5 O 3.7711 0.7700 0.0 0
M  V30 6 Br 10.4395 3.0801 0.0 0
M  V30 7 C 6.4384 2.3100 0.0 0
M  V30 8 C 7.7722 3.0801 0.0 0
M  V30 9 C 6.4384 0.7700 0.0 0
M  V30 10 C 9.1059 2.3100 0.0 0
M  V30 11 C 7.7722 0.0000 0.0 0
M  V30 12 C 9.1059 0.7700 0.0 0
M  V30 13 N 2.4374 3.0801 0.0 0
M  V30 14 C 1.0304 2.4536 0.0 0
M  V30 15 C 2.2763 4.6116 0.0 0
M  V30 16 C 0.0000 3.5981 0.0 0
M  V30 17 C 0.7700 4.9318 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 2 13
M  V30 7 1 6 10
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 81606-47-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1225280-53-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13323593
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 79-37-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-(3-Bromophenyl)-2-methyl-1-(pyrrolidin-1-yl)propan-1-one Oxalyl
chloride (3 mL) was added to a solution of Intermediate 8 (1.6 g, 6.58
mmol) in DCM (20 mL) at r.t. The mixture was stirred for 30 minutes and
then allowed to stand for 18 h. The mixture was concentrated in vacuo,
adding DCM (2x10 mL) to assist removal of oxalyl chloride. Half this
residue was dissolved in DCM (10 mL) and added to a stirred solution of
pyrrolidine (257 mg, 3.62 mmol) and triethylamine (366 mg, 3.62 mmol) in
DCM (10 mL), pre-cooled in an ice-water bath. The mixture was allowed to
warm to r.t., and after 15 minutes the mixture was partitioned between
water (20 mL) and DCM (10 mL). The aqueous phase was extracted with
further DCM (10 mL), and the combined organic phases dried (MgSO4) and
concentrated in vacuo to give the title compound (980 mg, essentially
quantitative) as a pale yellow-orange solid.
2-(3-Bromophenyl)-2-methyl-1-(pyrrolidin-1-yl)propan-1-one, yield (980
mg, essentially quantitative) δH (CDCl3) 7.41 (t, 1H), 7.34-7.38 (dt,
1H), 7.12-7.23 (m, 2H), 3.52 (t, 2H), 2.75 (t, 2H), 1.56-1.80 (m, 4H),
1.52 (s, 6H). LCMS (ES+) 297 (M+H)+, RT 3.67 minutes.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of fused pyrazines as phosphoinositide 3-kinase (PI3K)
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Buerli, Roland; Haughan, Alan Findlay; Mack, Stephen Robert; Perry,
Benjamin Garfield; Raphy, Gilles; Saville-Stones, Elizabeth Anne
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010052448 A2 2010-05-14

$RFMT $RIREG SCHEME285 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N-(4-nitrophenyl)butanamide
C10H11ClN2O3
82547-19-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 4.6201 0.0 0
M  V30 2 C 8.0022 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 O 8.0022 2.3101 0.0 0
M  V30 5 C 10.6697 3.8501 0.0 0
M  V30 6 C 12.0033 4.6201 0.0 0
M  V30 7 Cl 13.3370 3.8501 0.0 0
M  V30 8 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 9 O 1.3337 0.0000 0.0 0
M  V30 10 O 0.0000 2.3101 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 4.0010 4.6201 0.0 0
M  V30 14 C 4.0010 1.5400 0.0 0
M  V30 15 C 2.6673 3.8501 0.0 0
M  V30 16 C 2.6673 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 8 9
M  V30 9 2 8 10
M  V30 10 1 8 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Nitrophenyl)-1-pyrrolidinebutanamide
C14H19N3O3
875924-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6687 4.6201 0.0 0
M  V30 2 C 8.0023 3.8501 0.0 0
M  V30 3 C 9.3360 4.6201 0.0 0
M  V30 4 O 8.0023 2.3101 0.0 0
M  V30 5 C 10.6697 3.8501 0.0 0
M  V30 6 C 12.0035 4.6201 0.0 0
M  V30 7 N 1.3338 1.5400 0.0 0 VAL=5
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 9 O 0.0000 2.3101 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 4.0012 4.6201 0.0 0
M  V30 12 C 5.3348 2.3101 0.0 0
M  V30 13 C 2.6675 3.8501 0.0 0
M  V30 14 C 4.0012 1.5400 0.0 0
M  V30 15 C 2.6675 2.3101 0.0 0
M  V30 16 N 13.3372 3.8501 0.0 0
M  V30 17 C 13.4981 2.3185 0.0 0
M  V30 18 C 14.7440 4.4764 0.0 0
M  V30 19 C 15.0045 1.9983 0.0 0
M  V30 20 C 15.7746 3.3320 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 5 6
M  V30 7 1 6 16
M  V30 8 2 7 8
M  V30 9 2 7 9
M  V30 10 1 7 15
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 1 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 82547-19-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 875924-09-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8557405
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):NOTES
$DATUM alternative reaction conditions shown, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Click chemistry assembly of G-quadruplex ligands incorporating a
diarylurea scaffold and triazole linkers
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Drewe, William C.; Neidle, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2008), (42),
5295-5297

$RFMT $RIREG SCHEME286 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(2-Chloroethoxy)-N-(3-chloro-2-fluorophenyl)-7-methoxy-4-quinazolinamine
C17H14Cl2FN3O2
848440-10-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0020 6.9300 0.0 0
M  V30 2 O 4.0009 3.0800 0.0 0
M  V30 3 C 5.3347 2.3100 0.0 0
M  V30 4 C 5.3347 0.7700 0.0 0
M  V30 5 Cl 6.6684 0.0000 0.0 0
M  V30 6 O 1.3336 4.6200 0.0 0
M  V30 7 C 0.0000 5.3900 0.0 0
M  V30 8 F 10.6694 5.3900 0.0 0
M  V30 9 Cl 13.3367 6.9300 0.0 0
M  V30 10 C 5.3347 6.9300 0.0 0
M  V30 11 C 6.6684 7.7000 0.0 0
M  V30 12 C 4.0009 7.7000 0.0 0
M  V30 13 C 5.3347 5.3900 0.0 0
M  V30 14 N 6.6684 9.2400 0.0 0
M  V30 15 C 2.6673 6.9300 0.0 0
M  V30 16 N 4.0009 9.2400 0.0 0
M  V30 17 C 4.0009 4.6200 0.0 0
M  V30 18 C 5.3347 10.0100 0.0 0
M  V30 19 C 2.6673 5.3900 0.0 0
M  V30 20 C 9.3358 7.7000 0.0 0
M  V30 21 C 10.6694 6.9300 0.0 0
M  V30 22 C 9.3358 9.2400 0.0 0
M  V30 23 C 12.0031 7.7000 0.0 0
M  V30 24 C 10.6694 10.0100 0.0 0
M  V30 25 C 12.0031 9.2400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 1 2 17
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 19
M  V30 9 1 8 21
M  V30 10 1 9 23
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 2 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 2 13 17
M  V30 18 1 14 18
M  V30 19 2 15 19
M  V30 20 2 16 18
M  V30 21 1 17 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Chloro-2-fluorophenyl)-7-methoxy-6-[2-(1-pyrrolidinyl)ethoxy]-4-quinazol...
C21H22ClFN4O2
848440-11-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.6200 4.0011 0.0 0
M  V30 2 O 10.0100 5.3347 0.0 0
M  V30 3 C 11.5500 5.3347 0.0 0
M  V30 4 C 12.3200 6.6685 0.0 0
M  V30 5 O 11.5500 2.6674 0.0 0
M  V30 6 C 12.3200 1.3338 0.0 0
M  V30 7 F 3.0800 6.6685 0.0 0
M  V30 8 Cl 0.0000 6.6685 0.0 0
M  V30 9 C 6.9300 2.6674 0.0 0
M  V30 10 C 7.7000 1.3338 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 7.7000 4.0011 0.0 0
M  V30 13 C 9.2400 1.3338 0.0 0
M  V30 14 N 6.9300 0.0000 0.0 0
M  V30 15 N 4.6200 1.3338 0.0 0
M  V30 16 C 9.2400 4.0011 0.0 0
M  V30 17 C 10.0100 2.6674 0.0 0
M  V30 18 C 5.3900 0.0000 0.0 0
M  V30 19 C 3.0800 4.0011 0.0 0
M  V30 20 C 2.3100 5.3347 0.0 0
M  V30 21 C 2.3100 2.6674 0.0 0
M  V30 22 C 0.7700 5.3347 0.0 0
M  V30 23 C 0.7700 2.6674 0.0 0
M  V30 24 C 0.0000 4.0011 0.0 0
M  V30 25 N 13.8600 6.6685 0.0 0
M  V30 26 C 14.7652 5.4225 0.0 0
M  V30 27 C 14.7652 7.9144 0.0 0
M  V30 28 C 16.2298 5.8985 0.0 0
M  V30 29 C 16.2298 7.4385 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 2 16
M  V30 5 1 3 4
M  V30 6 1 4 25
M  V30 7 1 5 6
M  V30 8 1 5 17
M  V30 9 1 7 20
M  V30 10 1 8 22
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 10 13
M  V30 15 1 10 14
M  V30 16 2 11 15
M  V30 17 2 12 16
M  V30 18 2 13 17
M  V30 19 2 14 18
M  V30 20 1 15 18
M  V30 21 1 16 17
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848440-10-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 848440-11-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3808986
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Pyrrolidine (4.44 g, 5.13 ml, 62.5 mmol) was added to a stirred solution
of 5 (2.38 g, 6.25 mmol) in DMF (30 ml) and the resulting pale brown
solution was heated at 90°C for 2 hours. The reaction mixture was
evaporated to dryness using a rotary evaporator and under high vacuum to
afford 4 (2.6 g, 100%) as a brown foam; Mass Spectrum : (M+H)+ 417.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinazoline derivatives as EGFR tyrosine kinase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hennequin, Laurent Francois Andre; Halsall, Christopher Thomas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005026150 A1 2005-03-24

$RFMT $RIREG SCHEME287 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[[4-(2-Bromoethoxy)phenyl]methyl]-3-(2,4-dichlorophenyl)-7-hydroxy-8-iodo-2...
C24H16BrCl2IO4
848749-22-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 6.1601 0.0 0
M  V30 2 O 0.0000 6.1601 0.0 0
M  V30 3 Cl 0.0000 4.6201 0.0 0
M  V30 4 I 1.3337 11.5503 0.0 0
M  V30 5 O 4.0010 13.0903 0.0 0
M  V30 6 Cl 2.6673 0.0000 0.0 0
M  V30 7 O 10.6697 9.2402 0.0 0
M  V30 8 C 12.0033 8.4702 0.0 0
M  V30 9 C 13.3370 9.2402 0.0 0
M  V30 10 Br 14.6707 8.4702 0.0 0
M  V30 11 C 4.0010 6.9302 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 4.0010 8.4702 0.0 0
M  V30 14 C 1.3337 6.9302 0.0 0
M  V30 15 C 2.6673 9.2402 0.0 0
M  V30 16 C 5.3348 9.2402 0.0 0
M  V30 17 O 1.3337 8.4702 0.0 0
M  V30 18 C 2.6673 10.7802 0.0 0
M  V30 19 C 5.3348 10.7802 0.0 0
M  V30 20 C 4.0010 11.5503 0.0 0
M  V30 21 C 2.6673 4.6201 0.0 0
M  V30 22 C 1.3337 3.8501 0.0 0
M  V30 23 C 4.0010 3.8501 0.0 0
M  V30 24 C 1.3337 2.3101 0.0 0
M  V30 25 C 4.0010 2.3101 0.0 0
M  V30 26 C 2.6673 1.5400 0.0 0
M  V30 27 C 6.6685 6.9302 0.0 0
M  V30 28 C 8.0022 6.1601 0.0 0
M  V30 29 C 6.6685 8.4702 0.0 0
M  V30 30 C 9.3358 6.9302 0.0 0
M  V30 31 C 8.0022 9.2402 0.0 0
M  V30 32 C 9.3358 8.4702 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 27
M  V30 3 2 2 14
M  V30 4 1 3 22
M  V30 5 1 4 18
M  V30 6 1 5 20
M  V30 7 1 6 26
M  V30 8 1 7 8
M  V30 9 1 7 32
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 12 21
M  V30 16 1 13 15
M  V30 17 2 13 16
M  V30 18 1 14 17
M  V30 19 1 15 17
M  V30 20 2 15 18
M  V30 21 1 16 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(2,4-Dichlorophenyl)-7-hydroxy-8-iodo-4-[[4-[2-(1-pyrrolidinyl)ethoxy]pheny...
C28H24Cl2INO4
848749-23-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3347 6.1600 0.0 0
M  V30 2 O 0.0000 6.1600 0.0 0
M  V30 3 Cl 0.0000 4.6200 0.0 0
M  V30 4 I 1.3336 11.5500 0.0 0
M  V30 5 O 4.0011 13.0900 0.0 0
M  V30 6 Cl 2.6674 0.0000 0.0 0
M  V30 7 O 10.6694 9.2400 0.0 0
M  V30 8 C 12.0032 8.4700 0.0 0
M  V30 9 C 13.3369 9.2400 0.0 0
M  V30 10 C 4.0011 6.9300 0.0 0
M  V30 11 C 2.6674 6.1600 0.0 0
M  V30 12 C 4.0011 8.4700 0.0 0
M  V30 13 C 1.3336 6.9300 0.0 0
M  V30 14 C 2.6674 9.2400 0.0 0
M  V30 15 C 5.3347 9.2400 0.0 0
M  V30 16 O 1.3336 8.4700 0.0 0
M  V30 17 C 2.6674 10.7800 0.0 0
M  V30 18 C 5.3347 10.7800 0.0 0
M  V30 19 C 4.0011 11.5500 0.0 0
M  V30 20 C 2.6674 4.6200 0.0 0
M  V30 21 C 1.3336 3.8500 0.0 0
M  V30 22 C 4.0011 3.8500 0.0 0
M  V30 23 C 1.3336 2.3100 0.0 0
M  V30 24 C 4.0011 2.3100 0.0 0
M  V30 25 C 2.6674 1.5400 0.0 0
M  V30 26 C 6.6684 6.9300 0.0 0
M  V30 27 C 6.6684 8.4700 0.0 0
M  V30 28 C 8.0021 6.1600 0.0 0
M  V30 29 C 8.0021 9.2400 0.0 0
M  V30 30 C 9.3358 6.9300 0.0 0
M  V30 31 C 9.3358 8.4700 0.0 0
M  V30 32 N 14.6705 8.4700 0.0 0
M  V30 33 C 14.8314 6.9385 0.0 0
M  V30 34 C 16.0773 9.0963 0.0 0
M  V30 35 C 16.3379 6.6183 0.0 0
M  V30 36 C 17.1079 7.9519 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 26
M  V30 3 2 2 13
M  V30 4 1 3 21
M  V30 5 1 4 17
M  V30 6 1 5 19
M  V30 7 1 6 25
M  V30 8 1 7 8
M  V30 9 1 7 31
M  V30 10 1 8 9
M  V30 11 1 9 32
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 11 20
M  V30 16 1 12 14
M  V30 17 2 12 15
M  V30 18 1 13 16
M  V30 19 1 14 16
M  V30 20 2 14 17
M  V30 21 1 15 18
M  V30 22 1 17 19
M  V30 23 2 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 36 1 32 33
M  V30 37 1 32 34
M  V30 38 1 33 35
M  V30 39 1 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 848749-22-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 848749-23-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9784715
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM F.
3-(2,4-Dichlorophenyl)-7-hydroxy-8-iodo-4-(4-(2-pyrrolidin-1-yl-ethoxy)-benzyl)-chromen-2-one
To a stirred suspension
4-(4-(2-Bromoethoxy)-benzyl)-3-(2,4-dichlorophenyl)-7-hydroxy-8-iodo-chromen-2-one
(1.90 g, 2.94 mmol) in anhydrous THF (20 mL) was added pyrrolidine (1.46
mL, 17.6 mmol), and the resulting yellow solution was heated at 85° C.
for 1.5 h. The resultant mixture was cooled to room temperature and the
solvent was removed in vacuo. The resultant residue was dissolved in
CH2Cl2, washed with H2O and brine and dried (MgSO4). The organic phase
was concentrated in vacuo. The resultant residue was purified using flash
chromatography (200 g silica gel, 12:1→9:1→85:15 CH2Cl2:MeOH) to afford
the title compound as a yellow solid (1.87 g, 100%). 1H NMR (300 MHz,
CDCl3) δ 7.50 (d, J=2.0 Hz, 1H), 7.32 (d, J=8.8 Hz, 1H), 7.26 (dd, J=2.0,
8.0 Hz, 1H), 7.12 (d, J=8.0 Hz, 1H), 6.95-6.86 (m, 3H), 6.77-6.70 (m,
2H), 4.30 (t, J=5.0 Hz, 2H), 4.00 (d, J=15.5 Hz, 1H), 3.76 (d, J=15.5 Hz,
1H), 3.25 (t, J=5.0 Hz, 2H), 3.19-3.04 (m, 4H), 2.04-1.91 (m, 4H); MS
(ESI) m/z 635.6 (M)+; HPLC tR 5.85 min.
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal, reaction from p.51 in patent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzopyranone derivatives as inhibitors of the release of
IL-6 production
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Mckie, Jeffrey A.; Bhagwat, Shripad S.; Renaud, Johanne; Missbach, Martin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005028472 A1 2005-03-31

$RFMT $RIREG SCHEME288 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3S,4S)-3-[[(Phenylmethoxy)amino]carbonyl]-4-[(4-phenyl-1-piperazinyl)carbony...
C27H33N3O5
851001-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 38 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 8.0020 0.0 0
M  V30 2 O 9.2400 9.3358 0.0 0
M  V30 3 C 6.9300 8.0020 0.0 0
M  V30 4 N 5.3900 8.0020 0.0 0
M  V30 5 O 7.7000 9.3358 0.0 0
M  V30 6 O 4.6200 9.3358 0.0 0
M  V30 7 C 3.0800 9.3358 0.0 0
M  V30 8 C 6.9300 2.6673 0.0 0
M  V30 9 C 7.7000 1.3336 0.0 0
M  V30 10 O 9.2400 1.3336 0.0 0
M  V30 11 O 6.9300 0.0000 0.0 0
M  V30 12 C 9.2400 6.6684 0.0 0 CFG=1
M  V30 13 C 7.7000 6.6684 0.0 0 CFG=1
M  V30 14 C 10.0100 5.3347 0.0 0
M  V30 15 C 6.9300 5.3347 0.0 0
M  V30 16 C 9.2400 4.0009 0.0 0
M  V30 17 C 7.7000 4.0009 0.0 0 CFG=3
M  V30 18 N 11.5500 8.0020 0.0 0
M  V30 19 C 12.3200 6.6684 0.0 0
M  V30 20 C 12.3200 9.3358 0.0 0
M  V30 21 C 13.8600 6.6684 0.0 0
M  V30 22 C 13.8600 9.3358 0.0 0
M  V30 23 N 14.6300 8.0020 0.0 0
M  V30 24 C 2.3100 10.6694 0.0 0
M  V30 25 C 3.0800 12.0031 0.0 0
M  V30 26 C 0.7700 10.6694 0.0 0
M  V30 27 C 2.3100 13.3367 0.0 0
M  V30 28 C 0.0000 12.0031 0.0 0
M  V30 29 C 0.7700 13.3367 0.0 0
M  V30 30 C 16.1700 8.0020 0.0 0
M  V30 31 C 16.9400 6.6684 0.0 0
M  V30 32 C 16.9400 9.3358 0.0 0
M  V30 33 C 18.4800 6.6684 0.0 0
M  V30 34 C 18.4800 9.3358 0.0 0
M  V30 35 C 19.2500 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 12 1 CFG=1
M  V30 3 1 1 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 13 3 CFG=3
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 24
M  V30 10 1 8 9
M  V30 11 1 8 17
M  V30 12 1 9 10
M  V30 13 2 9 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 23
M  V30 26 1 23 30
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 33 2 30 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 2 32 34
M  V30 37 2 33 35
M  V30 38 1 34 35
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 12 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
(1S,2S)-5-[2-Oxo-2-(1-pyrrolidinyl)ethyl]-N-(phenylmethoxy)-2-[(4-phenyl-1-pi...
C31H40N4O4
851007-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  39 43 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.0100 10.4395 0.0 0
M  V30 2 O 9.2400 11.7731 0.0 0
M  V30 3 C 6.9300 10.4395 0.0 0
M  V30 4 N 5.3900 10.4395 0.0 0
M  V30 5 O 7.7000 11.7731 0.0 0
M  V30 6 O 4.6200 11.7731 0.0 0
M  V30 7 C 3.0800 11.7731 0.0 0
M  V30 8 C 6.9300 5.1048 0.0 0
M  V30 9 C 7.7000 3.7710 0.0 0
M  V30 10 O 9.2400 3.7710 0.0 0
M  V30 11 C 9.2400 9.1057 0.0 0 CFG=1
M  V30 12 C 7.7000 9.1057 0.0 0 CFG=1
M  V30 13 C 10.0100 7.7721 0.0 0
M  V30 14 C 6.9300 7.7721 0.0 0
M  V30 15 C 9.2400 6.4384 0.0 0
M  V30 16 C 7.7000 6.4384 0.0 0 CFG=3
M  V30 17 N 11.5500 10.4395 0.0 0
M  V30 18 C 12.3200 9.1057 0.0 0
M  V30 19 C 12.3200 11.7731 0.0 0
M  V30 20 C 13.8600 9.1057 0.0 0
M  V30 21 C 13.8600 11.7731 0.0 0
M  V30 22 N 14.6300 10.4395 0.0 0
M  V30 23 N 6.9300 2.4374 0.0 0
M  V30 24 C 7.5563 1.0306 0.0 0
M  V30 25 C 5.3985 2.2764 0.0 0
M  V30 26 C 6.4119 0.0000 0.0 0
M  V30 27 C 5.0783 0.7700 0.0 0
M  V30 28 C 2.3100 13.1068 0.0 0
M  V30 29 C 0.7700 13.1068 0.0 0
M  V30 30 C 3.0800 14.4404 0.0 0
M  V30 31 C 0.0000 14.4404 0.0 0
M  V30 32 C 2.3100 15.7742 0.0 0
M  V30 33 C 0.7700 15.7742 0.0 0
M  V30 34 C 16.1700 10.4395 0.0 0
M  V30 35 C 16.9400 9.1057 0.0 0
M  V30 36 C 16.9400 11.7731 0.0 0
M  V30 37 C 18.4800 9.1057 0.0 0
M  V30 38 C 18.4800 11.7731 0.0 0
M  V30 39 C 19.2500 10.4395 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 11 1 CFG=1
M  V30 3 1 1 17
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 12 3 CFG=3
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 7 28
M  V30 10 1 8 9
M  V30 11 1 8 16
M  V30 12 2 9 10
M  V30 13 1 9 23
M  V30 14 1 11 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 22
M  V30 26 1 22 34
M  V30 27 1 23 24
M  V30 28 1 23 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 27
M  V30 32 2 28 29
M  V30 33 1 28 30
M  V30 34 1 29 31
M  V30 35 2 30 32
M  V30 36 2 31 33
M  V30 37 1 32 33
M  V30 38 2 34 35
M  V30 39 1 34 36
M  V30 40 1 35 37
M  V30 41 2 36 38
M  V30 42 2 37 39
M  V30 43 1 38 39
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 11 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 851001-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 851007-83-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-6988502
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-02-4
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 77-92-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Part 7: 5- (2-Oxo-2-piperidiin-1-yl-ethyl)-2-
(S)- (4-phenyl-piperazine-1-carbonyl)- cyclohexan-(S)-carboxylic acid
benzyloxy-amide: To an oven-dried 5 mL conical vial equipped with a
magnetic stir bar and under a nitrogen gas atmosphere was placed
sequentially:
[3-(S)-benyloxycarbamoyl-4-(S)-(4-phenyl-piperazine-1-carbonyl)-cyclohexyl]-
acetic acid (16 mg, 0.033 mmol), anhydrous DMF (1 mL), PyBOP reagent (20
mg, 0.038 mmol), piperidine (0. 010 mL, 0. 101 mmol), and 4-methyl
morpholine (0. 01 mL, 0.092 mmol). After stirring the reaction mixture
overnight, the reaction was quenched with 5% citric acid (1 mL) and the
reaction mixture was diluted with ethyl acetate (15 mL) and water (4 mL).
The aqueous layer was extracted with ethyl acetate (3 x 3 mL) and the
combined organic phases were washed with saturated sodium bicarbonate (3
x 5 mL), brine (5 mL), dried (NaSO4), and concentrated in-vacuo.
Purification by Combiflash (0 to 10% methanol in methylene chloride over
30 min). 5-(2-Oxo-2-pyrrolidin-1-yl-ethyl)-2-(5)-(4-phenyl-piperazine-1
-carbonylcyclohexancarboxylic acid benzyloxy-amide, yield 18 mg, 100%.
LCMS (ESI): 533 (M + H+).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A preparation of (hetero)cyclic N-hydroxy-carboxamide derivatives, useful
as inhibitors of matrix metalloproteinases (MMPs)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Yun-long; Zhou, Jincong; Burns, David; Yao, Wenqing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005037826 A1 2005-04-28

$RFMT $RIREG SCHEME289 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[5-fluoro-2-(methoxycarbonyl)phenoxy]-1-piperidinecarboxy...
C18H24FNO5
852370-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3347 0.0 0
M  V30 2 C 2.3100 5.3347 0.0 0
M  V30 3 O 0.7700 5.3347 0.0 0
M  V30 4 O 3.0800 6.6685 0.0 0
M  V30 5 C 0.0000 6.6685 0.0 0
M  V30 6 F 5.3900 0.0000 0.0 0
M  V30 7 C 11.5500 5.3347 0.0 0
M  V30 8 O 12.3200 6.6685 0.0 0
M  V30 9 O 12.3200 4.0011 0.0 0
M  V30 10 C 13.8600 6.6685 0.0 0
M  V30 11 C 13.8600 8.2085 0.0 0
M  V30 12 C 15.4000 6.6685 0.0 0
M  V30 13 C 13.8600 5.1285 0.0 0
M  V30 14 C 4.6200 4.0011 0.0 0
M  V30 15 C 3.0800 4.0011 0.0 0
M  V30 16 C 5.3900 2.6674 0.0 0
M  V30 17 C 2.3100 2.6674 0.0 0
M  V30 18 C 4.6200 1.3338 0.0 0
M  V30 19 C 3.0800 1.3338 0.0 0
M  V30 20 C 6.9300 5.3347 0.0 0
M  V30 21 C 7.7000 6.6685 0.0 0
M  V30 22 C 7.7000 4.0011 0.0 0
M  V30 23 C 9.2400 6.6685 0.0 0
M  V30 24 C 9.2400 4.0011 0.0 0
M  V30 25 N 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 1 20
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 15
M  V30 6 1 3 5
M  V30 7 1 6 18
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 1 7 25
M  V30 11 1 8 10
M  V30 12 1 10 11
M  V30 13 1 10 12
M  V30 14 1 10 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 21 1 20 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 4-[2-(methoxycarbonyl)-5-(1-pyrrolidinyl)phenoxy]-1-piperid...
C22H32N2O5
852370-10-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 31 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3901 7.7722 0.0 0
M  V30 2 C 2.3101 7.7722 0.0 0
M  V30 3 O 0.7700 7.7722 0.0 0
M  V30 4 O 3.0801 9.1059 0.0 0
M  V30 5 C 0.0000 9.1059 0.0 0
M  V30 6 C 11.5503 7.7722 0.0 0
M  V30 7 O 12.3203 9.1059 0.0 0
M  V30 8 O 12.3203 6.4386 0.0 0
M  V30 9 C 13.8603 9.1059 0.0 0
M  V30 10 C 13.8603 7.5659 0.0 0
M  V30 11 C 15.4003 9.1059 0.0 0
M  V30 12 C 13.8603 10.6459 0.0 0
M  V30 13 C 4.6201 6.4386 0.0 0
M  V30 14 C 3.0801 6.4386 0.0 0
M  V30 15 C 5.3901 5.1047 0.0 0
M  V30 16 C 2.3101 5.1047 0.0 0
M  V30 17 C 4.6201 3.7711 0.0 0
M  V30 18 C 3.0801 3.7711 0.0 0
M  V30 19 C 6.9302 7.7722 0.0 0
M  V30 20 C 7.7002 9.1059 0.0 0
M  V30 21 C 7.7002 6.4386 0.0 0
M  V30 22 C 9.2402 9.1059 0.0 0
M  V30 23 C 9.2402 6.4386 0.0 0
M  V30 24 N 10.0102 7.7722 0.0 0
M  V30 25 N 5.3901 2.4374 0.0 0
M  V30 26 C 4.7638 1.0304 0.0 0
M  V30 27 C 6.9217 2.2763 0.0 0
M  V30 28 C 5.9082 0.0000 0.0 0
M  V30 29 C 7.2419 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 13
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 2 14
M  V30 6 1 3 5
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 6 24
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 17 25
M  V30 21 1 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 27 1 25 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 852370-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 852370-10-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9012708
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure:
2-(1-tert-Butoxycarbonylpiperidin-4-yloxy)-4-(methylthio)benzoic acid,
The methyl
2-(1-tert-butoxycarbonylpiperidin-4-yloxy)-4-(methylthio)benzoate (504
mg, 1.32 mmol) was dissolved in a mixture of 1 M LiOH (2 mL), MeOH (2
mL), and THF (6 mL) and left' to stir overnight. The mixture was
concentrated in vacuo to remove MeOH and THF. The residue was diluted
with dichloromethane (50 mL), washed with saturated aqueous citric acid
(2x5 mL) and water (2x5 mL), dried over sodium sulfate, filtered, and
concentrated to give the desired product as a yellow solid (417 mg, 1.13
mmol, 86%). Methyl
2-[2-(1-tert-butoxycarbonylpiperidin-4-yloxy)-4-(pyrrolidin-1-yl)-benzoylamino]benzoate,
Using methods substantially equivalent to those described in Example 4-E,
methyl
2-[2-(1-tert-butoxycarbonylpiperidin-4-yloxy)-4-(pyrrolidin-1-yl)benzoylamino]benzoate
(5.88 g, 11.23 mmol, 81%) was prepared from
2-(1-tert-butoxycarbonylpiperidin-4-yloxy)-4-(pyrrolidin-1-yl)benzoic
acid and methyl 2-aminobenzoate. IR(CHCl3): 1604, 1515, 1448,1266 cm-1.
1NMR(300 MHz, DMSO-d6): 8 11.37(s, 1H); 8.56(d, J=8.4 Hz, 1H); 7.92(d,
J=7.8 Hz, 1H); 7.72(d, J=8.7 Hz, 1H); 7.56(t, J=7.7 Hz, 1H); 7.11(t,
J=7.5 Hz, 1H); 6.23(d, J=9.0 Hz, 1H); 6.17(s, 1H); 4.77(m, 1H); 3.79(s,
3H); 3.67(d, J=13.5 Hz, 2H); 3.29(m, 4H); 3.03(m, 2H); 1.94(m, 4H);
1.69(m, 2H); 1.33(m, 2H); 1.32(s, 9H). IS-MS, m/e 524.5 (m+1). Analysis
for C29H37N3O3: Calc: C, 66.52; H, 7.12; N, 8.02; Found: C, 67.11; H,
7.07; N, 8.19.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of (hetero)aromatic ether amides as inhibitors of Factor Xa
and/or thrombin.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Argade, Ankush Baburao; Goodson, Theodore, Jr.; Herron, David Kent;
Joseph, Sajan; Lepore, Salvatore Donato; Marquart, Angela Lynn; Masters,
John Joseph; Mendel, David; Merritt, Leander; Ratz, Andrew Michael;
Smith, Gerald Floyd; Tebbe, Anne Louise; Wiley, Michael Robert; Yee, Ying
Kwong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006057845 A1 2006-06-01

$RFMT $RIREG SCHEME290 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-(2-cyanoethyl)-6,7-difluoro-1,4-dihydro-5-methoxy-4-oxo-1,8-naphthyri...
C15H13F2N3O4
858860-06-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6673 10.0102 0.0 0
M  V30 2 C 1.3337 10.7802 0.0 0
M  V30 3 O 5.3348 10.0102 0.0 0
M  V30 4 C 5.3348 3.8501 0.0 0
M  V30 5 C 6.6685 3.0801 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 N 6.6685 0.0000 0.0 0
M  V30 8 F 0.0000 8.4702 0.0 0
M  V30 9 C 8.0022 8.4702 0.0 0
M  V30 10 O 9.3360 7.7002 0.0 0
M  V30 11 O 8.0022 10.0102 0.0 0
M  V30 12 C 10.6697 8.4702 0.0 0
M  V30 13 C 12.0033 7.7002 0.0 0
M  V30 14 F 0.0000 5.3901 0.0 0
M  V30 15 C 4.0012 7.7002 0.0 0
M  V30 16 C 4.0012 6.1601 0.0 0
M  V30 17 C 2.6673 8.4702 0.0 0
M  V30 18 C 5.3348 8.4702 0.0 0
M  V30 19 N 5.3348 5.3901 0.0 0
M  V30 20 N 2.6673 5.3901 0.0 0
M  V30 21 C 1.3337 7.7002 0.0 0
M  V30 22 C 6.6685 7.7002 0.0 0
M  V30 23 C 6.6685 6.1601 0.0 0
M  V30 24 C 1.3337 6.1601 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 17
M  V30 3 2 3 18
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 3 6 7
M  V30 8 1 8 21
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 22
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 14 24
M  V30 15 1 15 16
M  V30 16 2 15 17
M  V30 17 1 15 18
M  V30 18 1 16 19
M  V30 19 2 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 1 20 24
M  V30 24 2 21 24
M  V30 25 2 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 1-(2-cyanoethyl)-6-fluoro-1,4-dihydro-5-methoxy-4-oxo-7-(1-pyrrolidinyl...
C19H21FN4O4
858860-08-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7721 3.8500 0.0 0
M  V30 2 C 9.1059 3.0800 0.0 0
M  V30 3 C 9.1059 1.5400 0.0 0
M  V30 4 N 9.1059 0.0000 0.0 0
M  V30 5 O 5.1048 10.0100 0.0 0
M  V30 6 C 3.7710 10.7800 0.0 0
M  V30 7 O 7.7721 10.0100 0.0 0
M  V30 8 F 2.4374 8.4700 0.0 0
M  V30 9 C 10.4395 8.4700 0.0 0
M  V30 10 O 11.7731 7.7000 0.0 0
M  V30 11 O 10.4395 10.0100 0.0 0
M  V30 12 C 13.1068 8.4700 0.0 0
M  V30 13 C 14.4406 7.7000 0.0 0
M  V30 14 C 6.4384 6.1600 0.0 0
M  V30 15 C 6.4384 7.7000 0.0 0
M  V30 16 N 7.7721 5.3900 0.0 0
M  V30 17 N 5.1048 5.3900 0.0 0
M  V30 18 C 5.1048 8.4700 0.0 0
M  V30 19 C 7.7721 8.4700 0.0 0
M  V30 20 C 9.1059 6.1600 0.0 0
M  V30 21 C 3.7710 6.1600 0.0 0
M  V30 22 C 3.7710 7.7000 0.0 0
M  V30 23 C 9.1059 7.7000 0.0 0
M  V30 24 N 2.4374 5.3900 0.0 0
M  V30 25 C 2.2764 3.8585 0.0 0
M  V30 26 C 1.0306 6.0163 0.0 0
M  V30 27 C 0.7700 3.5383 0.0 0
M  V30 28 C 0.0000 4.8719 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 16
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 18
M  V30 7 2 7 19
M  V30 8 1 8 22
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 23
M  V30 12 1 10 12
M  V30 13 1 12 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 2 14 17
M  V30 17 2 15 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 22
M  V30 22 1 19 23
M  V30 23 2 20 23
M  V30 24 2 21 22
M  V30 25 1 21 24
M  V30 26 1 24 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 28
M  V30 30 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 858860-06-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858860-08-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-1063511
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and antibacterial activity of 5-methoxy- and
5-hydroxy-6-fluoro-1,8-naphthyridone-3-carboxylic acid derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hansen, T. Matthew; Gu, Yu-Gui; Rehm, Tamara M.; Dandliker, Peter J.;
Chovan, Linda E.; Bui, Mai H.; Nilius, Angela M.; Beutel, Bruce A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(11), 2716-2719

$RFMT $RIREG SCHEME291 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-1,3-dioxo-1H-benz[de]isoquinoline-2(3H)-propanoic acid
C15H10BrNO4
86232-61-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.9302 0.0 0
M  V30 2 O 8.0022 2.3101 0.0 0
M  V30 3 Br 0.0000 2.3101 0.0 0
M  V30 4 C 8.0022 5.3901 0.0 0
M  V30 5 C 9.3360 4.6201 0.0 0
M  V30 6 C 10.6697 5.3901 0.0 0
M  V30 7 O 12.0033 4.6201 0.0 0
M  V30 8 O 10.6697 6.9302 0.0 0
M  V30 9 C 4.0012 3.0801 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 2.3101 0.0 0
M  V30 12 C 2.6673 2.3101 0.0 0
M  V30 13 C 5.3348 5.3901 0.0 0
M  V30 14 C 2.6673 5.3901 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 1.3337 3.0801 0.0 0
M  V30 18 C 2.6673 0.7700 0.0 0
M  V30 19 N 6.6685 4.6201 0.0 0
M  V30 20 C 1.3337 4.6201 0.0 0
M  V30 21 C 4.0012 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 13
M  V30 2 2 2 15
M  V30 3 1 3 17
M  V30 4 1 4 5
M  V30 5 1 4 19
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 2 9 12
M  V30 12 1 10 13
M  V30 13 2 10 14
M  V30 14 1 11 15
M  V30 15 2 11 16
M  V30 16 1 12 17
M  V30 17 1 12 18
M  V30 18 1 13 19
M  V30 19 1 14 20
M  V30 20 1 15 19
M  V30 21 1 16 21
M  V30 22 2 17 20
M  V30 23 2 18 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Dioxo-6-(1-pyrrolidinyl)-1H-benz[de]isoquinoline-2(3H)-propanoic acid
C19H18N2O4
1770916-24-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.7722 0.0000 0.0 0
M  V30 2 O 10.4396 4.6201 0.0 0
M  V30 3 C 10.4396 1.5400 0.0 0
M  V30 4 C 11.7733 2.3100 0.0 0
M  V30 5 C 13.1069 1.5400 0.0 0
M  V30 6 O 13.1069 0.0000 0.0 0
M  V30 7 O 14.4407 2.3100 0.0 0
M  V30 8 C 6.4385 3.8500 0.0 0
M  V30 9 C 5.1048 4.6201 0.0 0
M  V30 10 C 6.4385 2.3100 0.0 0
M  V30 11 C 7.7722 4.6201 0.0 0
M  V30 12 C 3.7710 3.8500 0.0 0
M  V30 13 C 5.1048 6.1601 0.0 0
M  V30 14 C 7.7722 1.5400 0.0 0
M  V30 15 C 5.1048 1.5400 0.0 0
M  V30 16 C 9.1060 3.8500 0.0 0
M  V30 17 C 7.7722 6.1601 0.0 0
M  V30 18 C 3.7710 2.3100 0.0 0
M  V30 19 C 6.4385 6.9301 0.0 0
M  V30 20 N 9.1060 2.3100 0.0 0
M  V30 21 N 2.4374 4.6201 0.0 0
M  V30 22 C 1.0306 3.9937 0.0 0
M  V30 23 C 2.2765 6.1516 0.0 0
M  V30 24 C 0.0000 5.1381 0.0 0
M  V30 25 C 0.7700 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 14
M  V30 2 2 2 16
M  V30 3 1 3 4
M  V30 4 1 3 20
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 10 15
M  V30 15 1 11 16
M  V30 16 2 11 17
M  V30 17 2 12 18
M  V30 18 1 12 21
M  V30 19 2 13 19
M  V30 20 1 14 20
M  V30 21 1 15 18
M  V30 22 1 16 20
M  V30 23 1 17 19
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86232-61-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1770916-24-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5110738
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Insights into Noncovalently Core Cross-Linked Block Copolymer Micelles by
Fluorescence Resonance Energy Transfer (FRET) Studies
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rajdev, Priya; Basak, Dipankar; Ghosh, Suhrit
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Macromolecules (Washington, DC, United States) (2015), 48(10), 3360-3367

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-1-pyrrolidin...
C17H25NO5S
86661-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6812 3.4208 0.0 0
M  V30 2 O 2.1749 3.1006 0.0 0
M  V30 3 O 4.1572 4.8855 0.0 0
M  V30 4 C 1.1445 4.2450 0.0 0
M  V30 5 C 0.0000 3.2146 0.0 0
M  V30 6 C 0.1140 5.3895 0.0 0
M  V30 7 C 2.2889 5.2756 0.0 0
M  V30 8 C 7.0133 3.7710 0.0 0
M  V30 9 O 8.5533 3.7710 0.0 0
M  V30 10 S 9.3233 5.1048 0.0 0 VAL=6
M  V30 11 O 10.0933 6.4384 0.0 0
M  V30 12 O 7.9897 5.8748 0.0 0
M  V30 13 C 14.6580 2.0248 0.0 0
M  V30 14 N 4.7118 2.2764 0.0 0
M  V30 15 C 6.2433 2.4374 0.0 0 CFG=2
M  V30 16 C 4.3916 0.7700 0.0 0
M  V30 17 C 6.8696 1.0306 0.0 0
M  V30 18 C 5.7253 0.0000 0.0 0
M  V30 19 C 10.6570 4.3348 0.0 0
M  V30 20 C 11.9906 5.1048 0.0 0
M  V30 21 C 10.6570 2.7948 0.0 0
M  V30 22 C 13.3244 4.3348 0.0 0
M  V30 23 C 11.9906 2.0248 0.0 0
M  V30 24 C 13.3244 2.7948 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 15 8 CFG=3
M  V30 10 1 9 10
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 19
M  V30 14 1 13 24
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-(1-pyrrolidinylmethyl)-1-pyrrolidinecarboxylate
C14H26N2O2
575469-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0171 2.6217 0.0 0
M  V30 2 O 8.3509 1.8517 0.0 0
M  V30 3 O 7.0171 4.1618 0.0 0
M  V30 4 C 9.6846 2.6217 0.0 0
M  V30 5 C 8.9146 3.9556 0.0 0
M  V30 6 C 11.0183 3.3917 0.0 0
M  V30 7 C 10.4546 1.2881 0.0 0
M  V30 8 C 3.9565 3.9845 0.0 0
M  V30 9 N 5.6835 1.8517 0.0 0
M  V30 10 C 4.2766 2.4782 0.0 0 CFG=2
M  V30 11 C 5.5225 0.3202 0.0 0
M  V30 12 C 3.2461 1.3337 0.0 0
M  V30 13 C 4.0161 0.0000 0.0 0
M  V30 14 N 2.4918 4.4604 0.0 0
M  V30 15 C 2.0159 5.9251 0.0 0
M  V30 16 C 1.2459 3.5553 0.0 0
M  V30 17 C 0.4759 5.9251 0.0 0
M  V30 18 C 0.0000 4.4604 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 10 8 CFG=1
M  V30 9 1 8 14
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86661-32-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 575469-09-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-18460680
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Synthesis of 6,6-Disubstituted Pentafulvenes Containing
a Chiral Pendant Hydroxy Group
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Nouch, Ryan; Cini, Melchior; Magre, Marc; Abid, Mohammed; Dieguez,
Montserrat; Pamies, Oscar; Woodward, Simon; Lewis, William
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2017), 23(68), 17195-17198

$RFMT $RIREG SCHEME292 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[[[(4-methylphenyl)sulfonyl]oxy]methyl]-1-pyrrolidin...
C17H25NO5S
86661-32-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 25 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.6812 3.4208 0.0 0
M  V30 2 O 2.1749 3.1006 0.0 0
M  V30 3 O 4.1572 4.8855 0.0 0
M  V30 4 C 1.1445 4.2450 0.0 0
M  V30 5 C 0.0000 3.2146 0.0 0
M  V30 6 C 0.1140 5.3895 0.0 0
M  V30 7 C 2.2889 5.2756 0.0 0
M  V30 8 C 7.0133 3.7710 0.0 0
M  V30 9 O 8.5533 3.7710 0.0 0
M  V30 10 S 9.3233 5.1048 0.0 0 VAL=6
M  V30 11 O 10.0933 6.4384 0.0 0
M  V30 12 O 7.9897 5.8748 0.0 0
M  V30 13 C 14.6580 2.0248 0.0 0
M  V30 14 N 4.7118 2.2764 0.0 0
M  V30 15 C 6.2433 2.4374 0.0 0 CFG=2
M  V30 16 C 4.3916 0.7700 0.0 0
M  V30 17 C 6.8696 1.0306 0.0 0
M  V30 18 C 5.7253 0.0000 0.0 0
M  V30 19 C 10.6570 4.3348 0.0 0
M  V30 20 C 11.9906 5.1048 0.0 0
M  V30 21 C 10.6570 2.7948 0.0 0
M  V30 22 C 13.3244 4.3348 0.0 0
M  V30 23 C 11.9906 2.0248 0.0 0
M  V30 24 C 13.3244 2.7948 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 15 8 CFG=3
M  V30 10 1 9 10
M  V30 11 2 10 11
M  V30 12 2 10 12
M  V30 13 1 10 19
M  V30 14 1 13 24
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 20 2 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-(1-pyrrolidinylmethyl)-1-pyrrolidinecarboxylate
C14H26N2O2
575469-09-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.0171 2.6217 0.0 0
M  V30 2 O 8.3509 1.8517 0.0 0
M  V30 3 O 7.0171 4.1618 0.0 0
M  V30 4 C 9.6846 2.6217 0.0 0
M  V30 5 C 8.9146 3.9556 0.0 0
M  V30 6 C 11.0183 3.3917 0.0 0
M  V30 7 C 10.4546 1.2881 0.0 0
M  V30 8 C 3.9565 3.9845 0.0 0
M  V30 9 N 5.6835 1.8517 0.0 0
M  V30 10 C 4.2766 2.4782 0.0 0 CFG=2
M  V30 11 C 5.5225 0.3202 0.0 0
M  V30 12 C 3.2461 1.3337 0.0 0
M  V30 13 C 4.0161 0.0000 0.0 0
M  V30 14 N 2.4918 4.4604 0.0 0
M  V30 15 C 2.0159 5.9251 0.0 0
M  V30 16 C 1.2459 3.5553 0.0 0
M  V30 17 C 0.4759 5.9251 0.0 0
M  V30 18 C 0.0000 4.4604 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 10 8 CFG=1
M  V30 9 1 8 14
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 86661-32-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 575469-09-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16337617
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of novel C-3 triterpenones with C-28 amide derivatives as HIV
inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reddy, Bandi Parthasaradhi; Reddy, Kura Rathnakar; Krupadanam, Gazula
Levi David; Reddy, Adulla Panduranga; Rao, Bammidi Eswara; Reddy,
Kasireddy Bhaskar; Sudhakar, Neela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2016147099 A2 2016-09-22

$RFMT $RIREG SCHEME293 STEP1
$RXN



  2  1
$MOL
3,4,5-Trimethoxybenzaldehyde
C10H12O4
86-81-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 1.3337 2.3100 0.0 0
M  V30 2 C 0.0000 3.0800 0.0 0
M  V30 3 O 4.0011 0.7700 0.0 0
M  V30 4 C 5.3348 0.0000 0.0 0
M  V30 5 O 1.3337 5.3901 0.0 0
M  V30 6 C 1.3337 6.9301 0.0 0
M  V30 7 C 6.6686 5.3901 0.0 0
M  V30 8 O 8.0022 4.6201 0.0 0
M  V30 9 C 2.6675 3.0800 0.0 0
M  V30 10 C 4.0011 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 5.3348 3.0800 0.0 0
M  V30 13 C 4.0011 5.3901 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 14
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(3,4,5-Trimethoxyphenyl)methyl]pyrrolidine
C14H21NO3
63407-07-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 4.0012 0.7700 0.0 0
M  V30 3 C 5.3348 0.0000 0.0 0
M  V30 4 O 1.3337 5.3901 0.0 0
M  V30 5 C 1.3337 6.9302 0.0 0
M  V30 6 O 1.3337 2.3101 0.0 0
M  V30 7 C 0.0000 3.0801 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 C 5.3348 3.0801 0.0 0
M  V30 10 C 4.0012 5.3901 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 2.6673 3.0801 0.0 0
M  V30 14 N 8.0022 4.6201 0.0 0
M  V30 15 C 8.1633 3.0885 0.0 0
M  V30 16 C 9.4091 5.2464 0.0 0
M  V30 17 C 9.6696 2.7684 0.0 0
M  V30 18 C 10.4396 4.1020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 11
M  V30 5 1 4 5
M  V30 6 1 4 12
M  V30 7 1 6 7
M  V30 8 1 6 13
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 86-81-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 63407-07-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-4967634
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetrical reversible neuromuscular blocking agents of ultra-short,
short, or intermediate duration
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Savarese, John J.; McGilvra, Jeff D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014005122 A2 2014-01-03

$RFMT $RIREG SCHEME294 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[2-(3′-cyano[1,1′-biphenyl]-4-yl)ethyl]-N-[2-[(3,5-dichlorophenyl)...
C25H20Cl3N3O2
868631-63-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 19.2504 8.0023 0.0 0
M  V30 2 N 20.0204 9.3360 0.0 0
M  V30 3 C 10.0102 5.3348 0.0 0
M  V30 4 C 9.2402 4.0012 0.0 0
M  V30 5 N 7.7002 4.0012 0.0 0
M  V30 6 C 6.9302 5.3348 0.0 0
M  V30 7 C 6.9302 2.6675 0.0 0
M  V30 8 C 5.3901 5.3348 0.0 0
M  V30 9 C 7.7002 1.3337 0.0 0
M  V30 10 O 5.3901 2.6675 0.0 0
M  V30 11 N 4.6201 6.6685 0.0 0
M  V30 12 O 4.6201 4.0012 0.0 0
M  V30 13 Cl 6.9302 0.0000 0.0 0
M  V30 14 Cl 0.0000 4.0012 0.0 0
M  V30 15 Cl 0.0000 9.3360 0.0 0
M  V30 16 C 16.1704 5.3348 0.0 0
M  V30 17 C 16.9404 6.6685 0.0 0
M  V30 18 C 16.9404 4.0012 0.0 0
M  V30 19 C 18.4804 6.6685 0.0 0
M  V30 20 C 18.4804 4.0012 0.0 0
M  V30 21 C 19.2504 5.3348 0.0 0
M  V30 22 C 14.6303 5.3348 0.0 0
M  V30 23 C 13.8603 4.0012 0.0 0
M  V30 24 C 13.8603 6.6685 0.0 0
M  V30 25 C 12.3203 4.0012 0.0 0
M  V30 26 C 12.3203 6.6685 0.0 0
M  V30 27 C 11.5503 5.3348 0.0 0
M  V30 28 C 3.0801 6.6685 0.0 0
M  V30 29 C 2.3101 5.3348 0.0 0
M  V30 30 C 2.3101 8.0023 0.0 0
M  V30 31 C 0.7700 5.3348 0.0 0
M  V30 32 C 0.7700 8.0023 0.0 0
M  V30 33 C 0.0000 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 19
M  V30 3 1 3 4
M  V30 4 1 3 27
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 11 28
M  V30 15 1 14 31
M  V30 16 1 15 32
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 22
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(3′-Cyano[1,1′-biphenyl]-4-yl)ethyl]-N-[2-[(3,5-dichlorophenyl)amino]-2-...
C29H28Cl2N4O2
518306-70-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 19.2502 10.4395 0.0 0
M  V30 2 N 20.0202 11.7731 0.0 0
M  V30 3 C 10.0101 7.7720 0.0 0
M  V30 4 C 9.2401 6.4383 0.0 0
M  V30 5 N 7.7001 6.4383 0.0 0
M  V30 6 C 6.9301 5.1047 0.0 0
M  V30 7 C 6.9301 7.7722 0.0 0
M  V30 8 C 7.7001 3.7710 0.0 0
M  V30 9 O 5.3901 5.1047 0.0 0
M  V30 10 C 5.3901 7.7722 0.0 0
M  V30 11 N 4.6201 9.1058 0.0 0
M  V30 12 O 4.6201 6.4383 0.0 0
M  V30 13 Cl 0.0000 6.4383 0.0 0
M  V30 14 Cl 0.0000 11.7731 0.0 0
M  V30 15 C 16.1702 7.7720 0.0 0
M  V30 16 C 16.9402 9.1058 0.0 0
M  V30 17 C 16.9402 6.4383 0.0 0
M  V30 18 C 18.4802 9.1058 0.0 0
M  V30 19 C 18.4802 6.4383 0.0 0
M  V30 20 C 19.2502 7.7720 0.0 0
M  V30 21 C 14.6302 7.7720 0.0 0
M  V30 22 C 13.8602 6.4383 0.0 0
M  V30 23 C 13.8602 9.1058 0.0 0
M  V30 24 C 12.3201 6.4383 0.0 0
M  V30 25 C 12.3201 9.1058 0.0 0
M  V30 26 C 11.5501 7.7720 0.0 0
M  V30 27 N 6.9301 2.4372 0.0 0
M  V30 28 C 7.5564 1.0304 0.0 0
M  V30 29 C 5.3985 2.2763 0.0 0
M  V30 30 C 6.4120 0.0000 0.0 0
M  V30 31 C 5.0784 0.7700 0.0 0
M  V30 32 C 3.0800 9.1058 0.0 0
M  V30 33 C 2.3100 7.7722 0.0 0
M  V30 34 C 2.3100 10.4395 0.0 0
M  V30 35 C 0.7700 7.7722 0.0 0
M  V30 36 C 0.7700 10.4395 0.0 0
M  V30 37 C 0.0000 9.1058 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 18
M  V30 3 1 3 4
M  V30 4 1 3 26
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 8 27
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 1 11 32
M  V30 15 1 13 35
M  V30 16 1 14 36
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 21
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 35 2 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 2 34 36
M  V30 39 2 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 868631-63-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 518306-70-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7085709
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biaryl diamides as potent melanin concentrating hormone receptor 1
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Palani, Anandan; Shapiro, Sherry; McBriar, Mark D.; Clader, John W.;
Greenlee, William J.; O'Neill, Kim; Hawes, Brian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(23), 5234-5236

$RFMT $RIREG SCHEME295 STEP1
$RXN



  2  1
$MOL
rel-(1R,3S)-1,3-Cyclopentanedicarboxylic acid
C7H10O4
876-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.2078 1.5400 0.0 0
M  V30 2 O 7.5415 2.3100 0.0 0
M  V30 3 O 6.2078 0.0000 0.0 0
M  V30 4 C 0.9052 2.6672 0.0 0
M  V30 5 O 0.2787 1.2602 0.0 0
M  V30 6 O 0.0000 3.9130 0.0 0
M  V30 7 C 4.8742 2.3100 0.0 0 CFG=2
M  V30 8 C 3.4672 1.6836 0.0 0
M  V30 9 C 4.7131 3.8416 0.0 0
M  V30 10 C 2.4368 2.8281 0.0 0 CFG=1
M  V30 11 C 3.2068 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 7 1 CFG=1
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 10 4 CFG=1
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 10)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(1R,3S)-3-(1-Pyrrolidinylcarbonyl)cyclopentanecarboxylic acid
C11H17NO3
1195981-73-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 O 3.7710 0.0000 0.0 0
M  V30 3 C 9.0738 2.6672 0.0 0
M  V30 4 O 9.9790 3.9130 0.0 0
M  V30 5 O 9.7001 1.2602 0.0 0
M  V30 6 C 5.1048 2.3100 0.0 0 CFG=1
M  V30 7 C 6.5116 1.6835 0.0 0
M  V30 8 C 5.2658 3.8416 0.0 0
M  V30 9 C 7.5421 2.8281 0.0 0 CFG=2
M  V30 10 C 6.7721 4.1617 0.0 0
M  V30 11 N 2.4374 2.3100 0.0 0
M  V30 12 C 2.2765 3.8416 0.0 0
M  V30 13 C 1.0306 1.6835 0.0 0
M  V30 14 C 0.7700 4.1617 0.0 0
M  V30 15 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 6 1 CFG=1
M  V30 3 1 1 11
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 9 3 CFG=1
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 6 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 876-05-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1195981-73-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-434882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 108-24-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Example LVII.
cis-3-(Pyrrolidine-1-carbonyl)-cyclopentanecarboxylic acid. A mixture of
cis-cyclopentane-1,3-dicarboxylic acid (1.00 g), acetic anhydride (1.20
mL), and toluene (5 mL) is stirred at 80°C for 40 min. After cooling to
room temperature, the solution is concentrated under reduced pressure.
The residue is taken up in dichloromethane (20 mL) and the resulting
solution is filtered to remove the non-dissolving part of the residue.
Pyrrolidine (0.53 mL) is added to the filtrate and the solution is
stirred at room temperature for 30 min. Then, the solution is
concentrated under reduced pressure and the residue is dissolved in
tetrahydrofuran and treated with Dowex H+ resin. The mixture is filtered
and the filrate is concentrated to afford the title compopund .
cis-3-(Pyrrolidine-1-carbonyl)-cyclopentanecarboxylic acid, as an oil.
Yield: 1.34 g (quantitative).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of alicyclic carboxylic acid derivatives of benzomorphans and
related scaffolds, medicaments containing such compounds and their use as
11β-hydroxysteroid dehydrogenase 1 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Peters, Stefan; Eckhardt, Matthias; Hamilton, Bradford S.; Himmelsbach,
Frank; Kley, Joerg; Lehmann-Lintz, Thorsten
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2009138386 A2 2009-11-19

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1S,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
192824-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=1
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 2.6673 6.2199 0.0 0
M  V30 11 C 1.3337 3.9098 0.0 0
M  V30 12 C 1.3337 6.9899 0.0 0
M  V30 13 C 0.0000 4.6799 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 8.0023 6.2199 0.0 0
M  V30 17 C 9.3360 3.9098 0.0 0
M  V30 18 C 9.3360 6.9899 0.0 0
M  V30 19 C 10.6697 4.6799 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=3
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 192824-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21679382
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2413567-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, catalyst prepared and used, other solvent (THF) may be
used, 83% ee
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereomeric P*,N,S-tridentate diamidophosphites with a ferrocene
moiety in asymmetric palladium catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Chuchelkin, Ilya V.; Zimarev, Vladislav S.;
Zheglov, Sergey V.; Gavrilov, Vladislav K.; Firsin, Ilya D.; Maximychev,
Alexander V.; Perepukhov, Alexander M.; Chernyshev, Vladimir V.;
Goulioukina, Nataliya S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2020), 913121199

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1S,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
192824-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=1
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 2.6673 6.2199 0.0 0
M  V30 11 C 1.3337 3.9098 0.0 0
M  V30 12 C 1.3337 6.9899 0.0 0
M  V30 13 C 0.0000 4.6799 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 8.0023 6.2199 0.0 0
M  V30 17 C 9.3360 3.9098 0.0 0
M  V30 18 C 9.3360 6.9899 0.0 0
M  V30 19 C 10.6697 4.6799 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=3
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 192824-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19480099
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-08-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 10416-59-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2249963-56-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, alternate solvent (tetrahydrofuran) may be used, 78% ee,
catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereomeric bisamidophosphites based on oxalamide 1,3-diol in
asymmetric metal complex catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, K. N.; Chuchelkin, I. V.; Zheglov, S. V.; Gavrilov, V. K.;
Zimarev, V. S.; Maksimova, M. G.; Shiryaev, A. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2018), 67(8), 1376-1382

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1S,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
192824-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=1
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 2.6673 6.2199 0.0 0
M  V30 11 C 1.3337 3.9098 0.0 0
M  V30 12 C 1.3337 6.9899 0.0 0
M  V30 13 C 0.0000 4.6799 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 8.0023 6.2199 0.0 0
M  V30 17 C 9.3360 3.9098 0.0 0
M  V30 18 C 9.3360 6.9899 0.0 0
M  V30 19 C 10.6697 4.6799 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=3
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 192824-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19405320
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2222304-40-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM (S)-2-[(N-arylamino)methyl]pyrrolidines-Based Phosphoramidite P,N-Ligand
Library for Asymmetric Metal-Catalyzed Allylic Substitution and Conjugate
1,4-Addition
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Mikhel, Igor S.; Chuchelkin, Ilya V.; Zheglov,
Sergey V.; Gavrilov, Vladislav K.; Birin, Kirill P.; Tafeenko, Victor A.;
Chernyshev, Vladimir V.; Goulioukina, Nataliya S.; Beletskaya, Irina P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2016), 1(14), 4173-4186

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1S,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
192824-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=1
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 2.6673 6.2199 0.0 0
M  V30 11 C 1.3337 3.9098 0.0 0
M  V30 12 C 1.3337 6.9899 0.0 0
M  V30 13 C 0.0000 4.6799 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 8.0023 6.2199 0.0 0
M  V30 17 C 9.3360 3.9098 0.0 0
M  V30 18 C 9.3360 6.9899 0.0 0
M  V30 19 C 10.6697 4.6799 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=3
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 192824-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3859469
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1341181-00-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, optimization study (ligand), catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphoramidites based on phenyl-substituted 1,2-diols as ligands in
palladium-catalyzed asymmetric allylations: the contribution of steric
demand and chiral centers to the enantioselectivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Zheglov, Sergey V.; Gavrilova, Mariya N.;
Chuchelkin, Ilya V.; Groshkin, Nikolay N.; Rastorguev, Eugenie A.;
Davankov, Vadim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(43), 5706-5710

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1S,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
192824-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=1
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 2.6673 6.2199 0.0 0
M  V30 11 C 1.3337 3.9098 0.0 0
M  V30 12 C 1.3337 6.9899 0.0 0
M  V30 13 C 0.0000 4.6799 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 8.0023 6.2199 0.0 0
M  V30 17 C 9.3360 3.9098 0.0 0
M  V30 18 C 9.3360 6.9899 0.0 0
M  V30 19 C 10.6697 4.6799 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=3
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 192824-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15122977
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1341180-90-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, optimization study (ligand), in-situ generated catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphoramidites based on phenyl-substituted 1,2-diols as ligands in
palladium-catalyzed asymmetric allylations: the contribution of steric
demand and chiral centers to the enantioselectivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Zheglov, Sergey V.; Gavrilova, Mariya N.;
Chuchelkin, Ilya V.; Groshkin, Nikolay N.; Rastorguev, Eugenie A.;
Davankov, Vadim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(43), 5706-5710

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1S,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
192824-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=1
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 2.6673 6.2199 0.0 0
M  V30 11 C 1.3337 3.9098 0.0 0
M  V30 12 C 1.3337 6.9899 0.0 0
M  V30 13 C 0.0000 4.6799 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 8.0023 6.2199 0.0 0
M  V30 17 C 9.3360 3.9098 0.0 0
M  V30 18 C 9.3360 6.9899 0.0 0
M  V30 19 C 10.6697 4.6799 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=3
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 192824-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10582861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 32216-28-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1259509-53-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Asymmetric allylic amination of
(E)-1,3-diphenylallyl acetate (10) with pyrrolidine. A solution of
[Pd(All)Cl]2 (0.0037 g, 0.01 mmol) and the corresponding ligand (0.02 or
0.04 mmol) (or a solution of [Pt(All)Cl]4 (0.005 g, 0.005 mmol) and the
corresponding ligand (0.02 or 0.04 mmol)) in the corresponding solvent (5
mL) was stirred for 40 min. (E)-1,3-Diphenylallyl acetate (10) (0.1 mL,
0.5 mmol) was added, and the reaction solution was stirred for 15 min.
Then freshly distilled pyrrolidine (0.12 mL, 1.5 mmol) was added. The
reaction mixture was stirred for 48 h, diluted with hexane (5 mL), and
filtered through Celite. The solvents were removed under reduced pressure
(40 Torr), and the residue was dried in vacuo (10 Torr). The conversion
of substrate 10 and the optical yields of product 12 were determined by
HPLC on chiral stationary phases. Yield quantitative.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 86% ee, alternatively reaction carried out using
tetahydrofuran as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphorodiamidite derivatives of 1,1'-bi-2-naphthol containing
stereogenic phosphorus atoms as ligands in enantioselective catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, K. N.; Safronov, A. S.; Rastorguev, E. A.; Groshkin, N. N.;
Zheglov, S. V.; Shiryaev, A. A.; Maksimova, M. G.; Petrovskii, P. V.;
Davankov, V. A.; Reetz, M. T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2010), 59(2), 434-440

$RFMT $RIREG SCHEME296 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1S,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
192824-29-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=1
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 2.6673 6.2199 0.0 0
M  V30 11 C 1.3337 3.9098 0.0 0
M  V30 12 C 1.3337 6.9899 0.0 0
M  V30 13 C 0.0000 4.6799 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 8.0023 6.2199 0.0 0
M  V30 17 C 9.3360 3.9098 0.0 0
M  V30 18 C 9.3360 6.9899 0.0 0
M  V30 19 C 10.6697 4.6799 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=3
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 192824-29-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12276469
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1228508-01-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereomeric P*-mono- and P*,P*-bidentate diamidophosphite ligands
based on 1,4:3,6-dianhydro-d-mannitol in asymmetric metallocomplex
catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, K. N.; Zheglov, S. V.; Vologzhanin, P. A.; Rastorguev, E. A.;
Shiryaev, A. A.; Maksimova, M. G.; Lyubimov, S. E.; Benetsky, E. B.;
Safronov, A. S.; Petrovskii, P. V.; Davankov, V. A.; Schaeffner, B.;
Boerner, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2008), 57(11), 2311-2319

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-21679381
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2413567-59-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, catalyst prepared and used, other solvent (THF) may be
used, 85% ee
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereomeric P*,N,S-tridentate diamidophosphites with a ferrocene
moiety in asymmetric palladium catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Chuchelkin, Ilya V.; Zimarev, Vladislav S.;
Zheglov, Sergey V.; Gavrilov, Vladislav K.; Firsin, Ilya D.; Maximychev,
Alexander V.; Perepukhov, Alexander M.; Chernyshev, Vladimir V.;
Goulioukina, Nataliya S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organometallic Chemistry (2020), 913121199

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-20410035
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2374287-05-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on stoichiometry of catalyst, solvent,
stereoselective, ee (77%)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Bisdiamidophosphite with a bisoxazoline moiety in palladium-catalyzed
enantioselective allylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, K. N.; Zheglov, S. V.; Gavrilov, V. K.; Firsin, I. D.;
Maksimova, M. G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2019), 68(7), 1376-1379

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29494743
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 10416-59-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2289616-04-0
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 127-08-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, diamidophosphite catalyst prepared and used,
optimization study, optimized on catalyst ratio, 94% ee, alternatively
DCM may be used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chiral inducers with (1R,2R)-1,2-diaminocyclohexane core for organo- and
metallocatalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Vladislav K.; Chuchelkin, Ilya V.; Zheglov, Sergey V.; Firsin,
Ilya D.; Shiryaev, Alexei A.; Gavrilov, Konstantin N.; Maximychev,
Alexander V.; Perepukhov, Alexander M.; Goulioukina, Nataliya S.;
Beletskaya, Irina P.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Mendeleev Communications (2019), 29(1), 35-37

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19480098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 127-08-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 10416-59-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2249963-54-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, alternate solvent (tetrahydrofuran) may be used, 26% ee,
catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereomeric bisamidophosphites based on oxalamide 1,3-diol in
asymmetric metal complex catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, K. N.; Chuchelkin, I. V.; Zheglov, S. V.; Gavrilov, V. K.;
Zimarev, V. S.; Maksimova, M. G.; Shiryaev, A. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2018), 67(8), 1376-1382

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-19358867
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2243403-40-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, optimization study, 56% ee, catalyst prepared and used,
optimized on solvent and catalyst/ligand ratio
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium and rhodium-catalyzed enantioselective reactions mediated by
pseudodipeptide-based phosphite-type ligand
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, K. N.; Chuchelkin, I. V.; Zheglov, S. V.; Gavrilov, V. K.;
Novikov, I. M.; Firsin, I. D.; Shiryaev, A. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2018), 67(5), 916-922

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-16473116
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2060566-29-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, optimization study, catalyst prepared and used,
optimized on catalyst, 96% ee
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium catalyzed asymmetric reactions assisted by P*,P*-bidentate
bisdiamidophosphites based on 1,4-diols
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Zheglov, Sergey V.; Gavrilov, Vladislav K.;
Maksimova, Marina G.; Tafeenko, Viktor A.; Chernyshev, Vladimir V.;
Birin, Kirill P.; Mikhel, Igor S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2017), 73(5), 461-471

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-17193874
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 4
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 14074-80-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2097448-41-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition (([Pd(allyl)Cl]2) (stage 2), stereoselective, ee
(74%), optimization study, optimized on catalyst and solvent and catalyst
ratio
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chiral amido- and diamidophosphites with a peripheral pyridine ring in
Pd-catalyzed asymmetric allylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, K. N.; Zheglov, S. V.; Novikov, I. M.; Gavrilov, V. K.;
Zamilatskov, I. A.; Mikhel, I. S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2016), 65(9), 2278-2285

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3014154
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1803403-91-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, ee (90%), optimization study, optimized on solvent and
stoichiometry of catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphorylated (S)-tert-leucinol isophthalic diamide as a ligand for
Pd-catalyzed asymmetric allylic substitution
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, K. N.; Zheglov, S. V.; Groshkin, N. N.; Gavrilov, V. K.;
Maksimova, M. G.; Volov, A. N.; Zamilatskov, I. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2014), 63(12), 2635-2640

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8416960
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1521246-77-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, optimization study, optimized on catalyst, optimized on
solvent, ee = 89%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nonsimple relationships between the P*-chiral diamidophosphite and the
arylphosphine moieties in Pd-catalyzed asymmetric reactions:
combinatorial approach and P,P*-bidentate phosphine-diamidophosphites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Shiryaev, Alexei A.; Zheglov, Sergey V.;
Gavrilov, Vladislav K.; Groshkin, Nikolay N.; Maksimova, Marina G.;
Volov, Alexandr N.; Zamilatskov, Ilya A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2014), 70(3), 616-624

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7613803
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1356476-30-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective (57% ee (R)), alternative preparation shown, catalyst
prepared and used, optimization study (optimized on solvent and ligand to
catalyst ratio)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphites and diamidophosphites based on mono-ethers of BINOL: a
comparison of enantioselectivity in asymmetric catalytic reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Zheglov, Sergey V.; Gavrilova, Mariya N.;
Novikov, Ivan M.; Maksimova, Marina G.; Groshkin, Nikolay N.; Rastorguev,
Eugenie A.; Davankov, Vadim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(5), 1581-1589

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9743190
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1356476-31-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective (70% ee (R)), alternative preparation shown, catalyst
prepared and used, optimization study (optimized on solvent and ligand to
catalyst ratio)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphites and diamidophosphites based on mono-ethers of BINOL: a
comparison of enantioselectivity in asymmetric catalytic reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Zheglov, Sergey V.; Gavrilova, Mariya N.;
Novikov, Ivan M.; Maksimova, Marina G.; Groshkin, Nikolay N.; Rastorguev,
Eugenie A.; Davankov, Vadim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2012), 68(5), 1581-1589

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15494129
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1341180-97-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Yield 100%. eeb,c: 63 (R).
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, alternatively reaction carried out by changing molar
ratio of ligand to Pd-complex in catalyst system, 63% ee
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chiral 1,3,2-dioxaphospholane amidophosphite in the palladium-catalyzed
enantioselective allylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, K. N.; Chuchelkin, I. V.; Zheglov, S. V.; Gavrilova, M. N.;
Rastorguev, E. A.; Davankov, V. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2011), 60(10), 2117-2119

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10449115
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1273551-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pd-catalyzed asymmetric reactions using resorcinol- and
hydroquinone-based P*,P*-bidentate diamidophosphites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Zheglov, Sergey V.; Shiryaev, Alexei A.;
Groshkin, Nikolay N.; Rastorguev, Eugenie A.; Benetskiy, Eduard B.;
Davankov, Vadim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(9), 964-968

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-12556200
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1273551-34-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pd-catalyzed asymmetric reactions using resorcinol- and
hydroquinone-based P*,P*-bidentate diamidophosphites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Zheglov, Sergey V.; Shiryaev, Alexei A.;
Groshkin, Nikolay N.; Rastorguev, Eugenie A.; Benetskiy, Eduard B.;
Davankov, Vadim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(9), 964-968

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8324432
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1273551-33-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pd-catalyzed asymmetric reactions using resorcinol- and
hydroquinone-based P*,P*-bidentate diamidophosphites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Zheglov, Sergey V.; Shiryaev, Alexei A.;
Groshkin, Nikolay N.; Rastorguev, Eugenie A.; Benetskiy, Eduard B.;
Davankov, Vadim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(9), 964-968

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5997750
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1341180-97-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, optimization study (ligand), in-situ generated catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphoramidites based on phenyl-substituted 1,2-diols as ligands in
palladium-catalyzed asymmetric allylations: the contribution of steric
demand and chiral centers to the enantioselectivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Zheglov, Sergey V.; Gavrilova, Mariya N.;
Chuchelkin, Ilya V.; Groshkin, Nikolay N.; Rastorguev, Eugenie A.;
Davankov, Vadim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(43), 5706-5710

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8123789
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1341181-04-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, optimization study (ligand), catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphoramidites based on phenyl-substituted 1,2-diols as ligands in
palladium-catalyzed asymmetric allylations: the contribution of steric
demand and chiral centers to the enantioselectivity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, Konstantin N.; Zheglov, Sergey V.; Gavrilova, Mariya N.;
Chuchelkin, Ilya V.; Groshkin, Nikolay N.; Rastorguev, Eugenie A.;
Davankov, Vadim A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2011), 52(43), 5706-5710

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-3881177
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1224213-82-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diamidophosphites with isomeric carborane fragments: a comparison of
catalytic activity in asymmetric Pd-catalyzed allylic substitution
reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lyubimov, Sergey E.; Davankov, Vadim A.; Gavrilov, Konstantin N.;
Grishina, Tatiana B.; Rastorguev, Eugenie A.; Tyutyunov, Andrey A.;
Verbitskaya, Tatiana A.; Kalinin, Valery N.; Hey-Hawkins, Evamarie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2010), 51(13), 1682-1684

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8453940
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1259509-53-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Asymmetric allylic amination of (E)-1,3-diphenylallyl acetate (10) with
pyrrolidine. A solution of [Pd(All)Cl]2 (0.0037 g, 0.01 mmol) and the
corresponding ligand (0.02 or 0.04 mmol) (or a solution of [Pt(All)Cl]4
(0.005 g, 0.005 mmol) and the corresponding ligand (0.02 or 0.04 mmol))
in the corresponding solvent (5 mL) was stirred for 40 min.
(E)-1,3-Diphenylallyl acetate (10) (0.1 mL, 0.5 mmol) was added, and the
reaction solution was stirred for 15 min. Then freshly distilled
pyrrolidine (0.12 mL, 1.5 mmol) was added. The reaction mixture was
stirred for 48 h, diluted with hexane (5 mL), and filtered through
Celite. The solvents were removed under reduced pressure (40 Torr), and
the residue was dried in vacuo (10 Torr). The conversion of substrate 10
and the optical yields of product 12 were determined by HPLC on chiral
stationary phases. Yield quantitative.
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, 88% ee, alternatively reaction carried out using
tetahydrofuran as solvent decreased conversion
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Phosphorodiamidite derivatives of 1,1'-bi-2-naphthol containing
stereogenic phosphorus atoms as ligands in enantioselective catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, K. N.; Safronov, A. S.; Rastorguev, E. A.; Groshkin, N. N.;
Zheglov, S. V.; Shiryaev, A. A.; Maksimova, M. G.; Petrovskii, P. V.;
Davankov, V. A.; Reetz, M. T.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2010), 59(2), 434-440

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-10138403
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1031399-78-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Diastereomeric P*-mono- and P*,P*-bidentate diamidophosphite ligands
based on 1,4:3,6-dianhydro-d-mannitol in asymmetric metallocomplex
catalysis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gavrilov, K. N.; Zheglov, S. V.; Vologzhanin, P. A.; Rastorguev, E. A.;
Shiryaev, A. A.; Maksimova, M. G.; Lyubimov, S. E.; Benetsky, E. B.;
Safronov, A. S.; Petrovskii, P. V.; Davankov, V. A.; Schaeffner, B.;
Boerner, A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Russian Chemical Bulletin (2008), 57(11), 2311-2319

$RFMT $RIREG SCHEME297 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(E)-1,3-Diphenyl-2-propenyl acetate
C17H16O2
87751-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0 CFG=3
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 2.3100 2.6674 0.0 0
M  V30 4 C 5.3900 5.3347 0.0 0
M  V30 5 C 3.0800 1.3336 0.0 0
M  V30 6 C 4.6200 1.3336 0.0 0
M  V30 7 O 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 5.3347 0.0 0
M  V30 9 C 3.0800 6.6685 0.0 0
M  V30 10 C 0.7700 5.3347 0.0 0
M  V30 11 C 2.3100 8.0021 0.0 0
M  V30 12 C 0.0000 6.6685 0.0 0
M  V30 13 C 0.7700 8.0021 0.0 0
M  V30 14 C 6.9300 5.3347 0.0 0
M  V30 15 C 7.7000 6.6685 0.0 0
M  V30 16 C 7.7000 4.0011 0.0 0
M  V30 17 C 9.2400 6.6685 0.0 0
M  V30 18 C 9.2400 4.0011 0.0 0
M  V30 19 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 4 14
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(1R,2E)-1,3-Diphenyl-2-propen-1-yl]pyrrolidine
C19H21N
858671-47-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 3.9098 0.0 0
M  V30 4 N 4.0012 2.3698 0.0 0
M  V30 5 C 2.7553 1.4646 0.0 0
M  V30 6 C 5.2470 1.4646 0.0 0
M  V30 7 C 3.2311 0.0000 0.0 0
M  V30 8 C 4.7712 0.0000 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 6.2199 0.0 0
M  V30 15 C 8.0023 4.6799 0.0 0
M  V30 16 C 9.3360 3.9098 0.0 0
M  V30 17 C 8.0023 6.2199 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 9.3360 6.9899 0.0 0
M  V30 20 C 10.6697 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4 CFG=1
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 3 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87751-69-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 858671-47-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-9618015
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12012-95-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 960538-39-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Various P*-chiral phosphite-type ligands: their synthesis,
stereochemistry and use in Pd-catalyzed allylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Benetsky, Eduard B.; Zheglov, Sergey V.; Grishina, Tatiana B.; Macaev,
Fliur Z.; Bet, Liudmila P.; Davankov, Vadim A.; Gavrilov, Konstantin N.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2007), 48(47), 8326-8330

$RFMT $RIREG SCHEME298 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-1-(2,3-dihydro-5-nitro-1H-indol-1-yl)ethanone
C10H9ClN2O3
87866-11-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0408 3.1885 0.0 0
M  V30 2 C 9.5056 2.7126 0.0 0
M  V30 3 O 7.7207 4.6949 0.0 0
M  V30 4 Cl 10.6500 3.7431 0.0 0
M  V30 5 N 0.7700 2.4782 0.0 0 VAL=5
M  V30 6 O 0.0000 1.1446 0.0 0
M  V30 7 O 0.0000 3.8119 0.0 0
M  V30 8 C 5.3901 2.4782 0.0 0
M  V30 9 C 4.6201 1.1446 0.0 0
M  V30 10 N 6.8964 2.1580 0.0 0
M  V30 11 C 4.6201 3.8119 0.0 0
M  V30 12 C 3.0801 1.1446 0.0 0
M  V30 13 C 5.6505 0.0000 0.0 0
M  V30 14 C 7.0574 0.6265 0.0 0
M  V30 15 C 3.0801 3.8119 0.0 0
M  V30 16 C 2.3101 2.4782 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 16
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 2 9 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2,3-Dihydro-5-nitro-1H-indol-1-yl)-2-(1-pyrrolidinyl)ethanone
C14H17N3O3
1400288-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.9855 4.5602 0.0 0
M  V30 2 C 9.0159 5.7048 0.0 0
M  V30 3 O 8.4614 3.0957 0.0 0
M  V30 4 N 1.3336 1.5400 0.0 0 VAL=5
M  V30 5 O 1.3336 0.0000 0.0 0
M  V30 6 O 0.0000 2.3100 0.0 0
M  V30 7 C 5.3347 3.8500 0.0 0
M  V30 8 N 6.4791 4.8804 0.0 0
M  V30 9 C 4.0011 4.6200 0.0 0
M  V30 10 C 5.3347 2.3100 0.0 0
M  V30 11 C 5.8528 6.2874 0.0 0
M  V30 12 C 2.6673 3.8500 0.0 0
M  V30 13 C 4.3212 6.1264 0.0 0
M  V30 14 C 4.0011 1.5400 0.0 0
M  V30 15 C 2.6673 2.3100 0.0 0
M  V30 16 N 10.5224 5.3846 0.0 0
M  V30 17 C 11.6667 6.4150 0.0 0
M  V30 18 C 11.1487 3.9777 0.0 0
M  V30 19 C 13.0004 5.6450 0.0 0
M  V30 20 C 12.6802 4.1386 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 16
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 15
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 9 12
M  V30 13 1 9 13
M  V30 14 1 10 14
M  V30 15 1 11 13
M  V30 16 1 12 15
M  V30 17 2 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 87866-11-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1400288-88-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-160690
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM pressure vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a potent, orally bioavailable and highly selective human
neuronal nitric oxide synthase (nNOS) inhibitor,
N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a
pre-clinical development candidate for the treatment of migraine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Annedi, Subhash C.; Maddaford, Shawn P.; Ramnauth, Jailall; Renton, Paul;
Rybak, Taras; Silverman, Sarah; Rakhit, Suman; Mladenova, Gabriela; Dove,
Peter; Andrews, John S.; Zhang, Dongqin; Porreca, Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2012), 5594-107

$RFMT $RIREG SCHEME299 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-[(3′-cyano[1,1′-biphenyl]-4-yl)methyl]-N-[2-[(3,5-dichlorophenyl)a...
C24H18Cl3N3O2
885315-76-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 8.0023 0.0 0
M  V30 2 N 0.0000 9.3360 0.0 0
M  V30 3 C 10.0102 5.3348 0.0 0
M  V30 4 N 10.7802 4.0012 0.0 0
M  V30 5 C 12.3203 4.0012 0.0 0
M  V30 6 C 10.0102 2.6673 0.0 0
M  V30 7 C 13.0903 5.3348 0.0 0
M  V30 8 C 10.7802 1.3337 0.0 0
M  V30 9 O 8.4702 2.6673 0.0 0
M  V30 10 N 14.6303 5.3348 0.0 0
M  V30 11 O 12.3203 6.6685 0.0 0
M  V30 12 Cl 10.0102 0.0000 0.0 0
M  V30 13 Cl 14.6303 10.6697 0.0 0
M  V30 14 Cl 19.2504 8.0023 0.0 0
M  V30 15 C 3.8501 5.3348 0.0 0
M  V30 16 C 3.0801 6.6685 0.0 0
M  V30 17 C 3.0801 4.0012 0.0 0
M  V30 18 C 1.5400 6.6685 0.0 0
M  V30 19 C 1.5400 4.0012 0.0 0
M  V30 20 C 0.7700 5.3348 0.0 0
M  V30 21 C 5.3901 5.3348 0.0 0
M  V30 22 C 6.1601 4.0012 0.0 0
M  V30 23 C 6.1601 6.6685 0.0 0
M  V30 24 C 7.7002 4.0012 0.0 0
M  V30 25 C 7.7002 6.6685 0.0 0
M  V30 26 C 8.4702 5.3348 0.0 0
M  V30 27 C 15.4003 6.6685 0.0 0
M  V30 28 C 14.6303 8.0023 0.0 0
M  V30 29 C 16.9404 6.6685 0.0 0
M  V30 30 C 15.4003 9.3360 0.0 0
M  V30 31 C 17.7104 8.0023 0.0 0
M  V30 32 C 16.9404 9.3360 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 18
M  V30 3 1 3 4
M  V30 4 1 3 26
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 10 27
M  V30 14 1 13 30
M  V30 15 1 14 31
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3′-Cyano[1,1′-biphenyl]-4-yl)methyl]-N-[2-[(3,5-dichlorophenyl)amino]-2-o...
C28H26Cl2N4O2
518306-76-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 10.4396 0.0 0
M  V30 2 N 0.0000 11.7732 0.0 0
M  V30 3 C 10.0102 7.7721 0.0 0
M  V30 4 N 10.7802 6.4384 0.0 0
M  V30 5 C 10.0102 5.1047 0.0 0
M  V30 6 C 12.3203 6.4384 0.0 0
M  V30 7 C 10.7802 3.7711 0.0 0
M  V30 8 O 8.4702 5.1047 0.0 0
M  V30 9 C 13.0903 7.7721 0.0 0
M  V30 10 N 14.6303 7.7721 0.0 0
M  V30 11 O 12.3203 9.1059 0.0 0
M  V30 12 Cl 14.6303 13.1069 0.0 0
M  V30 13 Cl 19.2504 10.4396 0.0 0
M  V30 14 C 3.8501 7.7721 0.0 0
M  V30 15 C 3.0801 9.1059 0.0 0
M  V30 16 C 3.0801 6.4384 0.0 0
M  V30 17 C 1.5400 9.1059 0.0 0
M  V30 18 C 1.5400 6.4384 0.0 0
M  V30 19 C 0.7700 7.7721 0.0 0
M  V30 20 C 5.3901 7.7721 0.0 0
M  V30 21 C 6.1601 9.1059 0.0 0
M  V30 22 C 6.1601 6.4384 0.0 0
M  V30 23 C 7.7002 9.1059 0.0 0
M  V30 24 C 7.7002 6.4384 0.0 0
M  V30 25 C 8.4702 7.7721 0.0 0
M  V30 26 N 10.0102 2.4373 0.0 0
M  V30 27 C 8.4787 2.2763 0.0 0
M  V30 28 C 10.6366 1.0304 0.0 0
M  V30 29 C 8.1585 0.7700 0.0 0
M  V30 30 C 9.4922 0.0000 0.0 0
M  V30 31 C 15.4003 9.1059 0.0 0
M  V30 32 C 14.6303 10.4396 0.0 0
M  V30 33 C 16.9404 9.1059 0.0 0
M  V30 34 C 15.4003 11.7732 0.0 0
M  V30 35 C 17.7104 10.4396 0.0 0
M  V30 36 C 16.9404 11.7732 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 17
M  V30 3 1 3 4
M  V30 4 1 3 25
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 7 26
M  V30 11 1 9 10
M  V30 12 2 9 11
M  V30 13 1 10 31
M  V30 14 1 12 34
M  V30 15 1 13 35
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 14 20
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 2 22 24
M  V30 27 2 23 25
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 2 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 2 33 35
M  V30 38 2 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 885315-76-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 518306-76-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2551203
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biaryl diamides as potent melanin concentrating hormone receptor 1
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Palani, Anandan; Shapiro, Sherry; McBriar, Mark D.; Clader, John W.;
Greenlee, William J.; O'Neill, Kim; Hawes, Brian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(23), 5234-5236

$RFMT $RIREG SCHEME300 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-[(3′-cyano[1,1′-biphenyl]-4-yl)methyl]-N-[2-[(3,5-dichlorophenyl)a...
C25H20Cl3N3O2
885315-81-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 9.3360 0.0 0
M  V30 2 N 0.0000 10.6697 0.0 0
M  V30 3 C 10.0102 6.6685 0.0 0
M  V30 4 N 10.7802 5.3348 0.0 0
M  V30 5 C 12.3203 5.3348 0.0 0
M  V30 6 C 10.0102 4.0012 0.0 0
M  V30 7 C 13.0903 6.6685 0.0 0
M  V30 8 C 10.7802 2.6673 0.0 0
M  V30 9 O 8.4702 4.0012 0.0 0
M  V30 10 N 14.6303 6.6685 0.0 0
M  V30 11 O 12.3203 8.0022 0.0 0
M  V30 12 C 10.0102 1.3337 0.0 0
M  V30 13 Cl 10.7802 0.0000 0.0 0
M  V30 14 Cl 19.2504 9.3360 0.0 0
M  V30 15 Cl 14.6303 12.0033 0.0 0
M  V30 16 C 5.3901 6.6685 0.0 0
M  V30 17 C 6.1601 5.3348 0.0 0
M  V30 18 C 6.1601 8.0022 0.0 0
M  V30 19 C 7.7002 5.3348 0.0 0
M  V30 20 C 7.7002 8.0022 0.0 0
M  V30 21 C 8.4702 6.6685 0.0 0
M  V30 22 C 3.8501 6.6685 0.0 0
M  V30 23 C 3.0801 8.0022 0.0 0
M  V30 24 C 3.0801 5.3348 0.0 0
M  V30 25 C 1.5400 8.0022 0.0 0
M  V30 26 C 1.5400 5.3348 0.0 0
M  V30 27 C 0.7700 6.6685 0.0 0
M  V30 28 C 15.4003 8.0022 0.0 0
M  V30 29 C 16.9404 8.0022 0.0 0
M  V30 30 C 14.6303 9.3360 0.0 0
M  V30 31 C 17.7104 9.3360 0.0 0
M  V30 32 C 15.4003 10.6697 0.0 0
M  V30 33 C 16.9404 10.6697 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 25
M  V30 3 1 3 4
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 10 28
M  V30 14 1 12 13
M  V30 15 1 14 31
M  V30 16 1 15 32
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 22
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 30 2 28 29
M  V30 31 1 28 30
M  V30 32 1 29 31
M  V30 33 2 30 32
M  V30 34 2 31 33
M  V30 35 1 32 33
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3′-Cyano[1,1′-biphenyl]-4-yl)methyl]-N-[2-[(3,5-dichlorophenyl)amino]-2-o...
C29H28Cl2N4O2
518306-57-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 40 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 10.4396 0.0 0
M  V30 2 N 0.0000 11.7732 0.0 0
M  V30 3 C 10.0102 7.7721 0.0 0
M  V30 4 N 10.7802 6.4384 0.0 0
M  V30 5 C 12.3203 6.4384 0.0 0
M  V30 6 C 10.0102 5.1047 0.0 0
M  V30 7 C 13.0903 7.7721 0.0 0
M  V30 8 C 8.4702 5.1047 0.0 0
M  V30 9 O 10.7802 3.7711 0.0 0
M  V30 10 N 14.6303 7.7721 0.0 0
M  V30 11 O 12.3203 9.1059 0.0 0
M  V30 12 C 7.7002 3.7711 0.0 0
M  V30 13 Cl 14.6303 13.1069 0.0 0
M  V30 14 Cl 19.2504 10.4396 0.0 0
M  V30 15 C 3.8501 7.7721 0.0 0
M  V30 16 C 3.0801 9.1059 0.0 0
M  V30 17 C 3.0801 6.4384 0.0 0
M  V30 18 C 1.5400 9.1059 0.0 0
M  V30 19 C 1.5400 6.4384 0.0 0
M  V30 20 C 0.7700 7.7721 0.0 0
M  V30 21 C 5.3901 7.7721 0.0 0
M  V30 22 C 6.1601 9.1059 0.0 0
M  V30 23 C 6.1601 6.4384 0.0 0
M  V30 24 C 7.7002 9.1059 0.0 0
M  V30 25 C 7.7002 6.4384 0.0 0
M  V30 26 C 8.4702 7.7721 0.0 0
M  V30 27 C 15.4003 9.1059 0.0 0
M  V30 28 C 14.6303 10.4396 0.0 0
M  V30 29 C 16.9404 9.1059 0.0 0
M  V30 30 C 15.4003 11.7732 0.0 0
M  V30 31 C 17.7104 10.4396 0.0 0
M  V30 32 C 16.9404 11.7732 0.0 0
M  V30 33 N 8.4702 2.4373 0.0 0
M  V30 34 C 10.0017 2.2763 0.0 0
M  V30 35 C 7.8439 1.0304 0.0 0
M  V30 36 C 10.3219 0.7700 0.0 0
M  V30 37 C 8.9883 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 18
M  V30 3 1 3 4
M  V30 4 1 3 26
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 10 27
M  V30 14 1 12 33
M  V30 15 1 13 30
M  V30 16 1 14 31
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 15 21
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 2 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 25
M  V30 28 2 24 26
M  V30 29 1 25 26
M  V30 30 2 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 2 29 31
M  V30 34 2 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 885315-81-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 518306-57-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2499313
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biaryl diamides as potent melanin concentrating hormone receptor 1
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Palani, Anandan; Shapiro, Sherry; McBriar, Mark D.; Clader, John W.;
Greenlee, William J.; O'Neill, Kim; Hawes, Brian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(23), 5234-5236

$RFMT $RIREG SCHEME301 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Chloro-N-[2-(3′-cyano[1,1′-biphenyl]-4-yl)ethyl]-N-[2-[(3,5-dichlorophenyl)...
C26H22Cl3N3O2
885315-93-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 36 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.7102 13.3369 0.0 0
M  V30 2 N 19.2502 13.3369 0.0 0
M  V30 3 C 10.7801 6.6684 0.0 0
M  V30 4 C 9.2401 6.6684 0.0 0
M  V30 5 N 8.4701 5.3348 0.0 0
M  V30 6 C 6.9301 5.3348 0.0 0
M  V30 7 C 9.2401 4.0010 0.0 0
M  V30 8 C 6.1601 6.6684 0.0 0
M  V30 9 C 8.4701 2.6673 0.0 0
M  V30 10 O 10.7801 4.0010 0.0 0
M  V30 11 N 4.6201 6.6684 0.0 0
M  V30 12 O 6.9301 8.0021 0.0 0
M  V30 13 C 9.2401 1.3337 0.0 0
M  V30 14 Cl 8.4701 0.0000 0.0 0
M  V30 15 Cl 4.6201 12.0032 0.0 0
M  V30 16 Cl 0.0000 9.3357 0.0 0
M  V30 17 C 13.0901 10.6695 0.0 0
M  V30 18 C 13.8602 9.3357 0.0 0
M  V30 19 C 11.5501 10.6695 0.0 0
M  V30 20 C 13.0901 8.0021 0.0 0
M  V30 21 C 10.7801 9.3357 0.0 0
M  V30 22 C 11.5501 8.0021 0.0 0
M  V30 23 C 13.8602 12.0032 0.0 0
M  V30 24 C 15.4002 12.0032 0.0 0
M  V30 25 C 13.0901 13.3369 0.0 0
M  V30 26 C 16.1702 13.3369 0.0 0
M  V30 27 C 13.8602 14.6705 0.0 0
M  V30 28 C 15.4002 14.6705 0.0 0
M  V30 29 C 3.8500 8.0021 0.0 0
M  V30 30 C 4.6201 9.3357 0.0 0
M  V30 31 C 2.3100 8.0021 0.0 0
M  V30 32 C 3.8500 10.6695 0.0 0
M  V30 33 C 1.5400 9.3357 0.0 0
M  V30 34 C 2.3100 10.6695 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 26
M  V30 3 1 3 4
M  V30 4 1 3 22
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 11 29
M  V30 15 1 13 14
M  V30 16 1 15 32
M  V30 17 1 16 33
M  V30 18 2 17 18
M  V30 19 1 17 19
M  V30 20 1 17 23
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 25 2 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 27
M  V30 29 2 26 28
M  V30 30 1 27 28
M  V30 31 2 29 30
M  V30 32 1 29 31
M  V30 33 1 30 32
M  V30 34 2 31 33
M  V30 35 2 32 34
M  V30 36 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[2-(3′-Cyano[1,1′-biphenyl]-4-yl)ethyl]-N-[2-[(3,5-dichlorophenyl)amino]-2-...
C30H30Cl2N4O2
518306-65-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 41 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 17.7100 15.7742 0.0 0
M  V30 2 N 19.2500 15.7742 0.0 0
M  V30 3 C 10.7800 9.1057 0.0 0
M  V30 4 C 9.2400 9.1057 0.0 0
M  V30 5 N 8.4700 7.7721 0.0 0
M  V30 6 C 6.9300 7.7721 0.0 0
M  V30 7 C 9.2400 6.4384 0.0 0
M  V30 8 C 6.1600 9.1057 0.0 0
M  V30 9 C 8.4700 5.1046 0.0 0
M  V30 10 O 10.7800 6.4384 0.0 0
M  V30 11 N 4.6200 9.1057 0.0 0
M  V30 12 O 6.9300 10.4395 0.0 0
M  V30 13 C 9.2400 3.7710 0.0 0
M  V30 14 Cl 0.0000 11.7731 0.0 0
M  V30 15 Cl 4.6200 14.4404 0.0 0
M  V30 16 C 13.0900 13.1068 0.0 0
M  V30 17 C 13.8600 11.7731 0.0 0
M  V30 18 C 11.5500 13.1068 0.0 0
M  V30 19 C 13.0900 10.4395 0.0 0
M  V30 20 C 10.7800 11.7731 0.0 0
M  V30 21 C 11.5500 10.4395 0.0 0
M  V30 22 C 13.8600 14.4404 0.0 0
M  V30 23 C 15.4000 14.4404 0.0 0
M  V30 24 C 13.0900 15.7742 0.0 0
M  V30 25 C 16.1700 15.7742 0.0 0
M  V30 26 C 13.8600 17.1079 0.0 0
M  V30 27 C 15.4000 17.1079 0.0 0
M  V30 28 C 3.8500 10.4395 0.0 0
M  V30 29 C 2.3100 10.4395 0.0 0
M  V30 30 C 4.6200 11.7731 0.0 0
M  V30 31 C 1.5400 11.7731 0.0 0
M  V30 32 C 3.8500 13.1068 0.0 0
M  V30 33 C 2.3100 13.1068 0.0 0
M  V30 34 N 8.4700 2.4374 0.0 0
M  V30 35 C 9.0963 1.0306 0.0 0
M  V30 36 C 6.9385 2.2764 0.0 0
M  V30 37 C 7.9519 0.0000 0.0 0
M  V30 38 C 6.6183 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 25
M  V30 3 1 3 4
M  V30 4 1 3 21
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 2 8 12
M  V30 13 1 9 13
M  V30 14 1 11 28
M  V30 15 1 13 34
M  V30 16 1 14 31
M  V30 17 1 15 32
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 16 22
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 37 1 34 35
M  V30 38 1 34 36
M  V30 39 1 35 37
M  V30 40 1 36 38
M  V30 41 1 37 38
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 885315-93-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 518306-65-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-11012503
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7681-82-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Biaryl diamides as potent melanin concentrating hormone receptor 1
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Palani, Anandan; Shapiro, Sherry; McBriar, Mark D.; Clader, John W.;
Greenlee, William J.; O'Neill, Kim; Hawes, Brian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2005), 15(23), 5234-5236

$RFMT $RIREG SCHEME302 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[2-[[4-(5-formyl-3-methyl-2-pyridinyl)benzoyl]amino]pheny...
C25H25N3O4
901300-03-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 14.6708 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 N 6.6687 3.0801 0.0 0
M  V30 4 O 8.0023 0.7700 0.0 0
M  V30 5 C 17.3383 7.7002 0.0 0
M  V30 6 O 17.3383 9.2402 0.0 0
M  V30 7 N 4.0012 4.6201 0.0 0
M  V30 8 C 2.6675 5.3901 0.0 0
M  V30 9 O 2.6675 6.9302 0.0 0
M  V30 10 O 1.3338 4.6201 0.0 0
M  V30 11 C 1.3338 7.7002 0.0 0
M  V30 12 C 2.1038 9.0338 0.0 0
M  V30 13 C 0.0000 8.4702 0.0 0
M  V30 14 C 0.5638 6.3665 0.0 0
M  V30 15 C 12.0035 4.6201 0.0 0
M  V30 16 C 12.0035 3.0801 0.0 0
M  V30 17 C 10.6697 5.3901 0.0 0
M  V30 18 C 10.6697 2.3101 0.0 0
M  V30 19 C 9.3360 4.6201 0.0 0
M  V30 20 C 9.3360 3.0801 0.0 0
M  V30 21 C 13.3372 5.3901 0.0 0
M  V30 22 C 14.6708 4.6201 0.0 0
M  V30 23 N 13.3372 6.9302 0.0 0
M  V30 24 C 16.0045 5.3901 0.0 0
M  V30 25 C 14.6708 7.7002 0.0 0
M  V30 26 C 16.0045 6.9302 0.0 0
M  V30 27 C 5.3348 2.3101 0.0 0
M  V30 28 C 4.0012 3.0801 0.0 0
M  V30 29 C 5.3348 0.7700 0.0 0
M  V30 30 C 2.6675 2.3101 0.0 0
M  V30 31 C 4.0012 0.0000 0.0 0
M  V30 32 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 22
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 20
M  V30 5 1 3 27
M  V30 6 2 5 6
M  V30 7 1 5 26
M  V30 8 1 7 8
M  V30 9 1 7 28
M  V30 10 1 8 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 15 21
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 29 2 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 29 31
M  V30 33 2 30 32
M  V30 34 1 31 32
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(2-Aminophenyl)-4-[3-methyl-5-(1-pyrrolidinylmethyl)-2-pyridinyl]benzamide
C24H26N4O
901300-43-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 11.5503 0.0000 0.0 0
M  V30 2 C 5.3901 2.6675 0.0 0
M  V30 3 N 4.6201 4.0012 0.0 0
M  V30 4 O 4.6201 1.3338 0.0 0
M  V30 5 C 16.1704 2.6675 0.0 0
M  V30 6 N 3.0801 6.6687 0.0 0
M  V30 7 C 10.0102 2.6675 0.0 0
M  V30 8 C 9.2402 1.3338 0.0 0
M  V30 9 C 9.2402 4.0012 0.0 0
M  V30 10 C 7.7002 1.3338 0.0 0
M  V30 11 C 7.7002 4.0012 0.0 0
M  V30 12 C 6.9302 2.6675 0.0 0
M  V30 13 C 11.5503 2.6675 0.0 0
M  V30 14 C 12.3203 1.3338 0.0 0
M  V30 15 N 12.3203 4.0012 0.0 0
M  V30 16 C 13.8603 1.3338 0.0 0
M  V30 17 C 13.8603 4.0012 0.0 0
M  V30 18 C 14.6303 2.6675 0.0 0
M  V30 19 N 16.9404 4.0012 0.0 0
M  V30 20 C 16.3139 5.4081 0.0 0
M  V30 21 C 18.4719 4.1621 0.0 0
M  V30 22 C 17.4584 6.4386 0.0 0
M  V30 23 C 18.7921 5.6686 0.0 0
M  V30 24 C 3.0801 4.0012 0.0 0
M  V30 25 C 2.3101 5.3348 0.0 0
M  V30 26 C 2.3101 2.6675 0.0 0
M  V30 27 C 0.7700 5.3348 0.0 0
M  V30 28 C 0.7700 2.6675 0.0 0
M  V30 29 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 14
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 12
M  V30 5 1 3 24
M  V30 6 1 5 18
M  V30 7 1 5 19
M  V30 8 1 6 25
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 7 13
M  V30 12 1 8 10
M  V30 13 2 9 11
M  V30 14 2 10 12
M  V30 15 1 11 12
M  V30 16 2 13 14
M  V30 17 1 13 15
M  V30 18 1 14 16
M  V30 19 2 15 17
M  V30 20 2 16 18
M  V30 21 1 17 18
M  V30 22 1 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 2 26 28
M  V30 31 2 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 901300-03-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 901300-43-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-313-CAS-13819901
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Example 17 Preparation of
(N-(2-aminophenyl)-4-[3-methyl-5-(pyrrolidin-1-ylmethyl)pyri
din-2-yl]benzamide) tert-Butyl
(2-{[4-(5-formylpyridin-2-yl)benzoyl]amino}phenyl)carbamate (200 mg, 0.46
mmol; prepared as described in method 3), pyrrolidine (49.4 mg, 0.70
mmol) and acetic acid (0.027 ml, 0.46 mmol) were stirred at ambient
temperature in tetrahydrofuran (5 ml) for 1 hour. Sodium
triacetoxyborohydride (147 mg, 0.70 mmol) was added and the mixture
stirred at ambient temperature for 3 hour. The solvent was evaporated and
the residue partitioned between dichloromethane and saturated sodium
bicarbonate solution. The organic solution was washed once with brine,
dried over magnesium sulphate, filtered and the solvent evaporated. The
residual gum was purified by silica chromatography eluting with ammonia
in MeOH (2M) DCM (5%). Concentration of the solvent gave the product as a
gum. This was dissolved in dichloromethane (4 ml) and trifluoroacetic
acid (1 ml) was added and the solution then stirred at ambient
temperature for 3 hours. The resulting solution was absorbed onto an
SCX-2 column which was washed with methanol (2 column volumes) and then
eluted with a 2M solution of ammonia in methanol (2 column volumes) the
concentrated to give the product as a gum. This was stirred in diethyl
ether to give the title compound as a white solid (85 mg, 100%). NMR
Spectrum: (DMSO-d6); 1.74 (m, 4H), 2.37 (s, 3H), 2.51 (m, 4H), 3.66 (s,
2H), 4.92 (brs, 2H), 6.62 (m, 1H), 6.81 (d, 1H), 6.99 (m, 1H), 7.21 (d,
1H), 7.69 (m, 3H), 8.07 (d, 2H), 8.44 (s, 1H), 9.72 (s, 1H); Mass
Spectrum: M+H+ 387.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N-phenyl-4-pyridin-2-yl-benzamides as histone deacylase
inhibitors and anti-cancer prodrugs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gibson, Keith Hopkinson; Stokes, Elaine Sophie Elizabeth; Waring, Michael
James; Andrews, David Michael; Matusiak, Zbigniew Stanely
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2006077387 A2 2006-07-27

$RFMT $RIREG SCHEME303 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Bromo-2-chlorobenzeneacetic acid
C8H6BrClO2
916516-89-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 6.1600 5.3349 0.0 0
M  V30 4 O 8.4700 4.0011 0.0 0
M  V30 5 Cl 4.6200 0.0000 0.0 0
M  V30 6 Br 0.0000 2.6674 0.0 0
M  V30 7 C 4.6200 2.6674 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 3.8500 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 2.3100 4.0011 0.0 0
M  V30 12 C 1.5400 2.6674 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 5 8
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(4-Bromo-2-chlorophenyl)-1-(1-pyrrolidinyl)ethanone
C12H13BrClNO
1639847-23-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 2.6674 0.0 0
M  V30 2 C 3.9098 4.0011 0.0 0
M  V30 3 O 4.6798 5.3349 0.0 0
M  V30 4 Cl 6.2198 0.0000 0.0 0
M  V30 5 Br 10.8398 2.6674 0.0 0
M  V30 6 C 6.2198 2.6674 0.0 0
M  V30 7 C 6.9898 1.3338 0.0 0
M  V30 8 C 6.9898 4.0011 0.0 0
M  V30 9 C 8.5298 1.3338 0.0 0
M  V30 10 C 8.5298 4.0011 0.0 0
M  V30 11 C 9.2998 2.6674 0.0 0
M  V30 12 N 2.3698 4.0011 0.0 0
M  V30 13 C 1.4645 5.2470 0.0 0
M  V30 14 C 1.4645 2.7552 0.0 0
M  V30 15 C 0.0000 4.7711 0.0 0
M  V30 16 C 0.0000 3.2311 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 2 12
M  V30 5 1 4 7
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 916516-89-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1639847-23-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-737066
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 125700-67-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM The structure-activity relationships of L3MBTL3 inhibitors: flexibility
of the dimer interface
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Camerino, Michelle A.; Zhong, Nan; Dong, Aiping; Dickson, Bradley M.;
James, Lindsey I.; Baughman, Brandi M.; Norris, Jacqueline L.; Kireev,
Dmitri B.; Janzen, William P.; Arrowsmith, Cheryl H.; Frye, Stephen V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM MedChemComm (2013), 4(11), 1501-1507

$RFMT $RIREG SCHEME304 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[2-Chloro-4-(4-fluorophenyl)-5-thiazolyl]-2-(methylthio)pyrimidine
C14H9ClFN3S2
917808-23-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.2962 0.0000 0.0 0
M  V30 2 S 10.2733 6.6362 0.0 0
M  V30 3 C 11.0433 7.9700 0.0 0
M  V30 4 F 0.0000 8.3856 0.0 0
M  V30 5 C 4.1218 3.8078 0.0 0
M  V30 6 C 5.6533 3.9689 0.0 0
M  V30 7 N 3.8016 2.3015 0.0 0
M  V30 8 S 6.2798 2.5619 0.0 0
M  V30 9 C 5.1353 1.5315 0.0 0
M  V30 10 C 3.0914 4.9523 0.0 0
M  V30 11 C 3.5673 6.4169 0.0 0
M  V30 12 C 1.5850 4.6322 0.0 0
M  V30 13 C 2.5368 7.5614 0.0 0
M  V30 14 C 0.5546 5.7765 0.0 0
M  V30 15 C 1.0304 7.2412 0.0 0
M  V30 16 C 6.4233 5.3025 0.0 0
M  V30 17 N 7.9633 5.3025 0.0 0
M  V30 18 C 5.6533 6.6362 0.0 0
M  V30 19 C 8.7333 6.6362 0.0 0
M  V30 20 C 6.4233 7.9700 0.0 0
M  V30 21 N 7.9633 7.9700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 19
M  V30 4 1 4 15
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 10
M  V30 8 1 6 8
M  V30 9 1 6 16
M  V30 10 2 7 9
M  V30 11 1 8 9
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[4-(4-Fluorophenyl)-2-(1-pyrrolidinyl)-5-thiazolyl]-2-(methylthio)pyrimidine
C18H17FN4S2
2380023-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.6518 1.3337 0.0 0
M  V30 2 C 5.8818 0.0000 0.0 0
M  V30 3 F 0.0000 9.3561 0.0 0
M  V30 4 C 6.6518 6.6684 0.0 0
M  V30 5 C 6.0255 8.0754 0.0 0
M  V30 6 S 8.1833 6.8294 0.0 0
M  V30 7 N 7.1699 9.1058 0.0 0
M  V30 8 C 8.5035 8.3358 0.0 0
M  V30 9 C 5.8818 5.3348 0.0 0
M  V30 10 N 6.6518 4.0011 0.0 0
M  V30 11 C 4.3418 5.3348 0.0 0
M  V30 12 C 5.8818 2.6673 0.0 0
M  V30 13 C 3.5718 4.0011 0.0 0
M  V30 14 N 4.3418 2.6673 0.0 0
M  V30 15 C 4.5190 8.3956 0.0 0
M  V30 16 C 3.4886 7.2510 0.0 0
M  V30 17 C 4.0432 9.8601 0.0 0
M  V30 18 C 1.9822 7.5712 0.0 0
M  V30 19 C 2.5367 10.1803 0.0 0
M  V30 20 C 1.5063 9.0359 0.0 0
M  V30 21 N 9.9105 8.9621 0.0 0
M  V30 22 C 10.2306 10.4686 0.0 0
M  V30 23 C 11.2441 8.1921 0.0 0
M  V30 24 C 11.7622 10.6295 0.0 0
M  V30 25 C 12.3885 9.2227 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 3 20
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 9
M  V30 7 1 5 7
M  V30 8 1 5 15
M  V30 9 1 6 8
M  V30 10 2 7 8
M  V30 11 1 8 21
M  V30 12 2 9 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 13
M  V30 16 2 12 14
M  V30 17 1 13 14
M  V30 18 2 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 19
M  V30 22 2 18 20
M  V30 23 1 19 20
M  V30 24 1 21 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 917808-23-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2380023-02-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-21570182
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Development of Chemical Entities Endowed with Potent Fast-Killing
Properties against Plasmodium falciparum Malaria Parasites
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Matralis, Alexios N.; Malik, Adnan; Penzo, Maria; Moreno, Inmaculada;
Almela, Maria J.; Camino, Isabel; Crespo, Benigno; Saadeddin, Anas;
Ghidelli-Disse, Sonja; Rueda, Lourdes; Calderon, Felix; Osborne, Simon
A.; Drewes, Gerard; Boesche, Markus; Fernandez-Alvaro, Elena; Martin
Hernando, Jose Ignacio; Baker, David A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2019), 62(20), 9217-9235

$RFMT $RIREG SCHEME305 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl glyoxylate
C4H6O3
924-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl α-1-pyrrolidinyl-1-pyrrolidineacetate
C12H22N2O2
1831197-73-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 3.9098 0.0 0
M  V30 2 C 5.1047 4.6799 0.0 0
M  V30 3 O 6.4386 3.9098 0.0 0
M  V30 4 O 5.1047 6.2199 0.0 0
M  V30 5 C 7.7722 4.6799 0.0 0
M  V30 6 C 9.1059 3.9098 0.0 0
M  V30 7 N 2.4374 4.6799 0.0 0
M  V30 8 C 2.2763 6.2114 0.0 0
M  V30 9 C 1.0304 4.0535 0.0 0
M  V30 10 C 0.7700 6.5316 0.0 0
M  V30 11 C 0.0000 5.1979 0.0 0
M  V30 12 N 3.7711 2.3698 0.0 0
M  V30 13 C 5.0170 1.4646 0.0 0
M  V30 14 C 2.5252 1.4646 0.0 0
M  V30 15 C 4.5411 0.0000 0.0 0
M  V30 16 C 3.0011 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 12
M  V30 4 1 2 3
M  V30 5 2 2 4
M  V30 6 1 3 5
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 924-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1831197-73-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-5916519
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 1076-43-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Aminal 7′aa. To ethyl glyoxylate (ethyl oxoacetate, 7′, 7.2 mg, 0.07
mmol) in C6D6 (up to 0.7 mL) was added pyrrolidine (10.0 mg, 0.14 mmol),
and the mixture was treated overnight with 4-Å molecular sieves.
Filtering and removal of the solvent under good vacuum, without heating,
afforded 17.0 mg (ca. 100%) of 7′aa as an oil; when distillation was
attempted at 1 mbar with a much larger volume of sample, only
decomposition was noted. 1H NMR (C6D6) δ 4.02 (q, J = 7.2, 2H), 3.80 (s,
1H), 2.89-2.72 (m, 8H), 1.60 (m, 8H), 0.99 (t, J = 7.1, 3H); 13C NMR
(C6D6) δ 169.4, 82.8, 59.8, 49.7, 24.0, 14.7; FTIR 1744; HRMS (ESI+), the
(M + H)+ peak, C12H23N2O2 +, m/z 227.1754, can hardly be observed (even
at low voltages and temperatures), while pyrrolidinium ion C4H8N+ =
CHCOOC2H5, m/z 156.1014, was the main peak; however, registering the
spectrum at 25 V, from a solution prepared in anhydrous benzene and
diluted just before injection with anhydrous acetonitrile, the (M + Na)+
peak was clearly observed, m/z calcd for C12H22N2NaO2 + 249.1573, found
249.1566.
$DTYPE RXN:VAR(1):NOTES
$DATUM 2 equiv. of pyrrolidine used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Importance of the Electron Correlation and Dispersion Corrections in
Calculations Involving Enamines, Hemiaminals, and Aminals. Comparison of
B3LYP, M06-2X, MP2, and CCSD Results with Experimental Data
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castro-Alvarez, Alejandro; Carneros, Hector; Sanchez, Dani; Vilarrasa,
Jaume
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(24), 11977-11985

$RFMT $RIREG SCHEME306 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl glyoxylate
C4H6O3
924-44-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0011 2.3100 0.0 0
M  V30 3 C 1.3338 2.3100 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 O 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl α-oxo-1-pyrrolidineacetate
C8H13NO3
41600-22-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1047 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 O 6.4385 1.5400 0.0 0
M  V30 5 O 5.1047 3.8501 0.0 0
M  V30 6 C 7.7722 2.3100 0.0 0
M  V30 7 C 9.1059 1.5400 0.0 0
M  V30 8 N 2.4374 2.3100 0.0 0
M  V30 9 C 1.0304 1.6836 0.0 0
M  V30 10 C 2.2763 3.8416 0.0 0
M  V30 11 C 0.0000 2.8281 0.0 0
M  V30 12 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 2 2 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 924-44-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 41600-22-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-211-CAS-18214717
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 1076-43-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Representative Example of an Exchange Reaction.
2,2-Dimethyl-1,3-dioxan-5-one (2, 14.0 mg, 0.10 mmol) was added to a
solution of 1a in C6D6 (0.7 mL) or in anhydrous DMSO-d 6 (0.7 mL), and 1H
NMR spectra were recorded until the relative heights of the peaks of 2,
1a, 2a, and 1 did not change further (usually within 1 h). Hemiaminal
HA-7′a. To ethyl glyoxylate (ethyl oxoacetate, 7′, 7.2 mg, 0.07 mmol) in
C6D6 (up to 0.7 mL) was added pyrrolidine (5.0 mg, 0.07 mmol), and the
spectra were registered. Removal of the solvent under good vacuum,
without heating, gave HA-7′a as a colorless oil (12.0 mg, ca. 100%). 1H
NMR (C6D6) δ 4.92 (s, 1H), 3.91 (qd, J = 7.1, 3.8, 2H), 2.76 (m, 4H),
1.53 (m, 4H), 0.87 (t, J = 7.1, 3H); 13C NMR (C6D6) δ 172.3, 82.1, 61.5,
47.1, 24.6, 14.1. FTIR 3430 (br), 1730; HRMS (ESI+) m/z calcd for
C8H16NO3 + (M + H)+ 174.1125, found 174.1119; the base peak was the
corresponding pyrrolidinium ion (C4H8N+ = CHCOOC2H5), m/z calcd for
C8H14NO2 + 156.1019, found 156.1014.
$DTYPE RXN:VAR(1):NOTES
$DATUM 1 equiv. of pyrrolidine used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Importance of the Electron Correlation and Dispersion Corrections in
Calculations Involving Enamines, Hemiaminals, and Aminals. Comparison of
B3LYP, M06-2X, MP2, and CCSD Results with Experimental Data
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Castro-Alvarez, Alejandro; Carneros, Hector; Sanchez, Dani; Vilarrasa,
Jaume
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2015), 80(24), 11977-11985

$RFMT $RIREG SCHEME307 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-O-1H-Benzotriazol-1-yl-2′-deoxy-3′,5′-bis-O-[(1,1-dimethylethyl)dimethylsil...
C28H43N7O4Si2
927818-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 14.1168 8.5618 0.0 0
M  V30 2 C 4.0011 7.8511 0.0 0
M  V30 3 O 4.0011 9.3911 0.0 0
M  V30 4 Si 2.6673 10.1611 0.0 0
M  V30 5 C 1.3336 10.9311 0.0 0
M  V30 6 C 3.4373 11.4949 0.0 0
M  V30 7 C 1.8973 8.8275 0.0 0
M  V30 8 C 0.5636 9.5975 0.0 0
M  V30 9 C 0.0000 11.7011 0.0 0
M  V30 10 C 2.1037 12.2649 0.0 0
M  V30 11 O 4.3513 4.5192 0.0 0
M  V30 12 Si 4.6715 3.0127 0.0 0
M  V30 13 C 4.9916 1.5064 0.0 0
M  V30 14 C 6.1777 3.3329 0.0 0
M  V30 15 C 3.1650 2.6925 0.0 0
M  V30 16 C 6.4979 1.8266 0.0 0
M  V30 17 C 5.3118 0.0000 0.0 0
M  V30 18 C 3.4852 1.1863 0.0 0
M  V30 19 C 10.0737 8.0578 0.0 0
M  V30 20 N 9.3036 6.7241 0.0 0
M  V30 21 C 11.5799 7.7376 0.0 0
M  V30 22 N 9.5978 9.5223 0.0 0
M  V30 23 C 10.3341 5.5796 0.0 0
M  V30 24 C 12.6105 8.8820 0.0 0
M  V30 25 N 11.7410 6.2059 0.0 0
M  V30 26 C 10.6282 10.6669 0.0 0
M  V30 27 N 12.1345 10.3467 0.0 0
M  V30 28 C 7.7721 6.5631 0.0 0 CFG=1
M  V30 29 O 6.7415 7.7076 0.0 0
M  V30 30 C 7.0021 5.2294 0.0 0
M  V30 31 C 5.3347 7.0811 0.0 0 CFG=2
M  V30 32 C 5.4957 5.5496 0.0 0 CFG=2
M  V30 33 N 15.1472 9.7062 0.0 0
M  V30 34 C 16.6789 9.5453 0.0 0
M  V30 35 N 14.8270 11.2126 0.0 0
M  V30 36 C 17.3052 10.9522 0.0 0
M  V30 37 C 17.5841 8.2994 0.0 0
M  V30 38 N 16.1608 11.9826 0.0 0
M  V30 39 C 18.8368 11.1132 0.0 0
M  V30 40 C 19.1157 8.4603 0.0 0
M  V30 41 C 19.7420 9.8673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 24
M  V30 2 1 1 33
M  V30 3 1 2 3
M  V30 4 1 31 2 CFG=1
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 5 10
M  V30 12 1 11 12
M  V30 13 1 32 11 CFG=3
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 1 28 20 CFG=1
M  V30 25 2 21 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 2 23 25
M  V30 29 1 24 27
M  V30 30 2 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 34 37
M  V30 40 2 35 38
M  V30 41 1 36 38
M  V30 42 2 36 39
M  V30 43 1 37 40
M  V30 44 1 39 41
M  V30 45 2 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 28 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9-[2-Deoxy-3,5-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-β-D-erythro-pentofura...
C26H47N5O3Si2
1018979-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.9277 3.4334 0.0 0
M  V30 2 Si 7.8973 2.2889 0.0 0
M  V30 3 C 6.8667 1.1445 0.0 0
M  V30 4 C 9.0416 1.2585 0.0 0
M  V30 5 C 6.7527 3.3195 0.0 0
M  V30 6 C 5.7223 2.1749 0.0 0
M  V30 7 C 5.8363 0.0000 0.0 0
M  V30 8 C 8.0112 0.1140 0.0 0
M  V30 9 C 10.8970 6.1438 0.0 0
M  V30 10 O 11.6670 7.4776 0.0 0
M  V30 11 Si 13.2070 7.4776 0.0 0
M  V30 12 C 14.7470 7.4776 0.0 0
M  V30 13 C 13.2070 5.9376 0.0 0
M  V30 14 C 13.2070 9.0176 0.0 0
M  V30 15 C 14.7470 9.0176 0.0 0
M  V30 16 C 16.2870 7.4776 0.0 0
M  V30 17 C 14.7470 5.9376 0.0 0
M  V30 18 C 4.2766 9.8349 0.0 0
M  V30 19 C 5.7413 9.3590 0.0 0
M  V30 20 C 3.9564 11.3413 0.0 0
M  V30 21 N 3.3715 8.5890 0.0 0
M  V30 22 N 5.7413 7.8190 0.0 0
M  V30 23 N 6.8856 10.3896 0.0 0
M  V30 24 N 5.1009 12.3717 0.0 0
M  V30 25 C 4.2766 7.3432 0.0 0
M  V30 26 C 6.5655 11.8959 0.0 0
M  V30 27 N 2.4919 11.8172 0.0 0
M  V30 28 C 1.2460 10.9120 0.0 0
M  V30 29 C 2.0160 13.2819 0.0 0
M  V30 30 C 0.0000 11.8172 0.0 0
M  V30 31 C 0.4760 13.2819 0.0 0
M  V30 32 C 6.9871 6.9138 0.0 0 CFG=2
M  V30 33 C 6.9871 5.3738 0.0 0
M  V30 34 O 8.4518 7.3898 0.0 0
M  V30 35 C 8.4518 4.8980 0.0 0 CFG=2
M  V30 36 C 9.3570 6.1438 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 35 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 36 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 20 27
M  V30 25 2 21 25
M  V30 26 1 22 25
M  V30 27 1 32 22 CFG=3
M  V30 28 1 23 26
M  V30 29 2 24 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 32 35 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 927818-50-6
$DTYPE RXN:RCT(2):AMD
$DATUM polymer supported
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018979-29-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8483269
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM quantitative yield.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of convertible nucleoside derivatives for use in aryl
nucleophilic substitution displacement reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lakshman, Mahesh K.; Bae, Suyeal
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008045535 A2 2008-04-17

$RFMT $RIREG SCHEME308 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-O-1H-Benzotriazol-1-yl-2′-deoxy-3′,5′-bis-O-[(1,1-dimethylethyl)dimethylsil...
C28H43N7O4Si2
927818-50-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  41 45 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 14.1168 8.5618 0.0 0
M  V30 2 C 4.0011 7.8511 0.0 0
M  V30 3 O 4.0011 9.3911 0.0 0
M  V30 4 Si 2.6673 10.1611 0.0 0
M  V30 5 C 1.3336 10.9311 0.0 0
M  V30 6 C 3.4373 11.4949 0.0 0
M  V30 7 C 1.8973 8.8275 0.0 0
M  V30 8 C 0.5636 9.5975 0.0 0
M  V30 9 C 0.0000 11.7011 0.0 0
M  V30 10 C 2.1037 12.2649 0.0 0
M  V30 11 O 4.3513 4.5192 0.0 0
M  V30 12 Si 4.6715 3.0127 0.0 0
M  V30 13 C 4.9916 1.5064 0.0 0
M  V30 14 C 6.1777 3.3329 0.0 0
M  V30 15 C 3.1650 2.6925 0.0 0
M  V30 16 C 6.4979 1.8266 0.0 0
M  V30 17 C 5.3118 0.0000 0.0 0
M  V30 18 C 3.4852 1.1863 0.0 0
M  V30 19 C 10.0737 8.0578 0.0 0
M  V30 20 N 9.3036 6.7241 0.0 0
M  V30 21 C 11.5799 7.7376 0.0 0
M  V30 22 N 9.5978 9.5223 0.0 0
M  V30 23 C 10.3341 5.5796 0.0 0
M  V30 24 C 12.6105 8.8820 0.0 0
M  V30 25 N 11.7410 6.2059 0.0 0
M  V30 26 C 10.6282 10.6669 0.0 0
M  V30 27 N 12.1345 10.3467 0.0 0
M  V30 28 C 7.7721 6.5631 0.0 0 CFG=1
M  V30 29 O 6.7415 7.7076 0.0 0
M  V30 30 C 7.0021 5.2294 0.0 0
M  V30 31 C 5.3347 7.0811 0.0 0 CFG=2
M  V30 32 C 5.4957 5.5496 0.0 0 CFG=2
M  V30 33 N 15.1472 9.7062 0.0 0
M  V30 34 C 16.6789 9.5453 0.0 0
M  V30 35 N 14.8270 11.2126 0.0 0
M  V30 36 C 17.3052 10.9522 0.0 0
M  V30 37 C 17.5841 8.2994 0.0 0
M  V30 38 N 16.1608 11.9826 0.0 0
M  V30 39 C 18.8368 11.1132 0.0 0
M  V30 40 C 19.1157 8.4603 0.0 0
M  V30 41 C 19.7420 9.8673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 24
M  V30 2 1 1 33
M  V30 3 1 2 3
M  V30 4 1 31 2 CFG=1
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 5 8
M  V30 10 1 5 9
M  V30 11 1 5 10
M  V30 12 1 11 12
M  V30 13 1 32 11 CFG=3
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 2 19 22
M  V30 23 1 20 23
M  V30 24 1 28 20 CFG=1
M  V30 25 2 21 24
M  V30 26 1 21 25
M  V30 27 1 22 26
M  V30 28 2 23 25
M  V30 29 1 24 27
M  V30 30 2 26 27
M  V30 31 1 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 32
M  V30 36 1 33 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 2 34 37
M  V30 40 2 35 38
M  V30 41 1 36 38
M  V30 42 2 36 39
M  V30 43 1 37 40
M  V30 44 1 39 41
M  V30 45 2 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 28 31 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
9-[2-Deoxy-3,5-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-β-D-erythro-pentofura...
C26H47N5O3Si2
1018979-29-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  36 39 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.9277 3.4334 0.0 0
M  V30 2 Si 7.8973 2.2889 0.0 0
M  V30 3 C 6.8667 1.1445 0.0 0
M  V30 4 C 9.0416 1.2585 0.0 0
M  V30 5 C 6.7527 3.3195 0.0 0
M  V30 6 C 5.7223 2.1749 0.0 0
M  V30 7 C 5.8363 0.0000 0.0 0
M  V30 8 C 8.0112 0.1140 0.0 0
M  V30 9 C 10.8970 6.1438 0.0 0
M  V30 10 O 11.6670 7.4776 0.0 0
M  V30 11 Si 13.2070 7.4776 0.0 0
M  V30 12 C 14.7470 7.4776 0.0 0
M  V30 13 C 13.2070 5.9376 0.0 0
M  V30 14 C 13.2070 9.0176 0.0 0
M  V30 15 C 14.7470 9.0176 0.0 0
M  V30 16 C 16.2870 7.4776 0.0 0
M  V30 17 C 14.7470 5.9376 0.0 0
M  V30 18 C 4.2766 9.8349 0.0 0
M  V30 19 C 5.7413 9.3590 0.0 0
M  V30 20 C 3.9564 11.3413 0.0 0
M  V30 21 N 3.3715 8.5890 0.0 0
M  V30 22 N 5.7413 7.8190 0.0 0
M  V30 23 N 6.8856 10.3896 0.0 0
M  V30 24 N 5.1009 12.3717 0.0 0
M  V30 25 C 4.2766 7.3432 0.0 0
M  V30 26 C 6.5655 11.8959 0.0 0
M  V30 27 N 2.4919 11.8172 0.0 0
M  V30 28 C 1.2460 10.9120 0.0 0
M  V30 29 C 2.0160 13.2819 0.0 0
M  V30 30 C 0.0000 11.8172 0.0 0
M  V30 31 C 0.4760 13.2819 0.0 0
M  V30 32 C 6.9871 6.9138 0.0 0 CFG=2
M  V30 33 C 6.9871 5.3738 0.0 0
M  V30 34 O 8.4518 7.3898 0.0 0
M  V30 35 C 8.4518 4.8980 0.0 0 CFG=2
M  V30 36 C 9.3570 6.1438 0.0 0 CFG=2
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 35 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 1 9 10
M  V30 10 1 36 9 CFG=3
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 12 17
M  V30 18 1 18 19
M  V30 19 2 18 20
M  V30 20 1 18 21
M  V30 21 1 19 22
M  V30 22 2 19 23
M  V30 23 1 20 24
M  V30 24 1 20 27
M  V30 25 2 21 25
M  V30 26 1 22 25
M  V30 27 1 32 22 CFG=3
M  V30 28 1 23 26
M  V30 29 2 24 26
M  V30 30 1 27 28
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 1 30 31
M  V30 35 1 32 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 36
M  V30 39 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 32 35 36)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 927818-50-6
$DTYPE RXN:RCT(2):AMD
$DATUM polymer-supported
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1018979-29-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4037043
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 110-71-4
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure C. Synthesis of N 6-Alkyl and N 6-Benzyl Derivatives.
In a clean, dry reaction vial equipped with a stirring bar was placed the
polymer-supported nucleoside (1.0 mol equiv) in dry DME (1.0 mL). The
requisite amine (4.0 mol equiv) was added, the reaction mixture was
flushed with nitrogen gas and allowed to stir under the appropriate
conditions. In case of N 6 -alkyl derivatives; the reaction mixtures were
directly loaded onto a bed of SiO2 and the products eluted with EtOAc.
For the N 6 - benzyl derivatives; the reaction mixtures was filtered, the
residue in each case was washed with EtOAc followed by CH2Cl2 and the
filtrates were evaporated to dryness. The crude reaction products were
purified by column chromatography on silica gel using appropriate
solvents indicated in Table 2.
6-(Pyrrolidin-1-yl)-9-[2-deoxy-3,5-bis-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]purine.
Clear, yellowish gum.
6-(Pyrrolidin-1-yl)-9-[2-deoxy-3,5-bis-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]purine.
Clear, yellowish gum. R f (20% EtOAc in hexanes) = 0.23. 1H NMR (500 MHz,
CDCl3): δ 8.33 (s, 1H, Ar-H), 7.95 (s, 1H, Ar-H), 6.44 (t, 1H, H-1', J =
6.7), 4.58 (app quint, 1H, H-3', J ≈ 3.0), 4.15 (br, 2H, NCH2), 4.00 (q,
1H, H-4', J = 3.7), 3.81 (dd, 1H, H-5', J = 11.0, 4.6), 3.76 (br, 2H,
NCH2), 3.75 (dd, 1H, H-5', J = 11.0, 3.4), 2.61 (app quint, 1H, H-2', J ≈
6.5), 2.40 (ddd, 1H, H-2', J = 13.1, 5.8, 3.4), 2.02 (br s, 4H,
pyrrolidinyl CH2), 0.90, 0.897 (2s, 18H, tert-Bu), 0.09, 0.07, 0.06 (3s,
12H, SiCH3). 13C NMR (125 MHz, CDCl3): δ 153.1, 152.7, 149.8, 120.6,
87.8, 84.0, 72.2, 62.9, 48.9 (br), 47.3 (br), 40.9, 26.0, 25.8, 24.3
(br), -4.7, -4.8, -5.4, -5.5. FAB HRMS calcd for C26H48N5O3Si2 (M+ + H)
534.3296, found 534.3279.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Novel Polymer Supported Approach to Nucleoside Modification
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bae, Suyeal; Lakshman, Mahesh K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(10), 3707-3713

$RFMT $RIREG SCHEME309 STEP1
$RXN



  2  1
$MOL
Veratryl alcohol
C9H12O3
93-03-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(3,4-Dimethoxyphenyl)methyl]pyrrolidine
C13H19NO2
22792-25-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 7.2419 1.3337 0.0 0
M  V30 2 C 6.4718 0.0000 0.0 0
M  V30 3 O 8.7819 4.0012 0.0 0
M  V30 4 C 9.5519 5.3348 0.0 0
M  V30 5 C 2.6218 4.0012 0.0 0
M  V30 6 C 6.4718 2.6675 0.0 0
M  V30 7 C 7.2419 4.0012 0.0 0
M  V30 8 C 4.9318 2.6675 0.0 0
M  V30 9 C 6.4718 5.3348 0.0 0
M  V30 10 C 4.1618 4.0012 0.0 0
M  V30 11 C 4.9318 5.3348 0.0 0
M  V30 12 N 1.8517 5.3348 0.0 0
M  V30 13 C 2.4782 6.7418 0.0 0
M  V30 14 C 0.3202 5.4958 0.0 0
M  V30 15 C 1.3337 7.7722 0.0 0
M  V30 16 C 0.0000 7.0022 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 3 4
M  V30 4 1 3 7
M  V30 5 1 5 10
M  V30 6 1 5 12
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 93-03-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22792-25-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40879620
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3144-16-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3049302-21-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a Schlenk tube, conversion = 70%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Alkylation of morpholine and pyrrolidine by phthalimide substituted
Ru(II)-NHC catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akkoc, Mitat; Gurbuz, Nevin; Ozdemir, Ismail
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polyhedron (2024), 261117109

$RFMT $RIREG SCHEME310 STEP1
$RXN



  2  1
$MOL
Veratryl alcohol
C9H12O3
93-03-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 O 0.7700 4.0011 0.0 0
M  V30 4 C 0.0000 5.3349 0.0 0
M  V30 5 C 6.9300 4.0011 0.0 0
M  V30 6 O 7.7000 5.3349 0.0 0
M  V30 7 C 3.0800 2.6674 0.0 0
M  V30 8 C 2.3100 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3349 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 4.6200 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 3 4
M  V30 4 1 3 8
M  V30 5 1 5 6
M  V30 6 1 5 11
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1,3-bis[(3,4-dimethoxyphenyl)methyl]-
C22H29NO4
3049302-30-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 7.5175 0.0 0
M  V30 2 O 0.0000 7.5175 0.0 0
M  V30 3 C 0.0000 9.0575 0.0 0
M  V30 4 O 0.0000 4.4374 0.0 0
M  V30 5 C 0.0000 2.8974 0.0 0
M  V30 6 C 10.6374 6.3905 0.0 0
M  V30 7 O 15.5110 4.2206 0.0 0
M  V30 8 C 16.1373 5.6274 0.0 0
M  V30 9 O 14.2582 1.4068 0.0 0
M  V30 10 C 13.6318 0.0000 0.0 0
M  V30 11 C 4.0010 6.7475 0.0 0
M  V30 12 C 2.6673 7.5175 0.0 0
M  V30 13 C 4.0010 5.2074 0.0 0
M  V30 14 C 1.3337 6.7475 0.0 0
M  V30 15 C 2.6673 4.4374 0.0 0
M  V30 16 C 1.3337 5.2074 0.0 0
M  V30 17 C 6.6685 6.7475 0.0 0
M  V30 18 C 8.0753 7.3739 0.0 0
M  V30 19 C 6.8294 5.2159 0.0 0
M  V30 20 N 9.1059 6.2294 0.0 0
M  V30 21 C 8.3358 4.8957 0.0 0
M  V30 22 C 11.5426 5.1445 0.0 0
M  V30 23 C 13.0742 5.3055 0.0 0
M  V30 24 C 10.9162 3.7376 0.0 0
M  V30 25 C 13.9794 4.0597 0.0 0
M  V30 26 C 11.8214 2.4918 0.0 0
M  V30 27 C 13.3529 2.6527 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 1 17
M  V30 3 1 2 3
M  V30 4 1 2 14
M  V30 5 1 4 5
M  V30 6 1 4 16
M  V30 7 1 6 20
M  V30 8 1 6 22
M  V30 9 1 7 8
M  V30 10 1 7 25
M  V30 11 1 9 10
M  V30 12 1 9 27
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 24 2 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 2 24 26
M  V30 28 2 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 93-03-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3049302-30-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-40879619
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3144-16-9
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3049302-28-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM reaction in a Schlenk tube, conversion = 100%
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Alkylation of morpholine and pyrrolidine by phthalimide substituted
Ru(II)-NHC catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Akkoc, Mitat; Gurbuz, Nevin; Ozdemir, Ismail
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Polyhedron (2024), 261117109

$RFMT $RIREG SCHEME311 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrole-3-carboxylic acid
C5H5NO2
931-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 O 5.1048 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 2.4374 2.3100 0.0 0
M  V30 5 C 1.0306 1.6835 0.0 0
M  V30 6 C 2.2764 3.8416 0.0 0
M  V30 7 C 0.0000 2.8281 0.0 0
M  V30 8 N 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinyl-1H-pyrrol-3-ylmethanone
C9H12N2O
207510-35-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 C 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 C 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 931-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 207510-35-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-9052076
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 110-86-1
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 538-75-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Preparation 5 - 3-Pyrrolidin-1-yl)carbonylpyrrole - An ice-cooled
solution of pyrole-3-carboxylic acid (0.5g) in DMF(15ml)/dichloromethane
(10ml) was treated with pyridine (0.36ml), pyrrolidine (0.38ml) and
dichlohexylcarbodimide (1.39g) and stirred overnight at room temperature.
The mixture was filtered and the filter washed with 10 NaHCO3 solution
(30ml) and water (2 x 30ml), dried and evaporated. Chromatography (50%
EtOAc/hexane) gave the title compound. Yield 0.17g. MS (+ve ion
electrospray): m/z 165, (MH+, 100%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mutilin 14-ester derivatives having antibacterial activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brooks, Gerald; Hunt, Eric
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2000037074 A1 2000-06-29

$RFMT $RIREG SCHEME312 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3,4-Dihydro-2,2,5,7,8-pentamethyl-N-[[(1-methylpropyl)amino]thioxomethyl]-2H-...
C19H30N2O3S2
947748-53-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 8.1851 4.6201 0.0 0 VAL=6
M  V30 2 N 9.5188 5.3901 0.0 0
M  V30 3 O 7.4151 5.9538 0.0 0
M  V30 4 O 8.9551 3.2864 0.0 0
M  V30 5 C 10.8525 4.6201 0.0 0
M  V30 6 N 12.1863 5.3901 0.0 0
M  V30 7 S 10.8525 3.0801 0.0 0
M  V30 8 C 13.5200 4.6201 0.0 0
M  V30 9 C 14.8536 5.3901 0.0 0
M  V30 10 C 13.5200 3.0801 0.0 0
M  V30 11 C 16.1873 4.6201 0.0 0
M  V30 12 C 5.5176 6.1601 0.0 0
M  V30 13 C 8.1851 1.5400 0.0 0
M  V30 14 C 5.5176 0.0000 0.0 0
M  V30 15 C 0.0000 2.5774 0.0 0
M  V30 16 C 0.9898 0.8629 0.0 0
M  V30 17 C 6.8515 3.8501 0.0 0
M  V30 18 C 5.5176 4.6201 0.0 0
M  V30 19 C 6.8515 2.3101 0.0 0
M  V30 20 C 4.1840 3.8501 0.0 0
M  V30 21 C 5.5176 1.5400 0.0 0
M  V30 22 C 4.1840 2.3101 0.0 0
M  V30 23 C 2.8503 4.6201 0.0 0
M  V30 24 O 2.8503 1.5400 0.0 0
M  V30 25 C 1.5166 3.8501 0.0 0
M  V30 26 C 1.5166 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 17
M  V30 5 1 2 5
M  V30 6 1 5 6
M  V30 7 2 5 7
M  V30 8 1 6 8
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 12 18
M  V30 13 1 13 19
M  V30 14 1 14 21
M  V30 15 1 15 26
M  V30 16 1 16 26
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 2 18 20
M  V30 20 1 19 21
M  V30 21 1 20 22
M  V30 22 1 20 23
M  V30 23 2 21 22
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[(3,4-Dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-yl)sulfonyl]-N′-(1-me...
C23H37N3O3S
947748-65-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1059 1.0817 0.0 0
M  V30 2 C 9.1059 7.2419 0.0 0
M  V30 3 S 6.4384 2.6218 0.0 0 VAL=6
M  V30 4 N 5.1047 1.8517 0.0 0
M  V30 5 O 5.6684 3.9554 0.0 0
M  V30 6 O 7.2084 1.2881 0.0 0
M  V30 7 C 3.7711 2.6218 0.0 0
M  V30 8 N 3.7711 4.1618 0.0 0
M  V30 9 C 2.4373 4.9318 0.0 0
M  V30 10 C 2.4373 6.4718 0.0 0
M  V30 11 C 1.1036 4.1618 0.0 0
M  V30 12 C 1.1036 7.2419 0.0 0
M  V30 13 C 6.4384 5.7018 0.0 0
M  V30 14 C 14.6235 4.6645 0.0 0
M  V30 15 C 13.6338 6.3790 0.0 0
M  V30 16 C 10.4396 3.3918 0.0 0
M  V30 17 C 10.4396 4.9318 0.0 0
M  V30 18 C 9.1059 2.6218 0.0 0
M  V30 19 C 11.7732 2.6218 0.0 0
M  V30 20 C 9.1059 5.7018 0.0 0
M  V30 21 O 11.7732 5.7018 0.0 0
M  V30 22 C 7.7721 3.3918 0.0 0
M  V30 23 C 13.1069 3.3918 0.0 0
M  V30 24 C 7.7721 4.9318 0.0 0
M  V30 25 C 13.1069 4.9318 0.0 0
M  V30 26 N 2.4373 1.8517 0.0 0
M  V30 27 C 2.2763 0.3202 0.0 0
M  V30 28 C 1.0304 2.4782 0.0 0
M  V30 29 C 0.7700 0.0000 0.0 0
M  V30 30 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 18
M  V30 2 1 2 20
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 3 6
M  V30 6 1 3 22
M  V30 7 1 4 7
M  V30 8 2 7 8 CFG=2
M  V30 9 1 7 26
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 13 24
M  V30 15 1 14 25
M  V30 16 1 15 25
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 19
M  V30 20 2 17 20
M  V30 21 1 17 21
M  V30 22 1 18 22
M  V30 23 1 19 23
M  V30 24 1 20 24
M  V30 25 1 21 25
M  V30 26 2 22 24
M  V30 27 1 23 25
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 947748-53-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 947748-65-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-7733643
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N-Pmc-N',N''-Substituted Guanidines 3 from
Thioureas 2 and Amines; General Two-Step Procedure To a 100 mL
round-bottomed flask containing a stirred solution of the representative
thiourea transfer agent 2 (1.25 mmol) in CH2Cl2 (50 mL) was added
EDCI·HCl (0.48 g, 2.50 mmol) in one portion. Following dissolution of the
EDCI·HCl (~15 s), the appropriate amine (1.1 equiv) was added to the
mixture and the solution was allowed to stir for 30 min. At the end of
this time, the solvent was removed in vacuo. The crude product was then
chromatographically purified over silica gel (20-40% EtOAc-hexanes).
N-Pmc-N'-(1-methylpropyl)-N''-bis(a,b-methylene)guanidine (3f) Yield:
0.65 g (~100%); colorless viscous oil. IR (film): 3319, 1576 cm-1. 1H NMR
(500 MHz, CDCl3): δ = 6.33 (d, J = 8.2 Hz, 1 H), 3.42 (br s, 4 H),
3.30-3.38 (m, 1 H), 2.59-2.67 (m, 8 H), 2.10 (s, 3 H), 1.84 (br s, 4 H),
1.80 (t, J = 6.8 Hz, 2 H), 1.19-1.40 (m, 8 H), 0.90 (d, J = 6.2 Hz, 2 H),
0.80 (t, J = 7.3 Hz, 2 H). 13C NMR (125 MHz, CDCl3): δ = 156.7, 153.1,
135.4, 134.6, 134.1, 123.6, 117.6, 73.3, 51.1, 49.0, 32.7, 30.1, 26.5,
25.1, 21.2, 20.2, 18.6, 17.4, 11.8, 10.1. MS (APCI): m/z = 436 (M + H).
Anal. Calcd for C23H37N3O3S: C, 63.41; H, 8.56; N, 9.65. Found: C, 63.08;
H, 8.59; N, 9.52.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic routes to N-Pmc-N',N'-disubstituted guanidines via
EDCI-mediated guanylation of amines with N-Pmc-N'-substituted thioureas
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Flemer, Stevenson Jr.; Madalengoitia, Jose S.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2007), (12), 1848-1860

$RFMT $RIREG SCHEME313 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S,3S)-3-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]-2-ethynyl-2-methyl-...
C18H26N2O5SSi
960595-75-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.0012 4.0836 0.0 0 VAL=6
M  V30 2 O 4.7712 5.4172 0.0 0
M  V30 3 O 3.2311 2.7499 0.0 0
M  V30 4 C 8.2085 4.0836 0.0 0
M  V30 5 O 9.5422 3.3135 0.0 0
M  V30 6 Si 10.8760 4.0836 0.0 0
M  V30 7 C 12.2097 4.8536 0.0 0
M  V30 8 C 11.6460 2.7499 0.0 0
M  V30 9 C 10.1060 5.4172 0.0 0
M  V30 10 C 11.4397 6.1872 0.0 0
M  V30 11 C 13.5434 5.6236 0.0 0
M  V30 12 C 12.9797 3.5199 0.0 0
M  V30 13 C 4.9250 0.9899 0.0 0
M  V30 14 C 3.7454 0.0000 0.0 0
M  V30 15 C 7.2845 0.9899 0.0 0
M  V30 16 N 4.0012 7.1636 0.0 0 VAL=5
M  V30 17 O 4.0012 8.7037 0.0 0
M  V30 18 O 5.3348 6.3936 0.0 0
M  V30 19 N 5.3348 3.3135 0.0 0
M  V30 20 C 6.8749 3.3135 0.0 0 CFG=2
M  V30 21 C 6.1048 1.9799 0.0 0 CFG=1
M  V30 22 C 2.6673 4.8536 0.0 0
M  V30 23 C 2.6673 6.3936 0.0 0
M  V30 24 C 1.3337 4.0836 0.0 0
M  V30 25 C 1.3337 7.1636 0.0 0
M  V30 26 C 0.0000 4.8536 0.0 0
M  V30 27 C 0.0000 6.3936 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 19
M  V30 4 1 1 22
M  V30 5 1 4 5
M  V30 6 1 20 4 CFG=3
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 7 12
M  V30 14 3 13 14
M  V30 15 1 21 13 CFG=3
M  V30 16 1 21 15 CFG=1
M  V30 17 2 16 17
M  V30 18 2 16 18
M  V30 19 1 16 23
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 21
M  V30 23 2 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 2 24 26
M  V30 27 2 25 27
M  V30 28 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 20 21)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S,2R)-1-[[[(1,1-Dimethylethyl)dimethylsilyl]oxy]methyl]-2-methyl-2-(1-py...
C22H35N3O5SSi
1243221-32-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  32 33 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 6.6684 0.0 0 CFG=1
M  V30 2 C 8.4700 6.6684 0.0 0 CFG=1
M  V30 3 N 6.1600 8.0020 0.0 0
M  V30 4 C 6.1600 5.3347 0.0 0
M  V30 5 C 8.4700 8.2084 0.0 0
M  V30 6 C 8.4700 5.1284 0.0 0
M  V30 7 S 4.6200 8.0020 0.0 0 VAL=6
M  V30 8 O 6.9300 4.0011 0.0 0
M  V30 9 C 8.4700 9.7484 0.0 0
M  V30 10 O 4.6200 9.5420 0.0 0
M  V30 11 O 4.6200 6.4620 0.0 0
M  V30 12 Si 6.1600 2.6673 0.0 0
M  V30 13 C 5.3900 1.3336 0.0 0
M  V30 14 C 7.4937 1.8973 0.0 0
M  V30 15 C 4.8264 3.4373 0.0 0
M  V30 16 C 4.0564 2.1037 0.0 0
M  V30 17 C 4.6200 0.0000 0.0 0
M  V30 18 C 6.7237 0.5636 0.0 0
M  V30 19 N 3.0800 10.6695 0.0 0 VAL=5
M  V30 20 O 2.3100 12.0031 0.0 0
M  V30 21 O 4.6200 10.6695 0.0 0
M  V30 22 N 10.0101 6.6684 0.0 0
M  V30 23 C 10.9153 5.4225 0.0 0
M  V30 24 C 10.9153 7.9143 0.0 0
M  V30 25 C 12.3798 5.8984 0.0 0
M  V30 26 C 12.3798 7.4384 0.0 0
M  V30 27 C 3.0800 8.0020 0.0 0
M  V30 28 C 2.3100 9.3358 0.0 0
M  V30 29 C 2.3100 6.6684 0.0 0
M  V30 30 C 0.7700 9.3358 0.0 0
M  V30 31 C 0.7700 6.6684 0.0 0
M  V30 32 C 0.0000 8.0020 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4 CFG=1
M  V30 4 1 2 5 CFG=3
M  V30 5 1 2 6
M  V30 6 1 2 22 CFG=1
M  V30 7 1 3 7
M  V30 8 1 4 8
M  V30 9 3 5 9
M  V30 10 2 7 10
M  V30 11 2 7 11
M  V30 12 1 7 27
M  V30 13 1 8 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 1 13 16
M  V30 18 1 13 17
M  V30 19 1 13 18
M  V30 20 2 19 20
M  V30 21 2 19 21
M  V30 22 1 19 28
M  V30 23 1 22 23
M  V30 24 1 22 24
M  V30 25 1 23 25
M  V30 26 1 24 26
M  V30 27 1 25 26
M  V30 28 2 27 28
M  V30 29 1 27 29
M  V30 30 1 28 30
M  V30 31 2 29 31
M  V30 32 2 30 32
M  V30 33 1 31 32
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 1 2)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 960595-75-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1243221-32-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-038-CAS-3518145
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM N-(2S,3R)-1-(tert-Butyldimethylsilyloxy)-3-methyl-3-(pyrrolidin-1-yl)pent-4-yn-2-yl)-2-nitrobenzenesulfonamide
(5a): To a solution of 1 (188 mg, 0.460 mmol) in PhCH3 (4.60 mL) under
argon at room temperature, pyrrolidine (76.0 μL, 0.920 mmol) was added
dropwise. After 1 h, the reaction was concentrated and purified using
silica gel chromatography (30% EtOAc-hexanes) to afford the ring open
product as a colorless oil (223 mg, quant). Rf 0.67 (50% EtOAc-hexanes);
1H NMR (500 MHz, CDCl3) δ 8.20 (1H, m), δ 7.88 (1H, m), δ 7.64 (2H, m), δ
4.13 (1H, dd, J=3.4 Hz, 10.7 Hz), δ 3.89 (1H, dd, J=4.0, 10.7 Hz), δ 3.69
(1H, t, J=3.5 Hz), δ 2.49 (4H, bs), δ 2.33 (1H, s), δ 1.51 (4H, bs), δ
1.33 (3H, s), δ 0.89 (9H, s), δ 0.05 (3H, s), δ 0.04 (3H, s); 13C NMR
(125 MHz, CDCl3) δ 147.5, 136.1, 132.6, 132.5, 130.6, 125.0, 82.7, 74.3,
63.7, 60.5, 60.2, 46.8, 25.9, 23.4, 21.6, 18.3,-5.6; IR (film): 3304(m),
2954(s), 2929(s), 2856(s), 1541(s), 1415(s) cm-1 ; HRMS (EI) m/z calcd.
for C22H35N3O5SSi (M+H)+ 482.2145; found: 482.2158; [α]25D +1.8 (c 0.84,
CHCl3).
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, mild conditions
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ring Opening of a Trisubstituted Aziridine With Amines: Regio- and
Stereoselective Formation of Substituted 1,2-Diamines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kelley, Brandon T.; Joullie, Madeleine M.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2010), 12(19), 4244-4247

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methyl acrylate
C4H6O2
96-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-pyrrolidinepropanoate
C8H15NO2
22041-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 C 6.4386 1.5400 0.0 0
M  V30 4 O 7.7722 2.3101 0.0 0
M  V30 5 O 6.4386 0.0000 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 N 2.4374 2.3101 0.0 0
M  V30 8 C 1.0304 1.6836 0.0 0
M  V30 9 C 2.2763 3.8416 0.0 0
M  V30 10 C 0.0000 2.8281 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 96-33-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22041-21-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-1779556
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of 3-(2-aminoethyl)-5-hydroxy-1H-pyrazole derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Groselj, Uros; Kralj, David; Wagger, Jernej; Dahmann, Georg; Stanovnik,
Branko; Svete, Jurij
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ARKIVOC (Gainesville, FL, United States) (2012), (3), 49-65

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methyl acrylate
C4H6O2
96-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-pyrrolidinepropanoate
C8H15NO2
22041-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 C 6.4386 1.5400 0.0 0
M  V30 4 O 7.7722 2.3101 0.0 0
M  V30 5 O 6.4386 0.0000 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 N 2.4374 2.3101 0.0 0
M  V30 8 C 1.0304 1.6836 0.0 0
M  V30 9 C 2.2763 3.8416 0.0 0
M  V30 10 C 0.0000 2.8281 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 96-33-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22041-21-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-9264389
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7446-70-0
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM silica supported
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the Synthesis of
Compounds 1 Aniline (1 mmol), methyl acrylate (1.5 mmol), and 0.2 g of
catalyst were placed into a small flask (or a test tube) and stirred at
60 °C for 4 h. The progress of the reaction was monitored with thin-layer
chromatography (TLC). Then ethyl acetate (10 mL) was added, and the
solution was filtered. The solid material was washed with 5 mL ethyl
acetate, and the combined organic filtrates were dried over Na2SO4. The
solvent was removed under reduced pressure, and the residue was analyzed
by its NMR spectra. In most cases, pure product was obtained. If needed,
the residue was separated by silica gel (Merck 80-240 mesh) column
chromatography using a 4:1 n-hexane-EtOAc mixture as eluent to afford the
pure product. All of the products are known, and the structure of the
products were determined from their NMR and IR spectra and by comparison
with those reported in the literature. Table 1 Entry: 8, Compound 7,
yield 100%.
$DTYPE RXN:VAR(1):NOTES
$DATUM solid-supported catalyst (Silica), Michael addition, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly efficient Michael addition reaction of amines catalyzed by
silica-supported aluminum chloride
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saidi, Mohammad R.; Pourshojaei, Yaghoub; Aryanasab, Fezzeh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2009), 39(6), 1109-1119

$RFMT $RIREG SCHEME314 STEP1
$RXN



  2  1
$MOL
Methyl acrylate
C4H6O2
96-33-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 C 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 1-pyrrolidinepropanoate
C8H15NO2
22041-21-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 C 6.4386 1.5400 0.0 0
M  V30 4 O 7.7722 2.3101 0.0 0
M  V30 5 O 6.4386 0.0000 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 N 2.4374 2.3101 0.0 0
M  V30 8 C 1.0304 1.6836 0.0 0
M  V30 9 C 2.2763 3.8416 0.0 0
M  V30 10 C 0.0000 2.8281 0.0 0
M  V30 11 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 96-33-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 22041-21-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-12256199
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10026-11-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure A mixture of morpholine (1
mmol), methyl acrylate (1.2 mmol), and zirconium(IV) chloride (10 mol%)
in anhydrous dichloromethane (10 mL) was kept at ambient temperature
under stirring for 1 h. It was quenched with water and the organic layer
separated. The aqueous layer was extracted with dichloromthane. The
combine organic layer was washed with water, dried over sodium sulphate,
and concentrated to give the crude product, which was purified by
silica-gel column chromatography using ethyl acetate-pet. ether (1 : 9).
Table 1, Entry 3, yield 100%.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Zirconium(IV) chloride-mediated chemoselective conjugate addition of
aliphatic amines to α,β-ethylenic compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meshram, H.; Lakshindra, C.; Reddy, P.; Sadashiv, K.; Yadav, J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthetic Communications (2006), 36(6), 795-801

$RFMT $RIREG SCHEME315 STEP1
$RXN



  2  1
$MOL
Methyl glycolate
C3H6O3
96-35-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 1.5400 0.0 0
M  V30 2 C 1.3338 2.3100 0.0 0
M  V30 3 O 4.0011 2.3100 0.0 0
M  V30 4 O 2.6674 0.0000 0.0 0
M  V30 5 O 0.0000 1.5400 0.0 0
M  V30 6 C 5.3349 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Hydroxy-1-(1-pyrrolidinyl)ethanone
C6H11NO2
45657-97-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1049 2.3100 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 O 6.4385 1.5400 0.0 0
M  V30 5 N 2.4374 2.3100 0.0 0
M  V30 6 C 2.2765 3.8416 0.0 0
M  V30 7 C 1.0306 1.6836 0.0 0
M  V30 8 C 0.7700 4.1618 0.0 0
M  V30 9 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 96-35-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 45657-97-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-17033775
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Transition State-Based Sialyltransferase Inhibitors: Mimicking
Oxocarbenium Ion by Simple Amide
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Guo, Jian; Li, Wenming; Xue, Weiwei; Ye, Xin-Shan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2017), 60(5), 2135-2141

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Nitrophenyl)sulfonyl]pyrrolidine
C10H12N2O4S
175278-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.9098 1.5400 0.0 0 VAL=6
M  V30 2 O 3.9098 3.0800 0.0 0
M  V30 3 O 3.9098 0.0000 0.0 0
M  V30 4 N 10.0698 1.5400 0.0 0 VAL=5
M  V30 5 O 10.8398 2.8737 0.0 0
M  V30 6 O 10.8398 0.2064 0.0 0
M  V30 7 C 5.4498 1.5400 0.0 0
M  V30 8 C 6.2198 0.2064 0.0 0
M  V30 9 C 6.2198 2.8737 0.0 0
M  V30 10 C 7.7598 0.2064 0.0 0
M  V30 11 C 7.7598 2.8737 0.0 0
M  V30 12 C 8.5298 1.5400 0.0 0
M  V30 13 N 2.3698 1.5400 0.0 0
M  V30 14 C 1.4645 2.7859 0.0 0
M  V30 15 C 1.4645 0.2941 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 1 13
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 175278-37-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-19477317
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3,4-Dihydroquinolin-2(1H)-ones as inhibitors of bromodomain-containing
protein 4 (BRD4) and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Jia; Brasier, Allan R.; Tian, Bing; Liu, Zhiqing; Chen, Haiying;
Rytting, Erik
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2018112037 A1 2018-06-21

$RFMT $RIREG SCHEME316 STEP1
$RXN



  2  1
$MOL
4-Nitrobenzenesulfonyl chloride
C6H4ClNO4S
98-74-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 1.5400 0.0 0 VAL=6
M  V30 2 Cl 8.4700 1.5400 0.0 0
M  V30 3 O 6.9300 3.0800 0.0 0
M  V30 4 O 6.9300 0.0000 0.0 0
M  V30 5 N 0.7700 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 0.2064 0.0 0
M  V30 7 O 0.0000 2.8736 0.0 0
M  V30 8 C 5.3900 1.5400 0.0 0
M  V30 9 C 4.6200 0.2064 0.0 0
M  V30 10 C 4.6200 2.8736 0.0 0
M  V30 11 C 3.0800 0.2064 0.0 0
M  V30 12 C 3.0800 2.8736 0.0 0
M  V30 13 C 2.3100 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 8
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Nitrophenyl)sulfonyl]pyrrolidine
C10H12N2O4S
175278-37-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.9098 1.5400 0.0 0 VAL=6
M  V30 2 O 3.9098 3.0800 0.0 0
M  V30 3 O 3.9098 0.0000 0.0 0
M  V30 4 N 10.0698 1.5400 0.0 0 VAL=5
M  V30 5 O 10.8398 2.8737 0.0 0
M  V30 6 O 10.8398 0.2064 0.0 0
M  V30 7 C 5.4498 1.5400 0.0 0
M  V30 8 C 6.2198 0.2064 0.0 0
M  V30 9 C 6.2198 2.8737 0.0 0
M  V30 10 C 7.7598 0.2064 0.0 0
M  V30 11 C 7.7598 2.8737 0.0 0
M  V30 12 C 8.5298 1.5400 0.0 0
M  V30 13 N 2.3698 1.5400 0.0 0
M  V30 14 C 1.4645 2.7859 0.0 0
M  V30 15 C 1.4645 0.2941 0.0 0
M  V30 16 C 0.0000 2.3100 0.0 0
M  V30 17 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 1 13
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 98-74-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 175278-37-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-393-CAS-16198951
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery and characterization of novel small-molecule inhibitors
targeting nicotinamide phosphoribosyltransferase
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xu, Tian-Ying; Zhang, Sai-Long; Dong, Guo-Qiang; Liu, Xin-Zhu; Wang, Xia;
Lv, Xiao-Qun; Qian, Qi-Jun; Zhang, Ruo-Yu; Sheng, Chun-Quan; Miao,
Chao-Yu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Scientific Reports (2015), 510043

$RFMT $RIREG SCHEME317 STEP1
$RXN



  2  1
$MOL
3,5-Dinitrobenzoyl chloride
C7H3ClN2O5
99-33-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 5.3901 0.0 0
M  V30 2 Cl 0.0000 4.6201 0.0 0
M  V30 3 O 1.3337 6.9302 0.0 0
M  V30 4 N 4.0012 0.7700 0.0 0 VAL=5
M  V30 5 O 5.3348 0.0000 0.0 0
M  V30 6 O 2.6675 0.0000 0.0 0
M  V30 7 N 6.6687 5.3901 0.0 0 VAL=5
M  V30 8 O 6.6687 6.9302 0.0 0
M  V30 9 O 8.0023 4.6201 0.0 0
M  V30 10 C 2.6675 4.6201 0.0 0
M  V30 11 C 2.6675 3.0801 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 4.0012 2.3101 0.0 0
M  V30 14 C 5.3348 4.6201 0.0 0
M  V30 15 C 5.3348 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 13
M  V30 7 2 7 8
M  V30 8 2 7 9
M  V30 9 1 7 14
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3,5-Dinitrophenyl)-1-pyrrolidinylmethanone
C11H11N3O5
331270-52-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 O 6.6685 6.9301 0.0 0
M  V30 3 N 1.3337 5.3901 0.0 0 VAL=5
M  V30 4 O 1.3337 6.9301 0.0 0
M  V30 5 O 0.0000 4.6201 0.0 0
M  V30 6 N 4.0011 0.7700 0.0 0 VAL=5
M  V30 7 O 2.6673 0.0000 0.0 0
M  V30 8 O 5.3348 0.0000 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 C 4.0011 5.3901 0.0 0
M  V30 11 C 5.3348 3.0801 0.0 0
M  V30 12 C 2.6673 4.6201 0.0 0
M  V30 13 C 4.0011 2.3100 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 N 8.0021 4.6201 0.0 0
M  V30 16 C 9.4091 5.2464 0.0 0
M  V30 17 C 8.1632 3.0885 0.0 0
M  V30 18 C 10.4395 4.1020 0.0 0
M  V30 19 C 9.6695 2.7684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 12
M  V30 7 2 6 7
M  V30 8 2 6 8
M  V30 9 1 6 13
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 99-33-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 331270-52-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-13983475
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM a) δ,5-dinitrophenyl)(pyrrolidin-1-yl)methanone. Pyrrolidine (0.331 mL,
4.00 mmol) was added slowly to a stirred solution of 3,5-dinitrobenzoyl
chloride (0.922 g, 4.00 mmol) and triethylamine (1.00 mL, 7.17 mmol)in
dichloromethane (40 mL) and the mixture stirred at room temperature for
0.5 h. The solvent was removed under reduced pressure and the residue
partitioned between ethyl acetate and 0.2 M aqueous hydrochloric acid
(100 mL). The extracts were washed with 0.1 M aqueous hydrochloric acid,
0.5 M aqueous potassium carbonate, water, brine, dried (MgSO4) and
evaporated under reduced pressure to give the title compound as a tan
solid. Yield (1.06 g, 100%). 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 1.92 -
2.13 (m, 4 H) 3.51 (t, J=6.44 Hz, 2 H) 3.73 (t, J=6.82 Hz, 2 H) 8.75 (d,
J=2.02 Hz, 2 H) 9.13 (t, J=2.15 Hz, 1 H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of quinoline derivatives as inhibitors of lactate
dehydrogenase A useful in the treatment of cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brown, Kristin K.; Chai, Deping; Dodson, Christopher S.; Duffy, Kevin J.;
Shaw, Antony Nicholas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013096153 A1 2013-06-27

$RFMT $RIREG SCHEME318 STEP1
$RXN



  2  1
$MOL
3-Nitrobenzaldehyde
C7H5NO3
99-61-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 C 6.6687 1.5400 0.0 0
M  V30 5 O 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 2 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Nitrophenyl)-1-pyrrolidinylmethanethione
C11H12N2O2S
87866-32-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 S 3.7711 0.0000 0.0 0
M  V30 3 N 9.1059 1.5400 0.0 0 VAL=5
M  V30 4 O 10.4396 2.3101 0.0 0
M  V30 5 O 9.1059 0.0000 0.0 0
M  V30 6 C 5.1048 2.3101 0.0 0
M  V30 7 C 6.4384 1.5400 0.0 0
M  V30 8 C 5.1048 3.8501 0.0 0
M  V30 9 C 7.7722 2.3101 0.0 0
M  V30 10 C 6.4384 4.6201 0.0 0
M  V30 11 C 7.7722 3.8501 0.0 0
M  V30 12 N 2.4374 2.3101 0.0 0
M  V30 13 C 1.0304 1.6837 0.0 0
M  V30 14 C 2.2763 3.8416 0.0 0
M  V30 15 C 0.0000 2.8281 0.0 0
M  V30 16 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 2 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 99-61-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 87866-32-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-561-CAS-16948315
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 100
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7704-34-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, alternative methods shown, Willgerodt-Kindler reaction,
sealed vessel used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Willgerodt-Kindler Reaction of Benzaldehydes: A Comparative Study for a
Sustainable Synthesis of Secondary Thiobenzamides
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Papa, Maria; Chiarotto, Isabella; Feroci, Marta
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemistrySelect (2017), 2(10), 3207-3210

$RFMT $RIREG SCHEME319 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophenol
C6H5NO3
100-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 O 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitro-2,6-bis(1-pyrrolidinylmethyl)phenol
C16H23N3O3
121836-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 5.3901 0.0 0
M  V30 2 O 6.4386 6.9302 0.0 0
M  V30 3 C 9.1061 5.3901 0.0 0
M  V30 4 N 6.4386 0.7700 0.0 0 VAL=5
M  V30 5 O 7.7722 0.0000 0.0 0
M  V30 6 O 5.1049 0.0000 0.0 0
M  V30 7 C 5.1049 4.6201 0.0 0
M  V30 8 C 6.4386 5.3901 0.0 0
M  V30 9 C 5.1049 3.0801 0.0 0
M  V30 10 C 7.7722 4.6201 0.0 0
M  V30 11 C 6.4386 2.3101 0.0 0
M  V30 12 C 7.7722 3.0801 0.0 0
M  V30 13 N 2.4374 4.6201 0.0 0
M  V30 14 C 1.0306 5.2464 0.0 0
M  V30 15 C 2.2765 3.0885 0.0 0
M  V30 16 C 0.0000 4.1020 0.0 0
M  V30 17 C 0.7700 2.7684 0.0 0
M  V30 18 N 10.4397 4.6201 0.0 0
M  V30 19 C 11.8466 5.2464 0.0 0
M  V30 20 C 10.6007 3.0885 0.0 0
M  V30 21 C 12.8771 4.1020 0.0 0
M  V30 22 C 12.1071 2.7684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 8
M  V30 4 1 3 10
M  V30 5 1 3 18
M  V30 6 2 4 5
M  V30 7 2 4 6
M  V30 8 1 4 11
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-02-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 121836-29-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32187769
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich like reaction,capped vial used,no solvent,paraformaldehyde used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Environmentally Responsible and Cost-Effective Synthesis of the
Antimalarial Drug Pyronaridine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kincaid, Joseph R. A.; Kavthe, Rahul D.; Caravez, Juan C.; Takale,
Balaram S.; Thakore, Ruchita R.; Lipshutz, Bruce H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2022), 24(18), 3342-3346

$RFMT $RIREG SCHEME319 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitrophenol
C6H5NO3
100-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.7700 1.3337 0.0 0 VAL=5
M  V30 2 O 0.0000 0.0000 0.0 0
M  V30 3 O 0.0000 2.6673 0.0 0
M  V30 4 O 6.9302 1.3337 0.0 0
M  V30 5 C 2.3101 1.3337 0.0 0
M  V30 6 C 3.0801 2.6673 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Nitro-2,6-bis(1-pyrrolidinylmethyl)phenol
C16H23N3O3
121836-29-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 5.3901 0.0 0
M  V30 2 O 6.4386 6.9302 0.0 0
M  V30 3 C 9.1061 5.3901 0.0 0
M  V30 4 N 6.4386 0.7700 0.0 0 VAL=5
M  V30 5 O 7.7722 0.0000 0.0 0
M  V30 6 O 5.1049 0.0000 0.0 0
M  V30 7 C 5.1049 4.6201 0.0 0
M  V30 8 C 6.4386 5.3901 0.0 0
M  V30 9 C 5.1049 3.0801 0.0 0
M  V30 10 C 7.7722 4.6201 0.0 0
M  V30 11 C 6.4386 2.3101 0.0 0
M  V30 12 C 7.7722 3.0801 0.0 0
M  V30 13 N 2.4374 4.6201 0.0 0
M  V30 14 C 1.0306 5.2464 0.0 0
M  V30 15 C 2.2765 3.0885 0.0 0
M  V30 16 C 0.0000 4.1020 0.0 0
M  V30 17 C 0.7700 2.7684 0.0 0
M  V30 18 N 10.4397 4.6201 0.0 0
M  V30 19 C 11.8466 5.2464 0.0 0
M  V30 20 C 10.6007 3.0885 0.0 0
M  V30 21 C 12.8771 4.1020 0.0 0
M  V30 22 C 12.1071 2.7684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 13
M  V30 3 1 2 8
M  V30 4 1 3 10
M  V30 5 1 3 18
M  V30 6 2 4 5
M  V30 7 2 4 6
M  V30 8 1 4 11
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-02-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 121836-29-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32523871
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent, Mannich-like reaction, paraformaldehyde used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An environmentally responsible and cost-effective synthesis of the
antimalarial drug pyronaridine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kincaid, Joseph R. A.; Kavthe, Rahul D.; Caravez, Juan C.; Takale,
Balaram S.; Thakore, Ruchita R.; Lipshutz, Bruce H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemRxiv (2022), 1-4

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
4-Nitrobenzyl bromide
C7H6BrNO2
100-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 Br 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Nitrophenyl)methyl]pyrrolidine
C11H14N2O2
133851-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 4.6201 0.0 0
M  V30 2 N 9.1059 1.5400 0.0 0 VAL=5
M  V30 3 O 10.4396 2.3101 0.0 0
M  V30 4 O 9.1059 0.0000 0.0 0
M  V30 5 C 5.1048 3.8501 0.0 0
M  V30 6 C 5.1048 2.3101 0.0 0
M  V30 7 C 6.4384 4.6201 0.0 0
M  V30 8 C 6.4384 1.5400 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 C 7.7722 2.3101 0.0 0
M  V30 11 N 2.4374 3.8501 0.0 0
M  V30 12 C 2.2763 2.3185 0.0 0
M  V30 13 C 1.0304 4.4764 0.0 0
M  V30 14 C 0.7700 1.9983 0.0 0
M  V30 15 C 0.0000 3.3320 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-11-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 133851-67-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-2146347
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydrazonodiaminopyrazoles as integrin-linked kinase
inhibitors with antiproliferative activity.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Zaihui; Daynard, Timothy S.; Chafeev, Mikhail A.; Wang, Shisen;
Chopiuk, Greg B.; Sviridov, Serguei V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2003045379 A1 2003-06-05

$RFMT $RIREG SCHEME320 STEP1
$RXN



  2  1
$MOL
4-Nitrobenzyl bromide
C7H6BrNO2
100-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 1.3337 0.0000 0.0 0
M  V30 4 C 6.6687 4.6201 0.0 0
M  V30 5 Br 8.0023 3.8501 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[(4-Nitrophenyl)methyl]pyrrolidine
C11H14N2O2
133851-67-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 4.6201 0.0 0
M  V30 2 N 9.1059 1.5400 0.0 0 VAL=5
M  V30 3 O 10.4396 2.3101 0.0 0
M  V30 4 O 9.1059 0.0000 0.0 0
M  V30 5 C 5.1048 3.8501 0.0 0
M  V30 6 C 5.1048 2.3101 0.0 0
M  V30 7 C 6.4384 4.6201 0.0 0
M  V30 8 C 6.4384 1.5400 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 C 7.7722 2.3101 0.0 0
M  V30 11 N 2.4374 3.8501 0.0 0
M  V30 12 C 2.2763 2.3185 0.0 0
M  V30 13 C 1.0304 4.4764 0.0 0
M  V30 14 C 0.7700 1.9983 0.0 0
M  V30 15 C 0.0000 3.3320 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 11
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 10
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-11-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 133851-67-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-14185197
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: A. A solution of 1-bromomethyl-3(or
4)-nitrobenzene (1 above) (n=1) (432 mg; 2.0 mmol), an appropriate amine
(a-d above) (4.1 mmol) and triethylamine (0.3 mL) in THF (15 mL) was
heated for 2 hour at 60°C. The solvent was evaporated. Water was added to
the residue and the product was isolated by extraction with ether (3×20
mL). The ether extract was dried over anhydrous MgSO4 and the solvent was
removed. The residue was used in the next step without further
purification. The yield of compounds (2a-d above) ranged from 81-99%.
Final product.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of hydrazonodiaminopyrazoles with antiproliferative activity.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Zaihui; Daynard, Timothy Scott; Sviridov, Serguei V.; Chafeev,
Mikhail A.; Wang, Shisen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030060453 A1 2003-03-27

$RFMT $RIREG SCHEME321 STEP1
$RXN



  4  1
$MOL
Benzocaine
C9H11NO2
94-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethoxybenzaldehyde
C9H10O2
10031-82-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.6685 3.0801 0.0 0
M  V30 2 C 8.0023 2.3101 0.0 0
M  V30 3 C 9.3360 3.0801 0.0 0
M  V30 4 C 1.3337 0.0000 0.0 0
M  V30 5 O 0.0000 0.7700 0.0 0
M  V30 6 C 5.3348 2.3101 0.0 0
M  V30 7 C 5.3348 0.7700 0.0 0
M  V30 8 C 4.0012 3.0801 0.0 0
M  V30 9 C 4.0012 0.0000 0.0 0
M  V30 10 C 2.6675 2.3101 0.0 0
M  V30 11 C 2.6675 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 2,3-dihydro-1H-pyrrole-1-carboxylate
C9H15NO2
73286-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 O 5.1048 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4386 2.6218 0.0 0
M  V30 5 C 7.2086 1.2881 0.0 0
M  V30 6 C 7.7722 3.3918 0.0 0
M  V30 7 C 5.6686 3.9554 0.0 0
M  V30 8 N 2.4374 1.8517 0.0 0
M  V30 9 C 2.2765 0.3202 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (3aR,9bR)-4-(4-ethoxyphenyl)-2,3,3a,4,5,9b-hexahydro-8-...
C29H37N3O4
862431-16-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3012 3.4469 0.0 0
M  V30 2 O 4.9810 1.9404 0.0 0
M  V30 3 O 4.1568 4.4773 0.0 0
M  V30 4 C 3.5165 1.4646 0.0 0
M  V30 5 C 3.0406 2.9293 0.0 0
M  V30 6 C 2.0518 0.9887 0.0 0
M  V30 7 C 3.9924 0.0000 0.0 0
M  V30 8 C 2.6217 8.0548 0.0 0
M  V30 9 O 1.8517 6.7211 0.0 0
M  V30 10 O 15.7119 6.7211 0.0 0
M  V30 11 C 16.4819 8.0548 0.0 0
M  V30 12 C 18.0220 8.0548 0.0 0
M  V30 13 C 7.2418 5.3875 0.0 0 CFG=2
M  V30 14 C 6.4718 6.7211 0.0 0
M  V30 15 C 8.7818 5.3875 0.0 0 CFG=2
M  V30 16 N 6.7659 3.9227 0.0 0
M  V30 17 C 7.2418 8.0548 0.0 0
M  V30 18 C 4.9318 6.7211 0.0 0
M  V30 19 C 9.5518 6.7211 0.0 0 CFG=3
M  V30 20 C 9.2577 3.9227 0.0 0
M  V30 21 C 8.0118 3.0175 0.0 0
M  V30 22 N 8.7818 8.0548 0.0 0
M  V30 23 C 6.4718 9.3884 0.0 0
M  V30 24 C 4.1618 8.0548 0.0 0
M  V30 25 C 4.9318 9.3884 0.0 0
M  V30 26 C 11.0919 6.7211 0.0 0
M  V30 27 C 11.8619 8.0548 0.0 0
M  V30 28 C 11.8619 5.3875 0.0 0
M  V30 29 C 13.4019 8.0548 0.0 0
M  V30 30 C 13.4019 5.3875 0.0 0
M  V30 31 C 14.1719 6.7211 0.0 0
M  V30 32 N 1.8517 9.3884 0.0 0
M  V30 33 C 2.4782 10.7954 0.0 0
M  V30 34 C 0.3202 9.5495 0.0 0
M  V30 35 C 1.3337 11.8258 0.0 0
M  V30 36 C 0.0000 11.0558 0.0 0
M  V30 37 H 5.7102 5.2264 0.0 0
M  V30 38 H 10.3134 5.2264 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 24
M  V30 10 1 8 32
M  V30 11 1 10 11
M  V30 12 1 10 31
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 13 16
M  V30 17 1 13 37 CFG=3
M  V30 18 1 14 17
M  V30 19 2 14 18
M  V30 20 1 15 19
M  V30 21 1 15 20
M  V30 22 1 15 38 CFG=3
M  V30 23 1 16 21
M  V30 24 1 17 22
M  V30 25 2 17 23
M  V30 26 1 18 24
M  V30 27 1 19 22
M  V30 28 1 19 26
M  V30 29 1 20 21
M  V30 30 1 23 25
M  V30 31 2 24 25
M  V30 32 2 26 27
M  V30 33 1 26 28
M  V30 34 1 27 29
M  V30 35 2 28 30
M  V30 36 2 29 31
M  V30 37 1 30 31
M  V30 38 1 32 33
M  V30 39 1 32 34
M  V30 40 1 33 35
M  V30 41 1 34 36
M  V30 42 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 94-09-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10031-82-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 73286-71-2
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 862431-16-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-1673162
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure:
Ethyl4-aminobenzoate (1 equiv.), aldehyde (1.1 equiv.), in dry toluene
was added a drop of TFA. The solution was refluxed for overnight, while
water was removed by Dean Stark trap. After removal of the solvent, the
resulted Schiffbase was used for next step directly. To the residue was
added allyI 2,3-dihydro-1H-pyrrole-1-carboxylate or other reactant as
shown in above scheme (1.1 equivalent) in acetonitrile. The reaction
mixture was stirred at room temperature for 16 hours. The solvent was
removed to give a residue, which was purified by silica gel column
chromatography giving the desired compound at approximately 1:1 ratio. A
mixture of carboxylic acid (1 equiv.), HATU (1.1 equiv.), DIPEA (1.1
equiv.) in DMF was stirred for 5 minutes. Then, a primary or secondary
amine was added to the solution. The reaction mixture was stirred at room
temperature for 4 hours. The solvent was removed in vacuo. The residue
was purified by flash column chromatography.The titled compounds of
Example 2 are made using the titled compounds made in Example 1 as the
starting materials. Tert-Butyl
8-[(4-methylpiperazin-l-yl)carbonyll-4-phenyl-2,3,3a,4,5,9b-hexahydro-
1H-pyrrolo[3,2-c]quinoline-l-carboxylate. The titled compound (235.1mg,
97% yield) was obtained by following the general procedure 5. tert-Butyl
4-(4-ethoxvphenyl)-8-(Pyrrolidin-1-ylcarbonyl)-2,3,3a,4,5,9b-hexahydro-1H-pyrrlo[3,2-c]quinoline-1-carboxylate.
The titled compound (225.6mg, 99% yield) was obtained by following the
general procedure 5. (ESI) (M+H)+= 492.6.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrroloquinolinecarboxamides and
piperidoquinolinecarboxamides as B2 Bradykinin receptor modulators for
pain management and other uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Yun-Jin; Tomaszewski, Miroslaw; Walpole, Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005075476 A1 2005-08-18

$RFMT $RIREG SCHEME322 STEP1
$RXN



  3  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Methyl-3-butyn-2-ol
C5H8O
115-19-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 1.5400 3.0800 0.0 0
M  V30 4 C 0.0000 1.5400 0.0 0
M  V30 5 O 1.5400 0.0000 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(5S)-2-Methyl-5-phenyl-5-(1-pyrrolidinyl)-3-pentyn-2-ol
C16H21NO
1467762-66-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3348 4.6799 0.0 0
M  V30 3 C 6.6685 5.4499 0.0 0
M  V30 4 C 8.0023 6.2199 0.0 0
M  V30 5 C 7.2323 7.5536 0.0 0
M  V30 6 C 9.3360 6.9899 0.0 0
M  V30 7 O 8.7723 4.8862 0.0 0
M  V30 8 N 4.0012 2.3698 0.0 0
M  V30 9 C 5.2470 1.4646 0.0 0
M  V30 10 C 2.7553 1.4646 0.0 0
M  V30 11 C 4.7712 0.0000 0.0 0
M  V30 12 C 3.2311 0.0000 0.0 0
M  V30 13 C 2.6675 4.6799 0.0 0
M  V30 14 C 2.6675 6.2199 0.0 0
M  V30 15 C 1.3337 3.9098 0.0 0
M  V30 16 C 1.3337 6.9899 0.0 0
M  V30 17 C 0.0000 4.6799 0.0 0
M  V30 18 C 0.0000 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8 CFG=1
M  V30 3 1 1 13
M  V30 4 3 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 115-19-5
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1467762-66-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-26996486
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7787-70-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2568347-80-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, molecular sieves used, catalyst prepared and used, %ee =
98%, reaction in a Schlenk tube
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrinap ligands for enantioselective syntheses of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Qi; Xu, Haibo; Li, Yuling; Yao, Yuan; Zhang, Xue; Guo, Yinlong; Ma,
Shengming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2021), 12(1), 19

$RFMT $RIREG SCHEME323 STEP1
$RXN



  4  1
$MOL
Benzocaine
C9H11NO2
94-09-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 O 6.6684 2.3100 0.0 0
M  V30 3 O 5.3348 0.0000 0.0 0
M  V30 4 C 8.0022 1.5400 0.0 0
M  V30 5 C 9.3359 2.3100 0.0 0
M  V30 6 N 0.0000 4.6201 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 2.6675 1.5400 0.0 0
M  V30 9 C 4.0011 3.8500 0.0 0
M  V30 10 C 1.3337 2.3100 0.0 0
M  V30 11 C 2.6675 4.6201 0.0 0
M  V30 12 C 1.3337 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 12
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl 2,3-dihydro-1H-pyrrole-1-carboxylate
C9H15NO2
73286-71-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 O 5.1048 1.8517 0.0 0
M  V30 3 O 3.7711 4.1618 0.0 0
M  V30 4 C 6.4386 2.6218 0.0 0
M  V30 5 C 7.2086 1.2881 0.0 0
M  V30 6 C 7.7722 3.3918 0.0 0
M  V30 7 C 5.6686 3.9554 0.0 0
M  V30 8 N 2.4374 1.8517 0.0 0
M  V30 9 C 2.2765 0.3202 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-1,1-Dimethylethyl (3aR,9bR)-2,3,3a,4,5,9b-hexahydro-4-phenyl-8-(1-pyrroli...
C27H33N3O3
862431-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  35 39 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.0451 3.7534 0.0 0
M  V30 2 O 5.5693 2.2889 0.0 0
M  V30 3 O 7.5514 4.0736 0.0 0
M  V30 4 C 6.5997 1.1444 0.0 0
M  V30 5 C 5.4551 0.1140 0.0 0
M  V30 6 C 7.6301 0.0000 0.0 0
M  V30 7 C 7.7440 2.1749 0.0 0
M  V30 8 C 10.6696 6.4042 0.0 0
M  V30 9 O 10.6696 4.8642 0.0 0
M  V30 10 C 5.3347 6.4042 0.0 0 CFG=2
M  V30 11 C 6.6685 7.1742 0.0 0
M  V30 12 C 4.0011 7.1742 0.0 0 CFG=2
M  V30 13 N 5.0145 4.8980 0.0 0
M  V30 14 C 6.6685 8.7142 0.0 0
M  V30 15 C 8.0021 6.4042 0.0 0
M  V30 16 C 4.0011 8.7142 0.0 0 CFG=3
M  V30 17 C 2.8567 6.1438 0.0 0
M  V30 18 C 3.4830 4.7369 0.0 0
M  V30 19 N 5.3347 9.4842 0.0 0
M  V30 20 C 8.0021 9.4842 0.0 0
M  V30 21 C 9.3358 7.1742 0.0 0
M  V30 22 C 9.3358 8.7142 0.0 0
M  V30 23 C 2.6674 9.4842 0.0 0
M  V30 24 C 1.3338 8.7142 0.0 0
M  V30 25 C 2.6674 11.0242 0.0 0
M  V30 26 C 0.0000 9.4842 0.0 0
M  V30 27 C 1.3338 11.7942 0.0 0
M  V30 28 C 0.0000 11.0242 0.0 0
M  V30 29 N 12.0032 7.1742 0.0 0
M  V30 30 C 13.4100 6.5479 0.0 0
M  V30 31 C 12.1642 8.7058 0.0 0
M  V30 32 C 14.4406 7.6923 0.0 0
M  V30 33 C 13.6706 9.0261 0.0 0
M  V30 34 H 6.5807 5.4990 0.0 0
M  V30 35 H 2.5943 7.8007 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 2 8 9
M  V30 9 1 8 21
M  V30 10 1 8 29
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 1 10 34 CFG=1
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 16
M  V30 18 1 12 17
M  V30 19 1 12 35 CFG=1
M  V30 20 1 13 18
M  V30 21 1 14 19
M  V30 22 2 14 20
M  V30 23 1 15 21
M  V30 24 1 16 19
M  V30 25 1 16 23
M  V30 26 1 17 18
M  V30 27 1 20 22
M  V30 28 2 21 22
M  V30 29 2 23 24
M  V30 30 1 23 25
M  V30 31 1 24 26
M  V30 32 2 25 27
M  V30 33 2 26 28
M  V30 34 1 27 28
M  V30 35 1 29 30
M  V30 36 1 29 31
M  V30 37 1 30 32
M  V30 38 1 31 33
M  V30 39 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 10 12)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 94-09-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 73286-71-2
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 862431-08-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-8376577
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 6
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1310-73-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General/Typical Procedure:
Ethyl4-aminobenzoate (1 equiv.), aldehyde (1.1 equiv.), in dry toluene
was added a drop of TFA. The solution was refluxed for overnight, while
water was removed by Dean Stark trap. After removal of the solvent, the
resulted Schiffbase was used for next step directly. To the residue was
added allyI 2,3-dihydro-1H-pyrrole-1-carboxylate or other reactant as
shown in above scheme (1.1 equivalent) in acetonitrile. The reaction
mixture was stirred at room temperature for 16 hours. The solvent was
removed to give a residue, which was purified by silica gel column
chromatography giving the desired compound at approximately 1:1 ratio. A
mixture of carboxylic acid (1 equiv.), HATU (1.1 equiv.), DIPEA (1.1
equiv.) in DMF was stirred for 5 minutes. Then, a primary or secondary
amine was added to the solution. The reaction mixture was stirred at room
temperature for 4 hours. The solvent was removed in vacuo. The residue
was purified by flash column chromatography.The titled compounds of
Example 2 are made using the titled compounds made in Example 1 as the
starting materials. Tert-Butyl
8-[(4-methylpiperazin-l-yl)carbonyll-4-phenyl-2,3,3a,4,5,9b-hexahydro-
1H-pyrrolo[3,2-c]quinoline-l-carboxylate. The titled compound (235.1mg,
97% yield) was obtained by following the general procedure 5. tert-Butyl
4-phenyl-8-(pyrrolidin-1-ylcarbonyl)-2,3,3a,4,5,9b-hexahydro-1H-pyrrolo[3,2-c]quinoline-1-carboxylate.
The titled compound (225.6mg, 99% yield) was obtained by following the
general procedure 5. (ESI) (M+H)+ = 448.6.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of pyrroloquinolinecarboxamides and
piperidoquinolinecarboxamides as B2 Bradykinin receptor modulators for
pain management and other uses
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Hu, Yun-Jin; Tomaszewski, Miroslaw; Walpole, Christopher
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005075476 A1 2005-08-18

$RFMT $RIREG SCHEME324 STEP1
$RXN



  3  1
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methylphenylacetylene
C9H8
766-97-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3336 0.0 0
M  V30 2 C 7.7000 1.3336 0.0 0
M  V30 3 C 0.0000 1.3336 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[3-(4-Methylphenyl)-1-phenyl-2-propyn-1-yl]pyrrolidine
C20H21N
1380113-56-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 3.7710 0.0 0
M  V30 2 C 4.6200 3.7710 0.0 0
M  V30 3 C 6.1600 3.7710 0.0 0
M  V30 4 C 12.3200 3.7710 0.0 0
M  V30 5 C 2.3100 5.1046 0.0 0
M  V30 6 C 3.0800 6.4384 0.0 0
M  V30 7 C 0.7700 5.1046 0.0 0
M  V30 8 C 2.3100 7.7721 0.0 0
M  V30 9 C 0.0000 6.4384 0.0 0
M  V30 10 C 0.7700 7.7721 0.0 0
M  V30 11 N 2.3100 2.4374 0.0 0
M  V30 12 C 2.9363 1.0304 0.0 0
M  V30 13 C 0.7785 2.2764 0.0 0
M  V30 14 C 1.7919 0.0000 0.0 0
M  V30 15 C 0.4583 0.7700 0.0 0
M  V30 16 C 7.7000 3.7710 0.0 0
M  V30 17 C 8.4700 2.4374 0.0 0
M  V30 18 C 8.4700 5.1046 0.0 0
M  V30 19 C 10.0100 2.4374 0.0 0
M  V30 20 C 10.0100 5.1046 0.0 0
M  V30 21 C 10.7800 3.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 3 2 3
M  V30 5 1 3 16
M  V30 6 1 4 21
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 766-97-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1380113-56-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-19791175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 189114-61-2
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2240142-71-4
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, no solvent, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Efficient Gold(I) Acyclic Diaminocarbenes for the Synthesis of
Propargylamines and Indolizines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Aliaga-Lavrijsen, Melanie; Herrera, Raquel P.; Villacampa, M. Dolores;
Gimeno, M. Concepcion
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Omega (2018), 3(8), 9805-9813

$RFMT $RIREG SCHEME325 STEP1
$RXN



  3  1
$MOL
2,4-Dihydroxyquinoline
C9H7NO2
86-95-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 N 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzaldehyde
C7H6O
100-52-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-3-(phenyl-1-pyrrolidinylmethyl)-2(1H)-quinolinone
C20H20N2O2
1874212-69-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 3.9098 0.0 0
M  V30 2 O 6.6685 2.3698 0.0 0
M  V30 3 O 4.0012 6.9899 0.0 0
M  V30 4 C 5.3348 4.6799 0.0 0
M  V30 5 C 6.6685 3.9098 0.0 0
M  V30 6 C 5.3348 6.2199 0.0 0
M  V30 7 C 8.0023 4.6799 0.0 0
M  V30 8 N 6.6685 6.9899 0.0 0
M  V30 9 C 8.0023 6.2199 0.0 0
M  V30 10 C 9.3360 3.9098 0.0 0
M  V30 11 C 9.3360 6.9899 0.0 0
M  V30 12 C 10.6697 4.6799 0.0 0
M  V30 13 C 10.6697 6.2199 0.0 0
M  V30 14 N 4.0012 2.3698 0.0 0
M  V30 15 C 5.2470 1.4646 0.0 0
M  V30 16 C 2.7553 1.4646 0.0 0
M  V30 17 C 4.7712 0.0000 0.0 0
M  V30 18 C 3.2311 0.0000 0.0 0
M  V30 19 C 2.6673 4.6799 0.0 0
M  V30 20 C 2.6673 6.2199 0.0 0
M  V30 21 C 1.3337 3.9098 0.0 0
M  V30 22 C 1.3337 6.9899 0.0 0
M  V30 23 C 0.0000 4.6799 0.0 0
M  V30 24 C 0.0000 6.2199 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 14
M  V30 3 1 1 19
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 2 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 9
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 1 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 86-95-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 100-52-7
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1874212-69-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-15721907
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Methylene-2,4-chromandione in situ trapping: introducing molecular
diversity on 4-hydroxycoumarin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Montagut-Romans, Adrien; Boulven, Manon; Lemaire, Marc; Popowycz,
Florence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(6), 4540-4544

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(3-nitrophenyl)acetamide
C8H7ClN2O3
10147-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 1.5400 0.0 0
M  V30 2 C 8.0022 2.3100 0.0 0
M  V30 3 C 9.3359 1.5400 0.0 0
M  V30 4 O 8.0022 3.8500 0.0 0
M  V30 5 Cl 10.6695 2.3100 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Nitrophenyl)-1-pyrrolidineacetamide
C12H15N3O3
882340-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3358 1.5400 0.0 0
M  V30 4 O 8.0022 3.8501 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0010 1.5400 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 N 10.6697 2.3101 0.0 0
M  V30 15 C 12.0765 1.6837 0.0 0
M  V30 16 C 10.8306 3.8416 0.0 0
M  V30 17 C 13.1069 2.8281 0.0 0
M  V30 18 C 12.3369 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 14
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 11
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10147-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 882340-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-15166351
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Method 2 (2a-i and 13a-c). 1a,b/d-e/g-i or
12a-c were dissolved in MeOH/THF (5-100 mL), and the required amine base
(2-3.6 equiv) was added. The mixture was either (a) stirred overnight at
room temperature prior to the solvent being removed (5% NH3 (aq) (50 mL)
was added and the product extracted with EtOAc (50 mL), washed with brine
(25 mL), and dried over MgSO4), (b) heated under reflux for 4 h prior to
workup as above, or (c) stirred at 30 °C overnight prior to workup as
above. 1c/f was reacted with neat pyrrolidine (20 mL, 0.240 mol) at room
temperature overnight, followed by evaporation of the excess pyrrolidine
and workup as described above.
N-(3-nitrophenyl)-2-(pyrrolidin-1-yl)acetamide (2d). Following method 2b,
1d (2.07g, 9.659 mmol) was reacted with pyrrolidine (1.61 ml, 19.287
mmol) to yield a brown oil (2.39g, 9.587 mmol, 99%). 1H NMR (400MHz,
d6-DMSO) δ 10.23 (1H, s), 8.71 (1H, t, J=2.2 Hz), 8.04 (1H, ddd, J=8.1,
2.2, 0.9 Hz), 7.91 (1H, ddd, J=8.1, 2.2, 0.9 Hz), 7.60 (1H, t, J=8.2 Hz),
3.30 (2H, s), 2.60 (4H, m), 1.76 (4H, m) ppm. 13C NMR (100MHz, d6-DMSO) δ
169.7, 147.9, 139.9, 130.0, 125.5, 117.8, 113.6, 59.5, 53.6, 23.5 ppm.
HRMS m/z calc. C12H15N3O3 [M+H]+ 250.1186, found 250.1181.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Rational Design of Substituted Diarylureas: A Scaffold for Binding to
G-Quadruplex Motifs
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Drewe, William C.; Nanjunda, Rupesh; Gunaratnam, Mekala; Beltran, Monica;
Parkinson, Gary N.; Reszka, Anthony P.; Wilson, W. David; Neidle, Stephen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2008), 51(24), 7751-7767

$RFMT $RIREG SCHEME326 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(3-nitrophenyl)acetamide
C8H7ClN2O3
10147-71-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6684 1.5400 0.0 0
M  V30 2 C 8.0022 2.3100 0.0 0
M  V30 3 C 9.3359 1.5400 0.0 0
M  V30 4 O 8.0022 3.8500 0.0 0
M  V30 5 Cl 10.6695 2.3100 0.0 0
M  V30 6 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 O 0.0000 2.3100 0.0 0
M  V30 9 C 5.3348 2.3100 0.0 0
M  V30 10 C 4.0011 1.5400 0.0 0
M  V30 11 C 5.3348 3.8500 0.0 0
M  V30 12 C 2.6673 2.3100 0.0 0
M  V30 13 C 4.0011 4.6201 0.0 0
M  V30 14 C 2.6673 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 12
M  V30 9 2 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 13
M  V30 13 2 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Nitrophenyl)-1-pyrrolidineacetamide
C12H15N3O3
882340-56-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.6685 1.5400 0.0 0
M  V30 2 C 8.0022 2.3101 0.0 0
M  V30 3 C 9.3358 1.5400 0.0 0
M  V30 4 O 8.0022 3.8501 0.0 0
M  V30 5 N 1.3337 1.5400 0.0 0 VAL=5
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 5.3348 2.3101 0.0 0
M  V30 9 C 4.0010 1.5400 0.0 0
M  V30 10 C 5.3348 3.8501 0.0 0
M  V30 11 C 2.6673 2.3101 0.0 0
M  V30 12 C 4.0010 4.6201 0.0 0
M  V30 13 C 2.6673 3.8501 0.0 0
M  V30 14 N 10.6697 2.3101 0.0 0
M  V30 15 C 12.0765 1.6837 0.0 0
M  V30 16 C 10.8306 3.8416 0.0 0
M  V30 17 C 13.1069 2.8281 0.0 0
M  V30 18 C 12.3369 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 14
M  V30 6 2 5 6
M  V30 7 2 5 7
M  V30 8 1 5 11
M  V30 9 2 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10147-71-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 882340-56-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8120990
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-41-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The synthesis of N-(3-nitrophenyl)-2-(pyrrolidin-1-yl)acetamide (5)
2-chloro-N-(3-nitrophenyl)acetamide (4) (2.07 g, 9.659 mmol) was
dissolved in MeOH (100 ml) and to this was added pyrrolidine (1.61 ml,
19.319 mmol, 2 equiv.) and the mixture heated at reflux for 4 hours and
stirred at room temperature overnight. The MeOH was removed in vacuo and
the resulting oil suspended in 5% NH3 (aq.) (50 ml), extracted into CHCl3
(2 x 50 ml) washing with brine (20 ml) and dried over MgSO4 to yield a
brown oil (2.390 g, 9.587 mmol, 99%). Rf 0.58 [MeOH]. 1H NMR (400 MHz,
d6-DMSO) δ 10.23 (1H, s, NH), 8.71 (1H, t, J=2.2 Hz, ArH), 8.04 (1H, ddd,
J=8.1, 2.2, 0.9 Hz, ArH), 7.91 (1H, ddd, J=8.1, 2.2, 0.9 Hz, ArH), 7.60
(1H, t, J=8.2 Hz, ArH), 3.30 (2H, s, CH2), 2.60 (4H, m, 2CH2), 1.76 (4H,
m, 2CH2) ppm. 13C NMR (100 MHz, d6-DMSO) δ 169.7 (C=O), 147.9 (ArC),
139.9 (ArC), 130.0 (ArCH), 125.5 (ArCH), 117.8 (ArCH), 113.6 (ArCH), 59.5
(CH2), 53.6 (2CH2), 23.5 (2CH2) ppm. IR (neat) υmax 3273, 2969, 1738,
1531, 1352, 1217 cm-1. HRMS m/z calc. C12H15N3O3 [M+1] 250.1186, found
[M+1] 250.1181.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Ureylene derivatives as DNA oligonucleotide ligands and their
preparation, pharmaceutical compositions and use in the treatment of
diseases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Moses, John Edward; Neidle, Stephen; Moorhouse, Adam Donald; Moore,
Michael
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008122667 A2 2008-10-16

$RFMT $RIREG SCHEME327 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Quinolinecarboxylic acid, 2,4-dimethyl-
C12H11NO2
1023812-35-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 0.0000 0.0 0
M  V30 2 C 0.0000 4.6201 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 O 8.0022 0.0000 0.0 0
M  V30 5 O 9.3359 2.3100 0.0 0
M  V30 6 C 4.0011 3.8500 0.0 0
M  V30 7 C 4.0011 2.3100 0.0 0
M  V30 8 C 5.3348 4.6201 0.0 0
M  V30 9 N 2.6675 4.6201 0.0 0
M  V30 10 C 5.3348 1.5400 0.0 0
M  V30 11 C 2.6675 1.5400 0.0 0
M  V30 12 C 6.6684 3.8500 0.0 0
M  V30 13 C 1.3337 3.8500 0.0 0
M  V30 14 C 6.6684 2.3100 0.0 0
M  V30 15 C 1.3337 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 13
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2,4-Dimethyl-6-quinolinyl)-1-pyrrolidinylmethanone
C16H18N2O
2148923-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 8.0022 1.5400 0.0 0
M  V30 3 O 8.0022 0.0000 0.0 0
M  V30 4 C 0.0000 4.6201 0.0 0
M  V30 5 C 4.0010 2.3101 0.0 0
M  V30 6 C 4.0010 3.8501 0.0 0
M  V30 7 C 5.3348 1.5400 0.0 0
M  V30 8 C 2.6673 1.5400 0.0 0
M  V30 9 C 5.3348 4.6201 0.0 0
M  V30 10 N 2.6673 4.6201 0.0 0
M  V30 11 C 6.6685 2.3101 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 6.6685 3.8501 0.0 0
M  V30 14 C 1.3337 3.8501 0.0 0
M  V30 15 N 9.3360 2.3101 0.0 0
M  V30 16 C 9.4969 3.8416 0.0 0
M  V30 17 C 10.7428 1.6837 0.0 0
M  V30 18 C 11.0032 4.1618 0.0 0
M  V30 19 C 11.7733 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 11
M  V30 4 1 2 15
M  V30 5 1 4 14
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 2 8 12
M  V30 13 2 9 13
M  V30 14 2 10 14
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1023812-35-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2148923-03-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-18520935
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M4 positive
allosteric modulator (PAM) chemotype via scaffold hopping
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Long, Madeline F.; Engers, Julie L.; Chang, Sichen; Zhan, Xiaoyan;
Weiner, Rebecca L.; Luscombe, Vincent B.; Rodriguez, Alice L.; Cho,
Hyekyung P.; Niswender, Colleen M.; Bridges, Thomas M.; Conn, P. Jeffrey;
Engers, Darren W.; Lindsley, Craig W.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2017), 27(22), 4999-5001

$RFMT $RIREG SCHEME328 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Phenylpicolinamide
C12H10N2O
10354-53-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0
M  V30 2 N 4.6201 1.3337 0.0 0
M  V30 3 O 4.6201 4.0010 0.0 0
M  V30 4 C 6.9302 2.6673 0.0 0
M  V30 5 C 7.7002 1.3337 0.0 0
M  V30 6 N 7.7002 4.0010 0.0 0
M  V30 7 C 9.2402 1.3337 0.0 0
M  V30 8 C 9.2402 4.0010 0.0 0
M  V30 9 C 10.0102 2.6673 0.0 0
M  V30 10 C 3.0801 1.3337 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 2.3101 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 C 0.7700 2.6673 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 10
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Phenyl-N-(tetrahydro-2-furanyl)-2-pyridinecarboxamide
C16H16N2O2
2183512-03-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 3.7710 0.0 0
M  V30 2 C 4.6200 5.1048 0.0 0
M  V30 3 O 5.3900 6.4384 0.0 0
M  V30 4 C 4.6200 2.4374 0.0 0
M  V30 5 C 3.0885 2.2764 0.0 0
M  V30 6 O 5.2463 1.0306 0.0 0
M  V30 7 C 2.7683 0.7700 0.0 0
M  V30 8 C 4.1019 0.0000 0.0 0
M  V30 9 C 6.9300 3.7710 0.0 0
M  V30 10 C 7.7000 5.1048 0.0 0
M  V30 11 C 7.7000 2.4374 0.0 0
M  V30 12 C 9.2400 5.1048 0.0 0
M  V30 13 C 9.2400 2.4374 0.0 0
M  V30 14 C 10.0100 3.7710 0.0 0
M  V30 15 C 3.0800 5.1048 0.0 0
M  V30 16 C 2.3100 6.4384 0.0 0
M  V30 17 N 2.3100 3.7710 0.0 0
M  V30 18 C 0.7700 6.4384 0.0 0
M  V30 19 C 0.7700 3.7710 0.0 0
M  V30 20 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 1 9
M  V30 4 2 2 3
M  V30 5 1 2 15
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10354-53-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2183512-03-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29618771
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 66-71-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Teflon lined sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and atom-economical route to N-aryl amino alcohols from
primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Zhen; Li, Juanjuan; Yue, Qiang; Zhang, Qian; Li, Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2018), 8(60), 34304-34308

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Phenyl isothiocyanate
C7H5NS
103-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Phenyl-1-pyrrolidinecarbothioamide
C11H14N2S
18792-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0
M  V30 2 N 4.6201 1.3337 0.0 0
M  V30 3 S 4.6201 4.0010 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 7.8354 1.4215 0.0 0
M  V30 6 C 7.8354 3.9132 0.0 0
M  V30 7 C 9.3000 1.8973 0.0 0
M  V30 8 C 9.3000 3.4374 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 9
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 103-72-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18792-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-18590594
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2133443-86-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk flask used, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 2-Picolylamino(diphenylphosphinoselenoic)amide supported zinc complexes:
Efficient catalyst for insertion of N-H bond into carbodiimides,
isocyanates, and isothiocyanate
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harinath, Adimulam; Bano, Kulsum; Ahmed, Shakil; Panda, Tarun K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Phosphorus, Sulfur and Silicon and the Related Elements (2018), 193(1),
23-32

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Phenyl isothiocyanate
C7H5NS
103-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Phenyl-1-pyrrolidinecarbothioamide
C11H14N2S
18792-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0
M  V30 2 N 4.6201 1.3337 0.0 0
M  V30 3 S 4.6201 4.0010 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 7.8354 1.4215 0.0 0
M  V30 6 C 7.8354 3.9132 0.0 0
M  V30 7 C 9.3000 1.8973 0.0 0
M  V30 8 C 9.3000 3.4374 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 9
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 103-72-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18792-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-16226949
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2032423-94-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk flask used, glovebox used, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydroamination of carbodiimides, isocyanates, and isothiocyanates by a
bis(phosphinoselenoic amide) supported titanium(IV) complex
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhattacharjee, Jayeeta; Das, Suman; Kottalanka, Ravi K.; Panda, Tarun K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2016), 45(44), 17824-17832

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Phenyl isothiocyanate
C7H5NS
103-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Phenyl-1-pyrrolidinecarbothioamide
C11H14N2S
18792-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0
M  V30 2 N 4.6201 1.3337 0.0 0
M  V30 3 S 4.6201 4.0010 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 7.8354 1.4215 0.0 0
M  V30 6 C 7.8354 3.9132 0.0 0
M  V30 7 C 9.3000 1.8973 0.0 0
M  V30 8 C 9.3000 3.4374 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 9
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 103-72-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18792-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-1545335
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Pyrrolidine-1-carbothioic acid phenylamide (37b): General Procedure for
the preparation of thioureas (37) and (44): To a solution of amine (6.0
mmol, 1.0 equiv.) in 15 mL of dry CH2Cl2 was treated dropwise with
isothiocyanate (6.0 mmol, 1.0 equiv.). The resulting solution was stirred
at room temperature for 16 hr, then diluted with H2O (50 mL) and
extracted with 3 x 15 mL of CH2Cl2. The combined organics were washed
with brine, dried over MgSO4, filtered and concentrated. The residue was
purified by recrystallization (CH2Cl2/hexanes) or column chromatography
through silica gel. According to the procedure described above, the title
compound was obtained in 99 % yield. White crystalline solid; mp 121-122
degC (CH2Cl2/hexanes); Rf = 0.41 (50 % EtOAc/50 % hexanes).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Mercury Promoted Synthesis of Substitutes 5-Aminotetrazoles and Studies
towards the Synthesis of the Martinelline Alkaloids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Powell, David Andrew
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM (2001), (20121004), No pp.

$RFMT $RIREG SCHEME329 STEP1
$RXN



  2  1
$MOL
Phenyl isothiocyanate
C7H5NS
103-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 3.0800 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 S 6.6685 1.5400 0.0 0
M  V30 4 C 2.6674 2.3100 0.0 0
M  V30 5 C 2.6674 0.7700 0.0 0
M  V30 6 C 1.3338 3.0800 0.0 0
M  V30 7 C 1.3338 0.0000 0.0 0
M  V30 8 C 0.0000 2.3100 0.0 0
M  V30 9 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Phenyl-1-pyrrolidinecarbothioamide
C11H14N2S
18792-49-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0
M  V30 2 N 4.6201 1.3337 0.0 0
M  V30 3 S 4.6201 4.0010 0.0 0
M  V30 4 N 6.9302 2.6673 0.0 0
M  V30 5 C 7.8354 1.4215 0.0 0
M  V30 6 C 7.8354 3.9132 0.0 0
M  V30 7 C 9.3000 1.8973 0.0 0
M  V30 8 C 9.3000 3.4374 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 2.3101 0.0000 0.0 0
M  V30 11 C 2.3101 2.6673 0.0 0
M  V30 12 C 0.7700 0.0000 0.0 0
M  V30 13 C 0.7700 2.6673 0.0 0
M  V30 14 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 9
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 103-72-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 18792-49-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-5749341
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for the preparation of
Thioureas (5). To a solution of amine 3 (6.0 mmol, 1.0 equiv) in 15 ml of
dry CH2Cl2 was treated dropwise with isothiocyanate 4 (6.0 mmol, 1.0
equiv). The resulting solution was stirred at room temperature for 16 h,
then diluted with H2O (50 ml) and extracted with 3 x 15ml of CH2Cl2. The
combined organics were washed with brine, dried over MgSO4, filtered and
concentrated. The residue was purified by recrystallization (CH2Cl2 :
Hexanes) or column chromatography through silica gel. 4-(methyl
4-butanoic acid)-3-thio-allophanic acid ethyl ester (table 1, entry 4):
entry 2 yield 5 [%]: 99
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A General Synthetic Method for the Formation of Substituted
5-Aminotetrazoles from Thioureas: A Strategy for Diversity Amplification
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Batey, Robert A.; Powell, David A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2000), 2(20), 3237-3240

$RFMT $RIREG SCHEME330 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Ethenyl-1,4-dihydro-1-[(4-methylphenyl)sulfonyl]-2H-3,1-benzoxazin-2-one
C17H15NO4S
1038502-72-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 4.0011 0.0 0 VAL=6
M  V30 2 O 6.9300 2.4611 0.0 0
M  V30 3 O 6.9300 5.5411 0.0 0
M  V30 4 O 5.3900 6.6685 0.0 0
M  V30 5 C 0.7700 4.0011 0.0 0
M  V30 6 C 0.0000 5.3347 0.0 0
M  V30 7 C 13.0900 4.0011 0.0 0
M  V30 8 N 5.3900 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 3.0800 2.6674 0.0 0
M  V30 12 C 5.3900 1.3338 0.0 0
M  V30 13 O 3.0800 5.3347 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 2.3100 1.3338 0.0 0
M  V30 16 C 4.6200 0.0000 0.0 0
M  V30 17 C 3.0800 0.0000 0.0 0
M  V30 18 C 8.4700 4.0011 0.0 0
M  V30 19 C 9.2400 2.6674 0.0 0
M  V30 20 C 9.2400 5.3347 0.0 0
M  V30 21 C 10.7800 2.6674 0.0 0
M  V30 22 C 10.7800 5.3347 0.0 0
M  V30 23 C 11.5500 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 1 18
M  V30 5 2 4 10
M  V30 6 2 5 6
M  V30 7 1 5 14
M  V30 8 1 7 23
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methyl-N-[2-[(1S)-1-(1-pyrrolidinyl)-2-propen-1-yl]phenyl]benzenesulfonamide
C20H24N2O2S
2112850-14-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 4.0011 0.0 0 CFG=2
M  V30 2 C 4.6798 5.3347 0.0 0
M  V30 3 C 3.9098 6.6685 0.0 0
M  V30 4 N 6.9898 4.0011 0.0 0
M  V30 5 S 8.5298 4.0011 0.0 0 VAL=6
M  V30 6 O 8.5298 2.4611 0.0 0
M  V30 7 O 8.5298 5.5411 0.0 0
M  V30 8 C 14.6898 4.0011 0.0 0
M  V30 9 C 4.6798 2.6674 0.0 0
M  V30 10 C 6.2198 2.6674 0.0 0
M  V30 11 C 3.9098 1.3338 0.0 0
M  V30 12 C 6.9898 1.3338 0.0 0
M  V30 13 C 4.6798 0.0000 0.0 0
M  V30 14 C 6.2198 0.0000 0.0 0
M  V30 15 N 2.3698 4.0011 0.0 0
M  V30 16 C 1.4645 5.2469 0.0 0
M  V30 17 C 1.4645 2.7552 0.0 0
M  V30 18 C 0.0000 4.7711 0.0 0
M  V30 19 C 0.0000 3.2311 0.0 0
M  V30 20 C 10.0698 4.0011 0.0 0
M  V30 21 C 10.8398 2.6674 0.0 0
M  V30 22 C 10.8398 5.3347 0.0 0
M  V30 23 C 12.3798 2.6674 0.0 0
M  V30 24 C 12.3798 5.3347 0.0 0
M  V30 25 C 13.1498 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 1 15 CFG=1
M  V30 4 2 2 3
M  V30 5 1 4 5
M  V30 6 1 4 10
M  V30 7 2 5 6
M  V30 8 2 5 7
M  V30 9 1 5 20
M  V30 10 1 8 25
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1038502-72-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2112850-14-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-17553225
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1360145-09-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, branch-selective, optimization study,
scalable
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydrogen Bond Direction Enables Palladium-Catalyzed Branch- and
Enantioselective Allylic Aminations and Beyond
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Ya-Ni; Wang, Bao-Cheng; Zhang, Mao-Mao; Gao, Xiao-Wen; Li,
Tian-Ren; Lu, Liang-Qiu; Xiao, Wen-Jing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(15), 4094-4097

$RFMT $RIREG SCHEME331 STEP1
$RXN



  2  1
$MOL
4-Chlorophenyl isocyanate
C7H4ClNO
104-12-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 O 8.0022 1.5400 0.0 0
M  V30 4 Cl 0.0000 0.0000 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 C 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 2 2 3
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)-1-pyrrolidinecarboxamide
C11H13ClN2O
35640-09-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 2.6673 0.0 0
M  V30 2 N 4.6798 1.3337 0.0 0
M  V30 3 O 4.6798 4.0010 0.0 0
M  V30 4 Cl 10.8399 1.3337 0.0 0
M  V30 5 N 2.3698 2.6673 0.0 0
M  V30 6 C 1.4646 1.4214 0.0 0
M  V30 7 C 1.4646 3.9132 0.0 0
M  V30 8 C 0.0000 1.8973 0.0 0
M  V30 9 C 0.0000 3.4373 0.0 0
M  V30 10 C 6.2198 1.3337 0.0 0
M  V30 11 C 6.9898 0.0000 0.0 0
M  V30 12 C 6.9898 2.6673 0.0 0
M  V30 13 C 8.5299 0.0000 0.0 0
M  V30 14 C 8.5299 2.6673 0.0 0
M  V30 15 C 9.2999 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 10
M  V30 5 1 4 15
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-12-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 35640-09-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-316-CAS-16226944
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2032423-94-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk flask used, glovebox used, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydroamination of carbodiimides, isocyanates, and isothiocyanates by a
bis(phosphinoselenoic amide) supported titanium(IV) complex
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bhattacharjee, Jayeeta; Das, Suman; Kottalanka, Ravi K.; Panda, Tarun K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2016), 45(44), 17824-17832

$RFMT $RIREG SCHEME332 STEP1
$RXN



  2  1
$MOL
p-Toluenesulfonic acid
C7H8O3S
104-15-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 2 O 1.5400 3.0800 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 O 0.0000 1.5400 0.0 0
M  V30 5 C 7.7000 1.5400 0.0 0
M  V30 6 C 3.0800 1.5400 0.0 0
M  V30 7 C 3.8500 0.2064 0.0 0
M  V30 8 C 3.8500 2.8736 0.0 0
M  V30 9 C 5.3900 0.2064 0.0 0
M  V30 10 C 5.3900 2.8736 0.0 0
M  V30 11 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 1 6
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 4-methylbenzenesulfonate
C7H8O3S.C4H9N
195515-34-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6041 5.5252 0.0 0
M  V30 2 C 3.8500 4.6200 0.0 0
M  V30 3 C 3.0800 6.9898 0.0 0
M  V30 4 C 5.0959 5.5252 0.0 0
M  V30 5 N 4.6200 6.9898 0.0 0
M  V30 6 S 1.5400 1.5400 0.0 0 VAL=6
M  V30 7 O 1.5400 3.0800 0.0 0
M  V30 8 O 1.5400 0.0000 0.0 0
M  V30 9 O 0.0000 1.5400 0.0 0
M  V30 10 C 7.7000 1.5400 0.0 0
M  V30 11 C 3.0800 1.5400 0.0 0
M  V30 12 C 3.8500 0.2064 0.0 0
M  V30 13 C 3.8500 2.8736 0.0 0
M  V30 14 C 5.3900 0.2064 0.0 0
M  V30 15 C 5.3900 2.8736 0.0 0
M  V30 16 C 6.1600 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 6 2 6 7
M  V30 7 2 6 8
M  V30 8 1 6 9
M  V30 9 1 6 11
M  V30 10 1 10 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 195515-34-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26929882
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Secondary amine salt catalyzed controlled activation of 2-deoxy sugar
lactols towardsαselective dehydrative glycosylation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghosh, Titli; Mukherji, Ananya; Srivastava, Hemant Kumar; Kancharla,
Pavan K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2018), 16(16), 2870-2875

$RFMT $RIREG SCHEME333 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Benzoic acid, 4-(chlorosulfonyl)-, ethyl ester
C9H9ClO4S
10486-51-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 2.6673 0.0 0
M  V30 2 O 8.4700 1.3336 0.0 0
M  V30 3 O 8.4700 4.0011 0.0 0
M  V30 4 C 10.0100 1.3336 0.0 0
M  V30 5 C 10.7800 0.0000 0.0 0
M  V30 6 S 1.5400 2.6673 0.0 0 VAL=6
M  V30 7 Cl 0.0000 2.6673 0.0 0
M  V30 8 O 1.5400 4.2073 0.0 0
M  V30 9 O 1.5400 1.1273 0.0 0
M  V30 10 C 6.1600 2.6673 0.0 0
M  V30 11 C 5.3900 4.0011 0.0 0
M  V30 12 C 5.3900 1.3336 0.0 0
M  V30 13 C 3.8500 4.0011 0.0 0
M  V30 14 C 3.8500 1.3336 0.0 0
M  V30 15 C 3.0800 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 2 6 9
M  V30 9 1 6 15
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 4-(1-pyrrolidinylsulfonyl)benzoate
C13H17NO4S
460998-12-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 3.9098 2.6673 0.0 0 VAL=6
M  V30 2 O 3.9098 1.1273 0.0 0
M  V30 3 O 3.9098 4.2073 0.0 0
M  V30 4 C 10.0698 2.6673 0.0 0
M  V30 5 O 10.8398 1.3336 0.0 0
M  V30 6 O 10.8398 4.0011 0.0 0
M  V30 7 C 12.3798 1.3336 0.0 0
M  V30 8 C 13.1498 0.0000 0.0 0
M  V30 9 C 5.4498 2.6673 0.0 0
M  V30 10 C 6.2198 4.0011 0.0 0
M  V30 11 C 6.2198 1.3336 0.0 0
M  V30 12 C 7.7598 4.0011 0.0 0
M  V30 13 C 7.7598 1.3336 0.0 0
M  V30 14 C 8.5298 2.6673 0.0 0
M  V30 15 N 2.3698 2.6673 0.0 0
M  V30 16 C 1.4645 3.9131 0.0 0
M  V30 17 C 1.4645 1.4214 0.0 0
M  V30 18 C 0.0000 3.4373 0.0 0
M  V30 19 C 0.0000 1.8973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 15
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 14
M  V30 8 1 5 7
M  V30 9 1 7 8
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 13
M  V30 14 2 12 14
M  V30 15 1 13 14
M  V30 16 1 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 10486-51-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 460998-12-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31331216
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Identification of thiophene-benzenesulfonamide derivatives for the
treatment of multidrug-resistant tuberculosis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Qin, Rongfei; Wang, Pengxu; Wang, Bin; Fu, Lei; Batt, Sarah M.; Besra,
Gurdyal S.; Wu, Chengwei; Wang, Yanan; Huang, Haihong; Lu, Yu; Li, Gang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2022), 231114145

$RFMT $RIREG SCHEME334 STEP1
$RXN



  3  1
$MOL
4-Methylbenzaldehyde
C8H8O
104-87-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 C 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Decyne
C10H18
764-93-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 0.7700 0.0 0
M  V30 2 C 5.3348 1.5400 0.0 0
M  V30 3 C 8.0022 1.5400 0.0 0
M  V30 4 C 4.0012 0.7700 0.0 0
M  V30 5 C 9.3360 0.7700 0.0 0
M  V30 6 C 2.6673 1.5400 0.0 0
M  V30 7 C 10.6697 1.5400 0.0 0
M  V30 8 C 1.3337 0.7700 0.0 0
M  V30 9 C 12.0033 0.7700 0.0 0
M  V30 10 C 0.0000 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 3 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-(4-Methylphenyl)-2-undecyn-1-yl]pyrrolidine
C22H33N
2422198-11-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.9098 0.0 0
M  V30 2 C 6.6685 4.6799 0.0 0
M  V30 3 C 8.0023 5.4499 0.0 0
M  V30 4 C 9.3360 6.2199 0.0 0
M  V30 5 C 10.6697 5.4499 0.0 0
M  V30 6 C 12.0035 6.2199 0.0 0
M  V30 7 C 13.3372 5.4499 0.0 0
M  V30 8 C 14.6708 6.2199 0.0 0
M  V30 9 C 16.0045 5.4499 0.0 0
M  V30 10 C 17.3383 6.2199 0.0 0
M  V30 11 C 18.6720 5.4499 0.0 0
M  V30 12 C 0.0000 6.9899 0.0 0
M  V30 13 C 4.0012 4.6799 0.0 0
M  V30 14 C 2.6675 3.9098 0.0 0
M  V30 15 C 4.0012 6.2199 0.0 0
M  V30 16 C 1.3337 4.6799 0.0 0
M  V30 17 C 2.6675 6.9899 0.0 0
M  V30 18 C 1.3337 6.2199 0.0 0
M  V30 19 N 5.3348 2.3698 0.0 0
M  V30 20 C 4.0889 1.4646 0.0 0
M  V30 21 C 6.5807 1.4646 0.0 0
M  V30 22 C 4.5648 0.0000 0.0 0
M  V30 23 C 6.1048 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 1 1 19
M  V30 4 3 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 12 18
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 20 1 19 20
M  V30 21 1 19 21
M  V30 22 1 20 22
M  V30 23 1 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-87-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 764-93-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2422198-11-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-22471474
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 34946-82-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of propargylamines via the A3 multicomponent reaction and their
biological evaluation as potential anticancer agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martinez-Amezaga, Maitena; Giordano, Rocio A.; Prada Gori, Denis N.;
Permingeat Squizatto, Caterina; Giolito, Maria V.; Scharovsky, O.
Graciela; Rozados, Viviana R.; Rico, Maria J.; Mata, Ernesto G.;
Delpiccolo, Carina M. L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2020), 18(13), 2475-2486

$RFMT $RIREG SCHEME335 STEP1
$RXN



  2  1
$MOL
4-Bromoanisole
C7H7BrO
104-92-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Br 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Methoxyphenyl)pyrrolidine
C11H15NO
54660-04-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 8.5299 1.3337 0.0 0
M  V30 2 C 9.2999 2.6673 0.0 0
M  V30 3 C 3.9098 1.3337 0.0 0
M  V30 4 C 4.6798 2.6673 0.0 0
M  V30 5 C 4.6798 0.0000 0.0 0
M  V30 6 C 6.2198 2.6673 0.0 0
M  V30 7 C 6.2198 0.0000 0.0 0
M  V30 8 C 6.9898 1.3337 0.0 0
M  V30 9 N 2.3698 1.3337 0.0 0
M  V30 10 C 1.4646 2.5795 0.0 0
M  V30 11 C 1.4646 0.0878 0.0 0
M  V30 12 C 0.0000 2.1037 0.0 0
M  V30 13 C 0.0000 0.5636 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 104-92-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54660-04-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39895258
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 124-41-4
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2897656-97-0
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7681-65-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):NOTES
$DATUM glove box used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Room-Temperature Cu-Catalyzed Amination of Aryl Bromides Enabled by
DFT-Guided Ligand Design
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kim, Seoung-Tae; Strauss, Michael J.; Cabre, Albert; Buchwald, Stephen L.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2023), 145(12), 6966-6975

$RFMT $RIREG SCHEME336 STEP1
$RXN



  3  1
$MOL
4-Cyanobenzaldehyde
C8H5NO
105-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9301 1.3337 0.0 0
M  V30 2 N 8.4701 1.3337 0.0 0
M  V30 3 C 0.7700 1.3337 0.0 0
M  V30 4 O 0.0000 2.6673 0.0 0
M  V30 5 C 5.3901 1.3337 0.0 0
M  V30 6 C 4.6201 2.6673 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 3.0800 2.6673 0.0 0
M  V30 9 C 3.0800 0.0000 0.0 0
M  V30 10 C 2.3100 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 5
M  V30 3 2 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Methylindole
C9H9N
933-67-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.0801 0.0 0
M  V30 2 C 2.4782 3.0801 0.0 0
M  V30 3 C 1.1444 2.3101 0.0 0
M  V30 4 C 3.8119 2.3101 0.0 0
M  V30 5 N 2.1579 4.5864 0.0 0
M  V30 6 C 1.1444 0.7700 0.0 0
M  V30 7 C 0.0000 3.3405 0.0 0
M  V30 8 C 3.8119 0.7700 0.0 0
M  V30 9 C 0.6263 4.7473 0.0 0
M  V30 10 C 2.4782 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 10
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(7-Methyl-1H-indol-3-yl)-1-pyrrolidinylmethyl]benzonitrile
C21H21N3
1634687-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.2308 4.9833 0.0 0
M  V30 2 C 0.8242 0.0000 0.0 0
M  V30 3 C 11.3908 4.9833 0.0 0
M  V30 4 N 12.9308 4.9833 0.0 0
M  V30 5 C 4.4608 3.6496 0.0 0
M  V30 6 C 2.9292 3.4886 0.0 0
M  V30 7 C 5.0872 2.2427 0.0 0
M  V30 8 C 2.6091 1.9823 0.0 0
M  V30 9 C 1.7849 4.5191 0.0 0
M  V30 10 N 3.9427 1.2123 0.0 0
M  V30 11 C 1.1444 1.5064 0.0 0
M  V30 12 C 0.3202 4.0431 0.0 0
M  V30 13 C 0.0000 2.5368 0.0 0
M  V30 14 C 6.7708 4.9833 0.0 0
M  V30 15 C 7.5408 3.6496 0.0 0
M  V30 16 C 7.5408 6.3169 0.0 0
M  V30 17 C 9.0808 3.6496 0.0 0
M  V30 18 C 9.0808 6.3169 0.0 0
M  V30 19 C 9.8508 4.9833 0.0 0
M  V30 20 N 4.4608 6.3169 0.0 0
M  V30 21 C 2.9292 6.4779 0.0 0
M  V30 22 C 5.0872 7.7239 0.0 0
M  V30 23 C 2.6091 7.9843 0.0 0
M  V30 24 C 3.9427 8.7543 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 1 14
M  V30 3 1 1 20
M  V30 4 1 2 11
M  V30 5 3 3 4
M  V30 6 1 3 19
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 2 6 9
M  V30 11 1 7 10
M  V30 12 1 8 10
M  V30 13 2 8 11
M  V30 14 1 9 12
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 105-07-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 933-67-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1634687-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-12969353
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-free, solvent-promoted and scalable multicomponent synthesis of
3-aminoalkylated indoles via a Mannich-type reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cao, Jian-Fei; Chen, Yan-Li; Guan, Zhi; He, Yan-Hong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Zeitschrift fuer Naturforschung, B: A Journal of Chemical Sciences
(2014), 69(6), 721-727

$RFMT $RIREG SCHEME337 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-(Bromomethyl)-5-nitrophenyl]morpholine
C11H13BrN2O3
1051900-48-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.0022 5.3901 0.0 0 VAL=5
M  V30 2 O 9.3359 4.6201 0.0 0
M  V30 3 O 8.0022 6.9301 0.0 0
M  V30 4 C 5.3348 0.7700 0.0 0
M  V30 5 Br 6.6684 0.0000 0.0 0
M  V30 6 C 4.0011 4.6201 0.0 0
M  V30 7 C 5.3348 5.3901 0.0 0
M  V30 8 C 4.0011 3.0800 0.0 0
M  V30 9 C 6.6684 4.6201 0.0 0
M  V30 10 C 5.3348 2.3100 0.0 0
M  V30 11 C 6.6684 3.0800 0.0 0
M  V30 12 N 2.6675 5.3901 0.0 0
M  V30 13 C 2.6675 6.9301 0.0 0
M  V30 14 C 1.3337 4.6201 0.0 0
M  V30 15 C 1.3337 7.7001 0.0 0
M  V30 16 C 0.0000 5.3901 0.0 0
M  V30 17 O 0.0000 6.9301 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 4 5
M  V30 5 1 4 10
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 12
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[3-Nitro-5-(1-pyrrolidinylmethyl)phenyl]morpholine
C15H21N3O3
1051900-56-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.0022 5.3901 0.0 0
M  V30 2 N 5.3348 0.7700 0.0 0 VAL=5
M  V30 3 O 4.0010 0.0000 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0010 4.6201 0.0 0
M  V30 6 C 5.3348 5.3901 0.0 0
M  V30 7 C 4.0010 3.0801 0.0 0
M  V30 8 C 6.6685 4.6201 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 6.6685 3.0801 0.0 0
M  V30 11 N 2.6673 5.3901 0.0 0
M  V30 12 C 2.6673 6.9302 0.0 0
M  V30 13 C 1.3337 4.6201 0.0 0
M  V30 14 C 1.3337 7.7002 0.0 0
M  V30 15 C 0.0000 5.3901 0.0 0
M  V30 16 O 0.0000 6.9302 0.0 0
M  V30 17 N 9.3360 4.6201 0.0 0
M  V30 18 C 10.7428 5.2464 0.0 0
M  V30 19 C 9.4969 3.0885 0.0 0
M  V30 20 C 11.7733 4.1020 0.0 0
M  V30 21 C 11.0032 2.7684 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 17
M  V30 3 2 2 3
M  V30 4 2 2 4
M  V30 5 1 2 9
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 5 11
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1051900-48-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1051900-56-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-5298155
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 584-08-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 311-28-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM A mixture of 4-[3-(bromomethyl)-5-nitro-phenyl]morpholine (Method 12, 325
mg, 1.08 mmol), the corresponding amine (1.3 mmol), potassium carbonate
(298 mg, 2.2 mmol) and tetrabutylammonium iodide (30 mg) in acetonitrile
(4 ml) was heated at 45°C for 3 hrs. After cooling, the mixture was
diluted with DCM. The resulting solids were filtered off.
4-[3-Nitro-5-(pyrrolidin-1-ylmethyl)phenyl]morpholine, yield 99%. NMR
(500 MHz, DMSOd6) 1.70 (m, 4H), 2.45 (m, 4H), 3.22 (m, 4H), 3.63 (s, 2H),
3.75 (m,4H), 7.32 (s, 1H), 7.54 (s, 1H), 7.56 (s, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of N,N'-diphenylpyrimidinediamine derivatives for use as
antiproliferative agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ashton, Susan Elizabeth; Barlaam, Bernard Christophe; Cross, Darren
Anthony Edward; Ducray, Richard; East, Simon John; Kettle, Jason Grant;
Pearson, Mark Andrew; Purkiss, Stuart Charles; Wedge, Stephen Robert
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2008104754 A1 2008-09-04

$RFMT $RIREG SCHEME338 STEP1
$RXN



  2  1
$MOL
Methyl acetoacetate
C5H8O3
105-45-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 1.5400 0.0 0
M  V30 2 C 2.6674 2.3100 0.0 0
M  V30 3 O 5.3347 2.3100 0.0 0
M  V30 4 O 4.0011 0.0000 0.0 0
M  V30 5 C 1.3338 1.5400 0.0 0
M  V30 6 C 6.6685 1.5400 0.0 0
M  V30 7 C 0.0000 2.3100 0.0 0
M  V30 8 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Butenoic acid, 3-(1-pyrrolidinyl)-, methyl ester
C9H15NO2
15424-17-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6217 0.0 0
M  V30 2 C 5.1047 1.8517 0.0 0
M  V30 3 C 3.7711 4.1618 0.0 0
M  V30 4 C 6.4385 2.6217 0.0 0
M  V30 5 O 7.7722 1.8517 0.0 0
M  V30 6 O 6.4385 4.1618 0.0 0
M  V30 7 C 9.1059 2.6217 0.0 0
M  V30 8 N 2.4374 1.8517 0.0 0
M  V30 9 C 2.2763 0.3202 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 105-45-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 15424-17-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-9481629
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM (1) Methyl 3-tetrahydropyrrolyl-2-butenoate Methyl acetoacetate (20 g,
172.23 mmol) was dissolved in 250 mL of toluene, and then pyrrolidine (43
ml, 516.70 mmol) and p-toluenesulfonic acid hydrate (about 100 mg) were
added dropwise. After installing a Dean-Stark separator to the reactor,
the reaction mixture was refluxed 140°C. for two days, and then solvent
was removed by concentrating the resulting mixture under a reduced
pressure, thereby to obtain the desired product (29 g, 99%). Methyl
3-tetrahydropyrrolyl-2-butenoate, yield (29 g, 99%). 1H NMR (CDCl3, 300
MHz) δ 4.41 (s, 1H, -C=CH-), 3.57 (s, 3H, -COCH3), 3.32-3.17 (brs, 4H,
pyrrolidine), 2.42 (s, 3H, CH3), 1.89 (s, 4H, pyrrolidine)13C NMR (CDCl3,
300 MHz) δ 169.9, 160.1, 129.3, 128.6, 125.6, 83.0, 50.2, 48.3, 25.5,
17.0
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric reduction of ketoesters using the carbonyl reductase of
Kluyveromyces marxianus to give chiral
dioxodihydroisoindolylmethylhydroxybutyrates.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koh, Hun Yeong; Choi, Kyuno; Cho, Yong Seo; Pae, Ae Nim; Cha, Joo Hwan;
Han, Ye Sun; Lee, Jong Soo; Yun, Hong Chul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030139464 A1 2003-07-24

$RFMT $RIREG SCHEME339 STEP1
$RXN



  2  1
$MOL
Diethyl 1,3-acetonedicarboxylate
C9H14O5
105-50-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 8.0022 2.3101 0.0 0
M  V30 4 O 6.6685 0.0000 0.0 0
M  V30 5 C 4.0010 1.5400 0.0 0
M  V30 6 C 9.3360 1.5400 0.0 0
M  V30 7 O 2.6673 2.3101 0.0 0
M  V30 8 O 4.0010 0.0000 0.0 0
M  V30 9 O 10.6697 2.3101 0.0 0
M  V30 10 O 9.3360 0.0000 0.0 0
M  V30 11 C 1.3337 1.5400 0.0 0
M  V30 12 C 12.0033 1.5400 0.0 0
M  V30 13 C 0.0000 2.3101 0.0 0
M  V30 14 C 13.3370 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 9 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,5-Diethyl 3-(1-pyrrolidinyl)-2-pentenedioate
C13H21NO4
42353-61-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 3.7710 0.0 0
M  V30 2 C 6.9300 3.7710 0.0 0
M  V30 3 C 4.6200 5.1046 0.0 0
M  V30 4 C 7.7000 5.1046 0.0 0
M  V30 5 C 3.0800 5.1046 0.0 0
M  V30 6 O 9.2400 5.1046 0.0 0
M  V30 7 O 6.9300 6.4384 0.0 0
M  V30 8 O 2.3100 6.4384 0.0 0
M  V30 9 O 2.3100 3.7710 0.0 0
M  V30 10 C 10.0100 6.4384 0.0 0
M  V30 11 C 0.7700 6.4384 0.0 0
M  V30 12 C 11.5500 6.4384 0.0 0
M  V30 13 C 0.0000 7.7721 0.0 0
M  V30 14 N 4.6200 2.4374 0.0 0
M  V30 15 C 5.2463 1.0304 0.0 0
M  V30 16 C 3.0885 2.2764 0.0 0
M  V30 17 C 4.1019 0.0000 0.0 0
M  V30 18 C 2.7683 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3 CFG=2
M  V30 3 1 1 14
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 10
M  V30 11 1 8 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 1 16 18
M  V30 18 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 105-50-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 42353-61-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-1915691
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Dean-Stark water separator used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new 3-(ethoxycarbonylmethyl)isoxazolopyridone as a precursor to
acylpyridones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jones, Raymond C. F.; Iley, James N.; Loizou, Georgia
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Heterocycles (2012), 84(2), 1235-1244

$RFMT $RIREG SCHEME340 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]thioxo...
C37H43N3O7S2
1060769-19-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 53 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.7533 5.2308 0.0 0
M  V30 2 O 5.7533 6.7708 0.0 0
M  V30 3 C 7.0869 7.5408 0.0 0
M  V30 4 N 7.0869 9.0808 0.0 0
M  V30 5 O 8.4206 6.7708 0.0 0
M  V30 6 C 8.4206 9.8508 0.0 0 CFG=1
M  V30 7 C 8.4206 11.3908 0.0 0
M  V30 8 C 9.7544 9.0808 0.0 0
M  V30 9 O 7.0869 12.1608 0.0 0
M  V30 10 O 9.7544 12.1608 0.0 0
M  V30 11 C 11.0880 9.8508 0.0 0
M  V30 12 C 7.0869 13.7008 0.0 0
M  V30 13 C 12.4216 9.0808 0.0 0
M  V30 14 C 5.7533 14.4708 0.0 0
M  V30 15 N 13.7554 9.8508 0.0 0
M  V30 16 C 5.7533 16.0108 0.0 0
M  V30 17 C 13.7554 11.3908 0.0 0
M  V30 18 N 15.0891 12.1608 0.0 0
M  V30 19 S 12.4216 12.1608 0.0 0
M  V30 20 S 16.4227 11.3908 0.0 0 VAL=6
M  V30 21 O 15.6527 10.0571 0.0 0
M  V30 22 O 17.1927 12.7244 0.0 0
M  V30 23 C 19.0902 12.9308 0.0 0
M  V30 24 C 16.4227 8.3108 0.0 0
M  V30 25 C 19.0902 6.7708 0.0 0
M  V30 26 C 23.9381 8.8204 0.0 0
M  V30 27 C 23.9381 10.8812 0.0 0
M  V30 28 C 4.4196 4.4608 0.0 0
M  V30 29 C 3.0127 5.0872 0.0 0
M  V30 30 C 4.2586 2.9292 0.0 0
M  V30 31 C 1.9823 3.9427 0.0 0
M  V30 32 C 2.5368 6.5518 0.0 0
M  V30 33 C 2.7523 2.6091 0.0 0
M  V30 34 C 5.2891 1.7849 0.0 0
M  V30 35 C 0.4759 4.2629 0.0 0
M  V30 36 C 1.0306 6.8719 0.0 0
M  V30 37 C 2.2764 1.1444 0.0 0
M  V30 38 C 4.8133 0.3202 0.0 0
M  V30 39 C 0.0000 5.7276 0.0 0
M  V30 40 C 3.3068 0.0000 0.0 0
M  V30 41 C 17.7564 10.6208 0.0 0
M  V30 42 C 19.0902 11.3908 0.0 0
M  V30 43 C 17.7564 9.0808 0.0 0
M  V30 44 C 20.4238 10.6208 0.0 0
M  V30 45 C 19.0902 8.3108 0.0 0
M  V30 46 C 20.4238 9.0808 0.0 0
M  V30 47 C 21.8883 11.0966 0.0 0
M  V30 48 O 21.8883 8.6049 0.0 0
M  V30 49 C 22.7935 9.8508 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 28
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 4 CFG=3
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 11
M  V30 12 1 9 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 17 18
M  V30 19 2 17 19
M  V30 20 1 18 20
M  V30 21 2 20 21
M  V30 22 2 20 22
M  V30 23 1 20 41
M  V30 24 1 23 42
M  V30 25 1 24 43
M  V30 26 1 25 45
M  V30 27 1 26 49
M  V30 28 1 27 49
M  V30 29 1 28 29
M  V30 30 1 28 30
M  V30 31 1 29 31
M  V30 32 2 29 32
M  V30 33 1 30 33
M  V30 34 2 30 34
M  V30 35 1 31 33
M  V30 36 2 31 35
M  V30 37 1 32 36
M  V30 38 2 33 37
M  V30 39 1 34 38
M  V30 40 1 35 39
M  V30 41 2 36 39
M  V30 42 1 37 40
M  V30 43 2 38 40
M  V30 44 1 41 42
M  V30 45 2 41 43
M  V30 46 2 42 44
M  V30 47 1 43 45
M  V30 48 1 44 46
M  V30 49 1 44 47
M  V30 50 2 45 46
M  V30 51 1 46 48
M  V30 52 1 47 49
M  V30 53 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]-1-pyr...
C41H50N4O7S
1060769-36-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  53 58 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 18.1849 5.3900 0.0 0
M  V30 2 O 16.8512 4.6200 0.0 0
M  V30 3 C 15.5174 5.3900 0.0 0
M  V30 4 N 14.1838 4.6200 0.0 0
M  V30 5 O 15.5174 6.9300 0.0 0
M  V30 6 C 12.8501 5.3900 0.0 0 CFG=2
M  V30 7 C 12.8501 6.9300 0.0 0
M  V30 8 C 11.5165 4.6200 0.0 0
M  V30 9 C 11.5165 7.7000 0.0 0
M  V30 10 O 11.5165 3.0800 0.0 0
M  V30 11 O 10.1827 5.3900 0.0 0
M  V30 12 C 11.5165 9.2400 0.0 0
M  V30 13 C 10.1827 2.3100 0.0 0
M  V30 14 N 10.1827 10.0101 0.0 0
M  V30 15 C 10.1827 0.7700 0.0 0
M  V30 16 C 10.1827 11.5501 0.0 0
M  V30 17 C 8.8490 0.0000 0.0 0
M  V30 18 N 8.8490 12.3201 0.0 0
M  V30 19 S 7.5154 11.5501 0.0 0 VAL=6
M  V30 20 O 6.7454 12.8837 0.0 0
M  V30 21 O 8.2854 10.2164 0.0 0
M  V30 22 C 4.8479 13.0901 0.0 0
M  V30 23 C 7.5154 8.4700 0.0 0
M  V30 24 C 4.8479 6.9300 0.0 0
M  V30 25 C 0.0000 8.9795 0.0 0
M  V30 26 C 0.0000 11.0405 0.0 0
M  V30 27 C 19.5185 4.6200 0.0 0
M  V30 28 C 19.6796 3.0885 0.0 0
M  V30 29 C 20.9255 5.2463 0.0 0
M  V30 30 C 21.1859 2.7682 0.0 0
M  V30 31 C 18.6490 1.9440 0.0 0
M  V30 32 C 21.9559 4.1020 0.0 0
M  V30 33 C 21.4013 6.7110 0.0 0
M  V30 34 C 21.6618 1.3036 0.0 0
M  V30 35 C 19.1249 0.4794 0.0 0
M  V30 36 C 23.4623 4.4221 0.0 0
M  V30 37 C 22.9076 7.0312 0.0 0
M  V30 38 C 20.6313 0.1591 0.0 0
M  V30 39 C 23.9382 5.8867 0.0 0
M  V30 40 N 11.5165 12.3201 0.0 0
M  V30 41 C 12.9233 11.6936 0.0 0
M  V30 42 C 11.6774 13.8516 0.0 0
M  V30 43 C 13.9537 12.8381 0.0 0
M  V30 44 C 13.1837 14.1718 0.0 0
M  V30 45 C 6.1817 10.7801 0.0 0
M  V30 46 C 4.8479 11.5501 0.0 0
M  V30 47 C 6.1817 9.2400 0.0 0
M  V30 48 C 3.5143 10.7801 0.0 0
M  V30 49 C 4.8479 8.4700 0.0 0
M  V30 50 C 3.5143 9.2400 0.0 0
M  V30 51 C 2.0498 11.2559 0.0 0
M  V30 52 O 2.0498 8.7642 0.0 0
M  V30 53 C 1.1445 10.0101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 27
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 6 4 CFG=3
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 8 11
M  V30 12 1 9 12
M  V30 13 1 10 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16 CFG=2
M  V30 17 2 15 17
M  V30 18 1 16 18
M  V30 19 1 16 40
M  V30 20 1 18 19
M  V30 21 2 19 20
M  V30 22 2 19 21
M  V30 23 1 19 45
M  V30 24 1 22 46
M  V30 25 1 23 47
M  V30 26 1 24 49
M  V30 27 1 25 53
M  V30 28 1 26 53
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 2 28 31
M  V30 33 1 29 32
M  V30 34 2 29 33
M  V30 35 1 30 32
M  V30 36 2 30 34
M  V30 37 1 31 35
M  V30 38 2 32 36
M  V30 39 1 33 37
M  V30 40 1 34 38
M  V30 41 2 35 38
M  V30 42 1 36 39
M  V30 43 2 37 39
M  V30 44 1 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 44
M  V30 49 1 45 46
M  V30 50 2 45 47
M  V30 51 2 46 48
M  V30 52 1 47 49
M  V30 53 1 48 50
M  V30 54 1 48 51
M  V30 55 2 49 50
M  V30 56 1 50 52
M  V30 57 1 51 53
M  V30 58 1 52 53
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 6)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1060769-19-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1060769-36-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-17072
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: L-Allyl
2-(((9H-Fluoren-9-yl)methoxy)carbonylamino)-5-(3-
benzyl-2-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-ylsulfonyl)
guanidino)pentanoate (2). Thiourea 1 (250 mg, 0.35 mmol) was dissolved in
CH2Cl2 (5 mL) and the solution was treated with EDCI (136 mg, 0.70 mmol)
followed by benzylamine (78 μL, 0.70 mmol). Immediate TLC analysis
indicated complete consumption of the starting material along with
formation of a slightly more polar species (Rf 0.54, 1:1 EtOAc/hexane).
The mixture was concentrated under vacuum and applied directly to a
silica column eluting with a gradient of 1:1 to 2:1 EtOAc/hexane.
Following solvent removal the title compound was obtained as a white
nanocrystalline foam (265 mg, 97%). Compound 11: L-allyl
2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(N'-(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-ylsulfonyl)pyrrolidine-1-carboximidamido)pentanoate
Analytical data: White nanocrystalline foam, Mp 65-67 °C; 1H NMR (300
MHz, CDCl3) δ 8.60 (s, 1H), 7.76-7.74 (m, 2H), 7.62-7.60 (m, 2H),
7.40-7.36 (m, 2H), 7.31-7.24 (m, 2H), 6.63 (t, 1H, J = 5.2 Hz), 5.97-5.82
(m, 1H), 5.70 (br d, 1H, J = 8.0 Hz), 5.37-5.20 (m, 2H), 4.64 (d, 2H, J =
5.5 Hz), 4.48-4.26 (m, 3H), 4.22 (t, 1H, J = 6.9 Hz), 3.45-3.33 (m, 4H),
3.28-3.04 (s, 2H), 2.92 (s, 2H), 2.62 (s, 3H), 2.54 (s, 3H), 2.08 (s,
3H), 2.00- 1.48 (m, 8H), 1.44 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 172.0,
158.7, 157.8, 156.4, 144.1, 144.0, 141.5, 138.5, 133.9, 132.4, 131.7,
127.9, 127.3, 125.4, 124.7, 120.2, 119.3, 117.6, 86.5, 67.4, 66.4, 53.8,
49.4, 47.4, 44.4, 43.4, 30.1, 29.7, 28.8, 26.6, 25.6, 19.5, 18.3, 12.7;
HRMS (MALDI) Calcd for C41H51N4O7S [M+H]+, 743.3479, found 743.3488.
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of NG-substituted L-arginine analogs suitable for solid phase
peptide synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Martin, Nathaniel I.; Liskamp, Rob M. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2008), 73(19), 7849-7851

$RFMT $RIREG SCHEME341 STEP1
$RXN



  3  1
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Silane, ethynyl-
C2H4Si
1066-27-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  3 2 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.5400 0.0000 0.0 0
M  V30 2 C 0.0000 0.0000 0.0 0
M  V30 3 Si 3.0800 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1′-(2-Butyne-1,4-diyl)bis[pyrrolidine]
C12H20N2
51-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 0.3117 0.0 0
M  V30 2 C 5.1048 1.0817 0.0 0
M  V30 3 C 6.4384 1.8517 0.0 0
M  V30 4 C 7.7721 2.6218 0.0 0
M  V30 5 N 2.4373 1.0817 0.0 0
M  V30 6 C 1.0304 0.4554 0.0 0
M  V30 7 C 2.2763 2.6133 0.0 0
M  V30 8 C 0.0000 1.5998 0.0 0
M  V30 9 C 0.7700 2.9335 0.0 0
M  V30 10 N 9.1059 1.8517 0.0 0
M  V30 11 C 10.5128 2.4781 0.0 0
M  V30 12 C 9.2669 0.3202 0.0 0
M  V30 13 C 11.5432 1.3337 0.0 0
M  V30 14 C 10.7732 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 3 2 3
M  V30 4 1 3 4
M  V30 5 1 4 10
M  V30 6 1 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1066-27-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 51-73-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28514175
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 866641-66-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM optimization study, optimized on catalyst, optimized on solvent,
optimized on time
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of Tremorine and Gemini Surfactant Precursors with Cationic
Ethynyl-Bridged Digold Catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Grirrane, Abdessamad; Alvarez, Eleuterio; Garcia, Hermenegildo; Corma,
Avelino
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2017), 23(12), 2792-2801

$RFMT $RIREG SCHEME342 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(Trimethylsilyl)acetylene
C5H10Si
1066-54-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  6 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Si 1.5400 1.5400 0.0 0
M  V30 2 C 3.0800 1.5400 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 C 1.5400 0.0000 0.0 0
M  V30 5 C 1.5400 3.0800 0.0 0
M  V30 6 C 4.6200 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 3 2 6
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Indole-5-carboxaldehyde
C9H7NO
1196-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.3709 3.0800 0.0 0
M  V30 2 O 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 C 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 N 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-[1-(1-Pyrrolidinyl)-3-(trimethylsilyl)-2-propyn-1-yl]-1H-indole
C18H24N2Si
1449427-34-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.1456 3.9099 0.0 0
M  V30 2 C 6.4793 4.6799 0.0 0
M  V30 3 C 7.8129 5.4499 0.0 0
M  V30 4 Si 9.1466 6.2199 0.0 0
M  V30 5 C 10.4804 6.9899 0.0 0
M  V30 6 C 9.9166 4.8863 0.0 0
M  V30 7 C 8.3766 7.5536 0.0 0
M  V30 8 C 3.8118 4.6799 0.0 0
M  V30 9 C 3.8118 6.2199 0.0 0
M  V30 10 C 2.4782 3.9099 0.0 0
M  V30 11 C 2.4782 6.9899 0.0 0
M  V30 12 C 1.1445 4.6799 0.0 0
M  V30 13 C 1.1445 6.2199 0.0 0
M  V30 14 C 2.1580 8.4962 0.0 0
M  V30 15 N 0.0000 7.2504 0.0 0
M  V30 16 C 0.6265 8.6573 0.0 0
M  V30 17 N 5.1456 2.3699 0.0 0
M  V30 18 C 3.8996 1.4647 0.0 0
M  V30 19 C 6.3915 1.4647 0.0 0
M  V30 20 C 4.3756 0.0000 0.0 0
M  V30 21 C 5.9156 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 17
M  V30 4 3 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 4 6
M  V30 8 1 4 7
M  V30 9 1 8 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 11 14
M  V30 15 2 12 13
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1066-54-2
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1196-69-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1449427-34-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-12579946
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 10294-28-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of indole-2-, 3-, or 5-substituted propargylamines via
gold(III)-catalyzed three component reaction of aldehyde, alkyne, and
amine in aqueous medium
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Srinivas, Venu; Koketsu, Mamoru
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2013), 69(37), 8025-8033

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Acrylonitrile
C3H3N
107-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinepropanenitrile
C7H12N2
26165-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4386 2.6218 0.0 0
M  V30 4 N 7.7722 3.3918 0.0 0
M  V30 5 N 2.4374 1.8517 0.0 0
M  V30 6 C 2.2765 0.3202 0.0 0
M  V30 7 C 1.0304 2.4782 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 107-13-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 26165-45-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-20803030
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7782-44-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 7440-57-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, solid-supported catalyst, catalyst prepared and used,
cellulose nanofibers support used, aza-Michael reaction, conversion
(99%), selectivity (100%), reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Green synthesis of Ag@Au bimetallic regenerated cellulose nanofibers for
catalytic applications
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Gopiraman, Mayakrishnan; Saravanamoorthy, Somasundaram; Baskar,
Ramaganthan; Ilangovan, Andivelu; Ill-Min, Chung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM New Journal of Chemistry (2019), 43(43), 17090-17103

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Acrylonitrile
C3H3N
107-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinepropanenitrile
C7H12N2
26165-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4386 2.6218 0.0 0
M  V30 4 N 7.7722 3.3918 0.0 0
M  V30 5 N 2.4374 1.8517 0.0 0
M  V30 6 C 2.2765 0.3202 0.0 0
M  V30 7 C 1.0304 2.4782 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 107-13-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 26165-45-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-15277469
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1522464-83-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 1665-00-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, optimization study, optimized on solvent and time, sealed
tube used in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Easily available nickel complexes as catalysts for the intermolecular
hydroamination of alkenes and alkynes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Reyes-Sanchez, Adan; Garcia-Ventura, Ilnett; Garcia, Juventino J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dalton Transactions (2014), 43(4), 1762-1768

$RFMT $RIREG SCHEME343 STEP1
$RXN



  2  1
$MOL
Acrylonitrile
C3H3N
107-13-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6673 0.0000 0.0 0
M  V30 2 C 1.3337 0.7700 0.0 0
M  V30 3 C 4.0010 0.7700 0.0 0
M  V30 4 N 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 3 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinepropanenitrile
C7H12N2
26165-45-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 6.4386 2.6218 0.0 0
M  V30 4 N 7.7722 3.3918 0.0 0
M  V30 5 N 2.4374 1.8517 0.0 0
M  V30 6 C 2.2765 0.3202 0.0 0
M  V30 7 C 1.0304 2.4782 0.0 0
M  V30 8 C 0.7700 0.0000 0.0 0
M  V30 9 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 2 3
M  V30 4 3 3 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 107-13-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 26165-45-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-7004105
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, aza-Michael reaction, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of β-amino acids via catalyst- and solvent-free aza-michael
reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zou, Bo; Jiang, Huan-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Chemistry (2008), 26(7), 1309-1314

$RFMT $RIREG SCHEME344 STEP1
$RXN



  3  1
$MOL
Propargyl alcohol
C3H4O
107-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  4 3 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 0.7700 0.0 0
M  V30 2 C 2.6673 0.0000 0.0 0
M  V30 3 C 0.0000 1.5400 0.0 0
M  V30 4 O 4.0010 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 3 1 3
M  V30 3 1 2 4
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohexanecarboxaldehyde
C7H12O
2043-61-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 O 5.3901 2.6673 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 2.3101 2.6673 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 C 0.7700 2.6673 0.0 0
M  V30 7 C 0.7700 0.0000 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4S)-4-Cyclohexyl-4-(1-pyrrolidinyl)-2-butyn-1-ol
C14H23NO
1467762-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.9098 0.0 0 CFG=2
M  V30 2 C 5.3347 4.6798 0.0 0
M  V30 3 C 6.6684 5.4498 0.0 0
M  V30 4 C 8.0022 6.2198 0.0 0
M  V30 5 O 9.3358 5.4498 0.0 0
M  V30 6 N 4.0011 2.3698 0.0 0
M  V30 7 C 2.7552 1.4645 0.0 0
M  V30 8 C 5.2470 1.4645 0.0 0
M  V30 9 C 3.2311 0.0000 0.0 0
M  V30 10 C 4.7711 0.0000 0.0 0
M  V30 11 C 2.6674 4.6798 0.0 0
M  V30 12 C 2.6674 6.2198 0.0 0
M  V30 13 C 1.3336 3.9098 0.0 0
M  V30 14 C 1.3336 6.9898 0.0 0
M  V30 15 C 0.0000 4.6798 0.0 0
M  V30 16 C 0.0000 6.2198 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6 CFG=1
M  V30 3 1 1 11
M  V30 4 3 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 107-19-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 2043-61-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1467762-80-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-25516853
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7787-70-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 2568347-80-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, molecular sieves used, catalyst prepared and used, %ee =
94%, reaction in a Schlenk tube, alternate reaction conditions gave lower
yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Pyrinap ligands for enantioselective syntheses of amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Liu, Qi; Xu, Haibo; Li, Yuling; Yao, Yuan; Zhang, Xue; Guo, Yinlong; Ma,
Shengming
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Nature Communications (2021), 12(1), 19

$RFMT $RIREG SCHEME345 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chlorostyrene
C8H7Cl
1073-67-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 1.3337 0.0 0
M  V30 2 C 0.0000 2.6673 0.0 0
M  V30 3 Cl 6.9302 1.3337 0.0 0
M  V30 4 C 2.3101 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 3.0801 0.0000 0.0 0
M  V30 7 C 4.6201 2.6673 0.0 0
M  V30 8 C 4.6201 0.0000 0.0 0
M  V30 9 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-(4-Chlorophenyl)ethyl]pyrrolidine
C12H16ClN
1187305-02-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 2.5795 0.0 0
M  V30 2 C 3.9098 1.2459 0.0 0
M  V30 3 Cl 10.8398 2.5795 0.0 0
M  V30 4 C 6.2198 2.5795 0.0 0
M  V30 5 C 6.9898 3.9132 0.0 0
M  V30 6 C 6.9898 1.2459 0.0 0
M  V30 7 C 8.5298 3.9132 0.0 0
M  V30 8 C 8.5298 1.2459 0.0 0
M  V30 9 C 9.2998 2.5795 0.0 0
M  V30 10 N 2.3698 1.2459 0.0 0
M  V30 11 C 1.4645 2.4917 0.0 0
M  V30 12 C 1.4645 0.0000 0.0 0
M  V30 13 C 0.0000 2.0159 0.0 0
M  V30 14 C 0.0000 0.4759 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 10
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1073-67-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1187305-02-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41528588
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3037071-70-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, no solvent, glove box used, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Approach to Substrate Activation or How Heterobimetallic Complexes
{[(p-tBu-C6H4)2CH]3M}K (M = Ca and Yb) Make Intermolecular Olefin
Hydroamination and NH3 Cascade Hydroamination/Hydroaminomethylation
Feasible
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Selikhov, Alexander N.; Cherkasov, Anton V.; Nelyubina, Yulia V.;
Trifonov, Alexander A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2023), 13(19), 12582-12590

$RFMT $RIREG SCHEME346 STEP1
$RXN



  3  1
$MOL
4-Methoxybenzaldehyde
C8H8O2
123-11-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 3.0801 0.0 0
M  V30 2 O 0.0000 2.3101 0.0 0
M  V30 3 O 6.6687 0.0000 0.0 0
M  V30 4 C 8.0023 0.7700 0.0 0
M  V30 5 C 2.6675 2.3101 0.0 0
M  V30 6 C 2.6675 0.7700 0.0 0
M  V30 7 C 4.0012 3.0801 0.0 0
M  V30 8 C 4.0012 0.0000 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 4
M  V30 4 1 3 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxycoumarin
C9H6O3
1076-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 O 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-3-[(4-methoxyphenyl)-1-pyrrolidinylmethyl]-2H-1-benzopyran-2-one
C21H21NO4
906723-52-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.9098 0.0 0
M  V30 2 O 4.0010 2.3698 0.0 0
M  V30 3 O 6.6685 6.9899 0.0 0
M  V30 4 O 12.0033 6.9899 0.0 0
M  V30 5 C 13.3370 6.2199 0.0 0
M  V30 6 C 5.3348 4.6799 0.0 0
M  V30 7 C 4.0010 3.9098 0.0 0
M  V30 8 C 5.3348 6.2199 0.0 0
M  V30 9 C 2.6673 4.6799 0.0 0
M  V30 10 O 4.0010 6.9899 0.0 0
M  V30 11 C 2.6673 6.2199 0.0 0
M  V30 12 C 1.3337 3.9098 0.0 0
M  V30 13 C 1.3337 6.9899 0.0 0
M  V30 14 C 0.0000 4.6799 0.0 0
M  V30 15 C 0.0000 6.2199 0.0 0
M  V30 16 C 8.0022 4.6799 0.0 0
M  V30 17 C 9.3360 3.9098 0.0 0
M  V30 18 C 8.0022 6.2199 0.0 0
M  V30 19 C 10.6697 4.6799 0.0 0
M  V30 20 C 9.3360 6.9899 0.0 0
M  V30 21 C 10.6697 6.2199 0.0 0
M  V30 22 N 6.6685 2.3698 0.0 0
M  V30 23 C 5.4226 1.4646 0.0 0
M  V30 24 C 7.9144 1.4646 0.0 0
M  V30 25 C 5.8985 0.0000 0.0 0
M  V30 26 C 7.4385 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 16
M  V30 3 1 1 22
M  V30 4 1 2 7
M  V30 5 2 3 8
M  V30 6 1 4 5
M  V30 7 1 4 21
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 13 2 9 12
M  V30 14 1 10 11
M  V30 15 2 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-11-5
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1076-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 906723-52-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-15721901
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Methylene-2,4-chromandione in situ trapping: introducing molecular
diversity on 4-hydroxycoumarin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Montagut-Romans, Adrien; Boulven, Manon; Lemaire, Marc; Popowycz,
Florence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(6), 4540-4544

$RFMT $RIREG SCHEME347 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Trifluoromethoxy)benzaldehyde
C8H5F3O2
659-28-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 3.0801 0.0 0
M  V30 2 C 1.3337 2.3101 0.0 0
M  V30 3 F 0.0000 3.0801 0.0 0
M  V30 4 F 0.0000 1.5400 0.0 0
M  V30 5 F 1.3337 0.7700 0.0 0
M  V30 6 C 8.0023 0.0000 0.0 0
M  V30 7 O 9.3360 0.7700 0.0 0
M  V30 8 C 4.0012 2.3101 0.0 0
M  V30 9 C 4.0012 0.7700 0.0 0
M  V30 10 C 5.3348 3.0801 0.0 0
M  V30 11 C 5.3348 0.0000 0.0 0
M  V30 12 C 6.6685 2.3101 0.0 0
M  V30 13 C 6.6685 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 1 2 4
M  V30 5 1 2 5
M  V30 6 2 6 7
M  V30 7 1 6 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxycoumarin
C9H6O3
1076-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 O 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-3-[1-pyrrolidinyl[4-(trifluoromethoxy)phenyl]methyl]-2H-1-benzopyra...
C21H18F3NO4
1874212-63-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.9098 0.0 0
M  V30 2 O 4.0010 2.3698 0.0 0
M  V30 3 O 6.6685 6.9899 0.0 0
M  V30 4 O 12.0033 6.9899 0.0 0
M  V30 5 C 13.3370 6.2199 0.0 0
M  V30 6 F 13.3370 4.6799 0.0 0
M  V30 7 F 14.6707 5.4499 0.0 0
M  V30 8 F 14.6707 6.9899 0.0 0
M  V30 9 C 5.3348 4.6799 0.0 0
M  V30 10 C 4.0010 3.9098 0.0 0
M  V30 11 C 5.3348 6.2199 0.0 0
M  V30 12 C 2.6673 4.6799 0.0 0
M  V30 13 O 4.0010 6.9899 0.0 0
M  V30 14 C 2.6673 6.2199 0.0 0
M  V30 15 C 1.3337 3.9098 0.0 0
M  V30 16 C 1.3337 6.9899 0.0 0
M  V30 17 C 0.0000 4.6799 0.0 0
M  V30 18 C 0.0000 6.2199 0.0 0
M  V30 19 C 8.0022 4.6799 0.0 0
M  V30 20 C 8.0022 6.2199 0.0 0
M  V30 21 C 9.3358 3.9098 0.0 0
M  V30 22 C 9.3358 6.9899 0.0 0
M  V30 23 C 10.6697 4.6799 0.0 0
M  V30 24 C 10.6697 6.2199 0.0 0
M  V30 25 N 6.6685 2.3698 0.0 0
M  V30 26 C 7.9144 1.4646 0.0 0
M  V30 27 C 5.4226 1.4646 0.0 0
M  V30 28 C 7.4385 0.0000 0.0 0
M  V30 29 C 5.8985 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 19
M  V30 3 1 1 25
M  V30 4 1 2 10
M  V30 5 2 3 11
M  V30 6 1 4 5
M  V30 7 1 4 24
M  V30 8 1 5 6
M  V30 9 1 5 7
M  V30 10 1 5 8
M  V30 11 2 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 12 15
M  V30 17 1 13 14
M  V30 18 2 14 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 2 17 18
M  V30 22 2 19 20
M  V30 23 1 19 21
M  V30 24 1 20 22
M  V30 25 2 21 23
M  V30 26 2 22 24
M  V30 27 1 23 24
M  V30 28 1 25 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 1 27 29
M  V30 32 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 659-28-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 1076-38-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1874212-63-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-15721902
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Methylene-2,4-chromandione in situ trapping: introducing molecular
diversity on 4-hydroxycoumarin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Montagut-Romans, Adrien; Boulven, Manon; Lemaire, Marc; Popowycz,
Florence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(6), 4540-4544

$RFMT $RIREG SCHEME348 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxycoumarin
C9H6O3
1076-38-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 0.0000 0.0 0
M  V30 2 O 6.9300 2.6674 0.0 0
M  V30 3 C 2.3100 2.6674 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 C 0.7700 2.6674 0.0 0
M  V30 7 O 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 C 0.0000 4.0011 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 11
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 11
M  V30 13 2 10 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(4-Pyridinyl)benzaldehyde
C12H9NO
99163-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.2402 1.3337 0.0 0
M  V30 2 O 10.0102 2.6673 0.0 0
M  V30 3 C 4.6201 1.3337 0.0 0
M  V30 4 C 5.3901 0.0000 0.0 0
M  V30 5 C 5.3901 2.6673 0.0 0
M  V30 6 C 6.9302 0.0000 0.0 0
M  V30 7 C 6.9302 2.6673 0.0 0
M  V30 8 C 7.7002 1.3337 0.0 0
M  V30 9 C 3.0801 1.3337 0.0 0
M  V30 10 C 2.3101 2.6673 0.0 0
M  V30 11 C 2.3101 0.0000 0.0 0
M  V30 12 C 0.7700 2.6673 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 14 N 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Hydroxy-3-[[4-(4-pyridinyl)phenyl]-1-pyrrolidinylmethyl]-2H-1-benzopyran-2-one
C25H22N2O3
1874212-65-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 34 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.9098 0.0 0
M  V30 2 O 4.0010 2.3698 0.0 0
M  V30 3 O 6.6685 6.9899 0.0 0
M  V30 4 C 5.3348 4.6799 0.0 0
M  V30 5 C 4.0010 3.9098 0.0 0
M  V30 6 C 5.3348 6.2199 0.0 0
M  V30 7 C 2.6673 4.6799 0.0 0
M  V30 8 O 4.0010 6.9899 0.0 0
M  V30 9 C 2.6673 6.2199 0.0 0
M  V30 10 C 1.3337 3.9098 0.0 0
M  V30 11 C 1.3337 6.9899 0.0 0
M  V30 12 C 0.0000 4.6799 0.0 0
M  V30 13 C 0.0000 6.2199 0.0 0
M  V30 14 C 8.0022 4.6799 0.0 0
M  V30 15 C 8.0022 6.2199 0.0 0
M  V30 16 C 9.3358 3.9098 0.0 0
M  V30 17 C 9.3358 6.9899 0.0 0
M  V30 18 C 10.6697 4.6799 0.0 0
M  V30 19 C 10.6697 6.2199 0.0 0
M  V30 20 N 6.6685 2.3698 0.0 0
M  V30 21 C 7.9144 1.4646 0.0 0
M  V30 22 C 5.4226 1.4646 0.0 0
M  V30 23 C 7.4385 0.0000 0.0 0
M  V30 24 C 5.8985 0.0000 0.0 0
M  V30 25 C 12.0033 6.9899 0.0 0
M  V30 26 C 13.3370 6.2199 0.0 0
M  V30 27 C 12.0033 8.5299 0.0 0
M  V30 28 C 14.6707 6.9899 0.0 0
M  V30 29 C 13.3370 9.3000 0.0 0
M  V30 30 N 14.6707 8.5299 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 1 14
M  V30 3 1 1 20
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 2 4 5
M  V30 7 1 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 7 10
M  V30 12 1 8 9
M  V30 13 2 9 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 2 12 13
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 15 17
M  V30 20 2 16 18
M  V30 21 2 17 19
M  V30 22 1 18 19
M  V30 23 1 19 25
M  V30 24 1 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 2 25 27
M  V30 31 2 26 28
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 2 29 30
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1076-38-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 99163-12-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1874212-65-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-096-CAS-15721906
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Mannich reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM 3-Methylene-2,4-chromandione in situ trapping: introducing molecular
diversity on 4-hydroxycoumarin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Montagut-Romans, Adrien; Boulven, Manon; Lemaire, Marc; Popowycz,
Florence
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2016), 6(6), 4540-4544

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
1,3-Dibromobenzene
C6H4Br2
108-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.0800 0.0 0
M  V30 2 Br 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromophenyl)pyrrolidine
C10H12BrN
219928-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 7.7721 3.0800 0.0 0
M  V30 2 C 3.7710 2.3100 0.0 0
M  V30 3 C 5.1046 3.0800 0.0 0
M  V30 4 C 3.7710 0.7700 0.0 0
M  V30 5 C 6.4384 2.3100 0.0 0
M  V30 6 C 5.1046 0.0000 0.0 0
M  V30 7 C 6.4384 0.7700 0.0 0
M  V30 8 N 2.4374 3.0800 0.0 0
M  V30 9 C 2.2764 4.6115 0.0 0
M  V30 10 C 1.0304 2.4535 0.0 0
M  V30 11 C 0.7700 4.9317 0.0 0
M  V30 12 C 0.0000 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 108-36-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 219928-13-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22798485
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 98327-87-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald-Hartwig coupling, sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM PSNCBAM-1 analogs: Structural evolutions and allosteric properties at
cannabinoid CB1 receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Meini, Serena; Gado, Francesca; Stevenson, Lesley A.; Digiacomo, Maria;
Saba, Alessandro; Codini, Simone; Macchia, Marco; Pertwee, Roger G.;
Bertini, Simone; Manera, Clementina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2020), 203112606

$RFMT $RIREG SCHEME349 STEP1
$RXN



  2  1
$MOL
1,3-Dibromobenzene
C6H4Br2
108-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 0.0000 3.0800 0.0 0
M  V30 2 Br 5.3349 3.0800 0.0 0
M  V30 3 C 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(3-Bromophenyl)pyrrolidine
C10H12BrN
219928-13-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 7.7721 3.0800 0.0 0
M  V30 2 C 3.7710 2.3100 0.0 0
M  V30 3 C 5.1046 3.0800 0.0 0
M  V30 4 C 3.7710 0.7700 0.0 0
M  V30 5 C 6.4384 2.3100 0.0 0
M  V30 6 C 5.1046 0.0000 0.0 0
M  V30 7 C 6.4384 0.7700 0.0 0
M  V30 8 N 2.4374 3.0800 0.0 0
M  V30 9 C 2.2764 4.6115 0.0 0
M  V30 10 C 1.0304 2.4535 0.0 0
M  V30 11 C 0.7700 4.9317 0.0 0
M  V30 12 C 0.0000 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 8
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 108-36-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 219928-13-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-18343524
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 98327-87-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1
receptor
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Bertini, Simone; Chicca, Andrea; Gado, Francesca; Arena, Chiara; Nieri,
Daniela; Digiacomo, Maria; Saccomanni, Giuseppe; Zhao, Pingwei; Abood,
Mary E.; Macchia, Marco; Gertsch, Jurg; Manera, Clementina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2017), 25(24), 6427-6434

$RFMT $RIREG SCHEME350 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-4-(phenylmethoxy)pyrimidine
C11H9ClN2O
108381-28-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 4.0012 2.3101 0.0 0
M  V30 3 Cl 10.6697 3.0801 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 N 8.0023 3.0801 0.0 0
M  V30 6 C 6.6685 0.7700 0.0 0
M  V30 7 C 9.3360 2.3101 0.0 0
M  V30 8 C 8.0023 0.0000 0.0 0
M  V30 9 N 9.3360 0.7700 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 2.6673 4.6201 0.0 0
M  V30 12 C 1.3337 2.3101 0.0 0
M  V30 13 C 1.3337 5.3901 0.0 0
M  V30 14 C 0.0000 3.0801 0.0 0
M  V30 15 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 4
M  V30 3 1 2 10
M  V30 4 1 3 7
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(Phenylmethoxy)-2-(1-pyrrolidinyl)pyrimidine
C15H17N3O
2089388-29-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 3.0801 0.0 0
M  V30 2 C 4.0010 2.3101 0.0 0
M  V30 3 C 9.3358 2.3101 0.0 0
M  V30 4 N 8.0022 3.0801 0.0 0
M  V30 5 N 9.3358 0.7700 0.0 0
M  V30 6 C 6.6685 2.3101 0.0 0
M  V30 7 C 8.0022 0.0000 0.0 0
M  V30 8 C 6.6685 0.7700 0.0 0
M  V30 9 N 10.6697 3.0801 0.0 0
M  V30 10 C 10.8306 4.6116 0.0 0
M  V30 11 C 12.0765 2.4537 0.0 0
M  V30 12 C 12.3369 4.9318 0.0 0
M  V30 13 C 13.1069 3.5981 0.0 0
M  V30 14 C 2.6673 3.0801 0.0 0
M  V30 15 C 1.3337 2.3101 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 0.0000 3.0801 0.0 0
M  V30 18 C 1.3337 5.3901 0.0 0
M  V30 19 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 9
M  V30 7 2 4 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 8
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 1 12 13
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 18
M  V30 20 2 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 108381-28-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2089388-29-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-17791034
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cyclopalladation in the Periphery of a NHC Ligand as the Crucial Step in
the Synthesis of Highly Active Suzuki-Miyaura Cross-Coupling Catalysts
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fizia, Agnes; Gaffga, Maximilian; Lang, Johannes; Sun, Yu;
Niedner-Schatteburg, Gereon; Thiel, Werner R.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2017), 23(58), 14563-14575

$RFMT $RIREG SCHEME351 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2S)-2-[(4S,5R)-2,2-Dimethyl-5-tetradecyl-1,3-dioxolan-4-yl]-1-[(2-nitropheny...
C27H44N2O6S
1085301-08-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  38 40 0 0 1
M  V30 BEGIN ATOM
M  V30 1 S 4.6200 5.9119 0.0 0 VAL=6
M  V30 2 O 3.2862 5.1419 0.0 0
M  V30 3 O 5.9536 6.6819 0.0 0
M  V30 4 C 8.5159 5.2529 0.0 0
M  V30 5 C 9.6955 6.2429 0.0 0
M  V30 6 C 11.1427 5.7162 0.0 0
M  V30 7 C 12.3225 6.7061 0.0 0
M  V30 8 C 13.7696 6.1793 0.0 0
M  V30 9 C 14.9492 7.1692 0.0 0
M  V30 10 C 16.3964 6.6425 0.0 0
M  V30 11 C 17.5760 7.6324 0.0 0
M  V30 12 C 19.0232 7.1057 0.0 0
M  V30 13 C 20.2030 8.0956 0.0 0
M  V30 14 C 21.6501 7.5688 0.0 0
M  V30 15 C 22.8297 8.5587 0.0 0
M  V30 16 C 24.2769 8.0320 0.0 0
M  V30 17 C 25.4565 9.0219 0.0 0
M  V30 18 C 10.0605 0.0000 0.0 0
M  V30 19 C 11.4921 1.4826 0.0 0
M  V30 20 N 1.5400 5.9119 0.0 0 VAL=5
M  V30 21 O 2.3100 4.5783 0.0 0
M  V30 22 O 0.0000 5.9119 0.0 0
M  V30 23 C 6.7236 3.8083 0.0 0 CFG=2
M  V30 24 N 5.3900 4.5783 0.0 0
M  V30 25 C 5.3900 3.0383 0.0 0
M  V30 26 C 7.7136 2.6286 0.0 0 CFG=2
M  V30 27 C 8.7832 3.7363 0.0 0 CFG=1
M  V30 28 O 8.4364 1.2688 0.0 0
M  V30 29 O 10.1674 3.0612 0.0 0
M  V30 30 C 9.9530 1.5363 0.0 0
M  V30 31 C 3.8500 7.2457 0.0 0
M  V30 32 C 2.3100 7.2457 0.0 0
M  V30 33 C 4.6200 8.5793 0.0 0
M  V30 34 C 1.5400 8.5793 0.0 0
M  V30 35 C 3.8500 9.9130 0.0 0
M  V30 36 C 2.3100 9.9130 0.0 0
M  V30 37 H 7.7136 4.9879 0.0 0
M  V30 38 H 6.4367 1.7675 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 24
M  V30 4 1 1 31
M  V30 5 1 4 5
M  V30 6 1 27 4 CFG=1
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 1 11 12
M  V30 14 1 12 13
M  V30 15 1 13 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 18 30
M  V30 20 1 19 30
M  V30 21 2 20 21
M  V30 22 2 20 22
M  V30 23 1 20 32
M  V30 24 1 23 24
M  V30 25 1 23 25 CFG=1
M  V30 26 1 23 26
M  V30 27 1 23 37
M  V30 28 1 24 25
M  V30 29 1 26 27
M  V30 30 1 26 28
M  V30 31 1 26 38 CFG=3
M  V30 32 1 27 29
M  V30 33 1 28 30
M  V30 34 1 29 30
M  V30 35 2 31 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 2 33 35
M  V30 39 2 34 36
M  V30 40 1 35 36
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 23 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
N-[(1S)-1-[(4S,5R)-2,2-Dimethyl-5-tetradecyl-1,3-dioxolan-4-yl]-2-(1-pyrrolid...
C31H53N3O6S
1085301-24-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  42 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 4.1618 6.6687 0.0 0 CFG=2
M  V30 2 N 4.9318 5.3348 0.0 0
M  V30 3 C 2.6218 6.6687 0.0 0
M  V30 4 S 4.1618 4.0012 0.0 0 VAL=6
M  V30 5 O 2.8281 4.7712 0.0 0
M  V30 6 O 5.4956 3.2311 0.0 0
M  V30 7 C 6.1778 5.5571 0.0 0
M  V30 8 C 7.5115 4.7870 0.0 0
M  V30 9 C 8.8452 5.5571 0.0 0
M  V30 10 C 10.1789 4.7870 0.0 0
M  V30 11 C 11.5127 5.5571 0.0 0
M  V30 12 C 12.8463 4.7870 0.0 0
M  V30 13 C 14.1800 5.5571 0.0 0
M  V30 14 C 15.5137 4.7870 0.0 0
M  V30 15 C 16.8475 5.5571 0.0 0
M  V30 16 C 18.1812 4.7870 0.0 0
M  V30 17 C 19.5148 5.5571 0.0 0
M  V30 18 C 20.8485 4.7870 0.0 0
M  V30 19 C 22.1823 5.5571 0.0 0
M  V30 20 C 23.5160 4.7870 0.0 0
M  V30 21 C 6.7868 10.9986 0.0 0
M  V30 22 C 8.4542 9.7872 0.0 0
M  V30 23 N 5.7018 1.3338 0.0 0 VAL=5
M  V30 24 O 6.4718 2.6675 0.0 0
M  V30 25 O 6.4718 0.0000 0.0 0
M  V30 26 C 4.9318 8.0023 0.0 0 CFG=2
M  V30 27 C 6.1778 7.0971 0.0 0 CFG=1
M  V30 28 O 5.4078 9.4669 0.0 0
M  V30 29 O 7.4237 8.0023 0.0 0
M  V30 30 C 6.9479 9.4669 0.0 0
M  V30 31 N 1.8517 8.0023 0.0 0
M  V30 32 C 0.3202 8.1633 0.0 0
M  V30 33 C 2.4782 9.4091 0.0 0
M  V30 34 C 0.0000 9.6697 0.0 0
M  V30 35 C 1.3337 10.4397 0.0 0
M  V30 36 C 3.3918 2.6675 0.0 0
M  V30 37 C 4.1618 1.3338 0.0 0
M  V30 38 C 1.8517 2.6675 0.0 0
M  V30 39 C 3.3918 0.0000 0.0 0
M  V30 40 C 1.0817 1.3338 0.0 0
M  V30 41 C 1.8517 0.0000 0.0 0
M  V30 42 H 3.5250 8.6287 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=1
M  V30 3 1 1 26
M  V30 4 1 2 4
M  V30 5 1 3 31
M  V30 6 2 4 5
M  V30 7 2 4 6
M  V30 8 1 4 36
M  V30 9 1 7 8
M  V30 10 1 27 7 CFG=3
M  V30 11 1 8 9
M  V30 12 1 9 10
M  V30 13 1 10 11
M  V30 14 1 11 12
M  V30 15 1 12 13
M  V30 16 1 13 14
M  V30 17 1 14 15
M  V30 18 1 15 16
M  V30 19 1 16 17
M  V30 20 1 17 18
M  V30 21 1 18 19
M  V30 22 1 19 20
M  V30 23 1 21 30
M  V30 24 1 22 30
M  V30 25 2 23 24
M  V30 26 2 23 25
M  V30 27 1 23 37
M  V30 28 1 26 27
M  V30 29 1 26 28
M  V30 30 1 26 42 CFG=1
M  V30 31 1 27 29
M  V30 32 1 28 30
M  V30 33 1 29 30
M  V30 34 1 31 32
M  V30 35 1 31 33
M  V30 36 1 32 34
M  V30 37 1 33 35
M  V30 38 1 34 35
M  V30 39 2 36 37
M  V30 40 1 36 38
M  V30 41 1 37 39
M  V30 42 2 38 40
M  V30 43 2 39 41
M  V30 44 1 40 41
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(3 1 26 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1085301-08-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1085301-24-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-038-CAS-8751966
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, alternative reaction conditions shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A practical access to 1,2-diaminophytosphingolipids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Harrak, Youseff; Llebaria, Amaden; Delgado, Antonio
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Organic Chemistry (2008), (27), 4647-4654

$RFMT $RIREG SCHEME352 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(Chloromethyl)-5-(3-methoxy-4-nitrophenyl)-1,3,4-oxadiazole
C10H8ClN3O4
1089279-03-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3336 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 10.5458 5.6761 0.0 0
M  V30 4 Cl 11.9526 5.0498 0.0 0
M  V30 5 N 0.7700 4.0009 0.0 0 VAL=5
M  V30 6 O 0.0000 5.3347 0.0 0
M  V30 7 O 0.0000 2.6673 0.0 0
M  V30 8 C 5.3900 4.0009 0.0 0
M  V30 9 C 4.6200 2.6673 0.0 0
M  V30 10 C 4.6200 5.3347 0.0 0
M  V30 11 C 3.0800 2.6673 0.0 0
M  V30 12 C 3.0800 5.3347 0.0 0
M  V30 13 C 2.3100 4.0009 0.0 0
M  V30 14 C 6.9300 4.0009 0.0 0
M  V30 15 O 7.8352 5.2469 0.0 0
M  V30 16 N 7.8352 2.7551 0.0 0
M  V30 17 C 9.2998 4.7709 0.0 0
M  V30 18 N 9.2998 3.2309 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 3 4
M  V30 4 1 3 17
M  V30 5 2 5 6
M  V30 6 2 5 7
M  V30 7 1 5 13
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 8 14
M  V30 11 1 9 11
M  V30 12 2 10 12
M  V30 13 2 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 2 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(3-Methoxy-4-nitrophenyl)-5-(1-pyrrolidinylmethyl)-1,3,4-oxadiazole
C14H16N4O4
1089279-07-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.3100 1.3338 0.0 0
M  V30 2 C 3.0800 0.0000 0.0 0
M  V30 3 C 10.5458 5.6763 0.0 0
M  V30 4 N 0.7700 4.0011 0.0 0 VAL=5
M  V30 5 O 0.0000 5.3347 0.0 0
M  V30 6 O 0.0000 2.6674 0.0 0
M  V30 7 C 5.3900 4.0011 0.0 0
M  V30 8 C 4.6200 2.6674 0.0 0
M  V30 9 C 4.6200 5.3347 0.0 0
M  V30 10 C 3.0800 2.6674 0.0 0
M  V30 11 C 3.0800 5.3347 0.0 0
M  V30 12 C 2.3100 4.0011 0.0 0
M  V30 13 C 6.9300 4.0011 0.0 0
M  V30 14 O 7.8353 5.2470 0.0 0
M  V30 15 N 7.8353 2.7552 0.0 0
M  V30 16 C 9.3000 4.7711 0.0 0
M  V30 17 N 9.3000 3.2311 0.0 0
M  V30 18 N 11.9526 5.0500 0.0 0
M  V30 19 C 12.2728 3.5436 0.0 0
M  V30 20 C 13.2863 5.8200 0.0 0
M  V30 21 C 13.8045 3.3826 0.0 0
M  V30 22 C 14.4308 4.7894 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 3 16
M  V30 4 1 3 18
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 7 13
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 2 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 2 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1089279-03-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1089279-07-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-8440817
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 24424-99-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step A:
2-[3-(methyloxy)-4-nitrophenyl]-5-(1-pyrrolidinylmethyl)-1,3,4-oxadiazole
To 2-(chloromethyl)-5-[3-(methyloxy)-4-nitrophenyl]-1,3,4-oxadiazole
(Example 26, step C) (1.01 g, 3.75 mmol) in dioxane (10 mL) was added
pyrrolidine (0.800 mL, 9.58 mmol). The reaction was stirred at rt
overnight. Upon completion by TLC, the reaction mixture was treated with
BOC-anhydride (0.371 g, 1.69 mmol) and cooled to 0°C. The mixture was
treated with TEA (0.279 mL, 2.00 mmol). Purification by flash
chromatography provided the title compound of step A (1.13 g, 3.70 mmol,
99%).
2-[3-(methyloxy)-4-nitrophenyl]-5-(1-pyrrolidinylmethyl)-1,3,4-oxadiazole,
Yield (1.13 g, 3.70 mmol, 99%). 1H NMR (400 MHz, DMSO-d6) δ ppm 1.64-1.72
(m, 4H), 2.56 (br. s, 4H), 3.92-3.96 (m, 2H), 3.98-4.02 (m, 3H),
7.64-7.69 (m, 1H), 7.79 (br. s, 1H), 8.01-8.06 (m, 1H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of imidazopyridines as inhibitors of IGF-1R and IR and one or
both of EGFR and ErbB2 kinases for treating neoplasm
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kuntz, Kevin; Uehling, David Edward; Waterson, Alex Gregory; Emmitte,
Kyle Allen; Stevens, Kirk; Shotwell, John Brad; Smith, Stephon Cornell;
Nailor, Kristen E.; Salovich, James M.; Wilson, Brian John; Cheung, Mui;
Mook, Robert Anthony; Baum, Erich W.; Moorthy, Ganesh
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20080300242 A1 2008-12-04

$RFMT $RIREG SCHEME353 STEP1
$RXN



  3  1
$MOL
Cyclohexanone
C6H10O
108-94-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Phenyl-3-(2-pyridinyl)-1,2,4-triazine
C14H10N4
16280-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 2.3101 0.0 0
M  V30 2 N 5.3348 3.0801 0.0 0
M  V30 3 C 4.0012 0.7700 0.0 0
M  V30 4 C 6.6685 2.3101 0.0 0
M  V30 5 N 5.3348 0.0000 0.0 0
M  V30 6 N 6.6685 0.7700 0.0 0
M  V30 7 C 2.6673 3.0801 0.0 0
M  V30 8 C 2.6673 4.6201 0.0 0
M  V30 9 C 1.3337 2.3101 0.0 0
M  V30 10 C 1.3337 5.3901 0.0 0
M  V30 11 C 0.0000 3.0801 0.0 0
M  V30 12 C 0.0000 4.6201 0.0 0
M  V30 13 C 8.0023 3.0801 0.0 0
M  V30 14 C 9.3360 2.3101 0.0 0
M  V30 15 N 8.0023 4.6201 0.0 0
M  V30 16 C 10.6697 3.0801 0.0 0
M  V30 17 C 9.3360 5.3901 0.0 0
M  V30 18 C 10.6697 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 4 13
M  V30 8 1 5 6
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(4aR,8aS)-4a,5,6,7,8,8a-Hexahydro-3-phenyl-1-(2-pyridinyl)-8a-1-pyrrolidi...
C24H27N3
692729-90-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 32 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.5366 5.3347 0.0 0 CFG=2
M  V30 2 C 6.3066 4.0011 0.0 0
M  V30 3 C 6.3066 6.6685 0.0 0 CFG=2
M  V30 4 C 3.9966 5.3347 0.0 0
M  V30 5 N 7.8466 4.0011 0.0 0
M  V30 6 C 7.8466 6.6685 0.0 0
M  V30 7 C 5.5366 8.0021 0.0 0
M  V30 8 C 3.2266 6.6685 0.0 0
M  V30 9 C 8.6166 5.3347 0.0 0
M  V30 10 C 3.9966 8.0021 0.0 0
M  V30 11 N 2.3828 3.1265 0.0 0
M  V30 12 C 2.3560 1.5867 0.0 0
M  V30 13 C 0.9268 3.6279 0.0 0
M  V30 14 C 0.8833 1.1365 0.0 0
M  V30 15 C 0.0000 2.3979 0.0 0
M  V30 16 C 5.5366 2.6674 0.0 0
M  V30 17 C 3.9966 2.6674 0.0 0
M  V30 18 N 6.3066 1.3336 0.0 0
M  V30 19 C 3.2266 1.3336 0.0 0
M  V30 20 C 5.5366 0.0000 0.0 0
M  V30 21 C 3.9966 0.0000 0.0 0
M  V30 22 C 10.1566 5.3347 0.0 0
M  V30 23 C 10.9266 4.0011 0.0 0
M  V30 24 C 10.9266 6.6685 0.0 0
M  V30 25 C 12.4666 4.0011 0.0 0
M  V30 26 C 12.4666 6.6685 0.0 0
M  V30 27 C 13.2366 5.3347 0.0 0
M  V30 28 H 7.0766 8.0021 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 11 CFG=1
M  V30 5 2 2 5
M  V30 6 1 2 16
M  V30 7 1 3 6
M  V30 8 1 3 7
M  V30 9 1 3 28 CFG=1
M  V30 10 1 4 8
M  V30 11 1 5 9
M  V30 12 2 6 9
M  V30 13 1 7 10
M  V30 14 1 8 10
M  V30 15 1 9 22
M  V30 16 1 11 12
M  V30 17 1 11 13
M  V30 18 1 12 14
M  V30 19 1 13 15
M  V30 20 1 14 15
M  V30 21 2 16 17
M  V30 22 1 16 18
M  V30 23 1 17 19
M  V30 24 2 18 20
M  V30 25 2 19 21
M  V30 26 1 20 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 1 3)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 108-94-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 16280-66-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 692729-90-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28214463
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, mol. sieves used, using THF or toluene/solvent at reflux
gave the same result
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Highly substituted pyridines via tethered imine-enamine (TIE) methodology
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Raw, Steven A.; Taylor, Richard J. K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2004), (5), 508-509

$RFMT $RIREG SCHEME354 STEP1
$RXN



  2  1
$MOL
2-Chloropyridine
C5H4ClN
109-09-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 4.6201 1.3337 0.0 0
M  V30 2 C 2.3101 0.0000 0.0 0
M  V30 3 C 3.0801 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 N 2.3101 2.6673 0.0 0
M  V30 6 C 0.0000 1.3337 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 4 6
M  V30 6 2 5 7
M  V30 7 1 6 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Pyrrolidinyl)pyridine
C9H12N2
54660-06-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.3698 1.3337 0.0 0
M  V30 2 C 1.4646 0.0878 0.0 0
M  V30 3 C 1.4646 2.5795 0.0 0
M  V30 4 C 0.0000 0.5636 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 3.9098 1.3337 0.0 0
M  V30 7 C 4.6798 0.0000 0.0 0
M  V30 8 N 4.6798 2.6673 0.0 0
M  V30 9 C 6.2198 0.0000 0.0 0
M  V30 10 C 6.2198 2.6673 0.0 0
M  V30 11 C 6.9898 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 5
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 109-09-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 54660-06-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-4790055
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 499795-24-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald-Hartwig amination
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Well-Defined Allylnickel Chloride/N-Heterocyclic Carbene
[(NHC)Ni(allyl)Cl] Complexes as Highly Active Precatalysts for C-N and
C-S Cross-Coupling Reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Iglesias, Maria Jose; Prieto, Auxiliadora; Nicasio, M. Carmen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2010), 352(11+12), 1949-1954

$RFMT $RIREG SCHEME355 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluoro-N-(3-methoxyphenyl)-3-nitrobenzamide
C14H11FN2O4
1096823-39-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.0801 0.0 0
M  V30 2 N 8.0022 2.3101 0.0 0
M  V30 3 O 6.6685 4.6201 0.0 0
M  V30 4 N 1.3337 3.0801 0.0 0 VAL=5
M  V30 5 O 1.3337 4.6201 0.0 0
M  V30 6 O 0.0000 2.3101 0.0 0
M  V30 7 F 1.3337 0.0000 0.0 0
M  V30 8 O 13.3370 2.3101 0.0 0
M  V30 9 C 14.6707 3.0801 0.0 0
M  V30 10 C 5.3348 2.3101 0.0 0
M  V30 11 C 4.0010 3.0801 0.0 0
M  V30 12 C 5.3348 0.7700 0.0 0
M  V30 13 C 2.6673 2.3101 0.0 0
M  V30 14 C 4.0010 0.0000 0.0 0
M  V30 15 C 2.6673 0.7700 0.0 0
M  V30 16 C 9.3358 3.0801 0.0 0
M  V30 17 C 10.6697 2.3101 0.0 0
M  V30 18 C 9.3358 4.6201 0.0 0
M  V30 19 C 12.0033 3.0801 0.0 0
M  V30 20 C 10.6697 5.3901 0.0 0
M  V30 21 C 12.0033 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 16
M  V30 5 2 4 5
M  V30 6 2 4 6
M  V30 7 1 4 13
M  V30 8 1 7 15
M  V30 9 1 8 9
M  V30 10 1 8 19
M  V30 11 2 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 2 12 14
M  V30 15 2 13 15
M  V30 16 1 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Methoxyphenyl)-3-nitro-4-(1-pyrrolidinyl)benzamide
C18H19N3O4
451506-83-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 2.4374 4.9318 0.0 0 VAL=5
M  V30 2 O 2.4374 6.4718 0.0 0
M  V30 3 O 1.1037 4.1618 0.0 0
M  V30 4 C 7.7722 4.9318 0.0 0
M  V30 5 N 9.1059 4.1618 0.0 0
M  V30 6 O 7.7722 6.4718 0.0 0
M  V30 7 O 14.4407 4.1618 0.0 0
M  V30 8 C 15.7746 4.9318 0.0 0
M  V30 9 C 3.7711 2.6218 0.0 0
M  V30 10 C 3.7711 4.1618 0.0 0
M  V30 11 C 5.1049 1.8517 0.0 0
M  V30 12 C 5.1049 4.9318 0.0 0
M  V30 13 C 6.4386 2.6218 0.0 0
M  V30 14 C 6.4386 4.1618 0.0 0
M  V30 15 N 2.4374 1.8517 0.0 0
M  V30 16 C 1.0306 2.4782 0.0 0
M  V30 17 C 2.2765 0.3202 0.0 0
M  V30 18 C 0.0000 1.3337 0.0 0
M  V30 19 C 0.7700 0.0000 0.0 0
M  V30 20 C 10.4397 4.9318 0.0 0
M  V30 21 C 11.7734 4.1618 0.0 0
M  V30 22 C 10.4397 6.4718 0.0 0
M  V30 23 C 13.1071 4.9318 0.0 0
M  V30 24 C 11.7734 7.2419 0.0 0
M  V30 25 C 13.1071 6.4718 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 5 20
M  V30 8 1 7 8
M  V30 9 1 7 23
M  V30 10 2 9 10
M  V30 11 1 9 11
M  V30 12 1 9 15
M  V30 13 1 10 12
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 16 1 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 2 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 2 22 24
M  V30 26 2 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1096823-39-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 451506-83-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-9550543
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM DMF can also be used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Selective antagonists of mouse trace amine-associated receptor 1
(mTAAR1): Discovery of EPPTB (RO5212773)
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Stalder, Henri; Hoener, Marius C.; Norcross, Roger D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2011), 21(4), 1227-1231

$RFMT $RIREG SCHEME356 STEP1
$RXN



  4  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Chloro-3-pyridineacetonitrile
C7H5ClN2
39891-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 3.0800 0.0 0
M  V30 2 C 6.6686 2.3100 0.0 0
M  V30 3 N 8.0022 1.5400 0.0 0
M  V30 4 Cl 0.0000 0.0000 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 2.6675 3.0800 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 1.3337 2.3100 0.0 0
M  V30 9 N 2.6675 0.0000 0.0 0
M  V30 10 C 1.3337 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 3 2 3
M  V30 4 1 4 10
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 2 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl vinyl ether
C4H8O
109-92-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 C 4.0010 0.0000 0.0 0
M  V30 4 C 0.0000 0.7700 0.0 0
M  V30 5 C 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethylthiosemicarbazide
C3H9N3S
13431-34-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 N 4.0011 2.3100 0.0 0
M  V30 3 N 1.3338 2.3100 0.0 0
M  V30 4 S 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 N 0.0000 1.5400 0.0 0
M  V30 7 C 6.6686 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 5 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C19H30N8S2
2763360-49-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5299 10.6697 0.0 0
M  V30 2 C 9.3000 9.3360 0.0 0
M  V30 3 C 8.5299 8.0022 0.0 0
M  V30 4 N 10.8400 9.3360 0.0 0
M  V30 5 N 9.3000 6.6685 0.0 0
M  V30 6 C 6.9899 8.0022 0.0 0
M  V30 7 N 11.6100 10.6697 0.0 0
M  V30 8 N 8.5299 5.3348 0.0 0
M  V30 9 C 13.1500 10.6697 0.0 0
M  V30 10 C 9.3000 4.0010 0.0 0
M  V30 11 N 13.9201 12.0033 0.0 0
M  V30 12 S 13.9201 9.3360 0.0 0
M  V30 13 N 8.5299 2.6673 0.0 0
M  V30 14 S 10.8400 4.0010 0.0 0
M  V30 15 C 15.4601 12.0033 0.0 0
M  V30 16 C 9.3000 1.3337 0.0 0
M  V30 17 C 16.2301 13.3370 0.0 0
M  V30 18 C 8.5299 0.0000 0.0 0
M  V30 19 C 3.9098 10.6697 0.0 0
M  V30 20 C 4.6799 9.3360 0.0 0
M  V30 21 N 4.6799 12.0033 0.0 0
M  V30 22 C 6.2199 9.3360 0.0 0
M  V30 23 C 6.2199 12.0033 0.0 0
M  V30 24 C 6.9899 10.6697 0.0 0
M  V30 25 N 2.3698 10.6697 0.0 0
M  V30 26 C 1.4646 9.4238 0.0 0
M  V30 27 C 1.4646 11.9155 0.0 0
M  V30 28 C 0.0000 9.8996 0.0 0
M  V30 29 C 0.0000 11.4397 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 24
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 5 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 2 9 12
M  V30 13 1 10 13
M  V30 14 2 10 14
M  V30 15 1 11 15
M  V30 16 1 13 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 19 20
M  V30 20 1 19 21
M  V30 21 1 19 25
M  V30 22 1 20 22
M  V30 23 2 21 23
M  V30 24 2 22 24
M  V30 25 1 23 24
M  V30 26 1 25 26
M  V30 27 1 25 27
M  V30 28 1 26 28
M  V30 29 1 27 29
M  V30 30 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 39891-09-3
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 109-92-2
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 13431-34-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2763360-49-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-31767149
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 7
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 1117-97-1
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 594-19-4
$DTYPE RXN:VAR(1):RGT(7):CAS_RN
$DATUM 29858-07-9
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 109-66-0
$DTYPE RXN:VAR(1):SOL(5):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(6):CAS_RN
$DATUM 64-17-5
$DTYPE RXN:VAR(1):NOTES
$DATUM thermal in stage 1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Copper complexes for treatment of neurodegenerative disorders
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lukashev, Matvey; Pushechnikov, Alexei; Demin, Peter; Denton, Kyle
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022047014 A1 2022-03-03

$RFMT $RIREG SCHEME357 STEP1
$RXN



  3  1
$MOL
Heptanal
C7H14O
111-71-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0012 0.0000 0.0 0
M  V30 2 C 5.3348 0.7700 0.0 0
M  V30 3 C 2.6675 0.7700 0.0 0
M  V30 4 C 6.6685 0.0000 0.0 0
M  V30 5 C 1.3337 0.0000 0.0 0
M  V30 6 C 8.0023 0.7700 0.0 0
M  V30 7 C 0.0000 0.7700 0.0 0
M  V30 8 O 9.3360 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-(2-Phenylethynyl)heptyl]pyrrolidine
C19H27N
1282610-29-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 7.7001 0.0 0
M  V30 2 C 3.7711 6.1601 0.0 0
M  V30 3 C 5.1047 8.4701 0.0 0
M  V30 4 C 3.7711 4.6201 0.0 0
M  V30 5 C 6.4384 7.7001 0.0 0
M  V30 6 C 7.7722 8.4701 0.0 0
M  V30 7 C 9.1059 7.7001 0.0 0
M  V30 8 C 10.4395 8.4701 0.0 0
M  V30 9 C 11.7732 7.7001 0.0 0
M  V30 10 N 2.4372 8.4701 0.0 0
M  V30 11 C 2.2763 10.0017 0.0 0
M  V30 12 C 1.0304 7.8437 0.0 0
M  V30 13 C 0.7700 10.3219 0.0 0
M  V30 14 C 0.0000 8.9882 0.0 0
M  V30 15 C 3.7711 3.0800 0.0 0
M  V30 16 C 5.1047 2.3100 0.0 0
M  V30 17 C 2.4372 2.3100 0.0 0
M  V30 18 C 5.1047 0.7700 0.0 0
M  V30 19 C 2.4372 0.7700 0.0 0
M  V30 20 C 3.7711 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 10
M  V30 4 3 2 4
M  V30 5 1 3 5
M  V30 6 1 4 15
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 111-71-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1282610-29-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-12105336
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 20667-12-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-catalyst, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Propargyl amines formed from three-component coupling reactions catalyzed
by silver oxide nanoparticles
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhou, Xin; Lu, Yi; Zhai, Ling-Ling; Zhao, Yue; Liu, Qing; Sun, Wei-Yin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2013), 3(6), 1732-1734

$RFMT $RIREG SCHEME358 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7-Oxo-1,3,5-cycloheptatrien-1-yl 1,1,1-trifluoromethanesulfonate
C8H5F3O4S
112533-23-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 3.4373 2.5916 0.0 0
M  V30 2 S 2.6673 3.9252 0.0 0 VAL=6
M  V30 3 C 1.3337 3.1552 0.0 0
M  V30 4 O 1.8973 5.2589 0.0 0
M  V30 5 O 4.0010 4.6952 0.0 0
M  V30 6 F 1.3337 1.6152 0.0 0
M  V30 7 F 0.0000 2.3852 0.0 0
M  V30 8 F 0.0000 3.9252 0.0 0
M  V30 9 O 4.6854 0.0000 0.0 0
M  V30 10 C 4.9774 2.5916 0.0 0
M  V30 11 C 5.6456 1.2040 0.0 0
M  V30 12 C 5.6456 3.9790 0.0 0
M  V30 13 C 7.1470 0.8613 0.0 0
M  V30 14 C 7.1470 4.3218 0.0 0
M  V30 15 C 8.3510 1.8215 0.0 0
M  V30 16 C 8.3510 3.3616 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 2 5
M  V30 6 1 3 6
M  V30 7 1 3 7
M  V30 8 1 3 8
M  V30 9 2 9 11
M  V30 10 1 10 11
M  V30 11 2 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Methylmaleimide
C5H5NO2
930-88-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.7106 0.0000 0.0 0
M  V30 2 O 0.0000 1.9692 0.0 0
M  V30 3 O 5.4211 1.9692 0.0 0
M  V30 4 N 2.7106 1.5400 0.0 0
M  V30 5 C 1.4647 2.4452 0.0 0
M  V30 6 C 3.9564 2.4452 0.0 0
M  V30 7 C 1.9406 3.9098 0.0 0
M  V30 8 C 3.4806 3.9098 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 2 2 5
M  V30 3 2 3 6
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4,8-Ethenocyclohepta[c]pyrrole-1,3,5(2H)-trione, 3a,4,8,8a-tetrahydro-2-methy...
C16H18N2O3
3031235-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 6.4892 6.8556 0.0 0
M  V30 2 O 5.3026 1.3628 0.0 0
M  V30 3 O 0.0000 2.4898 0.0 0
M  V30 4 C 2.2420 0.0000 0.0 0
M  V30 5 C 5.0368 4.6439 0.0 0 CFG=1
M  V30 6 C 3.8080 3.6643 0.0 0 CFG=1
M  V30 7 C 4.2301 5.7104 0.0 0
M  V30 8 C 5.0921 6.2077 0.0 0
M  V30 9 C 2.3016 3.9845 0.0 0 CFG=1
M  V30 10 C 3.9690 2.1328 0.0 0
M  V30 11 C 2.7882 5.9704 0.0 0
M  V30 12 C 3.8822 7.1605 0.0 0
M  V30 13 C 1.6671 5.3765 0.0 0 CFG=2
M  V30 14 C 1.5316 2.6508 0.0 0
M  V30 15 N 2.5621 1.5063 0.0 0
M  V30 16 C 2.3761 6.7914 0.0 0
M  V30 17 N 6.4122 3.9512 0.0 0
M  V30 18 C 7.7811 4.6567 0.0 0
M  V30 19 C 6.6603 2.4312 0.0 0
M  V30 20 C 8.8752 3.5729 0.0 0
M  V30 21 C 8.1825 2.1975 0.0 0
M  V30 22 H 5.2285 3.0696 0.0 0
M  V30 23 H 0.7634 4.0583 0.0 0
M  V30 24 H 0.1274 5.4049 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 8
M  V30 2 2 2 10
M  V30 3 2 3 14
M  V30 4 1 4 15
M  V30 5 1 5 6
M  V30 6 1 5 7 CFG=1
M  V30 7 1 5 8
M  V30 8 1 5 17
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 1 6 22 CFG=3
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 1 9 13
M  V30 15 1 9 14
M  V30 16 1 9 23 CFG=3
M  V30 17 1 10 15
M  V30 18 1 13 11 CFG=1
M  V30 19 2 12 16
M  V30 20 1 13 16
M  V30 21 1 13 24
M  V30 22 1 14 15
M  V30 23 1 17 18
M  V30 24 1 17 19
M  V30 25 1 18 20
M  V30 26 1 19 21
M  V30 27 1 20 21
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(4 5 6 9 13)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 112533-23-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 930-88-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3031235-42-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39513906
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 141-78-6
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, dr ratio:>20:1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Exploring Heterotropones and Examining Their Propensity to Undergo [4 +
2] Cycloadditions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Barloese, Casper Larsen; Faghtmann, Jonas; Kaasik, Mikk; Mastroddi,
Roberta; Joergensen, Karl Anker
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2024), 26(8), 1539-1543

$RFMT $RIREG SCHEME359 STEP1
$RXN



  2  1
$MOL
Methyl oleate
C19H36O2
112-62-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.4700 2.6674 0.0 0
M  V30 2 C 9.2400 1.3338 0.0 0
M  V30 3 C 6.9300 2.6674 0.0 0
M  V30 4 C 10.7800 1.3338 0.0 0
M  V30 5 C 6.1600 4.0011 0.0 0
M  V30 6 C 11.5500 0.0000 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 13.0900 0.0000 0.0 0
M  V30 9 C 3.8500 5.3347 0.0 0
M  V30 10 C 13.8600 1.3338 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 C 15.4000 1.3338 0.0 0
M  V30 13 O 1.5400 6.6685 0.0 0
M  V30 14 O 1.5400 4.0011 0.0 0
M  V30 15 C 16.1700 2.6674 0.0 0
M  V30 16 C 0.0000 6.6685 0.0 0
M  V30 17 C 17.7100 2.6674 0.0 0
M  V30 18 C 18.4800 4.0011 0.0 0
M  V30 19 C 20.0200 4.0011 0.0 0
M  V30 20 C 20.7900 5.3347 0.0 0
M  V30 21 C 22.3300 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 13 16
M  V30 16 1 15 17
M  V30 17 1 17 18
M  V30 18 1 18 19
M  V30 19 1 19 20
M  V30 20 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(9Z)-1-(1-Pyrrolidinyl)-9-octadecen-1-one
C22H41NO
4637-54-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6217 3.7710 0.0 0
M  V30 2 C 4.1617 3.7710 0.0 0
M  V30 3 O 1.8517 5.1046 0.0 0
M  V30 4 C 4.9317 5.1046 0.0 0
M  V30 5 C 6.4717 5.1046 0.0 0
M  V30 6 C 7.2417 6.4384 0.0 0
M  V30 7 C 8.7817 6.4384 0.0 0
M  V30 8 C 9.5517 7.7721 0.0 0
M  V30 9 C 11.0917 7.7721 0.0 0
M  V30 10 C 11.8617 9.1057 0.0 0
M  V30 11 C 13.4017 9.1057 0.0 0
M  V30 12 C 14.1717 7.7721 0.0 0
M  V30 13 C 15.7117 7.7721 0.0 0
M  V30 14 C 16.4817 6.4384 0.0 0
M  V30 15 C 18.0217 6.4384 0.0 0
M  V30 16 C 18.7917 5.1046 0.0 0
M  V30 17 C 20.3317 5.1046 0.0 0
M  V30 18 C 21.1017 3.7710 0.0 0
M  V30 19 C 22.6417 3.7710 0.0 0
M  V30 20 N 1.8517 2.4374 0.0 0
M  V30 21 C 2.4782 1.0304 0.0 0
M  V30 22 C 0.3202 2.2763 0.0 0
M  V30 23 C 1.3336 0.0000 0.0 0
M  V30 24 C 0.0000 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 20
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 2 10 11
M  V30 12 1 11 12
M  V30 13 1 12 13
M  V30 14 1 13 14
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 16 17
M  V30 18 1 17 18
M  V30 19 1 18 19
M  V30 20 1 20 21
M  V30 21 1 20 22
M  V30 22 1 21 23
M  V30 23 1 22 24
M  V30 24 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 112-62-9
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4637-54-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9879203
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1306-19-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 174899-83-3
$DTYPE RXN:VAR(1):NOTES
$DATUM optimized on catalyst and solvent for yield, ionic liquid used,
optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalytic Aminolysis (Amide Formation) from Esters and Carboxylic Acids:
Mechanism, Enhanced Ionic Liquid Effect, and its Origin
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM de Oliveira, Vanda Maria; Silva de Jesus, Richard; Gomes, Alexandre F.;
Gozzo, Fabio C.; Umpierre, Alexandre P.; Suarez, Paulo A. Z.; Rubim, Joel
C.; Neto, Brenno A. D.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemCatChem (2011), 3(12), 1911-1920

$RFMT $RIREG SCHEME360 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-chlorobenzoate
C8H7ClO2
1126-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.3101 1.3337 0.0 0
M  V30 2 O 1.5400 2.6673 0.0 0
M  V30 3 O 1.5400 0.0000 0.0 0
M  V30 4 C 0.0000 2.6673 0.0 0
M  V30 5 Cl 8.4702 1.3337 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 4.6201 0.0000 0.0 0
M  V30 8 C 4.6201 2.6673 0.0 0
M  V30 9 C 6.1601 0.0000 0.0 0
M  V30 10 C 6.1601 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 2 4
M  V30 5 1 5 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Chlorophenyl)-1-pyrrolidinylmethanone
C11H12ClNO
19202-05-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 Cl 9.1059 4.6201 0.0 0
M  V30 4 C 5.1048 2.3101 0.0 0
M  V30 5 C 5.1048 3.8501 0.0 0
M  V30 6 C 6.4386 1.5400 0.0 0
M  V30 7 C 6.4386 4.6201 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 7.7722 3.8501 0.0 0
M  V30 10 N 2.4374 2.3101 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 4
M  V30 3 1 1 10
M  V30 4 1 3 9
M  V30 5 2 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 8
M  V30 9 2 7 9
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1126-46-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 19202-05-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-4849457
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 137203-34-0
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM safety, scalable, Schlenk tube used, alternative reaction conditions
shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Investigating Scale-Up and Further Applications of DABAL-Me3 Promoted
Amide Synthesis
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lee, Darren S.; Amara, Zacharias; Poliakoff, Martyn; Harman, Thomas;
Reid, Gary; Rhodes, Barrie; Brough, Steve; McInally, Thomas; Woodward,
Simon
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Process Research & Development (2015), 19(7), 831-840

$RFMT $RIREG SCHEME361 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-N-(2,6-dimethylphenyl)acetamide
C10H12ClNO
1131-01-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0011 1.5400 0.0 0
M  V30 2 C 5.3347 2.3100 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 5.3347 3.8500 0.0 0
M  V30 5 Cl 8.0021 2.3100 0.0 0
M  V30 6 C 1.3336 0.0000 0.0 0
M  V30 7 C 4.0011 4.6200 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 1.3336 1.5400 0.0 0
M  V30 10 C 2.6674 3.8500 0.0 0
M  V30 11 C 0.0000 2.3100 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 0.0000 3.8500 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 5
M  V30 6 1 6 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrocaine
C14H20N2O
2210-77-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.0012 1.5400 0.0 0
M  V30 2 C 5.3348 2.3101 0.0 0
M  V30 3 C 6.6685 1.5400 0.0 0
M  V30 4 O 5.3348 3.8501 0.0 0
M  V30 5 C 4.0012 4.6201 0.0 0
M  V30 6 C 1.3337 0.0000 0.0 0
M  V30 7 C 2.6673 2.3101 0.0 0
M  V30 8 C 2.6673 3.8501 0.0 0
M  V30 9 C 1.3337 1.5400 0.0 0
M  V30 10 C 1.3337 4.6201 0.0 0
M  V30 11 C 0.0000 2.3101 0.0 0
M  V30 12 C 0.0000 3.8501 0.0 0
M  V30 13 N 8.0022 2.3101 0.0 0
M  V30 14 C 8.1633 3.8416 0.0 0
M  V30 15 C 9.4091 1.6837 0.0 0
M  V30 16 C 9.6696 4.1618 0.0 0
M  V30 17 C 10.4396 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 1 3 13
M  V30 6 1 5 8
M  V30 7 1 6 9
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1131-01-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2210-77-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-7868578
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: N-(2,6-Dimethyl-phenyl)-2-ethylamino-acetamide
2,6-Dimethylchloroacetanilide (3.95 g, 20 mmol) was treated with 2M
ethylamine in THF (50 mL, 100 mmol) and resulting mixture was stirred at
room temperature in a tightly sealed flask for 3 days. The precipitate
formed was filtered off, solid was washed with diethyl ether and combined
filtrates were evaporated to give a residue, which was recrystallized
from diethyl ether/hexane.
N-(2,6-Dimethyl-phenyl)-2-pyrrolidin-1-yl-acetamide Using the procedure
in Example 47 and replacing ethylamine with pyrrolidine 20 gave the title
compound. The product was purified by trituration with hexane.Yield:
0.460 g (99%); 1H NMR (400 MHz, CDCl3): δ 8.63 (bs, 1H), 7.08-7.10 (m,
3H), 3.35 (s, 2H), 2.76-s2.79 (m, 4H), 2.24 (s, 6H), 1.84-1.88 (m, 4H);
LC/MS (M+H)+ 233. Anal. Calcd for C14H20N2O: C, 72.38; H, 8.68; N, 12.06.
Found: C, 71.81; H, 8.51; N, 11.93.
$DTYPE RXN:VAR(1):NOTES
$DATUM tightly sealed flask used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of acetanilides and benzamides for the treatment of asthma
and pulmonary inflammation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Baker, William R.; Stasiak, Marcin; Macleod, David
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2005025498 A2 2005-03-24

$RFMT $RIREG SCHEME362 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(Ethenylsulfonyl)-1-phenyl-1H-tetrazole
C9H8N4O2S
1154397-00-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.6420 3.4208 0.0 0 VAL=6
M  V30 2 C 6.6724 4.5653 0.0 0
M  V30 3 O 4.4975 4.4512 0.0 0
M  V30 4 O 6.7864 2.3904 0.0 0
M  V30 5 C 8.1788 4.2450 0.0 0
M  V30 6 N 3.0800 2.4373 0.0 0
M  V30 7 C 4.6116 2.2764 0.0 0
M  V30 8 N 2.4536 1.0306 0.0 0
M  V30 9 N 4.9318 0.7700 0.0 0
M  V30 10 N 3.5980 0.0000 0.0 0
M  V30 11 C 2.3100 3.7709 0.0 0
M  V30 12 C 3.0800 5.1047 0.0 0
M  V30 13 C 0.7700 3.7709 0.0 0
M  V30 14 C 2.3100 6.4383 0.0 0
M  V30 15 C 0.0000 5.1047 0.0 0
M  V30 16 C 0.7700 6.4383 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 7
M  V30 5 2 2 5
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 6 11
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Phenyl-5-[[2-(1-pyrrolidinyl)ethyl]sulfonyl]-1H-tetrazole
C13H17N5O2S
2028322-36-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.6422 3.4209 0.0 0 VAL=6
M  V30 2 C 6.6726 4.5652 0.0 0
M  V30 3 O 4.4976 4.4513 0.0 0
M  V30 4 O 6.7866 2.3904 0.0 0
M  V30 5 C 8.1791 4.2451 0.0 0
M  V30 6 C 4.6118 2.2763 0.0 0
M  V30 7 N 3.0800 2.4374 0.0 0
M  V30 8 N 4.9319 0.7700 0.0 0
M  V30 9 N 2.4537 1.0304 0.0 0
M  V30 10 N 3.5981 0.0000 0.0 0
M  V30 11 C 2.3100 3.7711 0.0 0
M  V30 12 C 3.0800 5.1047 0.0 0
M  V30 13 C 0.7700 3.7711 0.0 0
M  V30 14 C 2.3100 6.4384 0.0 0
M  V30 15 C 0.0000 5.1047 0.0 0
M  V30 16 C 0.7700 6.4384 0.0 0
M  V30 17 N 9.2095 5.3896 0.0 0
M  V30 18 C 8.8893 6.8959 0.0 0
M  V30 19 C 10.7410 5.2285 0.0 0
M  V30 20 C 10.2230 7.6659 0.0 0
M  V30 21 C 11.3675 6.6355 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 2 1 4
M  V30 4 1 1 6
M  V30 5 1 2 5
M  V30 6 1 5 17
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 10
M  V30 13 2 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1154397-00-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2028322-36-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-16206371
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, Michael addition
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Expanding the Potential of Heteroaryl Vinyl Sulfones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rodrigo, Eduardo; Alonso, Ines; Garcia Ruano, Jose Luis; Cid, M. Belen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Organic Chemistry (2016), 81(22), 10887-10899

$RFMT $RIREG SCHEME363 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,3-Epithio-1H,3H-naphtho[1,8-cd][1,2,6]thiadiphosphorin, 1,3-disulfide
C10H6P2S4
115505-46-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 2.5880 0.0000 0.0 0
M  V30 2 S 6.9271 2.5007 0.0 0
M  V30 3 P 3.3242 1.3525 0.0 0 VAL=5
M  V30 4 C 2.3354 2.6785 0.0 0
M  V30 5 S 4.4473 1.7888 0.0 0
M  V30 6 S 4.4976 1.7013 0.0 0
M  V30 7 C 3.1357 4.0646 0.0 0
M  V30 8 C 0.7128 2.7463 0.0 0
M  V30 9 P 5.3877 2.5418 0.0 0 VAL=5
M  V30 10 C 4.7363 4.0621 0.0 0
M  V30 11 C 2.3578 5.4145 0.0 0
M  V30 12 C 0.0000 4.0514 0.0 0
M  V30 13 C 5.4912 5.5001 0.0 0
M  V30 14 C 3.2424 6.8132 0.0 0
M  V30 15 C 0.7040 5.3503 0.0 0
M  V30 16 C 4.7192 6.7710 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 3
M  V30 2 2 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 1 6 9
M  V30 10 1 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 10
M  V30 14 2 10 13
M  V30 15 1 11 14
M  V30 16 2 11 15
M  V30 17 1 12 15
M  V30 18 1 13 16
M  V30 19 2 14 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1-(3-mercapto-1,3-disulfido-1H,3H-naphtho[1,8-cd][1,2,6]thiadiph...
C14H15NP2S4.C4H9N
371197-40-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 5.8614 5.5426 0.0 0
M  V30 2 S 3.0112 10.4795 0.0 0
M  V30 3 S 4.9910 10.4795 0.0 0
M  V30 4 C 4.0011 6.2198 0.0 0
M  V30 5 C 2.6675 6.9898 0.0 0
M  V30 6 P 5.3348 6.9898 0.0 0 VAL=5
M  V30 7 C 4.0011 4.6798 0.0 0
M  V30 8 C 2.6675 8.5298 0.0 0
M  V30 9 C 1.3337 6.2198 0.0 0
M  V30 10 S 5.3348 8.5298 0.0 0
M  V30 11 C 2.6675 3.9098 0.0 0
M  V30 12 P 4.0011 9.2998 0.0 0 VAL=5
M  V30 13 C 1.3337 9.2998 0.0 0
M  V30 14 C 0.0000 6.9898 0.0 0
M  V30 15 C 1.3337 4.6798 0.0 0
M  V30 16 C 0.0000 8.5298 0.0 0
M  V30 17 N 6.8514 7.2571 0.0 0
M  V30 18 C 7.9592 6.1874 0.0 0
M  V30 19 C 7.5265 8.6413 0.0 0
M  V30 20 C 9.3189 6.9103 0.0 0
M  V30 21 C 9.0516 8.4269 0.0 0
M  V30 22 C 3.4136 0.9052 0.0 0
M  V30 23 C 4.6595 0.0000 0.0 0
M  V30 24 C 3.8895 2.3698 0.0 0
M  V30 25 C 5.9053 0.9052 0.0 0
M  V30 26 N 5.4295 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 2 2 12
M  V30 3 1 3 12
M  V30 4 1 4 5
M  V30 5 1 4 6
M  V30 6 2 4 7
M  V30 7 1 5 8
M  V30 8 2 5 9
M  V30 9 1 6 10
M  V30 10 1 6 17
M  V30 11 1 7 11
M  V30 12 1 8 12
M  V30 13 2 8 13
M  V30 14 1 9 14
M  V30 15 1 9 15
M  V30 16 1 10 12
M  V30 17 2 11 15
M  V30 18 1 13 16
M  V30 19 2 14 16
M  V30 20 1 17 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 21
M  V30 24 1 20 21
M  V30 25 1 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 1 24 26
M  V30 29 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 115505-46-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 371197-40-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29138920
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM The analogous reactions of 1 with 2b (morpholine), 2c (pyrrolidine) and
2d (NH3(g)) in a solution of dichloromethane gave the corresponding
compounds 3b, 3c and 3d in nearly quantitative yield (Scheme 1).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Reaction of 2,4-(naphthalene-1,8-diyl)-1,3,2,4-dithiadiphosphetane
2,4-disulfide with bases and acids
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fei, Zhaofu; Slawin, Alexandra M. Z.; Woollins, J. Derek
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Phosphorus, Sulfur and Silicon and the Related Elements (2001),
168-169393-396

$RFMT $RIREG SCHEME364 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Methoxy-4-methylphenyl)-2-pyridinecarboxamide
C14H14N2O2
1161205-10-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 4.0011 0.0 0
M  V30 2 C 6.9300 5.3347 0.0 0
M  V30 3 O 6.1600 6.6685 0.0 0
M  V30 4 O 1.5400 1.3338 0.0 0
M  V30 5 C 2.3100 0.0000 0.0 0
M  V30 6 C 0.0000 4.0011 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 3.8500 5.3347 0.0 0
M  V30 10 C 2.3100 2.6674 0.0 0
M  V30 11 C 2.3100 5.3347 0.0 0
M  V30 12 C 1.5400 4.0011 0.0 0
M  V30 13 C 8.4700 5.3347 0.0 0
M  V30 14 C 9.2400 6.6685 0.0 0
M  V30 15 N 9.2400 4.0011 0.0 0
M  V30 16 C 10.7800 6.6685 0.0 0
M  V30 17 C 10.7800 4.0011 0.0 0
M  V30 18 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 2 13
M  V30 5 1 4 5
M  V30 6 1 4 10
M  V30 7 1 6 12
M  V30 8 2 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 14 2 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 2 15 17
M  V30 18 2 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Methoxy-4-methylphenyl)-N-(tetrahydro-2-furanyl)-2-pyridinecarboxamide
C18H20N2O3
2183512-14-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 3.7710 0.0 0
M  V30 2 C 4.6200 5.1048 0.0 0
M  V30 3 O 5.3900 6.4384 0.0 0
M  V30 4 O 10.0100 6.4384 0.0 0
M  V30 5 C 11.5500 6.4384 0.0 0
M  V30 6 C 11.5500 3.7710 0.0 0
M  V30 7 C 6.9300 3.7710 0.0 0
M  V30 8 C 7.7000 5.1048 0.0 0
M  V30 9 C 7.7000 2.4374 0.0 0
M  V30 10 C 9.2400 5.1048 0.0 0
M  V30 11 C 9.2400 2.4374 0.0 0
M  V30 12 C 10.0100 3.7710 0.0 0
M  V30 13 C 4.6200 2.4374 0.0 0
M  V30 14 C 3.0885 2.2764 0.0 0
M  V30 15 O 5.2463 1.0306 0.0 0
M  V30 16 C 2.7683 0.7700 0.0 0
M  V30 17 C 4.1019 0.0000 0.0 0
M  V30 18 C 3.0800 5.1048 0.0 0
M  V30 19 C 2.3100 3.7710 0.0 0
M  V30 20 N 2.3100 6.4384 0.0 0
M  V30 21 C 0.7700 3.7710 0.0 0
M  V30 22 C 0.7700 6.4384 0.0 0
M  V30 23 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 2 2 3
M  V30 5 1 2 18
M  V30 6 1 4 5
M  V30 7 1 4 10
M  V30 8 1 6 12
M  V30 9 2 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1161205-10-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2183512-14-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30963581
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 66-71-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Teflon lined sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and atom-economical route to N-aryl amino alcohols from
primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Zhen; Li, Juanjuan; Yue, Qiang; Zhang, Qian; Li, Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2018), 8(60), 34304-34308

$RFMT $RIREG SCHEME365 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 2-oxo-3-[(phenylmethyl)amino]-1(2H)-pyridineacetate
C16H18N2O3
1177499-67-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3348 3.0800 0.0 0
M  V30 2 C 4.0011 2.3100 0.0 0
M  V30 3 O 8.0022 4.6201 0.0 0
M  V30 4 C 10.6697 3.0800 0.0 0
M  V30 5 C 12.0034 2.3100 0.0 0
M  V30 6 O 13.3370 3.0800 0.0 0
M  V30 7 O 12.0034 0.7700 0.0 0
M  V30 8 C 14.6707 2.3100 0.0 0
M  V30 9 C 16.0045 3.0800 0.0 0
M  V30 10 C 6.6686 2.3100 0.0 0
M  V30 11 C 8.0022 3.0800 0.0 0
M  V30 12 C 6.6686 0.7700 0.0 0
M  V30 13 N 9.3359 2.3100 0.0 0
M  V30 14 C 8.0022 0.0000 0.0 0
M  V30 15 C 9.3359 0.7700 0.0 0
M  V30 16 C 2.6675 3.0800 0.0 0
M  V30 17 C 2.6675 4.6201 0.0 0
M  V30 18 C 1.3338 2.3100 0.0 0
M  V30 19 C 1.3338 5.3901 0.0 0
M  V30 20 C 0.0000 3.0800 0.0 0
M  V30 21 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 16
M  V30 4 2 3 11
M  V30 5 1 4 5
M  V30 6 1 4 13
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 6 8
M  V30 10 1 8 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 17 19
M  V30 20 2 18 20
M  V30 21 2 19 21
M  V30 22 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[2-Oxo-2-(1-pyrrolidinyl)ethyl]-3-[(phenylmethyl)amino]-2(1H)-pyridinone
C18H21N3O2
1177499-77-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.6697 3.0801 0.0 0
M  V30 2 C 12.0035 2.3101 0.0 0
M  V30 3 O 12.0035 0.7700 0.0 0
M  V30 4 O 8.0023 4.6201 0.0 0
M  V30 5 N 5.3348 3.0801 0.0 0
M  V30 6 C 4.0012 2.3101 0.0 0
M  V30 7 N 9.3360 2.3101 0.0 0
M  V30 8 C 8.0023 3.0801 0.0 0
M  V30 9 C 9.3360 0.7700 0.0 0
M  V30 10 C 6.6687 2.3101 0.0 0
M  V30 11 C 8.0023 0.0000 0.0 0
M  V30 12 C 6.6687 0.7700 0.0 0
M  V30 13 N 13.3372 3.0801 0.0 0
M  V30 14 C 13.4981 4.6116 0.0 0
M  V30 15 C 14.7440 2.4537 0.0 0
M  V30 16 C 15.0045 4.9318 0.0 0
M  V30 17 C 15.7746 3.5981 0.0 0
M  V30 18 C 2.6675 3.0801 0.0 0
M  V30 19 C 2.6675 4.6201 0.0 0
M  V30 20 C 1.3338 2.3101 0.0 0
M  V30 21 C 1.3338 5.3901 0.0 0
M  V30 22 C 0.0000 3.0801 0.0 0
M  V30 23 C 0.0000 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 7
M  V30 3 2 2 3
M  V30 4 1 2 13
M  V30 5 2 4 8
M  V30 6 1 5 6
M  V30 7 1 5 10
M  V30 8 1 6 18
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 13 2 10 12
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1177499-67-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1177499-77-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-13745443
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM amine also used as solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Glycogen phosphorylase inhibitory effects of
2-oxo-1,2-dihydropyridin-3-yl amide derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Karis, N. David; Loughlin, Wendy A.; Jenkins, Ian D.; Healy, Peter C.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry (2009), 17(13), 4724-4733

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
2,3-Dichloro-1,4-naphthoquinone
C10H4Cl2O2
117-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 Cl 6.9300 2.6674 0.0 0
M  V30 4 Cl 5.3900 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-(1-pyrrolidinyl)-1,4-naphthalenedione
C14H12ClNO2
59641-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 Cl 5.3900 0.0000 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 4.6200 1.3338 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 0.7700 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 N 6.9300 2.6674 0.0 0
M  V30 15 C 7.8352 3.9133 0.0 0
M  V30 16 C 7.8352 1.4216 0.0 0
M  V30 17 C 9.2998 3.4374 0.0 0
M  V30 18 C 9.2998 1.8974 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 6
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 9
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 117-80-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59641-25-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-8905369
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM "On water" assisted synthesis and biological evaluation of nitrogen and
sulfur containing hetero-1,4-naphthoquinones as potent antifungal and
antibacterial agents
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tandon, Vishnu K.; Maurya, Hardesh K.; Verma, Manoj K.; Kumar, Rohitashw;
Shukla, Praveen K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM European Journal of Medicinal Chemistry (2010), 45(6), 2418-2426

$RFMT $RIREG SCHEME366 STEP1
$RXN



  2  1
$MOL
2,3-Dichloro-1,4-naphthoquinone
C10H4Cl2O2
117-80-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 O 2.3100 0.0000 0.0 0
M  V30 3 Cl 6.9300 2.6674 0.0 0
M  V30 4 Cl 5.3900 0.0000 0.0 0
M  V30 5 C 3.0800 4.0011 0.0 0
M  V30 6 C 2.3100 2.6674 0.0 0
M  V30 7 C 4.6200 4.0011 0.0 0
M  V30 8 C 2.3100 5.3349 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 0.7700 2.6674 0.0 0
M  V30 11 C 5.3900 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 4.6200 1.3338 0.0 0
M  V30 14 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 7
M  V30 2 2 2 9
M  V30 3 1 3 11
M  V30 4 1 4 13
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 2 5 8
M  V30 8 1 6 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 2 11 13
M  V30 15 2 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloro-3-(1-pyrrolidinyl)-1,4-naphthalenedione
C14H12ClNO2
59641-25-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 5.3900 5.3349 0.0 0
M  V30 2 Cl 5.3900 0.0000 0.0 0
M  V30 3 O 2.3100 0.0000 0.0 0
M  V30 4 C 5.3900 2.6674 0.0 0
M  V30 5 C 4.6200 4.0011 0.0 0
M  V30 6 C 4.6200 1.3338 0.0 0
M  V30 7 C 3.0800 4.0011 0.0 0
M  V30 8 C 3.0800 1.3338 0.0 0
M  V30 9 C 2.3100 2.6674 0.0 0
M  V30 10 C 2.3100 5.3349 0.0 0
M  V30 11 C 0.7700 2.6674 0.0 0
M  V30 12 C 0.7700 5.3349 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 N 6.9300 2.6674 0.0 0
M  V30 15 C 7.8352 3.9133 0.0 0
M  V30 16 C 7.8352 1.4216 0.0 0
M  V30 17 C 9.2998 3.4374 0.0 0
M  V30 18 C 9.2998 1.8974 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 5
M  V30 2 1 2 6
M  V30 3 2 3 8
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 14
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 7 10
M  V30 11 1 8 9
M  V30 12 2 9 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 117-80-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59641-25-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-10215264
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry-solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM "On water": unprecedented nucleophilic substitution and addition
reactions with 1,4-quinones in aqueous suspension
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Tandon, Vishnu K.; Maurya, Hardesh K.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2009), 50(43), 5896-5902

$RFMT $RIREG SCHEME367 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Acetylfuran
C6H6O2
1192-62-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 1.5400 0.0 0
M  V30 2 C 5.1048 2.3100 0.0 0
M  V30 3 O 3.7710 0.0000 0.0 0
M  V30 4 C 2.4374 2.3100 0.0 0
M  V30 5 C 1.0306 1.6835 0.0 0
M  V30 6 O 2.2764 3.8416 0.0 0
M  V30 7 C 0.0000 2.8281 0.0 0
M  V30 8 C 0.7700 4.1617 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-(2-Furanyl)ethyl]pyrrolidine
C10H15NO
1880783-26-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 3.7711 0.0000 0.0 0
M  V30 3 C 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 O 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 C 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 C 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 2 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1192-62-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1880783-26-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-35960962
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 1333-74-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 12112-67-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 657408-07-6
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-89-8
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM glove box used, in-situ generated catalyst in stage 1, high pressure in
stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Practical N-alkylation via homogeneous iridium-catalyzed direct reductive
amination
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Jing; Wang, Wenji; Yang, Xiongyu; Liu, Jingwen; Huang, Haizhou;
Chang, Mingxin
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Science China: Chemistry (2023), 66(2), 518-525

$RFMT $RIREG SCHEME368 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)-2-pyridinecarboxamide
C12H9FN2O
119284-18-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 F 11.5503 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 N 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 0.0000 0.0 0
M  V30 13 C 7.7002 2.6673 0.0 0
M  V30 14 C 9.2402 0.0000 0.0 0
M  V30 15 C 9.2402 2.6673 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 11
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Fluorophenyl)-N-(tetrahydro-2-furanyl)-2-pyridinecarboxamide
C16H15FN2O2
2183512-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 3.7710 0.0 0
M  V30 2 C 4.6200 5.1048 0.0 0
M  V30 3 O 5.3900 6.4384 0.0 0
M  V30 4 F 11.5500 3.7710 0.0 0
M  V30 5 C 6.9300 3.7710 0.0 0
M  V30 6 C 7.7000 5.1048 0.0 0
M  V30 7 C 7.7000 2.4374 0.0 0
M  V30 8 C 9.2400 5.1048 0.0 0
M  V30 9 C 9.2400 2.4374 0.0 0
M  V30 10 C 10.0100 3.7710 0.0 0
M  V30 11 C 4.6200 2.4374 0.0 0
M  V30 12 C 3.0885 2.2764 0.0 0
M  V30 13 O 5.2463 1.0306 0.0 0
M  V30 14 C 2.7683 0.7700 0.0 0
M  V30 15 C 4.1019 0.0000 0.0 0
M  V30 16 C 3.0800 5.1048 0.0 0
M  V30 17 C 2.3100 3.7710 0.0 0
M  V30 18 N 2.3100 6.4384 0.0 0
M  V30 19 C 0.7700 3.7710 0.0 0
M  V30 20 C 0.7700 6.4384 0.0 0
M  V30 21 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 2 2 3
M  V30 5 1 2 16
M  V30 6 1 4 10
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 119284-18-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2183512-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25066888
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 66-71-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Teflon lined sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and atom-economical route to N-aryl amino alcohols from
primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Zhen; Li, Juanjuan; Yue, Qiang; Zhang, Qian; Li, Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2018), 8(60), 34304-34308

$RFMT $RIREG SCHEME369 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Fluorobenzonitrile
C7H4FN
1194-02-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 9 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1600 1.3336 0.0 0
M  V30 2 N 7.7000 1.3336 0.0 0
M  V30 3 F 0.0000 1.3336 0.0 0
M  V30 4 C 4.6200 1.3336 0.0 0
M  V30 5 C 3.8500 0.0000 0.0 0
M  V30 6 C 3.8500 2.6673 0.0 0
M  V30 7 C 2.3100 0.0000 0.0 0
M  V30 8 C 2.3100 2.6673 0.0 0
M  V30 9 C 1.5400 1.3336 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 4
M  V30 3 1 3 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 2 6 8
M  V30 8 2 7 9
M  V30 9 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1-Pyrrolidinyl)benzonitrile
C11H12N2
10282-30-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 8.5298 1.3336 0.0 0
M  V30 2 N 10.0698 1.3336 0.0 0
M  V30 3 C 3.9098 1.3336 0.0 0
M  V30 4 C 4.6798 2.6673 0.0 0
M  V30 5 C 4.6798 0.0000 0.0 0
M  V30 6 C 6.2198 2.6673 0.0 0
M  V30 7 C 6.2198 0.0000 0.0 0
M  V30 8 C 6.9898 1.3336 0.0 0
M  V30 9 N 2.3698 1.3336 0.0 0
M  V30 10 C 1.4645 0.0878 0.0 0
M  V30 11 C 1.4645 2.5795 0.0 0
M  V30 12 C 0.0000 0.5636 0.0 0
M  V30 13 C 0.0000 2.1037 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 9
M  V30 6 1 4 6
M  V30 7 2 5 7
M  V30 8 2 6 8
M  V30 9 1 7 8
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1194-02-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 10282-30-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10554153
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedures for the Preparation of Compounds 30- 38:
(4-(Pyrrolidin-1-yl)phenyl)methanamine (3, R3 = H, R4 = Pyrrolidinyl). A
solution of 4-fluorobenzonitrile (1.10 g, 9.08 mmol) and pyrrolidine
(2.58 g, 36.3 mmol) in DMSO (15 mL) was heated to 120 °C in a sealed tube
for 2 h. The mixture was cooled to room temperature and partitioned
between Et2O and H2O. The separated aqueous phase was extracted with
Et2O, and the combined organic layer was washed with water and brine,
dried (Na2SO4), and concentrated in vacuo. The crude product was placed
under high vacuum overnight, resulting of 4-(pyrrolidin-1-yl)benzonitrile
as a light-orange solid. 4-(pyrrolidin-1-yl)benzonitrile, yield 99% 1H
NMR (DMSO-d6): δ 7.52 (m, 2H), 6.59 (m, 2H), 3.28 (m, 4H), 1.96 (m, 4H).
MS (ESI+): m/z 173 (M + H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM sealed tube used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM In vitro structure-activity relationship and in vivo characterization of
1-(aryl)-3-(4-(amino)benzyl)urea transient receptor potential vanilloid 1
antagonists
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Perner, Richard J.; DiDomenico, Stanley; Koenig, John R.; Gomtsyan,
Arthur; Bayburt, Erol K.; Schmidt, Robert G.; Drizin, Irene; Zheng, Guo
Zhu; Turner, Sean C.; Jinkerson, Tammie; Brown, Brian S.; Keddy, Ryan G.;
Lukin, Kurill; McDonald, Heath A.; Honore, Prisca; Mikusa, Joe; Marsh,
Kennan C.; Wetter, Jill M.; St. George, Karen; Jarvis, Michael F.;
Faltynek, Connie R.; Lee, Chih-Hung
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Medicinal Chemistry (2007), 50(15), 3651-3660

$RFMT $RIREG SCHEME370 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Citiolone
C6H9NO2S
1195-16-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 3.7710 1.3627 0.0 0
M  V30 2 C 5.1048 2.1327 0.0 0
M  V30 3 C 5.1048 3.6727 0.0 0
M  V30 4 O 6.4384 1.3627 0.0 0
M  V30 5 O 0.7102 0.0000 0.0 0
M  V30 6 C 2.4373 2.1327 0.0 0
M  V30 7 C 1.0306 1.5064 0.0 0
M  V30 8 C 2.2764 3.6643 0.0 0
M  V30 9 S 0.0000 2.6508 0.0 0
M  V30 10 C 0.7700 3.9846 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 2 3
M  V30 4 2 2 4
M  V30 5 2 5 7
M  V30 6 1 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[3-Mercapto-1-(1-pyrrolidinylcarbonyl)propyl]acetamide
C10H18N2O2S
2705932-59-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6798 4.0011 0.0 0
M  V30 2 C 3.9098 5.3347 0.0 0
M  V30 3 N 3.9098 2.6674 0.0 0
M  V30 4 C 6.2198 4.0011 0.0 0
M  V30 5 O 4.6798 6.6685 0.0 0
M  V30 6 C 4.6798 1.3338 0.0 0
M  V30 7 C 6.9898 5.3347 0.0 0
M  V30 8 C 3.9098 0.0000 0.0 0
M  V30 9 O 6.2198 1.3338 0.0 0
M  V30 10 S 8.5298 5.3347 0.0 0
M  V30 11 N 2.3698 5.3347 0.0 0
M  V30 12 C 1.4645 6.5807 0.0 0
M  V30 13 C 1.4645 4.0889 0.0 0
M  V30 14 C 0.0000 6.1047 0.0 0
M  V30 15 C 0.0000 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 11
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1195-16-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2705932-59-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-24090243
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-66-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Uncovering divergent fluorescence of aliphatic polyamides: Synthesis,
dual polymerization-induced emissions, and organelle-specific imaging
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Yan, Junjie; Wang, Xinyu; Xiong, Jianjun; Wang, Lizhen; Pan, Donghui; Xu,
Yuping; Yang, Min
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Engineering Journal (Amsterdam, Netherlands) (2022), 428132142

$RFMT $RIREG SCHEME371 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[4,5-Dimethoxy-2-(2-propyn-1-yl)phenyl]ethanone
C13H14O3
1204473-16-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 5.3901 0.0 0
M  V30 2 C 8.0023 4.6201 0.0 0
M  V30 3 C 9.3360 3.8501 0.0 0
M  V30 4 C 4.0012 6.9302 0.0 0
M  V30 5 C 2.6675 7.7002 0.0 0
M  V30 6 O 5.3348 7.7002 0.0 0
M  V30 7 O 4.0012 0.7700 0.0 0
M  V30 8 C 5.3348 0.0000 0.0 0
M  V30 9 O 1.3337 2.3101 0.0 0
M  V30 10 C 0.0000 3.0801 0.0 0
M  V30 11 C 5.3348 4.6201 0.0 0
M  V30 12 C 4.0012 5.3901 0.0 0
M  V30 13 C 5.3348 3.0801 0.0 0
M  V30 14 C 2.6675 4.6201 0.0 0
M  V30 15 C 4.0012 2.3101 0.0 0
M  V30 16 C 2.6675 3.0801 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 3 2 3
M  V30 4 1 4 5
M  V30 5 2 4 6
M  V30 6 1 4 12
M  V30 7 1 7 8
M  V30 8 1 7 15
M  V30 9 1 9 10
M  V30 10 1 9 16
M  V30 11 2 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 2 13 15
M  V30 15 2 14 16
M  V30 16 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1-(6,7-dimethoxy-4-methyl-2-naphthalenyl)-
C17H21NO2
1204473-19-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 8.0022 0.0 0
M  V30 2 O 2.3100 1.3336 0.0 0
M  V30 3 C 3.0800 0.0000 0.0 0
M  V30 4 O 0.7700 4.0011 0.0 0
M  V30 5 C 0.0000 5.3347 0.0 0
M  V30 6 C 5.3900 4.0011 0.0 0
M  V30 7 C 4.6200 5.3347 0.0 0
M  V30 8 C 6.9300 4.0011 0.0 0
M  V30 9 C 4.6200 2.6674 0.0 0
M  V30 10 C 3.0800 5.3347 0.0 0
M  V30 11 C 5.3900 6.6685 0.0 0
M  V30 12 C 7.7000 5.3347 0.0 0
M  V30 13 C 3.0800 2.6674 0.0 0
M  V30 14 C 2.3100 4.0011 0.0 0
M  V30 15 C 6.9300 6.6685 0.0 0
M  V30 16 N 9.2400 5.3347 0.0 0
M  V30 17 C 10.1453 6.5806 0.0 0
M  V30 18 C 10.1453 4.0889 0.0 0
M  V30 19 C 11.6098 6.1047 0.0 0
M  V30 20 C 11.6098 4.5647 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 3
M  V30 3 1 2 13
M  V30 4 1 4 5
M  V30 5 1 4 14
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 6 9
M  V30 9 1 7 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 2 11 15
M  V30 15 1 12 15
M  V30 16 1 12 16
M  V30 17 1 13 14
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1204473-16-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1204473-19-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25032925
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical procedure for the formation of
diethyl-naphthalen-2yl-amine (3a). To a mixture of
2-(prop-2-nyl)benzaldehyde 1a (57.6 mg, 0.4 mmol) and 4Å molecular sieves
(200 mg) in 5 ml 2-neck flask equipped with dry tube was added 2 ml of
diethylamine. The reaction mixture was stirred at ambient temperature for
2 hours. After consumption of 1a which was monitored by TLC, diethylamine
was recovered through distillation. The residue was diluted with
dichloromethane, and molecular sieves 4Å was removed by filtration. After
concentration, the residue was purified by a short silica gel column
(hexane/ethyl acetate = 40/1) to afford 74 mg (93%) of
diethyl-naphthalen-2-yl-amine 3a as a colorless oil.
1-(6,7-Dimethoxy-4-methyl-naphthalen-2-yl)-pyrrolidine (3t) White solid;
m.p. 159-162 °C; 1H NMR (600 MHz, CDCl3) δ 7.09 (s, 1H), 6.99 (s, 1H),
6.74 (s, 1H), 6.58 (s, 1H), 3.98 (s, 6H), 3.37 (t, J = 6.7 Hz, 4H), 2.60
(s, 3H), 1.06 (t, J = 6.7 Hz, 4H); 13C NMR (100 MHz, CDCl3) δ 19.86,
25.38, 47.79, 55.61, 55.77, 102.93, 103.45, 105.41, 114.61, 120.34,
131.21, 133.57, 144.89, 146.02, 149.54; IR(neat): 840, 1158, 1247, 1416,
1509, 1608, 2825 cm-1; HRMS (ESI): [M+H]+ calcd for C17H21NO2, 272.1645;
found, 272.1645.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzannulation from Alkyne without Metallic Catalysts at Room Temperature
to 100 °C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jin, Tienan; Yang, Fan; Yamamoto, Yoshinori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2010), 12(2), 388-390

$RFMT $RIREG SCHEME372 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[5-Chloro-2-(2-propyn-1-yl)phenyl]ethanone
C11H9ClO
1204473-17-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 C 1.3336 0.0000 0.0 0
M  V30 3 O 4.0011 0.0000 0.0 0
M  V30 4 C 5.3347 2.3100 0.0 0
M  V30 5 C 6.6685 3.0800 0.0 0
M  V30 6 C 8.0021 3.8500 0.0 0
M  V30 7 Cl 0.0000 5.3900 0.0 0
M  V30 8 C 2.6674 2.3100 0.0 0
M  V30 9 C 4.0011 3.0800 0.0 0
M  V30 10 C 1.3336 3.0800 0.0 0
M  V30 11 C 4.0011 4.6200 0.0 0
M  V30 12 C 1.3336 4.6200 0.0 0
M  V30 13 C 2.6674 5.3900 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 3 5 6
M  V30 7 1 7 12
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 2 10 12
M  V30 12 2 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1-(6-chloro-4-methyl-2-naphthalenyl)-
C15H16ClN
1204473-21-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9898 0.0000 0.0 0
M  V30 2 Cl 10.8398 4.0011 0.0 0
M  V30 3 C 6.2198 4.0011 0.0 0
M  V30 4 C 6.9898 2.6674 0.0 0
M  V30 5 C 4.6798 4.0011 0.0 0
M  V30 6 C 6.9898 5.3349 0.0 0
M  V30 7 C 6.2198 1.3338 0.0 0
M  V30 8 C 8.5298 2.6674 0.0 0
M  V30 9 C 3.9098 2.6674 0.0 0
M  V30 10 C 8.5298 5.3349 0.0 0
M  V30 11 C 4.6798 1.3338 0.0 0
M  V30 12 C 9.2998 4.0011 0.0 0
M  V30 13 N 2.3698 2.6674 0.0 0
M  V30 14 C 1.4645 1.4216 0.0 0
M  V30 15 C 1.4645 3.9133 0.0 0
M  V30 16 C 0.0000 1.8974 0.0 0
M  V30 17 C 0.0000 3.4374 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 12
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 1 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 1 9 11
M  V30 13 1 9 13
M  V30 14 1 10 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1204473-17-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1204473-21-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-25651190
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical procedure for the formation of
diethyl-naphthalen-2yl-amine (3a). To a mixture of
2-(prop-2-nyl)benzaldehyde 1a (57.6 mg, 0.4 mmol) and 4Å molecular sieves
(200 mg) in 5 ml 2-neck flask equipped with dry tube was added 2 ml of
diethylamine. The reaction mixture was stirred at ambient temperature for
2 hours. After consumption of 1a which was monitored by TLC, diethylamine
was recovered through distillation. The residue was diluted with
dichloromethane, and molecular sieves 4Å was removed by filtration. After
concentration, the residue was purified by a short silica gel column
(hexane/ethyl acetate = 40/1) to afford 74 mg (93%) of
diethyl-naphthalen-2-yl-amine 3a as a colorless oil.
1-(6-Chloro-4-methyl-naphthalen-2-yl)-pyrrolidine (3v) Slight red solid;
m.p. 119-121 °C; 1H NMR (600 MHz, CDCl3) δ 7.78 (d, J = 2.0 Hz, 1H), 7.52
(d, J = 2.7 Hz, 1H), 7.28 (dd, J = 8.7, 2.1 Hz, 1H), 6.87 (s, 1H), 6.58
(s, 1H), 3.38 (t, J = 6.6 Hz, 4H), 2.61 (s, 3H), 2.04 (t, J = 6.6 Hz,
4H); 13C NMR (75 MHz, CDCl3) δ 19.57, 25.45, 47.66, 102.87, 117.32,
123.01, 126.11, 126.20, 126.53, 127.78, 133.82, 134.45, 145.61; IR(neat):
836, 867, 1090, 1311, 1473, 1617, 2964 cm-1; HRMS (ESI): [M+H]+ calcd for
C15H16ClN, 246.1044; found, 246.1043.
$DTYPE RXN:VAR(1):NOTES
$DATUM green chemistry, regioselective, molecular sieves used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Benzannulation from Alkyne without Metallic Catalysts at Room Temperature
to 100 °C
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jin, Tienan; Yang, Fan; Yamamoto, Yoshinori
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2010), 12(2), 388-390

$RFMT $RIREG SCHEME373 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 5-[5-[[(2S)-1-[(1,1-dimethylethoxy)carbonyl]-2-azetidinyl]methoxy]-3-p...
C21H27N3O6
1222139-66-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  30 32 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 17.8724 4.7567 0.0 0
M  V30 2 C 18.7777 6.0027 0.0 0
M  V30 3 C 20.3092 5.8416 0.0 0
M  V30 4 O 21.2144 7.0875 0.0 0
M  V30 5 O 20.9357 4.4348 0.0 0
M  V30 6 C 22.7461 6.9266 0.0 0
M  V30 7 O 8.5687 4.3997 0.0 0
M  V30 8 C 7.2350 3.6297 0.0 0
M  V30 9 C 3.6438 2.6673 0.0 0
M  V30 10 O 2.1038 2.6673 0.0 0
M  V30 11 O 4.4139 1.3337 0.0 0
M  V30 12 C 1.3338 1.3337 0.0 0
M  V30 13 C 2.6675 0.5636 0.0 0
M  V30 14 C 0.5638 0.0000 0.0 0
M  V30 15 C 0.0000 2.1037 0.0 0
M  V30 16 C 13.9035 4.3997 0.0 0
M  V30 17 C 15.3104 3.7732 0.0 0
M  V30 18 O 14.0646 5.9312 0.0 0
M  V30 19 C 16.3409 4.9178 0.0 0
M  V30 20 N 15.5709 6.2514 0.0 0
M  V30 21 C 12.5698 3.6297 0.0 0
M  V30 22 C 11.2362 4.3997 0.0 0
M  V30 23 C 12.5698 2.0897 0.0 0
M  V30 24 C 9.9025 3.6297 0.0 0
M  V30 25 N 11.2362 1.3196 0.0 0
M  V30 26 C 9.9025 2.0897 0.0 0
M  V30 27 C 5.9014 4.3997 0.0 0 CFG=2
M  V30 28 N 4.4139 4.0010 0.0 0
M  V30 29 C 5.5028 5.8872 0.0 0
M  V30 30 C 4.0151 5.4886 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 19
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 7 8
M  V30 8 1 7 24
M  V30 9 1 27 8 CFG=1
M  V30 10 1 9 10
M  V30 11 2 9 11
M  V30 12 1 9 28
M  V30 13 1 10 12
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 12 15
M  V30 17 2 16 17
M  V30 18 1 16 18
M  V30 19 1 16 21
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 20
M  V30 23 1 21 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 2 25 26
M  V30 29 1 27 28
M  V30 30 1 27 29
M  V30 31 1 28 30
M  V30 32 1 29 30
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 27)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2S)-2-[[[5-[3-[3-oxo-3-(1-pyrrolidinyl)propyl]-5-isoxazoly...
C24H32N4O5
1222139-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 7.5922 3.2198 0.0 0
M  V30 2 O 9.1322 3.2198 0.0 0
M  V30 3 C 4.0011 2.2575 0.0 0
M  V30 4 O 2.6674 1.4875 0.0 0
M  V30 5 O 4.0011 3.7975 0.0 0
M  V30 6 C 1.3336 2.2575 0.0 0
M  V30 7 C 2.1036 3.5913 0.0 0
M  V30 8 C 0.0000 3.0275 0.0 0
M  V30 9 C 0.5636 0.9239 0.0 0
M  V30 10 C 17.3680 7.5624 0.0 0
M  V30 11 C 18.7748 6.9360 0.0 0
M  V30 12 C 20.0209 7.8413 0.0 0
M  V30 13 O 19.8598 9.3728 0.0 0
M  V30 14 C 6.8222 1.8862 0.0 0 CFG=2
M  V30 15 N 5.3347 1.4875 0.0 0
M  V30 16 C 7.2209 0.3986 0.0 0
M  V30 17 C 5.7333 0.0000 0.0 0
M  V30 18 C 9.9022 4.5535 0.0 0
M  V30 19 C 11.4423 4.5535 0.0 0
M  V30 20 C 9.1322 5.8871 0.0 0
M  V30 21 C 12.2123 5.8871 0.0 0
M  V30 22 N 9.9022 7.2209 0.0 0
M  V30 23 C 11.4423 7.2209 0.0 0
M  V30 24 C 13.7523 5.8871 0.0 0
M  V30 25 C 14.6575 7.1332 0.0 0
M  V30 26 O 14.6575 4.6413 0.0 0
M  V30 27 C 16.1222 6.6571 0.0 0
M  V30 28 N 16.1222 5.1171 0.0 0
M  V30 29 N 21.4277 7.2148 0.0 0
M  V30 30 C 21.7478 5.7085 0.0 0
M  V30 31 C 22.7613 7.9848 0.0 0
M  V30 32 C 23.2794 5.5476 0.0 0
M  V30 33 C 23.9058 6.9544 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 14 1 CFG=3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 15
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 1 10 27
M  V30 13 1 11 12
M  V30 14 2 12 13
M  V30 15 1 12 29
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 21 24
M  V30 26 2 22 23
M  V30 27 2 24 25
M  V30 28 1 24 26
M  V30 29 1 25 27
M  V30 30 1 26 28
M  V30 31 2 27 28
M  V30 32 1 29 30
M  V30 33 1 29 31
M  V30 34 1 30 32
M  V30 35 1 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 14)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1222139-66-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1222139-73-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-368-CAS-9950781
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM To
3-[5-[5-[[1-(tert-butoxycarbonyl)-2(S)-azetidinyl]methoxy]-3-pyridyl]-3-isoxazolyl]propionic
acid methyl ester (210 mg, 0.5 mmol) was added pyrrolidine (1.2 mL, 15
mmol). The mixture was heated at 100 °C for 12 h, cooled, and
concentrated. The residue was dissolved in water and extracted with
CH2Cl2. The organic phase was dried over MgSO4, filtered and concentrated
in vacuo. The residue was purified by CC on SiO2 with EtOAc/hexane 1:1 to
give
3-[5-[5-[[1-(tert-butoxycarbonyl)-2(S)-azetidinyl]methoxy]-3-pyridyl]-3-isoxazolyl]-1-(1-pyrrolidinyl)-1-propanone
(230 mg, 99%).
3-[5-[5-[[1-(tert-butoxycarbonyl)-2(S)-azetidinyl]methoxy]-3-
pyridyl]-3-isoxazolyl]-1-(1-pyrrolidinyl)-1-propanone, yield (230 mg,
99%).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of azetidinyl- and pyrrolidinylmethoxypyridines as nicotinic
acetylcholine receptor ligands
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Chandrasekhar, Jayaraman; Kozikowski, Alan P.; Liu, Jianhua; Tueckmantel,
Werner; Walker, Joel R.; Yuen, Po-Wai
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010045212 A2 2010-04-22

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
(2R,2′R)-2,2′-[(2-Iodo-1,3-phenylene)bis(oxy)]bis[propanoic acid]
C12H13IO6
1226896-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 3.0801 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0 CFG=2
M  V30 3 C 1.3337 3.0801 0.0 0
M  V30 4 C 2.6673 0.7700 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 I 6.6685 4.6201 0.0 0
M  V30 8 O 9.3360 3.0801 0.0 0
M  V30 9 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 10 C 12.0033 3.0801 0.0 0
M  V30 11 C 10.6697 0.7700 0.0 0
M  V30 12 O 13.3370 2.3101 0.0 0
M  V30 13 O 12.0033 4.6201 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 6.6685 0.0000 0.0 0
M  V30 19 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R,2′R)-2,2′-[(2-Iodo-1,3-phenylene)bis(oxy)]bis[1-(1-pyrrolidinyl)-1-propan...
C20H27IN2O4
1226896-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 11.7734 1.5400 0.0 0
M  V30 2 C 13.1071 2.3101 0.0 0 CFG=2
M  V30 3 C 14.4407 1.5400 0.0 0
M  V30 4 C 13.1071 3.8501 0.0 0
M  V30 5 O 14.4407 0.0000 0.0 0
M  V30 6 I 9.1059 0.0000 0.0 0
M  V30 7 O 6.4384 1.5400 0.0 0
M  V30 8 C 5.1047 2.3101 0.0 0 CFG=2
M  V30 9 C 3.7711 1.5400 0.0 0
M  V30 10 C 5.1047 3.8501 0.0 0
M  V30 11 O 3.7711 0.0000 0.0 0
M  V30 12 C 10.4396 2.3101 0.0 0
M  V30 13 C 9.1059 1.5400 0.0 0
M  V30 14 C 10.4396 3.8501 0.0 0
M  V30 15 C 7.7722 2.3101 0.0 0
M  V30 16 C 9.1059 4.6201 0.0 0
M  V30 17 C 7.7722 3.8501 0.0 0
M  V30 18 N 15.7744 2.3101 0.0 0
M  V30 19 C 15.9355 3.8416 0.0 0
M  V30 20 C 17.1814 1.6837 0.0 0
M  V30 21 C 17.4418 4.1618 0.0 0
M  V30 22 C 18.2118 2.8281 0.0 0
M  V30 23 N 2.4374 2.3101 0.0 0
M  V30 24 C 1.0304 1.6837 0.0 0
M  V30 25 C 2.2763 3.8416 0.0 0
M  V30 26 C 0.0000 2.8281 0.0 0
M  V30 27 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 2 3 5
M  V30 6 1 3 18
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 7 15
M  V30 10 1 8 9
M  V30 11 1 8 10 CFG=1
M  V30 12 2 9 11
M  V30 13 1 9 23
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1226896-33-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1226896-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-1513281
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Chiral hypervalent iodine-catalyzed enantioselective oxidative Kita
spirolactonization of 1-naphthol derivatives and one-pot
diastereo-selective oxidation to epoxyspirolactones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Uyanik, Muhammet; Yasui, Takeshi; Ishihara, Kazuaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2010), 66(31), 5841-5851

$RFMT $RIREG SCHEME374 STEP1
$RXN



  2  1
$MOL
(2R,2′R)-2,2′-[(2-Iodo-1,3-phenylene)bis(oxy)]bis[propanoic acid]
C12H13IO6
1226896-33-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 4.0010 3.0801 0.0 0
M  V30 2 C 2.6673 2.3101 0.0 0 CFG=2
M  V30 3 C 1.3337 3.0801 0.0 0
M  V30 4 C 2.6673 0.7700 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 4.6201 0.0 0
M  V30 7 I 6.6685 4.6201 0.0 0
M  V30 8 O 9.3360 3.0801 0.0 0
M  V30 9 C 10.6697 2.3101 0.0 0 CFG=2
M  V30 10 C 12.0033 3.0801 0.0 0
M  V30 11 C 10.6697 0.7700 0.0 0
M  V30 12 O 13.3370 2.3101 0.0 0
M  V30 13 O 12.0033 4.6201 0.0 0
M  V30 14 C 5.3348 2.3101 0.0 0
M  V30 15 C 6.6685 3.0801 0.0 0
M  V30 16 C 5.3348 0.7700 0.0 0
M  V30 17 C 8.0022 2.3101 0.0 0
M  V30 18 C 6.6685 0.0000 0.0 0
M  V30 19 C 8.0022 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 1 3 5
M  V30 6 2 3 6
M  V30 7 1 7 15
M  V30 8 1 8 9
M  V30 9 1 8 17
M  V30 10 1 9 10
M  V30 11 1 9 11 CFG=1
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(2R,2′R)-2,2′-[(2-Iodo-1,3-phenylene)bis(oxy)]bis[1-(1-pyrrolidinyl)-1-propan...
C20H27IN2O4
1226896-39-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 29 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 11.7734 1.5400 0.0 0
M  V30 2 C 13.1071 2.3101 0.0 0 CFG=2
M  V30 3 C 14.4407 1.5400 0.0 0
M  V30 4 C 13.1071 3.8501 0.0 0
M  V30 5 O 14.4407 0.0000 0.0 0
M  V30 6 I 9.1059 0.0000 0.0 0
M  V30 7 O 6.4384 1.5400 0.0 0
M  V30 8 C 5.1047 2.3101 0.0 0 CFG=2
M  V30 9 C 3.7711 1.5400 0.0 0
M  V30 10 C 5.1047 3.8501 0.0 0
M  V30 11 O 3.7711 0.0000 0.0 0
M  V30 12 C 10.4396 2.3101 0.0 0
M  V30 13 C 9.1059 1.5400 0.0 0
M  V30 14 C 10.4396 3.8501 0.0 0
M  V30 15 C 7.7722 2.3101 0.0 0
M  V30 16 C 9.1059 4.6201 0.0 0
M  V30 17 C 7.7722 3.8501 0.0 0
M  V30 18 N 15.7744 2.3101 0.0 0
M  V30 19 C 15.9355 3.8416 0.0 0
M  V30 20 C 17.1814 1.6837 0.0 0
M  V30 21 C 17.4418 4.1618 0.0 0
M  V30 22 C 18.2118 2.8281 0.0 0
M  V30 23 N 2.4374 2.3101 0.0 0
M  V30 24 C 1.0304 1.6837 0.0 0
M  V30 25 C 2.2763 3.8416 0.0 0
M  V30 26 C 0.0000 2.8281 0.0 0
M  V30 27 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 12
M  V30 3 1 2 3
M  V30 4 1 2 4 CFG=3
M  V30 5 2 3 5
M  V30 6 1 3 18
M  V30 7 1 6 13
M  V30 8 1 7 8
M  V30 9 1 7 15
M  V30 10 1 8 9
M  V30 11 1 8 10 CFG=1
M  V30 12 2 9 11
M  V30 13 1 9 23
M  V30 14 2 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 2 14 16
M  V30 18 2 15 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 25 1 23 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 27
M  V30 29 1 26 27
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(2 2 8)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1226896-33-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1226896-39-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-7007857
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):NOTES
$DATUM in-situ generated reactant in first stage
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Enantioselective Kita Oxidative Spirolactonization Catalyzed by In Situ
Generated Chiral Hypervalent Iodine(III) Species
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Uyanik, Muhammet; Yasui, Takeshi; Ishihara, Kazuaki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Angewandte Chemie, International Edition (2010), 49(12), 2175-2177,
S2175/1-S2175/79

$RFMT $RIREG SCHEME375 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Butyl-4-chloro-5,6,8,9-tetrahydro-9-methyl-7H-pyrimido[4,5-e][1,4]diazepin-...
C12H17ClN4O
1228425-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.3116 1.3337 0.0 0
M  V30 2 C 0.0000 3.5287 0.0 0
M  V30 3 C 5.8232 6.3331 0.0 0
M  V30 4 C 7.2568 5.7703 0.0 0
M  V30 5 C 8.4608 6.7305 0.0 0
M  V30 6 C 9.8944 6.1680 0.0 0
M  V30 7 O 3.2316 7.5809 0.0 0
M  V30 8 C 4.0016 2.6673 0.0 0
M  V30 9 C 2.4616 2.6673 0.0 0
M  V30 10 C 4.9618 3.8713 0.0 0
M  V30 11 C 4.7716 1.3337 0.0 0
M  V30 12 N 1.5014 3.8713 0.0 0
M  V30 13 N 1.6916 1.3337 0.0 0
M  V30 14 N 4.6192 5.3728 0.0 0
M  V30 15 N 4.0016 0.0000 0.0 0
M  V30 16 C 1.8442 5.3728 0.0 0
M  V30 17 C 2.4616 0.0000 0.0 0
M  V30 18 C 3.2316 6.0409 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 11
M  V30 2 1 2 12
M  V30 3 1 3 4
M  V30 4 1 3 14
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 7 18
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 2 8 11
M  V30 11 1 9 12
M  V30 12 2 9 13
M  V30 13 1 10 14
M  V30 14 1 11 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 17
M  V30 19 1 16 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Butyl-5,6,8,9-tetrahydro-9-methyl-4-(1-pyrrolidinyl)-7H-pyrimido[4,5-e][1,4...
C16H25N5O
1228425-84-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.8251 9.0009 0.0 0
M  V30 2 C 7.1653 5.3601 0.0 0
M  V30 3 C 8.3693 6.3203 0.0 0
M  V30 4 C 9.8029 5.7576 0.0 0
M  V30 5 C 11.0069 6.7178 0.0 0
M  V30 6 O 6.9503 8.2284 0.0 0
M  V30 7 C 3.0801 5.1047 0.0 0
M  V30 8 C 2.3100 3.7711 0.0 0
M  V30 9 C 2.3100 6.4384 0.0 0
M  V30 10 C 4.6028 4.8751 0.0 0
M  V30 11 N 0.7700 3.7711 0.0 0
M  V30 12 N 2.8726 7.8720 0.0 0
M  V30 13 N 0.7700 6.4384 0.0 0
M  V30 14 N 5.7317 5.9226 0.0 0
M  V30 15 C 0.0000 5.1047 0.0 0
M  V30 16 C 4.3443 8.3259 0.0 0
M  V30 17 C 5.6166 7.4584 0.0 0
M  V30 18 N 3.0801 2.4373 0.0 0
M  V30 19 C 4.6116 2.2763 0.0 0
M  V30 20 C 2.4536 1.0304 0.0 0
M  V30 21 C 4.9318 0.7700 0.0 0
M  V30 22 C 3.5981 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 12
M  V30 2 1 2 3
M  V30 3 1 2 14
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 2 6 17
M  V30 7 2 7 8
M  V30 8 1 7 9
M  V30 9 1 7 10
M  V30 10 1 8 11
M  V30 11 1 8 18
M  V30 12 1 9 12
M  V30 13 2 9 13
M  V30 14 1 10 14
M  V30 15 2 11 15
M  V30 16 1 12 16
M  V30 17 1 13 15
M  V30 18 1 14 17
M  V30 19 1 16 17
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1228425-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1228425-84-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-10714964
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 71-36-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General Procedure for Displacement of the
Chloro Group in 3.1a with n-BuNH2, Piperazine, and Pyrrolidine,
Preparation of Compounds 4.1.1a, 4.1.2a, and 4.1.3a. To a solution of
compound 3.1a (0.5 mmol) in n-BuOH (4.0 mL) was added amine (1.5 mmol)
followed by Et3N (2 mmol). The resulting solution was stirred for the
corresponding time at reflux. The volatiles were removed in vacuo, before
water (10 mL) was added. The reaction mixture was extracted with CH2Cl2
(3 × 10 mL). The combined organic layers were washed with brine (20 mL),
dried (Na2SO4), and concentrated in vacuo. Purification by flash column
chromatography (petroleum ether/DCM 2:1-1:2, v/v). desired products.
6-Butyl-9-methyl-4-(pyrrolidin-1-yl)-8,9-dihydro-5H-pyrimido[4,5-e][1,4]diazepin-7(6H)-one
4.1.3a. 99%. mp: 76-77 °C. 1H NMR δ 8.16 (s, 1H), 4.34 (s, 2H), 4.12 (s,
2H), 3.45-3.36 (m, 6H), 3.28 (s, 3H), 1.93 (s, 4H), 1.42-1.35 (m, 2H),
1.27-1.72 (m, 2H), 0.85 (t, 3H, J = 7.2). 13C NMR δ 168.9, 163.5, 161.6,
154.7, 94.7, 54.7, 50.6, 48.3, 47.1, 38.5, 30.3, 25.6, 19.8, 13.7. MS
(ESI): m/z 304.0 [M + H+].
$DTYPE RXN:VAR(1):NOTES
$DATUM combinatorial
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of Novel 8,9-Dihydro-5H-pyrimido[4,5-e][1,4]diazepin-7(6H)-ones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiang, Jinbao; Wen, Dongsheng; Xie, Hongxiang; Dang, Qun; Bai, Xu
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of Combinatorial Chemistry (2010), 12(4), 503-509

$RFMT $RIREG SCHEME376 STEP1
$RXN



  4  1
$MOL
4-Aminophenol
C6H7NO
123-30-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 0.0000 1.3337 0.0 0
M  V30 2 O 6.1601 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 3.8500 0.0000 0.0 0
M  V30 7 C 3.8500 2.6673 0.0 0
M  V30 8 C 4.6201 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 3
M  V30 2 1 2 8
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
7,10-Dichloro-2-methoxybenzo[b]-1,5-naphthyridine
C13H8Cl2N2O
6626-40-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 5.3348 0.0000 0.0 0
M  V30 2 O 10.6697 1.5400 0.0 0
M  V30 3 C 12.0033 2.3101 0.0 0
M  V30 4 Cl 0.0000 4.6201 0.0 0
M  V30 5 C 6.6685 2.3101 0.0 0
M  V30 6 C 6.6685 3.8501 0.0 0
M  V30 7 C 5.3348 1.5400 0.0 0
M  V30 8 N 8.0022 1.5400 0.0 0
M  V30 9 N 5.3348 4.6201 0.0 0
M  V30 10 C 8.0022 4.6201 0.0 0
M  V30 11 C 4.0012 2.3101 0.0 0
M  V30 12 C 9.3360 2.3101 0.0 0
M  V30 13 C 4.0012 3.8501 0.0 0
M  V30 14 C 9.3360 3.8501 0.0 0
M  V30 15 C 2.6673 1.5400 0.0 0
M  V30 16 C 2.6673 4.6201 0.0 0
M  V30 17 C 1.3337 2.3101 0.0 0
M  V30 18 C 1.3337 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 4 18
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 2 8 12
M  V30 12 1 9 13
M  V30 13 2 10 14
M  V30 14 2 11 13
M  V30 15 1 11 15
M  V30 16 1 12 14
M  V30 17 1 13 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Formaldehyde
CH2O
50-00-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  2 1 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.0000 0.0 0
M  V30 2 O 1.5400 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyronaridine
C29H32ClN5O2
74847-35-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  37 42 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 9.1059 7.2419 0.0 0
M  V30 2 O 14.4407 8.7819 0.0 0
M  V30 3 C 15.7746 9.5519 0.0 0
M  V30 4 Cl 3.7711 11.8620 0.0 0
M  V30 5 C 6.4386 2.6218 0.0 0
M  V30 6 C 3.7711 7.2419 0.0 0
M  V30 7 O 3.7711 4.1618 0.0 0
M  V30 8 C 9.1059 8.7819 0.0 0
M  V30 9 C 10.4397 9.5519 0.0 0
M  V30 10 C 7.7722 9.5519 0.0 0
M  V30 11 C 10.4397 11.0919 0.0 0
M  V30 12 N 11.7734 8.7819 0.0 0
M  V30 13 C 7.7722 11.0919 0.0 0
M  V30 14 C 6.4386 8.7819 0.0 0
M  V30 15 N 9.1059 11.8620 0.0 0
M  V30 16 C 11.7734 11.8620 0.0 0
M  V30 17 C 13.1071 9.5519 0.0 0
M  V30 18 C 6.4386 11.8620 0.0 0
M  V30 19 C 5.1049 9.5519 0.0 0
M  V30 20 C 13.1071 11.0919 0.0 0
M  V30 21 C 5.1049 11.0919 0.0 0
M  V30 22 C 7.7722 6.4718 0.0 0
M  V30 23 C 7.7722 4.9318 0.0 0
M  V30 24 C 6.4386 7.2419 0.0 0
M  V30 25 C 6.4386 4.1618 0.0 0
M  V30 26 C 5.1049 6.4718 0.0 0
M  V30 27 C 5.1049 4.9318 0.0 0
M  V30 28 N 7.7722 1.8517 0.0 0
M  V30 29 C 9.1792 2.4782 0.0 0
M  V30 30 C 7.9332 0.3202 0.0 0
M  V30 31 C 10.2097 1.3337 0.0 0
M  V30 32 C 9.4396 0.0000 0.0 0
M  V30 33 N 2.4374 6.4718 0.0 0
M  V30 34 C 1.0306 7.0983 0.0 0
M  V30 35 C 2.2765 4.9403 0.0 0
M  V30 36 C 0.0000 5.9538 0.0 0
M  V30 37 C 0.7700 4.6201 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 1 1 22
M  V30 3 1 2 3
M  V30 4 1 2 17
M  V30 5 1 4 21
M  V30 6 1 5 25
M  V30 7 1 5 28
M  V30 8 1 6 26
M  V30 9 1 6 33
M  V30 10 1 7 27
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 1 9 12
M  V30 15 2 10 13
M  V30 16 1 10 14
M  V30 17 2 11 15
M  V30 18 1 11 16
M  V30 19 2 12 17
M  V30 20 1 13 15
M  V30 21 1 13 18
M  V30 22 2 14 19
M  V30 23 2 16 20
M  V30 24 1 17 20
M  V30 25 2 18 21
M  V30 26 1 19 21
M  V30 27 2 22 23
M  V30 28 1 22 24
M  V30 29 1 23 25
M  V30 30 2 24 26
M  V30 31 2 25 27
M  V30 32 1 26 27
M  V30 33 1 28 29
M  V30 34 1 28 30
M  V30 35 1 29 31
M  V30 36 1 30 32
M  V30 37 1 31 32
M  V30 38 1 33 34
M  V30 39 1 33 35
M  V30 40 1 34 36
M  V30 41 1 35 37
M  V30 42 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-30-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 6626-40-0
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 50-00-0
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 74847-35-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-32523867
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7664-93-9
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 1309573-60-1
$DTYPE RXN:VAR(1):NOTES
$DATUM safety, reaction in a sealed vial, paraformaldehyde used, addition of
pyrrolidine is exothermic, Mannich-like reaction in stage 3, alternative
preparation shown
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An environmentally responsible and cost-effective synthesis of the
antimalarial drug pyronaridine
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kincaid, Joseph R. A.; Kavthe, Rahul D.; Caravez, Juan C.; Takale,
Balaram S.; Thakore, Ruchita R.; Lipshutz, Bruce H.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ChemRxiv (2022), 1-4

$RFMT $RIREG SCHEME377 STEP1
$RXN



  2  1
$MOL
Acetylacetone
C5H8O2
123-54-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  7 6 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3338 1.5400 0.0 0
M  V30 4 C 4.0011 0.0000 0.0 0
M  V30 5 O 5.3349 2.3100 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3338 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-(1-Pyrrolidinyl)-3-penten-2-one
C9H15NO
3389-57-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7710 2.6217 0.0 0
M  V30 2 C 5.1046 1.8517 0.0 0
M  V30 3 C 3.7710 4.1617 0.0 0
M  V30 4 C 6.4384 2.6217 0.0 0
M  V30 5 C 7.7721 1.8517 0.0 0
M  V30 6 O 6.4384 4.1617 0.0 0
M  V30 7 N 2.4374 1.8517 0.0 0
M  V30 8 C 1.0304 2.4782 0.0 0
M  V30 9 C 2.2764 0.3202 0.0 0
M  V30 10 C 0.0000 1.3336 0.0 0
M  V30 11 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 7 8
M  V30 8 1 7 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-54-6
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3389-57-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-8998561
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Reaction of 1,3-Dicarbonyl Compounds with Secondary Amines; General
Procedure In a Schlenk tube, first the Lewis acid (5 mol%) (when used),
then the dicarbonyl derivative (1 equiv), and the secondary amine (1.5
equiv) were successively added under argon. The mixture was stirred at
r.t. (or at 50 °C) and the reaction was monitored by TLC analysis. The
crude mixture was dissolved in CH2Cl2 (2 mL/mmol), and the final compound
was purified over alumina by flash chromatography with a 7:3 mixture of
heptane-EtOAc as eluent (Tables 1-4). 4-(Pyrrolidin-1-yl)pent-3-en-2-one
(1). Yield 99%. 1H NMR (200 MHz, CDCl3): δ = 1.98 (m, 4 H, CH2CH2), 2.05
(s, 3 H, COCH3), 2.58 (s, 3 H, CH3), 3.25 (m, 2 H, CHNCH), 3.48 (m, 2 H,
CHNCH), 4.98 (s, 1 H, =CH). 13C NMR (75 MHz, CDCl3): δ = 17.7, 25.5,
31.9, 48.5, 95.5, 160.3, 194.7. HRMS: m/z [M+] calcd for C9H15NO:
153.11536; found: 153.1158.
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tertiary 3-aminopropenones and 3-aminopropenoates: their preparation,
with and without lewis acids, from secondary amines and 1,3-diketo
compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vohra, Ramandeep Kaur; Renaud, Jean-Luc; Bruneau, Christian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2007), (5), 731-738

$RFMT $RIREG SCHEME378 STEP1
$RXN



  2  1
$MOL
Methyl (7R)-14-cyclohexyl-7-[3-[[(1,1-dimethylethoxy)carbonyl]methylamino]pro...
C37H50N2O6
1236154-05-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  45 49 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 10.7816 9.5890 0.0 0
M  V30 2 C 11.7190 10.8109 0.0 0
M  V30 3 C 13.2459 10.6097 0.0 0
M  V30 4 N 14.1833 11.8316 0.0 0
M  V30 5 C 15.7102 11.6306 0.0 0
M  V30 6 C 13.5940 13.2544 0.0 0
M  V30 7 O 16.6476 12.8523 0.0 0
M  V30 8 O 16.2996 10.2078 0.0 0
M  V30 9 C 18.1746 12.6513 0.0 0
M  V30 10 C 18.3755 14.1781 0.0 0
M  V30 11 C 19.7013 12.4503 0.0 0
M  V30 12 C 17.9736 11.1246 0.0 0
M  V30 13 C 6.0348 14.3164 0.0 0
M  V30 14 C 5.2648 15.6500 0.0 0
M  V30 15 C 6.0348 16.9838 0.0 0
M  V30 16 O 5.2648 18.3175 0.0 0
M  V30 17 C 7.8610 2.6528 0.0 0
M  V30 18 O 7.2346 1.2459 0.0 0
M  V30 19 O 9.3925 2.8137 0.0 0
M  V30 20 C 8.1399 0.0000 0.0 0
M  V30 21 C 5.6635 8.8278 0.0 0
M  V30 22 C 4.5190 7.7974 0.0 0
M  V30 23 N 6.9972 8.0578 0.0 0
M  V30 24 C 5.2648 10.3153 0.0 0
M  V30 25 C 5.1455 6.3904 0.0 0
M  V30 26 C 6.6770 6.5515 0.0 0
M  V30 27 C 8.4847 8.4563 0.0 0
M  V30 28 C 6.0348 11.6491 0.0 0
M  V30 29 C 3.7248 10.3153 0.0 0
M  V30 30 C 4.5190 4.9836 0.0 0
M  V30 31 C 7.5822 5.3055 0.0 0
M  V30 32 C 9.2547 9.7900 0.0 0 CFG=1
M  V30 33 C 5.2648 12.9827 0.0 0
M  V30 34 O 7.5225 12.0476 0.0 0
M  V30 35 C 2.9548 11.6491 0.0 0
M  V30 36 C 5.4242 3.7378 0.0 0
M  V30 37 C 6.9558 3.8987 0.0 0
M  V30 38 C 8.8561 11.2776 0.0 0
M  V30 39 C 3.7248 12.9827 0.0 0
M  V30 40 C 3.0127 8.1175 0.0 0
M  V30 41 C 2.5369 9.5821 0.0 0
M  V30 42 C 1.9821 6.9730 0.0 0
M  V30 43 C 1.0304 9.9024 0.0 0
M  V30 44 C 0.4759 7.2933 0.0 0
M  V30 45 C 0.0000 8.7579 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 32 1 CFG=3
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 33
M  V30 15 1 14 15
M  V30 16 1 15 16
M  V30 17 1 17 18
M  V30 18 2 17 19
M  V30 19 1 17 37
M  V30 20 1 18 20
M  V30 21 2 21 22
M  V30 22 1 21 23
M  V30 23 1 21 24
M  V30 24 1 22 25
M  V30 25 1 22 40
M  V30 26 1 23 26
M  V30 27 1 23 27
M  V30 28 1 24 28
M  V30 29 2 24 29
M  V30 30 1 25 26
M  V30 31 2 25 30
M  V30 32 2 26 31
M  V30 33 1 27 32
M  V30 34 2 28 33
M  V30 35 1 28 34
M  V30 36 1 29 35
M  V30 37 1 30 36
M  V30 38 1 31 37
M  V30 39 1 32 38
M  V30 40 1 33 39
M  V30 41 1 34 38
M  V30 42 2 35 39
M  V30 43 2 36 37
M  V30 44 1 40 41
M  V30 45 1 40 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 1 43 45
M  V30 49 1 44 45
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 32)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (7R)-14-cyclohexyl-7-[3-[[(1,1-dimethylethoxy)carbonyl]methylamino]pro...
C41H57N3O5
1236154-06-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  49 54 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 11.1658 8.9198 0.0 0
M  V30 2 C 9.9441 7.9824 0.0 0
M  V30 3 C 10.1450 6.4555 0.0 0
M  V30 4 N 8.9232 5.5181 0.0 0
M  V30 5 C 9.1243 3.9911 0.0 0
M  V30 6 C 7.5005 6.1074 0.0 0
M  V30 7 O 7.9025 3.0537 0.0 0
M  V30 8 O 10.5470 3.4018 0.0 0
M  V30 9 C 8.1034 1.5268 0.0 0
M  V30 10 C 6.5767 1.3258 0.0 0
M  V30 11 C 8.3046 0.0000 0.0 0
M  V30 12 C 9.6304 1.7278 0.0 0
M  V30 13 C 6.4384 13.6666 0.0 0
M  V30 14 C 5.1047 14.4366 0.0 0
M  V30 15 C 3.7711 13.6666 0.0 0
M  V30 16 C 18.1022 11.8405 0.0 0
M  V30 17 O 19.5090 12.4668 0.0 0
M  V30 18 O 17.9411 10.3089 0.0 0
M  V30 19 C 20.7549 11.5616 0.0 0
M  V30 20 C 11.9270 14.0379 0.0 0
M  V30 21 C 12.9576 15.1825 0.0 0
M  V30 22 N 12.6970 12.7043 0.0 0
M  V30 23 C 10.4395 14.4366 0.0 0
M  V30 24 C 14.3644 14.5560 0.0 0
M  V30 25 C 14.2035 13.0244 0.0 0
M  V30 26 C 12.2985 11.2168 0.0 0
M  V30 27 C 9.1058 13.6666 0.0 0
M  V30 28 C 10.4395 15.9766 0.0 0
M  V30 29 C 15.7714 15.1825 0.0 0
M  V30 30 C 15.4493 12.1192 0.0 0
M  V30 31 C 10.9648 10.4467 0.0 0 CFG=1
M  V30 32 C 7.7722 14.4366 0.0 0
M  V30 33 O 8.7073 12.1790 0.0 0
M  V30 34 C 9.1058 16.7467 0.0 0
M  V30 35 C 17.0172 14.2772 0.0 0
M  V30 36 C 16.8562 12.7457 0.0 0
M  V30 37 C 9.4773 10.8453 0.0 0
M  V30 38 C 7.7722 15.9766 0.0 0
M  V30 39 C 12.6374 16.6888 0.0 0
M  V30 40 C 13.7818 17.7193 0.0 0
M  V30 41 C 11.1727 17.1646 0.0 0
M  V30 42 C 13.4616 19.2256 0.0 0
M  V30 43 C 10.8525 18.6711 0.0 0
M  V30 44 C 11.9969 19.7015 0.0 0
M  V30 45 N 2.4374 14.4366 0.0 0
M  V30 46 C 1.0304 13.8101 0.0 0
M  V30 47 C 2.2763 15.9682 0.0 0
M  V30 48 C 0.0000 14.9547 0.0 0
M  V30 49 C 0.7700 16.2884 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 31 1 CFG=1
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 7 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 9 12
M  V30 13 1 13 14
M  V30 14 1 13 32
M  V30 15 1 14 15
M  V30 16 1 15 45
M  V30 17 1 16 17
M  V30 18 2 16 18
M  V30 19 1 16 36
M  V30 20 1 17 19
M  V30 21 2 20 21
M  V30 22 1 20 22
M  V30 23 1 20 23
M  V30 24 1 21 24
M  V30 25 1 21 39
M  V30 26 1 22 25
M  V30 27 1 22 26
M  V30 28 1 23 27
M  V30 29 2 23 28
M  V30 30 1 24 25
M  V30 31 2 24 29
M  V30 32 2 25 30
M  V30 33 1 26 31
M  V30 34 2 27 32
M  V30 35 1 27 33
M  V30 36 1 28 34
M  V30 37 1 29 35
M  V30 38 1 30 36
M  V30 39 1 31 37
M  V30 40 1 32 38
M  V30 41 1 33 37
M  V30 42 2 34 38
M  V30 43 2 35 36
M  V30 44 1 39 40
M  V30 45 1 39 41
M  V30 46 1 40 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 1 43 44
M  V30 50 1 45 46
M  V30 51 1 45 47
M  V30 52 1 46 48
M  V30 53 1 47 49
M  V30 54 1 48 49
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 31)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1236154-05-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1236154-06-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-032-CAS-6027156
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7446-11-9
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 56553-60-7
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 107-06-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM Step 5:
methyl(7R)-7-{3-[(tert-butoxycarbonyl)(methyl)amino]propyl}-14-cyclohexyl-4-[3-(pyrrolidin-1-yl)propyl]-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylate
The foregoing compound was dissolved in DCM/DMSO (10:1; 0.06M) and
triethylamine (5.6 eq) followed by sulphur trioxide complex (10.0 eq) was
added. After two hours the reaction was diluted with EtOAc and extracted
with 1N HCl, NaHCO3 and brine. After evaporation of all volatiles the
resulting oil was diluted with DCE (0.1 M) and pyrrolidine (3.0 eq) and
acetic acid (3.0 eq) were added. After 1 hour additional DCE was added to
bring the concentration to 0.05M, before sodium triacetoxyborohydride
(3.0 eq) was added and the reaction stirred for 15 hours. The reaction
was diluted with EtOAc and washed with 0.5N HCl, NaHCO3 and brine to
obtain the title compound as white solid (99%) after evaporation of all
volatiles.
methyl(7R)-7-{3-[(tert-butoxycarbonyl)(methyl)amino]propyl}-14-cyclohexyl-4-[3-(pyrrolidin-1-yl)propyl]-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylate,
yield 99% (ES+) m/z 673 (M+H)+.
$DTYPE RXN:VAR(1):NOTES
$DATUM incremental addition of DCE in stage 2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Macrocyclic and 7-aminoalkyl-substituted benzoxazocines, and their
preparation and use for the treatment or prevention of hepatitis C
infections
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Narjes, Frank; Stansfield, Ian; Ponzi, Simona; Pacini, Barbara; Mackay,
Angela; Meppen, Malte
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2010082050 A1 2010-07-22

$RFMT $RIREG SCHEME379 STEP1
$RXN



  3  1
$MOL
Butanal
C4H8O
123-72-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 4 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6674 0.7700 0.0 0
M  V30 2 C 1.3338 0.0000 0.0 0
M  V30 3 C 4.0010 0.0000 0.0 0
M  V30 4 C 0.0000 0.7700 0.0 0
M  V30 5 O 5.3348 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 3 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Phenylacetylene
C8H6
536-74-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 1.3337 0.0 0
M  V30 2 C 6.1601 1.3337 0.0 0
M  V30 3 C 3.0800 1.3337 0.0 0
M  V30 4 C 2.3100 0.0000 0.0 0
M  V30 5 C 2.3100 2.6673 0.0 0
M  V30 6 C 0.7700 0.0000 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 3 1 2
M  V30 2 1 1 3
M  V30 3 2 3 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 2 5 7
M  V30 7 2 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-[1-(2-Phenylethynyl)butyl]pyrrolidine
C16H21N
955387-92-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.6685 3.8501 0.0 0
M  V30 2 C 5.3348 4.6201 0.0 0
M  V30 3 C 6.6685 2.3101 0.0 0
M  V30 4 C 4.0012 5.3901 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 5.3348 0.0000 0.0 0
M  V30 7 N 8.0022 4.6201 0.0 0
M  V30 8 C 9.4091 3.9938 0.0 0
M  V30 9 C 8.1633 6.1517 0.0 0
M  V30 10 C 10.4396 5.1382 0.0 0
M  V30 11 C 9.6696 6.4718 0.0 0
M  V30 12 C 2.6673 6.1601 0.0 0
M  V30 13 C 2.6673 7.7002 0.0 0
M  V30 14 C 1.3337 5.3901 0.0 0
M  V30 15 C 1.3337 8.4702 0.0 0
M  V30 16 C 0.0000 6.1601 0.0 0
M  V30 17 C 0.0000 7.7002 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 7
M  V30 4 3 2 4
M  V30 5 1 3 5
M  V30 6 1 4 12
M  V30 7 1 5 6
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-72-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 536-74-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 955387-92-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-315-CAS-17897341
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 2126942-34-3
$DTYPE RXN:VAR(1):NOTES
$DATUM in the dark, sealed tube used, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A novel tetramer copper(I) complex containing diallylphosphine ligands:
Synthesis, characterization and catalytic application in A3-coupling
(Aldehyde-Amine-Alkyne) reactions
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Rosales, Jennifer; Garcia, Juan M.; Avila, Edward; Gonzalez, Teresa;
Coll, David Santiago; Ocando-Mavarez, Edgar
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Inorganica Chimica Acta (2017), 467155-162

$RFMT $RIREG SCHEME380 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cycloheptanone
C7H12O
502-42-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 4.9136 1.7302 0.0 0
M  V30 2 C 3.3736 1.7302 0.0 0
M  V30 3 C 2.7053 3.1178 0.0 0
M  V30 4 C 2.7053 0.3427 0.0 0
M  V30 5 C 1.2040 3.4604 0.0 0
M  V30 6 C 1.2040 0.0000 0.0 0
M  V30 7 C 0.0000 2.5002 0.0 0
M  V30 8 C 0.0000 0.9602 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 1 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Azido-1-methyl-4-nitro-1H-imidazole
C4H4N6O2
124641-94-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 4.8384 3.7710 0.0 0
M  V30 2 N 6.3784 3.7710 0.0 0 CHG=1 VAL=4
M  V30 3 N 7.9184 3.7710 0.0 0 CHG=-1
M  V30 4 N 1.5063 3.4208 0.0 0 VAL=5
M  V30 5 O 0.0000 3.1006 0.0 0
M  V30 6 O 1.9823 4.8855 0.0 0
M  V30 7 C 6.2011 0.7102 0.0 0
M  V30 8 C 4.0684 2.4374 0.0 0
M  V30 9 C 2.5368 2.2764 0.0 0
M  V30 10 N 4.6947 1.0306 0.0 0
M  V30 11 N 2.2167 0.7700 0.0 0
M  V30 12 C 3.5503 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 8
M  V30 3 2 2 3
M  V30 4 2 4 5
M  V30 5 2 4 6
M  V30 6 1 4 9
M  V30 7 1 7 10
M  V30 8 2 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 2 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclohepta[d]-1,2,3-triazole, 1,3a,4,5,6,7,8,8a-octahydro-1-(1-methyl-4-nitro...
C15H23N7O2
1902962-32-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 8.2586 7.5336 0.0 0 VAL=5
M  V30 2 O 9.7986 7.5336 0.0 0
M  V30 3 O 7.4886 8.8672 0.0 0
M  V30 4 C 4.2300 3.9063 0.0 0
M  V30 5 C 3.3950 7.0225 0.0 0
M  V30 6 N 4.9265 7.1834 0.0 0
M  V30 7 C 2.7687 8.4292 0.0 0
M  V30 8 C 2.6857 5.6556 0.0 0
M  V30 9 N 5.2469 8.6898 0.0 0
M  V30 10 N 3.9131 9.4598 0.0 0
M  V30 11 C 1.2783 8.8167 0.0 0
M  V30 12 C 1.1747 5.3579 0.0 0
M  V30 13 C 0.0460 7.8930 0.0 0
M  V30 14 C 0.0000 6.3536 0.0 0
M  V30 15 N 4.1405 2.4630 0.0 0
M  V30 16 C 5.5162 1.7708 0.0 0
M  V30 17 C 3.0570 1.3687 0.0 0
M  V30 18 C 5.2827 0.2486 0.0 0
M  V30 19 C 3.7631 0.0000 0.0 0
M  V30 20 C 5.9571 6.0390 0.0 0
M  V30 21 C 7.4886 6.2000 0.0 0
M  V30 22 N 5.6369 4.5326 0.0 0
M  V30 23 N 8.1149 4.7932 0.0 0
M  V30 24 C 6.9706 3.7626 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 4 22
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 15
M  V30 9 1 6 9
M  V30 10 1 6 20
M  V30 11 1 7 10
M  V30 12 1 7 11
M  V30 13 1 8 12
M  V30 14 2 9 10
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 14
M  V30 18 1 15 16
M  V30 19 1 15 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 19
M  V30 23 2 20 21
M  V30 24 1 20 22
M  V30 25 1 21 23
M  V30 26 1 22 24
M  V30 27 2 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 502-42-1
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 124641-94-7
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1902962-32-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-26323818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A catalyst and additive-free three-component reaction of highly
electrophilic azides with cyclic ketones and cycloaliphatic amines.
Synthesis of novel N-heteroaryl amidines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Efimov, Ilya; Beliaev, Nikolai; Beryozkina, Tetyana; Slepukhin, Pavel;
Bakulev, Vasiliy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2016), 57(18), 1949-1952

$RFMT $RIREG SCHEME381 STEP1
$RXN



  4  1
$MOL
3-Bromo-4-iodobenzaldehyde
C7H4BrIO
873387-82-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  10 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.1601 2.6673 0.0 0
M  V30 2 O 6.9302 4.0010 0.0 0
M  V30 3 Br 1.5400 0.0000 0.0 0
M  V30 4 I 0.0000 2.6673 0.0 0
M  V30 5 C 4.6201 2.6673 0.0 0
M  V30 6 C 3.8501 1.3337 0.0 0
M  V30 7 C 3.8501 4.0010 0.0 0
M  V30 8 C 2.3101 1.3337 0.0 0
M  V30 9 C 2.3101 4.0010 0.0 0
M  V30 10 C 1.5400 2.6673 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 3 8
M  V30 4 1 4 10
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 9
M  V30 9 2 8 10
M  V30 10 1 9 10
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 5-oxa-2,8-diazaspiro[3.5]nonane-8-carboxylate
C11H20N2O3
1251005-61-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.8872 3.0801 0.0 0
M  V30 2 O 7.2209 2.3101 0.0 0
M  V30 3 O 5.8872 4.6201 0.0 0
M  V30 4 C 8.5546 3.0801 0.0 0
M  V30 5 C 7.7846 4.4137 0.0 0
M  V30 6 C 9.8882 3.8501 0.0 0
M  V30 7 C 9.3246 1.7464 0.0 0
M  V30 8 C 1.8861 2.3101 0.0 0
M  V30 9 C 3.2197 3.0801 0.0 0
M  V30 10 C 0.3986 1.9115 0.0 0
M  V30 11 C 1.4875 3.7976 0.0 0
M  V30 12 O 1.8861 0.7700 0.0 0
M  V30 13 N 4.5534 2.3101 0.0 0
M  V30 14 N 0.0000 3.3990 0.0 0
M  V30 15 C 3.2197 0.0000 0.0 0
M  V30 16 C 4.5534 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 8 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 1 10 14
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 1 13 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Cyanophenylboronic acid
C7H6BNO2
126747-14-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 B 0.7700 1.3337 0.0 0
M  V30 2 O 0.0000 2.6673 0.0 0
M  V30 3 O 0.0000 0.0000 0.0 0
M  V30 4 C 6.9302 1.3337 0.0 0
M  V30 5 N 8.4702 1.3337 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 C 3.0801 0.0000 0.0 0
M  V30 8 C 3.0801 2.6673 0.0 0
M  V30 9 C 4.6201 0.0000 0.0 0
M  V30 10 C 4.6201 2.6673 0.0 0
M  V30 11 C 5.3901 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 6
M  V30 4 3 4 5
M  V30 5 1 4 11
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[1,1′-Biphenyl]-4-carbonitrile, 5′-(5-oxa-2,8-diazaspiro[3.5]non-2-ylmethyl)-...
C24H28N4O
3049377-21-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  29 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.7979 7.7721 0.0 0
M  V30 2 C 16.0380 5.1047 0.0 0
M  V30 3 N 17.5780 5.1047 0.0 0
M  V30 4 C 3.0800 7.7721 0.0 0
M  V30 5 C 4.1690 8.8611 0.0 0
M  V30 6 C 4.1690 6.6832 0.0 0
M  V30 7 C 2.3100 6.4385 0.0 0
M  V30 8 O 2.3100 9.1058 0.0 0
M  V30 9 N 5.2579 7.7721 0.0 0
M  V30 10 N 0.7700 6.4385 0.0 0
M  V30 11 C 0.7700 9.1058 0.0 0
M  V30 12 C 0.0000 7.7721 0.0 0
M  V30 13 C 7.5679 6.4385 0.0 0
M  V30 14 C 9.1080 6.4385 0.0 0
M  V30 15 C 6.7979 5.1047 0.0 0
M  V30 16 C 9.8780 5.1047 0.0 0
M  V30 17 C 7.5679 3.7710 0.0 0
M  V30 18 C 9.1080 3.7710 0.0 0
M  V30 19 C 11.4180 5.1047 0.0 0
M  V30 20 C 12.1880 3.7710 0.0 0
M  V30 21 C 12.1880 6.4385 0.0 0
M  V30 22 C 13.7280 3.7710 0.0 0
M  V30 23 C 13.7280 6.4385 0.0 0
M  V30 24 C 14.4980 5.1047 0.0 0
M  V30 25 N 9.8780 2.4374 0.0 0
M  V30 26 C 11.4095 2.2763 0.0 0
M  V30 27 C 9.2516 1.0304 0.0 0
M  V30 28 C 11.7297 0.7700 0.0 0
M  V30 29 C 10.3960 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 1 13
M  V30 3 3 2 3
M  V30 4 1 2 24
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 4 8
M  V30 9 1 5 9
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 1 8 11
M  V30 13 1 10 12
M  V30 14 1 11 12
M  V30 15 2 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 2 15 17
M  V30 19 2 16 18
M  V30 20 1 16 19
M  V30 21 1 17 18
M  V30 22 1 18 25
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 29 1 25 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 1 28 29
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 873387-82-7
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1251005-61-4
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(4):CAS_RN
$DATUM 126747-14-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3049377-21-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-42204861
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 8
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 64-19-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25895-60-7
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):RGT(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):RGT(5):CAS_RN
$DATUM 497-19-8
$DTYPE RXN:VAR(1):RGT(6):CAS_RN
$DATUM 76-05-1
$DTYPE RXN:VAR(1):RGT(7):CAS_RN
$DATUM 144-55-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 72287-26-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-56-1
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):SOL(3):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):SOL(4):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, solid-supported reagent (solid-supported reagent used
(stage 2)), Buchwald-Hartwig coupling (stage 3), Suzuki coupling (stage
5)
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of substituted biphenylcarbonitriles as LSD1 modulators
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Culurgioni, Simone; Besnard, Jeremy; Bradley, Anthony; Naik, Manisha;
Richards, Simon; Tanaka, Daisuke; Perez, Victor; Heng, Rama; Lepifre,
Frank
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2024141757 A1 2024-07-04

$RFMT $RIREG SCHEME382 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Chlorophenyl)-3-cyano-2-methyl-4-pyridinecarboxylic acid
C14H9ClN2O2
1253519-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 1.3338 0.0 0
M  V30 2 O 1.5400 1.3338 0.0 0
M  V30 3 O 3.8500 0.0000 0.0 0
M  V30 4 C 1.5400 4.0011 0.0 0
M  V30 5 N 0.0000 4.0011 0.0 0
M  V30 6 C 3.0800 6.6685 0.0 0
M  V30 7 Cl 12.3200 4.0011 0.0 0
M  V30 8 C 3.8500 2.6674 0.0 0
M  V30 9 C 3.0800 4.0011 0.0 0
M  V30 10 C 5.3900 2.6674 0.0 0
M  V30 11 C 3.8500 5.3347 0.0 0
M  V30 12 C 6.1600 4.0011 0.0 0
M  V30 13 N 5.3900 5.3347 0.0 0
M  V30 14 C 7.7000 4.0011 0.0 0
M  V30 15 C 8.4700 5.3347 0.0 0
M  V30 16 C 8.4700 2.6674 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 18 C 10.0100 2.6674 0.0 0
M  V30 19 C 10.7800 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 3 4 5
M  V30 5 1 4 9
M  V30 6 1 6 11
M  V30 7 1 7 19
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 2 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 2 16 18
M  V30 19 2 17 19
M  V30 20 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Chlorophenyl)-2-methyl-4-(1-pyrrolidinylcarbonyl)-3-pyridinecarbonitrile
C18H16ClN3O
1253519-59-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 25 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 3.7710 0.0 0
M  V30 2 O 1.5400 3.7710 0.0 0
M  V30 3 C 1.5400 6.4384 0.0 0
M  V30 4 N 0.0000 6.4384 0.0 0
M  V30 5 C 3.0800 9.1057 0.0 0
M  V30 6 Cl 12.3200 6.4384 0.0 0
M  V30 7 C 3.8500 5.1046 0.0 0
M  V30 8 C 3.0800 6.4384 0.0 0
M  V30 9 C 5.3900 5.1046 0.0 0
M  V30 10 C 3.8500 7.7721 0.0 0
M  V30 11 C 6.1600 6.4384 0.0 0
M  V30 12 N 5.3900 7.7721 0.0 0
M  V30 13 N 3.8500 2.4374 0.0 0
M  V30 14 C 3.2237 1.0304 0.0 0
M  V30 15 C 5.3815 2.2763 0.0 0
M  V30 16 C 4.3681 0.0000 0.0 0
M  V30 17 C 5.7017 0.7700 0.0 0
M  V30 18 C 7.7000 6.4384 0.0 0
M  V30 19 C 8.4700 7.7721 0.0 0
M  V30 20 C 8.4700 5.1046 0.0 0
M  V30 21 C 10.0100 7.7721 0.0 0
M  V30 22 C 10.0100 5.1046 0.0 0
M  V30 23 C 10.7800 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 7
M  V30 3 1 1 13
M  V30 4 3 3 4
M  V30 5 1 3 8
M  V30 6 1 5 10
M  V30 7 1 6 23
M  V30 8 1 7 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 11 12
M  V30 14 1 11 18
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 20 2 18 19
M  V30 21 1 18 20
M  V30 22 1 19 21
M  V30 23 2 20 22
M  V30 24 2 21 23
M  V30 25 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1253519-42-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1253519-59-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-13929219
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 128625-52-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: General procedure for the synthesis of 10
(Scheme S1, conditions c): The carboxylic acid 9 (1 eq, 0.15 mmol) was
dissolved in 5 mL DCM. Benzotriazol-1-yloxytripyrrolidinophosphonium
hexafluorophosphate (1.1 eq, 0.17 mmol 0.864 g) and triethylamine (2 eq,
0.30 mmol, 41 μl) were successively added followed by addition of amine
or 1-hydroxybenzotriazol ammonium salt (1.5 eq, 0.23 mmol, 0.035 g).
After 3-16 h stirring at room temperature (the reaction monitored by
TLC), the solvent was removed and the product 9 was isolated by
filtration on silica gel. 20b; colorless solid; 99% yield C18H16ClN3O, M
= 325.80 g/mol, HPLC-ESI-MS: [M + H]+ = 326 m/z. 1H NMR (400 MHz, CDCl3)
δ 1.98 (m, 4 H) 2.84 (s, 3 H) 3.32 (m, 2 H) 3.70 (m, 2 H) 7.44 (d, J =
8.7 Hz, 2 H) 7.60 (s, 1 H) 7.98 (d, J = 8.7 Hz, 2 H). 13C NMR (100 MHz,
CDCl3) δ 24.1 (CH3), 24.2 (CH2), 26.0 (CH2), 46.1 (CH2), 48.3 (CH2),
103.7 (C), 114.5 (CH), 115.5 (C), 128.7 (CH), 129.2 (CH), 135.4 (C),
137.0 (C), 149.8 (C), 158.7 (C), 162.5 (C), 164.2 (C). FT-ICR-MS:
calculated for C18H16ClN3ONa+: 348.0874, found: 348.0873.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design, Synthesis, and in Vitro Evaluation of Novel Aminomethyl-pyridines
as DPP-4 Inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kaczanowska, Katarzyna; Wiesmueller, Karl-Heinz; Schaffner, Arnaud-Pierre
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Medicinal Chemistry Letters (2010), 1(9), 530-535

$RFMT $RIREG SCHEME383 STEP1
$RXN



  2  1
$MOL
(1S)-1-[2-(Methoxycarbonyl)-6-(trifluoromethyl)phenyl]-1H-pyrrole-2-carboxyli...
C14H10F3NO4
1271488-57-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.1484 2.4374 0.0 0
M  V30 2 O 8.6884 2.4374 0.0 0
M  V30 3 O 6.3784 1.1037 0.0 0
M  V30 4 C 9.4584 1.1037 0.0 0
M  V30 5 C 2.5284 5.1048 0.0 0
M  V30 6 F 2.5284 3.5648 0.0 0
M  V30 7 F 0.9884 5.1048 0.0 0
M  V30 8 F 2.5284 6.6448 0.0 0
M  V30 9 C 1.5063 3.4208 0.0 0
M  V30 10 O 0.0000 3.1006 0.0 0
M  V30 11 O 1.9823 4.8855 0.0 0
M  V30 12 C 4.8384 3.7710 0.0 0
M  V30 13 C 6.3784 3.7710 0.0 0
M  V30 14 C 4.0684 5.1048 0.0 0
M  V30 15 C 7.1484 5.1048 0.0 0
M  V30 16 C 4.8384 6.4384 0.0 0
M  V30 17 C 6.3784 6.4384 0.0 0
M  V30 18 N 4.0684 2.4374 0.0 0
M  V30 19 C 2.5368 2.2764 0.0 0
M  V30 20 C 4.6947 1.0306 0.0 0
M  V30 21 C 2.2167 0.7700 0.0 0
M  V30 22 C 3.5503 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 13
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 14
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 11 1 9 19
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 12 18
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 1 18 19
M  V30 20 1 18 20
M  V30 21 2 19 21
M  V30 22 2 20 22
M  V30 23 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2S)-2-[2-(1-pyrrolidinylcarbonyl)-1H-pyrrol-1-yl]-3-(trifluoromethyl)...
C18H17F3N2O3
1638334-73-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.6266 2.4374 0.0 0
M  V30 2 O 11.1666 2.4374 0.0 0
M  V30 3 O 8.8566 1.1037 0.0 0
M  V30 4 C 11.9366 1.1037 0.0 0
M  V30 5 C 5.0066 5.1048 0.0 0
M  V30 6 F 5.0066 3.5648 0.0 0
M  V30 7 F 3.4666 5.1048 0.0 0
M  V30 8 F 5.0066 6.6448 0.0 0
M  V30 9 C 3.9845 3.4208 0.0 0
M  V30 10 O 4.4603 4.8855 0.0 0
M  V30 11 C 7.3166 3.7710 0.0 0
M  V30 12 C 8.8566 3.7710 0.0 0
M  V30 13 C 6.5466 5.1048 0.0 0
M  V30 14 C 9.6266 5.1048 0.0 0
M  V30 15 C 7.3166 6.4385 0.0 0
M  V30 16 C 8.8566 6.4385 0.0 0
M  V30 17 N 6.5466 2.4374 0.0 0
M  V30 18 C 5.0150 2.2764 0.0 0
M  V30 19 C 7.1729 1.0306 0.0 0
M  V30 20 C 4.6949 0.7700 0.0 0
M  V30 21 C 6.0285 0.0000 0.0 0
M  V30 22 N 2.4782 3.1007 0.0 0
M  V30 23 C 1.8517 1.6939 0.0 0
M  V30 24 C 1.3337 4.1311 0.0 0
M  V30 25 C 0.3202 1.8548 0.0 0
M  V30 26 C 0.0000 3.3611 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 12
M  V30 4 1 2 4
M  V30 5 1 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 5 13
M  V30 9 2 9 10
M  V30 10 1 9 18
M  V30 11 1 9 22
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 11 17
M  V30 15 1 12 14
M  V30 16 2 13 15
M  V30 17 2 14 16
M  V30 18 1 15 16
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 24 1 22 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1271488-57-3
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1638334-73-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4038507
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A new pyrrolidine-derived atropisomeric amino alcohol as a highly
efficient chiral ligand for the asymmetric addition of diethylzinc to
aldehydes
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Faigl, Ferenc; Erdelyi, Zsuzsa; Deak, Szilvia; Nyerges, Miklos;
Matravolgyi, Bela
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2014), 55(50), 6891-6894

$RFMT $RIREG SCHEME384 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2-Dihydro-9-methyl-3H-pyrrolo[1,2-a]indol-3-one
C12H11NO
13028-46-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 0.7103 5.7969 0.0 0
M  V30 2 C 4.0034 0.0000 0.0 0
M  V30 3 N 2.4374 3.6643 0.0 0
M  V30 4 C 3.9437 3.9845 0.0 0
M  V30 5 C 2.2763 2.1326 0.0 0
M  V30 6 C 1.0304 4.2906 0.0 0
M  V30 7 C 4.7137 2.6507 0.0 0
M  V30 8 C 4.7137 5.3181 0.0 0
M  V30 9 C 3.6833 1.5063 0.0 0
M  V30 10 C 0.7700 1.8124 0.0 0
M  V30 11 C 0.0000 3.1463 0.0 0
M  V30 12 C 6.2537 2.6507 0.0 0
M  V30 13 C 6.2537 5.3181 0.0 0
M  V30 14 C 7.0237 3.9845 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 6
M  V30 2 1 2 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 1 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 1 10 11
M  V30 15 1 12 14
M  V30 16 2 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-(3-Methyl-1H-indol-2-yl)-1-(1-pyrrolidinyl)-1-propanone
C16H20N2O
2426633-36-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0203 0.1773 0.0 0
M  V30 2 C 6.0811 1.5400 0.0 0
M  V30 3 C 7.4148 2.3101 0.0 0
M  V30 4 C 8.7485 1.5400 0.0 0
M  V30 5 O 8.7485 0.0000 0.0 0
M  V30 6 C 3.0801 4.1618 0.0 0
M  V30 7 C 2.3101 2.8281 0.0 0
M  V30 8 N 4.5864 3.8416 0.0 0
M  V30 9 C 2.3101 5.4955 0.0 0
M  V30 10 C 3.3405 1.6836 0.0 0
M  V30 11 C 0.7700 2.8281 0.0 0
M  V30 12 C 4.7473 2.3101 0.0 0
M  V30 13 C 0.7700 5.4955 0.0 0
M  V30 14 C 0.0000 4.1618 0.0 0
M  V30 15 N 10.0823 2.3101 0.0 0
M  V30 16 C 10.2432 3.8416 0.0 0
M  V30 17 C 11.4891 1.6836 0.0 0
M  V30 18 C 11.7495 4.1618 0.0 0
M  V30 19 C 12.5196 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 2 3
M  V30 3 1 2 12
M  V30 4 1 3 4
M  V30 5 2 4 5
M  V30 6 1 4 15
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 6 9
M  V30 10 1 7 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 1 9 13
M  V30 14 2 10 12
M  V30 15 1 11 14
M  V30 16 2 13 14
M  V30 17 1 15 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13028-46-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2426633-36-3
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-22218877
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 6674-22-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Photocatalytic Synthesis of Polycyclic Indolones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saget, Tanguy; Koenig, Burkhard
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2020), 26(31), 7004-7007

$RFMT $RIREG SCHEME385 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4Z)-4-(2-Phenylethyl)-4,6-heptadiene-2,3-dione
C15H16O2
1318801-69-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.0800 4.0011 0.0 0
M  V30 2 C 2.3100 2.6674 0.0 0
M  V30 3 C 4.6200 4.0011 0.0 0
M  V30 4 C 2.3100 5.3347 0.0 0
M  V30 5 C 3.0800 1.3338 0.0 0
M  V30 6 O 0.7700 2.6674 0.0 0
M  V30 7 C 5.3900 5.3347 0.0 0
M  V30 8 C 0.7700 5.3347 0.0 0
M  V30 9 C 4.6200 1.3338 0.0 0
M  V30 10 O 2.3100 0.0000 0.0 0
M  V30 11 C 0.0000 6.6685 0.0 0
M  V30 12 C 6.9300 5.3347 0.0 0
M  V30 13 C 7.7000 4.0011 0.0 0
M  V30 14 C 7.7000 6.6685 0.0 0
M  V30 15 C 9.2400 4.0011 0.0 0
M  V30 16 C 9.2400 6.6685 0.0 0
M  V30 17 C 10.0100 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 7 12
M  V30 11 2 8 11
M  V30 12 2 12 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 2 14 16
M  V30 16 2 15 17
M  V30 17 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
rel-(4R,5R)-5-Hydroxy-5-methyl-2-(2-phenylethyl)-4-(1-pyrrolidinylmethyl)-2-c...
C19H25NO2
1318801-70-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.9834 3.9689 0.0 0
M  V30 2 C 0.6978 6.2530 0.0 0
M  V30 3 O 1.9091 7.9204 0.0 0
M  V30 4 C 6.1391 5.6441 0.0 0
M  V30 5 C 6.9091 4.3103 0.0 0
M  V30 6 O 4.1699 8.3545 0.0 0
M  V30 7 C 2.2293 4.8741 0.0 0 CFG=1
M  V30 8 C 3.6940 4.3981 0.0 0
M  V30 9 C 2.2293 6.4141 0.0 0 CFG=1
M  V30 10 C 4.5991 5.6441 0.0 0
M  V30 11 C 3.6940 6.8900 0.0 0
M  V30 12 N 1.1444 2.4372 0.0 0
M  V30 13 C 0.0000 1.4068 0.0 0
M  V30 14 C 2.4780 1.6672 0.0 0
M  V30 15 C 0.6263 0.0000 0.0 0
M  V30 16 C 2.1579 0.1609 0.0 0
M  V30 17 C 8.4491 4.3103 0.0 0
M  V30 18 C 9.2191 2.9767 0.0 0
M  V30 19 C 9.2191 5.6441 0.0 0
M  V30 20 C 10.7591 2.9767 0.0 0
M  V30 21 C 10.7591 5.6441 0.0 0
M  V30 22 C 11.5291 4.3103 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 7 1 CFG=1
M  V30 2 1 1 12
M  V30 3 1 9 2 CFG=1
M  V30 4 1 9 3 CFG=3
M  V30 5 1 4 5
M  V30 6 1 4 10
M  V30 7 1 5 17
M  V30 8 2 6 11
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 1 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEREL1 ATOMS=(2 7 9)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1318801-69-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1318801-70-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30236669
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7447-41-8
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7647-01-0
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52093-30-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Typical Cyclization Procedure with malonate
nucleophile. To a solution of Y(OTf)3 (1.2 mg, 0.0022 mmol), and LiCl (19
mg, 0.44 mmol) in tetrahydrofuran (1 mL) was added Et3N (25 μl, 0.22
mmol) and dimethyl malonate (31 μL, 0.27 mmol), the resulting cloudy
solution was then stirred for 5 min at rt. Diene 4 (50 mg, 0.22 mmol) in
tetrahydrofuran (1 mL) was then added and the solution stirred for 30
min. The reaction mixture was then quenched with 1 M HCl (1 mL) and
extracted with diethyl ether (3 x 1 mL). The organic layers were
combined, washed with brine (1 mL), dried over Na2SO4, filtered, and the
solvent was removed under reduced pressure. Flash chromatography on
silica gel (hexane : ethyl acetate, 2 : 1) to give 8f. White crystalline
solid, purified by acid-base extraction to give 6 (65 mg, 99%). 1H NMR
(500 MHz, CDCl3) δ 7.30 - 7.24 (m, 1H), 7.24 - 7.21 (m, 1H), 7.17 (dd, J
= 16.8, 7.3 Hz, 1H), 2.93 (s, 1H), 2.85 - 2.78 (m, 1H), 2.63 - 2.44 (m,
2H), 1.79 (t, J = 6.4 Hz, 1H), 1.20 (s, 1H). 13C NMR (100 MHz, CDCl3) δ
210.7, 158.1, 141.2, 141.2, 128.5, 128.4, 126.1, 78.4, 55.4, 54.4, 49.2,
33.6, 26.9, 23.6, 21.4. IR (neat) (cm-1) 3592-3105, 2962, 2928, 2793,
1708, 1454, 1361, 1141, 1053. HRMS (EI): m/z, calcd for [C19H26NO2]:
300.1964; found: 300.1964.
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, optimized on catalyst,solvent, Nazarov
cyclization, optimization study
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Conjugate Addition-Initiated Nazarov Cyclization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Brooks, Joshua L.; Caruana, Patrick A.; Frontier, Alison J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2011), 133(32), 12454-12457

$RFMT $RIREG SCHEME386 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Methoxybenzoxazole
C8H7NO2
132227-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 6.3709 3.0800 0.0 0
M  V30 2 C 7.7047 2.3100 0.0 0
M  V30 3 C 2.3699 2.3100 0.0 0
M  V30 4 C 2.3699 0.7700 0.0 0
M  V30 5 C 3.7036 3.0800 0.0 0
M  V30 6 N 0.9052 2.7859 0.0 0
M  V30 7 C 3.7036 0.0000 0.0 0
M  V30 8 O 0.9052 0.2941 0.0 0
M  V30 9 C 5.0372 2.3100 0.0 0
M  V30 10 C 0.0000 1.5400 0.0 0
M  V30 11 C 5.0372 0.7700 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 2 4 7
M  V30 7 1 4 8
M  V30 8 1 5 9
M  V30 9 2 6 10
M  V30 10 1 7 11
M  V30 11 1 8 10
M  V30 12 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Methoxy-2-[(1-pyrrolidinylmethylene)amino]phenol
C12H16N2O2
1323158-63-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 6.1600 2.6674 0.0 0
M  V30 2 C 6.9300 4.0011 0.0 0
M  V30 3 O 4.6200 0.0000 0.0 0
M  V30 4 O 1.5400 5.3349 0.0 0
M  V30 5 C 0.0000 5.3349 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 3.8500 4.0011 0.0 0
M  V30 8 C 3.8500 1.3338 0.0 0
M  V30 9 C 2.3100 4.0011 0.0 0
M  V30 10 C 2.3100 1.3338 0.0 0
M  V30 11 C 1.5400 2.6674 0.0 0
M  V30 12 N 8.4700 4.0011 0.0 0
M  V30 13 C 9.3753 2.7552 0.0 0
M  V30 14 C 9.3753 5.2470 0.0 0
M  V30 15 C 10.8398 3.2311 0.0 0
M  V30 16 C 10.8398 4.7711 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 6
M  V30 3 1 2 12
M  V30 4 1 3 8
M  V30 5 1 4 5
M  V30 6 1 4 9
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 1 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 132227-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1323158-63-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29172367
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM N-Bromosuccinimide as an oxidant for the transition-metal-free synthesis
of 2-aminobenzoxazoles from benzoxazoles and secondary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xiaoe; Xu, Daqian; Miao, Chengxia; Zhang, Qiaohong; Sun, Wei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic & Biomolecular Chemistry (2014), 12(19), 3108-3113

$RFMT $RIREG SCHEME387 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-5-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)phenyl]-3′-[[(methylsulfon...
C34H35N3O8S
1330736-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 9.0654 0.0 0
M  V30 2 N 2.6528 9.6918 0.0 0
M  V30 3 O 4.2207 7.5338 0.0 0
M  V30 4 C 1.4069 8.7866 0.0 0
M  V30 5 C 0.0000 9.4129 0.0 0
M  V30 6 O 9.2154 13.4080 0.0 0
M  V30 7 C 9.9854 14.7416 0.0 0
M  V30 8 C 6.7701 4.0738 0.0 0
M  V30 9 O 7.8006 2.9292 0.0 0
M  V30 10 S 7.3247 1.4647 0.0 0 VAL=6
M  V30 11 C 8.7894 0.9888 0.0 0
M  V30 12 O 6.8488 0.0000 0.0 0
M  V30 13 O 5.8602 1.9406 0.0 0
M  V30 14 C 12.2954 8.0733 0.0 0
M  V30 15 C 13.8354 8.0733 0.0 0
M  V30 16 C 11.5254 6.7397 0.0 0
M  V30 17 O 13.8354 10.7406 0.0 0
M  V30 18 C 14.6054 12.0744 0.0 0
M  V30 19 C 6.7701 9.4947 0.0 0
M  V30 20 C 7.6754 10.7406 0.0 0
M  V30 21 C 5.3055 9.9706 0.0 0
M  V30 22 O 6.7701 11.9866 0.0 0
M  V30 23 N 5.3055 11.5106 0.0 0
M  V30 24 C 7.2460 8.0302 0.0 0
M  V30 25 C 6.3408 6.7842 0.0 0
M  V30 26 O 8.7107 7.5542 0.0 0
M  V30 27 C 7.2460 5.5383 0.0 0
M  V30 28 N 8.7107 6.0142 0.0 0
M  V30 29 C 9.2154 10.7406 0.0 0
M  V30 30 C 9.9854 12.0744 0.0 0
M  V30 31 C 9.9854 9.4069 0.0 0
M  V30 32 C 11.5254 12.0744 0.0 0
M  V30 33 C 11.5254 9.4069 0.0 0
M  V30 34 C 12.2954 10.7406 0.0 0
M  V30 35 C 9.2154 16.0753 0.0 0
M  V30 36 C 7.6754 16.0753 0.0 0
M  V30 37 C 9.9854 17.4091 0.0 0
M  V30 38 C 6.9054 17.4091 0.0 0
M  V30 39 C 9.2154 18.7427 0.0 0
M  V30 40 C 7.6754 18.7427 0.0 0
M  V30 41 C 16.1454 12.0744 0.0 0
M  V30 42 C 16.9154 10.7406 0.0 0
M  V30 43 C 16.9154 13.4080 0.0 0
M  V30 44 C 18.4554 10.7406 0.0 0
M  V30 45 C 18.4554 13.4080 0.0 0
M  V30 46 C 19.2254 12.0744 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 30
M  V30 8 1 7 35
M  V30 9 1 8 9
M  V30 10 1 8 27
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 33
M  V30 18 1 17 18
M  V30 19 1 17 34
M  V30 20 1 18 41
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 19 24
M  V30 24 1 20 22
M  V30 25 1 20 29
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-5-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)phenyl]-3′-(1-pyrrolidinyl...
C37H40N4O5
1330737-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 8.4126 0.0 0
M  V30 2 N 2.6528 9.0389 0.0 0
M  V30 3 O 4.2207 6.8809 0.0 0
M  V30 4 C 1.4069 8.1337 0.0 0
M  V30 5 C 0.0000 8.7601 0.0 0
M  V30 6 O 9.2154 12.7551 0.0 0
M  V30 7 C 9.9854 14.0887 0.0 0
M  V30 8 C 6.7701 3.4208 0.0 0
M  V30 9 C 12.2954 7.4203 0.0 0
M  V30 10 C 11.5254 6.0867 0.0 0
M  V30 11 C 13.8354 7.4203 0.0 0
M  V30 12 O 13.8354 10.0878 0.0 0
M  V30 13 C 14.6054 11.4214 0.0 0
M  V30 14 C 6.7701 8.8418 0.0 0
M  V30 15 C 7.6754 10.0878 0.0 0
M  V30 16 C 5.3055 9.3178 0.0 0
M  V30 17 O 6.7701 11.3336 0.0 0
M  V30 18 N 5.3055 10.8578 0.0 0
M  V30 19 C 7.2460 7.3772 0.0 0
M  V30 20 C 6.3408 6.1314 0.0 0
M  V30 21 O 8.7107 6.9014 0.0 0
M  V30 22 C 7.2460 4.8853 0.0 0
M  V30 23 N 8.7107 5.3614 0.0 0
M  V30 24 C 9.2154 10.0878 0.0 0
M  V30 25 C 9.9854 11.4214 0.0 0
M  V30 26 C 9.9854 8.7540 0.0 0
M  V30 27 C 11.5254 11.4214 0.0 0
M  V30 28 C 11.5254 8.7540 0.0 0
M  V30 29 C 12.2954 10.0878 0.0 0
M  V30 30 N 7.8006 2.2763 0.0 0
M  V30 31 C 7.4804 0.7700 0.0 0
M  V30 32 C 9.3322 2.4374 0.0 0
M  V30 33 C 8.8140 0.0000 0.0 0
M  V30 34 C 9.9586 1.0304 0.0 0
M  V30 35 C 9.2154 15.4225 0.0 0
M  V30 36 C 9.9854 16.7561 0.0 0
M  V30 37 C 7.6754 15.4225 0.0 0
M  V30 38 C 9.2154 18.0898 0.0 0
M  V30 39 C 6.9054 16.7561 0.0 0
M  V30 40 C 7.6754 18.0898 0.0 0
M  V30 41 C 16.1454 11.4214 0.0 0
M  V30 42 C 16.9154 10.0878 0.0 0
M  V30 43 C 16.9154 12.7551 0.0 0
M  V30 44 C 18.4554 10.0878 0.0 0
M  V30 45 C 18.4554 12.7551 0.0 0
M  V30 46 C 19.2254 11.4214 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 25
M  V30 8 1 7 35
M  V30 9 1 8 22
M  V30 10 1 8 30
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 28
M  V30 14 1 12 13
M  V30 15 1 12 29
M  V30 16 1 13 41
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 14 19
M  V30 20 1 15 17
M  V30 21 1 15 24
M  V30 22 2 16 18
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 2 22 23
M  V30 29 2 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 2 26 28
M  V30 33 2 27 29
M  V30 34 1 28 29
M  V30 35 1 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 34
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 46 2 41 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 2 43 45
M  V30 50 2 44 46
M  V30 51 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1330736-89-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1330737-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41294334
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Discovery of novel heat shock protein (Hsp90) inhibitors based on
luminespib with potent antitumor activity
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jung, Juyoung; Kwon, Jinsun; Hong, Soojung; Moon, An-Na; Jeong, Jinah;
Kwon, Sungwook; Kim, Jeong-ah; Lee, Myoungjae; Lee, Hongsub; Lee, Jin
Hee; Lee, Jeewoo
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Bioorganic & Medicinal Chemistry Letters (2020), 30(12), 127165

$RFMT $RIREG SCHEME387 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-5-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)phenyl]-3′-[[(methylsulfon...
C34H35N3O8S
1330736-89-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 50 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 9.0654 0.0 0
M  V30 2 N 2.6528 9.6918 0.0 0
M  V30 3 O 4.2207 7.5338 0.0 0
M  V30 4 C 1.4069 8.7866 0.0 0
M  V30 5 C 0.0000 9.4129 0.0 0
M  V30 6 O 9.2154 13.4080 0.0 0
M  V30 7 C 9.9854 14.7416 0.0 0
M  V30 8 C 6.7701 4.0738 0.0 0
M  V30 9 O 7.8006 2.9292 0.0 0
M  V30 10 S 7.3247 1.4647 0.0 0 VAL=6
M  V30 11 C 8.7894 0.9888 0.0 0
M  V30 12 O 6.8488 0.0000 0.0 0
M  V30 13 O 5.8602 1.9406 0.0 0
M  V30 14 C 12.2954 8.0733 0.0 0
M  V30 15 C 13.8354 8.0733 0.0 0
M  V30 16 C 11.5254 6.7397 0.0 0
M  V30 17 O 13.8354 10.7406 0.0 0
M  V30 18 C 14.6054 12.0744 0.0 0
M  V30 19 C 6.7701 9.4947 0.0 0
M  V30 20 C 7.6754 10.7406 0.0 0
M  V30 21 C 5.3055 9.9706 0.0 0
M  V30 22 O 6.7701 11.9866 0.0 0
M  V30 23 N 5.3055 11.5106 0.0 0
M  V30 24 C 7.2460 8.0302 0.0 0
M  V30 25 C 6.3408 6.7842 0.0 0
M  V30 26 O 8.7107 7.5542 0.0 0
M  V30 27 C 7.2460 5.5383 0.0 0
M  V30 28 N 8.7107 6.0142 0.0 0
M  V30 29 C 9.2154 10.7406 0.0 0
M  V30 30 C 9.9854 12.0744 0.0 0
M  V30 31 C 9.9854 9.4069 0.0 0
M  V30 32 C 11.5254 12.0744 0.0 0
M  V30 33 C 11.5254 9.4069 0.0 0
M  V30 34 C 12.2954 10.7406 0.0 0
M  V30 35 C 9.2154 16.0753 0.0 0
M  V30 36 C 7.6754 16.0753 0.0 0
M  V30 37 C 9.9854 17.4091 0.0 0
M  V30 38 C 6.9054 17.4091 0.0 0
M  V30 39 C 9.2154 18.7427 0.0 0
M  V30 40 C 7.6754 18.7427 0.0 0
M  V30 41 C 16.1454 12.0744 0.0 0
M  V30 42 C 16.9154 10.7406 0.0 0
M  V30 43 C 16.9154 13.4080 0.0 0
M  V30 44 C 18.4554 10.7406 0.0 0
M  V30 45 C 18.4554 13.4080 0.0 0
M  V30 46 C 19.2254 12.0744 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 21
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 30
M  V30 8 1 7 35
M  V30 9 1 8 9
M  V30 10 1 8 27
M  V30 11 1 9 10
M  V30 12 1 10 11
M  V30 13 2 10 12
M  V30 14 2 10 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 14 33
M  V30 18 1 17 18
M  V30 19 1 17 34
M  V30 20 1 18 41
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 19 24
M  V30 24 1 20 22
M  V30 25 1 20 29
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 2 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 45 2 41 42
M  V30 46 1 41 43
M  V30 47 1 42 44
M  V30 48 2 43 45
M  V30 49 2 44 46
M  V30 50 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Ethyl-5-[5-(1-methylethyl)-2,4-bis(phenylmethoxy)phenyl]-3′-(1-pyrrolidinyl...
C37H40N4O5
1330737-83-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  46 51 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0596 8.4126 0.0 0
M  V30 2 N 2.6528 9.0389 0.0 0
M  V30 3 O 4.2207 6.8809 0.0 0
M  V30 4 C 1.4069 8.1337 0.0 0
M  V30 5 C 0.0000 8.7601 0.0 0
M  V30 6 O 9.2154 12.7551 0.0 0
M  V30 7 C 9.9854 14.0887 0.0 0
M  V30 8 C 6.7701 3.4208 0.0 0
M  V30 9 C 12.2954 7.4203 0.0 0
M  V30 10 C 11.5254 6.0867 0.0 0
M  V30 11 C 13.8354 7.4203 0.0 0
M  V30 12 O 13.8354 10.0878 0.0 0
M  V30 13 C 14.6054 11.4214 0.0 0
M  V30 14 C 6.7701 8.8418 0.0 0
M  V30 15 C 7.6754 10.0878 0.0 0
M  V30 16 C 5.3055 9.3178 0.0 0
M  V30 17 O 6.7701 11.3336 0.0 0
M  V30 18 N 5.3055 10.8578 0.0 0
M  V30 19 C 7.2460 7.3772 0.0 0
M  V30 20 C 6.3408 6.1314 0.0 0
M  V30 21 O 8.7107 6.9014 0.0 0
M  V30 22 C 7.2460 4.8853 0.0 0
M  V30 23 N 8.7107 5.3614 0.0 0
M  V30 24 C 9.2154 10.0878 0.0 0
M  V30 25 C 9.9854 11.4214 0.0 0
M  V30 26 C 9.9854 8.7540 0.0 0
M  V30 27 C 11.5254 11.4214 0.0 0
M  V30 28 C 11.5254 8.7540 0.0 0
M  V30 29 C 12.2954 10.0878 0.0 0
M  V30 30 N 7.8006 2.2763 0.0 0
M  V30 31 C 7.4804 0.7700 0.0 0
M  V30 32 C 9.3322 2.4374 0.0 0
M  V30 33 C 8.8140 0.0000 0.0 0
M  V30 34 C 9.9586 1.0304 0.0 0
M  V30 35 C 9.2154 15.4225 0.0 0
M  V30 36 C 9.9854 16.7561 0.0 0
M  V30 37 C 7.6754 15.4225 0.0 0
M  V30 38 C 9.2154 18.0898 0.0 0
M  V30 39 C 6.9054 16.7561 0.0 0
M  V30 40 C 7.6754 18.0898 0.0 0
M  V30 41 C 16.1454 11.4214 0.0 0
M  V30 42 C 16.9154 10.0878 0.0 0
M  V30 43 C 16.9154 12.7551 0.0 0
M  V30 44 C 18.4554 10.0878 0.0 0
M  V30 45 C 18.4554 12.7551 0.0 0
M  V30 46 C 19.2254 11.4214 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 16
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 6 7
M  V30 7 1 6 25
M  V30 8 1 7 35
M  V30 9 1 8 22
M  V30 10 1 8 30
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 28
M  V30 14 1 12 13
M  V30 15 1 12 29
M  V30 16 1 13 41
M  V30 17 2 14 15
M  V30 18 1 14 16
M  V30 19 1 14 19
M  V30 20 1 15 17
M  V30 21 1 15 24
M  V30 22 2 16 18
M  V30 23 1 17 18
M  V30 24 2 19 20
M  V30 25 1 19 21
M  V30 26 1 20 22
M  V30 27 1 21 23
M  V30 28 2 22 23
M  V30 29 2 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 2 26 28
M  V30 33 2 27 29
M  V30 34 1 28 29
M  V30 35 1 30 31
M  V30 36 1 30 32
M  V30 37 1 31 33
M  V30 38 1 32 34
M  V30 39 1 33 34
M  V30 40 2 35 36
M  V30 41 1 35 37
M  V30 42 1 36 38
M  V30 43 2 37 39
M  V30 44 2 38 40
M  V30 45 1 39 40
M  V30 46 2 41 42
M  V30 47 1 41 43
M  V30 48 1 42 44
M  V30 49 2 43 45
M  V30 50 2 44 46
M  V30 51 1 45 46
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1330736-89-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1330737-83-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-031-CAS-6738818
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 2:
5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethyl-3'-(morpholinomethyl)-4,5'-biisoxazole-3-carboxamide.
To a solution of the intermediate compound (Step 1) (866.4mg, 1.34mmol)
in DMF (10.9ml) was added morpholine (458.4μl, 5.36mmol), and the
reaction mixture was left to stir at RT for 2 h. After this time, solvent
was evaporated in vacuo, and the residue was extracted between methylene
chloride and water. The organic phase was dried with magnesium sulfate,
and evaporated in vacuo. The residue was purified by silica gel column
chromatography.
(5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-3-(ethylcarbamoyl)-4,5'-biisoxazol-3'-yl)methyl
methane sulfonate (46.2mg, 0.072mmol) was reacted with pyrrolidine (25μl,
0.286mmol) . The intermediate compound
5-(2,4-bis(benzyloxy)-5-isopropylphenyl)-N-ethyl-3'-(pyrrolidin-1-ylmethyl)-4,5'-biisoxazole-3-carboxamide
(44.4mg, 0.072mmol) in a yield of 99%. 1H-NMR (400 MHz, CDCl3) δ
7.40-7.26 (m, 9H), 7.14 (m, 2H), 6.83 (s, 1H), 6.79 (t, 1H), 6.52 (s,
1H), 5.02 (s, 2H), 4.88 (s, 2H), 3.65 (s, 2H), 3.49 (m, 2H), 3.31 (m,
1H), 2.52 (s, 4H), 1.74 (m, 4H), 1.27 (t, 3H), 1.21 (d, 6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Five-membered heterocycle derivatives as HSP90 inhibitors and and their
preparation, pharmaceutical compositions and use in the treatment of
cancer
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Kang, Jae-Hoon; Lee, Hong-Sub; Kwon, Jin-Sun; Park, Joon-Tae; Hong,
Chang-Sung; Shin, Dong-Hyung; Hong, Soo-Jung; Moon, An-Na; Jeong, Jin-Ah;
Kwon, Sung-Wook
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011102660 A2 2011-08-25

$RFMT $RIREG SCHEME388 STEP1
$RXN



  3  1
$MOL
Thiocarbonyldiimidazole
C7H6N4S
6160-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 S 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-2,3,6-trideoxy-3-[(phenylmethoxy)methyl]-4,5-bis-O-(phenylmethyl)-D-m...
C28H33NO4
1349172-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 5.3901 0.0 0
M  V30 2 C 9.3359 4.6201 0.0 0
M  V30 3 O 5.3348 6.9301 0.0 0
M  V30 4 C 4.0011 7.7001 0.0 0
M  V30 5 C 10.6695 6.9301 0.0 0
M  V30 6 O 12.0034 7.7001 0.0 0
M  V30 7 C 13.3370 6.9301 0.0 0
M  V30 8 N 5.3348 10.0101 0.0 0
M  V30 9 O 8.0022 11.5501 0.0 0
M  V30 10 C 8.0022 6.9301 0.0 0 CFG=2
M  V30 11 C 6.6686 7.7001 0.0 0 CFG=2
M  V30 12 C 9.3359 7.7001 0.0 0 CFG=1
M  V30 13 C 6.6686 9.2401 0.0 0 CFG=1
M  V30 14 C 9.3359 9.2401 0.0 0
M  V30 15 C 8.0022 10.0101 0.0 0 CFG=2
M  V30 16 C 9.3359 3.0800 0.0 0
M  V30 17 C 10.6695 2.3100 0.0 0
M  V30 18 C 8.0022 2.3100 0.0 0
M  V30 19 C 10.6695 0.7700 0.0 0
M  V30 20 C 8.0022 0.7700 0.0 0
M  V30 21 C 9.3359 0.0000 0.0 0
M  V30 22 C 2.6675 6.9301 0.0 0
M  V30 23 C 2.6675 5.3901 0.0 0
M  V30 24 C 1.3338 7.7001 0.0 0
M  V30 25 C 1.3338 4.6201 0.0 0
M  V30 26 C 0.0000 6.9301 0.0 0
M  V30 27 C 0.0000 5.3901 0.0 0
M  V30 28 C 14.6707 7.7001 0.0 0
M  V30 29 C 16.0043 6.9301 0.0 0
M  V30 30 C 14.6707 9.2401 0.0 0
M  V30 31 C 17.3381 7.7001 0.0 0
M  V30 32 C 16.0043 10.0101 0.0 0
M  V30 33 C 17.3381 9.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 11 3 CFG=3
M  V30 6 1 4 22
M  V30 7 1 5 6
M  V30 8 1 12 5 CFG=3
M  V30 9 1 6 7
M  V30 10 1 7 28
M  V30 11 1 13 8 CFG=1
M  V30 12 1 15 9 CFG=3
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 10 11 12 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,5-Trideoxy-2-[(phenylmethoxy)methyl]-3,4-bis-O-(phenylmethyl)-5-[(1-pyrro...
C33H40N2O4S
1349172-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.9301 0.0 0
M  V30 2 C 4.0011 7.7001 0.0 0
M  V30 3 O 8.0022 5.3900 0.0 0
M  V30 4 C 9.3359 4.6200 0.0 0
M  V30 5 N 5.3348 10.0101 0.0 0
M  V30 6 C 5.3348 11.5501 0.0 0
M  V30 7 S 6.6686 12.3201 0.0 0
M  V30 8 C 10.6695 6.9301 0.0 0
M  V30 9 O 12.0033 7.7001 0.0 0
M  V30 10 C 13.3370 6.9301 0.0 0
M  V30 11 O 8.0022 11.5501 0.0 0
M  V30 12 C 6.6686 7.7001 0.0 0 CFG=2
M  V30 13 C 8.0022 6.9301 0.0 0 CFG=2
M  V30 14 C 6.6686 9.2401 0.0 0 CFG=1
M  V30 15 C 9.3359 7.7001 0.0 0 CFG=1
M  V30 16 C 8.0022 10.0101 0.0 0 CFG=2
M  V30 17 C 9.3359 9.2401 0.0 0
M  V30 18 C 2.6675 6.9301 0.0 0
M  V30 19 C 2.6675 5.3900 0.0 0
M  V30 20 C 1.3338 7.7001 0.0 0
M  V30 21 C 1.3338 4.6200 0.0 0
M  V30 22 C 0.0000 6.9301 0.0 0
M  V30 23 C 0.0000 5.3900 0.0 0
M  V30 24 C 9.3359 3.0800 0.0 0
M  V30 25 C 8.0022 2.3100 0.0 0
M  V30 26 C 10.6695 2.3100 0.0 0
M  V30 27 C 8.0022 0.7700 0.0 0
M  V30 28 C 10.6695 0.7700 0.0 0
M  V30 29 C 9.3359 0.0000 0.0 0
M  V30 30 N 4.0011 12.3201 0.0 0
M  V30 31 C 3.8402 13.8516 0.0 0
M  V30 32 C 2.5943 11.6936 0.0 0
M  V30 33 C 2.3337 14.1718 0.0 0
M  V30 34 C 1.5637 12.8382 0.0 0
M  V30 35 C 14.6706 7.7001 0.0 0
M  V30 36 C 16.0043 6.9301 0.0 0
M  V30 37 C 14.6706 9.2401 0.0 0
M  V30 38 C 17.3381 7.7001 0.0 0
M  V30 39 C 16.0043 10.0101 0.0 0
M  V30 40 C 17.3381 9.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 13 3 CFG=1
M  V30 6 1 4 24
M  V30 7 1 5 6
M  V30 8 1 14 5 CFG=1
M  V30 9 2 6 7
M  V30 10 1 6 30
M  V30 11 1 8 9
M  V30 12 1 15 8 CFG=3
M  V30 13 1 9 10
M  V30 14 1 10 35
M  V30 15 1 16 11 CFG=3
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 12 13 14 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6160-65-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1349172-71-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1349172-72-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-15137604
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Step 1.
N-((1S,2R,3R,4R,6R)-2,3-Bis(benzyloxy)-4-((benzyloxy)methyl)-6-hydroxycyclohexyl)pyrrolidine-1-carbothioamide.
A mixture of
(1R,2S,3R,4R,5R)-2-amino-3,4-bis(benzyloxy)-5-((benzyloxy)methyl)cyclohexanol
(0.210 g, 0.469 mmol), 1,1-thiocarbonyldiimidazole (Thio-CDI) (0.125 g,
0.704 mmol) in DCM (10 mL) was stirred at room temperature for 3 h.
Pyrrolidine (0.10 mL) was then added, and the mixture was further stirred
for 1 h. The solvent was removed under reduced pressure, and the residue
was purified on silica gel by automatic flash column chromatography
(EtOAc/hexanes, 2:3 to 4:1), affording the product. a pale yellow solid
(0.26 g, 99%). 1H NMR (400 MHz, CDCl3) δ 7.29-7.16 (m, 15H), 5.06 (d,
J=7.5 Hz, 1H), 4.77 (d, J=12.0 Hz, 1H), 4.71 (d, J=10.8 Hz, 1H),
4.70-4.66 (m, 1H), 4.57 (d, J=12.0 Hz, 1H), 4.50 (d, J=10.8 Hz, 1H), 4.42
(s, 2H), 4.19 (s, broad, 1H), 3.65 (t, J=8.8 Hz, 1H), 3.56 (dd, J=4.5,
8.8 Hz, 1H), 3.51-3.40 (m, 3H), 2.07-2.02 (m, 1H), 1.76-1.62 (m, 6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of benzooxazole and benzothiazole derivatives as selective
glycosidase inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Selnick, Harold G.; Liu, Kun; McEachern, Ernest J.; Zhou, Yuanxi; Zhu,
Yongbao
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2013025452 A1 2013-02-21

$RFMT $RIREG SCHEME388 STEP1
$RXN



  3  1
$MOL
Thiocarbonyldiimidazole
C7H6N4S
6160-65-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 S 3.7711 0.0000 0.0 0
M  V30 3 N 2.4374 2.3100 0.0 0
M  V30 4 C 2.2763 3.8416 0.0 0
M  V30 5 C 1.0304 1.6836 0.0 0
M  V30 6 C 0.7700 4.1618 0.0 0
M  V30 7 N 0.0000 2.8281 0.0 0
M  V30 8 N 5.1047 2.3100 0.0 0
M  V30 9 C 5.2658 3.8416 0.0 0
M  V30 10 C 6.5117 1.6836 0.0 0
M  V30 11 C 6.7721 4.1618 0.0 0
M  V30 12 N 7.5421 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 8
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 2 4 6
M  V30 7 2 5 7
M  V30 8 1 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 2 9 11
M  V30 12 2 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Amino-2,3,6-trideoxy-3-[(phenylmethoxy)methyl]-4,5-bis-O-(phenylmethyl)-D-m...
C28H33NO4
1349172-71-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  33 36 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 8.0022 5.3901 0.0 0
M  V30 2 C 9.3359 4.6201 0.0 0
M  V30 3 O 5.3348 6.9301 0.0 0
M  V30 4 C 4.0011 7.7001 0.0 0
M  V30 5 C 10.6695 6.9301 0.0 0
M  V30 6 O 12.0034 7.7001 0.0 0
M  V30 7 C 13.3370 6.9301 0.0 0
M  V30 8 N 5.3348 10.0101 0.0 0
M  V30 9 O 8.0022 11.5501 0.0 0
M  V30 10 C 8.0022 6.9301 0.0 0 CFG=2
M  V30 11 C 6.6686 7.7001 0.0 0 CFG=2
M  V30 12 C 9.3359 7.7001 0.0 0 CFG=1
M  V30 13 C 6.6686 9.2401 0.0 0 CFG=1
M  V30 14 C 9.3359 9.2401 0.0 0
M  V30 15 C 8.0022 10.0101 0.0 0 CFG=2
M  V30 16 C 9.3359 3.0800 0.0 0
M  V30 17 C 10.6695 2.3100 0.0 0
M  V30 18 C 8.0022 2.3100 0.0 0
M  V30 19 C 10.6695 0.7700 0.0 0
M  V30 20 C 8.0022 0.7700 0.0 0
M  V30 21 C 9.3359 0.0000 0.0 0
M  V30 22 C 2.6675 6.9301 0.0 0
M  V30 23 C 2.6675 5.3901 0.0 0
M  V30 24 C 1.3338 7.7001 0.0 0
M  V30 25 C 1.3338 4.6201 0.0 0
M  V30 26 C 0.0000 6.9301 0.0 0
M  V30 27 C 0.0000 5.3901 0.0 0
M  V30 28 C 14.6707 7.7001 0.0 0
M  V30 29 C 16.0043 6.9301 0.0 0
M  V30 30 C 14.6707 9.2401 0.0 0
M  V30 31 C 17.3381 7.7001 0.0 0
M  V30 32 C 16.0043 10.0101 0.0 0
M  V30 33 C 17.3381 9.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 10 1 CFG=1
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 11 3 CFG=3
M  V30 6 1 4 22
M  V30 7 1 5 6
M  V30 8 1 12 5 CFG=3
M  V30 9 1 6 7
M  V30 10 1 7 28
M  V30 11 1 13 8 CFG=1
M  V30 12 1 15 9 CFG=3
M  V30 13 1 10 11
M  V30 14 1 10 12
M  V30 15 1 11 13
M  V30 16 1 12 14
M  V30 17 1 13 15
M  V30 18 1 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 31 2 28 29
M  V30 32 1 28 30
M  V30 33 1 29 31
M  V30 34 2 30 32
M  V30 35 2 31 33
M  V30 36 1 32 33
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 10 11 12 13 15)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,2,5-Trideoxy-2-[(phenylmethoxy)methyl]-3,4-bis-O-(phenylmethyl)-5-[(1-pyrro...
C33H40N2O4S
1349172-72-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  40 44 0 0 1
M  V30 BEGIN ATOM
M  V30 1 O 5.3348 6.9301 0.0 0
M  V30 2 C 4.0011 7.7001 0.0 0
M  V30 3 O 8.0022 5.3900 0.0 0
M  V30 4 C 9.3359 4.6200 0.0 0
M  V30 5 N 5.3348 10.0101 0.0 0
M  V30 6 C 5.3348 11.5501 0.0 0
M  V30 7 S 6.6686 12.3201 0.0 0
M  V30 8 C 10.6695 6.9301 0.0 0
M  V30 9 O 12.0033 7.7001 0.0 0
M  V30 10 C 13.3370 6.9301 0.0 0
M  V30 11 O 8.0022 11.5501 0.0 0
M  V30 12 C 6.6686 7.7001 0.0 0 CFG=2
M  V30 13 C 8.0022 6.9301 0.0 0 CFG=2
M  V30 14 C 6.6686 9.2401 0.0 0 CFG=1
M  V30 15 C 9.3359 7.7001 0.0 0 CFG=1
M  V30 16 C 8.0022 10.0101 0.0 0 CFG=2
M  V30 17 C 9.3359 9.2401 0.0 0
M  V30 18 C 2.6675 6.9301 0.0 0
M  V30 19 C 2.6675 5.3900 0.0 0
M  V30 20 C 1.3338 7.7001 0.0 0
M  V30 21 C 1.3338 4.6200 0.0 0
M  V30 22 C 0.0000 6.9301 0.0 0
M  V30 23 C 0.0000 5.3900 0.0 0
M  V30 24 C 9.3359 3.0800 0.0 0
M  V30 25 C 8.0022 2.3100 0.0 0
M  V30 26 C 10.6695 2.3100 0.0 0
M  V30 27 C 8.0022 0.7700 0.0 0
M  V30 28 C 10.6695 0.7700 0.0 0
M  V30 29 C 9.3359 0.0000 0.0 0
M  V30 30 N 4.0011 12.3201 0.0 0
M  V30 31 C 3.8402 13.8516 0.0 0
M  V30 32 C 2.5943 11.6936 0.0 0
M  V30 33 C 2.3337 14.1718 0.0 0
M  V30 34 C 1.5637 12.8382 0.0 0
M  V30 35 C 14.6706 7.7001 0.0 0
M  V30 36 C 16.0043 6.9301 0.0 0
M  V30 37 C 14.6706 9.2401 0.0 0
M  V30 38 C 17.3381 7.7001 0.0 0
M  V30 39 C 16.0043 10.0101 0.0 0
M  V30 40 C 17.3381 9.2401 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 12 1 CFG=3
M  V30 3 1 2 18
M  V30 4 1 3 4
M  V30 5 1 13 3 CFG=1
M  V30 6 1 4 24
M  V30 7 1 5 6
M  V30 8 1 14 5 CFG=1
M  V30 9 2 6 7
M  V30 10 1 6 30
M  V30 11 1 8 9
M  V30 12 1 15 8 CFG=3
M  V30 13 1 9 10
M  V30 14 1 10 35
M  V30 15 1 16 11 CFG=3
M  V30 16 1 12 13
M  V30 17 1 12 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 1 15 17
M  V30 21 1 16 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 2 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 2 26 28
M  V30 32 2 27 29
M  V30 33 1 28 29
M  V30 34 1 30 31
M  V30 35 1 30 32
M  V30 36 1 31 33
M  V30 37 1 32 34
M  V30 38 1 33 34
M  V30 39 2 35 36
M  V30 40 1 35 37
M  V30 41 1 36 38
M  V30 42 2 37 39
M  V30 43 2 38 40
M  V30 44 1 39 40
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(5 12 13 14 15 16)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 6160-65-2
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1349172-71-9
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1349172-72-0
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-363-CAS-795143
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM [00162] A mixture of the above material (0.210 g, 0.469 mmol), thio-CDI
(0.125 g, 0.704 mmol) in DCM (10 mL) was stirred at room temperature for
3 h. Pyrrolidine (0.10 mL) was then added and the mixture was further
stirred for 1 h. The solvent was removed under reduced pressure and the
residue was purified on silica gel by automatic flash column
chromatography (EtOAc/hexanes, 2:3 to 4:1), affording
N-((1S,2R,3R,4R,6R)-2,3-bis(benzyloxy)-4-((benzyloxy)methyl)-6-hydroxycyclohexyl)pyrrolidine-1-carbothioamide.
As a pale yellow solid (0.26 g, 99%). 1H NMR (400 MHz, CDCl3) 6 7.29-7.16
(m, 15H), 5.06 (d, J= 7.5 Hz, 1H),.4.77 (d, J= 12.0 Hz, 1H), 4.71 (d, J=
10.8 Hz, 1H), 4.70-4.66 (m, 1H), 4.57 (d, J-12.0 Hz, 1H), 4.50 (d, J=
10.8 Hz, 1H), 4.42 (s, 2H), 4.19 (s, broad, 1H), 3.65 (t, J= 8.8 Hz, 1H),
3.56 (dd, J= 4.5, 8.8 Hz, 1H), 3.51-3.40 (m, 3H), 2.07-2.02 (m, 1H),
1.76-1.62 (m, 6H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hexahydrobenzazole derivatives as selective glycosidase inhibitors and
their preparation and use for the treatment of diseases related to
O-GlcNAcase deficiency or overexpression
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Li, Tong-Shuang; McEachern, Ernest J.; Vocadlo, David J.; Zhou, Yuanxi;
Zhu, Yongbao; Liu, Kun; Selnick, Harold G.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2011140640 A1 2011-11-17

$RFMT $RIREG SCHEME389 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-Chloro-N,N-dimethylthieno[2,3-d]pyrimidin-2-amine
C8H8ClN3S
1353680-85-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 3.7036 0.0000 0.0 0
M  V30 2 N 6.3708 4.6200 0.0 0
M  V30 3 C 6.3708 6.1600 0.0 0
M  V30 4 C 7.7046 3.8500 0.0 0
M  V30 5 C 2.3699 3.8500 0.0 0
M  V30 6 C 2.3699 2.3100 0.0 0
M  V30 7 N 3.7036 4.6200 0.0 0
M  V30 8 S 0.9052 4.3259 0.0 0
M  V30 9 C 3.7036 1.5400 0.0 0
M  V30 10 C 0.9052 1.8341 0.0 0
M  V30 11 C 5.0372 3.8500 0.0 0
M  V30 12 C 0.0000 3.0800 0.0 0
M  V30 13 N 5.0372 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 9
M  V30 2 1 2 3
M  V30 3 1 2 4
M  V30 4 1 2 11
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 8
M  V30 8 2 6 9
M  V30 9 1 6 10
M  V30 10 1 7 11
M  V30 11 1 8 12
M  V30 12 1 9 13
M  V30 13 2 10 12
M  V30 14 2 11 13
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N,N-Dimethyl-4-(1-pyrrolidinyl)thieno[2,3-d]pyrimidin-2-amine
C12H16N4S
1353680-91-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 7.7722 4.7474 0.0 0
M  V30 2 C 9.1058 3.9774 0.0 0
M  V30 3 C 7.7722 6.2874 0.0 0
M  V30 4 C 3.7711 3.9774 0.0 0
M  V30 5 C 3.7711 2.4374 0.0 0
M  V30 6 N 5.1047 4.7474 0.0 0
M  V30 7 C 5.1047 1.6674 0.0 0
M  V30 8 C 2.6267 1.4070 0.0 0
M  V30 9 C 6.4385 3.9774 0.0 0
M  V30 10 N 6.4385 2.4374 0.0 0
M  V30 11 S 4.7845 0.1611 0.0 0
M  V30 12 C 3.2530 0.0000 0.0 0
M  V30 13 N 2.4374 4.7474 0.0 0
M  V30 14 C 1.0304 4.1211 0.0 0
M  V30 15 C 2.2763 6.2790 0.0 0
M  V30 16 C 0.0000 5.2655 0.0 0
M  V30 17 C 0.7700 6.5993 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 2 4 5
M  V30 5 1 4 6
M  V30 6 1 4 13
M  V30 7 1 5 7
M  V30 8 1 5 8
M  V30 9 2 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 2 8 12
M  V30 13 1 9 10
M  V30 14 1 11 12
M  V30 15 1 13 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1353680-85-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1353680-91-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-15386432
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: 4-Substituted 2-Dimethylaminothieno[2,3-d]
pyrimidines 12a—j; General Procedure A soln of chloro compound 11 (0.20
g, 0.93 mmol) in THF (15 mL) was treated with the appropriate nucleophile
(1.02 mmol, 1.1 equiv) and the mixture was refluxed temperature for 8-12
h until the starting material was consumed (TLC). The soln was then
concentrated to dryness, and the residue was material was purified by
column chromatography.
N,N-Dimethyl-4-pyrrolidin-1-ylthieno[2,3-d]pyrimidin-2-amine (12f) Yellow
solid; yield: 99% mp 159-160 °C. IR(KBr): 3071,2971,2941, 1536 cm-1. 1H
NMR (300 MHz, CDCl3): δ = 1.99-2.03 (m, 4 H), 3.18 (s, 6 H), 3.76-3.78
(m, 4 H), 6.66 (d, J =6.1 Hz, 1 H), 7.13 (d, J= 6.1 Hz, 1 H). 13C NMR (75
MHz, CDCl3): δ = 25.4, 37.1, 48.4, 108.5, 113.3, 121.1,156.1,159.8,171.6.
MS (FAB): m/z (%) = 249 (100) [M + H]+. Anal. Calcd for C12H16N4S: C,
58.03; H, 6.49; N, 22.56; S, 12.91. Found: C, 57.96; H, 6.57; N, 22.68;
S, 12.78.
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Convenient one-pot synthesis of functionalized thieno[3,2-d]pyrimidine
and thieno[2,3-d]pyrimidine derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Fernandez-Mato, Antonio; Peinador, Carlos; Quintela, Jose Maria
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2011), (20), 3323-3331

$RFMT $RIREG SCHEME390 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-(1,1-Dimethylethyl) 7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-2,5(6H)-di...
C13H19N3O4
1355170-97-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 3.3531 0.0 0
M  V30 2 O 2.6675 2.5831 0.0 0
M  V30 3 O 4.0011 4.8931 0.0 0
M  V30 4 C 1.3337 3.3531 0.0 0
M  V30 5 C 2.1037 4.6869 0.0 0
M  V30 6 C 0.0000 4.1231 0.0 0
M  V30 7 C 0.5636 2.0194 0.0 0
M  V30 8 C 11.9997 3.7084 0.0 0
M  V30 9 O 12.2293 5.2311 0.0 0
M  V30 10 O 13.2038 2.7482 0.0 0
M  V30 11 C 8.0788 2.9967 0.0 0
M  V30 12 N 8.6415 1.5631 0.0 0
M  V30 13 C 6.6073 3.4507 0.0 0
M  V30 14 C 9.2684 3.9748 0.0 0
M  V30 15 N 10.1787 1.6552 0.0 0
M  V30 16 C 7.8715 0.2295 0.0 0
M  V30 17 N 5.3348 2.5831 0.0 0
M  V30 18 C 10.5662 3.1458 0.0 0
M  V30 19 C 6.3486 0.0000 0.0 0
M  V30 20 C 5.2197 1.0474 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 17
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 4 6
M  V30 7 1 4 7
M  V30 8 1 8 9
M  V30 9 2 8 10
M  V30 10 1 8 18
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 1 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 2 15 18
M  V30 19 1 16 19
M  V30 20 1 17 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl 7,8-dihydro-2-(1-pyrrolidinylcarbonyl)-4H-pyrazolo[1,5-a][1...
C17H26N4O3
2791271-86-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.5370 3.7084 0.0 0
M  V30 2 O 3.3073 5.2311 0.0 0
M  V30 3 C 11.5355 3.3531 0.0 0
M  V30 4 O 12.8693 2.5831 0.0 0
M  V30 5 O 11.5355 4.8931 0.0 0
M  V30 6 C 14.2030 3.3531 0.0 0
M  V30 7 C 13.4330 4.6869 0.0 0
M  V30 8 C 15.5366 4.1231 0.0 0
M  V30 9 C 14.9730 2.0194 0.0 0
M  V30 10 C 7.4578 2.9967 0.0 0
M  V30 11 N 6.8953 1.5631 0.0 0
M  V30 12 C 6.2683 3.9748 0.0 0
M  V30 13 C 8.9295 3.4507 0.0 0
M  V30 14 N 5.3579 1.6552 0.0 0
M  V30 15 C 7.6653 0.2295 0.0 0
M  V30 16 C 4.9706 3.1458 0.0 0
M  V30 17 N 10.2019 2.5831 0.0 0
M  V30 18 C 9.1881 0.0000 0.0 0
M  V30 19 C 10.3169 1.0474 0.0 0
M  V30 20 N 2.3330 2.7482 0.0 0
M  V30 21 C 2.4020 1.2097 0.0 0
M  V30 22 C 0.8484 3.1580 0.0 0
M  V30 23 C 0.9602 0.6687 0.0 0
M  V30 24 C 0.0000 1.8727 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 16
M  V30 3 1 1 20
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 17
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 1 6 8
M  V30 10 1 6 9
M  V30 11 1 10 11
M  V30 12 2 10 12
M  V30 13 1 10 13
M  V30 14 1 11 14
M  V30 15 1 11 15
M  V30 16 1 12 16
M  V30 17 1 13 17
M  V30 18 2 14 16
M  V30 19 1 15 18
M  V30 20 1 17 19
M  V30 21 1 18 19
M  V30 22 1 20 21
M  V30 23 1 20 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1355170-97-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2791271-86-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-33474039
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7087-68-5
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 148893-10-1
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tetrahydropyridopyrimidines as pan-KRas inhibitors and their preparation
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Xiaolun; Ivetac, Anthony; Lawson, John David; Marx, Matthew Arnold;
Smith, Christopher Ronald; Kulyk, Svitlana
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2022133038 A1 2022-06-23

$RFMT $RIREG SCHEME391 STEP1
$RXN



  2  1
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-2-oxo-1-(phenylmethyl)-2-(1-pyrrolidinyl)ethyl]carb...
C18H26N2O3
125139-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.1047 0.0 0 CFG=1
M  V30 2 C 4.6200 3.7710 0.0 0
M  V30 3 C 4.6200 6.4385 0.0 0
M  V30 4 N 6.9301 5.1047 0.0 0
M  V30 5 O 3.0800 3.7710 0.0 0
M  V30 6 C 7.7001 6.4385 0.0 0
M  V30 7 O 9.2401 6.4385 0.0 0
M  V30 8 O 6.9301 7.7721 0.0 0
M  V30 9 C 10.0101 7.7721 0.0 0
M  V30 10 C 11.3437 7.0021 0.0 0
M  V30 11 C 10.7801 9.1058 0.0 0
M  V30 12 C 8.6764 8.5421 0.0 0
M  V30 13 N 5.3900 2.4374 0.0 0
M  V30 14 C 4.7636 1.0304 0.0 0
M  V30 15 C 6.9216 2.2763 0.0 0
M  V30 16 C 5.9081 0.0000 0.0 0
M  V30 17 C 7.2417 0.7700 0.0 0
M  V30 18 C 3.0800 6.4385 0.0 0
M  V30 19 C 2.3100 5.1047 0.0 0
M  V30 20 C 2.3100 7.7721 0.0 0
M  V30 21 C 0.7700 5.1047 0.0 0
M  V30 22 C 0.7700 7.7721 0.0 0
M  V30 23 C 0.0000 6.4385 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 13
M  V30 6 1 3 18
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 125139-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-14258806
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 404586-94-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Carboxamidation of carboxylic acids with
1-tert-butoxy-2-tert-butoxycarbonyl-1,2-dihydroisoquinoline (BBDI)
without bases
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Saito, Yukako; Ouchi, Hidekazu; Takahata, Hiroki
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron (2008), 64(49), 11129-11135

$RFMT $RIREG SCHEME391 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
BOC-L-Phenylalanine
C14H19NO4
13734-34-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  19 19 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0 CFG=1
M  V30 2 C 4.6201 4.0012 0.0 0
M  V30 3 N 6.9302 2.6675 0.0 0
M  V30 4 C 4.6201 1.3338 0.0 0
M  V30 5 C 7.7002 4.0012 0.0 0
M  V30 6 O 3.0801 1.3338 0.0 0
M  V30 7 O 5.3901 0.0000 0.0 0
M  V30 8 O 9.2402 4.0012 0.0 0
M  V30 9 O 6.9302 5.3348 0.0 0
M  V30 10 C 10.0102 5.3348 0.0 0
M  V30 11 C 11.3439 4.5648 0.0 0
M  V30 12 C 10.7802 6.6687 0.0 0
M  V30 13 C 8.6766 6.1048 0.0 0
M  V30 14 C 3.0801 4.0012 0.0 0
M  V30 15 C 2.3101 5.3348 0.0 0
M  V30 16 C 2.3101 2.6675 0.0 0
M  V30 17 C 0.7700 5.3348 0.0 0
M  V30 18 C 0.7700 2.6675 0.0 0
M  V30 19 C 0.0000 4.0012 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2 CFG=3
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 2 14
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 8 10
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 10 13
M  V30 14 2 14 15
M  V30 15 1 14 16
M  V30 16 1 15 17
M  V30 17 2 16 18
M  V30 18 2 17 19
M  V30 19 1 18 19
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl N-[(1S)-2-oxo-1-(phenylmethyl)-2-(1-pyrrolidinyl)ethyl]carb...
C18H26N2O3
125139-05-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 5.3900 5.1047 0.0 0 CFG=1
M  V30 2 C 4.6200 3.7710 0.0 0
M  V30 3 C 4.6200 6.4385 0.0 0
M  V30 4 N 6.9301 5.1047 0.0 0
M  V30 5 O 3.0800 3.7710 0.0 0
M  V30 6 C 7.7001 6.4385 0.0 0
M  V30 7 O 9.2401 6.4385 0.0 0
M  V30 8 O 6.9301 7.7721 0.0 0
M  V30 9 C 10.0101 7.7721 0.0 0
M  V30 10 C 11.3437 7.0021 0.0 0
M  V30 11 C 10.7801 9.1058 0.0 0
M  V30 12 C 8.6764 8.5421 0.0 0
M  V30 13 N 5.3900 2.4374 0.0 0
M  V30 14 C 4.7636 1.0304 0.0 0
M  V30 15 C 6.9216 2.2763 0.0 0
M  V30 16 C 5.9081 0.0000 0.0 0
M  V30 17 C 7.2417 0.7700 0.0 0
M  V30 18 C 3.0800 6.4385 0.0 0
M  V30 19 C 2.3100 5.1047 0.0 0
M  V30 20 C 2.3100 7.7721 0.0 0
M  V30 21 C 0.7700 5.1047 0.0 0
M  V30 22 C 0.7700 7.7721 0.0 0
M  V30 23 C 0.0000 6.4385 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3 CFG=3
M  V30 3 1 1 4
M  V30 4 2 2 5
M  V30 5 1 2 13
M  V30 6 1 3 18
M  V30 7 1 4 6
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 7 9
M  V30 11 1 9 10
M  V30 12 1 9 11
M  V30 13 1 9 12
M  V30 14 1 13 14
M  V30 15 1 13 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 13734-34-4
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 125139-05-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-4512985
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 56602-33-6
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General Procedure for Preparating Monopeptides Boc-L-Xxx-NR2R3. To a
solution of Boc-L-Xxx-OH (1.33 g, 5 mmol), triethylamine (1.39 mL, 10
mmol), and a primary or secondary amine (5 mmol) in THF (20 mL) was added
(benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate
(BOP, 2.87 g, 6.5 mmol) at 0 °C. After being stirred for 2 h at the same
temperature, the reaction mixture was allowed to warm to ambient
temperature and stirred for an additional 6 h. The reaction was quenched
with water, and the solution was concentrated in vacuo. The residue was
extracted with EtOAc or CHCl3 and washed with saturated aqueous NaHCO3
and brine. The organic layer was dried over Na2SO4, filtered, and
concentrated in vacuo. The crude product was purified by column
chromatography on silica gel using hexane-EtOAc or CHCl3-MeOH as eluent
to give the corresponding monopeptide Boc-L-Xxx-NR2R3.
Boc-L-Phe-N(CH2CH2)2: >99% yield (brown oil). 1H NMR (CDCl3) δ 1.42 (s,
9H), 1.48-1.86 (m, 4H), 2.51-2.59 (m, 1H), 2.84-3.06 (m, 2H), 3.22-3.48
(m, 3H), 4.58 (dd, 1H, J = 7.2, 13.2 Hz), 5.41 (d, 1H, J = 8.4 Hz),
7.20-7.29 (m, 5H).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Design of an Organocatalyst for the Enantioselective Diels-Alder Reaction
with α-Acyloxyacroleins
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ishihara, Kazuaki; Nakano, Kazuhiko
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Journal of the American Chemical Society (2005), 127(30), 10504-10505

$RFMT $RIREG SCHEME392 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butyl acrylate
C7H12O2
141-32-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 1.5400 0.0 0
M  V30 2 O 4.0012 2.3101 0.0 0
M  V30 3 C 1.3337 2.3101 0.0 0
M  V30 4 O 2.6675 0.0000 0.0 0
M  V30 5 C 5.3348 1.5400 0.0 0
M  V30 6 C 0.0000 1.5400 0.0 0
M  V30 7 C 6.6685 2.3101 0.0 0
M  V30 8 C 8.0023 1.5400 0.0 0
M  V30 9 C 9.3360 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 2 1 4
M  V30 4 1 2 5
M  V30 5 2 3 6
M  V30 6 1 5 7
M  V30 7 1 7 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Butyl 1-pyrrolidinepropanoate
C11H21NO2
59629-69-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 14 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 C 6.4384 1.5400 0.0 0
M  V30 4 O 7.7721 2.3101 0.0 0
M  V30 5 O 6.4384 0.0000 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4396 2.3101 0.0 0
M  V30 8 C 11.7733 1.5400 0.0 0
M  V30 9 C 13.1069 2.3101 0.0 0
M  V30 10 N 2.4373 2.3101 0.0 0
M  V30 11 C 2.2763 3.8416 0.0 0
M  V30 12 C 1.0304 1.6836 0.0 0
M  V30 13 C 0.7700 4.1618 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 8 9
M  V30 10 1 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 14
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-32-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 59629-69-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-11627111
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, aza-Michael reaction, no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis of β-amino acids via catalyst- and solvent-free aza-michael
reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zou, Bo; Jiang, Huan-Feng
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chinese Journal of Chemistry (2008), 26(7), 1309-1314

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-(1-pyrrolidinyl)-2-butenoate
C10H17NO2
2723-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 3.7711 4.1618 0.0 0
M  V30 4 C 6.4384 2.6218 0.0 0
M  V30 5 O 7.7722 1.8517 0.0 0
M  V30 6 O 6.4384 4.1618 0.0 0
M  V30 7 C 9.1059 2.6218 0.0 0
M  V30 8 C 10.4396 1.8517 0.0 0
M  V30 9 N 2.4374 1.8517 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 2.2763 0.3202 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2723-42-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-4111504
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: Reaction of 1,3-Dicarbonyl Compounds with
Secondary Amines; General Procedure In a Schlenk tube, first the Lewis
acid (5 mol%) (when used), then the dicarbonyl derivative (1 equiv), and
the secondary amine (1.5 equiv) were successively added under argon. The
mixture was stirred at r.t. (or at 50 °C) and the reaction was monitored
by TLC analysis. The crude mixture was dissolved in CH2Cl2 (2 mL/mmol),
and the final compound was purified over alumina by flash chromatography
with a 7:3 mixture of heptane-EtOAc as eluent (Tables 1-4). Ethyl
3-(Pyrrolidin-1-yl)but-2-enoate (6). Yield 99%. 1H NMR (200 MHz, CDCl3):
δ = 1.28 (t, J = 7.1 Hz, 3 H, CH3CH2), 1.89-1.96 (m, 4 H, CH2CH2), 2.32
(s, 3 H, =CCH3), 3.11-3.31 (m, 4 H, CH2NCH2), 4.08 (q, J = 7.1 Hz, 2 H,
OCH2), 4.46 (s, 1 H, =CH). 13C NMR (75 MHz, CDCl3): δ = 15.2, 17.1, 25.6,
48.3, 58.5, 83.6, 160.0, 169.7. HRMS: m/z [M+] calcd for C10H17NO2:
183.12593; found: 183.1257.
$DTYPE RXN:VAR(1):NOTES
$DATUM no solvent
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tertiary 3-aminopropenones and 3-aminopropenoates: their preparation,
with and without lewis acids, from secondary amines and 1,3-diketo
compounds
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vohra, Ramandeep Kaur; Renaud, Jean-Luc; Bruneau, Christian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Synthesis (2007), (5), 731-738

$RFMT $RIREG SCHEME393 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl acetoacetate
C6H10O3
141-97-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3100 0.0 0
M  V30 2 C 4.0011 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 O 5.3348 2.3100 0.0 0
M  V30 5 O 4.0011 0.0000 0.0 0
M  V30 6 C 0.0000 2.3100 0.0 0
M  V30 7 O 1.3337 0.0000 0.0 0
M  V30 8 C 6.6686 1.5400 0.0 0
M  V30 9 C 8.0022 2.3100 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 2 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 8 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Ethyl 3-(1-pyrrolidinyl)-2-butenoate
C10H17NO2
2723-42-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  13 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 3.7711 4.1618 0.0 0
M  V30 4 C 6.4384 2.6218 0.0 0
M  V30 5 O 7.7722 1.8517 0.0 0
M  V30 6 O 6.4384 4.1618 0.0 0
M  V30 7 C 9.1059 2.6218 0.0 0
M  V30 8 C 10.4396 1.8517 0.0 0
M  V30 9 N 2.4374 1.8517 0.0 0
M  V30 10 C 1.0304 2.4782 0.0 0
M  V30 11 C 2.2763 0.3202 0.0 0
M  V30 12 C 0.0000 1.3337 0.0 0
M  V30 13 C 0.7700 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2 CFG=2
M  V30 2 1 1 3
M  V30 3 1 1 9
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 9 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 1 12 13
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 141-97-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2723-42-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-13732357
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 104-15-4
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM General/Typical Procedure: (1) Methyl 3-tetrahydropyrrolyl-2-butenoate
Methyl acetoacetate (20 g, 172.23 mmol) was dissolved in 250 mL of
toluene, and then pyrrolidine (43 ml, 516.70 mmol) and p-toluenesulfonic
acid hydrate (about 100 mg) were added dropwise. After installing a
Dean-Stark separator to the reactor, the reaction mixture was refluxed
140°C. for two days, and then solvent was removed by concentrating the
resulting mixture under a reduced pressure, thereby to obtain the desired
product (29 g, 99%). (2) Ethyl 3-tetrahydropyrrolyl-2-butenoate Ethyl
3-tetrahydropyrrolyl-2-butenoate was prepared (21 g, 99%) from ethyl
acetoacetate (15.0 g, 115.26 mmol) and pyrrolidine (71.1 mL, 345.78 mmol)
in the same manner as described in the above Example 1 (1), and the
obtained product was identified with the following NMR data. 1H NMR
(CDCl3, 300 MHz) δ 4.37 (s, 1H, -C=CH-), 4.00 (q, 2H, -OCH2CH3, J=7.1
Hz), 3.22 (brs, 4H, pyrrolidine), 2.38 (s, 3H, -CH3), 1.85 (s, 4H,
pyrrolidine), 1.17 (t, 3H, -OCH2CH3, J=7.1 Hz) 13C NMR (CDCl3, 300 MHz) δ
169.5, 159.9, 83.6, 58.4, 48.2, 25.5, 17.0, 15.1
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Asymmetric reduction of ketoesters using the carbonyl reductase of
Kluyveromyces marxianus to give chiral
dioxodihydroisoindolylmethylhydroxybutyrates.
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Koh, Hun Yeong; Choi, Kyuno; Cho, Yong Seo; Pae, Ae Nim; Cha, Joo Hwan;
Han, Ye Sun; Lee, Jong Soo; Yun, Hong Chul
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM United States, US20030139464 A1 2003-07-24

$RFMT $RIREG SCHEME394 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Chloroquinoxaline
C8H5ClN2
1448-87-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Cl 6.9302 2.6673 0.0 0
M  V30 2 C 3.0801 1.3337 0.0 0
M  V30 3 C 2.3101 2.6673 0.0 0
M  V30 4 N 4.6201 1.3337 0.0 0
M  V30 5 C 2.3101 0.0000 0.0 0
M  V30 6 N 3.0801 4.0010 0.0 0
M  V30 7 C 0.7700 2.6673 0.0 0
M  V30 8 C 5.3901 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 4.6201 4.0010 0.0 0
M  V30 11 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 8
M  V30 2 2 2 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 1 3 7
M  V30 7 2 4 8
M  V30 8 2 5 9
M  V30 9 2 6 10
M  V30 10 2 7 11
M  V30 11 1 8 10
M  V30 12 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-(1-Pyrrolidinyl)quinoxaline
C12H13N3
60814-24-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6673 0.0 0
M  V30 2 N 4.6201 1.3337 0.0 0
M  V30 3 C 4.6201 4.0010 0.0 0
M  V30 4 C 3.0801 1.3337 0.0 0
M  V30 5 N 3.0801 4.0010 0.0 0
M  V30 6 C 2.3101 2.6673 0.0 0
M  V30 7 C 2.3101 0.0000 0.0 0
M  V30 8 C 0.7700 2.6673 0.0 0
M  V30 9 C 0.7700 0.0000 0.0 0
M  V30 10 C 0.0000 1.3337 0.0 0
M  V30 11 N 6.9302 2.6673 0.0 0
M  V30 12 C 7.8354 3.9132 0.0 0
M  V30 13 C 7.8354 1.4215 0.0 0
M  V30 14 C 9.3000 3.4374 0.0 0
M  V30 15 C 9.3000 1.8973 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 2 3 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 1 5 6
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1448-87-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 60814-24-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-22606470
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 29166-72-1
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-66-6
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 15629-92-2
$DTYPE RXN:VAR(1):CAT(3):CAS_RN
$DATUM 72914-19-3
$DTYPE RXN:VAR(1):CAT(4):CAS_RN
$DATUM 2256751-76-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 67-68-5
$DTYPE RXN:VAR(1):NOTES
$DATUM chemoselective, regioselective, alternative reaction condition gave lower
yield
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Nickel-Catalyzed Amination of (Hetero)aryl Halides Facilitated by a
Catalytic Pyridinium Additive
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Han, Dongyang; Li, Sasa; Xia, Siqi; Su, Mincong; Jin, Jian
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2020), 26(54), 12349-12354

$RFMT $RIREG SCHEME395 STEP1
$RXN



  2  1
$MOL
4-Pentyn-1-one, 3-hydroxy-1,5-diphenyl-3-(trifluoromethyl)-
C18H13F3O2
1453809-91-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  23 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 2.6675 0.0 0
M  V30 2 C 4.6201 4.0011 0.0 0
M  V30 3 C 6.7239 3.4375 0.0 0
M  V30 4 C 6.1601 1.3337 0.0 0
M  V30 5 O 4.0564 1.8975 0.0 0
M  V30 6 C 3.0800 4.0011 0.0 0
M  V30 7 C 8.0575 4.2075 0.0 0
M  V30 8 F 7.4939 2.1037 0.0 0
M  V30 9 F 6.9301 0.0000 0.0 0
M  V30 10 F 4.8264 0.5636 0.0 0
M  V30 11 O 2.3100 2.6675 0.0 0
M  V30 12 C 2.3100 5.3348 0.0 0
M  V30 13 C 3.0800 6.6686 0.0 0
M  V30 14 C 0.7700 5.3348 0.0 0
M  V30 15 C 2.3100 8.0022 0.0 0
M  V30 16 C 0.0000 6.6686 0.0 0
M  V30 17 C 0.7700 8.0022 0.0 0
M  V30 18 C 9.3912 4.9775 0.0 0
M  V30 19 C 10.7248 4.2075 0.0 0
M  V30 20 C 9.3912 6.5175 0.0 0
M  V30 21 C 12.0586 4.9775 0.0 0
M  V30 22 C 10.7248 7.2875 0.0 0
M  V30 23 C 12.0586 6.5175 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 1 4
M  V30 4 1 1 5
M  V30 5 1 2 6
M  V30 6 3 3 7
M  V30 7 1 4 8
M  V30 8 1 4 9
M  V30 9 1 4 10
M  V30 10 2 6 11
M  V30 11 1 6 12
M  V30 12 1 7 18
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 19 2 18 19
M  V30 20 1 18 20
M  V30 21 1 19 21
M  V30 22 2 20 22
M  V30 23 2 21 23
M  V30 24 1 22 23
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL

C26H28F3N2O2P
2446075-33-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  34 38 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0011 5.4498 0.0 0
M  V30 2 P 4.0011 3.9098 0.0 0 VAL=5
M  V30 3 O 2.4611 3.9098 0.0 0
M  V30 4 C 4.3513 8.7819 0.0 0
M  V30 5 F 3.3209 7.6374 0.0 0
M  V30 6 F 3.2069 9.8123 0.0 0
M  V30 7 F 5.3817 9.9263 0.0 0
M  V30 8 C 5.3347 6.2198 0.0 0
M  V30 9 C 5.4958 7.7513 0.0 0
M  V30 10 O 6.7417 5.5935 0.0 0
M  V30 11 C 7.0021 8.0716 0.0 0
M  V30 12 C 7.7721 6.7378 0.0 0
M  V30 13 C 2.6674 6.2198 0.0 0
M  V30 14 C 2.6674 7.7598 0.0 0
M  V30 15 C 1.3338 5.4498 0.0 0
M  V30 16 C 1.3338 8.5298 0.0 0
M  V30 17 C 0.0000 6.2198 0.0 0
M  V30 18 C 0.0000 7.7598 0.0 0
M  V30 19 N 4.0011 2.3698 0.0 0
M  V30 20 C 2.7552 1.4645 0.0 0
M  V30 21 C 5.2470 1.4645 0.0 0
M  V30 22 C 3.2311 0.0000 0.0 0
M  V30 23 C 4.7711 0.0000 0.0 0
M  V30 24 N 5.5411 3.9098 0.0 0
M  V30 25 C 6.4463 5.1556 0.0 0
M  V30 26 C 6.4463 2.6639 0.0 0
M  V30 27 C 7.9109 4.6798 0.0 0
M  V30 28 C 7.9109 3.1398 0.0 0
M  V30 29 C 9.3036 6.5769 0.0 0
M  V30 30 C 9.9301 5.1701 0.0 0
M  V30 31 C 10.2089 7.8228 0.0 0
M  V30 32 C 11.4617 5.0090 0.0 0
M  V30 33 C 11.7404 7.6618 0.0 0
M  V30 34 C 12.3669 6.2549 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 8
M  V30 3 1 1 13
M  V30 4 2 2 3
M  V30 5 1 2 19
M  V30 6 1 2 24
M  V30 7 1 4 5
M  V30 8 1 4 6
M  V30 9 1 4 7
M  V30 10 1 4 9
M  V30 11 2 8 9
M  V30 12 1 8 10
M  V30 13 1 9 11
M  V30 14 1 10 12
M  V30 15 2 11 12
M  V30 16 1 12 29
M  V30 17 2 13 14
M  V30 18 1 13 15
M  V30 19 1 14 16
M  V30 20 2 15 17
M  V30 21 2 16 18
M  V30 22 1 17 18
M  V30 23 1 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 1 22 23
M  V30 28 1 24 25
M  V30 29 1 24 26
M  V30 30 1 25 27
M  V30 31 1 26 28
M  V30 32 1 27 28
M  V30 33 2 29 30
M  V30 34 1 29 31
M  V30 35 1 30 32
M  V30 36 2 31 33
M  V30 37 2 32 34
M  V30 38 1 33 34
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 1453809-91-0
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2446075-33-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-399-CAS-22375098
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 7719-12-2
$DTYPE RXN:VAR(1):RGT(3):CAS_RN
$DATUM 12125-02-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Catalyst-Free Preparation of Perfluoroalkyl-Phosphoryl Substituted Furans
from 1-Perfluoroalkyl 1,3-Diketones in Two Steps
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Lozovskiy, Stanislav V.; Vasilyev, Aleksander V.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2020), 362(15), 3121-3125

$RFMT $RIREG SCHEME396 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)-2-pyridinecarboxamide
C12H9ClN2O
14547-72-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 Cl 11.5503 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 N 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 0.0000 0.0 0
M  V30 13 C 7.7002 2.6673 0.0 0
M  V30 14 C 9.2402 0.0000 0.0 0
M  V30 15 C 9.2402 2.6673 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 11
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Chlorophenyl)-N-(tetrahydro-2-furanyl)-2-pyridinecarboxamide
C16H15ClN2O2
2183512-11-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 3.7710 0.0 0
M  V30 2 C 4.6200 5.1048 0.0 0
M  V30 3 O 5.3900 6.4384 0.0 0
M  V30 4 Cl 11.5500 3.7710 0.0 0
M  V30 5 C 6.9300 3.7710 0.0 0
M  V30 6 C 7.7000 5.1048 0.0 0
M  V30 7 C 7.7000 2.4374 0.0 0
M  V30 8 C 9.2400 5.1048 0.0 0
M  V30 9 C 9.2400 2.4374 0.0 0
M  V30 10 C 10.0100 3.7710 0.0 0
M  V30 11 C 4.6200 2.4374 0.0 0
M  V30 12 C 3.0885 2.2764 0.0 0
M  V30 13 O 5.2463 1.0306 0.0 0
M  V30 14 C 2.7683 0.7700 0.0 0
M  V30 15 C 4.1019 0.0000 0.0 0
M  V30 16 C 3.0800 5.1048 0.0 0
M  V30 17 C 2.3100 3.7710 0.0 0
M  V30 18 N 2.3100 6.4384 0.0 0
M  V30 19 C 0.7700 3.7710 0.0 0
M  V30 20 C 0.7700 6.4384 0.0 0
M  V30 21 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 2 2 3
M  V30 5 1 2 16
M  V30 6 1 4 10
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14547-72-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2183512-11-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-28438913
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 66-71-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Teflon lined sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and atom-economical route to N-aryl amino alcohols from
primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Zhen; Li, Juanjuan; Yue, Qiang; Zhang, Qian; Li, Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2018), 8(60), 34304-34308

$RFMT $RIREG SCHEME397 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)-2-pyridinecarboxamide
C12H9BrN2O
14547-73-0 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6201 2.6673 0.0 0
M  V30 2 N 5.3901 1.3337 0.0 0
M  V30 3 O 5.3901 4.0010 0.0 0
M  V30 4 Br 11.5503 1.3337 0.0 0
M  V30 5 C 3.0801 2.6673 0.0 0
M  V30 6 C 2.3101 1.3337 0.0 0
M  V30 7 N 2.3101 4.0010 0.0 0
M  V30 8 C 0.7700 1.3337 0.0 0
M  V30 9 C 0.7700 4.0010 0.0 0
M  V30 10 C 0.0000 2.6673 0.0 0
M  V30 11 C 6.9302 1.3337 0.0 0
M  V30 12 C 7.7002 0.0000 0.0 0
M  V30 13 C 7.7002 2.6673 0.0 0
M  V30 14 C 9.2402 0.0000 0.0 0
M  V30 15 C 9.2402 2.6673 0.0 0
M  V30 16 C 10.0102 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 5
M  V30 4 1 2 11
M  V30 5 1 4 16
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(4-Bromophenyl)-N-(tetrahydro-2-furanyl)-2-pyridinecarboxamide
C16H15BrN2O2
2183512-12-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 3.7710 0.0 0
M  V30 2 C 4.6200 5.1048 0.0 0
M  V30 3 O 5.3900 6.4384 0.0 0
M  V30 4 Br 11.5500 3.7710 0.0 0
M  V30 5 C 6.9300 3.7710 0.0 0
M  V30 6 C 7.7000 5.1048 0.0 0
M  V30 7 C 7.7000 2.4374 0.0 0
M  V30 8 C 9.2400 5.1048 0.0 0
M  V30 9 C 9.2400 2.4374 0.0 0
M  V30 10 C 10.0100 3.7710 0.0 0
M  V30 11 C 4.6200 2.4374 0.0 0
M  V30 12 C 3.0885 2.2764 0.0 0
M  V30 13 O 5.2463 1.0306 0.0 0
M  V30 14 C 2.7683 0.7700 0.0 0
M  V30 15 C 4.1019 0.0000 0.0 0
M  V30 16 C 3.0800 5.1048 0.0 0
M  V30 17 C 2.3100 3.7710 0.0 0
M  V30 18 N 2.3100 6.4384 0.0 0
M  V30 19 C 0.7700 3.7710 0.0 0
M  V30 20 C 0.7700 6.4384 0.0 0
M  V30 21 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 2 2 3
M  V30 5 1 2 16
M  V30 6 1 4 10
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 2 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 2 19 21
M  V30 23 1 20 21
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 14547-73-0
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2183512-12-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-30053453
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 66-71-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Teflon lined sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and atom-economical route to N-aryl amino alcohols from
primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Zhen; Li, Juanjuan; Yue, Qiang; Zhang, Qian; Li, Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2018), 8(60), 34304-34308

$RFMT $RIREG SCHEME398 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Bromo-4-methylphenyl)-2-pyridinecarboxamide
C13H11BrN2O
1457711-03-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 2.6674 0.0 0
M  V30 2 C 4.6200 4.0011 0.0 0
M  V30 3 O 5.3900 5.3349 0.0 0
M  V30 4 Br 10.0100 0.0000 0.0 0
M  V30 5 C 11.5500 2.6674 0.0 0
M  V30 6 C 6.9300 2.6674 0.0 0
M  V30 7 C 7.7000 1.3338 0.0 0
M  V30 8 C 7.7000 4.0011 0.0 0
M  V30 9 C 9.2400 1.3338 0.0 0
M  V30 10 C 9.2400 4.0011 0.0 0
M  V30 11 C 10.0100 2.6674 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 2.3100 2.6674 0.0 0
M  V30 14 N 2.3100 5.3349 0.0 0
M  V30 15 C 0.7700 2.6674 0.0 0
M  V30 16 C 0.7700 5.3349 0.0 0
M  V30 17 C 0.0000 4.0011 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 2 2 3
M  V30 4 1 2 12
M  V30 5 1 4 9
M  V30 6 1 5 11
M  V30 7 2 6 7
M  V30 8 1 6 8
M  V30 9 1 7 9
M  V30 10 2 8 10
M  V30 11 2 9 11
M  V30 12 1 10 11
M  V30 13 2 12 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 2 14 16
M  V30 17 2 15 17
M  V30 18 1 16 17
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-(3-Bromo-4-methylphenyl)-N-(tetrahydro-2-furanyl)-2-pyridinecarboxamide
C17H17BrN2O2
2183512-17-4 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  22 24 0 0 0
M  V30 BEGIN ATOM
M  V30 1 N 5.3900 3.7710 0.0 0
M  V30 2 C 4.6200 5.1048 0.0 0
M  V30 3 O 5.3900 6.4384 0.0 0
M  V30 4 Br 10.0100 6.4384 0.0 0
M  V30 5 C 11.5500 3.7710 0.0 0
M  V30 6 C 6.9300 3.7710 0.0 0
M  V30 7 C 7.7000 5.1048 0.0 0
M  V30 8 C 7.7000 2.4374 0.0 0
M  V30 9 C 9.2400 5.1048 0.0 0
M  V30 10 C 9.2400 2.4374 0.0 0
M  V30 11 C 10.0100 3.7710 0.0 0
M  V30 12 C 4.6200 2.4374 0.0 0
M  V30 13 C 3.0885 2.2764 0.0 0
M  V30 14 O 5.2463 1.0306 0.0 0
M  V30 15 C 2.7683 0.7700 0.0 0
M  V30 16 C 4.1019 0.0000 0.0 0
M  V30 17 C 3.0800 5.1048 0.0 0
M  V30 18 C 2.3100 3.7710 0.0 0
M  V30 19 N 2.3100 6.4384 0.0 0
M  V30 20 C 0.7700 3.7710 0.0 0
M  V30 21 C 0.7700 6.4384 0.0 0
M  V30 22 C 0.0000 5.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 6
M  V30 3 1 1 12
M  V30 4 2 2 3
M  V30 5 1 2 17
M  V30 6 1 4 9
M  V30 7 1 5 11
M  V30 8 2 6 7
M  V30 9 1 6 8
M  V30 10 1 7 9
M  V30 11 2 8 10
M  V30 12 2 9 11
M  V30 13 1 10 11
M  V30 14 1 12 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 16
M  V30 18 1 15 16
M  V30 19 2 17 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 23 2 20 22
M  V30 24 1 21 22
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1457711-03-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2183512-17-4
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-29918374
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 75-91-2
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 66-71-7
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 142-71-2
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 60-29-7
$DTYPE RXN:VAR(1):SOL(2):CAS_RN
$DATUM 7732-18-5
$DTYPE RXN:VAR(1):NOTES
$DATUM Teflon lined sealed vial used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM An efficient and atom-economical route to N-aryl amino alcohols from
primary amines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xiao, Zhen; Li, Juanjuan; Yue, Qiang; Zhang, Qian; Li, Dong
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM RSC Advances (2018), 8(60), 34304-34308

$RFMT $RIREG SCHEME399 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-Vinylcarbazole
C14H11N
1484-13-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3798 1.0304 0.0 0
M  V30 2 C 3.2354 0.0000 0.0 0
M  V30 3 C 4.3201 5.0149 0.0 0
M  V30 4 C 2.8138 4.6948 0.0 0
M  V30 5 C 5.0901 3.6813 0.0 0
M  V30 6 C 5.0901 6.3486 0.0 0
M  V30 7 C 2.6527 3.1632 0.0 0
M  V30 8 C 1.5679 5.6000 0.0 0
M  V30 9 N 4.0597 2.5367 0.0 0
M  V30 10 C 6.6301 3.6813 0.0 0
M  V30 11 C 6.6301 6.3486 0.0 0
M  V30 12 C 1.2459 2.5367 0.0 0
M  V30 13 C 0.1609 4.9735 0.0 0
M  V30 14 C 7.4001 5.0149 0.0 0
M  V30 15 C 0.0000 3.4420 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 9
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 2 5 10
M  V30 10 1 6 11
M  V30 11 1 7 9
M  V30 12 2 7 12
M  V30 13 1 8 13
M  V30 14 1 10 14
M  V30 15 2 11 14
M  V30 16 1 12 15
M  V30 17 2 13 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
9-[2-(1-Pyrrolidinyl)ethyl]-9H-carbazole
C18H20N2
4483-10-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.7309 5.6252 0.0 0
M  V30 2 C 7.1954 5.1492 0.0 0
M  V30 3 N 4.5863 4.5947 0.0 0
M  V30 4 C 3.0800 4.9148 0.0 0
M  V30 5 C 4.7474 3.0631 0.0 0
M  V30 6 C 2.3100 3.5812 0.0 0
M  V30 7 C 2.3100 6.2486 0.0 0
M  V30 8 C 3.3405 2.4368 0.0 0
M  V30 9 C 5.9933 2.1579 0.0 0
M  V30 10 C 0.7700 3.5812 0.0 0
M  V30 11 C 0.7700 6.2486 0.0 0
M  V30 12 C 3.1795 0.9052 0.0 0
M  V30 13 C 5.8322 0.6263 0.0 0
M  V30 14 C 0.0000 4.9148 0.0 0
M  V30 15 C 4.4254 0.0000 0.0 0
M  V30 16 N 8.3400 6.1798 0.0 0
M  V30 17 C 9.8463 5.8596 0.0 0
M  V30 18 C 8.1789 7.7114 0.0 0
M  V30 19 C 10.6163 7.1933 0.0 0
M  V30 20 C 9.5859 8.3377 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 16
M  V30 4 1 3 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 2 4 7
M  V30 8 1 5 8
M  V30 9 2 5 9
M  V30 10 1 6 8
M  V30 11 2 6 10
M  V30 12 1 7 11
M  V30 13 2 8 12
M  V30 14 1 9 13
M  V30 15 1 10 14
M  V30 16 2 11 14
M  V30 17 1 12 15
M  V30 18 2 13 15
M  V30 19 1 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1484-13-5
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 4483-10-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-41528603
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 3037071-70-5
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, no solvent, glove box used, catalyst prepared and used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New Approach to Substrate Activation or How Heterobimetallic Complexes
{[(p-tBu-C6H4)2CH]3M}K (M = Ca and Yb) Make Intermolecular Olefin
Hydroamination and NH3 Cascade Hydroamination/Hydroaminomethylation
Feasible
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Selikhov, Alexander N.; Cherkasov, Anton V.; Nelyubina, Yulia V.;
Trifonov, Alexander A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Catalysis (2023), 13(19), 12582-12590

$RFMT $RIREG SCHEME400 STEP1
$RXN



  3  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Cyclopropanecarboxaldehyde
C4H6O
1489-69-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.8737 2.1037 0.0 0
M  V30 2 O 4.2074 1.3337 0.0 0
M  V30 3 C 1.5400 1.3337 0.0 0
M  V30 4 C 0.7700 0.0000 0.0 0
M  V30 5 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 3 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Nonyne
C9H16
3452-09-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  9 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3348 1.5400 0.0 0
M  V30 2 C 4.0012 0.7700 0.0 0
M  V30 3 C 6.6685 0.7700 0.0 0
M  V30 4 C 2.6673 1.5400 0.0 0
M  V30 5 C 8.0023 1.5400 0.0 0
M  V30 6 C 1.3337 0.7700 0.0 0
M  V30 7 C 9.3360 0.7700 0.0 0
M  V30 8 C 0.0000 1.5400 0.0 0
M  V30 9 C 10.6697 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 3 7 9
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine, 1-(1-cyclopropyl-2-decyn-1-yl)-
C17H29N
3026917-85-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 19 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.8737 0.0 0
M  V30 2 C 5.1049 3.6437 0.0 0
M  V30 3 C 6.4386 4.4137 0.0 0
M  V30 4 C 7.7722 5.1838 0.0 0
M  V30 5 C 9.1059 4.4137 0.0 0
M  V30 6 C 10.4397 5.1838 0.0 0
M  V30 7 C 11.7734 4.4137 0.0 0
M  V30 8 C 13.1071 5.1838 0.0 0
M  V30 9 C 14.4407 4.4137 0.0 0
M  V30 10 C 15.7746 5.1838 0.0 0
M  V30 11 C 3.7711 1.3337 0.0 0
M  V30 12 C 4.5411 0.0000 0.0 0
M  V30 13 C 3.0011 0.0000 0.0 0
M  V30 14 N 2.4374 3.6437 0.0 0
M  V30 15 C 2.2765 5.1753 0.0 0
M  V30 16 C 1.0306 3.0174 0.0 0
M  V30 17 C 0.7700 5.4955 0.0 0
M  V30 18 C 0.0000 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 11
M  V30 3 1 1 14
M  V30 4 3 2 3
M  V30 5 1 3 4
M  V30 6 1 4 5
M  V30 7 1 5 6
M  V30 8 1 6 7
M  V30 9 1 7 8
M  V30 10 1 8 9
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 13
M  V30 15 1 14 15
M  V30 16 1 14 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1489-69-6
$DTYPE RXN:RCT(3):CAS_RN
$DATUM 3452-09-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 3026917-85-8
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-614-CAS-39432507
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 7440-22-4
$DTYPE RXN:VAR(1):CAT(1):AMD
$DATUM composite with copper-TPA and BIBRT MOF
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 3026917-51-8
$DTYPE RXN:VAR(1):CAT(2):AMD
$DATUM composite with silver
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Schlenk tube used, silver nanoparticles composite with copper MOF
heterogeneous catalyst prepared and used, reusable catalyst
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Cu(II)-Based Metal-Organic Framework Loaded with Silver Nanoparticles as
a Catalyst for the A3-Coupling Reaction
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Xie, Wang; Shi, Conghao; Li, Heng; Liu, Li; Zhao, Yue; Lin, Chen
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM ACS Applied Nano Materials (2024), 7(3), 3210-3219

$RFMT $RIREG SCHEME401 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl 4-(phenylmethoxy)-2-butynoate
C12H12O3
149125-61-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.0010 3.8501 0.0 0
M  V30 2 O 5.3348 3.0801 0.0 0
M  V30 3 C 6.6685 3.8501 0.0 0
M  V30 4 C 8.0022 3.0801 0.0 0
M  V30 5 C 9.3360 2.3101 0.0 0
M  V30 6 C 10.6697 1.5400 0.0 0
M  V30 7 O 12.0033 2.3101 0.0 0
M  V30 8 O 10.6697 0.0000 0.0 0
M  V30 9 C 13.3370 1.5400 0.0 0
M  V30 10 C 2.6673 3.0801 0.0 0
M  V30 11 C 2.6673 1.5400 0.0 0
M  V30 12 C 1.3337 3.8501 0.0 0
M  V30 13 C 1.3337 0.7700 0.0 0
M  V30 14 C 0.0000 3.0801 0.0 0
M  V30 15 C 0.0000 1.5400 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 2 3
M  V30 4 1 3 4
M  V30 5 3 4 5
M  V30 6 1 5 6
M  V30 7 1 6 7
M  V30 8 2 6 8
M  V30 9 1 7 9
M  V30 10 2 10 11
M  V30 11 1 10 12
M  V30 12 1 11 13
M  V30 13 2 12 14
M  V30 14 2 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Methyl (2E)-4-(phenylmethoxy)-3-(1-pyrrolidinyl)-2-butenoate
C16H21NO3
2368236-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7000 3.7710 0.0 0
M  V30 2 C 6.9300 5.1046 0.0 0
M  V30 3 C 9.2400 3.7710 0.0 0
M  V30 4 O 5.3900 5.1046 0.0 0
M  V30 5 C 10.0100 5.1046 0.0 0
M  V30 6 C 4.6200 6.4384 0.0 0
M  V30 7 O 11.5500 5.1046 0.0 0
M  V30 8 O 9.2400 6.4384 0.0 0
M  V30 9 C 12.3200 6.4384 0.0 0
M  V30 10 N 6.9300 2.4374 0.0 0
M  V30 11 C 5.3985 2.2764 0.0 0
M  V30 12 C 7.5563 1.0304 0.0 0
M  V30 13 C 5.0783 0.7700 0.0 0
M  V30 14 C 6.4119 0.0000 0.0 0
M  V30 15 C 3.0800 6.4384 0.0 0
M  V30 16 C 2.3100 7.7721 0.0 0
M  V30 17 C 2.3100 5.1046 0.0 0
M  V30 18 C 0.7700 7.7721 0.0 0
M  V30 19 C 0.7700 5.1046 0.0 0
M  V30 20 C 0.0000 6.4384 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 10
M  V30 4 1 2 4
M  V30 5 1 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 5 8
M  V30 9 1 6 15
M  V30 10 1 7 9
M  V30 11 1 10 11
M  V30 12 1 10 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 14
M  V30 16 2 15 16
M  V30 17 1 15 17
M  V30 18 1 16 18
M  V30 19 2 17 19
M  V30 20 2 18 20
M  V30 21 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 149125-61-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2368236-75-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-260-CAS-20384879
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-65-0
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Tandem [1,2]-Wittig Rearrangement/Lactonization of γ-Benzyloxy Vinylogous
Urethanes: Application to the Synthetic Studies of Maculalactone A,
Planchol C and γ-Lycorane
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ho, Guo-Ming; Li, Yu-Jang
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Asian Journal of Organic Chemistry (2018), 7(1), 145-149

$RFMT $RIREG SCHEME402 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2,6-Difluoropyridine
C5H3F2N
1513-65-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 0.0000 3.0800 0.0 0
M  V30 2 F 5.3349 3.0800 0.0 0
M  V30 3 N 2.6675 3.0800 0.0 0
M  V30 4 C 1.3338 2.3100 0.0 0
M  V30 5 C 4.0011 2.3100 0.0 0
M  V30 6 C 1.3338 0.7700 0.0 0
M  V30 7 C 4.0011 0.7700 0.0 0
M  V30 8 C 2.6675 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 4
M  V30 2 1 2 5
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 2 4 6
M  V30 6 1 5 7
M  V30 7 1 6 8
M  V30 8 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
2-Fluoro-6-(1-pyrrolidinyl)pyridine
C9H11FN2
1000981-50-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 13 0 0 0
M  V30 BEGIN ATOM
M  V30 1 F 7.7721 3.0800 0.0 0
M  V30 2 C 3.7710 2.3100 0.0 0
M  V30 3 N 5.1046 3.0800 0.0 0
M  V30 4 C 3.7710 0.7700 0.0 0
M  V30 5 C 6.4384 2.3100 0.0 0
M  V30 6 C 5.1046 0.0000 0.0 0
M  V30 7 C 6.4384 0.7700 0.0 0
M  V30 8 N 2.4374 3.0800 0.0 0
M  V30 9 C 2.2764 4.6115 0.0 0
M  V30 10 C 1.0304 2.4535 0.0 0
M  V30 11 C 0.7700 4.9317 0.0 0
M  V30 12 C 0.0000 3.5981 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 5
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 8
M  V30 5 2 3 5
M  V30 6 1 4 6
M  V30 7 1 5 7
M  V30 8 2 6 7
M  V30 9 1 8 9
M  V30 10 1 8 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1513-65-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1000981-50-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-5971604
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 109-72-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):EXP_PROC
$DATUM 2-Fluoro-6-pyrrolidin-1-ylpridine was prepared by an independent route:
n-Butyl lithium (0.35 mL, 2.5 M in THF) was added dropwise to a stirred
solution of pyrrolidine (0.068 g, 0.96 mmol) in dry THF (10 mL) at 0 °C.
After 20 minutes, 2,6-difluoropyridine (0.10 g, 0.88 mmol) was added
dropwise and the solution was stirred at 0 °C for 30 minutes. Water (4
mL) was added and product was extracted with diethyl ether (3 × 10 mL).
The combined extracts were dried (Na2SO4), solvents were removed in vacuo
and purified by chromatography (eluting with 1:1 ethyl acetate/petroleum
ether; Rf = 0.65) to give 2-fluoro-6-pyrrolidin-1-ylpridine (0.144 g, 99
%), the spectroscopic and analytical characteristics of which were
identical to that described above. 2-Fluoro-6-pyrrolidin-1-ylpridine,
yield (0.144 g, 99 %).
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthetic Entries to Substituted Bicyclic Pyridones
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Cheng, Dachen; Croft, Laura; Abdi, Muna; Lightfoot, Andrew; Gallagher,
Timothy
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2007), 9(25), 5175-5178

$RFMT $RIREG SCHEME403 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
5-Hexenoic acid
C6H10O2
1577-22-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  8 7 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 2.6675 2.3101 0.0 0
M  V30 2 C 4.0012 1.5400 0.0 0
M  V30 3 C 1.3337 1.5400 0.0 0
M  V30 4 C 5.3348 2.3101 0.0 0
M  V30 5 O 0.0000 2.3101 0.0 0
M  V30 6 O 1.3337 0.0000 0.0 0
M  V30 7 C 6.6687 1.5400 0.0 0
M  V30 8 C 8.0023 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 2 3 6
M  V30 6 1 4 7
M  V30 7 2 7 8
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(1-Pyrrolidinyl)-5-hexen-1-one
C10H17NO
1855623-36-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 C 5.1048 2.3101 0.0 0
M  V30 3 O 3.7711 0.0000 0.0 0
M  V30 4 C 6.4384 1.5400 0.0 0
M  V30 5 C 7.7722 2.3101 0.0 0
M  V30 6 C 9.1059 1.5400 0.0 0
M  V30 7 C 10.4396 2.3101 0.0 0
M  V30 8 N 2.4374 2.3101 0.0 0
M  V30 9 C 1.0304 1.6836 0.0 0
M  V30 10 C 2.2763 3.8416 0.0 0
M  V30 11 C 0.0000 2.8281 0.0 0
M  V30 12 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 8
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 1 5 6
M  V30 7 2 6 7
M  V30 8 1 8 9
M  V30 9 1 8 10
M  V30 10 1 9 11
M  V30 11 1 10 12
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1577-22-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1855623-36-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-23720118
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 1122-58-3
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Iridium-catalyzed enantioselective hydroalkynylation via alkene
isomerization
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Zhang, Wen-Wen; Li, Bi-Jie
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2021), 73153108

$RFMT $RIREG SCHEME404 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(1E)-2-[6-Chloro-9-(phenylmethyl)-9H-purin-8-yl]ethenyl]benzonitrile
C21H14ClN5
1585984-75-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  27 30 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3939 6.6519 0.0 0
M  V30 2 C 7.4547 5.2891 0.0 0
M  V30 3 C 8.7883 4.5191 0.0 0
M  V30 4 Cl 4.4535 0.0000 0.0 0
M  V30 5 C 14.1230 7.5991 0.0 0
M  V30 6 N 15.4567 8.3691 0.0 0
M  V30 7 N 4.7141 5.1454 0.0 0
M  V30 8 C 3.6835 4.0011 0.0 0
M  V30 9 C 6.1209 4.5191 0.0 0
M  V30 10 C 4.4535 2.6674 0.0 0
M  V30 11 N 2.1435 4.0011 0.0 0
M  V30 12 N 5.9600 2.9876 0.0 0
M  V30 13 C 3.6835 1.3338 0.0 0
M  V30 14 C 1.3735 2.6674 0.0 0
M  V30 15 N 2.1435 1.3338 0.0 0
M  V30 16 C 2.9292 7.1277 0.0 0
M  V30 17 C 1.7849 6.0973 0.0 0
M  V30 18 C 2.6091 8.6342 0.0 0
M  V30 19 C 0.3202 6.5732 0.0 0
M  V30 20 C 1.1444 9.1100 0.0 0
M  V30 21 C 0.0000 8.0795 0.0 0
M  V30 22 C 10.1220 5.2891 0.0 0
M  V30 23 C 11.4556 4.5191 0.0 0
M  V30 24 C 10.1220 6.8291 0.0 0
M  V30 25 C 12.7894 5.2891 0.0 0
M  V30 26 C 11.4556 7.5991 0.0 0
M  V30 27 C 12.7894 6.8291 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 7
M  V30 2 1 1 16
M  V30 3 2 2 3
M  V30 4 1 2 9
M  V30 5 1 3 22
M  V30 6 1 4 13
M  V30 7 3 5 6
M  V30 8 1 5 27
M  V30 9 1 7 8
M  V30 10 1 7 9
M  V30 11 1 8 10
M  V30 12 2 8 11
M  V30 13 2 9 12
M  V30 14 1 10 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 2 18 20
M  V30 23 2 19 21
M  V30 24 1 20 21
M  V30 25 2 22 23
M  V30 26 1 22 24
M  V30 27 1 23 25
M  V30 28 2 24 26
M  V30 29 2 25 27
M  V30 30 1 26 27
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(1E)-2-[9-(Phenylmethyl)-6-(1-pyrrolidinyl)-9H-purin-8-yl]ethenyl]benzonit...
C25H22N6
1585984-78-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  31 35 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.3940 9.0892 0.0 0
M  V30 2 C 7.4548 7.7265 0.0 0
M  V30 3 C 8.7885 6.9564 0.0 0
M  V30 4 C 14.1233 10.0365 0.0 0
M  V30 5 N 15.4569 10.8065 0.0 0
M  V30 6 C 4.4536 5.1047 0.0 0
M  V30 7 C 3.6836 6.4384 0.0 0
M  V30 8 C 3.6836 3.7711 0.0 0
M  V30 9 N 5.9600 5.4249 0.0 0
M  V30 10 N 4.7142 7.5829 0.0 0
M  V30 11 N 2.1436 6.4384 0.0 0
M  V30 12 N 2.1436 3.7711 0.0 0
M  V30 13 C 6.1210 6.9564 0.0 0
M  V30 14 C 1.3735 5.1047 0.0 0
M  V30 15 N 4.4536 2.4374 0.0 0
M  V30 16 C 5.9853 2.2763 0.0 0
M  V30 17 C 3.8273 1.0304 0.0 0
M  V30 18 C 6.3055 0.7700 0.0 0
M  V30 19 C 4.9718 0.0000 0.0 0
M  V30 20 C 2.9293 9.5651 0.0 0
M  V30 21 C 1.7849 8.5347 0.0 0
M  V30 22 C 2.6091 11.0715 0.0 0
M  V30 23 C 0.3202 9.0105 0.0 0
M  V30 24 C 1.1444 11.5474 0.0 0
M  V30 25 C 0.0000 10.5170 0.0 0
M  V30 26 C 10.1221 7.7265 0.0 0
M  V30 27 C 10.1221 9.2665 0.0 0
M  V30 28 C 11.4558 6.9564 0.0 0
M  V30 29 C 11.4558 10.0365 0.0 0
M  V30 30 C 12.7896 7.7265 0.0 0
M  V30 31 C 12.7896 9.2665 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 10
M  V30 2 1 1 20
M  V30 3 2 2 3
M  V30 4 1 2 13
M  V30 5 1 3 26
M  V30 6 3 4 5
M  V30 7 1 4 31
M  V30 8 1 6 7
M  V30 9 2 6 8
M  V30 10 1 6 9
M  V30 11 1 7 10
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 1 8 15
M  V30 15 2 9 13
M  V30 16 1 10 13
M  V30 17 1 11 14
M  V30 18 2 12 14
M  V30 19 1 15 16
M  V30 20 1 15 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 19
M  V30 24 2 20 21
M  V30 25 1 20 22
M  V30 26 1 21 23
M  V30 27 2 22 24
M  V30 28 2 23 25
M  V30 29 1 24 25
M  V30 30 2 26 27
M  V30 31 1 26 28
M  V30 32 1 27 29
M  V30 33 2 28 30
M  V30 34 2 29 31
M  V30 35 1 30 31
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1585984-75-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1585984-78-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-6492948
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 534-17-8
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 161265-03-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 123-91-1
$DTYPE RXN:VAR(1):NOTES
$DATUM literature preparation, Buchwald-Hartwig cross coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis and evaluation of spectroscopic properties of newly synthesized
push-pull 6-amino-8-styryl purines
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Vabre, Roxane; Legraverend, Michel; Piguel, Sandrine
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Dyes and Pigments (2014), 105145-151

$RFMT $RIREG SCHEME405 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
4-[(5-Bromo-1H-pyrazol-1-yl)methyl]benzoic acid
C11H9BrN2O2
1616099-11-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  16 17 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 4.6201 0.0 0
M  V30 2 Br 0.7103 5.9827 0.0 0
M  V30 3 C 9.1059 1.5400 0.0 0
M  V30 4 O 10.4396 2.3101 0.0 0
M  V30 5 O 9.1059 0.0000 0.0 0
M  V30 6 N 2.4374 3.8501 0.0 0
M  V30 7 C 1.0304 4.4764 0.0 0
M  V30 8 N 2.2763 2.3184 0.0 0
M  V30 9 C 0.0000 3.3319 0.0 0
M  V30 10 C 0.7700 1.9982 0.0 0
M  V30 11 C 5.1048 3.8501 0.0 0
M  V30 12 C 5.1048 2.3101 0.0 0
M  V30 13 C 6.4384 4.6201 0.0 0
M  V30 14 C 6.4384 1.5400 0.0 0
M  V30 15 C 7.7722 3.8501 0.0 0
M  V30 16 C 7.7722 2.3101 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 6
M  V30 2 1 1 11
M  V30 3 1 2 7
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 16
M  V30 7 1 6 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 2 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 2 13 15
M  V30 16 2 14 16
M  V30 17 1 15 16
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
[4-[(5-Bromo-1H-pyrazol-1-yl)methyl]phenyl]-1-pyrrolidinylmethanone
C15H16BrN3O
1616099-45-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 9.1060 1.5400 0.0 0
M  V30 2 O 9.1060 0.0000 0.0 0
M  V30 3 C 3.7711 4.6201 0.0 0
M  V30 4 Br 0.7104 5.9827 0.0 0
M  V30 5 C 7.7722 2.3100 0.0 0
M  V30 6 C 7.7722 3.8501 0.0 0
M  V30 7 C 6.4386 1.5400 0.0 0
M  V30 8 C 6.4386 4.6201 0.0 0
M  V30 9 C 5.1049 2.3100 0.0 0
M  V30 10 C 5.1049 3.8501 0.0 0
M  V30 11 N 10.4397 2.3100 0.0 0
M  V30 12 C 10.6006 3.8416 0.0 0
M  V30 13 C 11.8465 1.6836 0.0 0
M  V30 14 C 12.1071 4.1618 0.0 0
M  V30 15 C 12.8771 2.8281 0.0 0
M  V30 16 N 2.4374 3.8501 0.0 0
M  V30 17 C 1.0306 4.4764 0.0 0
M  V30 18 N 2.2765 2.3184 0.0 0
M  V30 19 C 0.0000 3.3319 0.0 0
M  V30 20 C 0.7700 1.9982 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 10
M  V30 5 1 3 16
M  V30 6 1 4 17
M  V30 7 2 5 6
M  V30 8 1 5 7
M  V30 9 1 6 8
M  V30 10 2 7 9
M  V30 11 2 8 10
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 16 1 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 2 17 19
M  V30 21 2 18 20
M  V30 22 1 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1616099-11-6
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1616099-45-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-8942805
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 2592-95-2
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 25952-53-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Preparation of
1-[aryl(alkyl)oxyl]-3-(3,4-dihydroisoquinolin-2(1H)-yl)propan-2-ol as
PRMT5 inhibitors
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Duncan, Kenneth W.; Chesworth, Richard; Munchhof, Michael John; Jin, Lei
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM World Intellectual Property Organization, WO2014100695 A1 2014-06-26

$RFMT $RIREG SCHEME406 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(2-Thienyl)-9H-pyrido[3,4-b]indole-3-carboxaldehyde
C16H10N2OS
1616696-12-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  20 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.9150 0.7700 0.0 0
M  V30 2 O 3.5812 0.0000 0.0 0
M  V30 3 C 4.9150 5.3901 0.0 0
M  V30 4 C 3.5812 4.6201 0.0 0
M  V30 5 C 6.2486 4.6201 0.0 0
M  V30 6 N 4.5948 6.8964 0.0 0
M  V30 7 C 2.4368 5.6505 0.0 0
M  V30 8 C 3.5812 3.0800 0.0 0
M  V30 9 N 6.2486 3.0800 0.0 0
M  V30 10 C 3.0631 7.0573 0.0 0
M  V30 11 C 0.9052 5.4896 0.0 0
M  V30 12 C 4.9150 2.3100 0.0 0
M  V30 13 C 2.1580 8.3032 0.0 0
M  V30 14 C 0.0000 6.7354 0.0 0
M  V30 15 C 0.6263 8.1423 0.0 0
M  V30 16 C 7.5823 5.3901 0.0 0
M  V30 17 C 7.7434 6.9216 0.0 0
M  V30 18 S 8.9893 4.7636 0.0 0
M  V30 19 C 9.2497 7.2418 0.0 0
M  V30 20 C 10.0197 5.9081 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 3 4
M  V30 4 2 3 5
M  V30 5 1 3 6
M  V30 6 1 4 7
M  V30 7 2 4 8
M  V30 8 1 5 9
M  V30 9 1 5 16
M  V30 10 1 6 10
M  V30 11 1 7 10
M  V30 12 2 7 11
M  V30 13 1 8 12
M  V30 14 2 9 12
M  V30 15 2 10 13
M  V30 16 1 11 14
M  V30 17 1 13 15
M  V30 18 2 14 15
M  V30 19 2 16 17
M  V30 20 1 16 18
M  V30 21 1 17 19
M  V30 22 1 18 20
M  V30 23 2 19 20
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Pyrrolidinyl[1-(2-thienyl)-9H-pyrido[3,4-b]indol-3-yl]methanethione
C20H17N3S2
2173050-36-5 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 29 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 7.7721 7.4002 0.0 0
M  V30 2 S 7.7721 8.9402 0.0 0
M  V30 3 C 3.7711 5.0901 0.0 0
M  V30 4 C 5.1048 4.3201 0.0 0
M  V30 5 C 3.7711 6.6302 0.0 0
M  V30 6 N 2.6265 4.0597 0.0 0
M  V30 7 C 4.7846 2.8138 0.0 0
M  V30 8 C 6.4384 5.0901 0.0 0
M  V30 9 N 5.1048 7.4002 0.0 0
M  V30 10 C 3.2530 2.6527 0.0 0
M  V30 11 C 5.6898 1.5678 0.0 0
M  V30 12 C 6.4384 6.6302 0.0 0
M  V30 13 C 2.6265 1.2459 0.0 0
M  V30 14 C 5.0633 0.1609 0.0 0
M  V30 15 C 3.5318 0.0000 0.0 0
M  V30 16 C 2.4373 7.4002 0.0 0
M  V30 17 C 2.2763 8.9317 0.0 0
M  V30 18 S 1.0304 6.7738 0.0 0
M  V30 19 C 0.7700 9.2519 0.0 0
M  V30 20 C 0.0000 7.9182 0.0 0
M  V30 21 N 9.1059 6.6302 0.0 0
M  V30 22 C 10.5127 7.2565 0.0 0
M  V30 23 C 9.2668 5.0986 0.0 0
M  V30 24 C 11.5432 6.1121 0.0 0
M  V30 25 C 10.7732 4.7784 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 12
M  V30 3 1 1 21
M  V30 4 1 3 4
M  V30 5 2 3 5
M  V30 6 1 3 6
M  V30 7 1 4 7
M  V30 8 2 4 8
M  V30 9 1 5 9
M  V30 10 1 5 16
M  V30 11 1 6 10
M  V30 12 1 7 10
M  V30 13 2 7 11
M  V30 14 1 8 12
M  V30 15 2 9 12
M  V30 16 2 10 13
M  V30 17 1 11 14
M  V30 18 1 13 15
M  V30 19 2 14 15
M  V30 20 2 16 17
M  V30 21 1 16 18
M  V30 22 1 17 19
M  V30 23 1 18 20
M  V30 24 2 19 20
M  V30 25 1 21 22
M  V30 26 1 21 23
M  V30 27 1 22 24
M  V30 28 1 23 25
M  V30 29 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1616696-12-8
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2173050-36-5
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-561-CAS-18598473
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7704-34-9
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 68-12-2
$DTYPE RXN:VAR(1):NOTES
$DATUM Willgerodt-Kindler reaction
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Practical synthesis of two novel series of 1,3-disubstituted β-carboline
derivatives
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Abranyi-Balogh, Peter; Volk, Balazs; Milen, Matyas
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Tetrahedron Letters (2018), 59(7), 617-619

$RFMT $RIREG SCHEME407 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-6,7-difluoro-1,4-dihydro-N,N-dimethyl-4-oxo-2-thioxo-3(2H)-quinazolin...
C13H13F2N3O2S
1660149-52-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.8500 1.3336 0.0 0
M  V30 2 C 4.6200 0.0000 0.0 0
M  V30 3 O 6.9300 6.6685 0.0 0
M  V30 4 S 6.9300 1.3336 0.0 0
M  V30 5 F 0.0000 5.3347 0.0 0
M  V30 6 C 8.4700 4.0011 0.0 0
M  V30 7 N 9.2400 5.3347 0.0 0
M  V30 8 O 9.2400 2.6674 0.0 0
M  V30 9 C 8.4700 6.6685 0.0 0
M  V30 10 C 10.7800 5.3347 0.0 0
M  V30 11 F 1.5400 8.0021 0.0 0
M  V30 12 C 3.8500 4.0011 0.0 0
M  V30 13 C 4.6200 5.3347 0.0 0
M  V30 14 N 4.6200 2.6674 0.0 0
M  V30 15 C 2.3100 4.0011 0.0 0
M  V30 16 C 6.1600 5.3347 0.0 0
M  V30 17 C 3.8500 6.6685 0.0 0
M  V30 18 C 6.1600 2.6674 0.0 0
M  V30 19 C 1.5400 5.3347 0.0 0
M  V30 20 N 6.9300 4.0011 0.0 0
M  V30 21 C 2.3100 6.6685 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 14
M  V30 3 2 3 16
M  V30 4 2 4 18
M  V30 5 1 5 19
M  V30 6 1 6 7
M  V30 7 2 6 8
M  V30 8 1 6 20
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 21
M  V30 12 1 12 13
M  V30 13 1 12 14
M  V30 14 2 12 15
M  V30 15 1 13 16
M  V30 16 2 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 21
M  V30 21 1 18 20
M  V30 22 2 19 21
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-Ethyl-6-fluoro-1,4-dihydro-N,N-dimethyl-4-oxo-7-(1-pyrrolidinyl)-2-thioxo-3...
C17H21FN4O2S
1660148-99-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  25 27 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 6.9300 1.3336 0.0 0
M  V30 2 C 6.1600 0.0000 0.0 0
M  V30 3 O 3.8500 6.6685 0.0 0
M  V30 4 S 3.8500 1.3336 0.0 0
M  V30 5 C 2.3100 4.0011 0.0 0
M  V30 6 N 1.5400 5.3347 0.0 0
M  V30 7 O 1.5400 2.6674 0.0 0
M  V30 8 C 2.3100 6.6685 0.0 0
M  V30 9 C 0.0000 5.3347 0.0 0
M  V30 10 F 9.2400 8.0021 0.0 0
M  V30 11 C 6.9300 4.0011 0.0 0
M  V30 12 C 6.1600 5.3347 0.0 0
M  V30 13 N 6.1600 2.6674 0.0 0
M  V30 14 C 8.4700 4.0011 0.0 0
M  V30 15 C 4.6200 5.3347 0.0 0
M  V30 16 C 6.9300 6.6685 0.0 0
M  V30 17 C 4.6200 2.6674 0.0 0
M  V30 18 C 9.2400 5.3347 0.0 0
M  V30 19 N 3.8500 4.0011 0.0 0
M  V30 20 C 8.4700 6.6685 0.0 0
M  V30 21 N 10.7800 5.3347 0.0 0
M  V30 22 C 11.6852 4.0889 0.0 0
M  V30 23 C 11.6852 6.5806 0.0 0
M  V30 24 C 13.1498 4.5647 0.0 0
M  V30 25 C 13.1498 6.1047 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 13
M  V30 3 2 3 15
M  V30 4 2 4 17
M  V30 5 1 5 6
M  V30 6 2 5 7
M  V30 7 1 5 19
M  V30 8 1 6 8
M  V30 9 1 6 9
M  V30 10 1 10 20
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 2 11 14
M  V30 14 1 12 15
M  V30 15 2 12 16
M  V30 16 1 13 17
M  V30 17 1 14 18
M  V30 18 1 15 19
M  V30 19 1 16 20
M  V30 20 1 17 19
M  V30 21 2 18 20
M  V30 22 1 18 21
M  V30 23 1 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 1 23 25
M  V30 27 1 24 25
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1660149-52-9
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1660148-99-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-8517936
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-05-8
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Synthesis, antibacterial, and DNA-PK evaluation of some novel
6-fluoro-7-(cyclic amino)-2-(thioxo or oxo)-3-substituted
quinazolin-4-ones as structural analogues of quinolone and
quinazolin-2,4-dione antibiotics
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Heppell, Jacob T.; Al-Rawi, Jasim M. A.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Medicinal Chemistry Research (2015), 24(6), 2756-2769

$RFMT $RIREG SCHEME408 STEP1
$RXN



  2  1
$MOL
4-Bromo-1-naphthalenecarboxylic acid
C11H7BrO2
16650-55-8 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.7700 4.0011 0.0 0
M  V30 2 O 0.0000 2.6674 0.0 0
M  V30 3 O 0.0000 5.3349 0.0 0
M  V30 4 Br 6.9300 4.0011 0.0 0
M  V30 5 C 3.0800 2.6674 0.0 0
M  V30 6 C 4.6200 2.6674 0.0 0
M  V30 7 C 2.3100 4.0011 0.0 0
M  V30 8 C 2.3100 1.3338 0.0 0
M  V30 9 C 5.3900 4.0011 0.0 0
M  V30 10 C 5.3900 1.3338 0.0 0
M  V30 11 C 3.0800 5.3349 0.0 0
M  V30 12 C 3.0800 0.0000 0.0 0
M  V30 13 C 4.6200 5.3349 0.0 0
M  V30 14 C 4.6200 0.0000 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 7
M  V30 4 1 4 9
M  V30 5 2 5 6
M  V30 6 1 5 7
M  V30 7 1 5 8
M  V30 8 1 6 9
M  V30 9 1 6 10
M  V30 10 2 7 11
M  V30 11 2 8 12
M  V30 12 2 9 13
M  V30 13 2 10 14
M  V30 14 1 11 13
M  V30 15 1 12 14
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(4-Bromo-1-naphthalenyl)-1-pyrrolidinylmethanone
C15H14BrNO
2238848-66-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  18 20 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 5.3901 5.3348 0.0 0
M  V30 2 O 4.6201 6.6686 0.0 0
M  V30 3 Br 2.3100 0.0000 0.0 0
M  V30 4 C 3.0800 4.0011 0.0 0
M  V30 5 C 4.6201 4.0011 0.0 0
M  V30 6 C 2.3100 2.6675 0.0 0
M  V30 7 C 2.3100 5.3348 0.0 0
M  V30 8 C 5.3901 2.6675 0.0 0
M  V30 9 C 3.0800 1.3338 0.0 0
M  V30 10 C 0.7700 2.6675 0.0 0
M  V30 11 C 0.7700 5.3348 0.0 0
M  V30 12 C 4.6201 1.3338 0.0 0
M  V30 13 C 0.0000 4.0011 0.0 0
M  V30 14 N 6.9301 5.3348 0.0 0
M  V30 15 C 7.8353 4.0889 0.0 0
M  V30 16 C 7.8353 6.5808 0.0 0
M  V30 17 C 9.2999 4.5648 0.0 0
M  V30 18 C 9.2999 6.1048 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 14
M  V30 4 1 3 9
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 4 7
M  V30 8 2 5 8
M  V30 9 1 6 9
M  V30 10 1 6 10
M  V30 11 2 7 11
M  V30 12 1 8 12
M  V30 13 2 9 12
M  V30 14 2 10 13
M  V30 15 1 11 13
M  V30 16 1 14 15
M  V30 17 1 14 16
M  V30 18 1 15 17
M  V30 19 1 16 18
M  V30 20 1 17 18
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 16650-55-8
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2238848-66-1
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-367-CAS-24181369
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 2
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 7719-09-7
$DTYPE RXN:VAR(1):RGT(2):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Palladium-Catalyzed C8-Oxygenation of Naphthalene Derivatives: Direct
Access to Naphtholactone Skeleton
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Berrou, Caroline; Prevost, Sebastien
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Advanced Synthesis & Catalysis (2021), 363(16), 4091-4095

$RFMT $RIREG SCHEME409 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-(4-Bromophenyl)benz[b]indeno[2,1-d]pyran
C22H13BrO
1675209-84-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 28 0 0 0
M  V30 BEGIN ATOM
M  V30 1 Br 11.5500 5.8614 0.0 0
M  V30 2 C 4.6200 4.5278 0.0 0
M  V30 3 C 3.0800 4.5278 0.0 0
M  V30 4 C 5.3900 5.8614 0.0 0
M  V30 5 C 5.0959 3.0632 0.0 0
M  V30 6 C 2.3100 5.8614 0.0 0
M  V30 7 C 2.6041 3.0632 0.0 0
M  V30 8 O 4.6200 7.1952 0.0 0
M  V30 9 C 3.8500 2.1580 0.0 0
M  V30 10 C 6.5028 2.4367 0.0 0
M  V30 11 C 3.0800 7.1952 0.0 0
M  V30 12 C 0.7700 5.8614 0.0 0
M  V30 13 C 4.0109 0.6263 0.0 0
M  V30 14 C 6.6637 0.9052 0.0 0
M  V30 15 C 2.3100 8.5288 0.0 0
M  V30 16 C 0.0000 7.1952 0.0 0
M  V30 17 C 5.4179 0.0000 0.0 0
M  V30 18 C 0.7700 8.5288 0.0 0
M  V30 19 C 6.9300 5.8614 0.0 0
M  V30 20 C 7.7000 7.1952 0.0 0
M  V30 21 C 7.7000 4.5278 0.0 0
M  V30 22 C 9.2400 7.1952 0.0 0
M  V30 23 C 9.2400 4.5278 0.0 0
M  V30 24 C 10.0100 5.8614 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 24
M  V30 2 1 2 3
M  V30 3 2 2 4
M  V30 4 1 2 5
M  V30 5 1 3 6
M  V30 6 2 3 7
M  V30 7 1 4 8
M  V30 8 1 4 19
M  V30 9 1 5 9
M  V30 10 2 5 10
M  V30 11 1 6 11
M  V30 12 2 6 12
M  V30 13 1 7 9
M  V30 14 1 8 11
M  V30 15 2 9 13
M  V30 16 1 10 14
M  V30 17 2 11 15
M  V30 18 1 12 16
M  V30 19 1 13 17
M  V30 20 2 14 17
M  V30 21 1 15 18
M  V30 22 2 16 18
M  V30 23 2 19 20
M  V30 24 1 19 21
M  V30 25 1 20 22
M  V30 26 2 21 23
M  V30 27 2 22 24
M  V30 28 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1-(4-Benz[b]indeno[2,1-d]pyran-6-ylphenyl)pyrrolidine
C26H21NO
1675210-07-7 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  28 33 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 4.6200 4.5278 0.0 0
M  V30 2 C 3.0800 4.5278 0.0 0
M  V30 3 C 5.3900 5.8614 0.0 0
M  V30 4 C 5.0959 3.0632 0.0 0
M  V30 5 C 2.3100 5.8614 0.0 0
M  V30 6 C 2.6041 3.0632 0.0 0
M  V30 7 O 4.6200 7.1952 0.0 0
M  V30 8 C 3.8500 2.1580 0.0 0
M  V30 9 C 6.5027 2.4367 0.0 0
M  V30 10 C 3.0800 7.1952 0.0 0
M  V30 11 C 0.7700 5.8614 0.0 0
M  V30 12 C 4.0109 0.6263 0.0 0
M  V30 13 C 6.6637 0.9052 0.0 0
M  V30 14 C 2.3100 8.5288 0.0 0
M  V30 15 C 0.0000 7.1952 0.0 0
M  V30 16 C 5.4179 0.0000 0.0 0
M  V30 17 C 0.7700 8.5288 0.0 0
M  V30 18 C 6.9300 5.8614 0.0 0
M  V30 19 C 7.7000 7.1952 0.0 0
M  V30 20 C 7.7000 4.5278 0.0 0
M  V30 21 C 9.2400 7.1952 0.0 0
M  V30 22 C 9.2400 4.5278 0.0 0
M  V30 23 C 10.0100 5.8614 0.0 0
M  V30 24 N 11.5500 5.8614 0.0 0
M  V30 25 C 12.4552 7.1074 0.0 0
M  V30 26 C 12.4552 4.6155 0.0 0
M  V30 27 C 13.9198 6.6314 0.0 0
M  V30 28 C 13.9198 5.0914 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 4
M  V30 4 1 2 5
M  V30 5 2 2 6
M  V30 6 1 3 7
M  V30 7 1 3 18
M  V30 8 1 4 8
M  V30 9 2 4 9
M  V30 10 1 5 10
M  V30 11 2 5 11
M  V30 12 1 6 8
M  V30 13 1 7 10
M  V30 14 2 8 12
M  V30 15 1 9 13
M  V30 16 2 10 14
M  V30 17 1 11 15
M  V30 18 1 12 16
M  V30 19 2 13 16
M  V30 20 1 14 17
M  V30 21 2 15 17
M  V30 22 2 18 19
M  V30 23 1 18 20
M  V30 24 1 19 21
M  V30 25 2 20 22
M  V30 26 2 21 23
M  V30 27 1 22 23
M  V30 28 1 23 24
M  V30 29 1 24 25
M  V30 30 1 24 26
M  V30 31 1 25 27
M  V30 32 1 26 28
M  V30 33 1 27 28
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1675209-84-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 1675210-07-7
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-172-CAS-496623
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 865-48-5
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 51364-51-3
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 98327-87-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM Buchwald-Hartwig coupling
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Triflic Acid Mediated Cascade Cyclization of Aryldiynes for the Synthesis
of Indeno[1,2-c]chromenes: Application to Dye-Sensitized Solar Cells
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jiang, Hua; Ferrara, Giovanni; Zhang, Xuan; Oniwa, Kazuaki; Islam,
Ashraful; Han, Liyuan; Sun, Ying-Ji; Bao, Ming; Asao, Naoki; Yamamoto,
Yoshinori; Jin, Tienan
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2015), 21(10), 4065-4070

$RFMT $RIREG SCHEME410 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
6-Bromo-4-ethenyl-1,4-dihydro-1-[(4-methylphenyl)sulfonyl]-2H-3,1-benzoxazin-...
C17H14BrNO4S
1675997-20-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 S 6.9300 5.3347 0.0 0 VAL=6
M  V30 2 O 6.9300 3.7947 0.0 0
M  V30 3 O 6.9300 6.8747 0.0 0
M  V30 4 O 5.3900 8.0021 0.0 0
M  V30 5 C 0.7700 5.3347 0.0 0
M  V30 6 C 0.0000 6.6685 0.0 0
M  V30 7 Br 2.3100 0.0000 0.0 0
M  V30 8 C 13.0900 5.3347 0.0 0
M  V30 9 N 5.3900 5.3347 0.0 0
M  V30 10 C 4.6200 4.0011 0.0 0
M  V30 11 C 4.6200 6.6685 0.0 0
M  V30 12 C 3.0800 4.0011 0.0 0
M  V30 13 C 5.3900 2.6674 0.0 0
M  V30 14 O 3.0800 6.6685 0.0 0
M  V30 15 C 2.3100 5.3347 0.0 0
M  V30 16 C 2.3100 2.6674 0.0 0
M  V30 17 C 4.6200 1.3336 0.0 0
M  V30 18 C 3.0800 1.3336 0.0 0
M  V30 19 C 8.4700 5.3347 0.0 0
M  V30 20 C 9.2400 4.0011 0.0 0
M  V30 21 C 9.2400 6.6685 0.0 0
M  V30 22 C 10.7800 4.0011 0.0 0
M  V30 23 C 10.7800 6.6685 0.0 0
M  V30 24 C 11.5500 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 2 1 3
M  V30 3 1 1 9
M  V30 4 1 1 19
M  V30 5 2 4 11
M  V30 6 2 5 6
M  V30 7 1 5 15
M  V30 8 1 7 18
M  V30 9 1 8 24
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 12 1 10 12
M  V30 13 2 10 13
M  V30 14 1 11 14
M  V30 15 1 12 15
M  V30 16 2 12 16
M  V30 17 1 13 17
M  V30 18 1 14 15
M  V30 19 1 16 18
M  V30 20 2 17 18
M  V30 21 2 19 20
M  V30 22 1 19 21
M  V30 23 1 20 22
M  V30 24 2 21 23
M  V30 25 2 22 24
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
N-[4-Bromo-2-[(1S)-1-(1-pyrrolidinyl)-2-propen-1-yl]phenyl]-4-methylbenzenesu...
C20H23BrN2O2S
2112850-35-6 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  26 28 0 0 1
M  V30 BEGIN ATOM
M  V30 1 C 3.9098 5.3347 0.0 0 CFG=2
M  V30 2 C 4.6798 6.6685 0.0 0
M  V30 3 C 3.9098 8.0021 0.0 0
M  V30 4 N 6.9898 5.3347 0.0 0
M  V30 5 S 8.5298 5.3347 0.0 0 VAL=6
M  V30 6 O 8.5298 3.7947 0.0 0
M  V30 7 O 8.5298 6.8747 0.0 0
M  V30 8 Br 3.9098 0.0000 0.0 0
M  V30 9 C 14.6898 5.3347 0.0 0
M  V30 10 C 4.6798 4.0011 0.0 0
M  V30 11 C 6.2198 4.0011 0.0 0
M  V30 12 C 3.9098 2.6674 0.0 0
M  V30 13 C 6.9898 2.6674 0.0 0
M  V30 14 C 4.6798 1.3336 0.0 0
M  V30 15 C 6.2198 1.3336 0.0 0
M  V30 16 N 2.3698 5.3347 0.0 0
M  V30 17 C 1.4645 6.5806 0.0 0
M  V30 18 C 1.4645 4.0889 0.0 0
M  V30 19 C 0.0000 6.1047 0.0 0
M  V30 20 C 0.0000 4.5647 0.0 0
M  V30 21 C 10.0698 5.3347 0.0 0
M  V30 22 C 10.8398 4.0011 0.0 0
M  V30 23 C 10.8398 6.6685 0.0 0
M  V30 24 C 12.3798 4.0011 0.0 0
M  V30 25 C 12.3798 6.6685 0.0 0
M  V30 26 C 13.1498 5.3347 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 10
M  V30 3 1 1 16 CFG=1
M  V30 4 2 2 3
M  V30 5 1 4 5
M  V30 6 1 4 11
M  V30 7 2 5 6
M  V30 8 2 5 7
M  V30 9 1 5 21
M  V30 10 1 8 14
M  V30 11 1 9 26
M  V30 12 2 10 11
M  V30 13 1 10 12
M  V30 14 1 11 13
M  V30 15 2 12 14
M  V30 16 2 13 15
M  V30 17 1 14 15
M  V30 18 1 16 17
M  V30 19 1 16 18
M  V30 20 1 17 19
M  V30 21 1 18 20
M  V30 22 1 19 20
M  V30 23 2 21 22
M  V30 24 1 21 23
M  V30 25 1 22 24
M  V30 26 2 23 25
M  V30 27 2 24 26
M  V30 28 1 25 26
M  V30 END BOND
M  V30 BEGIN COLLECTION
M  V30 MDLV30/STEABS ATOMS=(1 1)
M  V30 END COLLECTION
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1675997-20-2
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 2112850-35-6
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-353-CAS-17553247
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 3
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):CAT(1):CAS_RN
$DATUM 52522-40-4
$DTYPE RXN:VAR(1):CAT(2):CAS_RN
$DATUM 1360145-09-0
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 109-99-9
$DTYPE RXN:VAR(1):NOTES
$DATUM regioselective, stereoselective, branch-selective
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM Hydrogen Bond Direction Enables Palladium-Catalyzed Branch- and
Enantioselective Allylic Aminations and Beyond
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Wang, Ya-Ni; Wang, Bao-Cheng; Zhang, Mao-Mao; Gao, Xiao-Wen; Li,
Tian-Ren; Lu, Liang-Qiu; Xiao, Wen-Jing
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Organic Letters (2017), 19(15), 4094-4097

$RFMT $RIREG SCHEME411 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
tert-Butyl acetoacetate
C8H14O3
1694-31-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 10 0 0 0
M  V30 BEGIN ATOM
M  V30 1 O 2.6675 0.5637 0.0 0
M  V30 2 C 1.3337 1.3337 0.0 0
M  V30 3 C 4.0012 1.3337 0.0 0
M  V30 4 C 0.5637 0.0000 0.0 0
M  V30 5 C 0.0000 2.1037 0.0 0
M  V30 6 C 2.1037 2.6673 0.0 0
M  V30 7 C 5.3348 0.5637 0.0 0
M  V30 8 O 4.0012 2.8737 0.0 0
M  V30 9 C 6.6687 1.3337 0.0 0
M  V30 10 C 8.0023 0.5637 0.0 0
M  V30 11 O 6.6687 2.8737 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 2 5
M  V30 5 1 2 6
M  V30 6 1 3 7
M  V30 7 2 3 8
M  V30 8 1 7 9
M  V30 9 1 9 10
M  V30 10 2 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
1,1-Dimethylethyl (2E)-3-(1-pyrrolidinyl)-2-butenoate
C12H21NO2
155954-17-9 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 2.6218 0.0 0
M  V30 2 C 5.1048 1.8517 0.0 0
M  V30 3 C 3.7711 4.1618 0.0 0
M  V30 4 C 6.4384 2.6218 0.0 0
M  V30 5 O 7.7722 1.8517 0.0 0
M  V30 6 O 6.4384 4.1618 0.0 0
M  V30 7 C 9.1059 2.6218 0.0 0
M  V30 8 C 9.8759 1.2881 0.0 0
M  V30 9 C 10.4396 3.3918 0.0 0
M  V30 10 C 8.3359 3.9554 0.0 0
M  V30 11 N 2.4374 1.8517 0.0 0
M  V30 12 C 2.2763 0.3202 0.0 0
M  V30 13 C 1.0304 2.4782 0.0 0
M  V30 14 C 0.7700 0.0000 0.0 0
M  V30 15 C 0.0000 1.3337 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 3
M  V30 3 1 1 11
M  V30 4 1 2 4
M  V30 5 1 4 5
M  V30 6 2 4 6
M  V30 7 1 5 7
M  V30 8 1 7 8
M  V30 9 1 7 9
M  V30 10 1 7 10
M  V30 11 1 11 12
M  V30 12 1 11 13
M  V30 13 1 12 14
M  V30 14 1 13 15
M  V30 15 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1694-31-1
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 155954-17-9
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-309-CAS-529141
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 108-88-3
$DTYPE RXN:VAR(1):NOTES
$DATUM stereoselective, Dean-Stark trap used
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM New routes towards reutericyclin analogues
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Jones, Raymond C. F.; Bullous, James P.; Law, Carole C. M.; Elsegood,
Mark R. J.
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemical Communications (Cambridge, United Kingdom) (2014), 50(13),
1588-1590

$RFMT $RIREG SCHEME412 STEP1
$RXN



  2  1
$MOL
Pyrrolidine
C4H9N
123-75-1 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  5 5 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 0.0000 0.9052 0.0 0
M  V30 2 C 1.2459 0.0000 0.0 0
M  V30 3 C 0.4759 2.3698 0.0 0
M  V30 4 C 2.4917 0.9052 0.0 0
M  V30 5 N 2.0159 2.3698 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 1 1 3
M  V30 3 1 2 4
M  V30 4 1 3 5
M  V30 5 1 4 5
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
3-Methoxybenzoyl chloride
C8H7ClO2
1711-05-3 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 1.3337 1.5400 0.0 0
M  V30 2 Cl 1.3337 0.0000 0.0 0
M  V30 3 O 0.0000 2.3101 0.0 0
M  V30 4 O 6.6687 1.5400 0.0 0
M  V30 5 C 8.0023 2.3101 0.0 0
M  V30 6 C 2.6675 2.3101 0.0 0
M  V30 7 C 4.0012 1.5400 0.0 0
M  V30 8 C 2.6675 3.8501 0.0 0
M  V30 9 C 5.3348 2.3101 0.0 0
M  V30 10 C 4.0012 4.6201 0.0 0
M  V30 11 C 5.3348 3.8501 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 1 1 2
M  V30 2 2 1 3
M  V30 3 1 1 6
M  V30 4 1 4 5
M  V30 5 1 4 9
M  V30 6 2 6 7
M  V30 7 1 6 8
M  V30 8 1 7 9
M  V30 9 2 8 10
M  V30 10 2 9 11
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
$MOL
(3-Methoxyphenyl)-1-pyrrolidinylmethanone
C12H15NO2
207558-39-2 Copyright (C) 2024 ACS
  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS  15 16 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 3.7711 1.5400 0.0 0
M  V30 2 O 3.7711 0.0000 0.0 0
M  V30 3 O 9.1059 1.5400 0.0 0
M  V30 4 C 10.4396 2.3101 0.0 0
M  V30 5 C 5.1048 2.3101 0.0 0
M  V30 6 C 6.4384 1.5400 0.0 0
M  V30 7 C 5.1048 3.8501 0.0 0
M  V30 8 C 7.7722 2.3101 0.0 0
M  V30 9 C 6.4384 4.6201 0.0 0
M  V30 10 C 7.7722 3.8501 0.0 0
M  V30 11 N 2.4374 2.3101 0.0 0
M  V30 12 C 1.0304 1.6837 0.0 0
M  V30 13 C 2.2763 3.8416 0.0 0
M  V30 14 C 0.0000 2.8281 0.0 0
M  V30 15 C 0.7700 4.1618 0.0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 1 5
M  V30 3 1 1 11
M  V30 4 1 3 4
M  V30 5 1 3 8
M  V30 6 2 5 6
M  V30 7 1 5 7
M  V30 8 1 6 8
M  V30 9 2 7 9
M  V30 10 2 8 10
M  V30 11 1 9 10
M  V30 12 1 11 12
M  V30 13 1 11 13
M  V30 14 1 12 14
M  V30 15 1 13 15
M  V30 16 1 14 15
M  V30 END BOND
M  V30 END CTAB
M  END
$DTYPE RXN:RCT(1):CAS_RN
$DATUM 123-75-1
$DTYPE RXN:RCT(2):CAS_RN
$DATUM 1711-05-3
$DTYPE RXN:PRO(1):CAS_RN
$DATUM 207558-39-2
$DTYPE RXN:VAR(1):CAS_Reaction_Number
$DATUM 31-365-CAS-23188437
$DTYPE RXN:VAR(1):STEPS
$DATUM 1
$DTYPE RXN:VAR(1):STAGES
$DATUM 1
$DTYPE RXN:VAR(1):PRO(1):YIELD
$DATUM 99
$DTYPE RXN:VAR(1):RGT(1):CAS_RN
$DATUM 121-44-8
$DTYPE RXN:VAR(1):SOL(1):CAS_RN
$DATUM 75-09-2
$DTYPE RXN:VAR(1):REFERENCE(1):TITLE
$DATUM A Fast and General Route to Ketones from Amides and Organolithium
Compounds under Aerobic Conditions: Synthetic and Mechanistic Aspects
$DTYPE RXN:VAR(1):REFERENCE(1):AUTHOR
$DATUM Ghinato, Simone; Territo, Davide; Maranzana, Andrea; Capriati, Vito;
Blangetti, Marco; Prandi, Cristina
$DTYPE RXN:VAR(1):REFERENCE(1):CITATION
$DATUM Chemistry - A European Journal (2021), 27(8), 2868-2874

